Citrus Sinensis ID: 019953
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 333 | 2.2.26 [Sep-21-2011] | |||||||
| Q54Y26 | 530 | Probable serine/threonine | yes | no | 0.891 | 0.560 | 0.508 | 1e-82 | |
| Q2LZZ7 | 458 | Serine/threonine-protein | yes | no | 0.870 | 0.633 | 0.521 | 2e-81 | |
| Q9NBK5 | 463 | Serine/threonine-protein | yes | no | 0.906 | 0.652 | 0.501 | 6e-81 | |
| Q5AP53 | 732 | Serine/threonine-protein | N/A | no | 0.924 | 0.420 | 0.478 | 8e-81 | |
| Q6TGC6 | 507 | Serine/threonine-protein | N/A | no | 0.915 | 0.601 | 0.475 | 5e-80 | |
| Q9Y2H1 | 464 | Serine/threonine-protein | yes | no | 0.879 | 0.631 | 0.501 | 2e-79 | |
| Q91VJ4 | 465 | Serine/threonine-protein | yes | no | 0.879 | 0.630 | 0.501 | 3e-79 | |
| Q5R8M1 | 465 | Serine/threonine-protein | yes | no | 0.879 | 0.630 | 0.501 | 3e-79 | |
| Q15208 | 465 | Serine/threonine-protein | no | no | 0.879 | 0.630 | 0.501 | 3e-79 | |
| A2VDV2 | 465 | Serine/threonine-protein | yes | no | 0.879 | 0.630 | 0.501 | 4e-79 |
| >sp|Q54Y26|NDRA_DICDI Probable serine/threonine-protein kinase ndrA OS=Dictyostelium discoideum GN=ndrA PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 306 bits (784), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 156/307 (50%), Positives = 212/307 (69%), Gaps = 10/307 (3%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S+ TM++ AAK +IE +Y ++++ER +RR LE KL + + +E +L K+L++K
Sbjct: 36 SRPTMDRSLAAKMYIEQYYINAQQSVKERGQRRKDLELKLENMKLSSKESNDLRKELDKK 95
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
E+++MR+KR K+ DFE++ IIGRGAFGEV L R ++S ++YAMK+LKKSEM+K+ Q
Sbjct: 96 ESDYMRIKRLKLKRSDFEVIRIIGRGAFGEVSLVRHRESNDLYAMKRLKKSEMLKKEQAA 155
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
HVRAER++LA ++ +VKLYYSFQD YLYLIMEYLPGGDMM+LL++ D TEN ARFY
Sbjct: 156 HVRAERDVLASANTNWVVKLYYSFQDDNYLYLIMEYLPGGDMMSLLIKYDIFTENQARFY 215
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA+++LAIES+H YIHRDIKPDNLLLD GH+KL D GLC L++ ++ +
Sbjct: 216 IAETILAIESVHTLGYIHRDIKPDNLLLDSKGHVKLCDLGLCTGF--HRLHSSEFYQMLV 273
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+ M M + P T E++ W+ RR LA+S VGTPDY APEV L+ G
Sbjct: 274 GDAMTIKMKLIEATPLTQT--------ERIASWKKARRALAYSAVGTPDYTAPEVFLQIG 325
Query: 312 YGMECDW 318
Y E DW
Sbjct: 326 YNKEVDW 332
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2LZZ7|TRC_DROPS Serine/threonine-protein kinase tricorner OS=Drosophila pseudoobscura pseudoobscura GN=trc PE=3 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 160/307 (52%), Positives = 210/307 (68%), Gaps = 17/307 (5%)
Query: 15 TMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLE--RKE 72
T++K AK +EN+Y + ERK+R LE +L D + E K L+ +KE
Sbjct: 19 TLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQL--KDESLTESQRQEKRLQHAQKE 76
Query: 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH 132
TE++RLKR ++ V+DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV H
Sbjct: 77 TEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQVAH 136
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
VRAER++L E +VK+YYSFQD LYLIME+LPGGDMMTLLM++DTL+E +FYI
Sbjct: 137 VRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQFYI 196
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+++ LAI+SIHK +IHRDIKPDNLLLD GH+KLSDFGLC L S H D
Sbjct: 197 SETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKS-----HRTDFYRD 251
Query: 253 ENMAEPMDIDG-CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+ A+P D G C D+K + + W+ NRR LA+STVGTPDYIAPEV L+ G
Sbjct: 252 LSQAKPSDFIGTCASPMDSK-------RRAESWKRNRRALAYSTVGTPDYIAPEVFLQTG 304
Query: 312 YGMECDW 318
YG CDW
Sbjct: 305 YGPACDW 311
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila pseudoobscura pseudoobscura (taxid: 46245) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NBK5|TRC_DROME Serine/threonine-protein kinase tricorner OS=Drosophila melanogaster GN=trc PE=1 SV=1 | Back alignment and function description |
|---|
Score = 301 bits (770), Expect = 6e-81, Method: Compositional matrix adjust.
Identities = 163/325 (50%), Positives = 217/325 (66%), Gaps = 23/325 (7%)
Query: 2 EEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQ 61
++A+ + S T++K AK +EN+Y + ERK+R LE +L D + E
Sbjct: 7 QDADGASIRFSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQL--KDESLSEA 64
Query: 62 INLIKDLE--RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL 119
K L+ +KETE++RLKR ++ V+DFE L +IGRGAFGEVRL ++K +G++YAMK L
Sbjct: 65 QRQEKRLQHAQKETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVL 124
Query: 120 KKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR 179
+K++M+++ QV HVRAER++L E +VK+YYSFQD LYLIME+LPGGDMMTLLM+
Sbjct: 125 RKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLLMK 184
Query: 180 EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
+DTL+E +FYI+++ LAI+SIHK +IHRDIKPDNLLLD GH+KLSDFGLC L S
Sbjct: 185 KDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKS 244
Query: 240 TLYAIHEHKTIDDENMAEPMDIDG------CFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
H D + A+P D G C P D+K + + W+ NRR LA+
Sbjct: 245 -----HRTDFYRDLSQAKPSDFIGTCASLSCSP-MDSK-------RRAESWKRNRRALAY 291
Query: 294 STVGTPDYIAPEVLLKKGYGMECDW 318
STVGTPDYIAPEV L+ GYG CDW
Sbjct: 292 STVGTPDYIAPEVFLQTGYGPACDW 316
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5AP53|CBK1_CANAL Serine/threonine-protein kinase CBK1 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) GN=CBK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 8e-81, Method: Compositional matrix adjust.
Identities = 156/326 (47%), Positives = 222/326 (68%), Gaps = 18/326 (5%)
Query: 5 EEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDV-PMEEQIN 63
E + L SK T +K A+ K +EN+Y + + + ER +RR LE K+A+ D+ EE+ N
Sbjct: 250 ERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIERNQRRLELENKIANEDIGSSEERKN 309
Query: 64 -LIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
+++L +KE++F+RLKR K+ ++DF + +IG+GAFGEVRL ++K +G IYAMK L KS
Sbjct: 310 RQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS 369
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
EM + Q+ HV+AER++LA S IV LYYSFQD++YLYLIME+LPGGD+MT+L+R +
Sbjct: 370 EMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQDSQYLYLIMEFLPGGDLMTMLIRWEV 429
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
TE++ RFYIA+ VLAIE+IHK +IHRDIKPDN+L+D GH+KLSDFGL + +
Sbjct: 430 FTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNILIDNRGHVKLSDFGL-----STGFH 484
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPD--TDNKSS--------WKSPHEQLQHWQMNRRKLA 292
H+ + EP + P+ T ++S S + +Q W+ +RR +A
Sbjct: 485 KTHDSNYYNKLLEKEPSNTH-LQPNQLTSGRNSVMVDAIHLTMSNRQTMQTWRKSRRLMA 543
Query: 293 FSTVGTPDYIAPEVLLKKGYGMECDW 318
+STVGTPDYIAPE+ + +GYG ECDW
Sbjct: 544 YSTVGTPDYIAPEIFIHQGYGQECDW 569
|
Serine/threonine-protein kinase required for wild-type hyphal growth and transcriptional regulation of cell-wall-associated genes. Involved in the biofilm formation through phosphorylation of the master regulator of biofilm formation BCR1. Candida albicans (strain SC5314 / ATCC MYA-2876) (taxid: 237561) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6TGC6|CBK1_PNECA Serine/threonine-protein kinase CBK1 OS=Pneumocystis carinii GN=CBK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (762), Expect = 5e-80, Method: Compositional matrix adjust.
Identities = 146/307 (47%), Positives = 209/307 (68%), Gaps = 2/307 (0%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
+K T E+ A+ K +E+ Y+ ++ ER +RR E KLA E + + L +K
Sbjct: 50 TKTTHERAASVKLKLEHLYKVTVEQTVERNQRRMDFEAKLAQDRGSEERKKRQLNSLGQK 109
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
E++F+RL+R K+ ++DF + +IG+GAFGEVRL ++ +G IYAMK L KSEM K+ Q+
Sbjct: 110 ESQFLRLRRTKLSLNDFHTVKVIGKGAFGEVRLVQKIDTGKIYAMKTLLKSEMFKKDQLA 169
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
HV+AER++LAE S +V LYYSFQD++YLYLIME+LPGGD+MT+L++ DT +E+V RFY
Sbjct: 170 HVKAERDVLAESDSPWVVSLYYSFQDSQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY 229
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA+ +LAIE++HK +IHRDIKPDN+L+DK GH+KLSDFGL + A ++
Sbjct: 230 IAECILAIEAVHKLGFIHRDIKPDNILIDKTGHIKLSDFGLSMGFHKTHDNAYYQRLFES 289
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N + + DT + + S +++ W+ NRR +A+STVGTPDYIAPE+ + G
Sbjct: 290 KINTSTSSTQNSLMVDTISLT--MSSKDKIATWKKNRRIMAYSTVGTPDYIAPEIFTQHG 347
Query: 312 YGMECDW 318
YG ECDW
Sbjct: 348 YGQECDW 354
|
Protein kinase that seems to play a role in signaling pathways necessary for cell growth and mating. Pneumocystis carinii (taxid: 4754) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | Back alignment and function description |
|---|
Score = 295 bits (756), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 154/307 (50%), Positives = 208/307 (67%), Gaps = 14/307 (4%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V AK +EN Y + +ER+ R+ LE + + EE+ RK
Sbjct: 14 SNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHARK 73
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ +DDFE L +IGRGAFGEVRL ++K +G+IYAMK L+KS+M+++ QV
Sbjct: 74 ETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKSDMLEKEQVA 133
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 134 HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 193
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
I+++VLAI++IH+ +IHRDIKPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 194 ISETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA-------HRTEF 246
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ D F + ++K + + W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 YRNLTHNPPSDFSFQNMNSK-------RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG 299
Query: 312 YGMECDW 318
Y CDW
Sbjct: 300 YNKLCDW 306
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91VJ4|STK38_MOUSE Serine/threonine-protein kinase 38 OS=Mus musculus GN=Stk38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 154/307 (50%), Positives = 210/307 (68%), Gaps = 14/307 (4%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V K +EN Y + +ER+ R+ LE+ + + EE+ RK
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ ++DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E S +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA-------HRTEF 245
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ + D F + ++K + + W+ NRR+LAFSTVGTPDYIAPEV ++ G
Sbjct: 246 YRNLNHSLPSDFTFQNMNSK-------RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 312 YGMECDW 318
Y CDW
Sbjct: 299 YNKLCDW 305
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 154/307 (50%), Positives = 210/307 (68%), Gaps = 14/307 (4%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V K +EN Y + +ER+ R+ LE+ + + EE+ RK
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ ++DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E S +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA-------HRTEF 245
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ + D F + ++K + + W+ NRR+LAFSTVGTPDYIAPEV ++ G
Sbjct: 246 YRNLNHSLPSDFTFQNMNSK-------RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 312 YGMECDW 318
Y CDW
Sbjct: 299 YNKLCDW 305
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 154/307 (50%), Positives = 210/307 (68%), Gaps = 14/307 (4%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V K +EN Y + +ER+ R+ LE+ + + EE+ RK
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ ++DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E S +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA-------HRTEF 245
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ + D F + ++K + + W+ NRR+LAFSTVGTPDYIAPEV ++ G
Sbjct: 246 YRNLNHSLPSDFTFQNMNSK-------RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 312 YGMECDW 318
Y CDW
Sbjct: 299 YNKLCDW 305
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 154/307 (50%), Positives = 210/307 (68%), Gaps = 14/307 (4%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T E+V K +EN Y + +ER+ R+ LE+ + + EE+ RK
Sbjct: 13 SSHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETEF+RLKR ++ ++DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
H+RAER++L E S +VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L + H+T
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA-------HRTEF 245
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
N+ + D F + ++K + + W+ NRR+LAFSTVGTPDYIAPEV ++ G
Sbjct: 246 YRNLNHSLPSDFTFQNMNSK-------RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 312 YGMECDW 318
Y CDW
Sbjct: 299 YNKLCDW 305
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 333 | ||||||
| 343887276 | 538 | serine/threonine-protein kinase [Citrus | 0.954 | 0.591 | 1.0 | 0.0 | |
| 255550097 | 623 | serine/threonine-protein kinase, putativ | 0.930 | 0.497 | 0.938 | 1e-172 | |
| 224092142 | 474 | predicted protein [Populus trichocarpa] | 0.927 | 0.651 | 0.935 | 1e-171 | |
| 359476253 | 503 | PREDICTED: serine/threonine-protein kina | 0.954 | 0.632 | 0.905 | 1e-168 | |
| 357465779 | 509 | Serine/threonine protein kinase 38-like | 0.930 | 0.609 | 0.896 | 1e-168 | |
| 356514683 | 503 | PREDICTED: serine/threonine-protein kina | 0.918 | 0.608 | 0.906 | 1e-166 | |
| 356507026 | 503 | PREDICTED: serine/threonine-protein kina | 0.918 | 0.608 | 0.906 | 1e-166 | |
| 297802680 | 519 | hypothetical protein ARALYDRAFT_913113 [ | 0.951 | 0.610 | 0.880 | 1e-164 | |
| 186515794 | 507 | AGC (cAMP-dependent, cGMP-dependent and | 0.951 | 0.625 | 0.873 | 1e-164 | |
| 449486685 | 514 | PREDICTED: serine/threonine-protein kina | 0.912 | 0.591 | 0.909 | 1e-164 |
| >gi|343887276|dbj|BAK61822.1| serine/threonine-protein kinase [Citrus unshiu] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/318 (100%), Positives = 318/318 (100%)
Query: 1 MEEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEE 60
MEEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEE
Sbjct: 1 MEEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEE 60
Query: 61 QINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK 120
QINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK
Sbjct: 61 QINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK 120
Query: 121 KSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE 180
KSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE
Sbjct: 121 KSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE 180
Query: 181 DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST
Sbjct: 181 DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
Query: 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPD 300
LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPD
Sbjct: 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPD 300
Query: 301 YIAPEVLLKKGYGMECDW 318
YIAPEVLLKKGYGMECDW
Sbjct: 301 YIAPEVLLKKGYGMECDW 318
|
Source: Citrus unshiu Species: Citrus unshiu Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550097|ref|XP_002516099.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223544585|gb|EEF46101.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1572), Expect = e-172, Method: Compositional matrix adjust.
Identities = 291/310 (93%), Positives = 298/310 (96%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
VLGS LTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVP EEQI+LIKDL
Sbjct: 13 VLGSSLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPKEEQISLIKDL 72
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM+ RG
Sbjct: 73 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLMRG 132
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGDMMTLLMREDTLTENVA
Sbjct: 133 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMREDTLTENVA 192
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC+TL I E+K
Sbjct: 193 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCTTLSVIPENK 252
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
TIDD+N EPMDIDG PD DNKS+W+SPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 253 TIDDKNSNEPMDIDGGIPDADNKSNWRSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 312
Query: 309 KKGYGMECDW 318
KKGYGMECDW
Sbjct: 313 KKGYGMECDW 322
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224092142|ref|XP_002309485.1| predicted protein [Populus trichocarpa] gi|222855461|gb|EEE93008.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1564), Expect = e-171, Method: Compositional matrix adjust.
Identities = 289/309 (93%), Positives = 298/309 (96%)
Query: 10 LGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLE 69
LGS LTMEKVAAAKQFIENHYRAQMK I+ERKERRWVLERKLASSDVP EEQ+NLIKDLE
Sbjct: 12 LGSSLTMEKVAAAKQFIENHYRAQMKTIKERKERRWVLERKLASSDVPKEEQMNLIKDLE 71
Query: 70 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ 129
RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM+KRGQ
Sbjct: 72 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLKRGQ 131
Query: 130 VEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVAR 189
VEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGDMMTLL+REDTLTENVA+
Sbjct: 132 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLIREDTLTENVAK 191
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
FYIAQS+LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC+TL IHE+KT
Sbjct: 192 FYIAQSILAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCATLSVIHENKT 251
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309
IDDENM EPMDIDG D DNKSSW+SPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK
Sbjct: 252 IDDENMTEPMDIDGGIADADNKSSWRSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 311
Query: 310 KGYGMECDW 318
KGYGMECDW
Sbjct: 312 KGYGMECDW 320
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476253|ref|XP_002280119.2| PREDICTED: serine/threonine-protein kinase CBK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1537), Expect = e-168, Method: Compositional matrix adjust.
Identities = 289/319 (90%), Positives = 298/319 (93%), Gaps = 1/319 (0%)
Query: 1 MEEAE-EEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPME 59
MEE EEEVLGS LTMEKVAAAKQFIENHYR QMK IQERKERRWVLER+LASSDVP E
Sbjct: 1 MEEGSGEEEVLGSSLTMEKVAAAKQFIENHYRTQMKTIQERKERRWVLERRLASSDVPKE 60
Query: 60 EQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL 119
EQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKS NIYAMKKL
Sbjct: 61 EQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSENIYAMKKL 120
Query: 120 KKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR 179
KKSEM+ RGQVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGDMMTLLMR
Sbjct: 121 KKSEMLIRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMR 180
Query: 180 EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
EDTL+E+VA+FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC
Sbjct: 181 EDTLSESVAKFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCR 240
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
TL A+ E + +DDEN E MDIDG FPD DN+SSWKSP EQLQHWQMNRRKLAFSTVGTP
Sbjct: 241 TLSALKEDEVMDDENSRESMDIDGGFPDADNRSSWKSPREQLQHWQMNRRKLAFSTVGTP 300
Query: 300 DYIAPEVLLKKGYGMECDW 318
DYIAPEVLLKKGYGMECDW
Sbjct: 301 DYIAPEVLLKKGYGMECDW 319
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357465779|ref|XP_003603174.1| Serine/threonine protein kinase 38-like protein [Medicago truncatula] gi|355492222|gb|AES73425.1| Serine/threonine protein kinase 38-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1535), Expect = e-168, Method: Compositional matrix adjust.
Identities = 278/310 (89%), Positives = 299/310 (96%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
VLGS LTMEKVAAAK+FIENHYRAQMKNIQ+RKERRWVLERKLA+SDVP EE++NLIKDL
Sbjct: 15 VLGSSLTMEKVAAAKKFIENHYRAQMKNIQDRKERRWVLERKLATSDVPTEERLNLIKDL 74
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETE+MRLKRHKICV+DF+LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM++RG
Sbjct: 75 ERKETEYMRLKRHKICVNDFDLLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLRRG 134
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD+MTLLMREDTL+ENVA
Sbjct: 135 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDIMTLLMREDTLSENVA 194
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
RFY+AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP+DC TL +HE++
Sbjct: 195 RFYMAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPIDCITLPTLHENQ 254
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
T+DDE +AEPMDID C PD DN+ SW+SP EQLQHWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 255 TMDDETLAEPMDIDSCVPDADNRKSWRSPREQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 314
Query: 309 KKGYGMECDW 318
KKGYGMECDW
Sbjct: 315 KKGYGMECDW 324
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514683|ref|XP_003526033.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 591 bits (1523), Expect = e-166, Method: Compositional matrix adjust.
Identities = 281/310 (90%), Positives = 297/310 (95%), Gaps = 4/310 (1%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
VLGS LTMEKVAAAK+FIENHYRAQMKNIQERKERRWVLERKLASSDVP EE+INLIKDL
Sbjct: 14 VLGSSLTMEKVAAAKKFIENHYRAQMKNIQERKERRWVLERKLASSDVPNEERINLIKDL 73
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETE+MRLKRHKICV+DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM++RG
Sbjct: 74 ERKETEYMRLKRHKICVNDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLRRG 133
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGD+MTLLMREDTL+ENVA
Sbjct: 134 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDIMTLLMREDTLSENVA 193
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC+ L +HE++
Sbjct: 194 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCNALSTLHENQ 253
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
TIDDE +AEPMD+D D DN+SSW+SP EQLQHWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 254 TIDDETLAEPMDVD----DADNRSSWRSPREQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 309
Query: 309 KKGYGMECDW 318
KKGYGMECDW
Sbjct: 310 KKGYGMECDW 319
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507026|ref|XP_003522272.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-166, Method: Compositional matrix adjust.
Identities = 281/310 (90%), Positives = 296/310 (95%), Gaps = 4/310 (1%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
VLGS LTMEKVAAAK+FIENHYRAQMKNIQERKERRWVLERKLASSDVP EE+INLIKDL
Sbjct: 14 VLGSSLTMEKVAAAKKFIENHYRAQMKNIQERKERRWVLERKLASSDVPNEERINLIKDL 73
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETE+MRLKRHKICV+DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM++RG
Sbjct: 74 ERKETEYMRLKRHKICVNDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLRRG 133
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGD+MTLLMREDTL+ENVA
Sbjct: 134 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREDTLSENVA 193
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC L +HE++
Sbjct: 194 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCIALSTLHENQ 253
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
TIDDE +AEPMD+D D DN+SSW+SP EQLQHWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 254 TIDDETLAEPMDVD----DADNRSSWRSPREQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 309
Query: 309 KKGYGMECDW 318
KKGYGMECDW
Sbjct: 310 KKGYGMECDW 319
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297802680|ref|XP_002869224.1| hypothetical protein ARALYDRAFT_913113 [Arabidopsis lyrata subsp. lyrata] gi|297315060|gb|EFH45483.1| hypothetical protein ARALYDRAFT_913113 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1507), Expect = e-164, Method: Compositional matrix adjust.
Identities = 279/317 (88%), Positives = 295/317 (93%)
Query: 2 EEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQ 61
E +EEVLGS LTMEKVAAAKQ+IENHYRAQ KNIQERKERRW+LERKLASS VP EEQ
Sbjct: 8 ESGTDEEVLGSSLTMEKVAAAKQYIENHYRAQNKNIQERKERRWILERKLASSGVPKEEQ 67
Query: 62 INLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK 121
I++IKDLERKETEFMRLKR+KI VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK
Sbjct: 68 ISMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK 127
Query: 122 SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED 181
SEMV RGQVEHVRAERNLLAEVASH IVKLYYSFQD EYLYLIMEYLPGGDMMTLLMRED
Sbjct: 128 SEMVMRGQVEHVRAERNLLAEVASHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMRED 187
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
TL E+VARFYIAQSVLAIESIH++NYIHRDIKPDNLLLDK+GHMKLSDFGLCKPLDC L
Sbjct: 188 TLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNL 247
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
+I E++ DDE M+EPMD+D CFPDTDNK SW+SP EQLQHWQMNRRKLAFSTVGTPDY
Sbjct: 248 PSIQENRATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPDY 307
Query: 302 IAPEVLLKKGYGMECDW 318
IAPEVLLKKGYGMECDW
Sbjct: 308 IAPEVLLKKGYGMECDW 324
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186515794|ref|NP_001031780.2| AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein [Arabidopsis thaliana] gi|332660771|gb|AEE86171.1| AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1500), Expect = e-164, Method: Compositional matrix adjust.
Identities = 277/317 (87%), Positives = 294/317 (92%)
Query: 2 EEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQ 61
E +EEVLGS LTMEKVAAAKQ+IENHY+AQ KNIQERKERRW+LERKLASS VP EEQ
Sbjct: 8 ENGTDEEVLGSSLTMEKVAAAKQYIENHYKAQNKNIQERKERRWILERKLASSGVPKEEQ 67
Query: 62 INLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK 121
IN+IKDLERKETEFMRLKR+KI VDDFELLTIIGRGAFGEVRLCRE+KSGNIYAMKKLKK
Sbjct: 68 INMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCRERKSGNIYAMKKLKK 127
Query: 122 SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED 181
SEMV RGQVEHVRAERNLLAEV SH IVKLYYSFQD EYLYLIMEYLPGGDMMTLLMRED
Sbjct: 128 SEMVMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMRED 187
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
TL E+VARFYIAQSVLAIESIH++NYIHRDIKPDNLLLDK+GHMKLSDFGLCKPLDC L
Sbjct: 188 TLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNL 247
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
+I E++ DDE M+EPMD+D CFPDTDNK SW+SP EQLQHWQMNRRKLAFSTVGTPDY
Sbjct: 248 PSIQENRATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPDY 307
Query: 302 IAPEVLLKKGYGMECDW 318
IAPEVLLKKGYGMECDW
Sbjct: 308 IAPEVLLKKGYGMECDW 324
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449486685|ref|XP_004157368.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1500), Expect = e-164, Method: Compositional matrix adjust.
Identities = 282/310 (90%), Positives = 293/310 (94%), Gaps = 6/310 (1%)
Query: 9 VLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDL 68
V GS LTMEKVAAAK+FIENHYRAQMKNIQERKERRW+LERKLASSDVP EEQINLIKDL
Sbjct: 14 VQGSSLTMEKVAAAKKFIENHYRAQMKNIQERKERRWMLERKLASSDVPKEEQINLIKDL 73
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSG+IYAMKKLKKSEM+ RG
Sbjct: 74 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGDIYAMKKLKKSEMLMRG 133
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
QVEHVRAERNLLAEVASHCIVKLYYSFQD EYLYLIMEYLPGGDMMTLLMREDTLTENVA
Sbjct: 134 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMREDTLTENVA 193
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
+FYIAQSVLAIESIH+HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD TL A+HE+K
Sbjct: 194 KFYIAQSVLAIESIHRHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDSLTLSALHENK 253
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
+DDEN+AEPMDID DN+SSWKSP EQL HWQMNRRKLAFSTVGTPDYIAPEVLL
Sbjct: 254 AMDDENLAEPMDID------DNRSSWKSPSEQLHHWQMNRRKLAFSTVGTPDYIAPEVLL 307
Query: 309 KKGYGMECDW 318
KKGYGMECDW
Sbjct: 308 KKGYGMECDW 317
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 333 | ||||||
| TAIR|locus:2125894 | 519 | AT4G33080 [Arabidopsis thalian | 0.951 | 0.610 | 0.873 | 1.1e-149 | |
| TAIR|locus:2047590 | 527 | AT2G19400 [Arabidopsis thalian | 0.951 | 0.601 | 0.749 | 2.6e-130 | |
| TAIR|locus:2090925 | 568 | AT3G23310 [Arabidopsis thalian | 0.915 | 0.536 | 0.705 | 1.3e-114 | |
| TAIR|locus:2129650 | 551 | AT4G14350 [Arabidopsis thalian | 0.909 | 0.549 | 0.714 | 2.8e-114 | |
| TAIR|locus:2054784 | 569 | AT2G20470 [Arabidopsis thalian | 0.912 | 0.534 | 0.683 | 5.9e-112 | |
| TAIR|locus:2024167 | 569 | AT1G03920 [Arabidopsis thalian | 0.894 | 0.523 | 0.700 | 4.2e-111 | |
| TAIR|locus:2178208 | 516 | AT5G09890 [Arabidopsis thalian | 0.933 | 0.602 | 0.632 | 6.5e-106 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.906 | 0.537 | 0.655 | 1.2e-104 | |
| DICTYBASE|DDB_G0278457 | 530 | ndrA "NDR family protein kinas | 0.891 | 0.560 | 0.508 | 6.3e-76 | |
| UNIPROTKB|Q2LZZ7 | 458 | trc "Serine/threonine-protein | 0.870 | 0.633 | 0.521 | 2.1e-75 |
| TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1461 (519.4 bits), Expect = 1.1e-149, P = 1.1e-149
Identities = 277/317 (87%), Positives = 294/317 (92%)
Query: 2 EEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQ 61
E +EEVLGS LTMEKVAAAKQ+IENHY+AQ KNIQERKERRW+LERKLASS VP EEQ
Sbjct: 8 ENGTDEEVLGSSLTMEKVAAAKQYIENHYKAQNKNIQERKERRWILERKLASSGVPKEEQ 67
Query: 62 INLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK 121
IN+IKDLERKETEFMRLKR+KI VDDFELLTIIGRGAFGEVRLCRE+KSGNIYAMKKLKK
Sbjct: 68 INMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCRERKSGNIYAMKKLKK 127
Query: 122 SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED 181
SEMV RGQVEHVRAERNLLAEV SH IVKLYYSFQD EYLYLIMEYLPGGDMMTLLMRED
Sbjct: 128 SEMVMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMRED 187
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
TL E+VARFYIAQSVLAIESIH++NYIHRDIKPDNLLLDK+GHMKLSDFGLCKPLDC L
Sbjct: 188 TLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNL 247
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
+I E++ DDE M+EPMD+D CFPDTDNK SW+SP EQLQHWQMNRRKLAFSTVGTPDY
Sbjct: 248 PSIQENRATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPDY 307
Query: 302 IAPEVLLKKGYGMECDW 318
IAPEVLLKKGYGMECDW
Sbjct: 308 IAPEVLLKKGYGMECDW 324
|
|
| TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1256 (447.2 bits), Expect = 2.6e-130, Sum P(2) = 2.6e-130
Identities = 239/319 (74%), Positives = 280/319 (87%)
Query: 1 MEEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEE 60
+E+ E+E L S T+EKVAAAK++IENHY +M++IQ+RKERRWVLE+K+AS DV +E
Sbjct: 18 VEDNFEDEGLVSNSTLEKVAAAKKYIENHYNRRMRHIQQRKERRWVLEQKIASLDVSEKE 77
Query: 61 QINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK 120
Q+ L++DL+RKETE+ RL R+++CVDDF+LL+IIGRGAFGEVRLCREKK+GNIYAMKKLK
Sbjct: 78 QLELLEDLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEVRLCREKKTGNIYAMKKLK 137
Query: 121 KSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE 180
KSEM+ RGQVEHVRAERNLLAEVAS CIVKLYYSFQD EYLYLIMEYL GGD+MTLLMRE
Sbjct: 138 KSEMLSRGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLYLIMEYLSGGDVMTLLMRE 197
Query: 181 DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
+TLTE VARFYIAQSVLAIESIHKHNY+HRDIKPDNLLLDK GHMKLSDFGLCKPLDC
Sbjct: 198 ETLTETVARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKYGHMKLSDFGLCKPLDCRN 257
Query: 241 LYAIHEHKTIDDENMAEPMDID-GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
+ A++ ++ ++DEN+ E +D D C + WKSP EQLQHWQ+NRRKLA+STVGTP
Sbjct: 258 ISAMNVNEPLNDENINESIDGDENCSIGRRGRR-WKSPLEQLQHWQINRRKLAYSTVGTP 316
Query: 300 DYIAPEVLLKKGYGMECDW 318
DYIAPEVLLKKGYG+ECDW
Sbjct: 317 DYIAPEVLLKKGYGVECDW 335
|
|
| TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1130 (402.8 bits), Expect = 1.3e-114, P = 1.3e-114
Identities = 220/312 (70%), Positives = 263/312 (84%)
Query: 7 EEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIK 66
EE + S +T +K AAAKQ+IENHY+ Q+++ Q+RKERR +LE KLA+++V EEQ NL+K
Sbjct: 40 EEAV-SNVTKQKAAAAKQYIENHYKKQVQSQQQRKERRDMLENKLAAAEVSEEEQKNLLK 98
Query: 67 DLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK 126
DLE+KETE+MR +RHK+ DDFE LT+IG+GAFGEVR+CREK +GN+YAMKKLKKSEM++
Sbjct: 99 DLEKKETEYMRRQRHKMGTDDFEPLTMIGKGAFGEVRICREKTTGNVYAMKKLKKSEMLR 158
Query: 127 RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN 186
RGQVEHV+AERNLLAEV S+CIVKLY SFQD EYLYLIMEYLPGGDMMTLLMR+DTLTE+
Sbjct: 159 RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTED 218
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246
ARFY+ ++VLAIESIHKHNYIHRDIKPDNLLLD++GHMKLSDFGLCKPLDCS L E
Sbjct: 219 EARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRSGHMKLSDFGLCKPLDCSIL---QE 275
Query: 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306
+ N++ + DG P ++ +S EQLQ+WQ NRR LA+STVGTPDYIAPEV
Sbjct: 276 KDFVVAHNLSGALQSDGR-PVAPRRT--RSQMEQLQNWQRNRRMLAYSTVGTPDYIAPEV 332
Query: 307 LLKKGYGMECDW 318
LLKKGYGMECDW
Sbjct: 333 LLKKGYGMECDW 344
|
|
| TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1127 (401.8 bits), Expect = 2.8e-114, P = 2.8e-114
Identities = 223/312 (71%), Positives = 261/312 (83%)
Query: 7 EEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIK 66
EE L S +T EK AAAK +IENHY+ QM+++QERKERR +LE+KLA+++V EEQ NL+K
Sbjct: 39 EEAL-SNITKEKAAAAKLYIENHYKMQMQSLQERKERRKMLEKKLAAAEVSEEEQNNLLK 97
Query: 67 DLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK 126
DLE KETE+MR +RHK+ DDFE LT+IG+GAFGEVR+CREK +GN+YAMKKLKKSEM++
Sbjct: 98 DLEMKETEYMRRQRHKMGADDFEPLTMIGKGAFGEVRICREKGTGNVYAMKKLKKSEMLR 157
Query: 127 RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN 186
RGQVEHV+AERNLLAEV S+CIVKLY SFQD EYLYLIMEYLPGGDMMTLLMR+DTLTE+
Sbjct: 158 RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTED 217
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246
ARFYI ++VLAIESIHKHNYIHRDIKPDNLLLDK+GHMKLSDFGLCKPLDCS L +
Sbjct: 218 EARFYIGETVLAIESIHKHNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCSNLQ--EK 275
Query: 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306
T+ N++ + DG P ++ EQL +WQ NRR LA+STVGTPDYIAPEV
Sbjct: 276 DFTVA-RNVSGALQSDGR-PVATRRTQ----QEQLLNWQRNRRMLAYSTVGTPDYIAPEV 329
Query: 307 LLKKGYGMECDW 318
LLKKGYGMECDW
Sbjct: 330 LLKKGYGMECDW 341
|
|
| TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1105 (394.0 bits), Expect = 5.9e-112, P = 5.9e-112
Identities = 216/316 (68%), Positives = 261/316 (82%)
Query: 3 EAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQI 62
E +EE V S T +KVAAAKQ+IENHY+ QMK +QERKERR +LE+KLA +DV E+Q
Sbjct: 41 ETDEEAV--SNTTKQKVAAAKQYIENHYKEQMKILQERKERRSMLEQKLADADVSEEDQN 98
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
NL+K LE+KETE+MRL+RHK+ V DF+LLT+IG+GAFGEVR+CREK +G +YAMKKLKK+
Sbjct: 99 NLLKFLEKKETEYMRLQRHKLGVADFDLLTMIGKGAFGEVRVCREKTTGQVYAMKKLKKA 158
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
EM++RGQVEHVRAERNLLAEV S+ IVKLY SFQD ++LYL+MEYLPGGDMMTLLMR+DT
Sbjct: 159 EMLRRGQVEHVRAERNLLAEVDSNYIVKLYCSFQDDDHLYLVMEYLPGGDMMTLLMRKDT 218
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
LTE A+FY+A++VLAIESIH+HNYIHRDIKPDNLLLD+ GH++LSDFGLCKPLDCS
Sbjct: 219 LTEEEAKFYVAETVLAIESIHRHNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCS--- 275
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302
AI E+ ++ N + + P ++ EQL+HWQ NRR LA+STVGTPDYI
Sbjct: 276 AIGENDFSNNSNGSTEQEAGSTAPK-------RTQQEQLEHWQRNRRTLAYSTVGTPDYI 328
Query: 303 APEVLLKKGYGMECDW 318
APEVLLKKGYGMECDW
Sbjct: 329 APEVLLKKGYGMECDW 344
|
|
| TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1097 (391.2 bits), Expect = 4.2e-111, P = 4.2e-111
Identities = 215/307 (70%), Positives = 253/307 (82%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T +KVAAAKQ+IENHY+ QMKN+ ERKERR LE+KLA +DV E+Q NL+K LE+K
Sbjct: 61 SNSTKQKVAAAKQYIENHYKEQMKNLNERKERRTTLEKKLADADVCEEDQTNLMKFLEKK 120
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
ETE+MRL+RHK+ DDFELLT+IG+GAFGEVR+ RE +G+++AMKKLKKSEM++RGQVE
Sbjct: 121 ETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVVREINTGHVFAMKKLKKSEMLRRGQVE 180
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
HVRAERNLLAEV S+CIVKLY SFQD EYLYLIMEYLPGGDMMTLLMR+DTL+E+ A+FY
Sbjct: 181 HVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLIMEYLPGGDMMTLLMRKDTLSEDEAKFY 240
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA+SVLAIESIH NYIHRDIKPDNLLLD+ GH++LSDFGLCKPLDCS ID
Sbjct: 241 IAESVLAIESIHNRNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSV---------ID 291
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
E+ G ++ + + +S EQL+HWQ NRR LA+STVGTPDYIAPEVLLKKG
Sbjct: 292 GEDFTVGNAGSGGGSESVSTTPKRSQQEQLEHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 351
Query: 312 YGMECDW 318
YGMECDW
Sbjct: 352 YGMECDW 358
|
|
| TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 6.5e-106, P = 6.5e-106
Identities = 200/316 (63%), Positives = 251/316 (79%)
Query: 3 EAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQI 62
E E + + S +T +K AAAKQFIENHY+ ++ + ER ERR +RK+ + +P+EEQ
Sbjct: 17 ETETDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHERMERRREFQRKVQEAQLPVEEQD 76
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
++++L R+ETE+MRL+R KI +DDFELLT+IG+GAFGEVRLCR + + +YAMKKLKK+
Sbjct: 77 EMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLCRLRSTSEVYAMKKLKKT 136
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
EM+ RGQVEHVR+ERNLLAEV S IVKL+YSFQD+E LYLIMEYLPGGD+MTLLMRED
Sbjct: 137 EMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIMEYLPGGDIMTLLMREDI 196
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
L+E+VARFYIA+S+LAI SIH+HNY+HRDIKPDNL+LDK+GH+KLSDFGLCKPLD
Sbjct: 197 LSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHLKLSDFGLCKPLDDKYSS 256
Query: 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302
+ E DDE +++ + D D K+ W+ P EQL W+ NRR LA+STVGT DY+
Sbjct: 257 LLLE----DDEMLSQDSENQSGKSDAD-KAPWQMPKEQLLQWKRNRRALAYSTVGTLDYM 311
Query: 303 APEVLLKKGYGMECDW 318
APEVLLKKGYGMECDW
Sbjct: 312 APEVLLKKGYGMECDW 327
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
Identities = 202/308 (65%), Positives = 249/308 (80%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S T +KVAAAKQ+IENHY+ Q K++QERKERR +LE+ LA +DV +E++++++K+ E+K
Sbjct: 44 SNATKQKVAAAKQYIENHYKIQKKSLQERKERRSILEQNLADADVTVEDKMDILKNFEKK 103
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
E E+MRL+R K+ VDDFELL+IIGRGAFGEVR+C+EK +G++YAMKKLKKSEM++RGQVE
Sbjct: 104 EMEYMRLQRQKMGVDDFELLSIIGRGAFGEVRICKEKSTGSVYAMKKLKKSEMLRRGQVE 163
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
HV+AERN+LAEV S IVKL YSFQD E+LYLIMEYLPGGDMMTLLMR+DTL E+ RFY
Sbjct: 164 HVKAERNVLAEVDSPFIVKLCYSFQDDEHLYLIMEYLPGGDMMTLLMRKDTLREDETRFY 223
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
+AQ++LAIESIHKHNY+HRDIKPDNLL+ +NGH+KLSDFGL K L+ S + + + +D
Sbjct: 224 VAQTILAIESIHKHNYVHRDIKPDNLLITRNGHIKLSDFGLSKSLE-SKNFPDFKAELVD 282
Query: 252 DENM-AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310
A D P ++ EQL HWQ NRR LAFSTVGTPDYIAPEVLLKK
Sbjct: 283 RSTKPAAEHDRLSKPPSAPRRTQ----QEQLLHWQQNRRTLAFSTVGTPDYIAPEVLLKK 338
Query: 311 GYGMECDW 318
GYGMECDW
Sbjct: 339 GYGMECDW 346
|
|
| DICTYBASE|DDB_G0278457 ndrA "NDR family protein kinase A" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 6.3e-76, P = 6.3e-76
Identities = 156/307 (50%), Positives = 212/307 (69%)
Query: 12 SKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERK 71
S+ TM++ AAK +IE +Y ++++ER +RR LE KL + + +E +L K+L++K
Sbjct: 36 SRPTMDRSLAAKMYIEQYYINAQQSVKERGQRRKDLELKLENMKLSSKESNDLRKELDKK 95
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
E+++MR+KR K+ DFE++ IIGRGAFGEV L R ++S ++YAMK+LKKSEM+K+ Q
Sbjct: 96 ESDYMRIKRLKLKRSDFEVIRIIGRGAFGEVSLVRHRESNDLYAMKRLKKSEMLKKEQAA 155
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
HVRAER++LA ++ +VKLYYSFQD YLYLIMEYLPGGDMM+LL++ D TEN ARFY
Sbjct: 156 HVRAERDVLASANTNWVVKLYYSFQDDNYLYLIMEYLPGGDMMSLLIKYDIFTENQARFY 215
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
IA+++LAIES+H YIHRDIKPDNLLLD GH+KL D GLC L++ ++ +
Sbjct: 216 IAETILAIESVHTLGYIHRDIKPDNLLLDSKGHVKLCDLGLCTGFH--RLHSSEFYQMLV 273
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+ M M + P T E++ W+ RR LA+S VGTPDY APEV L+ G
Sbjct: 274 GDAMTIKMKLIEATPLTQT--------ERIASWKKARRALAYSAVGTPDYTAPEVFLQIG 325
Query: 312 YGMECDW 318
Y E DW
Sbjct: 326 YNKEVDW 332
|
|
| UNIPROTKB|Q2LZZ7 trc "Serine/threonine-protein kinase tricorner" [Drosophila pseudoobscura pseudoobscura (taxid:46245)] | Back alignment and assigned GO terms |
|---|
Score = 760 (272.6 bits), Expect = 2.1e-75, P = 2.1e-75
Identities = 160/307 (52%), Positives = 210/307 (68%)
Query: 15 TMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLE--RKE 72
T++K AK +EN+Y + ERK+R LE +L D + E K L+ +KE
Sbjct: 19 TLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQL--KDESLTESQRQEKRLQHAQKE 76
Query: 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH 132
TE++RLKR ++ V+DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV H
Sbjct: 77 TEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQVAH 136
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
VRAER++L E +VK+YYSFQD LYLIME+LPGGDMMTLLM++DTL+E +FYI
Sbjct: 137 VRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQFYI 196
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+++ LAI+SIHK +IHRDIKPDNLLLD GH+KLSDFGLC L S H D
Sbjct: 197 SETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKS-----HRTDFYRD 251
Query: 253 ENMAEPMDIDG-CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+ A+P D G C D+K + + W+ NRR LA+STVGTPDYIAPEV L+ G
Sbjct: 252 LSQAKPSDFIGTCASPMDSK-------RRAESWKRNRRALAYSTVGTPDYIAPEVFLQTG 304
Query: 312 YGMECDW 318
YG CDW
Sbjct: 305 YGPACDW 311
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9Y2H1 | ST38L_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5016 | 0.8798 | 0.6314 | yes | no |
| Q5R8M1 | STK38_PONAB | 2, ., 7, ., 1, 1, ., 1 | 0.5016 | 0.8798 | 0.6301 | yes | no |
| Q2LZZ7 | TRC_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.5211 | 0.8708 | 0.6331 | yes | no |
| A2VDV2 | STK38_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.5016 | 0.8798 | 0.6301 | yes | no |
| Q91VJ4 | STK38_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5016 | 0.8798 | 0.6301 | yes | no |
| Q9NBK5 | TRC_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.5015 | 0.9069 | 0.6522 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 333 | |||
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-133 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-105 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-99 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-86 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-85 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-79 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-77 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-71 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-71 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-70 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-69 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-69 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-68 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-66 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-63 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-58 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-57 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-57 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-56 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-56 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-54 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-52 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-52 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-51 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-49 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-49 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-48 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-46 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-45 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-45 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-44 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-43 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-43 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-42 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-42 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-42 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-41 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-40 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-39 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-38 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-38 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-38 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-37 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-37 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-36 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-36 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-35 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-35 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-35 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-33 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-33 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-32 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-32 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-32 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-31 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-31 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-30 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-29 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-28 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-27 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-26 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-19 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-13 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 8e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.001 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.001 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.004 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 382 bits (983), Expect = e-133
Identities = 141/233 (60%), Positives = 172/233 (73%), Gaps = 11/233 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE + +IGRGAFGEVRL ++K +G+IYAMKKL+KSEM+++ QV HVRAER++LAE +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+VKLYYSFQD YLYLIMEYLPGGDMMTLLM++DT TE RFYIA+++LAI+SIHK
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
YIHRDIKPDNLLLD GH+KLSDFGLC L S H+T ++ + F
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS-------HRTEFYRILSH--ALPSNF 171
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
D +K S + + W+ NRR LA+STVGTPDYIAPEV L+ GY ECDW
Sbjct: 172 LDFISKP--MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 310 bits (797), Expect = e-105
Identities = 125/233 (53%), Positives = 161/233 (69%), Gaps = 20/233 (8%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE++ +IGRGAFGEV L R+K +G +YAMK L+KS+M+KR Q+ HVRAER++LA+ S
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IVKLYYSFQD E+LYL+MEY+PGGD+M LL+R+D E ARFYIA+ VLA++S+HK
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+IHRDIKPDN+L+D +GH+KL+DFGLCK +++ K +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK--------KMNKAKDREYYLNDSHNL----- 167
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
DN + H+Q RR A STVGTPDYIAPEVL YG+ECDW
Sbjct: 168 LFRDNVLVRRRDHKQ-------RRVRANSTVGTPDYIAPEVLRGTPYGLECDW 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 297 bits (761), Expect = 4e-99
Identities = 128/241 (53%), Positives = 171/241 (70%), Gaps = 18/241 (7%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DF + +IG+GAFGEVRL ++K +G IYAMK L KSEM K+ Q+ HV+AER++LAE S
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+V LYYSFQD +YLYLIME+LPGGD+MT+L++ DT +E+V RFY+A+ VLAIE++HK
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+IHRDIKPDN+L+D+ GH+KLSDFGL ST + HK D + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGL------STGF----HKQHDSAYYQKLLQGKSNK 170
Query: 266 PDTDNKSSWK--------SPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
DN++S S +Q+ W+ NRR +A+STVGTPDYIAPE+ L++GYG ECD
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230
Query: 318 W 318
W
Sbjct: 231 W 231
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 263 bits (674), Expect = 3e-86
Identities = 127/233 (54%), Positives = 168/233 (72%), Gaps = 14/233 (6%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE L +IGRGAFGEVRL ++K +G+IYAMK L+K++M+++ QV H+RAER++L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+VK++YSFQD LYLIME+LPGGDMMTLLM++DTL+E +FYIA++VLAI++IH+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+IHRDIKPDNLLLD GH+KLSDFGLC L H+T N+ D F
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK-------KAHRTEFYRNLTHNPPSDFSF 173
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ ++K + + W+ NRR+LA+STVGTPDYIAPEV ++ GY CDW
Sbjct: 174 QNMNSK-------RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDW 219
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 2e-85
Identities = 129/233 (55%), Positives = 170/233 (72%), Gaps = 14/233 (6%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DFE L +IGRGAFGEVRL ++K +G++YAMK L+K++M+++ QV H+RAER++L E S
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+VK++YSFQD LYLIME+LPGGDMMTLLM++DTLTE +FYIA++VLAI+SIH+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+IHRDIKPDNLLLD GH+KLSDFGLC L H+T N+ + D F
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK-------KAHRTEFYRNLNHSLPSDFTF 173
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ ++K + + W+ NRR+LAFSTVGTPDYIAPEV ++ GY CDW
Sbjct: 174 QNMNSK-------RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDW 219
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 2e-79
Identities = 114/235 (48%), Positives = 153/235 (65%), Gaps = 14/235 (5%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F + IG GAFGEV L R+ + +YAMK L+K++++ R Q HV+AER++LAE +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+VKLYYSFQD + LY +M+Y+PGGDMM+LL+R E++ARFYIA+ AIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC---STLYAIHEHKTIDD-ENMAEPMDIDG 263
IHRDIKPDN+L+D++GH+KL+DFGLC S Y +H D E E +ID
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
C P E+ + ++R LA S VGTP+YIAPEVLL+ GY CDW
Sbjct: 183 CRL---------KPLERR-RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 2e-77
Identities = 89/225 (39%), Positives = 126/225 (56%), Gaps = 49/225 (21%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G+FG+V L R+K +G +YAMK LKK +++KR +VEH ERN+L+ + IVKL+Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
+FQ E LYL++EY PGG++ + L +E +E ARFY A+ VLA+E +H I+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P+N+LLD +GH+KL+DFGL K L
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL------------------------------------- 143
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ + GTP+Y+APEVLL KGYG DW
Sbjct: 144 ------------SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 2e-71
Identities = 93/225 (41%), Positives = 136/225 (60%), Gaps = 41/225 (18%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
I +GA+G V L ++K +G+IYA+K +KK++M+++ QV+ V ER++L++ S +VKLYY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
SFQ + LYL+MEYLPGGD+ +LL +L E+VAR YIA+ VLA+E +H + IHRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
PDN+L+D NGH+KL+DFGL S + + ++D+ D +
Sbjct: 121 PDNILIDSNGHLKLTDFGL------SKVGLVRRQINLNDDE------------KEDKR-- 160
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
VGTPDYIAPEV+L +G+ DW
Sbjct: 161 ---------------------IVGTPDYIAPEVILGQGHSKTVDW 184
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 8e-71
Identities = 88/233 (37%), Positives = 124/233 (53%), Gaps = 52/233 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE + +G G+FG V L R K SG YA+K L K+++VK QVEHV E+ +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+V LY SFQD LYL+MEY+PGG++ + L + E VARFY AQ VLA+E +H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+ ++RD+KP+NLLLD +G++K++DFG K + T
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT------------------------- 155
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
++ GTP+Y+APE++L KGYG DW
Sbjct: 156 ---------------------------YTLCGTPEYLAPEIILSKGYGKAVDW 181
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 2e-70
Identities = 109/232 (46%), Positives = 156/232 (67%), Gaps = 4/232 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F + +G GAFGEV L + + +YAMK L+K +++ R QV HV+AER++LAE +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+VKLYYSFQD + LY +M+Y+PGGDMM+LL+R + E +ARFYIA+ LAIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRDIKPDN+L+D +GH+KL+DFGLC + ++ + ++ EP D+ + D
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL---WDD 179
Query: 268 TDN-KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
N + + + + + ++R LA S VGTP+YIAPEVLL+KGY CDW
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 6e-69
Identities = 111/235 (47%), Positives = 153/235 (65%), Gaps = 10/235 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F + +G GAFGEV L R+ + +YAMK L+K +++ R QV HV+AER++LAE +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+V+LYYSFQD + LY +M+Y+PGGDMM+LL+R E++ARFYIA+ A+ES+HK +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID--DENMAEPMDIDGCF 265
IHRDIKPDN+L+D++GH+KL+DFGL C+ H+ K D + MD +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL-----CTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 266 PDTDNKSSWK--SPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
D N P E+ Q ++R LA S VGTP+YIAPEVLL+ GY CDW
Sbjct: 178 GDPANCRCGDRLKPLERRAARQ-HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 7e-69
Identities = 81/231 (35%), Positives = 124/231 (53%), Gaps = 52/231 (22%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E+L +G G+FG+V L R+KK+G + A+K +KK ++ K E + E +L ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IV+LY F+D + LYL+MEY GGD+ LL + L+E+ ARFY+ Q + A+E +H
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
+HRD+KP+N+LLD++GH+KL+DFGL +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------------------- 145
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
Q++ + + VGTP+Y+APEVLL KGYG D
Sbjct: 146 -----------------QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 3e-68
Identities = 106/255 (41%), Positives = 146/255 (57%), Gaps = 53/255 (20%)
Query: 68 LERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR 127
L R E ++ + ++ +DF+++ +IGRGAFGEV+L R K S +YAMK L K EM+KR
Sbjct: 25 LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR 84
Query: 128 GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
ER+++A S IV+L+Y+FQD +YLY++MEY+PGGD++ L+ D + E
Sbjct: 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKW 143
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
ARFY A+ VLA+++IH +IHRD+KPDN+LLDK+GH+KL+DFG C
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM------------- 190
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
MD +G M R A VGTPDYI+PEVL
Sbjct: 191 ----------KMDANG----------------------MVRCDTA---VGTPDYISPEVL 215
Query: 308 LKKG----YGMECDW 318
+G YG ECDW
Sbjct: 216 KSQGGDGYYGRECDW 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 1e-66
Identities = 103/239 (43%), Positives = 136/239 (56%), Gaps = 54/239 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE+L +IGRGAFGEV + + K +G +YAMK L K EM+KR + R ER++L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
I L+Y+FQD LYL+M+Y GGD++TLL + ED L E++ARFY+A+ VLAI+S+H+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
Y+HRDIKPDN+LLDKNGH++L+DFG C L
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL--------------------------- 153
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDW 318
D +S+ VGTPDYI+PE+L K YG ECDW
Sbjct: 154 -ADGTVQSN--------------------VAVGTPDYISPEILQAMEDGKGRYGPECDW 191
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-63
Identities = 96/240 (40%), Positives = 136/240 (56%), Gaps = 55/240 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DF++ +++GRG FGEV++ REK +G+IYAMK +KKS ++ + V ER++L+ S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
I +L Y+FQD + LYL+MEY PGGD+++LL R ED E++A+FY+A+ VLAI S+H+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
Y+HRDIKP+N+L+D+ GH+KL+DFG L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------KKGYGMECDW 318
N+ + VGTPDYIAPEVL K YG+ECDW
Sbjct: 154 ---------------------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-58
Identities = 83/234 (35%), Positives = 129/234 (55%), Gaps = 30/234 (12%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDF+ IIG G+F V L +EK++ YA+K L K +++K +V++V+ E+ +L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
H I+KLYY+FQD E LY ++EY P G+++ + + +L E RFY A+ +LA+E +H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
IHRD+KP+N+LLDK+ H+K++DFG K L D + E D
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVL--------------DPNSSPESNKGDAT 166
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
D+ + RR +F VGT +Y++PE+L +K G D
Sbjct: 167 NIDSQIEK-------------NRRRFASF--VGTAEYVSPELLNEKPAGKSSDL 205
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 1e-57
Identities = 105/239 (43%), Positives = 137/239 (57%), Gaps = 54/239 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE++ +IGRGAFGEV + + K + IYAMK L K EM+KR + R ERN+L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
I L+Y+FQD YLYL+M+Y GGD++TLL + ED L E++ARFYIA+ VLAI SIH+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+Y+HRDIKPDN+LLD NGH++L+DFG C M+ DG
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCL-----------------------KMNQDGT 157
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL--LKKG---YGMECDW 318
+ VGTPDYI+PE+L ++ G YG ECDW
Sbjct: 158 VQSS-------------------------VAVGTPDYISPEILQAMEDGMGKYGPECDW 191
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 3e-57
Identities = 75/148 (50%), Positives = 109/148 (73%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DF++LT +G+G +G+V L ++K +G I A+K++KKS + K +V HV ER++L S
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
+VKL Y+FQD EYLYL MEY+PGGD TLL L+E+ ARFY+A+ A++++H+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
YIHRD+KP+N L+D +GH+KL+DFGL K
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 2e-56
Identities = 106/264 (40%), Positives = 146/264 (55%), Gaps = 66/264 (25%)
Query: 59 EEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKK 118
++ IN I+DL K +D+E++ +IGRGAFGEV+L R K + +YAMK
Sbjct: 29 KDTINKIRDLRMK-------------AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 75
Query: 119 LKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM 178
L K EM+KR ER+++A S +V+L+Y+FQD YLY++MEY+PGGD++ L+
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 135
Query: 179 REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238
D + E ARFY A+ VLA+++IH +IHRD+KPDN+LLDK+GH+KL+DFG C
Sbjct: 136 NYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---- 190
Query: 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGT 298
M+ +G M R A VGT
Sbjct: 191 -------------------KMNKEG----------------------MVRCDTA---VGT 206
Query: 299 PDYIAPEVLLKKG----YGMECDW 318
PDYI+PEVL +G YG ECDW
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDW 230
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 3e-56
Identities = 77/225 (34%), Positives = 113/225 (50%), Gaps = 50/225 (22%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G FG V L + K +A+K +KK +V+ GQ EH+ +E+ +L E IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
+F+D +Y+Y++MEY GG++ T+L E ARFYIA VLA E +H I+RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P+NLLLD NG++KL DFG K
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK--------------------------------------- 141
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
++ + ++ GTP+Y+APE++L KGY D+
Sbjct: 142 -----------KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 8e-54
Identities = 104/269 (38%), Positives = 151/269 (56%), Gaps = 54/269 (20%)
Query: 55 DVP-MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNI 113
D P + + N+ L R E ++++ ++ +D++++ +IGRGAFGEV+L R K S +
Sbjct: 11 DFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV 70
Query: 114 YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173
YAMK L K EM+KR ER+++A S +V+L+ +FQD +YLY++MEY+PGGD+
Sbjct: 71 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL 130
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
+ L+ D + E A+FY A+ VLA+++IH IHRD+KPDN+LLDK+GH+KL+DFG C
Sbjct: 131 VNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC 189
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
+ D+ M C DT
Sbjct: 190 MKM--------------DETGMVR------C--DT------------------------- 202
Query: 294 STVGTPDYIAPEVLLKKG----YGMECDW 318
VGTPDYI+PEVL +G YG ECDW
Sbjct: 203 -AVGTPDYISPEVLKSQGGDGYYGRECDW 230
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-53
Identities = 79/231 (34%), Positives = 121/231 (52%), Gaps = 50/231 (21%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
FELL +IG+GAFG+V + +++ + ++AMK + K + V++G V +V ER +L E+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+V L+YSFQD E +YL+++ L GGD+ L ++ +E +F+I + VLA+E +H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRDIKPDN+LLD+ GH+ ++DF + A
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNI----------ATKVTP------------------- 152
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
L ST GTP Y+APEVL ++GY + DW
Sbjct: 153 ---------------------DTLTTSTSGTPGYMAPEVLCRQGYSVAVDW 182
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-52
Identities = 77/232 (33%), Positives = 110/232 (47%), Gaps = 51/232 (21%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ELL +G G+FG V + K +G I A+K LKK + R E +L ++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IV+L +F+D ++LYL+MEY GGD+ L R L+E+ A+ Q + +E +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
IHRD+KP+N+LLD+NG +K++DFGL K L S T
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS----SSSLTTF----------------- 158
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDW 318
VGTP Y+APEVLL GYG + D
Sbjct: 159 ----------------------------VGTPWYMAPEVLLGGNGYGPKVDV 182
|
Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 82/242 (33%), Positives = 122/242 (50%), Gaps = 36/242 (14%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F+ + ++G+G G V L R K +G ++A+K L K EM+KR +V+ V E+ +LA +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIH 203
+ LY SFQ YL L+M+Y PGG++ LL R+ L+E VARFY A+ +LA+E +H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
++RD+KP+N+LL ++GH+ LSDF L K D P+
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP----------------PPV---- 160
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST-------VGTPDYIAPEVLLKKGYGMEC 316
S S + + VGT +YIAPEV+ G+G
Sbjct: 161 -SKALRKGSRRSSVNSIP------SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV 213
Query: 317 DW 318
DW
Sbjct: 214 DW 215
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 4e-52
Identities = 98/239 (41%), Positives = 136/239 (56%), Gaps = 54/239 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DFE+L +IGRGAFGEV + + K + ++AMK L K EM+KR + R ER++L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
I L+Y+FQD LYL+M+Y GGD++TLL + ED L E++ARFY+A+ V+AI+S+H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+Y+HRDIKPDN+L+D NGH++L+DFG C L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---------------------------- 152
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECDW 318
D +SS VGTPDYI+PE+L K YG ECDW
Sbjct: 153 MEDGTVQSS--------------------VAVGTPDYISPEILQAMEDGKGKYGPECDW 191
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 1e-51
Identities = 84/226 (37%), Positives = 118/226 (52%), Gaps = 54/226 (23%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER-NLLAEVASHCIVKLY 152
I +GAFG V L +++ +G+ +A+K LKKS+M+ + QV +V+AER ++ + S + KLY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
YSFQ +YLYL+MEYL GGD +L+ L E+ A+ YIA+ VL +E +H+ IHRDI
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
KP+NLL+D+ GH+KL+DFGL N E G
Sbjct: 124 KPENLLIDQTGHLKLTDFGL-------------------SRNGLENKKFVG--------- 155
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
TPDY+APE +L G DW
Sbjct: 156 -------------------------TPDYLAPETILGVGDDKMSDW 176
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-49
Identities = 72/233 (30%), Positives = 117/233 (50%), Gaps = 52/233 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DD E + +G G FG V L R++ S + YA+K + E+++ Q +HV E+ +L EV+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I++L+++ D +LY++MEY+PGG++ + L + + FY ++ V A+E +H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
++RD+KP+N+LLDK GH+KL+DFG K K D
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-------------KLRD-------------- 153
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ W + GTP+Y+APEV+ KG+ DW
Sbjct: 154 ----------------RTWTL---------CGTPEYLAPEVIQSKGHNKAVDW 181
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 83/233 (35%), Positives = 128/233 (54%), Gaps = 34/233 (14%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DFE + +I GA+G V L R K++ +AMKK+ K ++ R Q++ V ER++L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+V ++ SF+ +L ++MEY+ GGD TLL L ++AR Y A++VLA+E +H +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
+HRD+KPDNLL+ GH+KL+DFGL K S ++E +++ E +D C
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH--IEKDTREFLDKQVC- 177
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP+YIAPEV+L++GYG DW
Sbjct: 178 -------------------------------GTPEYIAPEVILRQGYGKPVDW 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 69/150 (46%), Positives = 102/150 (68%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+++F ++ I RGAFG+V L R+K + +YA+K +KK++M+ + V V+AER+ LA
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
S IV LYYS Q +YL+MEYL GGD+ +LL E +A YI++ LA++ +H+
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
H IHRD+KPDN+L+ GH+KL+DFGL K
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 6e-46
Identities = 81/236 (34%), Positives = 122/236 (51%), Gaps = 52/236 (22%)
Query: 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVK 150
+IG+G+FG+V L + K G YA+K L+K ++K+ + +H+ AERN+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L+YSFQ + LY +++Y+ GG++ L RE + E ARFY A+ A+ +H N I+R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
D+KP+N+LLD GH+ L+DFGLCK E +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK------------------EGIE-------------- 148
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW--LVSVLH 324
K + GTP+Y+APEVL K+ Y DW L +VL+
Sbjct: 149 -----------------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 82/232 (35%), Positives = 121/232 (52%), Gaps = 53/232 (22%)
Query: 91 LTIIGRGAFGEVRLCR---EKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEVASH 146
L ++G+G +G+V R +G I+AMK LKK+ +V+ + H +AERN+L V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IV L Y+FQ LYLI+EYL GG++ L RE E+ A FY+++ LA+E +H+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
I+RD+KP+N+LLD GH+KL+DFGLCK +IHE
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKE-------SIHE-------------------- 153
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ H + GT +Y+APE+L++ G+G DW
Sbjct: 154 ------------GTVTH----------TFCGTIEYMAPEILMRSGHGKAVDW 183
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 84/237 (35%), Positives = 119/237 (50%), Gaps = 54/237 (22%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVK 150
IG+G FG+V R+K + IYAMK L K E+V + +V H ERN+L S IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L +SFQ LYL+ +Y+ GG++ L +E +E+ A+FYIA+ VLA+E +HK++ ++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
D+KP+N+LLD GH+ L DFGL K
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA----------------------------------- 145
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD-WLVSVLHF 325
+ K + GT +Y+APEVLL +KGY D W + VL F
Sbjct: 146 --------------NLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVF 188
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-44
Identities = 82/225 (36%), Positives = 120/225 (53%), Gaps = 49/225 (21%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+G+FG+V R++ + IYA+K ++K+ +V R +V H AER +LA+V IV L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
SFQ E LYL++ ++ GG++ L RE + ARFY A+ + A+E++HK N I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P+N+LLD GH+ L DFGLCK NM D D ++
Sbjct: 121 PENILLDYQGHIALCDFGLCK------------------LNMK----------DDDKTNT 152
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTP+Y+APE+LL GY DW
Sbjct: 153 F---------------------CGTPEYLAPELLLGHGYTKAVDW 176
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 3e-44
Identities = 65/148 (43%), Positives = 100/148 (67%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DFE+ +G G+FG VR+ + K +G YA+K LKK E++K QV+HV E+++L E++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IV + SFQD +Y ++E++ GG++ T L + +VA+FY A+ VLA E +H +
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
I+RD+KP+NLLLD GH+K++DFG K
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 4e-43
Identities = 75/227 (33%), Positives = 107/227 (47%), Gaps = 54/227 (23%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G FG V L R+KK+G A+K +KK + +E + E +L ++ IVKLY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
F+D +LYL+MEY GG + LL E L+E+ + Q + +E +H + IHRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 213 KPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
KP+N+LLD NG +KL+DFGL K L
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLT---------------------------------- 144
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD 317
+ + L + VGTP Y+APEVLL K Y + D
Sbjct: 145 ---------------SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 8e-43
Identities = 77/235 (32%), Positives = 116/235 (49%), Gaps = 55/235 (23%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL--AEVAS 145
F L ++GRG FG+V L KK+G +YA+K LKK +++ R +VE + E+ + A
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
H +V L+ FQ +++ +MEY GGD+M + + D +E A FY A VL ++ +H+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+ ++RD+K DNLLLD G +K++DFGLCK E M
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK------------------EGM--------- 152
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFST-VGTPDYIAPEVLLKKGYGMECDW 318
+R ST GTP+++APEVL + Y DW
Sbjct: 153 -------------------GFGDRT----STFCGTPEFLAPEVLTETSYTRAVDW 184
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 84/231 (36%), Positives = 127/231 (54%), Gaps = 53/231 (22%)
Query: 91 LTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
L ++G+G+FG+V L R+ +G +YAMK LKK+ + R +V + ER++LAEV
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IVKL+Y+FQ LYLI+++L GGD+ T L +E TE +FY+A+ LA++ +H
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
I+RD+KP+N+LLD+ GH+KL+DFGL K ++ID E
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK-------------ESIDHE-------------- 152
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
K A+S GT +Y+APEV+ ++G+ DW
Sbjct: 153 ----------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADW 181
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 4e-42
Identities = 73/227 (32%), Positives = 112/227 (49%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K + +YA+K LKK +++ VE E+ +LA H + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ FQ + L+ +MEY+ GGD+M + R E ARFY A+ VL ++ +H+ I+RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD GH+K++DFG+CK E +
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCK------------------EGILG-----------GVT 152
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+S + GTPDYIAPE+L + YG DW
Sbjct: 153 TS--------------------TFCGTPDYIAPEILSYQPYGPAVDW 179
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 7e-42
Identities = 82/227 (36%), Positives = 118/227 (51%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IG+G+FG+V L + K G+ YA+K L+K ++K+ + H+ AERN+L + H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+YSFQ E LY +++Y+ GG++ L RE E ARFY A+ AI +H N I+RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+KP+N+LLD GH+ L+DFGLCK E + EP + F
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK------------------EGV-EPEETTSTF------ 156
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP+Y+APEVL K+ Y DW
Sbjct: 157 ------------------------CGTPEYLAPEVLRKEPYDRTVDW 179
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-41
Identities = 68/153 (44%), Positives = 101/153 (66%), Gaps = 5/153 (3%)
Query: 87 DFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMV-KRGQVEHVRAERNLLAE 142
+FELL ++G GA+G+V L R+ +G +YAMK LKK+ +V K EH R ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 143 V-ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
V +V L+Y+FQ L+LI++Y+ GG++ T L + + TE+ R YIA+ VLA++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+H+ I+RDIK +N+LLD GH+ L+DFGL K
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 61/142 (42%), Positives = 91/142 (64%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++G+G FG+V L REK +G YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
YSFQ + L +MEY GG++ L RE +E+ ARFY A+ V A+ +H + ++RD+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 213 KPDNLLLDKNGHMKLSDFGLCK 234
K +NL+LDK+GH+K++DFGLCK
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 73/227 (32%), Positives = 109/227 (48%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K + +YA+K LKK +++ V+ E+ +LA A H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ FQ + L+ +MEY+ GGD+M + R E +RFY A+ LA+ +H+H I+RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD GH KL+DFG+CK E +
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCK------------------EGILN-------------- 149
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTPDYIAPE+L + YG DW
Sbjct: 150 -----------------GVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 1e-39
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 51/229 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++GRG+FG V L +K +G + A+K ++ S + ++E + E +L+ + IV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65
Query: 153 YSFQDTE--YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
S +D E L + +EY+ GG + +LL + L E V R Y Q + + +H + +HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
DIK N+L+D +G +KL+DFG K I+ +
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAK-----------RLGDIETGEGTGSV----------- 163
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
GTP ++APEV+ + YG D W
Sbjct: 164 -------------------------RGTPYWMAPEVIRGEEYGRAADIW 187
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 83/238 (34%), Positives = 129/238 (54%), Gaps = 54/238 (22%)
Query: 87 DFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAE 142
+FELL ++G GA+G+V L R+ +G +YAMK L+K+ +V++ + VEH R ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 143 V-ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
V S +V L+Y+FQ L+LI++Y+ GG+M T L + D +E+ RFY + +LA+E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+HK ++RDIK +N+LLD GH+ L+DFGL K E ++E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK------------------EFLSE---- 158
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECDW 318
++ +S GT +Y+APE++ K G+G DW
Sbjct: 159 --------------------------EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDW 190
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 79/242 (32%), Positives = 122/242 (50%), Gaps = 55/242 (22%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNI--YAMKKLKKSEMVKRGQVEHVRAE 136
+++K+ +DF + +G G+FG V L K+ + A+K+ +KS+++K+ QV+HV +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 137 RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
R +L + V LY SF+D YLYL++E++ GG+ T L R +V FY AQ V
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
L E + N ++RD+KP+NLLLDK+G +K++DFG K +D T
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT---------------- 185
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316
++ GTP+YIAPE+LL G+G
Sbjct: 186 ------------------------------------YTLCGTPEYIAPEILLNVGHGKAA 209
Query: 317 DW 318
DW
Sbjct: 210 DW 211
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-38
Identities = 77/227 (33%), Positives = 116/227 (51%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IG+G+FG+V L R K YA+K L+K ++K+ + +H+ +ERN+L + H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
++SFQ + LY +++Y+ GG++ L RE E ARFY A+ A+ +H N ++RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+KP+N+LLD GH+ L+DFGLCK EN+ E F
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK------------------ENI-EHNGTTSTF------ 156
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP+Y+APEVL K+ Y DW
Sbjct: 157 ------------------------CGTPEYLAPEVLHKQPYDRTVDW 179
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 71/233 (30%), Positives = 111/233 (47%), Gaps = 50/233 (21%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA-EVAS 145
DF L ++G+G+FG+V L K + +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
I+RD+K DN++LD GH+K++DFG+CK EN+ F
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK------------------ENI---------F 153
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ + GTPDYIAPE++ + YG DW
Sbjct: 154 GGKTTR----------------------TFCGTPDYIAPEIIAYQPYGKSVDW 184
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 54/231 (23%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+E++ IG+G+FG+V L R K G +Y +K++ S M + E E +L ++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL----MREDTLTENVARFYIAQSVLAIESI 202
I+K Y SF++ L ++MEY GGD+ + E + Q LA++ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H +HRDIKP N+ L NG +KL DFG+ K L + A KT+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA----KTV------------ 163
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313
VGTP Y++PE+ K Y
Sbjct: 164 ---------------------------------VGTPYYLSPELCQNKPYN 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 74/227 (32%), Positives = 110/227 (48%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K + +A+K LKK +++ VE ER +LA H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ +FQ E+L+ +MEYL GGD+M + E ARFY A+ + ++ +HK I+RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLDK+GH+K++DFG+CK
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKE------------------------------------ 145
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
MN A + GTPDYIAPE+L + Y DW
Sbjct: 146 -------------NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 79/235 (33%), Positives = 121/235 (51%), Gaps = 52/235 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IG+G+FG+V L + K G YA+K L+K ++ R + +H+ AERN+L + H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+YSFQ TE LY +++++ GG++ L RE + E ARFY A+ A+ +H N ++RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+KP+N+LLD GH+ L+DFGL C A + T
Sbjct: 122 LKPENILLDSQGHVVLTDFGL-----CKEGIAQSDTTT---------------------- 154
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW--LVSVLH 324
+ GTP+Y+APEV+ K+ Y DW L +VL+
Sbjct: 155 ----------------------TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLY 187
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-36
Identities = 70/238 (29%), Positives = 106/238 (44%), Gaps = 63/238 (26%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
FE+L IG+G FGEV R K++G A+K +K K+ E + E +L +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTE-NVARFYIAQSVL-AIES 201
IVK Y S+ + L+++ME+ GG D++ + TLTE +A Y+ + +L +E
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIA--YVCKELLKGLEY 113
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H + IHRDIK N+LL +G +KL DFGL
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA--------------------------- 146
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
Q++ K + VGTP ++APEV+ K Y + D W
Sbjct: 147 -----------------------QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIW 181
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 75/227 (33%), Positives = 111/227 (48%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L R K+SG +YA+K LKK +++ VE E+ +L+ +H + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
Y FQ + L+ +ME++ GGD+M + + E ARFY A+ A+ +H I+RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD GH KL+DFG+CK I KT
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKE-------GIFNGKTTS-------------------- 154
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTPDYIAPE+L + YG DW
Sbjct: 155 ----------------------TFCGTPDYIAPEILQEMLYGPSVDW 179
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-35
Identities = 67/153 (43%), Positives = 101/153 (66%), Gaps = 5/153 (3%)
Query: 87 DFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQV-EHVRAERNLLAE 142
+FELL ++G GA+G+V L R+ SG +YAMK LKK+ +V++ + EH R ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 143 V-ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ S +V L+Y+FQ L+LI++Y+ GG++ T L + + E + Y + VLA+E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+HK I+RDIK +N+LLD NGH+ L+DFGL K
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 73/228 (32%), Positives = 113/228 (49%), Gaps = 50/228 (21%)
Query: 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVK 150
+IGRG++ +V L KK+ IYAMK +KK + ++ V+ E+++ ++H +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L+ FQ L+ ++E++ GGD+M + R+ L E ARFY A+ LA+ +H+ I+R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
D+K DN+LLD GH+KL+D+G+CK E + P D F
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK------------------EGI-RPGDTTSTF----- 156
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP+YIAPE+L + YG DW
Sbjct: 157 -------------------------CGTPNYIAPEILRGEDYGFSVDW 179
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-35
Identities = 62/142 (43%), Positives = 91/142 (64%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++G+G FG+V L REK +G YAMK L+K ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
Y+FQ + L +MEY GG++ L RE TE ARFY A+ V A+E +H + ++RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 213 KPDNLLLDKNGHMKLSDFGLCK 234
K +NL+LDK+GH+K++DFGLCK
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 76/227 (33%), Positives = 120/227 (52%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IGRG++ +V L R KK+ IYAMK +KK + ++ V+ E+++ + +S+ +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ FQ T L+L++EY+ GGD+M + R+ L E ARFY A+ +A+ +H+ I+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD +GH+KL+D+G+CK +G P D
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK---------------------------EGLGPG-DTT 153
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
S++ GTP+YIAPE+L + YG DW
Sbjct: 154 STF---------------------CGTPNYIAPEILRGEEYGFSVDW 179
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 61/142 (42%), Positives = 91/142 (64%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++G+G FG+V L REK SG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
YSFQ + L +MEY+ GG++ L RE +E+ RFY A+ V A++ +H ++RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 213 KPDNLLLDKNGHMKLSDFGLCK 234
K +NL+LDK+GH+K++DFGLCK
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-33
Identities = 75/227 (33%), Positives = 115/227 (50%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
+IGRG++ +V L R KK+ IYAMK +KK + ++ V+ E+++ + ++H +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ FQ L+ ++EY+ GGD+M + R+ L E ARFY A+ LA+ +H+ I+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD GH+KL+D+G+CK E + P D F
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK------------------EGL-RPGDTTSTF------ 156
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP+YIAPE+L + YG DW
Sbjct: 157 ------------------------CGTPNYIAPEILRGEDYGFSVDW 179
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 54/157 (34%), Positives = 88/157 (56%), Gaps = 7/157 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVA 144
D E + ++G+G+ G V R K +G IYA+KK+ + R Q+ E L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL---LRELKTLRSCE 57
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIH 203
S +VK Y +F + +++EY+ GG + LL + + E V YIA+ +L ++ +H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-YIARQILKGLDYLH 116
Query: 204 -KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
K + IHRDIKP NLL++ G +K++DFG+ K L+ +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 52/227 (22%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV C+ K +G +YA KKL K + KR + E+ +L +V+S IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+F+ + L L+M + GGD+ + + E E A FY AQ + +E +H+ ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+KP+N+LLD +G++++SD GL A+
Sbjct: 121 LKPENVLLDDHGNVRISDLGL----------AVE-------------------LKGG--- 148
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
K GTP Y+APEVL + Y DW
Sbjct: 149 ---KKIK---------------GRAGTPGYMAPEVLQGEVYDFSVDW 177
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 6e-32
Identities = 68/168 (40%), Positives = 95/168 (56%), Gaps = 8/168 (4%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +L +G G+FGEV L R++K + A+K L K K +VE E +LA +
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 147 -CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSVLAIESI 202
IVKLY FQD LYL+MEY+ GG + LL R+ L+E+ A F +AQ + A+E +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 203 HKHNYIHRDIKPDNLLLDKNGHM-KLSDFGLCKPLDCSTLYAIHEHKT 249
H IHRDIKP+N+LLD++G + KL DFGL K L +
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
|
Length = 384 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 7e-32
Identities = 70/233 (30%), Positives = 112/233 (48%), Gaps = 50/233 (21%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-AS 145
DF L ++G+G+FG+V L K + +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ + + +H+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
I+RD+K DN++LD GH+K++DFG+CK E+M + +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------EHMVDGVTTR--- 159
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTPDYIAPE++ + YG DW
Sbjct: 160 ----------------------------TFCGTPDYIAPEIIAYQPYGKSVDW 184
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 62/143 (43%), Positives = 93/143 (65%), Gaps = 1/143 (0%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
++G+G FG+V L +EK +G YAMK LKK +V + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH-KHNYIHRD 211
YSFQ + L +MEY GG++ L RE +E+ ARFY A+ V A++ +H + N ++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCK 234
+K +NL+LDK+GH+K++DFGLCK
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K + +A+K LKK ++ VE E+ +L+ H + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
Y +FQ E L+ +MEYL GGD+M + A FY A+ + ++ +H ++RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN+LLD +GH+K++DFG+CK ENM D K
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK------------------ENML-----------GDAK 152
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ + GTPDYIAPE+LL + Y DW
Sbjct: 153 TC--------------------TFCGTPDYIAPEILLGQKYNTSVDW 179
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 57/143 (39%), Positives = 85/143 (59%), Gaps = 4/143 (2%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV C+ + +G +YA KKL K + KR E E+ +LA+V S IV L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDT----LTENVARFYIAQSVLAIESIHKHNYIH 209
+FQ L L+M + GGD+ + D E A FY AQ + +E +H+ I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 210 RDIKPDNLLLDKNGHMKLSDFGL 232
RD+KP+N+LLD +G++++SD GL
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 74/233 (31%), Positives = 111/233 (47%), Gaps = 50/233 (21%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DF L ++G+G+FG+V L K + +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 147 -CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
I+RD+K DN++LD GH+K++DFG+CK ENM DG
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------ENM-----WDGVT 157
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
T GTPDYIAPE++ + YG DW
Sbjct: 158 TKT--------------------------FCGTPDYIAPEIIAYQPYGKSVDW 184
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-30
Identities = 62/160 (38%), Positives = 92/160 (57%), Gaps = 5/160 (3%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DFE+L IG+G+FG V K +YAMK++ S+M +R + E + E +LA++ S
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTEN-VARFYIAQSVLAIESIH 203
I++ Y SF D L ++MEY GD+ LL R L E+ V RF+I Q +L + +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+HRDIK NL LD ++K+ D G+ K L +T +A
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 22/163 (13%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK-----SEMVKRGQVEHVRAERNLLAE 142
++++ +G G FG V L R K++G + A+KK+KK E + + V++ L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM---NLREVKS----LRK 53
Query: 143 VASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQSV 196
+ H IVKL F++ + LY + EY+ G L LM++ +E+V R I Q +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
+ IHKH + HRD+KP+NLL+ +K++DFGL + +
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 45/147 (30%), Positives = 83/147 (56%), Gaps = 1/147 (0%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+++L +IGRGAFG V ++G+ A+K++ ++ K ++ + E +LL +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IVK S + ++ LY+I+EY G + ++ + E++ Y+ Q + + +H+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLC 233
IHRDIK N+L K+G +KL+DFG+
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 71/227 (31%), Positives = 111/227 (48%), Gaps = 50/227 (22%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G+G+FG+V L K G +A+K LKK ++ VE E+ +LA + + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
Y +FQ E+L+ +ME+L GGD+M + + A FY A+ V ++ +H I+RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNK 271
+K DN++LD++GH+K++DFG+CK EN+ DN+
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK------------------ENVF-----------GDNR 152
Query: 272 SSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+S + GTPDYIAPE+L Y DW
Sbjct: 153 AS--------------------TFCGTPDYIAPEILQGLKYTFSVDW 179
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 60/237 (25%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ F++L +G G++G V K++G + A+K + + ++ + E ++L + S
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PV--EEDLQEIIKEISILKQCDS 57
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTENVARFYIAQSVLAIESI 202
IVK Y S+ L+++MEY G D+M + TLTE + Q++ +E +
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H + IHRDIK N+LL++ G KL+DFG+
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVS----------------------------- 146
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
QL M +R + +GTP ++APEV+ + GY + D W
Sbjct: 147 ----------------GQLTD-TMAKRN---TVIGTPFWMAPEVIQEIGYNNKADIW 183
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 68/231 (29%), Positives = 99/231 (42%), Gaps = 49/231 (21%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK--KSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
++G+GAFG V LC + +G A+K++ + +V + E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
Y +D E L + MEY+PGG + L LTE V R Y Q + +E +H + +HR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
DIK N+L D G++KL DFG K L I T
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQ-----TICSSGTGMK------------------ 165
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320
S GTP +++PEV+ +GYG + D W V
Sbjct: 166 -----------------------SVTGTPYWMSPEVISGEGYGRKADVWSV 193
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 4e-28
Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 59/235 (25%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
++ L IG GA GEV ++ +G A+KK++ + K + + ++ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEIL----IMKDCKHPN 76
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTE-NVARFYIAQSVL-AIESIHK 204
IV Y S+ + L+++MEY+ GG + ++ + + E +A Y+ + VL +E +H
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA--YVCREVLQGLEYLHS 134
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
N IHRDIK DN+LL K+G +KL+DFG L
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL---------------------------- 166
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
T KS +R S VGTP ++APEV+ +K YG + D W
Sbjct: 167 ---TKEKS---------------KRN---SVVGTPYWMAPEVIKRKDYGPKVDIW 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 73/231 (31%), Positives = 107/231 (46%), Gaps = 55/231 (23%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HC--IV 149
IIGRG FGEV CR+ +G +YAMK L K + + ER +L+ V++ C IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIH 209
+ Y+F + L I++ + GGD+ L + +E RFY A+ +L +E +H ++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTD 269
RD+KP N+LLD++GH+++SD GL C
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----CDF----------------------------- 147
Query: 270 NKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECDWL 319
S K PH ++VGT Y+APEVL K Y DW
Sbjct: 148 ---SKKKPH---------------ASVGTHGYMAPEVLQKGVAYDSSADWF 180
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 56/168 (33%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D+E+L IG+G+FG VR R K G I K++ M + + + +E N+L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHP 59
Query: 147 CIVKLYYSFQDTE--YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIE 200
IV+ Y D LY++MEY GGD+ L+ + + E + Q +LA+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 201 SIH-----KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
H + +HRD+KP N+ LD N ++KL DFGL K L + +A
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 57/236 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKK--LKKSEMVKRGQVEHVRAERNLLAEV 143
+ F LL IG+G+FGEV +K++ + A+K L+++E ++E ++ E L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
S I K Y SF L++IMEY GG + LL + L E F + + +L +E +H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+ IHRDIK N+LL + G +KL+DFG+ S
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGV------SG----------------------- 146
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
QL M++R + VGTP ++APEV+ + GY + D W
Sbjct: 147 ----------------QLTS-TMSKRN---TFVGTPFWMAPEVIKQSGYDEKADIW 182
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 51/147 (34%), Positives = 85/147 (57%), Gaps = 2/147 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F ++G+G FGEV C+ + +G +YA KKL+K + KR E+ +L +V S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKH 205
+V L Y+++ + L L++ + GGD+ + M E A FY A+ +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++RD+KP+N+LLD GH+++SD GL
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 5/161 (3%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LLAEVAS 145
++ L IG G +G V R+K +G I A+KK+K + A R LL E+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I+KL F+ LYL+ E++ + R+ L E++ + Y+ Q + + H H
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246
+HRD+KP+NLL++ G +KL+DFGL + H
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 60/156 (38%), Positives = 85/156 (54%), Gaps = 7/156 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS---EMVKRGQVEHVRAERNLLAEVA 144
+E+L ++G GA+G V CR K +G I A+KK K+S E VK+ + V+ R L E
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-- 60
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
IV L +F+ LYL+ EY+ + L L + R YI Q + AI H
Sbjct: 61 --NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
HN IHRDIKP+N+L+ ++G +KL DFG + L
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 56/230 (24%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVR---AERNLLAEVASHCIVK 150
+G G+FG V G+ +A+K++ ++ + GQ E V+ E LL+++ IV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQ-EAVKQLEQEIALLSKLQHPNIVQ 66
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
+ ++ + LY+ +E +PGG + LL + + E V R Y Q +L +E +H N +HR
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDN 270
DIK N+L+D NG +KL+DFG+ K
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAK------------------------------------ 150
Query: 271 KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECD-W 318
Q+ A S G+P ++APEV+ ++G YG+ D W
Sbjct: 151 --------------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIW 186
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 74/232 (31%), Positives = 111/232 (47%), Gaps = 57/232 (24%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VKRGQVEHVRAERNLLAEVAS-HC--I 148
IIGRG FGEV CR+ +G +YAMK L K + +K+G+ + ER +L+ V++ C I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-ERIMLSLVSTGDCPFI 59
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYI 208
V + Y+F + L I++ + GGD+ L + +E RFY + +L +E +H +
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDT 268
+RD+KP N+LLD++GH+++SD GL C
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA----CDF---------------------------- 147
Query: 269 DNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECDWL 319
S K PH ++VGT Y+APEVL K Y DW
Sbjct: 148 ----SKKKPH---------------ASVGTHGYMAPEVLQKGTAYDSSADWF 180
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 51/228 (22%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G FG+V +G + A+K+++ + ++ + E +L E+ H + YY
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVL-ELLKHPNLVKYY 65
Query: 154 SFQ-DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
+ E +Y+ MEY GG + LL L E+V R Y Q + + +H H +HRDI
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
KP N+ LD NG +KL DFG L K+
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKL----------------------------------KN 151
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECD 317
+ + E++Q GTP Y+APEV+ KG+G D
Sbjct: 152 NTTTMGEEVQSL-----------AGTPAYMAPEVITGGKGKGHGRAAD 188
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 52/147 (35%), Positives = 87/147 (59%), Gaps = 2/147 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F ++G+G FGEV C+ + +G +YA KKL+K + KR E+ +L +V S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKH 205
+V L Y+++ + L L++ + GGD+ + M E E A FY A+ +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++RD+KP+N+LLD +GH+++SD GL
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 51/147 (34%), Positives = 87/147 (59%), Gaps = 2/147 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F ++G+G FGEV C+ + +G +YA K+L+K + KR E+ +L +V S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKH 205
+V L Y+++ + L L++ + GGD+ + M E A FY A+ + +E +H+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGL 232
N ++RD+KP+N+LLD GH+++SD GL
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 52/238 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DD+EL+ +IG GA V + A+K++ + + V+ +R E +++
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+VK Y SF + L+L+M YL GG D+M L E + + + + +E +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H + IHRDIK N+LL ++G +K++DFG+ ++A+ D
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGV-------------------SASLADGGD-- 157
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-LKKGYGMECD-W 318
RK+ + VGTP ++APEV+ GY + D W
Sbjct: 158 ------------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIW 191
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-23
Identities = 50/147 (34%), Positives = 84/147 (57%), Gaps = 2/147 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F ++G+G FGEV C+ + +G +YA KKL+K + KR E+ +L +V S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKH 205
+V L Y+++ + L L++ + GGD+ + M E A FY A+ +E + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++RD+KP+N+LLD GH+++SD GL
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 7/154 (4%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL---KKSEMVKRGQVEHVRAERNLLAEV 143
+++L IG GA G V +++++G A+KK+ + + + ++A L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA----LQAC 56
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
+VKL F L+MEY+P L E L E + Y+ + + +H
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +HRD+KP NLL+ +G +K++DFGL +
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFS 150
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 54/169 (31%), Positives = 90/169 (53%), Gaps = 16/169 (9%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
FEL+ +IG G +G+V R KK+G + A+K + + + E ++ E N+L + +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 145 SH-CIVKLYYSF------QDTEYLYLIMEYLPGG---DMM-TLLMREDTLTENVARFYIA 193
+H I Y +F + + L+L+ME GG D++ L + L E + +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+++ + +H++ IHRDIK N+LL KN +KL DFG+ LD STL
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD-STLG 168
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-23
Identities = 55/159 (34%), Positives = 81/159 (50%), Gaps = 4/159 (2%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +L ++G G+FG L + S YAMK+++ VE R E LLA++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP--KSSSAVEDSRKEAVLLAKMKHP 58
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDTLTENVARFYIAQSVLAIESIHK 204
IV SF+ +LY++MEY GGD+M L R E+ + Q L ++ IH+
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+HRDIK N+ L +NG +KL DFG + L YA
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-23
Identities = 52/155 (33%), Positives = 85/155 (54%), Gaps = 6/155 (3%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK------KSEMVKRGQVEHVRAERNLLAEVASH 146
+IG G+FG V L SG + A+K+++ S+ KR ++ + E LL E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IV+ S D ++L + +EY+PGG + LL E + R ++ Q + + +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
IHRDIK N+L+D G +K+SDFG+ K L+ ++L
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-23
Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 57/242 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+D+EL+ IG G +G+V R+ +G + A+K +K + E ++ E ++L E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDM-MTLLMREDTLTENVARFYIAQSVLAIESIHK 204
IV + S+ + L+++MEY GG + + L+E + +++ + +H+
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
IHRDIK N+LL ++G +KL+DFG+ L +
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT------------------------- 154
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKGYGMECD-WLV 320
+ +RK S +GTP ++APEV K GY +CD W +
Sbjct: 155 ---------------------IAKRK---SFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190
Query: 321 SV 322
+
Sbjct: 191 GI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 5e-23
Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 89 ELLTIIGRGAFGEVRLCR-EKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
L +G GAFGEV + K A+K LK+ + Q+E E ++ ++
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKL- 58
Query: 145 SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIES 201
H IVKL + E L ++MEY+PGGD++ L R L+ + + Q +E
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
+ N+IHRD+ N L+ +N +K+SDFGL + L Y + K
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK 165
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 6e-23
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 89 ELLTIIGRGAFGEVRLCR-EKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
L +G GAFGEV + + K G A+K LK+ + Q+E E ++ ++
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL- 58
Query: 145 SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLAIESI 202
H +VKL + E LY++MEY+ GGD+++ L L+ + + Q +E +
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
N+IHRD+ N L+ +N +K+SDFGL + L Y
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 158
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (238), Expect = 1e-22
Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 7/148 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-QVEHVRAERNLLAEVASH 146
+E L +G G +G V R+KK+G I A+KK++ + + G +R E +LL E+ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR-EISLLKEL-KH 57
Query: 147 -CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESIHK 204
IVKL LYL+ EY D+ L R L+ N+ + + Q + + H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H +HRD+KP N+L++++G +KL+DFGL
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 54/152 (35%), Positives = 88/152 (57%), Gaps = 7/152 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE---MVKRGQVEHVRAERNLLAEVA 144
+E L ++G G++G V C+ K++G I A+KK +SE MVK+ + +R +L ++
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+V L F+ + LYL+ E++ + L + L E+ R Y+ Q + IE H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
HN IHRDIKP+N+L+ ++G +KL DFG + L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 6e-22
Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E + IG G +G+V R KK+G + A+KK++ + + +R E LL ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 148 IVKLY---YSFQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIH 203
IV+L S Y++ EY+ D+ LL + TE+ + Y+ Q + ++ +H
Sbjct: 60 IVRLKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +HRDIK N+L++ +G +KL+DFGL +P
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYT 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 50/141 (35%), Positives = 78/141 (55%), Gaps = 2/141 (1%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV + K +G +YA KKL K + K+ + E+ +L +V S IV L Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVAR--FYIAQSVLAIESIHKHNYIHRD 211
+F+ +L L+M + GGD+ + + R Y AQ I +H + ++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 212 IKPDNLLLDKNGHMKLSDFGL 232
+KP+N+LLD G+ +LSD GL
Sbjct: 121 MKPENVLLDDQGNCRLSDLGL 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 2e-21
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
EL +G GAFGEV K G A+K LK+ + + E E +++ ++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV-LAIESI 202
+ IV+L E LY++ EY+PGGD++ L + +A + +E +
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
N++HRD+ N L+ +N +K+SDFGL +
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 52/159 (32%), Positives = 88/159 (55%), Gaps = 4/159 (2%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E++ IG G+FG++ L + K +K++ ++M + + E + E LLA++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKH 205
IV + SFQ+ L+++MEY GGD+M + R+ +E+ + Q L ++ IH
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 206 NYIHRDIKPDNLLLDKNGHM-KLSDFGLCKPLDCSTLYA 243
+HRDIK N+ L KNG + KL DFG+ + L+ S A
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 59/245 (24%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
DF++L +G+G++G V + YA+K++ M ++ + + V R +LA V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTL-----TENVARFYIAQSVLAIES 201
I+ +F D L ++MEY P GD+ + + + + R +I Q + +++
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQA 118
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H+ +HRD+K N+LL N +K+ D G+ K L
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVL------------------------- 153
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320
++ +A + +GTP Y+APEV + Y + D W +
Sbjct: 154 --------------------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187
Query: 321 SVLHF 325
L +
Sbjct: 188 GCLLY 192
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-21
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 54/233 (23%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E + ++GRGAFG V LCR K + +K++ +M K + + E +L ++
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPN 60
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESIHKH 205
I++ Y +F + + L ++MEY PGG + + L E+ + Q +LA+ +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 206 NYIHRDIKPDNLLLDKNGH-MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+HRD+K N+LLDK+ +K+ DFG+ K L
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL---------------------------- 152
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
S KS A++ VGTP YI+PE+ K Y + D
Sbjct: 153 --------SSKSK--------------AYTVVGTPCYISPELCEGKPYNQKSD 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-21
Identities = 60/153 (39%), Positives = 88/153 (57%), Gaps = 5/153 (3%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ FE+L ++G GA+G V CR K++ I A+KK K SE + + +R E +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIH 203
IV+L +F+ LYL+ EY+ +M+ LL M E V R YI Q + AI H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWCH 117
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
K++ +HRDIKP+NLL+ N +KL DFG + L
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 74/242 (30%), Positives = 109/242 (45%), Gaps = 55/242 (22%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL----KKSEMVKRGQVEHVRAERNLLAE 142
++ L ++GRGAFGEV LC + +G A+K++ E K +V + E LL
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSK--EVNALECEIQLLKN 60
Query: 143 VASHCIVKLYYSFQDTEY--LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
+ IV+ Y +D E L + +EY+PGG + L LTENV R Y Q + +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H + +HRDIK N+L D G++KL DFG K + +TI
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-----------QTI---------- 159
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319
C T K S GTP +++PEV+ +GYG + D W
Sbjct: 160 ---CMSGTGIK----------------------SVTGTPYWMSPEVISGEGYGRKADVWS 194
Query: 320 VS 321
V+
Sbjct: 195 VA 196
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-20
Identities = 43/149 (28%), Positives = 76/149 (51%), Gaps = 2/149 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEVAS 145
+E +G G + V R+K++G I A+KK+K E + + A R LL E+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I+ L F + L+ E++ + + LT + Y+ ++ +E +H +
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+HRD+KP+NLL+ +G +KL+DFGL +
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 72/242 (29%), Positives = 107/242 (44%), Gaps = 55/242 (22%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK----KSEMVKRGQVEHVRAERNLLAE 142
++ L ++G+GAFG V LC + +G A+K+++ E K +V + E LL
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSK--EVNALECEIQLLKN 60
Query: 143 VASHCIVKLYYSFQDT--EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
+ IV+ Y +D L + ME++PGG + L LTENV R Y Q + +
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H + +HRDIK N+L D G++KL DFG K L +TI
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-----------QTI---------- 159
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319
C T K S GTP +++PEV+ +GYG + D W
Sbjct: 160 ---CLSGTGMK----------------------SVTGTPYWMSPEVISGEGYGRKADIWS 194
Query: 320 VS 321
V
Sbjct: 195 VG 196
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-20
Identities = 48/150 (32%), Positives = 84/150 (56%), Gaps = 9/150 (6%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK-------KSEMVKRGQVEHVRAERNLLAEVAS 145
+IG+G +G V L +G + A+K+++ + + ++ V+ +R+E L ++
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 146 HCIVKLYYSFQDTE-YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
IV+ Y F+ TE YL + +EY+PGG + + L E + RF+ Q + + +H
Sbjct: 68 LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+HRD+K DNLL+D +G K+SDFG+ K
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-20
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 55/232 (23%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ IG G+ G V + +K +G A+KK+ ++ K+ + E + E ++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHP 76
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKH 205
IV++Y S+ + L+++ME+L GG + ++ E +A + +VL A+ +H
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALSFLHAQ 134
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
IHRDIK D++LL +G +KLSDFG C + E
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC--------------AQVSKE------------ 168
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ RRK S VGTP ++APEV+ + YG E D
Sbjct: 169 --------------------VPRRK---SLVGTPYWMAPEVISRLPYGTEVD 197
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 48/146 (32%), Positives = 81/146 (55%), Gaps = 3/146 (2%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G+FG+ L + K+ G Y +K++ S+M + + E R E +L+ + IV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQE 66
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
SF++ LY++M+Y GGD+ + R E+ + Q LA++ +H +HRD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLD 237
IK N+ L K+G +KL DFG+ + L+
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVLN 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 51/154 (33%), Positives = 87/154 (56%), Gaps = 7/154 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE---MVKRGQVEHVRAERNLLAE 142
+ +E L+ IG G++G V CR +++G I A+KK +SE ++K+ + +R +L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ +V L F+ L+L+ EY + L + E++ + I Q++ A+
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
HKHN IHRD+KP+N+L+ K G +KL DFG + L
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 51/164 (31%), Positives = 88/164 (53%), Gaps = 12/164 (7%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+++L IG G F EV + +K+G YA+K +KK QV ++R E L ++ H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNLR-EIQALRRLSPHP 58
Query: 148 -IVKLYYSFQD--TEYLYLIMEYLPGGDM-MTLLM--REDTLTENVARFYIAQSVLAIES 201
I++L D T L L+ E + DM + L+ R+ L E + Y+ Q + +++
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
+H++ HRDIKP+N+L+ + +KL+DFG C+ + Y +
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEY 158
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-18
Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 4/143 (2%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEHVRAERNLLAEVASHCIV 149
+G GAF R+ K+G + A+K++ Q VE +R E L+A + I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIH 209
++ + + + L +E++ GG + LL + E V Y Q + + +H++ IH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 210 RDIKPDNLLLDKNGH-MKLSDFG 231
RD+K NLL+D G ++++DFG
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFG 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-18
Identities = 68/231 (29%), Positives = 102/231 (44%), Gaps = 54/231 (23%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK----KSEMVKRGQVEHVRAERNLLAEVASHCI 148
++G+GAFG V LC + +G A K+++ E K +V + E LL + I
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK--EVSALECEIQLLKNLQHERI 66
Query: 149 VKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
V+ Y +D + L + MEY+PGG + L LTE+V R Y Q + + +H +
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
+HRDIK N+L D G++KL DFG K L +TI C
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRL-----------QTI-------------CMS 162
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
T + S GTP +++PEV+ +GYG + D
Sbjct: 163 GTGIR----------------------SVTGTPYWMSPEVISGEGYGRKAD 191
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---A 144
++ L +IGRGA+G V + +G + A+K + V ++ E LL+++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQ 60
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
I K Y S+ L++IMEY GG + TL M+ + E I + ++A++ IHK
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
IHRDIK N+L+ G++KL DFG+ L+ ++
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 16/158 (10%)
Query: 93 IIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+G GAFGEV + K A+K LK+ + + E ++ ++ +V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVV 59
Query: 150 KLY-YSFQDTEYLYLIMEYLPGGDMMTLL---------MREDTLTENVARFYIAQSVLAI 199
+L ++ E LYL++EY+ GGD++ L + TL+ + Q +
Sbjct: 60 RLLGVCTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
E + ++HRD+ N L+ ++ +K+SDFGL + +
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA---E 142
DD E L +G G G V + +G I A+K + ++E A + + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---------RLEINEAIQKQILRELD 51
Query: 143 VASHC----IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVL 197
+ C IV Y +F + + + MEY+ GG + +L + + E + IA +VL
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-IAVAVL 110
Query: 198 A--IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
KH IHRD+KP N+L++ G +KL DFG+ L
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 53/237 (22%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+ +F++ IG+G F V G + A+KK++ EM+ + E +LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARF-YIAQSVLAIE 200
++K SF + L +++E GD+ ++ ++ L + Y Q A+E
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H +HRDIKP N+ + G +KL D GL + T A
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA----------------- 163
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
S VGTP Y++PE + + GY + D
Sbjct: 164 --------------------------------HSLVGTPYYMSPERIHENGYNFKSD 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-18
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 18/157 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE--MVKRGQVEHVRAERNLLAEV 143
+ L+ +G GA G V CR K +G I+A+K + +++ Q+ +R E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-QI--LR-ELEINKSC 56
Query: 144 ASHCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMREDTLTENVARF------YIAQS 195
S IVK Y +F D + + + MEY GG + ++ + + + R IA+S
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK---VKKRGGRIGEKVLGKIAES 113
Query: 196 VL-AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
VL + +H IHRDIKP N+LL + G +KL DFG
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-18
Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 3/158 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ + ++G+GAFGE L R + ++ K++ + + ++ + E +L+ +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPN 60
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKH 205
I+ Y F D L + MEY GG + ++R+ E + +Y+ Q V A+ IHK
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+HRDIK N+ L K G +KL DFG+ K L A
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 9e-18
Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 1/95 (1%)
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYI 208
+KLYYS + LIM+Y+ GD+ LL +E L+E + I Q V A+ +HKHN I
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 209 HRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLY 242
H DIK +N+L D + L D+GLCK + + Y
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY 166
|
Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 55/153 (35%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVAS 145
D+ + IG G +G V R KK+G I AMKK++ +SE + G E +LL E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN------VARFYIAQSVLAI 199
IV L LYLI E+L M L D+L + + + Y+ Q + I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H +HRD+KP NLL+D G +KL+DFGL
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 47/228 (20%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEVASHCIV 149
++G+GA+G V C G + A+K+++ + + + E ++ E +LL + IV
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIH 209
+ + D + + ME++PGG + ++L R L E V Y Q + + +H + +H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTD 269
RDIK +N++L NG +KL DFG + L L+ H NM + M
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH-------SNMLKSMH--------- 169
Query: 270 NKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
GTP ++APEV+ + GYG + D
Sbjct: 170 ---------------------------GTPYWMAPEVINESGYGRKSD 190
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 17/155 (10%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LLAEVAS 145
+ELL IG GA+G V +K++G A+KK+ V ++ R R LL +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 146 HCIVKL--------YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
I+ L F D +Y++ E + D+ ++ LT++ ++++ Q +
Sbjct: 59 ENIIGLLDILRPPSPEDFND---VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++ +H N IHRD+KP N+L++ N +K+ DFGL
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL 149
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-17
Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 17/161 (10%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
FEL+ ++G G +G+V R K+G + A+K + +E + E ++ E N+L + + H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 148 IVKLYYSF--------QDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVL 197
+ YY D + L+L+ME+ G + L+ + + L E+ YI + +L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-YICREIL 131
Query: 198 -AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +H H IHRDIK N+LL +N +KL DFG+ LD
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEVA 144
++ + IG G +G V R+K +G I A+KK++ + E V + E +LL E+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELN 56
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDM-MTLLMR---EDTLTENVARFYIAQSVLAIE 200
IV+L LYL+ E+L D+ + M L + + Y+ Q + I
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H H +HRD+KP NLL+D+ G +KL+DFGL
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 56/232 (24%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G+ G V + REK SG A+K + ++ K+ + E + E ++ + +V++Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKHNYIHRDI 212
S+ E L+++ME+L GG + ++ + E +A + +SVL A+ +H IHRDI
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT--VCESVLQALCYLHSQGVIHRDI 143
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
K D++LL +G +KLSDFG C
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCA-------------------------------------- 165
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
Q+ R+ L VGTP ++APEV+ + YG E D W + ++
Sbjct: 166 -------QISKDVPKRKSL----VGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-17
Identities = 48/161 (29%), Positives = 76/161 (47%), Gaps = 28/161 (17%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEVA 144
F+ + IG G +G V R K +G + A+KK++ ++E V + E +LL E+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYL-----------PGGDMMTLLMREDTLTENVARFYIA 193
IVKL LYL+ E+L P + L++ Y+
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YLF 107
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
Q + + H H +HRD+KP NLL++ G +KL+DFGL +
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 6/158 (3%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D+ E+L +G+G +G V + +G AMK+++ + + + E ++L + S
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSVLAIESI 202
IV Y +F +Y+ MEY+ G + L + + + E+V R V ++ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 203 -HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
+HN IHRD+KP N+L++ NG +KL DFG+ L S
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E L IG GA+G V R+ +G A+KK++ + + +R E LL ++ S
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFE 59
Query: 148 ---IVKLYYSFQDTEY-----LYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVL 197
IV+L L L+ E++ D+ T L + + L + + Q +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
++ +H H +HRD+KP N+L+ +G +K++DFGL +
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 54/166 (32%), Positives = 89/166 (53%), Gaps = 17/166 (10%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K CVD F+++ IG G +G+V R+K +G + A+KK++ + + +R E +L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILR 61
Query: 142 EVASHCIVKLY---------YSF-QDTEYLYLIMEYLPGGDMMTLLMREDTL---TENVA 188
++ IV L F +D YL+ EY+ D+M LL E L +E+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLL--ESGLVHFSEDHI 118
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ ++ Q + + HK N++HRDIK N+LL+ G +KL+DFGL +
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E++ IG+G +G+V KK G++ A+K L V E + AE N+L + +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYNILQSLPN 77
Query: 146 H-CIVKLYYSFQDTEY-----LYLIMEYLPGGDMMTL----LMREDTLTENVARFYIAQS 195
H +VK Y F + L+L++E GG + L L+ L E + + + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
+L ++ +H + IHRD+K +N+LL G +KL DFG+ L + L
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 54/231 (23%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+GA G V + +G A+K++ + K+ E + E ++ E IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
S+ + L+++MEYL GG + T ++ E + E + + A+E +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
DN+LL +G +KL+DFG C +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQI------------------------------------- 165
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
+P EQ + M VGTP ++APEV+ +K YG + D W + ++
Sbjct: 166 --TP-EQSKRSTM---------VGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-16
Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
FEL+ ++G G +G+V R K+G + A+K + V + E ++ E N+L + + H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 148 IVKLYY-SFQDT------EYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLA 198
+ YY +F + L+L+ME+ G + L+ + +TL E + + +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +H+H IHRDIK N+LL +N +KL DFG+ LD
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-16
Identities = 48/149 (32%), Positives = 80/149 (53%), Gaps = 3/149 (2%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG+G+FGEV + ++ + A+K + E ++E ++ E +L++ S
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
I + Y S+ L++IMEYL GG + LL + L E + + + ++ +H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
IHRDIK N+LL + G +KL+DFG+ L
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 48/149 (32%), Positives = 79/149 (53%), Gaps = 3/149 (2%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG+G+FGEV + ++ + A+K + E ++E ++ E +L++ S
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+ K Y S+ L++IMEYL GG + LL R E + + + ++ +H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
IHRDIK N+LL + G +KL+DFG+ L
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 48/166 (28%), Positives = 90/166 (54%), Gaps = 14/166 (8%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E++ IG+G +G+V KK+G+ A+K L + E + AE N+L ++
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73
Query: 146 H-CIVKLYYSF-----QDTEYLYLIMEYLPGGDMMTL----LMREDTLTENVARFYIAQS 195
H +VK Y + ++ + L+L++E GG + L L R + + E + + + ++
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
++ ++ +H + IHRD+K +N+LL G +KL DFG+ L + L
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKK-LKKSEMVKRGQVEHVRAER--NLLAE 142
D+E+L +G G FGEV R+ K+G + A+KK L +E K G + A R +L +
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGF--PITALREIKILKK 63
Query: 143 VASHCIVKL---YYSFQDTEY-----LYLIMEYLPGGDMMTLLMRED-TLTENVARFYIA 193
+ +V L D +Y++ Y+ D+ LL LTE+ + Y+
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYML 122
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
Q + I +H+++ +HRDIK N+L+D G +K++DFGL +P D
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-16
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 56/232 (24%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G+ G V + EK +G A+KK+ ++ K+ + E + E ++ + +V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKHNYIHRDI 212
S+ + L+++ME+L GG + ++ E +A + SVL A+ +H IHRDI
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--VCLSVLRALSYLHNQGVIHRDI 144
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
K D++LL +G +KLSDFG C +
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCA------------------------------------QV 168
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
S + P +RK S VGTP ++APEV+ + YG E D W + ++
Sbjct: 169 SKEVP----------KRK---SLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 56/232 (24%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG G+ G V + K SG + A+KK+ ++ K+ + E + E ++ + +V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKHNYIHRDI 212
S+ + L+++ME+L GG + ++ E +A + +VL A+ +H IHRDI
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLAVLKALSVLHAQGVIHRDI 142
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272
K D++LL +G +KLSDFG C + +K
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQV---------------------------------SK- 168
Query: 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
++ RRK S VGTP ++APE++ + YG E D W + ++
Sbjct: 169 ------------EVPRRK---SLVGTPYWMAPELISRLPYGPEVDIWSLGIM 205
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 48/149 (32%), Positives = 80/149 (53%), Gaps = 3/149 (2%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG+G+FGEV + ++ + A+K + E ++E ++ E +L++ S
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+ K Y S+ L++IMEYL GG + LL L E + + + ++ +H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
IHRDIK N+LL ++G +KL+DFG+ L
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 18/161 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E L IG G +G+V R+K +G + A+KK + EM + G E +LL + S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQML-S 58
Query: 146 HC--IVKLYYSFQDTE------YLYLIMEYLPGGDMMTLLMRE-----DTLTENVARFYI 192
IV+L + E LYL+ EYL D+ + L + ++
Sbjct: 59 ESIYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGL 232
Q + + HKH +HRD+KP NLL+DK G +K++D GL
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 54/155 (34%), Positives = 86/155 (55%), Gaps = 13/155 (8%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-QVEHVRAERNLLAEV 143
VD++E L I G +G V R+KK+G I A+KKLK E K G + +R E N+L ++
Sbjct: 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLR-EINILLKL 61
Query: 144 ASHCIVKLYY----SFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVL 197
IV + S D +Y++MEY+ D+ +L+ M++ L V + + Q +
Sbjct: 62 QHPNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEV-KCLMLQLLS 117
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ +H + +HRD+K NLLL+ G +K+ DFGL
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL 152
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 60/243 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEV 143
+DFEL+ IG G +G+V R +G + A+K KL+ E V+ E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-----DFAVVQQEIIMMKDC 63
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
IV + S+ + L++ ME+ GG + + L+E+ + +++ + +H
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+HRDIK N+LL NGH+KL+DFG+ + +
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT------------------------ 159
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECD-WL 319
+ +RK S +GTP ++APEV K GY CD W
Sbjct: 160 ----------------------IAKRK---SFIGTPYWMAPEVAAVERKGGYNQLCDIWA 194
Query: 320 VSV 322
V +
Sbjct: 195 VGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 52/160 (32%), Positives = 86/160 (53%), Gaps = 18/160 (11%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LLAEVAS 145
+E+L +G+GA+G V ++++ + A+KK+ + R + R R L E+
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA---FRNATDAQRTFREIMFLQELGD 65
Query: 146 H-CIVKL---YYSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSVLA 198
H IVKL + D + +YL+ EY M T L +R + L + R+ + Q + A
Sbjct: 66 HPNIVKLLNVIKAENDKD-IYLVFEY-----METDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238
++ IH N IHRD+KP N+LL+ + +KL+DFGL + L
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 48/149 (32%), Positives = 85/149 (57%), Gaps = 8/149 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEV 143
D +E++ +G GAFG+V + K++G A K +++ E ++E E ++L+E
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-----ELEDFMVEIDILSEC 59
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESI 202
IV LY ++ L++++E+ GG + ++++ E LTE R+ Q + A+ +
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
H H IHRD+K N+LL +G +KL+DFG
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFG 148
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSG-NIYAMKK-------LKKSEMVKRGQVEHVRAERNL 139
+ +L +G GAFG V R+K +G N+ A+K+ K + + + + +E +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 140 LAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDM----MTLLMREDTLTENVARFYIAQ 194
+ E H IV+ Y +F + + LY++M+ + G + +L ++ TE Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 195 SVLAIESIHKHNYI-HRDIKPDNLLLDKNGHMKLSDFGLCK 234
VLA+ +HK I HRD+ P+N++L ++ + ++DFGL K
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 54/231 (23%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+GA G V + +G A+K++ + K+ E + E ++ E + IV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 83
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
S+ + L+++MEYL GG + T ++ E + E + + A++ +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
DN+LL +G +KL+DFG C + P+ +S
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQIT----------------------------PEQSKRS- 173
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
+ VGTP ++APEV+ +K YG + D W + ++
Sbjct: 174 --------------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 54/231 (23%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+GA G V + +G A+K++ + K+ + E + E ++ E+ + IV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
SF + L+++MEYL GG + T ++ E + E + + A+E +H + IHRDIK
Sbjct: 84 SFLVGDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
DN+LL +G +KL+DFG C + P+ +S
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQIT----------------------------PEQSKRS- 173
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
+ VGTP ++APEV+ +K YG + D W + ++
Sbjct: 174 --------------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 54/231 (23%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+GA G V + +G A++++ + K+ E + E ++ E + IV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
S+ + L+++MEYL GG + T ++ E + E + + A+E +H + IHRDIK
Sbjct: 85 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
DN+LL +G +KL+DFG C
Sbjct: 144 SDNILLGMDGSVKLTDFGFCA--------------------------------------- 164
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
Q+ Q R + VGTP ++APEV+ +K YG + D W + ++
Sbjct: 165 ------QITPEQSKRSTM----VGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 47/173 (27%), Positives = 85/173 (49%), Gaps = 20/173 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL-----L 140
++ + IG GA+G V + +SG A+KK+ + V A+R L L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV------PTLAKRTLRELKIL 58
Query: 141 AEVASHCIVKLYYSFQ----DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
I+ + + D + +Y++M+ L D+ ++ + LTE R+++ Q +
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL 117
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
++ IH N IHRD+KP NLL++++ +++ DFG+ + L S EHK
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT----EHKY 166
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 3/146 (2%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D+EL+ +G G +G+V R +G + A+K +K + ++ E ++ E
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHC 66
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
IV + S+ E L++ MEY GG + + L+E + +++ + +H
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGL 232
+HRDIK N+LL NG +KL+DFG+
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 49/147 (33%), Positives = 72/147 (48%), Gaps = 3/147 (2%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE L +G G G V + SG I A +KL E +K + E +L E S
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLE-IKPAIRNQIIRELKVLHECNS 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV-ARFYIAQSVLAIESIHK 204
IV Y +F + + ME++ GG + +L + + EN+ + IA K
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFG 231
H +HRD+KP N+L++ G +KL DFG
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFG 145
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 50/155 (32%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-QVEHVRAERNLLAEV 143
V +FE L IG G +G V R+ SG I A+KK++ + + G + +R E LL +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLR-EITLLLNL 63
Query: 144 ASHCIVKLYYSF--QDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIE 200
IV+L + + ++L+MEY D+ +LL T +E+ + + Q + ++
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235
+H++ IHRD+K NLLL G +K++DFGL +
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 49/147 (33%), Positives = 84/147 (57%), Gaps = 6/147 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVASH 146
+E++ +G GAFG+V + K++G + A K ++ KSE ++E E +LA
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDYMVEIEILATCNHP 69
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHKH 205
IVKL +F L++++E+ PGG + +++ D LTE + Q + A++ +H
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGL 232
IHRD+K N+LL +G +KL+DFG+
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGV 156
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 1/148 (0%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+E L IG G +G V + +++ I A+K+++ + + +R E LL E+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKN 60
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IV+LY + L L+ EY + + + ++ Q + + H HN
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKP 235
+HRD+KP NLL++KNG +KL+DFGL +
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 34/167 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-- 143
+D + L IGRGAFG V K SG I A+K+++ S + ++ Q + LL ++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQ-------KRLLMDLDV 55
Query: 144 ---ASHC--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM----------REDTLTENVA 188
+S C IVK Y + ++ ME +M + + + + E +
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEEIL 109
Query: 189 RFYIAQSVL-AIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
IA + + A+ + + IHRD+KP N+LLD+NG++KL DFG+
Sbjct: 110 G-KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 43/174 (24%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR--------GQVE-HVRAERNL--LAE 142
+G G +G+V + +G I A+KK+K E+ G H R L + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ I+ L + + +++ L+M+ + D+ ++ R+ LTE+ + + Q + + +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
HK ++HRD+ P N+ ++ G K++DFGL + Y + DE M
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLAR----RYGYPPYSDTLSKDETMQ 185
|
Length = 335 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 48/149 (32%), Positives = 85/149 (57%), Gaps = 6/149 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL-KKSEMVKRGQVEHVRAERNLLAEVA 144
+ +E++ +G GAFG+V + K++G + A K + KSE ++E E ++LA
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCD 60
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIH 203
IVKL +F L++++E+ GG + +++ E LTE R Q++ A+ +H
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++ IHRD+K N+L +G +KL+DFG+
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 64/254 (25%), Positives = 103/254 (40%), Gaps = 66/254 (25%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKL 151
+G+G+FG V L ++KK+ +K LK+ + + + E LL+++ IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 152 YYSFQDTEYLYLIMEYLPGGDM----MTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+ SF + + +I EY G D+ L TL+EN + Q +L + +H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
+HRD+K N+ L KN +K+ DFG+ + L
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLL------------------------------- 155
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W-LVSVLH- 324
M LA + GTP Y++PE L +GY + D W L +L+
Sbjct: 156 ------------------MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
Query: 325 -------FNSYRFL 331
F FL
Sbjct: 198 MCCLAHAFEGQNFL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 42/151 (27%), Positives = 80/151 (52%), Gaps = 4/151 (2%)
Query: 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+ ++G+G++GEV L R + G Y +KKL +R + + E LL+++ IV
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIV 62
Query: 150 KLYYSFQDTE-YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHN 206
S++ + LY++M + GGD+ L + L EN + Q +A++ +H+ +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+HRD+K N+ L + +K+ D G+ + L+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 51/163 (31%), Positives = 86/163 (52%), Gaps = 18/163 (11%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+++ ++D E L IG G G+V R KK+G++ A+K+++++ + E+ R +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMD 63
Query: 139 LLAEVASH-C--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA-- 193
L + SH C IVK Y F +++ ME M T L + + I
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSDVFICMEL-----MSTCLDKLLKRIQGPIPEDILGK 118
Query: 194 QSVLAIESIH----KHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+V ++++H KH IHRD+KP N+LLD +G++KL DFG+
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI 161
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 15/167 (8%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
V +E L IG+G FGEV R KK+ I A+KK+ + + +R E +L +
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLK 69
Query: 145 SHCIVKL----------YYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIA 193
+V L Y ++ + YL+ E+ D+ LL ++ T + + +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGS--FYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMK 126
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
+ + IH++ +HRD+K N+L+ K+G +KL+DFGL + S
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSK 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+D +E + IG G +G V R++ + A+KK++ E G E +LL E+
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQ 59
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTE-----NVARFYIAQSVLAI 199
IV+L + LYL+ EYL + L D+ + + + Y+ Q + I
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 200 ESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCK 234
H H +HRD+KP NLL+D+ +KL+DFGL +
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-12
Identities = 31/138 (22%), Positives = 71/138 (51%), Gaps = 14/138 (10%)
Query: 97 GAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI---VKLYY 153
G +V L + ++ + +K L+KS R ++ + HC+ V L+
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLT-----------IIPHCVPNMVCLHK 52
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
+ ++L++++ GG + + + + + E + + A+ V+A++++H+ + RD+
Sbjct: 53 YIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN 112
Query: 214 PDNLLLDKNGHMKLSDFG 231
P+N+LLD GH++L+ F
Sbjct: 113 PNNILLDDRGHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 24/166 (14%)
Query: 91 LTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +G+G FG V LCR + +G + A+KKL+ S + E +L +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65
Query: 147 CIVK---LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF-------YIAQSV 196
IVK + YS L L+MEYLP G + D L ++ R Y +Q
Sbjct: 66 NIVKYKGVCYSAGRRN-LRLVMEYLPYGSL------RDYLQKHRERLDHRKLLLYASQIC 118
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+E + Y+HRD+ N+L++ +K+ DFGL K L Y
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LLAEV 143
++ L+ IG GA+G V K +G A+KK+ E Q R R +L
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH----QTFCQRTLREIKILRRF 60
Query: 144 ASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
I+ + SF+ +Y++ E + D+ L+ + L+ + ++++ Q +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRG 118
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++ IH N +HRD+KP NLLL+ N +K+ DFGL
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGL 152
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 25/157 (15%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC----- 147
++G+G +G V R+ + A+K++ + + R + L E+A H
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---------RYVQPLHEEIALHSYLKHR 65
Query: 148 -IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL------MREDTLTENVARFYIAQSVLAIE 200
IV+ S + + + ME +PGG + LL ++++ E FY Q + ++
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQILEGLK 122
Query: 201 SIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPL 236
+H + +HRDIK DN+L++ +G +K+SDFG K L
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 42/152 (27%), Positives = 80/152 (52%), Gaps = 10/152 (6%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL--KKSEMVKRGQVEHVRAERNLLAEVA 144
+ E + IG GA G V + +G +YA+K + + V+R + E +L +V
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEILRDVN 130
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+VK + F + +++E++ GG + + ++ +VAR Q + I +H+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHR 186
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
+ +HRDIKP NLL++ ++K++DFG+ + L
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
|
Length = 353 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL---KKSEMVKRGQVEHVRAERNLLAE 142
+D E ++ +G G G V + +G + A K + KS + K+ + E ++ E
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHE 59
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA--IE 200
S IV Y +F + + + ME++ G + + + + + IA +V+
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-KIAVAVVEGLTY 118
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ H +HRDIKP N+L++ G +KL DFG+
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGV 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 27/161 (16%)
Query: 88 FELLTIIGRGAFGEVRLCR--EKKSGNIYAMKKL----KKSEMVKRGQVE-----HVRAE 136
+EL+ +G+GA+G V R E A+KK+ K + KR E H R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 137 RNLLAEVASHCIVKL----YYSFQDTEYLYL-IMEYLPGGDMMTLLMREDTLTENVARFY 191
+N+ C+ + +F + YLY +ME D+ ++ LT+ + +
Sbjct: 62 KNIT------CLYDMDIVFPGNFNEL-YLYEELMEA----DLHQIIRSGQPLTDAHFQSF 110
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
I Q + ++ IH N +HRD+KP NLL++ + +K+ DFGL
Sbjct: 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL 151
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 44/158 (27%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+I + +L+ +G G FGEV + S + A+K LK M V+ E NL+
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMK 56
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAI 199
+ +V+LY E +Y+I EY+ G ++ L ++ + + + AQ +
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
I + NYIHRD++ N+L+ ++ K++DFGL + ++
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 6/155 (3%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
++ D + +G G +GEV KK A+K LK+ M +VE E ++
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 57
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIA-QSVLAI 199
E+ +V+L Y+I E++ G+++ L + V Y+A Q A+
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
E + K N+IHRD+ N L+ +N +K++DFGL +
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-12
Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 4/161 (2%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+F++ IGRG F EV A+KK++ EM+ + E +LL ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIESI 202
++K SF + L +++E GD+ ++ ++ + E Y Q A+E +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
H +HRDIKP N+ + G +KL D GL + T A
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 4/161 (2%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+F + IGRG F EV G A+KK++ +++ E +LL ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIESI 202
++K Y SF + L +++E GD+ ++ ++ + E Y Q A+E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
H +HRDIKP N+ + G +KL D GL + T A
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 3/151 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG G+FG V R+ ++ + A+KK+ S + + + E L ++
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
++ + +L+MEY G L + + L E ++ + +H H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFG---LCKP 235
IHRDIK N+LL + G +KL+DFG L P
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSP 167
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-11
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 2/149 (1%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E L +G G++ V + K +G + A+K ++ E + G E +LL +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV L+ E L L+ EY+ + L + ++ Q + + IH+
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+HRD+KP NLL+ G +KL+DFGL +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVASH 146
F+ L +G G + V R + +G I A+K++ +E G E +L+ E+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDM---MTLLMREDTLTENVARFYIAQSVLAIESIH 203
IV+L+ L L+ EY+ D+ M L N + + Q + I H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
++ +HRD+KP NLL++K G +KL+DFGL +
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 70/248 (28%), Positives = 111/248 (44%), Gaps = 81/248 (32%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-- 143
DD E++ +GRGA+G V R +G I A+K++ R V + ++ LL ++
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVN-SQEQKRLLMDLDI 52
Query: 144 ---ASHC--IVKLYYS-FQDTEYLYLIMEYLPGGDMMTLL-------------MREDTLT 184
+ C V Y + F++ + +++ ME M T L + ED L
Sbjct: 53 SMRSVDCPYTVTFYGALFREGD-VWICMEV-----MDTSLDKFYKKVYDKGLTIPEDILG 106
Query: 185 ENVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+ IA S++ A+E +H K + IHRD+KP N+L+++NG +KL DFG+ L S
Sbjct: 107 K------IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA- 159
Query: 243 AIHEHKTID---DENMAEPMDIDGCFPDTDNK-------------------------SSW 274
KTID MA P I+ P+ + K SW
Sbjct: 160 -----KTIDAGCKPYMA-PERIN---PELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210
Query: 275 KSPHEQLQ 282
K+P +QL+
Sbjct: 211 KTPFQQLK 218
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 3/152 (1%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE ++ +G G G V + K SG I A +KL E +K + E +L E S
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLE-IKPAIRNQIIRELQVLHECNS 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV-ARFYIAQSVLAIESIHK 204
IV Y +F + + ME++ GG + +L + E + + IA K
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
H +HRD+KP N+L++ G +KL DFG+ L
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE ++ +G G G V K SG I A +KL E +K + E +L E S
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLE-IKPAIRNQIIRELQVLHECNS 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI--- 202
IV Y +F + + ME++ GG + +L + + E + S+ I+ +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 119
Query: 203 -HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
KH +HRD+KP N+L++ G +KL DFG+ L
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 39/140 (27%), Positives = 71/140 (50%), Gaps = 4/140 (2%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IG+G FG+V K + + A+K + S + + + ++ +L + IVKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCR-STLPPDLKRKFLQEAE-ILKQYDHPNIVKLIG 59
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
+ +Y++ME +PGG ++T L ++ + LT + +E + N IHRD+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 213 KPDNLLLDKNGHMKLSDFGL 232
N L+ +N +K+SDFG+
Sbjct: 120 AARNCLVGENNVLKISDFGM 139
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ +L+ +G G FGEV + + A+K LK+ M E AE NL+ ++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIH 203
+V+LY + E +Y+I EY+ G ++ L + + + + AQ + I
Sbjct: 61 PRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ NYIHRD++ N+L+ + K++DFGL +
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 47/152 (30%), Positives = 68/152 (44%), Gaps = 17/152 (11%)
Query: 94 IGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRA----ERNLLAEVAS 145
+G G FG+V LCR +G A+K L S E R+ E +L +
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS------GEEQHRSDFEREIEILRTLDH 65
Query: 146 HCIVKL-YYSFQDTEY-LYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESI 202
IVK + L LIMEYLP G + L R D + + +Q ++ +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
YIHRD+ N+L++ +K+SDFGL K
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 4/152 (2%)
Query: 84 CVDD----FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
DD F L IG G+FG V R+ ++ + A+KK+ S + + + E
Sbjct: 9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
L ++ ++ + +L+MEY G L + + L E ++ +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
+H HN IHRD+K N+LL + G +KL DFG
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 49/154 (31%), Positives = 68/154 (44%), Gaps = 16/154 (10%)
Query: 90 LLTIIGR----GAFGEVRLCREKKSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVA 144
L T++GR AF R G+ K + K M+ Q + R+E + LA
Sbjct: 71 LTTLVGRNPTTAAFVATR-------GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD 123
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDM----MTLLMREDTLTENVARFYIAQSVLAIE 200
IVK + F+ + L LIMEY GGD+ L E Q VLA++
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+H +HRD+K N+ L G +KL DFG K
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217
|
Length = 478 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 20/158 (12%)
Query: 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKK---SEM-VKRGQVE-----HVRAERNLLA 141
L +G GA+G V +K++G A+KKL + SE+ KR E H++ E N++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE-NVIG 78
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAI 199
+ FQD YL+M Y M T L + L+E+ ++ + Q + +
Sbjct: 79 LLDVFTSAVSGDEFQD---FYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 4/145 (2%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G GAFG V R++ +G A+KK+ K + E LL + I+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 154 SF-QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI 212
F E +Y + E L G D+ LL L + ++++ Q + ++ +H +HRD+
Sbjct: 77 IFISPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDL 134
Query: 213 KPDNLLLDKNGHMKLSDFGLCKPLD 237
KP N+L+++N +K+ DFGL + D
Sbjct: 135 KPSNILINENCDLKICDFGLARIQD 159
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 15/158 (9%)
Query: 89 ELLTIIGRGAFGE--VRLCREKKSGNIYAMKKL----KKSEMVKRGQVEHVRAERNLLAE 142
ELLT+IG+ V L + K + + A+KK+ E +K Q E + R L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQE-IITSRQLQHP 59
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAI 199
I+ SF LY++ + G L++ + L E F + + A+
Sbjct: 60 ----NILPYVTSFIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAFILKDVLNAL 114
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ IH +IHR +K ++LL +G + LS +
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-10
Identities = 41/144 (28%), Positives = 67/144 (46%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
F L IG G+FG V R+ ++ + A+KK+ S + + + E L +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
++ + +L+MEY G L + + L E ++ + +H HN
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFG 231
IHRDIK N+LL + G +KL+DFG
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 43/161 (26%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK---SEMVKRGQVEHVRAERNLLAE 142
D ++ L+ +G GA+G+V + K+G A+KKL + S + + +R LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR----LLKH 70
Query: 143 VASHCIVKLYYSFQDTEYL------YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ ++ L F L YL+ L G D+ + ++ L+++ +F + Q +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVYQIL 128
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ IH IHRD+KP N+ ++++ +K+ DFGL + D
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 56/239 (23%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK----SEMVKRGQVEHVRAERNLLAEV 143
++++ +IG+G GEV L + A+KK+++ + ++K+ +R E + A++
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLR-EAKIAADL 59
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM---REDTLTENVARFYIAQSVLA-- 198
IV +Y D + +Y M Y+ G + +LL ++++L++ +A SV A
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFL 116
Query: 199 ---------IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
IE +H +HRD+KPDN+LL G + + D+G
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI--------------- 161
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
+ + E ++ + + M + VGTPDY+APE LL
Sbjct: 162 --FKKLEE-----------EDLLDIDVDERNICYSSMT---IPGKIVGTPDYMAPERLL 204
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK---SEMVKRGQVEHVRAERNLLAE 142
D + L +G GA+G V ++++G A+KKL + SE+ + +R LL
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKH 70
Query: 143 VASHCIVKLYYSFQDTEYL------YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ ++ L F L YL+M ++ G + LM+ + L+E+ +F + Q +
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 25/162 (15%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA--- 144
+++ +IG+G++G V + +G A+KK+ EHV +L E+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKLLR 54
Query: 145 --SHC-IVKLYY--------SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA 193
H IV++ + F+D +Y++ E L D+ ++ D LT +F++
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHHQFFLY 110
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235
Q + A++ IH N HRD+KP N+L + + +K+ DFGL +
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 67/253 (26%), Positives = 115/253 (45%), Gaps = 53/253 (20%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM----VKRGQVE-----HVRAE 136
+ ++ L+ +G GA+G V + K+G A+KKL + KR E H++ E
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 137 RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
N++ + + F D +YL+ +L G D+ ++ + LT++ +F I Q +
Sbjct: 77 -NVIGLLDVFTPARSLEEFND---VYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQIL 130
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS---------------TL 241
++ IH + IHRD+KP NL ++++ +K+ DFGL + D L
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML 190
Query: 242 YAIHEHKTIDDEN----MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297
+H ++T+D + MAE + FP TD+ +++ KL VG
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---------------IDQLKLILRLVG 235
Query: 298 TPDYIAPEVLLKK 310
TP LLKK
Sbjct: 236 TP----GAELLKK 244
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 94 IGRGAFGEVRLCREK----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+G G FG+V LCR +G A+K LK + ++ E +L + IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 150 KLYYSFQDTEY---LYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKH 205
K Y + + LIME+LP G + L R ++ + Y Q ++ +
Sbjct: 70 K-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
Y+HRD+ N+L++ +K+ DFGL K ++ Y
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 165
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 93 IIGRGAFGEVRLCREKK-----SGNI-YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+G GAFGEV SG I A+K L+K + + E + E +L++
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFL-KEAHLMSNFNHP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED---------TLTENVAR-FYIAQSV 196
IVKL E Y+IME + GGD+++ L TL E + +A+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGH-----MKLSDFGLCKPLDCSTLYAIHEHKTID 251
+ +E +H +IHRD+ N L+ + G+ +K+ DFGL + + S Y +
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 252 DENMAEPMDIDGCF 265
MA +DG F
Sbjct: 177 VRWMAPESLLDGKF 190
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 4/152 (2%)
Query: 84 CVDDFELLTI----IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
DD E + + IG G+FG V + + A+KK+ S + + + E
Sbjct: 15 YKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKF 74
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
L ++ ++ + +L+MEY G L + + L E ++ +
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 134
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
+H HN IHRDIK N+LL + G +KL+DFG
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFG 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 94 IGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+G G FG+V L +G + A+K LK+ + + E N+L + IV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIV 69
Query: 150 KLY--YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI-AQSVL-AIESIHKH 205
K S Q + L LIMEY+P G + L + N+A+ + AQ + + +H
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL---NLAQLLLFAQQICEGMAYLHSQ 126
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+YIHRD+ N+LLD + +K+ DFGL K + Y
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 93 IIGRGAFGEVR--LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
++G+G FGEV ++K + K+ E+ + +E +L + IVK
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYI--AQSVLAIESIHKHN 206
L + +Y++ME +PGGD ++ L + ++ T+ + +F + A + +ES N
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KN 113
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
IHRD+ N L+ +N +K+SDFG+ + D
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQED 144
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 6/146 (4%)
Query: 94 IGRGAFGEVR--LCREKKSGNI-YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
+G G FG V + K + A+K LK+ + G+ E +R E +++A++ CIV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-AAGKKEFLR-EASVMAQLDHPCIVR 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L + E L L+ME P G ++ L + + + + Q + + + +++HR
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPL 236
D+ N+LL K+SDFG+ + L
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 41/146 (28%), Positives = 76/146 (52%), Gaps = 8/146 (5%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G FGEV + K + A+K +K M VE AE N++ + +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 67
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIHKHNYIHRD 211
+ E +Y+I E++ G ++ L ++ + + + + AQ + I + NYIHRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ N+L+ + K++DFGL + ++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIE 153
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 40/141 (28%), Positives = 71/141 (50%), Gaps = 2/141 (1%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G + V R K + N+ A+K+++ E + +R E +LL + IV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR-LEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213
L L+ EYL L + ++ + + ++ Q + + HK +HRD+K
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 214 PDNLLLDKNGHMKLSDFGLCK 234
P NLL+++ G +KL+DFGL +
Sbjct: 131 PQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 40/152 (26%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEVASHCIVKL 151
IGRGA+G V + ++ A+KK+ +++ R R LL + ++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 152 --------YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
+F D +Y +M+ D+ ++ TL+++ ++++ Q + ++ IH
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235
N +HRD+KP NLLL+ N +K+ DFGL +
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLART 157
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 15/159 (9%)
Query: 88 FELLTIIGRGAFGEVRLCRE-KKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEV 143
+E + IG GA+G+V R+ K G A+K+++ E + + V R+L E
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--ET 60
Query: 144 ASH-CIVKLY----YSFQDTEY-LYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQS 195
H +V+L+ S D E L L+ E++ D+ T L + E + + + Q
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ ++ +H H +HRD+KP N+L+ +G +KL+DFGL +
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 2/144 (1%)
Query: 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
L +G G + V R K + N+ A+K+++ + G E +LL ++ IV
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L+ + L L+ EYL + + ++ + + ++ Q + + H+ +HR
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCK 234
D+KP NLL+++ G +KL+DFGL +
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 23/169 (13%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSG--NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+D + +IG G FG+V R KK G A+K++K E + E +L ++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKL 64
Query: 144 ASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES- 201
H I+ L + + YLYL +EY P G+++ L R+ + E F IA S + S
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123
Query: 202 ----------------IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 2/144 (1%)
Query: 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
L +G G + V R K + N+ A+K+++ + G E +LL ++ IV
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
L+ + L L+ EYL L +++ + + ++ Q + + H+ +HR
Sbjct: 69 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCK 234
D+KP NLL+++ G +KL+DFGL +
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D L +G G FG V+ + + ++ A+K +K+ M + +E + L E
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHEK--- 60
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKH 205
+V+LY +Y++ EY+ G ++ L + + + V + +
Sbjct: 61 -LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+IHRD+ N L+D G +K+SDFGL +
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 60/238 (25%), Positives = 91/238 (38%), Gaps = 60/238 (25%)
Query: 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKL 151
++G GA G V + G +A+K + M + +AE L IVK
Sbjct: 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 152 YYSF--------QDTEYLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAI 199
+ F ++ + L+++Y GD+ + T E+ A Q +LA+
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
+H + IHRDIK N+LL NG +KL DFG K +YA T+ D
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK------MYA----ATVSD------- 199
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
D+ F GTP Y+APE+ +K Y + D
Sbjct: 200 DVGRTF------------------------------CGTPYYVAPEIWRRKPYSKKAD 227
|
Length = 496 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-- 144
+ +L IG+G FG+V L + G A+K LK + A + LAE +
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAEASVM 54
Query: 145 ---SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVL-A 198
H +V+L LY++ EY+ G ++ L R + + A V
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+E + + N++HRD+ N+L+ ++ K+SDFGL K
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 12/156 (7%)
Query: 91 LTIIGRGAFGEVRLCREKKS--GNIYAMKKLKKSEMVKRGQVE-HVRAERNLLAEVASHC 147
+T +GRG FGEV L + K + +K + K ++ R E ++ +++
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM----REDTL----TENVARFYIA-QSVLA 198
+V+L ++ E Y+I+EY GD+ L +++ L + + Q L
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
++ + ++HRD+ N L+ +K+S L K
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 85 VDDFELLTI--IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+D EL + +G G FG V L + + ++ A+K +++ M + +E + L
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKL--- 56
Query: 143 VASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIE 200
SH +V+LY ++++ EY+ G ++ L + V A+E
Sbjct: 57 --SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + +IHRD+ N L+ ++ +K+SDFGL
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFGL 146
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY--AMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+D + +IG G FG+V KK G A+K LK E E +L ++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 144 ASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTEN 186
H I+ L + ++ YLY+ +EY P G+++ L + TLT
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ + ++ + + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ +L+ +G G FGEV + + + A+K LK M +E E ++ ++
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIH 203
+V+LY + E +Y++ EY+ G ++ L + + AQ + I
Sbjct: 61 DKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ NYIHRD++ N+L+ K++DFGL +
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 94 IGRGAFGEVR--LCREKKSGNIYAMKKLK-------KSEMVKRGQVEHVRAERNLLAEVA 144
+G G FG V+ + + +K A+K LK + EM++ ++ H ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH---------QLD 53
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESI 202
+ IV++ + E L L+ME GG + L +++ NV + Q + ++ +
Sbjct: 54 NPYIVRMI-GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYL 111
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
N++HRD+ N+LL + K+SDFGL K L
Sbjct: 112 EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 7/147 (4%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+L +G G FGEV + + + A+K LK M E E ++ ++
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKH 205
+V+LY + E +Y++ EY+ G ++ L + L AQ + +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGL 232
NYIHRD+ N+L+ +N K++DFGL
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 8/154 (5%)
Query: 91 LTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148
L +G G++ V + +G + A+K +K E V + E +LL + I
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANI 65
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYI 208
V L+ E L + EY+ ++ L R ++ Q + + IH + +
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 209 HRDIKPDNLLLDKNGHMKLSDFGLC--KPLDCST 240
HRD+KP NLL+ G +KL+DFGL K + T
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 3/142 (2%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
IGRG FGEV R + A+K + E + E +L + + IV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA-IESIHKHNYIHRDI 212
+ +Y++ME + GGD +T L E + + ++ A +E + + IHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 213 KPDNLLLDKNGHMKLSDFGLCK 234
N L+ + +K+SDFG+ +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 40/168 (23%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH--------VRA 135
++ ++ L +G G++ V R K +G + A+K+++ +EH +R
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIR- 52
Query: 136 ERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL-----------PGGDMMTLLMREDTLT 184
E +LL ++ IV L+ + L L+ EYL GG L+
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-----------LS 101
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ R ++ Q + + H+ +HRD+KP NLL+ + G +KL+DFGL
Sbjct: 102 MHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 4/145 (2%)
Query: 94 IGRGAFGEVR--LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKL 151
+G G FG V+ + + KKS A+K LK + E +R E N++ ++ + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIVRM 61
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
+ E L+ME G + L + +TE + Q + ++ + + N++HRD
Sbjct: 62 I-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPL 236
+ N+LL + K+SDFGL K L
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 8/143 (5%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV + + + A+K LK M ++ + + L E +V+LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEK----LVQLYA 68
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIHKHNYIHRD 211
+ E +Y++ EY+ G ++ L E + + AQ + + + NY+HRD
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 212 IKPDNLLLDKNGHMKLSDFGLCK 234
++ N+L+ +N K++DFGL +
Sbjct: 128 LRAANILVGENLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 37/146 (25%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G+G FGEV + + + A+K LK M+ ++ E ++ ++ +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLYA 68
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA--IESIHKHNYIHRD 211
+ E +Y++ E++ G ++ L D + + + +A + I + NYIHRD
Sbjct: 69 VVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 212 IKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ N+L+ N K++DFGL + ++
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 40/166 (24%), Positives = 64/166 (38%), Gaps = 21/166 (12%)
Query: 86 DDFELLTIIGRGAFGEVRL--CREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLL 140
D L +G GAFG+V L C + N + A+K LK E + E LL
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELL 62
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--------------TLTEN 186
IVK Y + + ++ EY+ GD+ L LT +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
Q + + +++HRD+ N L+ + +K+ DFG+
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 11/150 (7%)
Query: 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148
+LL +G G FGEV + + A+K LK M + AE ++ ++ +
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKKLRHPKL 63
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHK 204
++LY E +Y++ E + G ++ L L + + AQ + +
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID--MAAQVASGMAYLEA 121
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
NYIHRD+ N+L+ +N K++DFGL +
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAERNLLAEVA 144
+E + IG GA+G V R+ SG+ A+K ++ + + V V + L E
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRL--EAF 59
Query: 145 SH-CIVKLY----YSFQDTEY-LYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSV 196
H IV+L S D E + L+ E++ D+ T L + L + + Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238
++ +H + +HRD+KP+N+L+ G +KL+DFGL + C
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 42/167 (25%), Positives = 71/167 (42%), Gaps = 19/167 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VKRGQVEHVRAERNLLAEVA 144
+D L IG G FG+V +Y + +K + VK + + R + A
Sbjct: 6 EDITLGRCIGEGQFGDVYQ-------GVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEA 58
Query: 145 --------SHCIVKLYYSFQDTEYLYLIMEYLPGGDM-MTLLMREDTLTENVARFYIAQS 195
H IVKL + ++++ME P G++ L + + +L Y Q
Sbjct: 59 YIMRQFDHPH-IVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL 116
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
A+ + ++HRDI N+L+ +KL DFGL + L+ + Y
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 27/97 (27%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHM 225
E++ G + M +D NV + + Q + + +H+ +HRDIKP+NLL+ +G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 226 KLSDFG----LCKPLDCSTLYAIHEHKTIDDENMAEP 258
K+ DFG +C ++ + LY + + + E + P
Sbjct: 349 KIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385
|
Length = 507 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRA---ERNLLAEVA 144
++ LT +G GA+G V + + A+KKL + + H R E LL +
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ----SLIHARRTYRELRLLKHMK 72
Query: 145 SHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
++ L S ++ +YL+ L G D+ ++ + L++ +F I Q +
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRG 130
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ IH IHRD+KP N+ ++++ +++ DFGL + D
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 18/155 (11%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+IG G FGEV RL K A+K LK K Q +E +++ + I+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNII 68
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI------- 202
L ++ + ++ EY+ G + L + D +F + Q V + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
Y+HRD+ N+L++ N K+SDFGL + L+
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 36/143 (25%), Positives = 77/143 (53%), Gaps = 8/143 (5%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153
+G G FG V L + + + A+K + + M + +E E ++ +++ +V+LY
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYG 66
Query: 154 SFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVL-AIESIHKHNYIHRD 211
+ LY++ E++ G ++ L R+ L++++ + Q V +E + ++++IHRD
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-LSMCQDVCEGMEYLERNSFIHRD 125
Query: 212 IKPDNLLLDKNGHMKLSDFGLCK 234
+ N L+ G +K+SDFG+ +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 41/151 (27%), Positives = 77/151 (50%), Gaps = 10/151 (6%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +LL IG+G FG+V L + GN A+K +K + AE +++ ++
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 59
Query: 147 CIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVL-AIESIH 203
+V+L ++ LY++ EY+ G ++ L R ++ + V A+E +
Sbjct: 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+N++HRD+ N+L+ ++ K+SDFGL K
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 93 IIGRGAFGEVRLCREKKSG-NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVK 150
+IG G FG+V R KK G + A K K E + E +L ++ H I+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN--VARFYIAQSVLA---------- 198
L + + YLYL +EY P G+++ L + L + A S L+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 199 ----IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
++ + + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 93 IIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+IG G FGEV K G A+K LK K Q + +E +++ + + H I+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNII 69
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA-IESIHKHNYI 208
+L + +I EY+ G + L D + + + + A ++ + NY+
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
HRD+ N+L++ N K+SDFGL + L+
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLE 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 8e-07
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 28/192 (14%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEV------RLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
+KRH I L +G GAFG+V LC E+ + A+K LK + R
Sbjct: 2 IKRHNIV-----LKRELGEGAFGKVFLAECYNLCPEQDK-ILVAVKTLKDASDNARKDF- 54
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMM---------TLLMREDT 182
H AE LL + IVK Y + + L ++ EY+ GD+ +LM E
Sbjct: 55 HREAE--LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112
Query: 183 LTENVAR---FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238
+ + +IAQ + A + + +++HRD+ N L+ +N +K+ DFG+ + +
Sbjct: 113 RPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 172
Query: 239 STLYAIHEHKTI 250
+ Y + H +
Sbjct: 173 TDYYRVGGHTML 184
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 18/167 (10%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNL 139
I + +IG G FGEV R K G A+K LK K Q E ++
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK--QRLDFLTEASI 58
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+ + I++L + + +I EY+ G + L D +F + Q V +
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTVGQLVGML 112
Query: 200 ESI-------HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
I + NY+HRD+ N+L++ N K+SDFGL + L+ S
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 31/165 (18%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D E IG GAFG V + + G A+KK+ V + V R R L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFREL------- 50
Query: 147 CIVKLYYSFQDT-----------------EYLYLIMEYLPGGDMMTLLMREDTLTENVAR 189
K+ F+ E +Y++ E L D+ +++ L+ + +
Sbjct: 51 ---KMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQPLSSDHVK 106
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
++ Q + ++ +H +HRDIKP NLL++ N +K+ DFGL +
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 26/159 (16%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVR----AERNLLAEVAS 145
+IG G FGEV RL K A+K LK G E R +E +++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS------GYTEKQRRDFLSEASIMGQFDH 64
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI--- 202
I+ L + + +I E++ G + + L + D +F + Q V + I
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAG 118
Query: 203 ----HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ NY+HRD+ N+L++ N K+SDFGL + L+
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 23/78 (29%), Positives = 46/78 (58%), Gaps = 3/78 (3%)
Query: 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 220
+Y++ EY+ + ++ + L+E AR ++ Q + ++ IH N +HRD+KP N+ ++
Sbjct: 91 VYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148
Query: 221 KNGHM-KLSDFGLCKPLD 237
+ K+ DFGL + +D
Sbjct: 149 TEDLVLKIGDFGLARIVD 166
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKL------KKSEMVKRGQVEHVRAERNLLA 141
++L IIG G+FG V + A+KK+ K E++ + H+ N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NII- 122
Query: 142 EVASHCIVKLYY---SFQDTE---YLYLIMEYLPGG--DMMTLLMRED-TLTENVARFYI 192
+K YY F+ E +L ++ME++P M R + L + + Y
Sbjct: 123 ------FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-MKLSDFGLCKPL 236
Q A+ IH HRD+KP NLL+D N H +KL DFG K L
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221
|
Length = 440 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 43/168 (25%), Positives = 67/168 (39%), Gaps = 25/168 (14%)
Query: 86 DDFELLTIIGRGAFGEV-----RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
D LL +G GAFGEV R A+K L E E ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIM 63
Query: 141 AEVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVAR---------- 189
++ IV+L SF+ ++++E + GGD+ + L E +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCK 234
+A+ +E H +IHRDI N LL G K++DFG+ +
Sbjct: 123 RDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEM---VKRGQ-----VEHVRAERN------- 138
+G G FGEV LC + M+K + V Q V+ +R + N
Sbjct: 13 LGEGQFGEVHLCEAE------GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 139 -----LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR----EDTLTENVA- 188
+++ + I++L ++ L +I EY+ GD+ L R E +V
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 189 ------RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
F Q ++ + N++HRD+ N L+ KN +K++DFG+ + L Y
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 243 AIH 245
I
Sbjct: 187 RIQ 189
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 86 DDFELLTIIGRGAFGEVR------LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
++ +G GAFG+V L + + A+K LK + + E + +E +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPT--AHSSEREALMSELKI 91
Query: 140 LAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSV 196
++ + +H IV L + + +I EY GD++ L R E LT + Q
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHM-KLSDFGLCK 234
+ + N IHRD+ N+LL +G + K+ DFGL +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 16/28 (57%), Positives = 19/28 (67%)
Query: 291 LAFSTVGTPDYIAPEVLLKKGYGMECDW 318
A S VG+PDY+APEVL KGY D+
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVDY 181
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 40/178 (22%), Positives = 79/178 (44%), Gaps = 28/178 (15%)
Query: 94 IGRGAFGEVRLCREK--------------KSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
+G G FGEV LC + + A+K L+ +++ K + + ++ E +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR-ADVTKTARNDFLK-EIKI 70
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-----TLTENVARFYIA- 193
++ + + I++L + L +I EY+ GD+ L + + T N+ IA
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 194 ------QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
Q ++ + N++HRD+ N L+ + +K++DFG+ + L Y I
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 45/214 (21%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
++++E++ IG G FGEV L + K++ + K + + +R + + V E N++ E+
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK 70
Query: 145 SHCIVKLYYSF--QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA----QSVLA 198
IV+ F + + LY++ME+ GD+ + + + + I Q + A
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 199 IESIHK-------HNYIHRDIKPDNLLLDK---------------NGH--MKLSDFGLCK 234
+ H +HRD+KP N+ L NG K+ DFGL K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 235 --------------PLDCSTLYAIHEHKTIDDEN 254
P S +HE K+ DD++
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKS 224
|
Length = 1021 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 49/152 (32%), Positives = 70/152 (46%), Gaps = 21/152 (13%)
Query: 94 IGRGAFGEVRLCREKKSGNIYA---MKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCI 148
IG G FG+V L E SG A +K+L+ S V + +E + R+L C
Sbjct: 3 IGNGWFGKVIL-GEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC- 60
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLL--------MREDTLTENVARFYIAQSVLAIE 200
L + T YL L+ME+ P GD+ L M D T IA +L
Sbjct: 61 --LGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL--- 114
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+HK+N+IH D+ N LL + +K+ D+GL
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 21/171 (12%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
++ F LKR ++ L IG GA G V + G A+KKL + + Q
Sbjct: 14 DSTFTVLKR-------YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTH 63
Query: 132 HVRAERNL--LAEVASHCIVKLYYSF------QDTEYLYLIMEYLPGGDMMTLLMREDTL 183
RA R L L V I+ L F ++ + +YL+ME + + M D
Sbjct: 64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD-- 121
Query: 184 TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ + Q + I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 122 -HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ +L+ + G+ GEV +C K G+ K + K+ + + + + SH
Sbjct: 94 YNILSSLTPGSEGEVFVC--TKHGDEQRKKVIVKAVTGGKTPGREIDILKTI-----SHR 146
Query: 148 -IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHKH 205
I+ L ++++ + ++M D+ T + R L A I + +L A+ +H
Sbjct: 147 AIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGR 204
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFG-LCKPLDC 238
IHRD+K +N+ LD+ + L DFG CK
Sbjct: 205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
|
Length = 392 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D + I+G G G V + I A+K + V+ + + +E +L + S
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK--QIMSELEILYKCDSP 59
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDM-MTLLMREDTLTENVARFYIAQSVL-AIESIHK 204
I+ Y +F + + E++ GG + + + E L IA +V+ + +
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR------IAVAVVKGLTYLWS 113
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
+HRD+KP N+L++ G +KL DFG+ L
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 23/167 (13%)
Query: 87 DFELLTIIGRGAFGEV-----RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
L +G GAFG+V E+ S A+K LK++ K + R E L++
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMS 63
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR----EDTLTENVAR-------- 189
++ IV L + ++ EYL GD+ L+R D E+
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 190 ---FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+IA + A +E + H+++HRD+ N L+ + +K+SDFGL
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK- 121
N +E ++ F LKR ++ L IG GA G V + A+KKL +
Sbjct: 1 NQFYSVEVGDSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 53
Query: 122 ---SEMVKRGQVEHVRAE----RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMM 174
KR E V + +N+++ + K FQD +YL+ME +
Sbjct: 54 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD---VYLVMELMDANLCQ 110
Query: 175 TLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ M D + + Q + I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 111 VIQMELD---HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 89 ELLTIIGRG--AFGEVRLCREKKSGNIYAMKKLK----KSEMVKRGQVE-HVRAERNLLA 141
ELLT+IGRG V L R K +G ++++ +EMV Q E HV +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHV-------S 53
Query: 142 EVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVL- 197
++ +H IV +F L+++ ++ G L+ D ++E +A YI Q VL
Sbjct: 54 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSE-LAIAYILQGVLK 112
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228
A++ IH Y+HR +K ++L+ +G + LS
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 9/165 (5%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEVAS 145
+F L +G G FGEV K + A+K LK +++K+ + V+A + L +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKH-- 63
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF-YIAQSVL-AIESIH 203
++ L+ E +Y+I E + G ++ L + VA +A V + +
Sbjct: 64 --LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
+ N IHRD+ N+L+ ++ K++DFGL + + +Y + K
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKK 165
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 27/172 (15%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS-EMVKRGQV 130
++ F LKR ++ L IG GA G V + +G A+KKL + + V +
Sbjct: 9 DSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK- 60
Query: 131 EHVRAERNL-LAEVASH-CIVKLYYSF------QDTEYLYLIMEYLPGG--DMMTLLMRE 180
RA R L L ++ +H I+ L F ++ + +YL+ME + ++ + +
Sbjct: 61 ---RAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH 117
Query: 181 DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ ++ + + Q + I+ +H IHRD+KP N+++ + +K+ DFGL
Sbjct: 118 ERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 24/178 (13%)
Query: 94 IGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148
+G GAFG+V L K + A+K LK + R + E LL + I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHEHI 69
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----TLTENVAR-----------FYIA 193
VK Y D + L ++ EY+ GD+ L L + R +IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 194 QSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+ + + + +++HRD+ N L+ N +K+ DFG+ + + + Y + H +
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 55 DVPMEEQI-NLIKDLERKETE----FMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKK 109
D M+ I ++ D + + + R I F +L GA G C + K
Sbjct: 56 DKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDNK 115
Query: 110 SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169
+ + ++K GQ E ++L + I++L +F ++ LI LP
Sbjct: 116 T---------CEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LP 163
Query: 170 --GGDMMTLLM--REDTLTENVARFYIAQSVL-AIESIHKHNYIHRDIKPDNLLLDKNGH 224
D+ L R + + +A I +SVL AI+ +H++ IHRDIK +N+ ++ G
Sbjct: 164 RYKTDLYCYLAAKRNIAICDILA---IERSVLRAIQYLHENRIIHRDIKAENIFINHPGD 220
Query: 225 MKLSDFG-LCKPLD 237
+ L DFG C P+D
Sbjct: 221 VCLGDFGAACFPVD 234
|
Length = 391 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 4/122 (3%)
Query: 115 AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DTEYLYLIMEYLPGGDM 173
A+K L+ + Q R E L A + IV L S + L+ + EY+PG +
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDF 230
+L + L + Q + A+ H +HRD+KP N+++ + G H K+ DF
Sbjct: 67 REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126
Query: 231 GL 232
G+
Sbjct: 127 GI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 68 LERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR 127
+E ++ F LKR ++ L IG GA G V + A+KKL + +
Sbjct: 13 VEIGDSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQ 62
Query: 128 GQVEHVRAERNL-LAEVASH-CIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMR 179
Q RA R L L + +H I+ L S ++ + +Y++ME + + M
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 180 EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
D + + Q + I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 123 LD---HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 88 FELLTIIGRGAFGEVR---LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
F L ++G+G FG VR L E S A+K LK +++ +E E + E
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 145 SHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMR----EDTLT---ENVARFY 191
++KL + +I+ ++ GD+ T L+ E+ T + + RF
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
I +E + N+IHRD+ N +L++N + ++DFGL K
Sbjct: 120 I-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 29/170 (17%)
Query: 94 IGRGAFGEVRLCR----------------EKKSGNIYAMKKLKKSEMVKRGQVEHVRAER 137
+G G FGEV LC + + A+K L+ E E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEV 70
Query: 138 NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD-----------MMTLLMREDTLTEN 186
+L+ ++ I +L L +IMEY+ GD L +L+ +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
+ Q + + N++HRD+ N L+ KN +K++DFG+ + L
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 33/178 (18%)
Query: 87 DFELLTIIGRGAFGEV------RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L +G G FG+V RL + + A+K LK++ ++ + +E NLL
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLL 57
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR--------------------- 179
+V ++KLY + L LI+EY G + + L
Sbjct: 58 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 180 ---EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
E LT + Q ++ + + +HRD+ N+L+ + MK+SDFGL +
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 33/165 (20%), Positives = 69/165 (41%), Gaps = 23/165 (13%)
Query: 86 DDFELLTIIGRGAFGEVR--LCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L+ +G+G+FG V L + G A+K + +E + E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--NENASMRERIEFLNEASVM 63
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENV------ARFY- 191
E H +V+L + ++ME + GD+ + L R + +F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 192 ----IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
IA + + + ++HRD+ N ++ ++ +K+ DFG+
Sbjct: 124 MAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGM 165
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 41/186 (22%), Positives = 74/186 (39%), Gaps = 35/186 (18%)
Query: 94 IGRGAFGEVRLCR---------------EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+G G FGEV LC +K + K+ + + K + + ++ E
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK-EVK 71
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR---EDTLTENVARFYIAQS 195
+L+ + I++L D + L +I EY+ GD+ L +D A
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 196 VLAI----------------ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
+ AI + + N++HRD+ N L+ +N +K++DFG+ + L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191
Query: 240 TLYAIH 245
Y I
Sbjct: 192 DYYRIQ 197
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 20/108 (18%), Positives = 41/108 (37%), Gaps = 12/108 (11%)
Query: 131 EHVRAERNLLAEVASHCIV--KLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
E +L +A + K+ S + + YL+ME++ G L +
Sbjct: 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDI 91
Query: 189 RFYIAQSVLAIESIHKHNY---IHRDIKPDNLLLDKNGHMKLSDFGLC 233
+A+ + +H+ H D+ P N+L+D + + D+
Sbjct: 92 AEQLAE---LLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 14/23 (60%), Positives = 18/23 (78%)
Query: 296 VGTPDYIAPEVLLKKGYGMECDW 318
+GTPDY+APE+LL K +G DW
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDW 563
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 9/162 (5%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+IG+G FG V L A+K L + ++ +VE E ++ + + ++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNVL 59
Query: 150 KLYYSFQDTEYLYLI-MEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIESIHKHN 206
L +E L+ + Y+ GD+ + R +T V + Q +E +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
++HRD+ N +LD++ +K++DFGL + + Y++H H
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 35/149 (23%), Positives = 64/149 (42%), Gaps = 8/149 (5%)
Query: 94 IGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
+G G+FG VR SG A+K LK ++ ++ E ++ + +++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYI 208
LY L ++ E P G ++ L ++ + Y Q + + +I
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
HRD+ N+LL + +K+ DFGL + L
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALP 148
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 8e-04
Identities = 39/154 (25%), Positives = 60/154 (38%), Gaps = 30/154 (19%)
Query: 93 IIGRGA-----------FGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+IG+GA V R K Y +L E ++ E RAE LL+
Sbjct: 340 LIGKGAEADIKKGEYLGRDAVIKERVPKG---YRHPEL--DERLRT---ERTRAEARLLS 391
Query: 142 EVASHCI-VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
E + + Y D E ++MEY+ G D+ +L L V +
Sbjct: 392 EARRAGVPTPVIYDV-DPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGE--------IVA 442
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+HK +H D+ N ++ + + L DFGL K
Sbjct: 443 KLHKAGIVHGDLTTSNFIVR-DDRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 48/188 (25%), Positives = 74/188 (39%), Gaps = 42/188 (22%)
Query: 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE--MVKR----GQV 130
L R DDF L +G GAFG V K S K+ KK ++K+ G V
Sbjct: 123 GLFRPSFKKDDFVLGKKLGEGAFGVVY----KASL---VNKQSKKEGKYVLKKATEYGAV 175
Query: 131 EHVRAERNLLAEVASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTE 185
E ER A + C +Y S + + +L+ Y G + LM+
Sbjct: 176 EIWMNERVRRA-CPNSCADFVYGFLEPVSSKKEDEYWLVWRY-EGESTLADLMQSKEFPY 233
Query: 186 NVARFY----------------IAQSVL-----AIESIHKHNYIHRDIKPDNLLLD-KNG 223
NV + I Q+++ A++ +H +HRD+KP N++ +G
Sbjct: 234 NVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG 293
Query: 224 HMKLSDFG 231
K+ D G
Sbjct: 294 SFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 27/184 (14%)
Query: 77 RLKRHKICVDDFELLTIIGRGAFGEVRLC--------REKKSGNIYAMKKLKKSE----- 123
+LK + F ++ + GAFG++ +C E + G + K E
Sbjct: 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK 198
Query: 124 MVKRGQVEHVRAERNLLA--EVASHCIVKLYYSFQDTEYLYLIME--------YLPGGDM 173
VK G ++ E +LA + I+K+ + Y+I + ++
Sbjct: 199 RVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA- 257
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
+D R + Q + A+E IH IHRDIK +N+ L+ +G + L DFG
Sbjct: 258 ---FDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 234 KPLD 237
P +
Sbjct: 315 MPFE 318
|
Length = 501 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 43/181 (23%), Positives = 73/181 (40%), Gaps = 28/181 (15%)
Query: 86 DDFELLTIIGRGAFGEVRL-------CREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
D L +G GAFG+V + S A+K LK K + + +E
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETS--TVAVKMLKDDATEK--DLSDLVSEME 67
Query: 139 LLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR----------------ED 181
++ + H I+ L LY+++EY G++ L E+
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
TLT+ + Q +E + IHRD+ N+L+ ++ MK++DFGL + +
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 242 Y 242
Y
Sbjct: 188 Y 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 35/179 (19%)
Query: 94 IGRGAFGEVRLCREKKSGNIY----------AMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+G AFG++ G++Y A+K LK ++ Q + E +L+AE+
Sbjct: 13 LGECAFGKIY------KGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMR-----------EDTLTENVAR-- 189
IV L + + ++ EYL GD+ L+MR ED ++
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 190 --FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
+IA + A +E + H ++H+D+ N+L+ + H+K+SD GL + + + Y +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 88 FELLTIIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+L I+G G FG V +L ++ S A+K +K ++E +E + +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFD 59
Query: 145 SHCIVKLY-YSFQDTEYLYL-----IMEYLPGGDMMTLL--MREDTLTENVA-----RFY 191
++KL F+ + + I+ ++ GD+ + L R L E + +F
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF- 118
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ L +E + N+IHRD+ N +L ++ + ++DFGL K
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 29/192 (15%)
Query: 86 DDFELLTIIGRGAFGEVRLCRE-----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
++ E + IG+GAFG V R + + A+K LK+ E Q + R E L+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQR-EAALM 62
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFY-------- 191
AE IVKL + + L+ EY+ GD+ L R +++
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 192 ------------IAQSVLA-IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238
IA+ V A + + + ++HRD+ N L+ +N +K++DFGL + +
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 239 STLYAIHEHKTI 250
+ Y E+ I
Sbjct: 183 ADYYKASENDAI 194
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 29/174 (16%)
Query: 94 IGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148
+G GAFG+V L ++ + A+K LK++ R + + E LL + I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69
Query: 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-----------------TLTENVA-RF 190
V+ Y + L ++ EY+ GD+ L TL + +A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
IA ++ + S+H ++HRD+ N L+ + +K+ DFG+ + + + Y +
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 22/79 (27%), Positives = 42/79 (53%), Gaps = 8/79 (10%)
Query: 161 LYLIMEYLPGGDMMTLLMREDTLTENVARF-----YIAQSVLAIESIHKHNYIHRDIKPD 215
LY++ME + G+++ L +V + +A+ + +ES +HRD+
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAAR 129
Query: 216 NLLLDKNGHMKLSDFGLCK 234
N+L+ ++G K+SDFGL +
Sbjct: 130 NILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 31/157 (19%)
Query: 94 IGRGAFGEVRLCREKKSGNIYA---MKKLKKS-------EMVKRGQVEHVRAERNLLAEV 143
IG G FG+V L E G A +K+L+ S ++ Q N+L +
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL------MREDTLTENVARFY--IAQS 195
CI + YL L++E+ P GD+ L + + + + R +A
Sbjct: 62 G-QCI-------ESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+L + H+ ++IH D+ N L + +K+ D+GL
Sbjct: 113 LLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 4/45 (8%)
Query: 187 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
VAR Q + AI+ IH IHRDIK +N+L++ + L DFG
Sbjct: 265 VAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 89 ELLTIIGRG--AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
EL IGRG V L R +G + ++ ++ EH++A +N V SH
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITD----LENCTEEHLKALQN--EVVLSH 54
Query: 147 C-----IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAI 199
I+ + F +L++I ++ G +LL + ++E + + ++ +
Sbjct: 55 FFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGL 114
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228
+H++ YIHR+IK ++L+ +G + LS
Sbjct: 115 NYLHQNGYIHRNIKASHILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.004
Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 88 FELLTIIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+E+ IGRG +G V + K K G YA+KK K + G + E LL E+
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 146 HCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLM-----REDTLTENVARFYIAQSVLA 198
+V L F + + +YL+ +Y D+ ++ + ++ ++ + + Q +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 199 IESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGL 232
+ +H + +HRD+KP N+L+ + G +K+ D GL
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 34/150 (22%), Positives = 67/150 (44%), Gaps = 6/150 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L+ IG G FG V L + + A+K +++ M + E E ++ +++
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSE----EDFIEEAQVMMKLSH 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHK 204
+V+LY + + L+ E++ G + L + + V + +
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
N IHRD+ N L+ +N +K+SDFG+ +
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 333 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.46 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.46 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.84 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.79 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.61 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.56 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.44 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.42 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.41 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.19 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.12 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.95 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.89 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.78 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.74 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.57 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.39 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.33 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.19 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.17 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.14 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.0 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.0 | |
| PLN02236 | 344 | choline kinase | 96.92 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.89 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.74 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.53 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.19 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.85 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.59 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.42 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.37 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.92 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.89 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.61 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.95 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.48 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.42 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-62 Score=445.57 Aligned_cols=325 Identities=62% Similarity=0.930 Sum_probs=288.7
Q ss_pred hhcccCCHHHHHHHHHHHHHHHHHHHHHHhcHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhhhhhhccccC
Q 019953 6 EEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICV 85 (333)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (333)
+-+...+..|.+++++++.+|++||..+++..++|++|++.+++.++..+.+.+.+.+.++....++.++++++...+..
T Consensus 61 ~~~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~~ 140 (550)
T KOG0605|consen 61 EYEFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLSL 140 (550)
T ss_pred ccccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCCc
Confidence 34557788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|+++++||+|+||.||+|+.+.||..+|+|++++.......++.+++.|.++|....+|+||++|.+|++..++||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||++||++..+|.+.+.+++..++.++++++.||..||+.|+|||||||+|+|||..|++||+|||||..+...+.....
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999877665432211
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
........+.... ..+..+.-+...+..+...+++.|+.+++..+-+++|||.||||||+.+.+|+..|| ||+||||
T Consensus 301 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 301 RLDEQMQINLSEA--KPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred cchhhhhhhhccC--CCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 1000011111110 111112113346777899999999999999999999999999999999999999999 9999999
Q ss_pred Hhhhcccc
Q 019953 325 FNSYRFLE 332 (333)
Q Consensus 325 ~~l~t~~~ 332 (333)
|+||.+.|
T Consensus 379 yEmLvGyP 386 (550)
T KOG0605|consen 379 YEMLVGYP 386 (550)
T ss_pred HHHHhCCC
Confidence 99987653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=357.92 Aligned_cols=199 Identities=34% Similarity=0.600 Sum_probs=182.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|.+.+.||+|+||+||+|+++.++..||||.+..... .....+.+..|+.+|+.++|||||.+++++..++.+|+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999987643 33456778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC------CcEEEEeccCcccCC
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN------GHMKLSDFGLCKPLD 237 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~------~~vkl~DFGla~~~~ 237 (333)
|||||+||+|.+++...+.+++..++.++.|++.||.+||+++||||||||.||||+.+ -.+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999865 468999999999887
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... +.+.||+|.|||||+++.+.|+.|+|
T Consensus 167 ~~~~--------------------------------------------------a~tlcGSplYMAPEV~~~~~YdAKAD 196 (429)
T KOG0595|consen 167 PGSM--------------------------------------------------AETLCGSPLYMAPEVIMSQQYDAKAD 196 (429)
T ss_pred chhH--------------------------------------------------HHHhhCCccccCHHHHHhccccchhh
Confidence 4432 23779999999999999999999999
Q ss_pred -hHHHHHHHhhhccccC
Q 019953 318 -WLVSVLHFNSYRFLEF 333 (333)
Q Consensus 318 -ws~g~il~~l~t~~~~ 333 (333)
||+|+|+|+|+++.++
T Consensus 197 LWSiG~Ilyq~l~g~~P 213 (429)
T KOG0595|consen 197 LWSIGTILYQCLTGKPP 213 (429)
T ss_pred HHHHHHHHHHHHhCCCC
Confidence 9999999999998754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=354.12 Aligned_cols=202 Identities=46% Similarity=0.817 Sum_probs=187.6
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
....++|+++++||+|+||+|++++.+.+++.||+|++++..............|..+|..++||+||.++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35578999999999999999999999999999999999998888877888899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+|+||+.||.|...|...+.+++..++.++++++.||.|||++|||||||||+|||+|.+|+++|+|||+|+..-..+
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999543222
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
..+.++|||+.|||||++.+.+|+.++| ||+
T Consensus 180 ------------------------------------------------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL 211 (357)
T KOG0598|consen 180 ------------------------------------------------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSL 211 (357)
T ss_pred ------------------------------------------------CccccccCCccccChHHHhcCCCCcccchHhH
Confidence 1223679999999999999999999999 999
Q ss_pred HHHHHhhhcccc
Q 019953 321 SVLHFNSYRFLE 332 (333)
Q Consensus 321 g~il~~l~t~~~ 332 (333)
|+++|+|+++.+
T Consensus 212 GillYeML~G~p 223 (357)
T KOG0598|consen 212 GILLYEMLTGKP 223 (357)
T ss_pred HHHHHHHhhCCC
Confidence 999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=330.42 Aligned_cols=198 Identities=45% Similarity=0.816 Sum_probs=188.1
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
...++|+.++.||.|+||.|.+++++.+|..+|+|++.+.......+.++..+|..+|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56788999999999999999999999999999999999998888888999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+||||++||.|.+++++.+.+++..++.+++|++.||+|||+++|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
+.+.||||.|+|||++.+.+|+.++| |++|
T Consensus 198 -------------------------------------------------T~TlCGTPeYLAPEii~sk~ynkavDWWalG 228 (355)
T KOG0616|consen 198 -------------------------------------------------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALG 228 (355)
T ss_pred -------------------------------------------------EEEecCCccccChHHhhcCCCCcchhHHHHH
Confidence 33789999999999999999999999 8899
Q ss_pred HHHHhhhcccc
Q 019953 322 VLHFNSYRFLE 332 (333)
Q Consensus 322 ~il~~l~t~~~ 332 (333)
|++|+|+.+.+
T Consensus 229 VLIYEMlaG~p 239 (355)
T KOG0616|consen 229 VLIYEMLAGYP 239 (355)
T ss_pred HHHHHHHcCCC
Confidence 99999987653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=352.60 Aligned_cols=198 Identities=32% Similarity=0.533 Sum_probs=187.3
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
.+|...+.||+|||..||.+++..+|..||+|++.+....+....+.+.+|++|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|+|..++|..+++..++++|.+++.++.||+.||.|||+++|||||||..|+|++++.+|||+|||||..+...+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~----- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG----- 172 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-----
Confidence 999999999999988999999999999999999999999999999999999999999999999999999886442
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
.+..+.||||.|+||||+...+++.-+| ||+||||
T Consensus 173 --------------------------------------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvm 208 (592)
T KOG0575|consen 173 --------------------------------------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVM 208 (592)
T ss_pred --------------------------------------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHH
Confidence 2334789999999999999999999999 9999999
Q ss_pred Hhhhcccc
Q 019953 325 FNSYRFLE 332 (333)
Q Consensus 325 ~~l~t~~~ 332 (333)
|.||.+.|
T Consensus 209 YtLL~G~P 216 (592)
T KOG0575|consen 209 YTLLVGRP 216 (592)
T ss_pred HhhhhCCC
Confidence 99998765
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=345.53 Aligned_cols=306 Identities=42% Similarity=0.708 Sum_probs=260.6
Q ss_pred HHHHHHHHHHHHHHHHhcHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhhhhhhccccCCCceEeeeEeeec
Q 019953 19 VAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGA 98 (333)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~ 98 (333)
=.+-|=|.|.|+...++.-++|..|+..+|+.+....++...+....+-+..+++.+.+++.......-|..++.||-|+
T Consensus 562 PqafkFfMEQHVEnvlksyqqr~~Rk~QLEkEM~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGvGA 641 (1034)
T KOG0608|consen 562 PQAFKFFMEQHVENVLKSYQQREKRKKQLEKEMVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGVGA 641 (1034)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeecccc
Confidence 34566778899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCHHHHHH
Q 019953 99 FGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM 178 (333)
Q Consensus 99 ~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 178 (333)
||+|.+++...+...||+|.+.+.+...+.++.+...|.+||..-.++.||++|.+|++...+|+||+|++||++..+|.
T Consensus 642 FGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI 721 (1034)
T KOG0608|consen 642 FGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI 721 (1034)
T ss_pred cceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH
Confidence 99999999999999999999999888888889999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCC
Q 019953 179 REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258 (333)
Q Consensus 179 ~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (333)
..+.|.+..++++++++..|+++.|..|+|||||||+|||||.+|++||+||||+.-+-+-++..++. ...+..-+.
T Consensus 722 rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq---~gdH~RqDS 798 (1034)
T KOG0608|consen 722 RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ---EGDHHRQDS 798 (1034)
T ss_pred HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc---CCCcccccc
Confidence 99999999999999999999999999999999999999999999999999999999887655433322 112222222
Q ss_pred CCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
|+-+..+.+.+++......+. -+.-++..+.+.+||+.|+||||+...+|+..|| |+.|||||+|+.+.
T Consensus 799 mep~~e~~d~~~~lkvL~~ra----~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 799 MEPSPEWADISKCLKVLERRA----MRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCchhhccccccchHHHHHH----HhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 333333333333211111110 1233456677889999999999999999999999 88899999998764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=339.19 Aligned_cols=198 Identities=31% Similarity=0.550 Sum_probs=175.2
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhh----hHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG----QVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||++++....... ......+|+++|++++|||||+++++|..+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456789999999999999999999999999999999886543311 2334678999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC---CcEEEEeccCcccC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN---GHMKLSDFGLCKPL 236 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~---~~vkl~DFGla~~~ 236 (333)
+.|+||||++||+|.+.+-.++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999876 68999999999986
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC---C
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY---G 313 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---~ 313 (333)
... ....+.||||.|.||||+.+.++ .
T Consensus 330 g~~--------------------------------------------------sfm~TlCGTpsYvAPEVl~~kg~~~~~ 359 (475)
T KOG0615|consen 330 GEG--------------------------------------------------SFMKTLCGTPSYVAPEVLASKGVEYYP 359 (475)
T ss_pred ccc--------------------------------------------------eehhhhcCCccccChhheecCCeeccc
Confidence 522 23447899999999999988764 4
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| ||+||++|-+|++.
T Consensus 360 ~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 360 SKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred chheeeeccceEEEEeccC
Confidence 4779 99999999888764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=340.90 Aligned_cols=214 Identities=37% Similarity=0.636 Sum_probs=190.2
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 161 (333)
....+|.+++.||.|+|++|++|++..+++.||||++.+.......-.+.+..|..+|..| .||.|+++|..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3467899999999999999999999999999999999988877777778888999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+|+||+++|+|.+++.+-+.|++..++.+++||+.||+|||++|||||||||+|||+|.|++++|+|||.|+.+++...
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
..... . ... .......+++||..|++||++.....++++| |++
T Consensus 230 ~~~~~---------~-----~~~----------------------~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAl 273 (604)
T KOG0592|consen 230 SQENP---------V-----DPN----------------------QASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWAL 273 (604)
T ss_pred cccCc---------c-----Ccc----------------------cccCcccceeeeecccCHHHhcCCCCCcccchHHH
Confidence 22100 0 000 0111134789999999999999999999999 999
Q ss_pred HHHHHhhhcccc
Q 019953 321 SVLHFNSYRFLE 332 (333)
Q Consensus 321 g~il~~l~t~~~ 332 (333)
|||+|+|+.+.|
T Consensus 274 GCilyQmlaG~P 285 (604)
T KOG0592|consen 274 GCILYQMLAGQP 285 (604)
T ss_pred HHHHHHHhcCCC
Confidence 999999998864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=328.23 Aligned_cols=200 Identities=32% Similarity=0.544 Sum_probs=177.7
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEE-EEeeCC
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY-SFQDTE 159 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~ 159 (333)
......+|+++++||.|+||.||++.+..+|..||.|.+.-.. ........+..|+.+|++|+|||||++++ .|..++
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 3445667999999999999999999999999999999998544 34456677889999999999999999998 666666
Q ss_pred e-EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEecccCCCcEEEccCCcEEEEec
Q 019953 160 Y-LYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHK--HN--YIHRDIKPDNLLLDKNGHMKLSDF 230 (333)
Q Consensus 160 ~-~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~--~~--ivHrDlkp~Nill~~~~~vkl~DF 230 (333)
. ++||||+|.+|+|..+++. .+.+++..++.++.|++.||..+|. .. |+||||||.||+|+.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 6 8999999999999999854 4579999999999999999999998 45 999999999999999999999999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 310 (333)
|+++.+.... ..+.+.+|||.||+||++.+.
T Consensus 173 GL~r~l~s~~-------------------------------------------------tfA~S~VGTPyYMSPE~i~~~ 203 (375)
T KOG0591|consen 173 GLGRFLSSKT-------------------------------------------------TFAHSLVGTPYYMSPERIHES 203 (375)
T ss_pred hhHhHhcchh-------------------------------------------------HHHHhhcCCCcccCHHHHhcC
Confidence 9999887543 234478999999999999999
Q ss_pred CCCcccc-hHHHHHHHhhhcc
Q 019953 311 GYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t~ 330 (333)
+|+++|| ||+||++|+|+.-
T Consensus 204 ~Y~~kSDiWslGCllyEMcaL 224 (375)
T KOG0591|consen 204 GYNFKSDIWSLGCLLYEMCAL 224 (375)
T ss_pred CCCcchhHHHHHHHHHHHHhc
Confidence 9999999 9999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=321.30 Aligned_cols=196 Identities=30% Similarity=0.496 Sum_probs=178.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC-e
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-Y 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~ 160 (333)
.+..++.+.+..||+|..|+||+|+|+.+++.+|+|++... .++....++.+|+.+++.++||+||.+||.|..++ .
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 34556788899999999999999999999999999999433 24556677999999999999999999999999999 4
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
+.++||||++|+|.+++...+.+++.....++.+|+.||.|||+ ++||||||||+|||++..|.|||||||.++.+..+
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999999999999988899999999999999999999995 89999999999999999999999999999976533
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.+.+++||..|||||-+.+..|+.++| |
T Consensus 233 ---------------------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIW 261 (364)
T KOG0581|consen 233 ---------------------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIW 261 (364)
T ss_pred ---------------------------------------------------hcccccccccccChhhhcCCcCCccccee
Confidence 233789999999999999999999999 9
Q ss_pred HHHHHHHhhhcc
Q 019953 319 LVSVLHFNSYRF 330 (333)
Q Consensus 319 s~g~il~~l~t~ 330 (333)
|+|+.++++.++
T Consensus 262 SLGLsllE~a~G 273 (364)
T KOG0581|consen 262 SLGLSLLELAIG 273 (364)
T ss_pred cccHHHHHHhhC
Confidence 999999999876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=310.53 Aligned_cols=197 Identities=31% Similarity=0.498 Sum_probs=174.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
+.|+.+.++|+|+||+|++|+++.||+.||||.+..... ++...+-.++|+.+|++++|+|+|.++.+|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 468888999999999999999999999999999976542 3445566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC-Cccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC-STLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~-~~~~~~ 244 (333)
|||+..-|..+-.....++...++.++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+.. +..++
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT- 159 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT- 159 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh-
Confidence 9998766666555567899999999999999999999999999999999999999999999999999998873 22221
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~ 322 (333)
..+.|.+|+|||.+.| ..|+.++| |++||
T Consensus 160 -------------------------------------------------DYVATRWYRaPELLvGDtqYG~pVDiWAiGC 190 (396)
T KOG0593|consen 160 -------------------------------------------------DYVATRWYRAPELLVGDTQYGKPVDIWAIGC 190 (396)
T ss_pred -------------------------------------------------hhhhhhhccChhhhcccCcCCCcccchhhhH
Confidence 3478999999999998 78999999 99999
Q ss_pred HHHhhhccccC
Q 019953 323 LHFNSYRFLEF 333 (333)
Q Consensus 323 il~~l~t~~~~ 333 (333)
++-+|+++.++
T Consensus 191 v~aEl~~G~pL 201 (396)
T KOG0593|consen 191 VFAELLTGEPL 201 (396)
T ss_pred HHHHHhcCCcC
Confidence 99999999874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.65 Aligned_cols=201 Identities=38% Similarity=0.688 Sum_probs=183.4
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCC
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTE 159 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 159 (333)
..+..++|.++++||+|+||+|++|..+.+++.+|||++++........++....|..|+.... ||.++.++.+|++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3567789999999999999999999999999999999999999888889999999999998885 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++|.||||+.||++ ..+...+.+++..++.+++.|+.||.|||++|||+||||.+|||+|.+|++||+|||+++..-..
T Consensus 443 ~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999999994 33445578999999999999999999999999999999999999999999999999999965422
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
+ ..+.++||||.|||||++.+..|+.++| |
T Consensus 522 g-------------------------------------------------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW 552 (694)
T KOG0694|consen 522 G-------------------------------------------------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWW 552 (694)
T ss_pred C-------------------------------------------------CccccccCChhhcChhhhccCcccchhhHH
Confidence 2 2344889999999999999999999999 8
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
++||+||+||.+.
T Consensus 553 ~lGVLlyeML~Gq 565 (694)
T KOG0694|consen 553 GLGVLLYEMLVGE 565 (694)
T ss_pred HHHHHHHHHHcCC
Confidence 8999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.05 Aligned_cols=201 Identities=32% Similarity=0.593 Sum_probs=176.5
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh--hhHHHHHHHHHHHHHhc-CCceeEEEEEEeeC
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR--GQVEHVRAERNLLAEVA-SHCIVKLYYSFQDT 158 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 158 (333)
....+.|.+.+.||+|+||+|+.|.+..++..||+|++........ .....+.+|+.+++.+. ||||++++.++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3456799999999999999999999999999999998766422111 23445668999999999 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-CcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DFGla~~~~ 237 (333)
..+|+|||||.||+|.+++...+++.+..++.++.|++.|+.|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999998899999999999999999999999999999999999999999 999999999999763
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-CC-cc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YG-ME 315 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~~ 315 (333)
.. .....+.|||+.|+|||++.+.+ |+ .+
T Consensus 173 ~~-------------------------------------------------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~ 203 (370)
T KOG0583|consen 173 GE-------------------------------------------------DGLLKTFCGSPAYAAPEVLSGKGTYSGKA 203 (370)
T ss_pred CC-------------------------------------------------CCcccCCCCCcccCCHHHhCCCCCcCCch
Confidence 11 11233779999999999999988 85 78
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| ||+||++|.|+++.
T Consensus 204 aDvWS~GViLy~ml~G~ 220 (370)
T KOG0583|consen 204 ADVWSLGVILYVLLCGR 220 (370)
T ss_pred hhhhhhHHHHHHHHhCC
Confidence 99 99999999887753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=322.24 Aligned_cols=199 Identities=32% Similarity=0.457 Sum_probs=175.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--CeE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYL 161 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 161 (333)
..+.|+.+++||+|+||.||+|++..+|+.||+|.+..... ..+......+|+.||++|+||||+++.+..... ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 45679999999999999999999999999999999987653 345566678899999999999999999988766 689
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
|||+|||++ +|.-++... -.|++.+++.+|.|++.||+|||.+||+|||||.+|||||.+|.+||+|||||+.++...
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999976 787777664 479999999999999999999999999999999999999999999999999999876544
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-h
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-W 318 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-w 318 (333)
.. ..++.+-|.+|+|||.++| ..|+.++| |
T Consensus 273 ~~------------------------------------------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlW 304 (560)
T KOG0600|consen 273 SA------------------------------------------------PYTSRVVTLWYRPPELLLGATSYGTAVDLW 304 (560)
T ss_pred Cc------------------------------------------------ccccceEEeeccChHHhcCCcccccceeeh
Confidence 21 1225578999999999998 56999999 9
Q ss_pred HHHHHHHhhhcccc
Q 019953 319 LVSVLHFNSYRFLE 332 (333)
Q Consensus 319 s~g~il~~l~t~~~ 332 (333)
|+||||-+|+++.+
T Consensus 305 S~GCIl~El~~gkP 318 (560)
T KOG0600|consen 305 SVGCILAELFLGKP 318 (560)
T ss_pred hhhHHHHHHHcCCC
Confidence 99999999999876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=323.12 Aligned_cols=196 Identities=31% Similarity=0.562 Sum_probs=178.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+... .......+.+|++|++.++||||+.++++|.+..++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 478888999999999999999999999999999987642 2335667899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|||.| +|..++..++.+++..++.++.+++.||+|||+++|+|||+||.|||+..++.+|+||||+|+.....+
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 99965 999999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
....+..|||.|||||++.+++|+..+| ||+|||+
T Consensus 155 --------------------------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcil 190 (808)
T KOG0597|consen 155 --------------------------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCIL 190 (808)
T ss_pred --------------------------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHH
Confidence 1223567999999999999999999999 9999999
Q ss_pred Hhhhcccc
Q 019953 325 FNSYRFLE 332 (333)
Q Consensus 325 ~~l~t~~~ 332 (333)
|+|+++.|
T Consensus 191 YE~~~G~P 198 (808)
T KOG0597|consen 191 YELYVGQP 198 (808)
T ss_pred HHHhcCCC
Confidence 99999865
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=306.24 Aligned_cols=249 Identities=30% Similarity=0.515 Sum_probs=191.9
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
....+..++|++++.||.|.-|+||+|+...++..+|+|++.+.....+....+.+.|.+||+.++||.++.+|..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 34556678899999999999999999999999999999999998887777788889999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
++.|+|||||+||+|..++.+. +.+++..+++++++++.||+|||-.|||+|||||+||||.++|++-|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999998764 57999999999999999999999999999999999999999999999999999887
Q ss_pred CCCcccccccccccCccccCCCCCC---CCCCCCCCCCCCC------CCchHHhHHH-HhhhhccccccCCCCCCccccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDI---DGCFPDTDNKSSW------KSPHEQLQHW-QMNRRKLAFSTVGTPDYIAPEV 306 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~gt~~y~APE~ 306 (333)
.-. ++............ .+-.. .+|+.-....+.. .+-...++.. ......++.+++||..|+|||+
T Consensus 230 ~~~--Pt~~~s~~~~~~~~-~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 230 PVS--PTLVKSSSPRSSGS-QPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred CCC--CeeeccCCCCCCCC-CcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 322 22111111000000 00000 1111111000000 0000011111 1122345668899999999999
Q ss_pred ccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 307 LLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 307 ~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
+.|.+.+.++| |.+|+++|+|+-+
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG 331 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYG 331 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999 8899999998754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=310.53 Aligned_cols=196 Identities=30% Similarity=0.597 Sum_probs=183.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
..+|++.+.||+|.||+|-+|.+...|+.||||.+++....+.+..-++.+|++||..|+||||+.+|.+|.+...+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35799999999999999999999999999999999999888888888999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||..+|.|++|+...+.+++..++.+++||.+|+.|+|+++++|||||.+|||+|.|+++||+|||++-.+....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---- 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---- 207 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998765433
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D-ws~g~ 322 (333)
...++||+|-|.+||++.|.+| ++.+| |++||
T Consensus 208 ----------------------------------------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGv 241 (668)
T KOG0611|consen 208 ----------------------------------------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGV 241 (668)
T ss_pred ----------------------------------------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHH
Confidence 3347899999999999999998 56799 99999
Q ss_pred HHHhhhcc
Q 019953 323 LHFNSYRF 330 (333)
Q Consensus 323 il~~l~t~ 330 (333)
+||.|+-+
T Consensus 242 LLYtLVyG 249 (668)
T KOG0611|consen 242 LLYTLVYG 249 (668)
T ss_pred HHHHHhhc
Confidence 99988643
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=314.84 Aligned_cols=232 Identities=54% Similarity=0.926 Sum_probs=184.1
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||+||+|.+..+++.||||++.............+..|+.++..++|++|+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544555667888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876432211000
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
.... ...++... ............|..+......+.+||+.|+|||++.+..++.++| ||+||++
T Consensus 161 ~~~~---------~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 161 RNLN---------HSLPSDFT-----FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred cccc---------cccccccc-----ccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 0000 00000000 0000001111223333333344678999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 227 ~ell~G~ 233 (363)
T cd05628 227 YEMLIGY 233 (363)
T ss_pred HHHHhCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=315.41 Aligned_cols=244 Identities=51% Similarity=0.887 Sum_probs=190.4
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|.+++.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997765444455667888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++|+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999999755332211100
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
..... ......+.+..... ..+..............|..+......+.+||+.|+|||++.+..++.++| ||+||++
T Consensus 161 ~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 161 QKLLQ-GKSNKNRIDNRNSV-AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred ccccc-cccccccccccccc-ccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00000 00000000000000 000111222344555667666555555678999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 239 ~elltG~ 245 (377)
T cd05629 239 FECLIGW 245 (377)
T ss_pred hhhhcCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.52 Aligned_cols=203 Identities=28% Similarity=0.453 Sum_probs=175.8
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCce-EEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNI-YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
..+.+......+.+.||+|+||+||++.+. |+. ||+|++......... ...+.+|+.+|..++|||||.++|++..
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 345555667777888999999999999876 566 999999876544333 6789999999999999999999999998
Q ss_pred CC-eEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-cEecccCCCcEEEccCC-cEEEEeccC
Q 019953 158 TE-YLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHN-YIHRDIKPDNLLLDKNG-HMKLSDFGL 232 (333)
Q Consensus 158 ~~-~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlkp~Nill~~~~-~vkl~DFGl 232 (333)
.. ..++||||+++|+|..++.. ...++...+..++.|++.||.|||+++ ||||||||+|||++.++ ++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 87 79999999999999999987 678999999999999999999999999 99999999999999998 999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc--CC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL--KK 310 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~ 310 (333)
++....... ......||+.|||||++. +.
T Consensus 191 sr~~~~~~~-------------------------------------------------~~~~~~GT~~wMAPEv~~~~~~ 221 (362)
T KOG0192|consen 191 SREKVISKT-------------------------------------------------SMTSVAGTYRWMAPEVLRGEKS 221 (362)
T ss_pred ceeeccccc-------------------------------------------------cccCCCCCccccChhhhcCCCC
Confidence 987553210 011246999999999999 56
Q ss_pred CCCcccc-hHHHHHHHhhhccc-cC
Q 019953 311 GYGMECD-WLVSVLHFNSYRFL-EF 333 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t~~-~~ 333 (333)
.|+.++| ||+|+++|+|+|+. ||
T Consensus 222 ~~~~K~DvySFgIvlWEl~t~~~Pf 246 (362)
T KOG0192|consen 222 PYTEKSDVYSFGIVLWELLTGEIPF 246 (362)
T ss_pred cCCccchhhhHHHHHHHHHHCCCCC
Confidence 9999999 99999999999983 55
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=288.59 Aligned_cols=197 Identities=28% Similarity=0.497 Sum_probs=174.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|..++.||+|.||.||+|++..+|+.||||.++.....+ .......+|+..|+.++|+||+.++++|.....+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46888999999999999999999999999999998775432 33345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||++ .+|...++... .++...++.++.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.+.....
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~- 158 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ- 158 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence 9994 69999997654 79999999999999999999999999999999999999999999999999999887543211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~ 322 (333)
...+-|.+|+|||.+.|. .|+..+| |+.||
T Consensus 159 ------------------------------------------------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGC 190 (318)
T KOG0659|consen 159 ------------------------------------------------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGC 190 (318)
T ss_pred ------------------------------------------------ccceeeeeccChHHhccchhcCCcchhhhHHH
Confidence 123789999999999884 5999999 99999
Q ss_pred HHHhhhccccC
Q 019953 323 LHFNSYRFLEF 333 (333)
Q Consensus 323 il~~l~t~~~~ 333 (333)
|+-+|+-+.||
T Consensus 191 I~AELllr~P~ 201 (318)
T KOG0659|consen 191 IFAELLLRVPF 201 (318)
T ss_pred HHHHHHccCCC
Confidence 99999998886
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=311.13 Aligned_cols=235 Identities=59% Similarity=0.964 Sum_probs=185.3
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444455667888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999999876433211100
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
.... ....... ................|...+.....+.+||+.|+|||++.+..++.++| ||+||++
T Consensus 161 ~~~~-------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 161 RILS-------HALPSNF----LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred cccc-------ccccccc----cccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 0000 0000000 00000011111122233333333444668999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 230 ~el~~G~ 236 (364)
T cd05599 230 YEMLVGY 236 (364)
T ss_pred HHhhcCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=310.72 Aligned_cols=241 Identities=47% Similarity=0.787 Sum_probs=181.3
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|++++.||+|+||+||+|.+..+++.||||++.............+..|+.+++.++|+||+++++++.+...+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987655455556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++|+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+..........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987654322111100
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHH--HHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQH--WQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
...........+..+.. ...... .......+.. ..........+.+||+.|+|||++.+..++.++| ||+||+
T Consensus 162 ~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 162 KGSHIRQDSMEPSDLWD---DVSNCR-CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccCcccccc---cccccc-cccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00000000000000000 000000 0000000000 0001112233568999999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 238 l~elltG~ 245 (381)
T cd05626 238 LFEMLVGQ 245 (381)
T ss_pred HHHHHhCC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.11 Aligned_cols=197 Identities=42% Similarity=0.754 Sum_probs=178.6
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
...++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 44678999999999999999999999999999999998765444455667888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 999999999999999888889999999999999999999999999999999999999999999999999998653221
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
...+|++.|+|||++.+..++.++| |++|
T Consensus 173 --------------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 202 (329)
T PTZ00263 173 --------------------------------------------------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMG 202 (329)
T ss_pred --------------------------------------------------ceecCChhhcCHHHHcCCCCCCcceeechH
Confidence 1346999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 203 ~il~elltg~ 212 (329)
T PTZ00263 203 VLLYEFIAGY 212 (329)
T ss_pred HHHHHHHcCC
Confidence 9999999874
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=308.30 Aligned_cols=240 Identities=45% Similarity=0.768 Sum_probs=180.5
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++++.||+|+||.||+|.+..+++.||+|++.............+..|+.+++.++|+||+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999987654445556778889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
||++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+..........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987553222111000
Q ss_pred cc---ccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 247 HK---TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 247 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.. ......... ....+......+..........+ ........+.+||+.|+|||++.+.+++.++| ||+||
T Consensus 162 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 162 SGDHVRQDSMDFSN----EWGDPANCRCGDRLKPLERRAAR-QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccc----cccccccccccccccchhhhhcc-ccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00 000000000 00000000000000000000000 01112233568999999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 237 il~elltG~ 245 (382)
T cd05625 237 ILYEMLVGQ 245 (382)
T ss_pred HHHHHHhCC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=308.61 Aligned_cols=232 Identities=54% Similarity=0.940 Sum_probs=183.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||.||+|.+..+++.||||++.............+..|+.++..++|++|+++++.+...+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998665444555667888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999999866433211100
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
......+ +. +..............|..+......+.+||+.|+|||++.+..++.++| ||+||++
T Consensus 161 ~~~~~~~-------------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 161 RNLTHNP-------------PS-DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred cccccCC-------------cc-cccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 0000000 00 0000000001111123233333444668999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 227 yel~tG~ 233 (360)
T cd05627 227 YEMLIGY 233 (360)
T ss_pred eecccCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=311.45 Aligned_cols=196 Identities=30% Similarity=0.540 Sum_probs=171.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCC-eE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTE-YL 161 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~ 161 (333)
..++|.++++||.|+||.||+|+...+|..||||.++..-. ..++.- -.+|+..|++++ ||||+++.+++.+.. .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 45789999999999999999999999999999999976543 222222 356999999998 999999999998877 99
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
|+|||||+ .+|+++++. ++.|++..++.|+.||+.||+|+|++|+.|||+||+||||..+..+||+|||+|+.+.+..
T Consensus 86 ~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred eeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence 99999994 599999866 4579999999999999999999999999999999999999999999999999999886554
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-h
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-W 318 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-w 318 (333)
.++ ..+.|.+|+|||++.. .-|+.+.| |
T Consensus 165 PYT--------------------------------------------------eYVSTRWYRAPEvLLrs~~Ys~pvD~w 194 (538)
T KOG0661|consen 165 PYT--------------------------------------------------EYVSTRWYRAPEVLLRSGYYSSPVDMW 194 (538)
T ss_pred Ccc--------------------------------------------------hhhhcccccchHHhhhccccCCchHHH
Confidence 222 4578999999999865 66999999 9
Q ss_pred HHHHHHHhhhcccc
Q 019953 319 LVSVLHFNSYRFLE 332 (333)
Q Consensus 319 s~g~il~~l~t~~~ 332 (333)
++|||++++++..+
T Consensus 195 A~GcI~aEl~sLrP 208 (538)
T KOG0661|consen 195 AVGCIMAELYSLRP 208 (538)
T ss_pred HHHHHHHHHHHhcc
Confidence 99999999998765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=300.42 Aligned_cols=194 Identities=37% Similarity=0.745 Sum_probs=174.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654433344566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----- 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----
Confidence 999999999999888889999999999999999999999999999999999999999999999999988653211
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
...+|++.|+|||++.+..++.++| ||+||++
T Consensus 156 -----------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 188 (291)
T cd05612 156 -----------------------------------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILI 188 (291)
T ss_pred -----------------------------------------------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 1346999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 189 ~~l~~g~ 195 (291)
T cd05612 189 YEMLVGY 195 (291)
T ss_pred HHHHhCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=334.33 Aligned_cols=205 Identities=51% Similarity=0.885 Sum_probs=187.4
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
........++|.++++||+|+||.|.+++++.+++.||+|++++....++.....|..|.++|..-+.+.|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 44556678899999999999999999999999999999999999888888888889999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+.++|+||||++||+|..++.+...+++..++++++.|+.||.-||+.|+|||||||+|||||..|++||+|||.+..+.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999999887
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc----C-CCC
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL----K-KGY 312 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~ 312 (333)
..+. ..+...+|||.|+|||++. + +.|
T Consensus 227 ~dG~------------------------------------------------V~s~~aVGTPDYISPEvLqs~~~~~g~y 258 (1317)
T KOG0612|consen 227 ADGT------------------------------------------------VRSSVAVGTPDYISPEVLQSQGDGKGEY 258 (1317)
T ss_pred CCCc------------------------------------------------EEeccccCCCCccCHHHHHhhcCCcccc
Confidence 4431 2334679999999999995 3 569
Q ss_pred Ccccc-hHHHHHHHhhhcc
Q 019953 313 GMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~ 330 (333)
++.|| ||+||++|+|+-+
T Consensus 259 G~ecDwWSlGV~~YEMlyG 277 (1317)
T KOG0612|consen 259 GRECDWWSLGVFMYEMLYG 277 (1317)
T ss_pred CCccchhhhHHHHHHHHcC
Confidence 99999 9999999998755
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=307.07 Aligned_cols=240 Identities=45% Similarity=0.784 Sum_probs=180.4
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++|+||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997665444445567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|||++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998755322211100
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
.... ......+............ ...+. ....-.........+.+||+.|+|||++.+..++.++| ||+||++
T Consensus 161 ~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 161 QKGD---HHRQDSMEPSEEWSEIDRC--RLKPL-ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred cccc---ccccccccccccccccccc--cccch-hhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0000 0000000000000000000 00000 00000001112223568999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 235 yell~G~ 241 (376)
T cd05598 235 YEMLVGQ 241 (376)
T ss_pred eehhhCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=304.26 Aligned_cols=200 Identities=40% Similarity=0.734 Sum_probs=178.1
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCC-ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSG-NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
...+..++|++.+.||+|+||.||+|.+..++ ..||+|++.............+..|+.+++.++||||+++++++...
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34566788999999999999999999876654 68999999766544445566788899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
+.+|+||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999986532
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
.. .+.+||+.|+|||++.+..++.++|
T Consensus 184 ~~----------------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~Di 211 (340)
T PTZ00426 184 RT----------------------------------------------------YTLCGTPEYIAPEILLNVGHGKAADW 211 (340)
T ss_pred Cc----------------------------------------------------ceecCChhhcCHHHHhCCCCCccccc
Confidence 11 1346999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 212 wSlGvil~ell~G~ 225 (340)
T PTZ00426 212 WTLGIFIYEILVGC 225 (340)
T ss_pred cchhhHHHHHhcCC
Confidence 99999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=302.06 Aligned_cols=194 Identities=47% Similarity=0.848 Sum_probs=176.0
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||.||+|.+..+++.||||++.............+..|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~------ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ 154 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998864321
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
....+||+.|+|||++.+..++.++| |++||++
T Consensus 155 ----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 188 (333)
T cd05600 155 ----------------------------------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188 (333)
T ss_pred ----------------------------------------------cCCcccCccccChhHhcCCCCCCccceecchHHH
Confidence 11447999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 189 ~ell~g~ 195 (333)
T cd05600 189 YEFLCGF 195 (333)
T ss_pred hhhhhCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=313.52 Aligned_cols=196 Identities=30% Similarity=0.569 Sum_probs=179.2
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.+-|++++.||.|+.|.|.+|++..||+.+|||++.+...........+.+|+-+|+.+.|||++.+|+++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46799999999999999999999999999999999887433444455688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
.||++||-|.+++...+++++..+.+++.|++.|+.|+|..+|+||||||+|+|+|.++++||+|||+|..-..+.
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---- 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---- 166 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998754332
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D-ws~g~ 322 (333)
...+.||+|.|.|||+++|.+| +.++| ||+||
T Consensus 167 ----------------------------------------------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGV 200 (786)
T KOG0588|consen 167 ----------------------------------------------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGV 200 (786)
T ss_pred ----------------------------------------------cccccCCCcccCCchhhcCCCCCCCccccchhHH
Confidence 3336799999999999999999 56899 99999
Q ss_pred HHHhhhcc
Q 019953 323 LHFNSYRF 330 (333)
Q Consensus 323 il~~l~t~ 330 (333)
|+|-|||+
T Consensus 201 ILfALLtG 208 (786)
T KOG0588|consen 201 ILFALLTG 208 (786)
T ss_pred HHHHHHhC
Confidence 99999986
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.51 Aligned_cols=205 Identities=47% Similarity=0.865 Sum_probs=176.9
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
+.......++|++.+.||+|+||.||+|.+..+++.||+|++.............+..|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 34455667899999999999999999999999999999999976544444445567789999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+..+|+||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999999998654 68999999999999999999999999999999999999999999999999998654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC----CC
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG----YG 313 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~ 313 (333)
..... ...+.+||+.|+|||++.+.+ ++
T Consensus 194 ~~~~~------------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~ 225 (370)
T cd05621 194 ETGMV------------------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYG 225 (370)
T ss_pred cCCce------------------------------------------------ecccCCCCcccCCHHHHhccCCCCCCC
Confidence 22110 011457999999999997643 78
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| ||+||++|+|+++.
T Consensus 226 ~~~DiwSlG~ilyell~G~ 244 (370)
T cd05621 226 RECDWWSVGVFLFEMLVGD 244 (370)
T ss_pred cccCEEeehHHHHHHHhCC
Confidence 9999 99999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=290.95 Aligned_cols=198 Identities=29% Similarity=0.440 Sum_probs=171.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe--eCCeE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DTEYL 161 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 161 (333)
..++|+.+..|++|+||.||+|+++.+++.||+|.++-... .....-...+|+.+|.+++|||||.+-.+.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 45679999999999999999999999999999999976643 2333344567999999999999999987764 34579
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
|+|||||+. +|..++.+- .+|...+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+.++-
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999965 888888764 489999999999999999999999999999999999999999999999999999886542
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-h
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-W 318 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-w 318 (333)
+..+..+-|.+|+|||.+.|. .|+.+.| |
T Consensus 232 -------------------------------------------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMW 262 (419)
T KOG0663|consen 232 -------------------------------------------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMW 262 (419)
T ss_pred -------------------------------------------------ccCcceEEEeeecCHHHhcCCcccCcchhhh
Confidence 122356889999999999985 5999999 9
Q ss_pred HHHHHHHhhhcccc
Q 019953 319 LVSVLHFNSYRFLE 332 (333)
Q Consensus 319 s~g~il~~l~t~~~ 332 (333)
|+|||+-+|++..|
T Consensus 263 SvGCI~aE~l~~kP 276 (419)
T KOG0663|consen 263 SVGCIFAELLTQKP 276 (419)
T ss_pred hHHHHHHHHHhcCC
Confidence 99999999998765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=300.21 Aligned_cols=191 Identities=39% Similarity=0.674 Sum_probs=170.0
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 171 (333)
+.||+|+||.||+|.+..+|+.||||++.............+..|+.+++.++||||+++++.+...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444455566788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccC
Q 019953 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (333)
Q Consensus 172 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 251 (333)
+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---------- 150 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC----------
Confidence 9999998888899999999999999999999999999999999999999999999999999875321110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.....+||+.|+|||++.+..++.++| ||+||++|+|+++
T Consensus 151 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 191 (323)
T cd05571 151 ---------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (323)
T ss_pred ---------------------------------------cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcC
Confidence 011457999999999999999999999 9999999999987
Q ss_pred c
Q 019953 331 L 331 (333)
Q Consensus 331 ~ 331 (333)
.
T Consensus 192 ~ 192 (323)
T cd05571 192 R 192 (323)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=301.47 Aligned_cols=206 Identities=47% Similarity=0.876 Sum_probs=177.5
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
.+....+..++|++.+.||+|+||.||+|.+..+++.||+|++.............+..|+.+++.++||||+++++.+.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556677789999999999999999999999999999999997654444444556778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
....+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 99999999999999999998865 45899999999999999999999999999999999999999999999999999865
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC----C
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG----Y 312 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~ 312 (333)
...... .....+||+.|+|||++.+.. +
T Consensus 193 ~~~~~~------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~ 224 (371)
T cd05622 193 NKEGMV------------------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYY 224 (371)
T ss_pred CcCCcc------------------------------------------------cccCcccCccccCHHHHhccCCCccC
Confidence 432110 011457999999999997643 8
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| ||+||++|+|+++.
T Consensus 225 ~~~~DiwSlGvilyell~G~ 244 (371)
T cd05622 225 GRECDWWSVGVFLYEMLVGD 244 (371)
T ss_pred CCccceeehhHHHHHHHhCC
Confidence 89999 99999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=288.97 Aligned_cols=195 Identities=31% Similarity=0.592 Sum_probs=170.7
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.++..++|++|+++++.+...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999999999999999999876544333334457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--- 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---
Confidence 9999999888754 34689999999999999999999999999999999999999999999999999886532210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....|++.|+|||++.+..++.++| ||+||+
T Consensus 158 -----------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvi 190 (285)
T cd05631 158 -----------------------------------------------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCL 190 (285)
T ss_pred -----------------------------------------------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHH
Confidence 01346999999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 l~el~~g~ 198 (285)
T cd05631 191 IYEMIQGQ 198 (285)
T ss_pred HHHHHhCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=289.71 Aligned_cols=206 Identities=28% Similarity=0.455 Sum_probs=181.0
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..+.+..++|++.+.||.|.-++||+|++..++..||||++...... ...+.+.+|+..|+.++||||+.++.+|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 45667789999999999999999999999999999999999876543 3478899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
..+|+||.||.+|++.+++... ..+.+..+..+.++++.||.|||++|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999763 46999999999999999999999999999999999999999999999999987766
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGM 314 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ 314 (333)
..++.-. +....+++|||+|||||+++. .+|+.
T Consensus 177 ~~~G~R~---------------------------------------------~~rf~tfvgtp~wmAPEvl~q~~~GYdf 211 (516)
T KOG0582|consen 177 FDSGDRQ---------------------------------------------VTRFNTFVGTPCWMAPEVLMQQLHGYDF 211 (516)
T ss_pred cccCcee---------------------------------------------eEeeccccCcccccChHHhhhcccCccc
Confidence 5443111 111147799999999999754 67999
Q ss_pred ccc-hHHHHHHHhhhccc
Q 019953 315 ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~ 331 (333)
|+| ||+|+...+|-++.
T Consensus 212 KaDIwSfGITA~ELA~G~ 229 (516)
T KOG0582|consen 212 KADIWSFGITACELAHGH 229 (516)
T ss_pred hhhhhhhhHHHHHHhcCC
Confidence 999 99999999997663
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=288.24 Aligned_cols=196 Identities=29% Similarity=0.480 Sum_probs=168.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc-eeEEEEEEeeCC-----
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTE----- 159 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----- 159 (333)
..|+.++.||+|+||+||+|+...+|+.||+|.++..... +.......+|+.+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4577778899999999999999999999999999876432 334455778999999999999 999999998877
Q ss_pred -eEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 160 -YLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 160 -~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
.+++|+||+ ..+|..++.... .++...++.++.|++.||+|||+++|+||||||.||||+.+|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999999 569999987644 57888999999999999999999999999999999999999999999999999
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCC
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYG 313 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~ 313 (333)
...-+. ....+-++|.+|+|||++.|. .|+
T Consensus 169 a~~ip~-------------------------------------------------~~yt~evvTlWYRaPEvLlGs~~Ys 199 (323)
T KOG0594|consen 169 AFSIPM-------------------------------------------------RTYTPEVVTLWYRAPEVLLGSTSYS 199 (323)
T ss_pred HhcCCc-------------------------------------------------ccccccEEEeeccCHHHhcCCCcCC
Confidence 654221 112245799999999999986 799
Q ss_pred cccc-hHHHHHHHhhhcccc
Q 019953 314 MECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~~ 332 (333)
...| ||+|||+.+|++..+
T Consensus 200 ~~vDiWs~GcIfaEm~~~~~ 219 (323)
T KOG0594|consen 200 TSVDIWSLGCIFAEMFTRRP 219 (323)
T ss_pred CCcchHhHHHHHHHHHhCCC
Confidence 9999 999999999998654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=293.24 Aligned_cols=198 Identities=33% Similarity=0.537 Sum_probs=168.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC--eEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE--YLY 162 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 162 (333)
..++...+.||+|+||.||++.+..+|..+|||.+...... ..+.+.+|+.+|.+++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 34688889999999999999999999999999998765221 1566889999999999999999999754444 699
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-CCcEEEEeccCcccCCCCc
Q 019953 163 LIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~~~~ 240 (333)
+.|||+++|+|.+++...+ .+++..++.+..|++.||.|||++|||||||||+|||++. ++.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998876 7999999999999999999999999999999999999999 7999999999998765311
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-h
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-W 318 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-w 318 (333)
.. .....+..||+.|||||++.++ ...+++| |
T Consensus 173 ~~----------------------------------------------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiW 206 (313)
T KOG0198|consen 173 TK----------------------------------------------SDSELSVQGTPNYMAPEVIRNGEVARRESDIW 206 (313)
T ss_pred cc----------------------------------------------ccccccccCCccccCchhhcCCCcCCccchhh
Confidence 00 0112256799999999999963 3345999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++.+|+|+.
T Consensus 207 SlGCtVvEM~Tg~ 219 (313)
T KOG0198|consen 207 SLGCTVVEMLTGK 219 (313)
T ss_pred hcCCEEEeccCCC
Confidence 9999999999974
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.24 Aligned_cols=196 Identities=36% Similarity=0.648 Sum_probs=171.7
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC-ceeEEEEEEeeCCeEEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 165 (333)
+|++++.||+|+||.||+|.+..+++.||||++.............+..|..++..+.|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999999999999999999876544444556677899999999776 5888999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-----
Confidence 999999999999888889999999999999999999999999999999999999999999999999987432111
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
......+||+.|+|||++.+.+++.++| ||+||++
T Consensus 156 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 191 (324)
T cd05587 156 --------------------------------------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191 (324)
T ss_pred --------------------------------------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHH
Confidence 0111447999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+|+.
T Consensus 192 ~elltG~ 198 (324)
T cd05587 192 YEMLAGQ 198 (324)
T ss_pred HHHHhCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=277.00 Aligned_cols=200 Identities=37% Similarity=0.549 Sum_probs=184.1
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
.....++|++++.||+|.||.||+|+...++-.||+|++.+..........++.+|++|...|+||||.++|++|-++..
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 34567899999999999999999999999999999999999887777777889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 161 LYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
+|+++||...|.+...+. ....+++..+..++.|++.||.|+|..+||||||||+|+|++..+.+||+|||-+..-++
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999998 556799999999999999999999999999999999999999999999999998876442
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
+ ..++.|||..|.+||...+.+++.++|
T Consensus 177 ~---------------------------------------------------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~ 205 (281)
T KOG0580|consen 177 N---------------------------------------------------KRKTLCGTLDYLPPEMVEGRGHDKFVDL 205 (281)
T ss_pred C---------------------------------------------------CceeeecccccCCHhhcCCCCccchhhH
Confidence 2 223779999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++|++.|+++.+.
T Consensus 206 w~lgvl~yeflvg~ 219 (281)
T KOG0580|consen 206 WSLGVLCYEFLVGL 219 (281)
T ss_pred HHHHHHHHHHHhcC
Confidence 99999999998764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=294.43 Aligned_cols=191 Identities=40% Similarity=0.683 Sum_probs=168.9
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 171 (333)
+.||+|+||.||+|.+..+|..||+|++.............+..|+.+++.++||||+++++.+...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445566778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccC
Q 019953 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (333)
Q Consensus 172 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 251 (333)
+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---------- 150 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----------
Confidence 9999998888899999999999999999999999999999999999999999999999999875321110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.....+|++.|+|||++.+..++.++| ||+||++|+|+++
T Consensus 151 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g 191 (323)
T cd05595 151 ---------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (323)
T ss_pred ---------------------------------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC
Confidence 011346999999999999999999999 9999999999986
Q ss_pred c
Q 019953 331 L 331 (333)
Q Consensus 331 ~ 331 (333)
.
T Consensus 192 ~ 192 (323)
T cd05595 192 R 192 (323)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=298.70 Aligned_cols=204 Identities=48% Similarity=0.876 Sum_probs=175.9
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
....+..++|++.+.||+|+||.||+|.+..++..||+|++.............+..|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 44556678999999999999999999999999999999999765444444455677899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
+.+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999998865 4588999999999999999999999999999999999999999999999999886542
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC----CCCc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK----GYGM 314 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~ 314 (333)
.... .....+||+.|+|||++.+. .++.
T Consensus 195 ~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 226 (370)
T cd05596 195 NGMV------------------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (370)
T ss_pred CCcc------------------------------------------------cCCCCCCCcCeECHHHhccCCCCCCCCC
Confidence 2100 01134799999999999754 4889
Q ss_pred ccc-hHHHHHHHhhhccc
Q 019953 315 ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~ 331 (333)
++| ||+||++|+|+++.
T Consensus 227 ~~DiwSlGvilyelltG~ 244 (370)
T cd05596 227 ECDWWSVGVFLYEMLVGD 244 (370)
T ss_pred ceeeeehhHHHHHHHhCC
Confidence 999 99999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=293.01 Aligned_cols=189 Identities=43% Similarity=0.750 Sum_probs=168.4
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCH
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 173 (333)
||+|+||.||+|.+..+++.||+|++.............+..|+.++..++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999765444445566778899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCcc
Q 019953 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253 (333)
Q Consensus 174 ~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~ 253 (333)
.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------------ 148 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------------ 148 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------------
Confidence 99998888899999999999999999999999999999999999999999999999999875322110
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.....+||+.|+|||++.+..++.++| |++||++|+|+++.
T Consensus 149 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~ 190 (312)
T cd05585 149 -------------------------------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL 190 (312)
T ss_pred -------------------------------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCC
Confidence 011347999999999999999999999 99999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=303.86 Aligned_cols=196 Identities=27% Similarity=0.477 Sum_probs=176.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
....|....+||+|+.|.||.|....+++.||||.+.... ....+-+.+|+.+|+..+|+|||.+++.|.-.+.+|+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3456888899999999999999999999999999997653 3334568899999999999999999999988899999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||++||+|.+.+.. ..+++.++..++.+++.||.|||.+||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 9999999999888844 4599999999999999999999999999999999999999999999999999998865431
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
...+.+|||+|||||++....|+.++| ||||+
T Consensus 425 -----------------------------------------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGI 457 (550)
T KOG0578|consen 425 -----------------------------------------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGI 457 (550)
T ss_pred -----------------------------------------------ccccccCCCCccchhhhhhcccCccccchhhhh
Confidence 223679999999999999999999999 99999
Q ss_pred HHHhhhcccc
Q 019953 323 LHFNSYRFLE 332 (333)
Q Consensus 323 il~~l~t~~~ 332 (333)
|.++|+-+.|
T Consensus 458 MaIEMveGEP 467 (550)
T KOG0578|consen 458 MAIEMVEGEP 467 (550)
T ss_pred HHHHHhcCCC
Confidence 9999998764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=294.39 Aligned_cols=191 Identities=39% Similarity=0.684 Sum_probs=169.3
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 171 (333)
+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++.+...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765444455567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccC
Q 019953 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (333)
Q Consensus 172 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 251 (333)
+|...+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---------- 150 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---------- 150 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc----------
Confidence 9999998888899999999999999999999999999999999999999999999999999875321110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.....+||+.|+|||++.+..++.++| ||+||++|+|+++
T Consensus 151 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 191 (328)
T cd05593 151 ---------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (328)
T ss_pred ---------------------------------------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC
Confidence 011346999999999999999999999 9999999999986
Q ss_pred c
Q 019953 331 L 331 (333)
Q Consensus 331 ~ 331 (333)
.
T Consensus 192 ~ 192 (328)
T cd05593 192 R 192 (328)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=298.61 Aligned_cols=226 Identities=54% Similarity=0.902 Sum_probs=181.2
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|.+.+.||+|+||.||+|.+..+++.||||++.............+..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765545456667888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999999876543311100
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
......... ..+. ..................||+.|+|||++.+..++.++| |++||++
T Consensus 161 ~~~~~~~~~------~~~~--------------~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 220 (350)
T cd05573 161 LNDSHNLLF------RDNV--------------LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220 (350)
T ss_pred ccccccccc------cccc--------------cccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhh
Confidence 000000000 0000 000000001111223457999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 221 ~ell~g~ 227 (350)
T cd05573 221 YEMLYGF 227 (350)
T ss_pred hhhccCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=303.58 Aligned_cols=191 Identities=26% Similarity=0.412 Sum_probs=169.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-C-----CceeEEEEEEeeCC
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-S-----HCIVKLYYSFQDTE 159 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~ 159 (333)
.+|.+++.||+|+||+|.+|.+..|++.||||++++.. ....+...|+.+|..++ | .|+|+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 37899999999999999999999999999999998764 34455667999999997 3 28999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC--cEEEEeccCccc
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG--HMKLSDFGLCKP 235 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~--~vkl~DFGla~~ 235 (333)
++|||+|++ ..+|+++++.++ .++...++.++.||+.||.+||+.||||+||||+||||...+ .|||+|||+|..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 679999998764 688999999999999999999999999999999999997544 799999999986
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
...... +.+.+..|+||||+.|.+|+.+
T Consensus 341 ~~q~vy----------------------------------------------------tYiQSRfYRAPEVILGlpY~~~ 368 (586)
T KOG0667|consen 341 ESQRVY----------------------------------------------------TYIQSRFYRAPEVILGLPYDTA 368 (586)
T ss_pred cCCcce----------------------------------------------------eeeeccccccchhhccCCCCCc
Confidence 543221 4578999999999999999999
Q ss_pred cc-hHHHHHHHhhhccccC
Q 019953 316 CD-WLVSVLHFNSYRFLEF 333 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~~~ 333 (333)
.| ||||||+.||+++.|+
T Consensus 369 IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 369 IDMWSLGCILAELFTGEPL 387 (586)
T ss_pred cceeehhhhHHhHhcCccc
Confidence 99 9999999999999774
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.26 Aligned_cols=196 Identities=36% Similarity=0.646 Sum_probs=170.8
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
+|.+.+.||+|+||.||+|.+..+++.||||++................|..++..+ .|++|+.+++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999876443444445566678888777 5788999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~---- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC----
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875332110
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
.....+||+.|+|||++.+.+++.++| ||+||++
T Consensus 157 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 191 (323)
T cd05616 157 ---------------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191 (323)
T ss_pred ---------------------------------------------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHH
Confidence 011346999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+|+.
T Consensus 192 ~elltg~ 198 (323)
T cd05616 192 YEMLAGQ 198 (323)
T ss_pred HHHHhCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=302.48 Aligned_cols=197 Identities=32% Similarity=0.575 Sum_probs=178.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe-EEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY-LYL 163 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~l 163 (333)
.++|..++++|+|+||.+++++++.+++.|++|.+.......+.. ....+|+.+++++.|||||.+.++|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 468999999999999999999999999999999998765544433 367889999999999999999999998887 999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 164 IMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
||+||+||++.+.+... ..+++..+..|+.|++.|+.|||+++|+|||||+.||+++.++.|+|.|||+|+.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999999999999764 479999999999999999999999999999999999999999999999999999886543
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
..+.+.+|||.||+||++.+.+|+.++| |++
T Consensus 161 ------------------------------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL 192 (426)
T KOG0589|consen 161 ------------------------------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSL 192 (426)
T ss_pred ------------------------------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence 1334779999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|++..
T Consensus 193 GC~~yEm~~lk 203 (426)
T KOG0589|consen 193 GCCLYEMCTLK 203 (426)
T ss_pred cchHHHHHhcc
Confidence 99999998753
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=292.51 Aligned_cols=198 Identities=52% Similarity=0.888 Sum_probs=172.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||++.+..+++.||+|++.............+..|..++..+.|++|+.+++.+...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654444445556788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-- 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce--
Confidence 99999999999976 467899999999999999999999999999999999999999999999999998765432110
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-----CCCCcccc-h
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYGMECD-W 318 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~D-w 318 (333)
.....+|++.|+|||++.+ ..++.++| |
T Consensus 159 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 192 (331)
T cd05624 159 ----------------------------------------------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 192 (331)
T ss_pred ----------------------------------------------eeccccCCcccCCHHHHhccccCCCCCCCcccEE
Confidence 0013469999999999976 56889999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++|+|+++.
T Consensus 193 SlGvil~ell~g~ 205 (331)
T cd05624 193 SLGVCMYEMLYGE 205 (331)
T ss_pred eeehhhhhhhhCC
Confidence 9999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=295.13 Aligned_cols=197 Identities=37% Similarity=0.610 Sum_probs=177.5
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 162 (333)
....|++.+.||.|.||.||.|.+..+|+.+|+|++.+...........+.+|+.+|+.+. ||||+.+++.|.+...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467999999999999999999999999999999998876554445567889999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC----CcEEEEeccCcccCCC
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN----GHMKLSDFGLCKPLDC 238 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~----~~vkl~DFGla~~~~~ 238 (333)
+|||+|.||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||++.....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999776 49999999999999999999999999999999999999643 4799999999998764
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
.. .....+|||.|+|||++...+|+..+|
T Consensus 192 ~~--------------------------------------------------~~~~~~Gtp~y~APEvl~~~~y~~~~Di 221 (382)
T KOG0032|consen 192 GE--------------------------------------------------RLHTIVGTPEYVAPEVLGGRPYGDEVDV 221 (382)
T ss_pred Cc--------------------------------------------------eEeeecCCccccCchhhcCCCCCcccch
Confidence 21 223679999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|.|+.+.
T Consensus 222 WS~Gvi~yiLL~G~ 235 (382)
T KOG0032|consen 222 WSIGVILYILLSGV 235 (382)
T ss_pred hHHHHHHHHHhhCC
Confidence 99999999988764
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=290.08 Aligned_cols=196 Identities=36% Similarity=0.650 Sum_probs=170.9
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC-CceeEEEEEEeeCCeEEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 165 (333)
+|++.+.||+|+||.||+|.+..+|+.||+|++.............+..|..++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47889999999999999999999999999999987654444455667778888888865 57888999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~---- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc----
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875322110
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
.....+||+.|+|||++.+..++.++| ||+||++
T Consensus 157 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 191 (323)
T cd05615 157 ---------------------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191 (323)
T ss_pred ---------------------------------------------cccCccCCccccCHHHHcCCCCCCccchhhhHHHH
Confidence 011346999999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 192 ~elltG~ 198 (323)
T cd05615 192 YEMLAGQ 198 (323)
T ss_pred HHHHhCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=286.43 Aligned_cols=205 Identities=40% Similarity=0.740 Sum_probs=186.2
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
...+..++|..+++||+|.||+|.+|+.+.+|+.||||++++........+.+...|-.+|+..+||.+..+-.+|+...
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34566789999999999999999999999999999999999988888888888899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+|+||||..||.|...+.....+++..++.+..+|+.||.|||+++||.||||.+|.|+|.+|++||+|||+++.--..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999864322
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
+ ...+++||||.|+|||++....|++++| |
T Consensus 322 g-------------------------------------------------~t~kTFCGTPEYLAPEVleDnDYgraVDWW 352 (516)
T KOG0690|consen 322 G-------------------------------------------------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWW 352 (516)
T ss_pred c-------------------------------------------------ceeccccCChhhcCchhhccccccceeehh
Confidence 1 1234789999999999999999999999 7
Q ss_pred HHHHHHHhh-hccccC
Q 019953 319 LVSVLHFNS-YRFLEF 333 (333)
Q Consensus 319 s~g~il~~l-~t~~~~ 333 (333)
-+||+||+| |...||
T Consensus 353 G~GVVMYEMmCGRLPF 368 (516)
T KOG0690|consen 353 GVGVVMYEMMCGRLPF 368 (516)
T ss_pred hhhHHHHHHHhccCcc
Confidence 799999976 455554
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=291.78 Aligned_cols=191 Identities=37% Similarity=0.646 Sum_probs=168.7
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+++.||+|+++............+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544445556678899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--------- 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999874221110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+||+.|+|||++.+..++.++| |++||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 191 (329)
T cd05588 152 ----------------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191 (329)
T ss_pred ----------------------------------------ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH
Confidence 011347999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 g~ 193 (329)
T cd05588 192 GR 193 (329)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=290.40 Aligned_cols=198 Identities=51% Similarity=0.886 Sum_probs=172.7
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||.||++.+..+++.||+|++.............+..|..++..++|+||+.+++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998655444555666888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-- 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998765432210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-----CCCCcccc-h
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYGMECD-W 318 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~D-w 318 (333)
.....+||+.|+|||++.+ ..++.++| |
T Consensus 159 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 192 (331)
T cd05597 159 ----------------------------------------------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW 192 (331)
T ss_pred ----------------------------------------------cccceeccccccCHHHHhhccccccCCCCcceee
Confidence 0012369999999999973 45788999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
++||++|+|+++.
T Consensus 193 slG~~l~el~~g~ 205 (331)
T cd05597 193 SLGVCMYEMLYGE 205 (331)
T ss_pred hhhhHHHHHhhCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=290.56 Aligned_cols=200 Identities=33% Similarity=0.605 Sum_probs=181.7
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
..+..+.|..-++||+||||.|+-|+-..||+.||+|.+.+.....+....-..+|..+|..++.+.||.+-..|.+...
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 45667889999999999999999999999999999999987766666555667889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
+|+||..|+||+|.-.|.+.+ .|++..+++++++|+.||.+||+.+||.||+||+|||+|++|++.|+|+|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999998887655 799999999999999999999999999999999999999999999999999998875
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
.... .+.+||.+|||||++.+..|+.+.|
T Consensus 340 g~~~--------------------------------------------------~~rvGT~GYMAPEvl~ne~Y~~s~Dw 369 (591)
T KOG0986|consen 340 GKPI--------------------------------------------------RGRVGTVGYMAPEVLQNEVYDFSPDW 369 (591)
T ss_pred CCcc--------------------------------------------------ccccCcccccCHHHHcCCcccCCccH
Confidence 5421 1458999999999999999999999
Q ss_pred hHHHHHHHhhhcc
Q 019953 318 WLVSVLHFNSYRF 330 (333)
Q Consensus 318 ws~g~il~~l~t~ 330 (333)
|++||++|+|+.+
T Consensus 370 f~lGCllYemi~G 382 (591)
T KOG0986|consen 370 FSLGCLLYEMIAG 382 (591)
T ss_pred HHHHhHHHHHHcc
Confidence 8899999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=291.24 Aligned_cols=202 Identities=35% Similarity=0.598 Sum_probs=166.4
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh-----------hhhHHHHHHHHHHHHHhcCCceeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-----------RGQVEHVRAERNLLAEVASHCIVKL 151 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~ 151 (333)
...+.|++++.||+|.||+|-+|++..+++.||||++.+..... ...++...+|+.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44688999999999999999999999999999999998754321 1234678899999999999999999
Q ss_pred EEEEeeC--CeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEE
Q 019953 152 YYSFQDT--EYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228 (333)
Q Consensus 152 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~ 228 (333)
+.+..+. ..+|||+|||..|.+...- ...+ +++.+++.++.+++.||+|||.+|||||||||+|+||+.+|+|||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 9998764 4799999999988775543 2344 9999999999999999999999999999999999999999999999
Q ss_pred eccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc
Q 019953 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308 (333)
Q Consensus 229 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~ 308 (333)
|||.+.....+... +..+++ ..++|||.|+|||...
T Consensus 253 DFGVs~~~~~~~~~---------------------------------~~d~~L-----------~~tvGTPAF~APE~c~ 288 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDE---------------------------------GSDDQL-----------SRTVGTPAFFAPELCS 288 (576)
T ss_pred ccceeeecccCCcc---------------------------------ccHHHH-----------hhcCCCccccchHhhc
Confidence 99998866433110 111111 1368999999999997
Q ss_pred CCC----CCcccc-hHHHHHHHhhhc
Q 019953 309 KKG----YGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 309 ~~~----~~~~~D-ws~g~il~~l~t 329 (333)
++. -+++.| |++||.||.|+-
T Consensus 289 ~~~~~~~~g~a~DiWalGVTLYCllf 314 (576)
T KOG0585|consen 289 GGNSFSYSGFALDIWALGVTLYCLLF 314 (576)
T ss_pred CCCCccccchhhhhhhhhhhHHHhhh
Confidence 732 367899 999999997754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=291.99 Aligned_cols=191 Identities=40% Similarity=0.676 Sum_probs=168.1
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 171 (333)
+.||+|+||.||+|.+..+|..||+|++.............+..|+.++..++||||+++++.+...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444444556778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 172 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
+|..++.....+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--------- 151 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---------
Confidence 999999888889999999999999999999997 7999999999999999999999999999875321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+||+.|+|||++.+..++.++| ||+||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 191 (325)
T cd05594 152 ----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 191 (325)
T ss_pred ----------------------------------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeecc
Confidence 011346999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 G~ 193 (325)
T cd05594 192 GR 193 (325)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=288.63 Aligned_cols=191 Identities=38% Similarity=0.650 Sum_probs=165.0
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHH-hcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+++.||||++................|..++.. ..||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987543333344455566667665 4899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--------- 151 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875432110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+||+.|+|||++.+..++.++| ||+||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 191 (316)
T cd05592 152 ----------------------------------------KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191 (316)
T ss_pred ----------------------------------------ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh
Confidence 111447999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 G~ 193 (316)
T cd05592 192 GQ 193 (316)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=283.31 Aligned_cols=199 Identities=30% Similarity=0.468 Sum_probs=172.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-----CC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-----TE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 159 (333)
...|..++.||.|+||.|+.|.+..+|..||||.+... .......+...+|+.+|+.++|+||+.+++++.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 45666789999999999999999999999999999743 3344456678889999999999999999999876 34
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+|+|+|+| +.+|...++.++.+++..+..+++|++.||.|+|+.+|+||||||+|++++.+..+||+|||+|+..+..
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 699999999 7799999988888999999999999999999999999999999999999999999999999999987543
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D- 317 (333)
.. ....+..+-|.+|.|||++.+ ..||.+.|
T Consensus 179 ~~-----------------------------------------------~~~mTeYVaTRWYRAPElll~~~~Yt~aiDi 211 (359)
T KOG0660|consen 179 FE-----------------------------------------------DGFMTEYVATRWYRAPELLLNSSEYTKAIDI 211 (359)
T ss_pred Cc-----------------------------------------------ccchhcceeeeeecCHHHHhccccccchhhh
Confidence 10 011124578999999999864 77999999
Q ss_pred hHHHHHHHhhhcccc
Q 019953 318 WLVSVLHFNSYRFLE 332 (333)
Q Consensus 318 ws~g~il~~l~t~~~ 332 (333)
||+|||+-+|+++.+
T Consensus 212 WSvGCI~AEmL~gkp 226 (359)
T KOG0660|consen 212 WSVGCILAEMLTGKP 226 (359)
T ss_pred hhhhHHHHHHHcCCC
Confidence 999999999999875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=288.64 Aligned_cols=191 Identities=39% Similarity=0.673 Sum_probs=169.1
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+++.||+|++.............+..|..++..+ .||+|+.+++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554455566788899999888 689999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--------- 151 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+||+.|+|||++.+..++.++| ||+||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~ 191 (327)
T cd05617 152 ----------------------------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA 191 (327)
T ss_pred ----------------------------------------ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh
Confidence 011357999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 g~ 193 (327)
T cd05617 192 GR 193 (327)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=289.18 Aligned_cols=191 Identities=38% Similarity=0.667 Sum_probs=167.4
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+++.||||++.............+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999999999999999999876544444555677788888866 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
++|...+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--------- 151 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875322110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+|++.|+|||++.+..++.++| ||+||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 191 (321)
T cd05591 152 ----------------------------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA 191 (321)
T ss_pred ----------------------------------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc
Confidence 011346999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 g~ 193 (321)
T cd05591 192 GQ 193 (321)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=291.40 Aligned_cols=198 Identities=48% Similarity=0.867 Sum_probs=174.3
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.............+..|+.+++.++|+||+++++.+...+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-- 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-- 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence 999999999999775 67999999999999999999999999999999999999999999999999999876432210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc------CCCCCcccc-
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------KKGYGMECD- 317 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~~~D- 317 (333)
......||+.|+|||++. +..++.++|
T Consensus 159 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di 192 (330)
T cd05601 159 ----------------------------------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192 (330)
T ss_pred ----------------------------------------------eeecccCCccccCHHHhccccccccCCCCCccee
Confidence 011346999999999987 566889999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 193 wslG~il~el~~g~ 206 (330)
T cd05601 193 WSLGVIAYEMIYGR 206 (330)
T ss_pred ecccceeeeeccCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=289.77 Aligned_cols=191 Identities=38% Similarity=0.659 Sum_probs=167.8
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+++.||+|++.............+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876444444556677888888776 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--------- 151 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--------- 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+||+.|+|||++.+..++.++| ||+||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (329)
T cd05618 152 ----------------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191 (329)
T ss_pred ----------------------------------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh
Confidence 011347999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 g~ 193 (329)
T cd05618 192 GR 193 (329)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=288.48 Aligned_cols=191 Identities=38% Similarity=0.661 Sum_probs=167.3
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+++.||||++.............+..|..++..+ .||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544444556677788888776 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--------- 151 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--------- 151 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+||+.|+|||++.+..++.++| ||+||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (320)
T cd05590 152 ----------------------------------------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191 (320)
T ss_pred ----------------------------------------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh
Confidence 011346999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 g~ 193 (320)
T cd05590 192 GH 193 (320)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=288.21 Aligned_cols=194 Identities=37% Similarity=0.649 Sum_probs=167.3
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHH---HHhcCCceeEEEEEEeeCCeEEEE
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL---AEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
|++++.||+|+||.||+|.+..+++.||||++...........+.+..|..++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999999999999999999876544444455666676655 456799999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||+++++|...+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--- 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--- 156 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC---
Confidence 999999999888754 5799999999999999999999999999999999999999999999999999875322110
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....+|++.|+|||++.+..++.++| ||+||+
T Consensus 157 ----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 190 (324)
T cd05589 157 ----------------------------------------------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL 190 (324)
T ss_pred ----------------------------------------------cccccccCccccCHhHhcCCCCCcccchhhHHHH
Confidence 011457999999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 l~el~~G~ 198 (324)
T cd05589 191 IYEMLVGE 198 (324)
T ss_pred HHHHHhCC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=297.19 Aligned_cols=200 Identities=27% Similarity=0.425 Sum_probs=172.2
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
...|++....+++++.||+|-||.||+|.+.. ...||+|.++..... .+.+.+|+.+|++|+|++||++++++..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 35666777778899999999999999999863 337999999875332 2457789999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
++.+||||||++.|+|.++|.. ...+.......++.|||+|++||+++++|||||.++|||++++..+||+|||+|+.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 8899999999999999999987 45788999999999999999999999999999999999999999999999999996
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
+....+..- ...--+.-|.|||++.-..++.+
T Consensus 353 ~~d~~Y~~~------------------------------------------------~~~kfPIkWtAPEa~~~~~FS~k 384 (468)
T KOG0197|consen 353 IGDDEYTAS------------------------------------------------EGGKFPIKWTAPEALNYGKFSSK 384 (468)
T ss_pred cCCCceeec------------------------------------------------CCCCCCceecCHHHHhhCCcccc
Confidence 554432210 01123557999999999999999
Q ss_pred cc-hHHHHHHHhhhcc
Q 019953 316 CD-WLVSVLHFNSYRF 330 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~ 330 (333)
|| ||+||+||+|+|+
T Consensus 385 SDVWSFGVlL~E~fT~ 400 (468)
T KOG0197|consen 385 SDVWSFGVLLWELFTY 400 (468)
T ss_pred cceeehhhhHHHHhcc
Confidence 99 9999999999986
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=288.07 Aligned_cols=198 Identities=48% Similarity=0.860 Sum_probs=171.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||++.+..+++.||+|++.............+..|..++..++|++|+.+++.+...+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444445556788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-- 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-- 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc--
Confidence 99999999999976 467899999999999999999999999999999999999999999999999998764322100
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----CCCCCcccc-h
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECD-W 318 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~D-w 318 (333)
.....+||+.|+|||++. ...++.++| |
T Consensus 159 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvw 192 (332)
T cd05623 159 ----------------------------------------------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192 (332)
T ss_pred ----------------------------------------------eecccccCccccCHHHHhccccCCCCCCCcCCEE
Confidence 011346999999999986 356899999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++|+|+++.
T Consensus 193 SlGvil~ell~g~ 205 (332)
T cd05623 193 SLGVCMYEMLYGE 205 (332)
T ss_pred eeHHHHHHHhcCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=288.66 Aligned_cols=191 Identities=41% Similarity=0.730 Sum_probs=164.4
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHH-HHHHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||+||+|.+..+|+.||||++.............+..|.. +++.++||||+++++.+...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433333344445544 56789999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---------- 150 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987532111
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
......+||+.|+|||++.+..++.++| |++||++|+|++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 191 (323)
T cd05575 151 ---------------------------------------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191 (323)
T ss_pred ---------------------------------------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhc
Confidence 0111346999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 g~ 193 (323)
T cd05575 192 GL 193 (323)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=287.79 Aligned_cols=191 Identities=41% Similarity=0.715 Sum_probs=164.1
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHH-HHHHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+++.||+|++.............+..|.. +++.++||||+++++.+...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433333344445544 67889999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
++|...+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--------- 151 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---------
Confidence 99999988888899999999999999999999999999999999999999999999999999874321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+|++.|+|||++.+..++.++| |++||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (321)
T cd05603 152 ----------------------------------------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY 191 (321)
T ss_pred ----------------------------------------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc
Confidence 011346999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 g~ 193 (321)
T cd05603 192 GL 193 (321)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=288.16 Aligned_cols=191 Identities=39% Similarity=0.686 Sum_probs=163.4
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHH-HHHHHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER-NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+++.||+|++.............+..|. .+++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999765433333333344444 456788999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--------- 151 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--------- 151 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+||+.|+|||++.+..++.++| ||+||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (325)
T cd05602 152 ----------------------------------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 191 (325)
T ss_pred ----------------------------------------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc
Confidence 011447999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 g~ 193 (325)
T cd05602 192 GL 193 (325)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=294.17 Aligned_cols=196 Identities=31% Similarity=0.531 Sum_probs=179.1
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
..|..++.||+|+||.||+|.+..+++.||||++..... ...++.+++|+.+|.+++++||.++|+.+..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 457778999999999999999999999999999987643 445677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|||.||++.+.+.....+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~----- 165 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV----- 165 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh-----
Confidence 999999999999888888999999999999999999999999999999999999999999999999998765322
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
....+++|||.||||||+.+.+|+.++| ||||+++
T Consensus 166 --------------------------------------------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITa 201 (467)
T KOG0201|consen 166 --------------------------------------------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITA 201 (467)
T ss_pred --------------------------------------------hccccccccccccchhhhccccccchhhhhhhhHHH
Confidence 2224889999999999999999999999 9999999
Q ss_pred Hhhhcccc
Q 019953 325 FNSYRFLE 332 (333)
Q Consensus 325 ~~l~t~~~ 332 (333)
++|.++.|
T Consensus 202 iEla~GeP 209 (467)
T KOG0201|consen 202 IELAKGEP 209 (467)
T ss_pred HHHhcCCC
Confidence 99999875
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=286.08 Aligned_cols=191 Identities=36% Similarity=0.626 Sum_probs=165.4
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+|..||+|++................|..++... +||+|+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999875433333445566677777754 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999874321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+||+.|+|||++.+..++.++| |++||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~ 191 (316)
T cd05620 152 ----------------------------------------RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191 (316)
T ss_pred ----------------------------------------ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh
Confidence 011357999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 g~ 193 (316)
T cd05620 192 GQ 193 (316)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=288.89 Aligned_cols=191 Identities=40% Similarity=0.707 Sum_probs=164.6
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHH-HHHHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||+||+|.+..+|+.||+|++.............+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333333344555554 46778999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--------- 151 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--------- 151 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+|++.|+|||++.+..++.++| |++||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (325)
T cd05604 152 ----------------------------------------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191 (325)
T ss_pred ----------------------------------------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc
Confidence 011446999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 G~ 193 (325)
T cd05604 192 GL 193 (325)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=286.62 Aligned_cols=197 Identities=42% Similarity=0.737 Sum_probs=169.0
Q ss_pred CceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHhh-hhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeE
Q 019953 87 DFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 161 (333)
+|++++.||+|+||.||+|.+. .++..||+|++....... ......+..|+.++..+ .|++|+.+++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998764 478999999997653322 22345577899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876432211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws 319 (333)
......+||+.|+|||++.+. .++.++| ||
T Consensus 161 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 192 (332)
T cd05614 161 ------------------------------------------------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192 (332)
T ss_pred ------------------------------------------------CccccccCCccccCHHHhcCCCCCCCcccccc
Confidence 011145799999999999875 4899999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+|+.
T Consensus 193 lG~il~elltg~ 204 (332)
T cd05614 193 LGILIFELLTGA 204 (332)
T ss_pred chhhhhhhhcCC
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=288.43 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=164.9
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 154 (333)
|.+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.++..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 4567789999999999999999999752 345789999987532 122345688899999999 89999999998
Q ss_pred EeeC-CeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 019953 155 FQDT-EYLYLIMEYLPGGDMMTLLMRE----------------------------------------------------- 180 (333)
Q Consensus 155 ~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------- 180 (333)
+... +.+++||||+++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8654 4689999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccC
Q 019953 181 ---------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (333)
Q Consensus 181 ---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 251 (333)
..++...+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-------- 231 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-------- 231 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh--------
Confidence 236777888899999999999999999999999999999999999999999998653221100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
...+..+++.|+|||++.+..++.++| ||+||++|+|++
T Consensus 232 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~ 271 (338)
T cd05102 232 ---------------------------------------RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271 (338)
T ss_pred ---------------------------------------cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence 001234678899999999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=282.35 Aligned_cols=188 Identities=27% Similarity=0.477 Sum_probs=160.2
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC-----eE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-----YL 161 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 161 (333)
.|.-.+++|+|+||.||.|....++..||||..-...- .--+|+.+|+.++|||||++..+|.... +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 57888999999999999999999999999998754421 1234999999999999999998875422 45
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-CcEEEEeccCcccC
Q 019953 162 YLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPL 236 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DFGla~~~ 236 (333)
.+||||++. +|...++. +..++.-.++.++.|++.||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 689999965 88888763 5678999999999999999999999999999999999999966 89999999999988
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGME 315 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~ 315 (333)
..++.++ +..-|..|+|||.+.| ..|+.+
T Consensus 177 ~~~epni--------------------------------------------------SYicSRyYRaPELifga~~Yt~~ 206 (364)
T KOG0658|consen 177 VKGEPNI--------------------------------------------------SYICSRYYRAPELIFGATEYTTS 206 (364)
T ss_pred ccCCCce--------------------------------------------------eEEEeccccCHHHHcCccccCce
Confidence 7554221 4467899999999988 569999
Q ss_pred cc-hHHHHHHHhhhcccc
Q 019953 316 CD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~~ 332 (333)
.| ||+||++-+|+-+-+
T Consensus 207 IDiWSaGCV~aELl~g~p 224 (364)
T KOG0658|consen 207 IDIWSAGCVMAELLKGQP 224 (364)
T ss_pred eEEhhhhHHHHHHhcCCc
Confidence 99 999999999987654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=284.02 Aligned_cols=191 Identities=35% Similarity=0.626 Sum_probs=165.0
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHH-hcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||.||+|.+..+++.||||++................|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987543333334455667777775 4899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---------
Confidence 99999998877899999999999999999999999999999999999999999999999999875321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+||+.|+|||++.+..++.++| |++||++|+|++
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (316)
T cd05619 152 ----------------------------------------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191 (316)
T ss_pred ----------------------------------------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 011346999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 G~ 193 (316)
T cd05619 192 GQ 193 (316)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=281.40 Aligned_cols=198 Identities=34% Similarity=0.488 Sum_probs=170.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..++.+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999875432 2233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--- 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc---
Confidence 99988777666555567999999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
......|++.|+|||++.+..++.++| ||+||++
T Consensus 157 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil 191 (287)
T cd07848 157 ---------------------------------------------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL 191 (287)
T ss_pred ---------------------------------------------cccccccccccCCcHHHcCCCCCCchhHHhHHHHH
Confidence 011346899999999999999999999 9999999
Q ss_pred Hhhhcccc
Q 019953 325 FNSYRFLE 332 (333)
Q Consensus 325 ~~l~t~~~ 332 (333)
|+|+++.+
T Consensus 192 ~el~~g~~ 199 (287)
T cd07848 192 GELSDGQP 199 (287)
T ss_pred HHHHhCCC
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=276.12 Aligned_cols=197 Identities=29% Similarity=0.524 Sum_probs=174.8
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..+.|++-+.||+|.|+.|+++.+..+|+.+|+|+++....... ..+.+.+|+.|-+.++|||||++.+.+...+..|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 45678999999999999999999999999999999987655444 56778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cEEEEeccCcccCCCCc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLDCST 240 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~~~~~ 240 (333)
|+|++.|++|..-+-..--+++..+..++.|++.+|.|+|.+||||||+||.|+++.+.. -+||+|||+|..+....
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 999999999987776666789999999999999999999999999999999999996443 59999999999876322
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
....++|||.|||||++...+|+..+| |+
T Consensus 168 --------------------------------------------------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~ 197 (355)
T KOG0033|consen 168 --------------------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 197 (355)
T ss_pred --------------------------------------------------ccccccCCCcccCHHHhhcCCCCCcchhhh
Confidence 122668999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+|||+|.||.+.
T Consensus 198 cGViLfiLL~G~ 209 (355)
T KOG0033|consen 198 CGVILYILLVGY 209 (355)
T ss_pred hhHHHHHHHhCC
Confidence 999999887653
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.75 Aligned_cols=192 Identities=23% Similarity=0.323 Sum_probs=168.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.+...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3455789999999999999999999999999999997532 2356799999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++|||++ +++|..++.....++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9999999 578999888878899999999999999999999999999999999999999999999999999875321110
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
......+||+.|+|||++.+..++.++| ||+
T Consensus 238 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 269 (391)
T PHA03212 238 ------------------------------------------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269 (391)
T ss_pred ------------------------------------------------cccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence 0111347999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 270 Gvil~elltg~ 280 (391)
T PHA03212 270 GIVLFEMATCH 280 (391)
T ss_pred HHHHHHHHHCC
Confidence 99999999874
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=284.51 Aligned_cols=192 Identities=41% Similarity=0.755 Sum_probs=165.6
Q ss_pred eeeEeeecceEEEEEEEe---cCCceEEEEecchhHHh-hhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 91 LTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMV-KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
++.||+|+||.||+|.+. .+++.||+|++...... .......+..|+.+++.++||||+++++.+..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47889999999765432 22233456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|.+++.....+.+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 155 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT----- 155 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-----
Confidence 999999999998888899999999999999999999999999999999999999999999999999874321110
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
.....+|++.|+|||++.+..++.++| |++||++|
T Consensus 156 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 191 (323)
T cd05584 156 --------------------------------------------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMY 191 (323)
T ss_pred --------------------------------------------cccccCCCccccChhhccCCCCCCcceecccHHHHH
Confidence 011346999999999999999999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 192 ell~G~ 197 (323)
T cd05584 192 DMLTGA 197 (323)
T ss_pred HHhcCC
Confidence 999874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=282.11 Aligned_cols=195 Identities=28% Similarity=0.439 Sum_probs=165.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875432 12223466799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 99995 6787777553 5689999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
......|++.|+|||++.+ ..++.++| ||+|
T Consensus 159 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 191 (303)
T cd07869 159 -----------------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVG 191 (303)
T ss_pred -----------------------------------------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHH
Confidence 0113468999999999876 45899999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 192 ~il~~l~~g~ 201 (303)
T cd07869 192 CIFVEMIQGV 201 (303)
T ss_pred HHHHHHHhCC
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=283.54 Aligned_cols=191 Identities=38% Similarity=0.661 Sum_probs=167.8
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+||+||+|.+..+++.||||++.............+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544445556677888888877 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
++|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--------- 151 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999874321110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+|++.|+|||++.+..++.++| |++||++|+|++
T Consensus 152 ----------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~ 191 (318)
T cd05570 152 ----------------------------------------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA 191 (318)
T ss_pred ----------------------------------------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh
Confidence 011346999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 192 G~ 193 (318)
T cd05570 192 GQ 193 (318)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=277.13 Aligned_cols=195 Identities=32% Similarity=0.591 Sum_probs=170.3
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.....+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999976544333334456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+++|+|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence 99999999887543 4689999999999999999999999999999999999999999999999999876432110
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
....+|++.|+|||++.+..++.++| ||+||+
T Consensus 158 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~ 190 (285)
T cd05605 158 -----------------------------------------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCL 190 (285)
T ss_pred -----------------------------------------------cccccCCCCccCcHHhcCCCCCccccchhHHHH
Confidence 01346899999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 l~el~~g~ 198 (285)
T cd05605 191 IYEMIEGK 198 (285)
T ss_pred HHHHHHCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=271.24 Aligned_cols=197 Identities=30% Similarity=0.552 Sum_probs=174.3
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh-----hhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----KRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 159 (333)
..|.-.+.||.|..+.|.+|.+..+|+.+|+|++...... .....+...+|+.||+++ .||+|+.+.++|..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3566778899999999999999999999999998643211 223345677899999998 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+++|+|.|+.|.|.+++.+.-.+++...+.+|+|++.|+.|||..+||||||||+|||++++.+++|+|||++..+..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988765
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc------CCCCC
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------KKGYG 313 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~ 313 (333)
.. ....||||+|.|||.+. ..+|+
T Consensus 177 ek--------------------------------------------------LrelCGTPgYLAPEtikC~m~e~~pGYs 206 (411)
T KOG0599|consen 177 EK--------------------------------------------------LRELCGTPGYLAPETIKCSMYENHPGYS 206 (411)
T ss_pred hh--------------------------------------------------HHHhcCCCcccChhheeeecccCCCCcc
Confidence 42 22569999999999985 35699
Q ss_pred cccc-hHHHHHHHhhhcccc
Q 019953 314 MECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~~ 332 (333)
..+| |++|||||.|+.+.+
T Consensus 207 ~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 207 KEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred chhhHHHHHHHHHHHHcCCC
Confidence 9999 999999999998754
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=282.98 Aligned_cols=196 Identities=29% Similarity=0.407 Sum_probs=174.1
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++..++.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 34578999999999999999999999999999999987542 2233456888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999999998888899999999999999999999986 69999999999999999999999999987653211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.....|++.|+|||++.+..++.++| ||+
T Consensus 159 --------------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 188 (331)
T cd06649 159 --------------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (331)
T ss_pred --------------------------------------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence 01346899999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 189 G~il~el~tg~ 199 (331)
T cd06649 189 GLSLVELAIGR 199 (331)
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=279.06 Aligned_cols=195 Identities=27% Similarity=0.423 Sum_probs=166.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 4679999999999999999999999999999999865421 12234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||++ ++|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 82 FEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred EeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 99996 4898888654 4578999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
......|++.|+|||++.+ ..++.++| ||+|
T Consensus 159 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 191 (288)
T cd07871 159 -----------------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG 191 (288)
T ss_pred -----------------------------------------------cccCceecccccChHHhcCCcccCcHHHHHHHH
Confidence 0113368999999999876 56899999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 192 ~~l~~l~~g~ 201 (288)
T cd07871 192 CILYEMATGR 201 (288)
T ss_pred HHHHHHHhCC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=276.99 Aligned_cols=189 Identities=35% Similarity=0.613 Sum_probs=164.8
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCH
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 173 (333)
||+|+||+||+|.+..+++.||+|.+.............+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999765544444445677899999999999999999999999999999999999999
Q ss_pred HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccc
Q 019953 174 MTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (333)
Q Consensus 174 ~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 249 (333)
..++.. +..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~------- 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK------- 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-------
Confidence 887743 346899999999999999999999999999999999999999999999999998765432210
Q ss_pred cCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhh
Q 019953 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSY 328 (333)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~ 328 (333)
.....|++.|+|||++.+..++.++| ||+||++|+|+
T Consensus 154 ------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 191 (280)
T cd05608 154 ------------------------------------------TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191 (280)
T ss_pred ------------------------------------------ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHH
Confidence 11346899999999999999999999 99999999999
Q ss_pred ccc
Q 019953 329 RFL 331 (333)
Q Consensus 329 t~~ 331 (333)
++.
T Consensus 192 ~g~ 194 (280)
T cd05608 192 AAR 194 (280)
T ss_pred hCC
Confidence 864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=283.91 Aligned_cols=198 Identities=25% Similarity=0.384 Sum_probs=166.4
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----CeE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----EYL 161 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 161 (333)
+|++.+.||+|+||.||+|.+..++..||||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 58999999999999999999999999999999864321 222334577899999999999999999887543 358
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+||||| +++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999 578999998888899999999999999999999999999999999999999999999999999986432110
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCcccc-h
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD-W 318 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~D-w 318 (333)
.. ......+|++.|+|||++.+ ..++.++| |
T Consensus 159 ~~----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Dvw 192 (338)
T cd07859 159 TA----------------------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192 (338)
T ss_pred cc----------------------------------------------ccccCCCCCCCcCCHHHHhccccccCchhHHH
Confidence 00 00113469999999999876 67899999 9
Q ss_pred HHHHHHHhhhcccc
Q 019953 319 LVSVLHFNSYRFLE 332 (333)
Q Consensus 319 s~g~il~~l~t~~~ 332 (333)
|+||++|+|+|+.+
T Consensus 193 SlGvvl~el~tg~~ 206 (338)
T cd07859 193 SIGCIFAEVLTGKP 206 (338)
T ss_pred HHHHHHHHHHcCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.75 Aligned_cols=201 Identities=37% Similarity=0.688 Sum_probs=186.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.+...+++.+..||-||||.|-++........+|+|++++....+..+.+++..|..+|..+++|.||++|..|.++.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34556788889999999999999887666667999999998888888888999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|++||-|-||.|+..+...+.|.+..+++++..+++|++|||++|||.|||||+|++++.+|.+||.|||+|+.+..+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999987543
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.++++||||.|.|||++.+.+.+.++| |++
T Consensus 575 -------------------------------------------------KTwTFcGTpEYVAPEIILnKGHD~avDyWaL 605 (732)
T KOG0614|consen 575 -------------------------------------------------KTWTFCGTPEYVAPEIILNKGHDRAVDYWAL 605 (732)
T ss_pred -------------------------------------------------ceeeecCCcccccchhhhccCcchhhHHHHH
Confidence 455899999999999999999999999 999
Q ss_pred HHHHHhhhcccc
Q 019953 321 SVLHFNSYRFLE 332 (333)
Q Consensus 321 g~il~~l~t~~~ 332 (333)
|+++|+|+++.|
T Consensus 606 GIli~ELL~G~p 617 (732)
T KOG0614|consen 606 GILIYELLTGSP 617 (732)
T ss_pred HHHHHHHHcCCC
Confidence 999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=287.66 Aligned_cols=201 Identities=26% Similarity=0.324 Sum_probs=171.9
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
.......+++|.-...||+|+||.||+|.. .+|..||||.+....... ...+.+|+.++.+++|||+|+++|+|.+
T Consensus 67 ~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 67 YDELRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred HHHHHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 344455568899999999999999999985 445899999886653221 3449999999999999999999999998
Q ss_pred CC-eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cEecccCCCcEEEccCCcEEEEecc
Q 019953 158 TE-YLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHN---YIHRDIKPDNLLLDKNGHMKLSDFG 231 (333)
Q Consensus 158 ~~-~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~Nill~~~~~vkl~DFG 231 (333)
.+ ..+||+||+++|+|.+.+.... ++++.....|+.+++.||.|||... ||||||||+|||+|++.++||+|||
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG 222 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG 222 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence 88 5999999999999999997754 8999999999999999999999853 9999999999999999999999999
Q ss_pred CcccCCC-CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccccc-CCCCCCcccccccC
Q 019953 232 LCKPLDC-STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST-VGTPDYIAPEVLLK 309 (333)
Q Consensus 232 la~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~APE~~~~ 309 (333)
+|+..+. .... .+. .||.+|+|||.+..
T Consensus 223 La~~~~~~~~~~--------------------------------------------------~~~~~gt~gY~~PEy~~~ 252 (361)
T KOG1187|consen 223 LAKLGPEGDTSV--------------------------------------------------STTVMGTFGYLAPEYAST 252 (361)
T ss_pred CcccCCccccce--------------------------------------------------eeecCCCCccCChhhhcc
Confidence 9976543 2110 011 69999999999999
Q ss_pred CCCCcccc-hHHHHHHHhhhcccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~~ 332 (333)
+..+.++| ||+||++.+|+|+.+
T Consensus 253 g~lt~KsDVySFGVvllElitgr~ 276 (361)
T KOG1187|consen 253 GKLTEKSDVYSFGVVLLELITGRK 276 (361)
T ss_pred CCcCcccccccchHHHHHHHhCCc
Confidence 99999999 999999999999763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=291.99 Aligned_cols=191 Identities=24% Similarity=0.364 Sum_probs=171.9
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..|++.++...-++-||+|+.|.||+|+.. ++.||||.++... ..++.=|++|+|+||+.+.|+|...
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCC
Confidence 457788888888899999999999999754 7899999875432 1256668899999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..+|||||||..|.|...|+..++++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++....
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999886543
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
. ...++++||..|||||++.+.+.+.++|
T Consensus 265 ~--------------------------------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDI 294 (904)
T KOG4721|consen 265 K--------------------------------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDI 294 (904)
T ss_pred h--------------------------------------------------hhhhhhhhhHhhhCHHHhhcCCcccccce
Confidence 2 2334889999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||+||+|||+.
T Consensus 295 wSfGVVLWEmLT~E 308 (904)
T KOG4721|consen 295 WSFGVVLWEMLTGE 308 (904)
T ss_pred ehhHHHHHHHHhcC
Confidence 99999999999975
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=284.13 Aligned_cols=189 Identities=43% Similarity=0.730 Sum_probs=161.9
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh---cCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
||+|+||+||+|.+..+++.||||++................|..++... .||+|+.+++.+.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999765443333444455667777665 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--------- 151 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--------- 151 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875322110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHHHHhhh
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVLHFNSY 328 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~il~~l~ 328 (333)
.....+||+.|+|||++.+. .++.++| |++||++|+|+
T Consensus 152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell 191 (330)
T cd05586 152 ----------------------------------------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC 191 (330)
T ss_pred ----------------------------------------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec
Confidence 01134799999999999764 5899999 99999999999
Q ss_pred ccc
Q 019953 329 RFL 331 (333)
Q Consensus 329 t~~ 331 (333)
++.
T Consensus 192 tG~ 194 (330)
T cd05586 192 CGW 194 (330)
T ss_pred cCC
Confidence 863
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=280.19 Aligned_cols=196 Identities=29% Similarity=0.405 Sum_probs=172.9
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++|+||+++++++...+.++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34578999999999999999999999999999999886542 2233456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999999998888899999999999999999999975 79999999999999999999999999987543211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.....|++.|+|||++.+..++.++| |++
T Consensus 159 --------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 188 (333)
T cd06650 159 --------------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (333)
T ss_pred --------------------------------------------------cccCCCCccccCHHHhcCCCCCcHHHHHHH
Confidence 01346899999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 189 G~il~~l~~g~ 199 (333)
T cd06650 189 GLSLVEMAIGR 199 (333)
T ss_pred HHHHHHHHHCC
Confidence 99999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=290.92 Aligned_cols=197 Identities=29% Similarity=0.447 Sum_probs=169.4
Q ss_pred CCCceEeeeEeeecceEEEEEEEecC-CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKS-GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+..|+.+++.++||||+++++.+...+.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998777 7889999775432 2233457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 164 IMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
||||+++|+|.+++.. ..++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987753 346899999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
... ....+.+||+.|+|||++.+..++.++| |
T Consensus 223 ~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 255 (478)
T PTZ00267 223 VSL-----------------------------------------------DVASSFCGTPYYLAPELWERKRYSKKADMW 255 (478)
T ss_pred ccc-----------------------------------------------ccccccCCCccccCHhHhCCCCCCcHHhHH
Confidence 110 0112457999999999999999999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++|+|+++.
T Consensus 256 slG~~l~el~tg~ 268 (478)
T PTZ00267 256 SLGVILYELLTLH 268 (478)
T ss_pred HHHHHHHHHHhCC
Confidence 9999999999873
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=280.46 Aligned_cols=190 Identities=42% Similarity=0.703 Sum_probs=165.6
Q ss_pred eeEeeecceEEEEEEEe---cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEecc
Q 019953 92 TIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (333)
+.||+|+||.||++.+. .+|+.||+|++...... ......+..|+.+++.++||||+++++++...+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 57999999999998763 57899999999865432 223345677999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccc
Q 019953 169 PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248 (333)
Q Consensus 169 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 248 (333)
++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~------- 153 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK------- 153 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-------
Confidence 9999999998888899999999999999999999999999999999999999999999999999875432210
Q ss_pred ccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhh
Q 019953 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNS 327 (333)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l 327 (333)
.....+|++.|+|||++.+..++.++| |++||++|+|
T Consensus 154 ------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el 191 (318)
T cd05582 154 ------------------------------------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEM 191 (318)
T ss_pred ------------------------------------------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeee
Confidence 111446999999999999999999999 9999999999
Q ss_pred hccc
Q 019953 328 YRFL 331 (333)
Q Consensus 328 ~t~~ 331 (333)
+++.
T Consensus 192 ~tg~ 195 (318)
T cd05582 192 LTGS 195 (318)
T ss_pred ccCC
Confidence 9874
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=288.18 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=175.8
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCc---e-EEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEE
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN---I-YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~---~-vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 153 (333)
...|++..++..+.++||+|+||.||+|.....+. . ||+|............+..+.+|+++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45688888999999999999999999998765422 3 8999988644445677888999999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
++.....+++|||+|+||+|.+++.+.. .++..+...++.+.+.||+|||++++|||||.++|+|++.++.+||+|||+
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999999999998876 599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccccc-CCCCCCcccccccCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST-VGTPDYIAPEVLLKKG 311 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~ 311 (333)
++....-. . .... .-+..|+|||.+....
T Consensus 309 s~~~~~~~---~-----------------------------------------------~~~~~klPirWLAPEtl~~~~ 338 (474)
T KOG0194|consen 309 SRAGSQYV---M-----------------------------------------------KKFLKKLPIRWLAPETLNTGI 338 (474)
T ss_pred ccCCccee---e-----------------------------------------------ccccccCcceecChhhhccCc
Confidence 88643110 0 0001 2456899999999999
Q ss_pred CCcccc-hHHHHHHHhhhc
Q 019953 312 YGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t 329 (333)
|+.++| |++||++|++++
T Consensus 339 ~s~kTDV~sfGV~~~Eif~ 357 (474)
T KOG0194|consen 339 FSFKTDVWSFGVLLWEIFE 357 (474)
T ss_pred cccccchhheeeeEEeeec
Confidence 999999 999999999987
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=270.51 Aligned_cols=188 Identities=32% Similarity=0.516 Sum_probs=162.4
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCH
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 173 (333)
||+|+||.||++.+..+|+.||+|.+.............+..|+.+++.++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999765433333334456699999999999999999999999999999999999999
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccC
Q 019953 174 MTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (333)
Q Consensus 174 ~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 251 (333)
.+.+... ..++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---------- 150 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---------- 150 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----------
Confidence 9887543 3588888899999999999999999999999999999999999999999999876543211
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.....|++.|+|||++.+..++.++| ||+||++|+|+++
T Consensus 151 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g 190 (277)
T cd05607 151 ----------------------------------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190 (277)
T ss_pred ----------------------------------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC
Confidence 01235899999999999999999999 9999999999986
Q ss_pred c
Q 019953 331 L 331 (333)
Q Consensus 331 ~ 331 (333)
.
T Consensus 191 ~ 191 (277)
T cd05607 191 R 191 (277)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=274.65 Aligned_cols=198 Identities=22% Similarity=0.372 Sum_probs=164.5
Q ss_pred cCCCceEeeeEeeecceEEEEEEEec----------------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKK----------------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 147 (333)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35689999999999999999997532 34579999987542 1223456788999999999999
Q ss_pred eeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcE
Q 019953 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-------------------TLTENVARFYIAQSVLAIESIHKHNYI 208 (333)
Q Consensus 148 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~qi~~~L~~LH~~~iv 208 (333)
|+++++++...+..++||||+++++|.+++.... .++...+..++.|++.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999885431 356678889999999999999999999
Q ss_pred ecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhh
Q 019953 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNR 288 (333)
Q Consensus 209 HrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (333)
||||||+|||++.++.+||+|||+++.+.......
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~--------------------------------------------- 195 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR--------------------------------------------- 195 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeE---------------------------------------------
Confidence 99999999999999999999999998654322110
Q ss_pred hccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 289 RKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 289 ~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
......++..|+|||++.+..++.++| ||+|+++|+|++.
T Consensus 196 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 196 --IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred --ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 011234678999999999999999999 9999999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=269.90 Aligned_cols=195 Identities=32% Similarity=0.603 Sum_probs=169.7
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|++|+.+++.+...+..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37788999999999999999999999999999876544333334456779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--- 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---
Confidence 99999999887543 4699999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....|++.|+|||++.+..++.++| ||+|++
T Consensus 158 -----------------------------------------------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~ 190 (285)
T cd05632 158 -----------------------------------------------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCL 190 (285)
T ss_pred -----------------------------------------------ccCCCCCcCccChHHhcCCCCCcccchHHHHHH
Confidence 01346899999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 l~~l~~g~ 198 (285)
T cd05632 191 IYEMIEGQ 198 (285)
T ss_pred HHHHHhCC
Confidence 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=270.73 Aligned_cols=195 Identities=32% Similarity=0.597 Sum_probs=169.4
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+..|+.+++.++|++|+.+++.+...+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876543333334456779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---
Confidence 99999999888543 3589999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....|++.|+|||++.+..++.++| ||+|++
T Consensus 158 -----------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~ 190 (285)
T cd05630 158 -----------------------------------------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 190 (285)
T ss_pred -----------------------------------------------ccCCCCCccccChHHHcCCCCCCccccHHHHHH
Confidence 01346899999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 l~~l~~g~ 198 (285)
T cd05630 191 LYEMIAGQ 198 (285)
T ss_pred HHHHHhCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=300.04 Aligned_cols=215 Identities=24% Similarity=0.355 Sum_probs=171.6
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999987543323334456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 166 EYLPGGDMMTLLMRE-----------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 166 e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
||++|++|.+++... ...+...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999988641 234556778899999999999999999999999999999999999999999998
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCc
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ 314 (333)
............. .. ..+ ... .........+||+.|+|||++.+.+++.
T Consensus 162 ~i~~~~~~~~~l~-~~-~~~-----s~~------------------------s~~t~~g~~vGT~~YmAPE~l~g~~~S~ 210 (932)
T PRK13184 162 FKKLEEEDLLDID-VD-ERN-----ICY------------------------SSMTIPGKIVGTPDYMAPERLLGVPASE 210 (932)
T ss_pred ecccccccccccc-cc-ccc-----ccc------------------------cccccCCCCCCCCCCCCHHHhcCCCCCc
Confidence 7632211000000 00 000 000 0001112357999999999999999999
Q ss_pred ccc-hHHHHHHHhhhccc
Q 019953 315 ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~ 331 (333)
++| ||+||++|+|+|+.
T Consensus 211 kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 211 STDIYALGVILYQMLTLS 228 (932)
T ss_pred HhHHHHHHHHHHHHHHCC
Confidence 999 99999999999874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=284.79 Aligned_cols=198 Identities=31% Similarity=0.565 Sum_probs=178.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
....+.|.+.+.||+|.|++|.+|.+..++..||||.+.+........ ..+.+|+.+|+.+.|||||+++.+......+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 345678999999999999999999999999999999998876544433 3478899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+||||+.+|.+.+++.+++...+..++.++.|++.|++|||+++|||||||++|+|++.+.++||+|||++..+.....
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998875542
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D-ws 319 (333)
. .+.||++.|.|||++.|..| ++.+| |+
T Consensus 211 l--------------------------------------------------qt~cgsppyAaPEl~~g~~y~gpe~D~Ws 240 (596)
T KOG0586|consen 211 L--------------------------------------------------QTFCGSPPYAAPELFNGKKYDGPEVDIWS 240 (596)
T ss_pred c--------------------------------------------------cccCCCCCccChHhhcCcccCCcceehhh
Confidence 2 26699999999999999887 56899 99
Q ss_pred HHHHHHhhhcc
Q 019953 320 VSVLHFNSYRF 330 (333)
Q Consensus 320 ~g~il~~l~t~ 330 (333)
+|+++|.|+.+
T Consensus 241 lgvvly~LV~G 251 (596)
T KOG0586|consen 241 LGVVLYALVEG 251 (596)
T ss_pred hhhhheeeeec
Confidence 99999987643
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=269.55 Aligned_cols=194 Identities=46% Similarity=0.837 Sum_probs=175.6
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+.||||+++++++...+.+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997665444455667888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~----- 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT----- 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC-----
Confidence 999999999999888889999999999999999999999999999999999999999999999999988654221
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
....|++.|+|||.+.+..++.++| |++|+++
T Consensus 156 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 188 (290)
T cd05580 156 -----------------------------------------------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188 (290)
T ss_pred -----------------------------------------------CCCCCCccccChhhhcCCCCCccccHHHHHHHH
Confidence 1336899999999999989999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 189 ~~l~~g~ 195 (290)
T cd05580 189 YEMLAGY 195 (290)
T ss_pred HHHHhCC
Confidence 9999865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=279.66 Aligned_cols=194 Identities=27% Similarity=0.397 Sum_probs=163.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE---- 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 159 (333)
..++|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35789999999999999999999999999999999865422 2233455778999999999999999999886543
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 --YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.+|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999965 6666653 348888999999999999999999999999999999999999999999999987543
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... .....||+.|+|||++.+..++.++|
T Consensus 175 ~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~D 204 (359)
T cd07876 175 TNFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVD 204 (359)
T ss_pred cCcc--------------------------------------------------CCCCcccCCCCCchhccCCCCCcchh
Confidence 2110 11346899999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 205 iwSlG~il~el~tg~ 219 (359)
T cd07876 205 IWSVGCIMGELVKGS 219 (359)
T ss_pred hHHHHHHHHHHHhCC
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=289.99 Aligned_cols=202 Identities=28% Similarity=0.455 Sum_probs=170.6
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC--
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-- 159 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 159 (333)
....++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.++..+.|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3456799999999999999999999999999999999875432 2234455778999999999999999987764322
Q ss_pred ------eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEe
Q 019953 160 ------YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSD 229 (333)
Q Consensus 160 ------~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~D 229 (333)
.+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 37899999999999998864 34689999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||+++.+...... ......+||+.|+|||++.+
T Consensus 187 FGls~~~~~~~~~-----------------------------------------------~~~~~~~Gt~~Y~aPE~~~~ 219 (496)
T PTZ00283 187 FGFSKMYAATVSD-----------------------------------------------DVGRTFCGTPYYVAPEIWRR 219 (496)
T ss_pred cccCeeccccccc-----------------------------------------------cccccccCCcceeCHHHhCC
Confidence 9999865422100 01114579999999999999
Q ss_pred CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| ||+||++|+|+++.
T Consensus 220 ~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 220 KPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred CCCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999 99999999999864
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=279.56 Aligned_cols=195 Identities=32% Similarity=0.519 Sum_probs=174.4
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.+=|.+.+.||+|-|.+|-+|++.-+|..||||++.+..... ....++.+|+..|+.++|||||++|.+......+|||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345889999999999999999999999999999999876543 4456688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc-cCCcEEEEeccCcccCCCCccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~-~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+|+-++|+|++|+.++ ..+.+..++.++.||+.||.|+|+..+|||||||+||.+. .-|.|||+|||++-.+.++..
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 9999999999999876 4699999999999999999999999999999999999876 558999999999988765532
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCc-ccc-hHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM-ECD-WLV 320 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~-~~D-ws~ 320 (333)
..+.||+..|.|||++.|..|+. ++| |++
T Consensus 175 -------------------------------------------------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSL 205 (864)
T KOG4717|consen 175 -------------------------------------------------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSL 205 (864)
T ss_pred -------------------------------------------------hhcccchhhccCchhhhcCccCCcchhhhHH
Confidence 23679999999999999999965 789 999
Q ss_pred HHHHHhhhcc
Q 019953 321 SVLHFNSYRF 330 (333)
Q Consensus 321 g~il~~l~t~ 330 (333)
|||+|.|+-+
T Consensus 206 GVILyMLVCG 215 (864)
T KOG4717|consen 206 GVILYMLVCG 215 (864)
T ss_pred HHHHHHHHhC
Confidence 9999988644
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=267.84 Aligned_cols=203 Identities=38% Similarity=0.672 Sum_probs=185.2
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDT 158 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 158 (333)
.+.+..++|.++++||+|+|.+|.+++...+.+.||+|++++.-....+.+++.+.|..++..- +||.+|-++.+|+++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3556678999999999999999999999999999999999988777778889999999998876 789999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..+++|.||++||+|.-.+.....+++..++.+..+++.||.|||+.|||.||||.+|||+|..|++||+|+|+++.--.
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999999999998888888999999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
++ ..+.++||||.|+|||++.|..|++++|
T Consensus 404 ~g-------------------------------------------------d~tstfcgtpnyiapeilrgeeygfsvdw 434 (593)
T KOG0695|consen 404 PG-------------------------------------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDW 434 (593)
T ss_pred CC-------------------------------------------------cccccccCCCcccchhhhcccccCceehH
Confidence 22 2234789999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++||+||+|+.+.
T Consensus 435 walgvlmfemmagr 448 (593)
T KOG0695|consen 435 WALGVLMFEMMAGR 448 (593)
T ss_pred HHHHHHHHHHHcCC
Confidence 88999999998764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=281.86 Aligned_cols=201 Identities=24% Similarity=0.362 Sum_probs=167.0
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCC-----ceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEE
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSG-----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 153 (333)
.|.+..++|++.+.||+|+||.||+|.+...| ..||+|++..... ......+.+|+.+++.+ +|+||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 45566778999999999999999999865443 5799999975432 22345678899999999 8999999999
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE----------------------------------------------------- 180 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------- 180 (333)
.+...+.+++|||||++|+|.+++...
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 999999999999999999999988532
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 181 -----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 181 -----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
..++...+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 136778889999999999999999999999999999999999999999999988654322100
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......+++.|+|||++.+..++.++| ||+||
T Consensus 270 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGv 302 (374)
T cd05106 270 -----------------------------------------------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 302 (374)
T ss_pred -----------------------------------------------eccCCCCccceeCHHHhcCCCCCccccHHHHHH
Confidence 000223567899999999999999999 99999
Q ss_pred HHHhhhc
Q 019953 323 LHFNSYR 329 (333)
Q Consensus 323 il~~l~t 329 (333)
++|+|++
T Consensus 303 il~ellt 309 (374)
T cd05106 303 LLWEIFS 309 (374)
T ss_pred HHHHHHh
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=285.27 Aligned_cols=192 Identities=26% Similarity=0.370 Sum_probs=159.2
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC----
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT---- 158 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 158 (333)
....+|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 44578999999999999999999999999999999885432 1234599999999999999998876432
Q ss_pred ----CeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-cEEEEe
Q 019953 159 ----EYLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSD 229 (333)
Q Consensus 159 ----~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-~vkl~D 229 (333)
..+++||||+++ +|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 257799999964 6766654 345799999999999999999999999999999999999999665 799999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||+++.+..... ..+.+||+.|+|||++.+
T Consensus 215 FGla~~~~~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 215 FGSAKNLLAGQR--------------------------------------------------SVSYICSRFYRAPELMLG 244 (440)
T ss_pred cccchhccCCCC--------------------------------------------------cccCCCCcCccCHHHhcC
Confidence 999986543211 113468999999999876
Q ss_pred C-CCCcccc-hHHHHHHHhhhcccc
Q 019953 310 K-GYGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 310 ~-~~~~~~D-ws~g~il~~l~t~~~ 332 (333)
. .|+.++| ||+||++|+|+++.+
T Consensus 245 ~~~~~~~~DiwSlGvil~elltG~~ 269 (440)
T PTZ00036 245 ATNYTTHIDLWSLGCIIAEMILGYP 269 (440)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 4 6999999 999999999999754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=269.81 Aligned_cols=195 Identities=28% Similarity=0.450 Sum_probs=160.1
Q ss_pred CCceEeeeEeeecceEEEEEEEec-CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh---cCCceeEEEEEEe-----
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQ----- 156 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~----- 156 (333)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+...... ........+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 4788999988654321 12223345577776665 6999999999875
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
....+++||||++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999995 6898888653 458999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCc
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ 314 (333)
...... ......|++.|+|||++.+..++.
T Consensus 159 ~~~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ 188 (290)
T cd07862 159 IYSFQM--------------------------------------------------ALTSVVVTLWYRAPEVLLQSSYAT 188 (290)
T ss_pred eccCCc--------------------------------------------------ccccccccccccChHHHhCCCCCC
Confidence 653221 011346899999999999999999
Q ss_pred ccc-hHHHHHHHhhhcccc
Q 019953 315 ECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~~ 332 (333)
++| ||+||++|+|+++.+
T Consensus 189 ~~DiwslG~il~el~~g~~ 207 (290)
T cd07862 189 PVDLWSVGCIFAEMFRRKP 207 (290)
T ss_pred ccchHHHHHHHHHHHcCCC
Confidence 999 999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=289.15 Aligned_cols=187 Identities=29% Similarity=0.456 Sum_probs=165.0
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
|.-++.||.|+||.||-|++..+...||||.+.-......+.-..+.+|+..|+.++|||++.+-|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56678899999999999999999999999999765444444445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 168 LPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 168 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
| -|+-.+++.- .+++.+..+..|+.+.+.||.|||+++.||||||+.|||++++|.|||+|||.|....+.
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------- 179 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch-------
Confidence 9 5688888865 457999999999999999999999999999999999999999999999999999875433
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CCCCcccc-hHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECD-WLVSV 322 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~D-ws~g~ 322 (333)
.+++|||+||||||+.. +.|+.++| ||+|+
T Consensus 180 ----------------------------------------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGI 213 (948)
T KOG0577|consen 180 ----------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213 (948)
T ss_pred ----------------------------------------------hcccCCccccchhHheeccccccCCccceeeccc
Confidence 27899999999999863 56999999 99999
Q ss_pred HHHhhh
Q 019953 323 LHFNSY 328 (333)
Q Consensus 323 il~~l~ 328 (333)
...+|-
T Consensus 214 TCIELA 219 (948)
T KOG0577|consen 214 TCIELA 219 (948)
T ss_pred hhhhhh
Confidence 887764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=268.17 Aligned_cols=194 Identities=29% Similarity=0.445 Sum_probs=160.2
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh---cCCceeEEEEEEee-----C
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQD-----T 158 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~ 158 (333)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ........+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 589999999999999999999999999999998653221 11122344566666655 79999999998754 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
..+++||||++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 45899999996 5888888653 35899999999999999999999999999999999999999999999999998865
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
..... .....|++.|+|||++.+..++.++
T Consensus 159 ~~~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 188 (288)
T cd07863 159 SCQMA--------------------------------------------------LTPVVVTLWYRAPEVLLQSTYATPV 188 (288)
T ss_pred cCccc--------------------------------------------------CCCccccccccCchHhhCCCCCCcc
Confidence 42210 0123689999999999999999999
Q ss_pred c-hHHHHHHHhhhcccc
Q 019953 317 D-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 317 D-ws~g~il~~l~t~~~ 332 (333)
| ||+||++|+|+++.+
T Consensus 189 DiwslG~~l~~l~~g~~ 205 (288)
T cd07863 189 DMWSVGCIFAEMFRRKP 205 (288)
T ss_pred hhhhHHHHHHHHHhCCc
Confidence 9 999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=280.77 Aligned_cols=188 Identities=33% Similarity=0.589 Sum_probs=165.5
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
.+.||+|-||+||-|.++.+|+.||||++.+....... ...+++|+.||+++.||.||.+--.|.+.+.+++|||-+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 36899999999999999999999999999876554333 367899999999999999999999999999999999999 5
Q ss_pred CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cEEEEeccCcccCCCCcccccc
Q 019953 171 GDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 171 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|+...++.. .+.+++...++++.||+.||.|||.++|+|+||||+|||+.+.. .+||||||+|+.++....
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---- 722 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---- 722 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh----
Confidence 666666643 46899999999999999999999999999999999999997553 799999999999875432
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
..+.+|||.|+|||++.+++|+++-| ||.|||+
T Consensus 723 ----------------------------------------------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIi 756 (888)
T KOG4236|consen 723 ----------------------------------------------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVII 756 (888)
T ss_pred ----------------------------------------------hhhhcCCccccCHHHHhhccccccccceeeeEEE
Confidence 23779999999999999999999999 9999999
Q ss_pred Hhhhcc
Q 019953 325 FNSYRF 330 (333)
Q Consensus 325 ~~l~t~ 330 (333)
|--|++
T Consensus 757 YVsLSG 762 (888)
T KOG4236|consen 757 YVSLSG 762 (888)
T ss_pred EEEecc
Confidence 965544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=280.07 Aligned_cols=200 Identities=24% Similarity=0.342 Sum_probs=166.1
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEE-----ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCRE-----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 154 (333)
+.+..++|++.+.||+|+||.||+|.+ ..++..||||+++.... ......+.+|+.++..+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 445567899999999999999999974 34567899999865421 22345678899999999 89999999999
Q ss_pred EeeCCeEEEEEeccCCCCHHHHHHhCC-----------------------------------------------------
Q 019953 155 FQDTEYLYLIMEYLPGGDMMTLLMRED----------------------------------------------------- 181 (333)
Q Consensus 155 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 181 (333)
+......++|||||++|+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999885421
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 182 ----------------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 182 ----------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 3677788899999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... ......++..|+|||++.+..++.++| |
T Consensus 268 ~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~ 300 (375)
T cd05104 268 SNYV-----------------------------------------------VKGNARLPVKWMAPESIFNCVYTFESDVW 300 (375)
T ss_pred cccc-----------------------------------------------ccCCCCCCcceeChhHhcCCCCCCCCCHH
Confidence 1100 000223567899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
|+||++|+|++
T Consensus 301 slG~~l~ellt 311 (375)
T cd05104 301 SYGILLWEIFS 311 (375)
T ss_pred HHHHHHHHHHh
Confidence 99999999987
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=280.23 Aligned_cols=195 Identities=25% Similarity=0.382 Sum_probs=166.2
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC-----eE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-----YL 161 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 161 (333)
+|++++.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999986432 12223456778999999999999999999998776 78
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+||||+. ++|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999995 68888888888899999999999999999999999999999999999999999999999999986532211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws 319 (333)
. ......+++.|+|||++.+. .++.++| |+
T Consensus 159 ~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 190 (372)
T cd07853 159 K------------------------------------------------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWS 190 (372)
T ss_pred c------------------------------------------------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHh
Confidence 0 01123588999999999874 4899999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 191 lG~il~el~~g~ 202 (372)
T cd07853 191 VGCIFAELLGRR 202 (372)
T ss_pred HHHHHHHHHcCC
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=288.37 Aligned_cols=193 Identities=31% Similarity=0.460 Sum_probs=167.4
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC------e
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE------Y 160 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 160 (333)
.|...+.||+|+||.||+++++.+|..||||.++... .....+...+|+++|++++|+|||+++++-.+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4567789999999999999999999999999998754 2344566778999999999999999998765543 4
Q ss_pred EEEEEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc--CC--cEEEEeccCc
Q 019953 161 LYLIMEYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK--NG--HMKLSDFGLC 233 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~--~~--~vkl~DFGla 233 (333)
..+|||||.||||...+... ..+++.....+..+++.||.|||++||+||||||.||++.. +| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 67999999999999999764 36999999999999999999999999999999999999853 33 5799999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-CCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGY 312 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~ 312 (333)
+.++++. ...+.+||+.|.+||+.- .+.|
T Consensus 172 rel~d~s--------------------------------------------------~~~S~vGT~~YLhPel~E~q~~y 201 (732)
T KOG4250|consen 172 RELDDNS--------------------------------------------------LFTSLVGTEEYLHPELYERQKKY 201 (732)
T ss_pred ccCCCCC--------------------------------------------------eeeeecCchhhcChHHHhhccCc
Confidence 9887654 223789999999999998 4889
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+..+| ||+||++|+..|+.
T Consensus 202 ~~tVDLWS~GvtlY~caTG~ 221 (732)
T KOG4250|consen 202 TATVDLWSFGVTLYECATGE 221 (732)
T ss_pred CceeehhhhhhHHHHHhccC
Confidence 99999 99999999998763
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=276.80 Aligned_cols=194 Identities=27% Similarity=0.415 Sum_probs=164.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT----- 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 158 (333)
..++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45789999999999999999999999999999999865422 222345567799999999999999999988643
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
...++||||+++ ++.+.+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999965 66666643 48888999999999999999999999999999999999999999999999998653
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... .....||+.|+|||++.+..++.++|
T Consensus 171 ~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~D 200 (355)
T cd07874 171 TSFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVD 200 (355)
T ss_pred Cccc--------------------------------------------------cCCccccCCccCHHHHcCCCCCchhh
Confidence 2210 11346899999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 201 iwslG~il~el~~g~ 215 (355)
T cd07874 201 IWSVGCIMGEMVRHK 215 (355)
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=262.22 Aligned_cols=194 Identities=36% Similarity=0.587 Sum_probs=170.7
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
|++++.||+|+||+||+|.+..+++.||+|++......... ......|+.+++.++||||+++++++......++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999876543332 22345599999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccc
Q 019953 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247 (333)
Q Consensus 168 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~ 247 (333)
+++++|.+++.....++...+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~------- 152 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN------- 152 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999877889999999999999999999999999999999999999999999999999998641111
Q ss_pred cccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-CCCCCcccc-hHHHHHHH
Q 019953 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~~D-ws~g~il~ 325 (333)
.......+++.|+|||++. +..++.++| |++|+++|
T Consensus 153 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 190 (260)
T PF00069_consen 153 ------------------------------------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILY 190 (260)
T ss_dssp ------------------------------------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccccccccccccccccccccccccccccccccccc
Confidence 0111446899999999998 889999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 191 ~l~~~~ 196 (260)
T PF00069_consen 191 ELLTGK 196 (260)
T ss_dssp HHHHSS
T ss_pred cccccc
Confidence 999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.61 Aligned_cols=193 Identities=22% Similarity=0.439 Sum_probs=161.0
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC------ceeEEEEEEe
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH------CIVKLYYSFQ 156 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~ 156 (333)
...++|++++.||+|+||+||+|.+..+++.||||++..... .......|+.++..+.|. +++.+++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 345789999999999999999999999999999999864321 122345577777777554 5888888887
Q ss_pred eC-CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCC-----------
Q 019953 157 DT-EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNG----------- 223 (333)
Q Consensus 157 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~----------- 223 (333)
.. .++|+||+++ +++|.+++.....+++..+..++.|++.||.|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 54 5789999998 78999999888889999999999999999999998 5999999999999998765
Q ss_pred -----cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCC
Q 019953 224 -----HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGT 298 (333)
Q Consensus 224 -----~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 298 (333)
.+||+|||++...... ....+||
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~----------------------------------------------------~~~~~gt 308 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS----------------------------------------------------RTAIVST 308 (467)
T ss_pred CCCCceEEECCCCccccCccc----------------------------------------------------cccccCC
Confidence 4999999987532211 1145799
Q ss_pred CCCcccccccCCCCCcccc-hHHHHHHHhhhcccc
Q 019953 299 PDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 299 ~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~~ 332 (333)
+.|+|||++.+..|+.++| |++||++|+|+++..
T Consensus 309 ~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 309 RHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred ccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999 999999999999754
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=260.42 Aligned_cols=200 Identities=33% Similarity=0.530 Sum_probs=172.7
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh--hhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
++|++.+.||+|++|.||.|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.....+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998654221 12234567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.+.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987653211000
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.......|++.|+|||++.+..++.++| |++|+
T Consensus 162 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (263)
T cd06625 162 ----------------------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGC 195 (263)
T ss_pred ----------------------------------------------ccccCCCcCccccCcceeccCCCCchhhhHHHHH
Confidence 0001345889999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 196 il~el~~g~ 204 (263)
T cd06625 196 TVVEMLTEK 204 (263)
T ss_pred HHHHHHhCC
Confidence 999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=275.84 Aligned_cols=201 Identities=36% Similarity=0.646 Sum_probs=180.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 160 (333)
.+...+|.++.+||+|+||+|.+|..+.+.+.||||++++....+...++-...|..+|.... -|.++.++.+|++-..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 456778999999999999999999999999999999999987777677777777888888774 5689999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|.||||+.||+|.-.+..-+.+.+..+..++++|+-||-|||++|||.||||.+|||++.+|++||+|||+++.--...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998532221
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
..+.++||||.|+|||++.-++|+.++| |+
T Consensus 505 -------------------------------------------------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa 535 (683)
T KOG0696|consen 505 -------------------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 535 (683)
T ss_pred -------------------------------------------------cceeeecCCCcccccceEEecccccchhHHH
Confidence 2344889999999999999999999999 88
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
.||+||+|+.+-
T Consensus 536 ~GVLLyEmlaGQ 547 (683)
T KOG0696|consen 536 FGVLLYEMLAGQ 547 (683)
T ss_pred HHHHHHHHHcCC
Confidence 899999999874
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=276.21 Aligned_cols=194 Identities=26% Similarity=0.393 Sum_probs=164.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT----- 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 158 (333)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 35789999999999999999999999999999999875421 223345567899999999999999999887543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
..+|+||||++ ++|...+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 35799999996 477776643 47888899999999999999999999999999999999999999999999998653
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... .....||+.|+|||++.+..++.++|
T Consensus 178 ~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~D 207 (364)
T cd07875 178 TSFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVD 207 (364)
T ss_pred CCCc--------------------------------------------------ccCCcccCCcCCHHHHhCCCCCchhh
Confidence 2210 11346899999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 208 iwSlG~il~ell~g~ 222 (364)
T cd07875 208 IWSVGCIMGEMIKGG 222 (364)
T ss_pred HHhHHHHHHHHHhCC
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=277.04 Aligned_cols=193 Identities=26% Similarity=0.404 Sum_probs=162.2
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|+.++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3567889999999999999999999999999999986432 12334567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+++++|.+. ....+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999999988643 3456777888999999999999999999999999999999999999999999886542210
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-----CCCCcccc-
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYGMECD- 317 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~~D- 317 (333)
.....+|+..|+|||++.. ...+.++|
T Consensus 224 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dv 256 (353)
T PLN00034 224 -----------------------------------------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDI 256 (353)
T ss_pred -----------------------------------------------cccccccCccccCccccccccccCcCCCcchhH
Confidence 0113469999999999843 33457899
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 257 wslGvil~el~~g~ 270 (353)
T PLN00034 257 WSLGVSILEFYLGR 270 (353)
T ss_pred HHHHHHHHHHHhCC
Confidence 99999999998864
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=289.89 Aligned_cols=207 Identities=24% Similarity=0.409 Sum_probs=167.2
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEE-Eee--
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYS-FQD-- 157 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~-- 157 (333)
.+...++++.+.|.+|||+.||+|.+...|..||+|++... +......+.+|+++|+.|. |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 34445678999999999999999999888899999998765 3455677899999999996 9999999993 221
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEccCCcEEEEe
Q 019953 158 ----TEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLSD 229 (333)
Q Consensus 158 ----~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~~~~~vkl~D 229 (333)
.-.++|+||||.||+|.++++. ...|++.++..|+.|++.|+.+||... |||||||-+||||..+|+.||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 1358899999999999999974 456999999999999999999999987 99999999999999999999999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc--
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-- 307 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-- 307 (333)
||.+...-..-. ...+...-.. -.....|+.|+|||++
T Consensus 190 FGSatt~~~~~~-----------------------------------~~~e~~~ve~-----eI~k~TTp~YRsPEMIDl 229 (738)
T KOG1989|consen 190 FGSATTKILSPT-----------------------------------SAQEVNYVEE-----EIEKYTTPQYRSPEMIDL 229 (738)
T ss_pred ccccccccCCCc-----------------------------------cHHHHHHHHH-----HHHhhCCccccChHHHhh
Confidence 998874322110 0011111110 0123589999999997
Q ss_pred -cCCCCCcccc-hHHHHHHHhhhccc
Q 019953 308 -LKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 308 -~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.|.+++.|+| |+|||+||.||-|.
T Consensus 230 ysg~pI~eKsDIWALGclLYkLCy~t 255 (738)
T KOG1989|consen 230 YSGLPIGEKSDIWALGCLLYKLCYFT 255 (738)
T ss_pred hcCCCCcchhHHHHHHHHHHHHHHhC
Confidence 4889999999 99999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=282.03 Aligned_cols=200 Identities=21% Similarity=0.305 Sum_probs=172.8
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..|.+..+.+.+...||+|+||+||+|.|.. .||||+++-... ..+..+.|++|+.++++.+|.||+-+.|++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 6788889999999999999999999999864 499999976644 344778899999999999999999999999988
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.. .||+.||+|.+|+.++... ..|.....+.|+.|++.|+.|||.++|||||||..||++.+++.|||+|||++..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 87 9999999999999999764 468889999999999999999999999999999999999999999999999987532
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCCCc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGM 314 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~ 314 (333)
--. .........|...|||||+++ ..+|++
T Consensus 540 ~w~-----------------------------------------------g~~q~~qp~gsilwmAPEvIRmqd~nPfS~ 572 (678)
T KOG0193|consen 540 RWS-----------------------------------------------GEQQLEQPHGSLLWMAPEVIRMQDDNPFSF 572 (678)
T ss_pred eec-----------------------------------------------cccccCCCccchhhhcHHHHhhcccCCCCc
Confidence 110 001111335888999999996 467999
Q ss_pred ccc-hHHHHHHHhhhcc
Q 019953 315 ECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~ 330 (333)
.+| |++|+++|+|+|+
T Consensus 573 qSDVYaFGiV~YELltg 589 (678)
T KOG0193|consen 573 QSDVYAFGIVWYELLTG 589 (678)
T ss_pred ccchhhhhHHHHHHHhC
Confidence 999 9999999999986
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=261.68 Aligned_cols=197 Identities=29% Similarity=0.484 Sum_probs=170.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||||.+.............+..|+.+++.++||||+++++.+...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999886543333344456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 166 EYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 166 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988753 34588999999999999999999999999999999999999999999999999886543210
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
......|++.|+|||.+.+..++.++| |++
T Consensus 162 -------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 192 (267)
T cd08228 162 -------------------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred -------------------------------------------------HHhcCCCCccccChhhhccCCCCchhhHHHH
Confidence 001335889999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 193 G~~l~el~~g~ 203 (267)
T cd08228 193 GCLLYEMAALQ 203 (267)
T ss_pred HHHHHHHhcCC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=265.92 Aligned_cols=186 Identities=19% Similarity=0.214 Sum_probs=162.0
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee----CCeEEEEEec
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----TEYLYLIMEY 167 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~ 167 (333)
..||+|++|.||+|.+ +|+.||||.+...........+.+.+|+.+|+.++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999986 689999999976543333345678899999999999999999999876 3578999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 168 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
+++|+|.+++.....++......++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------ 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------ 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------
Confidence 9999999999888889999999999999999999998 499999999999999999999999999988653221
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCcccc-hHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD-WLVSVL 323 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~D-ws~g~i 323 (333)
....|++.|+|||++.+ ..++.++| ||+||+
T Consensus 178 ----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvi 211 (283)
T PHA02988 178 ----------------------------------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211 (283)
T ss_pred ----------------------------------------------ccccCcccccCHHHhhhccccccchhhhhHHHHH
Confidence 02358899999999976 68999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 212 l~el~~g~ 219 (283)
T PHA02988 212 LWEIFTGK 219 (283)
T ss_pred HHHHHHCC
Confidence 99999874
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=266.46 Aligned_cols=193 Identities=30% Similarity=0.426 Sum_probs=170.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++++..++.+++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999986432 2233455778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 999999999999888889999999999999999999997 699999999999999999999999999887543211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....|++.|+|||++.+..++.++| |++|++
T Consensus 155 -----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 187 (308)
T cd06615 155 -----------------------------------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187 (308)
T ss_pred -----------------------------------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHH
Confidence 11346899999999999888999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 188 l~~l~~g~ 195 (308)
T cd06615 188 LVEMAIGR 195 (308)
T ss_pred HHHHHhCC
Confidence 99999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=268.29 Aligned_cols=195 Identities=27% Similarity=0.426 Sum_probs=165.4
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|.+.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4679999999999999999999999999999999875432 12233466799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+++ +|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 999964 788877654 4588999999999999999999999999999999999999999999999999875432210
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
......+++.|+|||++.+ ..++.++| |++|
T Consensus 160 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 192 (309)
T cd07872 160 -----------------------------------------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG 192 (309)
T ss_pred -----------------------------------------------ccccccccccccCCHHHhCCCCCCcHHHHHHHH
Confidence 0012357899999999875 56899999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+|+.
T Consensus 193 ~il~el~tg~ 202 (309)
T cd07872 193 CIFFEMASGR 202 (309)
T ss_pred HHHHHHHhCC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=276.28 Aligned_cols=202 Identities=25% Similarity=0.364 Sum_probs=167.8
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecC-----CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~ 152 (333)
..+.+..++|.+++.||+|+||.||+|.+... +..||||++.... .......+.+|+.+++.+. ||||++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 35666788999999999999999999987433 3469999996542 2233456888999999996 99999999
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhC----------------------------------------------------
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRE---------------------------------------------------- 180 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------- 180 (333)
+++...+.+|+|||||++|+|.+++...
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 9999999999999999999999887542
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCc
Q 019953 181 --------------------------------------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDN 216 (333)
Q Consensus 181 --------------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~N 216 (333)
..+++..+..++.|++.||.|||+.+|+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 136677788899999999999999999999999999
Q ss_pred EEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccC
Q 019953 217 LLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (333)
Q Consensus 217 ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (333)
||++.++.+||+|||+++.+...... .......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~-----------------------------------------------~~~~~~~ 300 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNY-----------------------------------------------VSKGSTF 300 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccc-----------------------------------------------cccCCcC
Confidence 99999999999999998865322110 0011335
Q ss_pred CCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 297 GTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 297 gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+++.|+|||++.+..++.++| |++||++|+|++
T Consensus 301 ~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 334 (400)
T cd05105 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334 (400)
T ss_pred CCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 788999999999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=274.54 Aligned_cols=186 Identities=19% Similarity=0.326 Sum_probs=162.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
..+|++++.||+|+||.||+|.+..++..||+|+..... ...|+.+++.++|+||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 457999999999999999999999999999999854331 23588999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||++. ++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--- 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---
Confidence 99994 688887754 4579999999999999999999999999999999999999999999999999987432111
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......||+.|+|||++.+..++.++| |++||
T Consensus 212 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 244 (357)
T PHA03209 212 -----------------------------------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGI 244 (357)
T ss_pred -----------------------------------------------ccccccccccccCCeecCCCCCCchhhHHHHHH
Confidence 011346999999999999999999999 99999
Q ss_pred HHHhhhcc
Q 019953 323 LHFNSYRF 330 (333)
Q Consensus 323 il~~l~t~ 330 (333)
++|+|+++
T Consensus 245 vl~ell~~ 252 (357)
T PHA03209 245 VLFEMLAY 252 (357)
T ss_pred HHHHHHHc
Confidence 99999874
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=260.62 Aligned_cols=195 Identities=29% Similarity=0.519 Sum_probs=169.4
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 457999999999999999999999999999999986442 12334577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 161 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--- 161 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc---
Confidence 99999999999998778899999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCCCcccc-hHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECD-WLV 320 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~D-ws~ 320 (333)
......|++.|+|||++. +..++.++| |++
T Consensus 162 ----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~ 195 (267)
T cd06646 162 ----------------------------------------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195 (267)
T ss_pred ----------------------------------------------ccCccccCccccCHhHcccccCCCCcchhhHHHH
Confidence 011346889999999985 455888999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 196 G~il~el~~g~ 206 (267)
T cd06646 196 GITAIELAELQ 206 (267)
T ss_pred HHHHHHHHhCC
Confidence 99999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=262.10 Aligned_cols=189 Identities=25% Similarity=0.401 Sum_probs=165.1
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36888999999999999999999999999999986542 1223355788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----- 149 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----- 149 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----
Confidence 99999988654 347888899999999999999999999999999999999999999999999987653221
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
....+|++.|+|||++.+..++.++| |++|+++
T Consensus 150 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 183 (279)
T cd06619 150 ----------------------------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183 (279)
T ss_pred ----------------------------------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHH
Confidence 01346899999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 184 ~~l~~g~ 190 (279)
T cd06619 184 MELALGR 190 (279)
T ss_pred HHHHhCC
Confidence 9999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=262.93 Aligned_cols=195 Identities=30% Similarity=0.535 Sum_probs=169.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|.+.+.||+|+||.||.|.+..+++.||+|+++.... .....+.+|+.+++.++||||+++++.+...+..++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3578889999999999999999999999999999865422 2234567799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--- 161 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--- 161 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCCCcccc-hHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECD-WLV 320 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~D-ws~ 320 (333)
......|++.|+|||++. +..++.++| ||+
T Consensus 162 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSl 195 (267)
T cd06645 162 ----------------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV 195 (267)
T ss_pred ----------------------------------------------ccccccCcccccChhhhccccCCCCCchhhhHHH
Confidence 011346899999999984 566899999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 196 G~il~~l~~~~ 206 (267)
T cd06645 196 GITAIELAELQ 206 (267)
T ss_pred HHHHHHHhcCC
Confidence 99999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=261.93 Aligned_cols=196 Identities=18% Similarity=0.273 Sum_probs=165.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
...+|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 3467999999999999999999765 3567899999876422 2234567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999998764 57899999999999999999999999999999999999999999999999977643211
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
... ......++..|+|||++.+..++.++| |
T Consensus 161 ~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 192 (266)
T cd05064 161 AIY------------------------------------------------TTMSGKSPVLWAAPEAIQYHHFSSASDVW 192 (266)
T ss_pred chh------------------------------------------------cccCCCCceeecCHHHHhhCCccchhHHH
Confidence 100 000223567899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
|+||++|++++
T Consensus 193 slG~~l~ell~ 203 (266)
T cd05064 193 SFGIVMWEVMS 203 (266)
T ss_pred HHHHHHHHHhc
Confidence 99999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=293.87 Aligned_cols=202 Identities=27% Similarity=0.493 Sum_probs=169.3
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD- 157 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 157 (333)
.......++|.+++.||+|+||.||+|.+..++..||+|++...... ......+..|+.+++.+.||||++++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 45566778999999999999999999999999999999998754322 2334567889999999999999999998854
Q ss_pred -CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcEecccCCCcEEEcc----
Q 019953 158 -TEYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKH-------NYIHRDIKPDNLLLDK---- 221 (333)
Q Consensus 158 -~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~-------~ivHrDlkp~Nill~~---- 221 (333)
...+|+||||+++++|.+++.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4579999999999999998865 35799999999999999999999985 4999999999999964
Q ss_pred -------------CCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhh
Q 019953 222 -------------NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNR 288 (333)
Q Consensus 222 -------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (333)
.+.+||+|||++..+.....
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----------------------------------------------- 197 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM----------------------------------------------- 197 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc-----------------------------------------------
Confidence 23599999999986542210
Q ss_pred hccccccCCCCCCcccccccC--CCCCcccc-hHHHHHHHhhhccc
Q 019953 289 RKLAFSTVGTPDYIAPEVLLK--KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 289 ~~~~~~~~gt~~y~APE~~~~--~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
....+||+.|+|||++.+ ..++.++| ||+||++|+|+|+.
T Consensus 198 ---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 198 ---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 113469999999999965 45899999 99999999999964
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=273.30 Aligned_cols=192 Identities=26% Similarity=0.426 Sum_probs=163.7
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC------
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 158 (333)
.++|++++.||+|+||.||+|.+..++..||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4689999999999999999999999999999999875432 222334567899999999999999999887533
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
...|++|+++ +++|.+++. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 3579999998 788887774 45699999999999999999999999999999999999999999999999999886432
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D 317 (333)
.. ...+|++.|+|||++.+ ..++.++|
T Consensus 171 ~~----------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~D 198 (343)
T cd07878 171 EM----------------------------------------------------TGYVATRWYRAPEIMLNWMHYNQTVD 198 (343)
T ss_pred Cc----------------------------------------------------CCccccccccCchHhcCCccCCchhh
Confidence 11 13468999999999987 57899999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 199 iwslG~il~el~~g~ 213 (343)
T cd07878 199 IWSVGCIMAELLKGK 213 (343)
T ss_pred hHhHHHHHHHHHHCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=276.42 Aligned_cols=191 Identities=22% Similarity=0.346 Sum_probs=164.9
Q ss_pred cCCCceEeeeEeeecceEEEEEEEe--cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
...+|.+++.||+|+||.||+|... .++..||+|.+.... ...+|+.+++.++||||+++++.+.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3467999999999999999999753 356789999886432 245699999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+|||++ +++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 162 ~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9999999 468888887777899999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
. ......+||+.|+|||++.+..++.++| |++
T Consensus 241 ~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 273 (392)
T PHA03207 241 T-----------------------------------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273 (392)
T ss_pred c-----------------------------------------------ccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence 0 0011347999999999999999999999 999
Q ss_pred HHHHHhhhcc
Q 019953 321 SVLHFNSYRF 330 (333)
Q Consensus 321 g~il~~l~t~ 330 (333)
||++|+|+++
T Consensus 274 Gvil~el~~g 283 (392)
T PHA03207 274 GLVLFEMSVK 283 (392)
T ss_pred HHHHHHHHHC
Confidence 9999999875
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=261.95 Aligned_cols=201 Identities=17% Similarity=0.280 Sum_probs=166.2
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
|.+..++|++.+.||+|+||.||.|.+.. ++..||+|++..... ......+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34566789999999999999999998642 356799999864321 12334577899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcE
Q 019953 156 QDTEYLYLIMEYLPGGDMMTLLMRED----------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHM 225 (333)
Q Consensus 156 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~v 225 (333)
......++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 98899999999999999999986522 35677888899999999999999999999999999999999999
Q ss_pred EEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccc
Q 019953 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (333)
Q Consensus 226 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE 305 (333)
+|+|||++..+........ .....+++.|+|||
T Consensus 159 ~l~dfg~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~y~aPE 191 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRK-----------------------------------------------GGKGLLPVRWMSPE 191 (277)
T ss_pred EECCCCCccccCCcceeec-----------------------------------------------CCCCccCHhhcChh
Confidence 9999999886543221100 00124678899999
Q ss_pred cccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 306 VLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 306 ~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
++.+..++.++| ||+||++|+|+++
T Consensus 192 ~~~~~~~~~~~Di~slG~~l~el~~~ 217 (277)
T cd05062 192 SLKDGVFTTYSDVWSFGVVLWEIATL 217 (277)
T ss_pred HhhcCCcCchhHHHHHHHHHHHHHcC
Confidence 999999999999 9999999999983
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=260.01 Aligned_cols=194 Identities=24% Similarity=0.462 Sum_probs=165.9
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||+|+|+.|--|....+|..||||++.+. .......+.+|++++..+ .|+||+.++++|.++..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 6899999999999999999999999999765 334556688899999998 589999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cEEEEeccCcccCCCCcccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLDCSTLYAIHEH 247 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~~~~~~~~~~~~ 247 (333)
|+|.+.|.+...|++..+..+..+|+.||.|||.+||.||||||+|||..... -||||||.+..-+...+.-.
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s---- 236 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS---- 236 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC----
Confidence 99999999999999999999999999999999999999999999999997665 48999999987654433110
Q ss_pred cccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---C--CCCCcccc-hHHH
Q 019953 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---K--KGYGMECD-WLVS 321 (333)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~--~~~~~~~D-ws~g 321 (333)
.. ......+.+|+..|||||+.. + .-|+.+|| ||+|
T Consensus 237 ------pa--------------------------------stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG 278 (463)
T KOG0607|consen 237 ------PA--------------------------------STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG 278 (463)
T ss_pred ------CC--------------------------------CCccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence 00 001122568999999999963 3 44899999 9999
Q ss_pred HHHHhhhcc
Q 019953 322 VLHFNSYRF 330 (333)
Q Consensus 322 ~il~~l~t~ 330 (333)
||+|-||.+
T Consensus 279 vIlYImLsG 287 (463)
T KOG0607|consen 279 VILYIMLSG 287 (463)
T ss_pred HHHHHHHhC
Confidence 999998875
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=261.40 Aligned_cols=212 Identities=39% Similarity=0.675 Sum_probs=174.7
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||++.+..+++.||+|.+.............+..|+.+++.++||||+++++.+...+.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987665433444566778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||++|++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998753211110000
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
.... ... ..........|+..|+|||.+.+..++.++| |++|+++
T Consensus 161 ~~~~----------------~~~------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl 206 (305)
T cd05609 161 EGHI----------------EKD------------------TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206 (305)
T ss_pred cccc----------------ccc------------------hhhccccCCccCccccCchhccCCCCCchhhHHHHHHHH
Confidence 0000 000 0000111345888999999999999999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 207 ~el~~g~ 213 (305)
T cd05609 207 YEFLVGC 213 (305)
T ss_pred HHHHhCC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=262.97 Aligned_cols=197 Identities=24% Similarity=0.413 Sum_probs=166.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCC-----ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSG-----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3467999999999999999999876554 679999986442 223345578899999999999999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~ 222 (333)
...+++|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999998654 347788899999999999999999999999999999999999
Q ss_pred CcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCc
Q 019953 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (333)
Q Consensus 223 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 302 (333)
+.++|+|||++.......... ......+++.|+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~ 193 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYR-----------------------------------------------VQSKSLLPVRWM 193 (283)
T ss_pred CcEEECCCcceeecccccccc-----------------------------------------------ccCCCccccccc
Confidence 999999999998654322110 011235788999
Q ss_pred ccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 303 APEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 303 APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
|||.+.+..++.++| ||+||++|+|++
T Consensus 194 aPE~~~~~~~~~~sDv~slG~il~el~~ 221 (283)
T cd05048 194 PPEAILYGKFTTESDIWSFGVVLWEIFS 221 (283)
T ss_pred CHHHhccCcCchhhhHHHHHHHHHHHHc
Confidence 999999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=257.24 Aligned_cols=200 Identities=33% Similarity=0.527 Sum_probs=169.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHH--hhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--CeE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYL 161 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 161 (333)
.+|.+.+.||+|+||.||.|.+..++..||||.+..... ........+.+|+.+++.+.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998754321 1123456788899999999999999999988763 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++||||+++++|.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998877889999999999999999999999999999999999999999999999999886532110
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.. .......|+..|+|||++.+..++.++| |++
T Consensus 162 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (265)
T cd06652 162 SG----------------------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADIWSV 195 (265)
T ss_pred cc----------------------------------------------cccccCCCCccccChhhhcCCCCCcchhHHHH
Confidence 00 0011335889999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 196 G~il~el~~g~ 206 (265)
T cd06652 196 GCTVVEMLTEK 206 (265)
T ss_pred HHHHHHHhhCC
Confidence 99999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=278.19 Aligned_cols=189 Identities=23% Similarity=0.228 Sum_probs=163.4
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
...|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.+++.++|+||+++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 1245699999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||++ .++|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence 9999 46888887653 46999999999999999999999999999999999999999999999999999865322100
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.......||+.|+|||++.+..++.++| ||+||
T Consensus 317 ----------------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGv 350 (461)
T PHA03211 317 ----------------------------------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGL 350 (461)
T ss_pred ----------------------------------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHH
Confidence 0011346999999999999999999999 99999
Q ss_pred HHHhhhcc
Q 019953 323 LHFNSYRF 330 (333)
Q Consensus 323 il~~l~t~ 330 (333)
++|+|+++
T Consensus 351 iL~El~~g 358 (461)
T PHA03211 351 VIFEAAVH 358 (461)
T ss_pred HHHHHHHc
Confidence 99999763
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=257.19 Aligned_cols=197 Identities=28% Similarity=0.492 Sum_probs=171.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+.+++.++|++++++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999899999999987544333444567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 166 EYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 166 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
||+++++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999998854 34589999999999999999999999999999999999999999999999999876542211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
. .....|++.|+|||++.+..++.++| |++
T Consensus 162 ~-------------------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 192 (267)
T cd08224 162 A-------------------------------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred c-------------------------------------------------cceecCCccccCHHHhccCCCCchhcHHHH
Confidence 0 01335889999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 193 G~il~~l~~g~ 203 (267)
T cd08224 193 GCLLYEMAALQ 203 (267)
T ss_pred HHHHHHHHHCC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=259.22 Aligned_cols=195 Identities=42% Similarity=0.778 Sum_probs=174.3
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++.+.||.|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999986654444456778889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+.+++|..++....++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-----
Confidence 999999999998777899999999999999999999999999999999999999999999999999886543210
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
.....|+..|+|||++.+..++.++| |++|+++|
T Consensus 156 ---------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~ 190 (258)
T cd05578 156 ---------------------------------------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAY 190 (258)
T ss_pred ---------------------------------------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHH
Confidence 00235888999999999988999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 191 ~l~~g~ 196 (258)
T cd05578 191 ECLRGK 196 (258)
T ss_pred HHHhCC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=265.65 Aligned_cols=196 Identities=21% Similarity=0.330 Sum_probs=163.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCce----EEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNI----YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
...+|++.+.||+|+||.||+|.+..++.. ||+|.+.... .......+..|+.+++.+.||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346799999999999999999998766654 8999986432 122345577899999999999999999988765
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..++|++|+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 577999999999999999764 4688889999999999999999999999999999999999999999999999987653
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
..... ......++..|+|||++.+..++.++|
T Consensus 162 ~~~~~-----------------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di 194 (316)
T cd05108 162 DEKEY-----------------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDV 194 (316)
T ss_pred CCcce-----------------------------------------------eccCCccceeecChHHhccCCCCchhhh
Confidence 22100 000223567899999999999999999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
|++||++|+|++
T Consensus 195 ~slGv~l~el~t 206 (316)
T cd05108 195 WSYGVTVWELMT 206 (316)
T ss_pred HHHHHHHHHHHc
Confidence 999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=254.37 Aligned_cols=195 Identities=35% Similarity=0.576 Sum_probs=171.1
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|.+.+.||+|++|.||+|.+..++..|++|.+...... ......+..|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488899999999999999999999999999998754322 3345567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-- 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-- 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--
Confidence 99999999998764 57899999999999999999999999999999999999999999999999998866432210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....|++.|+|||++.+..++.++| |++|++
T Consensus 158 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 190 (256)
T cd08529 158 -----------------------------------------------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVV 190 (256)
T ss_pred -----------------------------------------------hhccccCccccCHHHhcCCCCCCccchHHHHHH
Confidence 01336889999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 l~~l~~g~ 198 (256)
T cd08529 191 LYECCTGK 198 (256)
T ss_pred HHHHHhCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=266.18 Aligned_cols=190 Identities=24% Similarity=0.380 Sum_probs=153.9
Q ss_pred eeeEeeecceEEEEEEEe--cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee--CCeEEEEEe
Q 019953 91 LTIIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TEYLYLIME 166 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 166 (333)
.+.||+|+||.||+|.+. .+++.||+|.+..... ...+.+|+.+++.++||||+++++.+.. +..+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999865 4678999999865421 2335679999999999999999998854 457899999
Q ss_pred ccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE----ccCCcEEEEeccCc
Q 019953 167 YLPGGDMMTLLMRE---------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLC 233 (333)
Q Consensus 167 ~~~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill----~~~~~vkl~DFGla 233 (333)
|+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 994 5888877432 258899999999999999999999999999999999999 45678999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGY 312 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~ 312 (333)
+.+....... ......+||+.|+|||++.+ ..+
T Consensus 160 ~~~~~~~~~~----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~ 193 (317)
T cd07868 160 RLFNSPLKPL----------------------------------------------ADLDPVVVTFWYRAPELLLGARHY 193 (317)
T ss_pred eccCCCCccc----------------------------------------------cccCCccccccccCCHHHcCCCCc
Confidence 8654321100 00113468999999999987 458
Q ss_pred Ccccc-hHHHHHHHhhhcccc
Q 019953 313 GMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~~ 332 (333)
+.++| ||+||++|+|+++.+
T Consensus 194 ~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 194 TKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred CchhhHHHHHHHHHHHHhCCC
Confidence 99999 999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=269.58 Aligned_cols=200 Identities=26% Similarity=0.365 Sum_probs=165.1
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 154 (333)
|.+..++|++.+.||+|+||.||+|.+.. +++.||+|++..... ......+..|+.++..+ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 56777899999999999999999997533 457899999864321 12334567799999999 89999999998
Q ss_pred Eee-CCeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 019953 155 FQD-TEYLYLIMEYLPGGDMMTLLMRE----------------------------------------------------- 180 (333)
Q Consensus 155 ~~~-~~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------- 180 (333)
+.. +..++++|||+++++|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 764 45789999999999999988542
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCc
Q 019953 181 --------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252 (333)
Q Consensus 181 --------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~ 252 (333)
..++...+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.......
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~--------- 230 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--------- 230 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh---------
Confidence 257888899999999999999999999999999999999999999999999998764322110
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
......++..|+|||++.+..++.++| ||+||++|+|++
T Consensus 231 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t 270 (337)
T cd05054 231 --------------------------------------RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270 (337)
T ss_pred --------------------------------------hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHH
Confidence 011234677899999999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=287.92 Aligned_cols=203 Identities=27% Similarity=0.455 Sum_probs=176.7
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 153 (333)
...++...+.+..+.||+|+||+||+|+.. .....||||.++.... ......|++|++++..++|||||+++|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 445667788899999999999999999753 2356799999986543 335567999999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHhC----------CC----CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE----------DT----LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 219 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~----~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill 219 (333)
+|..++.+|+|+|||..|||..+|... .. ++..+...++.||+.|+.||-++.+|||||..+|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 999999999999999999999999632 22 7888999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCC
Q 019953 220 DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299 (333)
Q Consensus 220 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 299 (333)
.++..|||+|||+++.+.+++++.+.. ...-+.
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~-----------------------------------------------~t~lPI 669 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRG-----------------------------------------------NTLLPI 669 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccC-----------------------------------------------Cceeee
Confidence 999999999999999988777654221 123467
Q ss_pred CCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 300 DYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 300 ~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.|||||.|+-..||.+|| ||+||+||++++|
T Consensus 670 RWMppEsIly~kFTteSDVWs~GVvLWEIFsy 701 (774)
T KOG1026|consen 670 RWMPPESILYGKFTTESDVWSFGVVLWEIFSY 701 (774)
T ss_pred ecCCHHHhhcCcccchhhhhhhhhhhhhhhcc
Confidence 999999999999999999 9999999999987
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=257.00 Aligned_cols=196 Identities=26% Similarity=0.381 Sum_probs=169.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.+...+|.+.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.++|+||+++++++..+..+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 455667999999999999999999999999999999986542 2234577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999999998653 35888999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... .....+++.|+|||++.+..++.++| |
T Consensus 158 ~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 189 (263)
T cd05052 158 TYTA------------------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVW 189 (263)
T ss_pred eeec------------------------------------------------cCCCCCccccCCHHHhccCCCCchhHHH
Confidence 2100 00123467899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++||++|+|++
T Consensus 190 slG~il~el~t 200 (263)
T cd05052 190 AFGVLLWEIAT 200 (263)
T ss_pred HHHHHHHHHHc
Confidence 99999999998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=258.39 Aligned_cols=197 Identities=29% Similarity=0.500 Sum_probs=171.3
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..++..||||.+.............+.+|+.+++.+.|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57889999999999999999999999999999887544333444566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 166 EYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 166 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 34689999999999999999999999999999999999999999999999999876542211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
......|++.|+|||.+.+..++.++| |++
T Consensus 162 -------------------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl 192 (267)
T cd08229 162 -------------------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred -------------------------------------------------ccccccCCcCccCHHHhcCCCccchhhHHHH
Confidence 001336889999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 193 G~il~~l~~g~ 203 (267)
T cd08229 193 GCLLYEMAALQ 203 (267)
T ss_pred HHHHHHHHhCC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=254.06 Aligned_cols=195 Identities=30% Similarity=0.548 Sum_probs=171.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||.|+||.||+|.+..++..+++|++..... .....+.+|+.+++.++||||+++++.+...+.++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 3689999999999999999999988999999999875432 2456688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999999998776 6899999999999999999999999999999999999999999999999999876542210
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC---CCCcccc-hH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK---GYGMECD-WL 319 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~~D-ws 319 (333)
......++..|+|||++.+. .++.++| |+
T Consensus 157 -----------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~s 189 (262)
T cd06613 157 -----------------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWA 189 (262)
T ss_pred -----------------------------------------------ccccccCCccccCchhhcccccCCcCchhhhHH
Confidence 01134688899999999877 8999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+|+++|+|+|+.
T Consensus 190 lG~~l~~~~tg~ 201 (262)
T cd06613 190 LGITAIELAELQ 201 (262)
T ss_pred HHHHHHHHHhCC
Confidence 999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=260.69 Aligned_cols=225 Identities=36% Similarity=0.599 Sum_probs=176.1
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||+|.+.............+..|+.+++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999899999999998764443345566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 166 EYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 166 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998753 568999999999999999999999999999999999999999999999999988664332111
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHH-HhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHW-QMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
....... ... .......... ............|+..|+|||++.+..++.++| |++|
T Consensus 161 ~~~~~~~--~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG 219 (316)
T cd05574 161 SKALRKG--SRR-------------------SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219 (316)
T ss_pred ccccccc--ccc-------------------ccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHH
Confidence 0000000 000 0000000000 000011112457899999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
+++|+|+++.
T Consensus 220 ~ll~~l~~g~ 229 (316)
T cd05574 220 ILLYEMLYGT 229 (316)
T ss_pred HHHHHHhhCC
Confidence 9999998864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=258.96 Aligned_cols=197 Identities=21% Similarity=0.388 Sum_probs=165.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEe----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREK----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
..++|++.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3467999999999999999999853 4567899999875321 233456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~ 222 (333)
..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 247788889999999999999999999999999999999999
Q ss_pred CcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCc
Q 019953 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (333)
Q Consensus 223 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 302 (333)
+.++|+|||+++......... ......++..|+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~ 193 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYR-----------------------------------------------VQPKSLLPIRWM 193 (283)
T ss_pred CcEEeccccccccccCCccee-----------------------------------------------cccCCCccceec
Confidence 999999999998764322100 011234677899
Q ss_pred ccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 303 APEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 303 APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
|||++.+..++.++| |++|+++|+|++
T Consensus 194 aPE~~~~~~~~~~~Dv~slG~il~el~~ 221 (283)
T cd05090 194 PPEAIMYGKFSSDSDIWSFGVVLWEIFS 221 (283)
T ss_pred ChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 999999999999999 999999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=282.86 Aligned_cols=194 Identities=29% Similarity=0.509 Sum_probs=170.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
+.|.|+..||-|+||+||+|..+.++...|.|+|... ..+..+.+.-|++||..+.||+||++++.|..++.++++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4578888999999999999999999988899998643 3456677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||.||-+..++.. ...+++.++..+++|++.||.|||+++|||||||+.|||++-+|.++|+|||.+.....-
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----- 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----- 183 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-----
Confidence 99999998877654 568999999999999999999999999999999999999999999999999988754321
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----CCCCCcccc-h
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECD-W 318 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~D-w 318 (333)
.....++.|||+||||||++ ..+|++++| |
T Consensus 184 --------------------------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiW 219 (1187)
T KOG0579|consen 184 --------------------------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIW 219 (1187)
T ss_pred --------------------------------------------HhhhccccCCcccccchheeeccccCCCchhhhhHH
Confidence 11223789999999999975 578999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+|+.|.+|--+.
T Consensus 220 SlGITLIEMAqiE 232 (1187)
T KOG0579|consen 220 SLGITLIEMAQIE 232 (1187)
T ss_pred hhhhHHHHHhccC
Confidence 9999999986554
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=258.76 Aligned_cols=199 Identities=28% Similarity=0.467 Sum_probs=169.8
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
-...+.|++++.||.|+||.||+|.+..++..|++|++.... ......+..|+.+++.++|+||+++++.+..++..
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 344577999999999999999999999999999999986542 23455677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
++||||+++++|..++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999999999887754 4578999999999999999999999999999999999999999999999999887532211
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----CCCCCcc
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGME 315 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~ 315 (333)
. ......+++.|+|||++. +..++.+
T Consensus 165 ~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 195 (292)
T cd06644 165 Q-------------------------------------------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYK 195 (292)
T ss_pred c-------------------------------------------------ccceecCCccccCceeeccccccCCCCCch
Confidence 0 011345889999999985 3557889
Q ss_pred cc-hHHHHHHHhhhcccc
Q 019953 316 CD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~~ 332 (333)
+| |++||++|+|+++.+
T Consensus 196 ~Dv~slG~il~el~~g~~ 213 (292)
T cd06644 196 ADIWSLGITLIEMAQIEP 213 (292)
T ss_pred hhhHhHHHHHHHHhcCCC
Confidence 99 999999999998753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=262.67 Aligned_cols=195 Identities=26% Similarity=0.433 Sum_probs=162.4
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCce--EEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNI--YAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 159 (333)
+..++|++.+.||+|+||.||+|.+..++.. +|+|.+.... .......+.+|+.++..+ +|+||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3457899999999999999999998877764 5777665321 223345677899999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
.+++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999986532 478889999999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.++|+|||++........ .....++..|+|
T Consensus 162 ~~kl~dfg~~~~~~~~~~--------------------------------------------------~~~~~~~~~y~a 191 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK--------------------------------------------------KTMGRLPVRWMA 191 (303)
T ss_pred cEEeCccccCcccchhhh--------------------------------------------------cccCCCcccccC
Confidence 999999999863211000 001124668999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
||++.+..++.++| ||+||++|+|+|
T Consensus 192 PE~~~~~~~~~~~Di~slG~il~ellt 218 (303)
T cd05088 192 IESLNYSVYTTNSDVWSYGVLLWEIVS 218 (303)
T ss_pred HHHHhccCCcccccchhhhhHHHHHHh
Confidence 99999889999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=253.30 Aligned_cols=194 Identities=32% Similarity=0.578 Sum_probs=168.7
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++.+.||.|+||.||++.+..++..||+|.+..... ....+.+..|+.+++.++|+||+++++.+.....+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58899999999999999999999999999999864322 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+++++|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--- 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence 9999999998864 34588999999999999999999999999999999999999999999999999876532210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
......|++.|+|||++.+..++.++| |++|++
T Consensus 156 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i 189 (255)
T cd08219 156 ----------------------------------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCI 189 (255)
T ss_pred ----------------------------------------------ccccccCCccccCHHHHccCCcCchhhhhhhchh
Confidence 011346899999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 190 ~~~l~~g~ 197 (255)
T cd08219 190 LYELCTLK 197 (255)
T ss_pred heehhhcc
Confidence 99999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=258.92 Aligned_cols=195 Identities=24% Similarity=0.428 Sum_probs=165.2
Q ss_pred CCCceEeeeEeeecceEEEEEEE-----ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCRE-----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
..+|.+.+.||+|+||.||++.+ ..++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 45799999999999999999975 2345679999886542 223456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEE
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED-------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vk 226 (333)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999986533 489999999999999999999999999999999999999999999
Q ss_pred EEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccc
Q 019953 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (333)
Q Consensus 227 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~ 306 (333)
|+|||++..+....... ......+++.|+|||+
T Consensus 161 l~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~ 193 (288)
T cd05093 161 IGDFGMSRDVYSTDYYR-----------------------------------------------VGGHTMLPIRWMPPES 193 (288)
T ss_pred eccCCccccccCCceee-----------------------------------------------cCCCCCccccccCHHH
Confidence 99999988654322110 0012246788999999
Q ss_pred ccCCCCCcccc-hHHHHHHHhhhc
Q 019953 307 LLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 307 ~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+.+..++.++| ||+||++|+|++
T Consensus 194 ~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 194 IMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred hccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999 999999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=259.75 Aligned_cols=196 Identities=23% Similarity=0.386 Sum_probs=165.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.+.|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4578899999999999999998743 467899999875422 223456888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcE
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED--------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHM 225 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~v 225 (333)
..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997542 37888899999999999999999999999999999999999999
Q ss_pred EEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccc
Q 019953 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (333)
Q Consensus 226 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE 305 (333)
+|+|||++..+....... ......+++.|+|||
T Consensus 162 kl~d~g~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE 194 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYR-----------------------------------------------VGGHTMLPIRWMPPE 194 (280)
T ss_pred EECCcccceecccCccee-----------------------------------------------cCCCCcccceecChh
Confidence 999999987653222100 001224678899999
Q ss_pred cccCCCCCcccc-hHHHHHHHhhhc
Q 019953 306 VLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 306 ~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
++.+..++.++| ||+||++|+|++
T Consensus 195 ~~~~~~~~~~~Di~slG~il~e~~~ 219 (280)
T cd05049 195 SIMYRKFTTESDVWSFGVVLWEIFT 219 (280)
T ss_pred hhccCCcchhhhHHHHHHHHHHHHh
Confidence 999999999999 999999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=256.72 Aligned_cols=188 Identities=35% Similarity=0.605 Sum_probs=156.3
Q ss_pred eEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHH---HHhcCCceeEEEEEEeeCCeEEEEEeccC
Q 019953 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL---AEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (333)
.||+|+||.||++.+..+++.||+|.+................+..++ ....||+|+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998654322222222233344333 33478999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccc
Q 019953 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (333)
Q Consensus 170 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 249 (333)
+++|.+++.....+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-------- 152 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-------- 152 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--------
Confidence 999999998888899999999999999999999999999999999999999999999999999875432110
Q ss_pred cCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-CCCCCcccc-hHHHHHHHhh
Q 019953 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD-WLVSVLHFNS 327 (333)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~~D-ws~g~il~~l 327 (333)
....|++.|+|||++. +..++.++| |++||++|+|
T Consensus 153 -------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l 189 (279)
T cd05633 153 -------------------------------------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKL 189 (279)
T ss_pred -------------------------------------------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence 0235899999999986 466899999 9999999999
Q ss_pred hccc
Q 019953 328 YRFL 331 (333)
Q Consensus 328 ~t~~ 331 (333)
+++.
T Consensus 190 ~~g~ 193 (279)
T cd05633 190 LRGH 193 (279)
T ss_pred HhCC
Confidence 9864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=254.11 Aligned_cols=202 Identities=30% Similarity=0.496 Sum_probs=171.5
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh------hhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV------KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
+|.+...||.|++|.||.|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999999889999999988653221 12234567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
.... .........|++.|+|||.+.+..++.++| |+
T Consensus 161 ~~~~-------------------------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 197 (267)
T cd06628 161 LSTK-------------------------------------------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWS 197 (267)
T ss_pred ccCC-------------------------------------------ccccccccCCCcCccChhHhccCCCCchhhhHH
Confidence 1000 000011345889999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+|+++|+|+++.
T Consensus 198 lG~il~~l~~g~ 209 (267)
T cd06628 198 LGCLVVEMLTGK 209 (267)
T ss_pred HHHHHHHHhhCC
Confidence 999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=256.16 Aligned_cols=196 Identities=31% Similarity=0.465 Sum_probs=168.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+..|+.+++.++|+|++++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999998999999998865421 1222345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++++|..++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--- 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc---
Confidence 99999888887777778999999999999999999999999999999999999999999999999999876432210
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~i 323 (333)
.....++..|+|||++.+ ..++.++| |++|++
T Consensus 157 ----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i 190 (286)
T cd07847 157 ----------------------------------------------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCV 190 (286)
T ss_pred ----------------------------------------------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHH
Confidence 012357889999999876 55899999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 ~~~l~~g~ 198 (286)
T cd07847 191 FAELLTGQ 198 (286)
T ss_pred HHHHHhCC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=259.12 Aligned_cols=196 Identities=24% Similarity=0.392 Sum_probs=167.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCC----------------ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSG----------------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 148 (333)
.++|++++.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876533 5689999875432 2345668889999999999999
Q ss_pred eEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcE
Q 019953 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-----------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (333)
Q Consensus 149 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Ni 217 (333)
+++++++..+...++|||++++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997654 689999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC
Q 019953 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (333)
Q Consensus 218 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 297 (333)
+++.++.++|+|||++.......... ......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~ 194 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYR-----------------------------------------------VQGRAPL 194 (296)
T ss_pred eecCCCceEEccccceeecccCccee-----------------------------------------------ecCcCCC
Confidence 99999999999999987654322110 0112346
Q ss_pred CCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 298 TPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 298 t~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
++.|+|||++.+..++.++| |++||++|+|++
T Consensus 195 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 195 PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred CceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence 78999999999889999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=250.89 Aligned_cols=195 Identities=27% Similarity=0.551 Sum_probs=167.3
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-CCeEEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-TEYLYLIM 165 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 165 (333)
+|++++.||+|++|.||.+.+..+++.||+|.+..... .......+..|+.+++.++|+|++++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999865432 22334567789999999999999999988764 44689999
Q ss_pred eccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 166 EYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 166 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-- 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence 99999999999875 34689999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......|++.|+|||++.+..++.++| |++|+
T Consensus 158 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08223 158 -----------------------------------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGC 190 (257)
T ss_pred -----------------------------------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHH
Confidence 011346899999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 191 il~~l~~g~ 199 (257)
T cd08223 191 CVYEMATLK 199 (257)
T ss_pred HHHHHHcCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=256.68 Aligned_cols=195 Identities=32% Similarity=0.475 Sum_probs=165.0
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|.+.+.||+|++|.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58899999999999999999999999999999865422 22233557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 167 YLPGGDMMTLLMR---EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 167 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|++ ++|.+++.. +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 996 688887754 25689999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
......+++.|+|||++.+ ..++.++| |++|
T Consensus 157 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 189 (285)
T cd07861 157 -----------------------------------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG 189 (285)
T ss_pred -----------------------------------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHH
Confidence 0012357899999999875 45799999 9999
Q ss_pred HHHHhhhcccc
Q 019953 322 VLHFNSYRFLE 332 (333)
Q Consensus 322 ~il~~l~t~~~ 332 (333)
|++|+|+|+.+
T Consensus 190 ~il~~l~tg~~ 200 (285)
T cd07861 190 TIFAEMATKKP 200 (285)
T ss_pred HHHHHHHHCCC
Confidence 99999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=257.80 Aligned_cols=196 Identities=28% Similarity=0.475 Sum_probs=170.6
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
....+|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.+.|+|++++++.+......+
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 345689999999999999999999999999999999875432 22355778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+||||+++++|.+++.. ..++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999999999998854 4688999999999999999999999999999999999999999999999999886432210
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
......|++.|+|||.+.+..++.++| |++|
T Consensus 172 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G 203 (296)
T cd06654 172 ------------------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203 (296)
T ss_pred ------------------------------------------------ccCcccCCccccCHHHHcCCCCCccchHHHHH
Confidence 001236889999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 204 vil~~l~~g~ 213 (296)
T cd06654 204 IMAIEMIEGE 213 (296)
T ss_pred HHHHHHHhCC
Confidence 9999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=256.65 Aligned_cols=197 Identities=21% Similarity=0.324 Sum_probs=164.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCc----eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
..++|++.+.||+|+||.||+|.+..++. .||+|++..... ......+.+|+.++..+.||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 35689999999999999999999877776 489998865322 22345577899999999999999999988754
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..+++|+|+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 578999999999999999764 4689999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
..... ......+++.|+|||++.+..++.++|
T Consensus 162 ~~~~~-----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di 194 (279)
T cd05109 162 DETEY-----------------------------------------------HADGGKVPIKWMALESILHRRFTHQSDV 194 (279)
T ss_pred cccee-----------------------------------------------ecCCCccchhhCCHHHhccCCCCchhHH
Confidence 22100 000123567899999999999999999
Q ss_pred hHHHHHHHhhhcc
Q 019953 318 WLVSVLHFNSYRF 330 (333)
Q Consensus 318 ws~g~il~~l~t~ 330 (333)
|++||++|+|+++
T Consensus 195 ~slG~~l~el~t~ 207 (279)
T cd05109 195 WSYGVTVWELMTF 207 (279)
T ss_pred HHHHHHHHHHHcC
Confidence 9999999999873
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=255.90 Aligned_cols=199 Identities=19% Similarity=0.293 Sum_probs=166.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecC-----CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
++..++|.+.+.||+|+||.||+|.+... +..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45667899999999999999999987643 47899999865421 223345778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEE
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRED----------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vk 226 (333)
.....++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+||+++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999986422 367778899999999999999999999999999999999999999
Q ss_pred EEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccc
Q 019953 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (333)
Q Consensus 227 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~ 306 (333)
|+|||+++.+....... ......++..|+|||.
T Consensus 160 l~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~ 192 (277)
T cd05032 160 IGDFGMTRDIYETDYYR-----------------------------------------------KGGKGLLPVRWMAPES 192 (277)
T ss_pred ECCcccchhhccCcccc-----------------------------------------------cCCCCCccccccCHHH
Confidence 99999988654322100 0012346789999999
Q ss_pred ccCCCCCcccc-hHHHHHHHhhhc
Q 019953 307 LLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 307 ~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+.+..++.++| |++||++|+|++
T Consensus 193 ~~~~~~~~~~Di~slG~il~el~t 216 (277)
T cd05032 193 LKDGVFTTKSDVWSFGVVLWEMAT 216 (277)
T ss_pred HhcCCCCcccchHHHHHHHHHhhc
Confidence 99889999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=260.48 Aligned_cols=203 Identities=23% Similarity=0.370 Sum_probs=167.8
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEec-------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCcee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIV 149 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 149 (333)
.+.+.+..++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+..|+.+++.+ +|+||+
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 35567777899999999999999999998643 23569999987542 122345577799999999 799999
Q ss_pred EEEEEEeeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccC
Q 019953 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213 (333)
Q Consensus 150 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlk 213 (333)
++++++...+..++||||+++++|.+++.... .++...+..++.|++.||.|||++|++|||||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 99999999999999999999999999997532 47888899999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccc
Q 019953 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293 (333)
Q Consensus 214 p~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (333)
|+||+++.++.++|+|||++..+....... ...
T Consensus 168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~-----------------------------------------------~~~ 200 (307)
T cd05098 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYK-----------------------------------------------KTT 200 (307)
T ss_pred HHheEEcCCCcEEECCCcccccccccchhh-----------------------------------------------ccc
Confidence 999999999999999999987653211000 000
Q ss_pred ccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 294 STVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 294 ~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
...+++.|+|||++.+..++.++| |++||++|+|++
T Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~ 237 (307)
T cd05098 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237 (307)
T ss_pred cCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHc
Confidence 112457899999999999999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=260.15 Aligned_cols=195 Identities=26% Similarity=0.439 Sum_probs=165.7
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|.+.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999865432 12233466799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||++ ++|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence 99996 588888765 35688999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
......+++.|+|||++.+ ..++.++| |++|
T Consensus 160 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG 192 (301)
T cd07873 160 -----------------------------------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 192 (301)
T ss_pred -----------------------------------------------cccccceeecccCcHHHhCCCCCccHHHHHHHH
Confidence 0012357899999999876 45889999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+|+.
T Consensus 193 ~~l~el~tg~ 202 (301)
T cd07873 193 CIFYEMSTGR 202 (301)
T ss_pred HHHHHHHhCC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=252.72 Aligned_cols=189 Identities=25% Similarity=0.392 Sum_probs=159.8
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 171 (333)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999876432 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 172 DMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 172 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~------- 151 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS------- 151 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-------
Confidence 9999986643 58999999999999999999999999999999999999999999999999987543211000
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
......++..|+|||.+.+..++.++| |++|+++|+|++
T Consensus 152 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~ 191 (252)
T cd05084 152 ----------------------------------------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191 (252)
T ss_pred ----------------------------------------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 000112346799999999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=250.70 Aligned_cols=195 Identities=29% Similarity=0.533 Sum_probs=170.7
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++++.||.|+||.||.+.+..++..+++|.+...... ......+.+|+.+++.++|+||+++++++...+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 589999999999999999999999999999988654322 2334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999764 4689999999999999999999999999999999999999999999999999886543221
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
......|++.|+|||++.+..++.++| |++|++
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i 190 (256)
T cd08221 157 ----------------------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCV 190 (256)
T ss_pred ----------------------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHH
Confidence 011346899999999999988999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 ~~~l~~g~ 198 (256)
T cd08221 191 LYELLTLK 198 (256)
T ss_pred HHHHHHCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=256.75 Aligned_cols=201 Identities=18% Similarity=0.299 Sum_probs=165.0
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
|.+..++|++.+.||+|+||.||+|.+.. .+..||+|.+..... ......+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 45667899999999999999999987642 355899998864421 12233467799999999999999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcE
Q 019953 156 QDTEYLYLIMEYLPGGDMMTLLMRE----------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHM 225 (333)
Q Consensus 156 ~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~v 225 (333)
......++||||+++|+|.+++... ...+...+..++.|++.||.|||+++|+||||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 9889999999999999999999652 124566788899999999999999999999999999999999999
Q ss_pred EEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccc
Q 019953 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (333)
Q Consensus 226 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE 305 (333)
+|+|||+++.+....... ......++..|+|||
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~~pE 191 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-----------------------------------------------KGGKGLLPVRWMAPE 191 (288)
T ss_pred EECcCCcccccccccccc-----------------------------------------------ccCCCcccccccCHH
Confidence 999999988654322100 000224577899999
Q ss_pred cccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 306 VLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 306 ~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.+.+..++.++| |++||++|+|+++
T Consensus 192 ~~~~~~~~~~~DvwslG~~l~el~~~ 217 (288)
T cd05061 192 SLKDGVFTTSSDMWSFGVVLWEITSL 217 (288)
T ss_pred HhccCCCChHhHHHHHHHHHHHHHhC
Confidence 999999999999 9999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=252.54 Aligned_cols=200 Identities=32% Similarity=0.513 Sum_probs=169.6
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHH--hhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee--CCeE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TEYL 161 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 161 (333)
.+|+..+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468999999999999999999999999999998864321 122344567889999999999999999998865 3578
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+++|||+++++|.+++.....+++.....++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998877899999999999999999999999999999999999999999999999999886532110
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.. .......++..|+|||.+.+..++.++| |++
T Consensus 162 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (266)
T cd06651 162 SG----------------------------------------------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195 (266)
T ss_pred cC----------------------------------------------CccccCCccccccCHHHhCCCCCCchhhhHHH
Confidence 00 0001235889999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 196 G~i~~el~~g~ 206 (266)
T cd06651 196 GCTVVEMLTEK 206 (266)
T ss_pred HHHHHHHHHCC
Confidence 99999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=244.52 Aligned_cols=207 Identities=23% Similarity=0.367 Sum_probs=176.4
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee---
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--- 157 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 157 (333)
.-+..++|.+.+.||+|||+.||++.+..++..||+|.+.... ....+..++|++..++++|||++++++....
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3456789999999999999999999999999999999997664 3455678899999999999999999876533
Q ss_pred --CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEccCCcEEEEe
Q 019953 158 --TEYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLSD 229 (333)
Q Consensus 158 --~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~~~~~vkl~D 229 (333)
....|++++|...|+|.+.+.. +..+++..+.+|+.+++.||.+||... +.||||||.|||+.+.+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 3359999999999999998854 347999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL- 308 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~- 308 (333)
||.+....- ..........+|+|...+ -|..|+|||.+.
T Consensus 173 ~GS~~~a~i--------------------------------~i~~~~~a~~lQe~a~e~--------Ct~pyRAPELf~v 212 (302)
T KOG2345|consen 173 LGSATQAPI--------------------------------QIEGSRQALRLQEWAEER--------CTIPYRAPELFNV 212 (302)
T ss_pred ccCccccce--------------------------------EeechHHHHHHHHHHHHh--------CCCcccCchheec
Confidence 999876431 112234567899998763 688999999985
Q ss_pred --CCCCCcccc-hHHHHHHHhhhcc
Q 019953 309 --KKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 309 --~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
+...+.++| ||+||++|.|+-+
T Consensus 213 k~~~ti~ertDIWSLGCtLYa~mf~ 237 (302)
T KOG2345|consen 213 KSHCTITERTDIWSLGCTLYAMMFG 237 (302)
T ss_pred ccCcccccccchhhhhHHHHHHHHc
Confidence 567899999 9999999987654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=253.52 Aligned_cols=196 Identities=25% Similarity=0.417 Sum_probs=167.2
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
|.+..++|++++.||+|+||.||+|.+. ++..||+|.+..... ..+.+..|+.+++.++|+||+++++.+...+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP 75 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456788999999999999999999864 567799998865322 24567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.+++|||+++++|.+++.. ...++...+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999999999865 34688888999999999999999999999999999999999999999999999987543
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
.... ......++..|+|||++.+..++.++|
T Consensus 156 ~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 187 (261)
T cd05072 156 NEYT------------------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDV 187 (261)
T ss_pred Ccee------------------------------------------------ccCCCccceecCCHHHhccCCCChhhhh
Confidence 2110 000223677899999999999999999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
|++||++|+|+|
T Consensus 188 ~slG~~l~~l~t 199 (261)
T cd05072 188 WSFGILLYEIVT 199 (261)
T ss_pred hhhHHHHHHHHc
Confidence 999999999997
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=254.33 Aligned_cols=200 Identities=28% Similarity=0.460 Sum_probs=170.9
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHH---hhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM---VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
+|+..+.||+|++|.||++.+..+++.||+|++..... ........+..|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999999999999999999864321 112235668889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-cEEEEeccCcccCCCCccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~~~~~~~ 242 (333)
||||+++++|.+++....++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998878899999999999999999999999999999999999998776 6999999998876432100
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
. ........|+..|+|||++.+..++.++| |++|
T Consensus 161 ~---------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 195 (268)
T cd06630 161 A---------------------------------------------GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVG 195 (268)
T ss_pred C---------------------------------------------CccccccccccceeCHhHhccCCCCcccchHHHH
Confidence 0 00011346889999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
+++|+|+++.
T Consensus 196 ~~l~~l~~g~ 205 (268)
T cd06630 196 CVIIEMATAK 205 (268)
T ss_pred HHHHHHHhCC
Confidence 9999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.84 Aligned_cols=200 Identities=33% Similarity=0.546 Sum_probs=169.7
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhH--HhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--CeE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE--MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYL 161 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 161 (333)
.+|.+.+.||+|+||.||+|.+..++..||+|.+.... .........+.+|+.+++.++|+||+++++.+.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875321 11233456788899999999999999999988653 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++||||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999999999999998777899999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.. .......|+..|+|||.+.+..++.++| |++
T Consensus 162 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 195 (264)
T cd06653 162 SG----------------------------------------------TGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195 (264)
T ss_pred cC----------------------------------------------ccccccCCcccccCHhhhcCCCCCccccHHHH
Confidence 00 0011345889999999999989999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 196 G~il~~l~~g~ 206 (264)
T cd06653 196 ACTVVEMLTEK 206 (264)
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=259.64 Aligned_cols=201 Identities=24% Similarity=0.413 Sum_probs=167.1
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEe-------cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEE
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREK-------KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKL 151 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 151 (333)
.+.+..++|.+.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 45666788999999999999999999753 234579999986432 123345678899999999 89999999
Q ss_pred EEEEeeCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCC
Q 019953 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (333)
Q Consensus 152 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 215 (333)
++.+......++||||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999998653 24677788899999999999999999999999999
Q ss_pred cEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccccc
Q 019953 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (333)
Q Consensus 216 Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (333)
||+++.++.++|+|||+++.+....... .....
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~-----------------------------------------------~~~~~ 199 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYK-----------------------------------------------KTTNG 199 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccc-----------------------------------------------cccCC
Confidence 9999999999999999998764322100 00122
Q ss_pred CCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 296 VGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 296 ~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.+++.|+|||++.+..++.++| |++|+++|+|++
T Consensus 200 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred CCCceeeCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence 4667899999999999999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=257.25 Aligned_cols=201 Identities=24% Similarity=0.406 Sum_probs=168.2
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecC-----CceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEE
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY 153 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 153 (333)
.+.+..++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+.++..+ +|+||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3456677899999999999999999987643 37899999875422 22345577899999999 8999999999
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcE
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMR----------------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Ni 217 (333)
++...+.++++|||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 99999999999999999999999853 24588889999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC
Q 019953 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (333)
Q Consensus 218 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 297 (333)
+++.++.++|+|||+++.+....... ......+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~ 196 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYR-----------------------------------------------KTTNGRL 196 (293)
T ss_pred EEcCCCeEEeCcccccccccccccee-----------------------------------------------ccCCCCC
Confidence 99999999999999998765332110 0001235
Q ss_pred CCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 298 TPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 298 t~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+..|+|||++.+..++.++| |++||++|+|++
T Consensus 197 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (293)
T cd05053 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229 (293)
T ss_pred CccccCHHHhccCCcCcccceeehhhHHHHHhc
Confidence 67899999999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=254.86 Aligned_cols=188 Identities=36% Similarity=0.618 Sum_probs=156.6
Q ss_pred eEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHH---HHHHHhcCCceeEEEEEEeeCCeEEEEEeccC
Q 019953 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER---NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (333)
.||+|+||.||+|.+..+++.||+|.+................|. ..++...||+|+.+++.+......++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998754322111111222333 34445578999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccc
Q 019953 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (333)
Q Consensus 170 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 249 (333)
|++|..++.....+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--------- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---------
Confidence 99999999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred cCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHHHHHhh
Q 019953 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSVLHFNS 327 (333)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~il~~l 327 (333)
.....|++.|+|||++.+ ..++.++| |++|+++|+|
T Consensus 152 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l 189 (278)
T cd05606 152 ------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 189 (278)
T ss_pred ------------------------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHH
Confidence 013368999999999975 46899999 9999999999
Q ss_pred hccc
Q 019953 328 YRFL 331 (333)
Q Consensus 328 ~t~~ 331 (333)
+++.
T Consensus 190 ~~g~ 193 (278)
T cd05606 190 LRGH 193 (278)
T ss_pred HhCC
Confidence 9874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=256.99 Aligned_cols=195 Identities=29% Similarity=0.503 Sum_probs=168.7
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||.|+||.||+|.+..++..||+|++.... ......+..|+.+++.++|+||+++++.+......++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 467999999999999999999998899999999986542 23345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999998764 5799999999999999999999999999999999999999999999999998775432110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----CCCCCcccc-
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECD- 317 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~D- 317 (333)
......|++.|+|||++. +.+++.++|
T Consensus 159 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi 191 (280)
T cd06611 159 -----------------------------------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADI 191 (280)
T ss_pred -----------------------------------------------ccceeecchhhcCHHHHhhcccCCCCCCccccH
Confidence 011346899999999985 456788999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+++.
T Consensus 192 ~slG~il~~l~~g~ 205 (280)
T cd06611 192 WSLGITLIELAQME 205 (280)
T ss_pred HHHHHHHHHHHhCC
Confidence 99999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=259.54 Aligned_cols=193 Identities=28% Similarity=0.474 Sum_probs=164.0
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58899999999999999999999999999999865422 22233456779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 167 YLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 167 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|++ ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---- 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---- 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC----
Confidence 996 578777754 56789999999999999999999999999999999999999999999999999876532210
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~i 323 (333)
......+++.|+|||++.+. .++.++| |++||+
T Consensus 155 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 189 (284)
T cd07839 155 ---------------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 189 (284)
T ss_pred ---------------------------------------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHH
Confidence 00123578899999998774 4799999 999999
Q ss_pred HHhhhcc
Q 019953 324 HFNSYRF 330 (333)
Q Consensus 324 l~~l~t~ 330 (333)
+|+|+|+
T Consensus 190 l~~l~tg 196 (284)
T cd07839 190 FAELANA 196 (284)
T ss_pred HHHHHhc
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=254.97 Aligned_cols=194 Identities=34% Similarity=0.584 Sum_probs=171.0
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||.|++|.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++++..+..+++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46888999999999999999999999999999987543 1233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 153 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---- 153 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc----
Confidence 999999999998765 789999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
......|++.|+|||.+.+..++.++| |++|+++
T Consensus 154 ---------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il 188 (274)
T cd06609 154 ---------------------------------------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188 (274)
T ss_pred ---------------------------------------------ccccccCCccccChhhhccCCCCchhhHHHHHHHH
Confidence 011346888999999999989999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+|+.
T Consensus 189 ~~l~tg~ 195 (274)
T cd06609 189 IELAKGE 195 (274)
T ss_pred HHHHhCC
Confidence 9999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.73 Aligned_cols=201 Identities=29% Similarity=0.481 Sum_probs=169.6
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhH---HhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE---MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
+|++.+.||+|+||.||+|.+ .++..+|+|.+.... .........+.+|+.+++.++|+||+++++++......++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478889999999999999986 478899999886432 1122334568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+++++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999887889999999999999999999999999999999999999999999999999988654221100
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
. .........|++.|+|||++.+..++.++| |++|+
T Consensus 160 ~-------------------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~ 196 (265)
T cd06631 160 T-------------------------------------------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGC 196 (265)
T ss_pred c-------------------------------------------ccccccccCCCccccChhhhcCCCCcchhhHHHHHH
Confidence 0 000011345899999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 197 ~~~~l~~g~ 205 (265)
T cd06631 197 TVFEMATGK 205 (265)
T ss_pred HHHHHHhCC
Confidence 999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.62 Aligned_cols=192 Identities=29% Similarity=0.523 Sum_probs=165.2
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
|++.+.||.|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 577889999999999999999999999999986542 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 168 LPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 168 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
+++++|..++.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-----
Confidence 999999888755 45789999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----CCCCCcccc-hHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECD-WLV 320 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~D-ws~ 320 (333)
......|++.|+|||++. +..++.++| |++
T Consensus 159 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 194 (282)
T cd06643 159 --------------------------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194 (282)
T ss_pred --------------------------------------------ccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence 011346899999999984 456888999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 195 Gvil~el~~g~ 205 (282)
T cd06643 195 GITLIEMAQIE 205 (282)
T ss_pred HHHHHHHccCC
Confidence 99999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=258.28 Aligned_cols=196 Identities=29% Similarity=0.469 Sum_probs=168.1
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh--hhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
+|++.+.||+|+||.||+|.+..+++.||||.+...... .......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999989999999999765432 122234466799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+ +++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 9999 899999997765 7999999999999999999999999999999999999999999999999999876432100
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
.....+++.|+|||++.+ ..++.++| |++|
T Consensus 159 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 190 (298)
T cd07841 159 ------------------------------------------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190 (298)
T ss_pred ------------------------------------------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHH
Confidence 012246888999999865 56799999 9999
Q ss_pred HHHHhhhcccc
Q 019953 322 VLHFNSYRFLE 332 (333)
Q Consensus 322 ~il~~l~t~~~ 332 (333)
|++|+|+++.+
T Consensus 191 ~il~e~~~g~~ 201 (298)
T cd07841 191 CIFAELLLRVP 201 (298)
T ss_pred HHHHHHHcCCc
Confidence 99999998854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.02 Aligned_cols=190 Identities=27% Similarity=0.522 Sum_probs=169.8
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
|.++.+||+|+||.||+|.++.+|+.+|||.++... ....+.+|+.+|+++++|++|++||+|-....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 677889999999999999999999999999987553 345588899999999999999999998888889999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 168 LPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 168 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|..|++.++++- ++++++..+..++...+.||.|||...-||||||+.|||++.+|..||+|||.+..++..-
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM------ 183 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM------ 183 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH------
Confidence 999999999865 5689999999999999999999999999999999999999999999999999998765311
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
-...+..|||.||||||+..-+|+..+| ||+|+...
T Consensus 184 -------------------------------------------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaI 220 (502)
T KOG0574|consen 184 -------------------------------------------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAI 220 (502)
T ss_pred -------------------------------------------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhh
Confidence 1112668999999999999999999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|--+.
T Consensus 221 EMAEG~ 226 (502)
T KOG0574|consen 221 EMAEGR 226 (502)
T ss_pred hhhcCC
Confidence 886554
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=254.40 Aligned_cols=195 Identities=29% Similarity=0.492 Sum_probs=170.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
...+|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+.....+++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 3467999999999999999999999999999999986542 2234567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|+||+++++|..++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 9999999999998864 46899999999999999999999999999999999999999999999999998865422110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.....|++.|+|||.+.+..++.++| |++||
T Consensus 172 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv 203 (296)
T cd06655 172 ------------------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203 (296)
T ss_pred ------------------------------------------------CCCcCCCccccCcchhcCCCCCchhhHHHHHH
Confidence 01236889999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 204 il~~lltg~ 212 (296)
T cd06655 204 MAIEMVEGE 212 (296)
T ss_pred HHHHHHhCC
Confidence 999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=250.96 Aligned_cols=192 Identities=21% Similarity=0.407 Sum_probs=163.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|+||.||++.+. ++..+|+|.+..... ....+..|+.+++.++||||+++++++......++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 357899999999999999999875 456799998764422 124577799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999998653 468899999999999999999999999999999999999999999999999987653221100
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.....++..|+|||++.+..++.++| |++|+
T Consensus 158 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~ 189 (256)
T cd05114 158 ------------------------------------------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189 (256)
T ss_pred ------------------------------------------------cCCCCCchhhCChhhcccCccchhhhhHHHHH
Confidence 00223567899999999999999999 99999
Q ss_pred HHHhhhc
Q 019953 323 LHFNSYR 329 (333)
Q Consensus 323 il~~l~t 329 (333)
++|+|++
T Consensus 190 ~l~el~~ 196 (256)
T cd05114 190 LMWEVFT 196 (256)
T ss_pred HHHHHHc
Confidence 9999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=257.95 Aligned_cols=194 Identities=25% Similarity=0.412 Sum_probs=170.7
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||+||++.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+...+.+++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 467899999999999999999999999999999886532 223345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+++++|.+++...+.++...+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 9999999999999887889999999999999999999997 699999999999999999999999999886542111
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
....+|+..|+|||++.+..++.++| |++||
T Consensus 159 ------------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 190 (284)
T cd06620 159 ------------------------------------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGI 190 (284)
T ss_pred ------------------------------------------------cCccccCcccCCHHHHccCCCCccchHHHHHH
Confidence 01346899999999999889999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+|+.
T Consensus 191 ~l~~l~tg~ 199 (284)
T cd06620 191 SIIELALGK 199 (284)
T ss_pred HHHHHHhCC
Confidence 999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=258.66 Aligned_cols=197 Identities=21% Similarity=0.388 Sum_probs=163.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecC--------------CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCcee
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKS--------------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 149 (333)
..++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.+++.++|+|++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 346899999999999999999987543 2358999987542 123345678899999999999999
Q ss_pred EEEEEEeeCCeEEEEEeccCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcE
Q 019953 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (333)
Q Consensus 150 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Ni 217 (333)
++++++...+..++||||+++++|.+++.... .++...+..++.|++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999985432 367788889999999999999999999999999999
Q ss_pred EEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC
Q 019953 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (333)
Q Consensus 218 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 297 (333)
+++.++.+||+|||++.......... ......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~ 193 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYR-----------------------------------------------IQGRAVL 193 (295)
T ss_pred EEcCCCcEEecccccccccccCccee-----------------------------------------------ccCcCcC
Confidence 99999999999999987653221100 0012346
Q ss_pred CCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 298 TPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 298 t~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
++.|+|||++.+..++.++| ||+||++|+|++
T Consensus 194 ~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 194 PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred ceeecChhhhccCCcCchhhHHHHHHHHHHHHH
Confidence 77899999999999999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=256.70 Aligned_cols=194 Identities=28% Similarity=0.488 Sum_probs=169.6
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
..+|.+++.||+|+||.||+|.+..+++.||+|.+..... .....+..|+.+++.++|+||+++++.+......++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 4689999999999999999999999999999999865432 2235577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 999999999999854 45888999999999999999999999999999999999999999999999998765322100
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....|++.|+|||.+.+..++.++| |++||+
T Consensus 172 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvi 204 (297)
T cd06656 172 -----------------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204 (297)
T ss_pred -----------------------------------------------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHH
Confidence 01235889999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 205 l~~l~tg~ 212 (297)
T cd06656 205 AIEMVEGE 212 (297)
T ss_pred HHHHHhCC
Confidence 99999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=257.83 Aligned_cols=197 Identities=32% Similarity=0.502 Sum_probs=169.1
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4689999999999999999999889999999998654322 223455778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++++|..+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---- 155 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc----
Confidence 9999988888776666799999999999999999999999999999999999999999999999999886532210
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~i 323 (333)
......++..|+|||++.+ ..++.++| ||+|++
T Consensus 156 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 190 (286)
T cd07846 156 ---------------------------------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCL 190 (286)
T ss_pred ---------------------------------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHH
Confidence 0112358899999999876 45788999 999999
Q ss_pred HHhhhcccc
Q 019953 324 HFNSYRFLE 332 (333)
Q Consensus 324 l~~l~t~~~ 332 (333)
+|+|+++.+
T Consensus 191 l~el~~g~~ 199 (286)
T cd07846 191 VTEMLTGEP 199 (286)
T ss_pred HHHHHcCCC
Confidence 999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=251.83 Aligned_cols=196 Identities=22% Similarity=0.318 Sum_probs=166.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.++|++.+.||+|+||.||+|.+..+ ...||||.+.... .......+..|+.+++.++||||+++++.+...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999988644 4579999986542 223345577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
++||||+++++|.+++... ..++...+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999998664 468999999999999999999999999999999999999999999999999998764211
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
... ......+++.|+|||.+.+..++.++| |+
T Consensus 161 ~~~-----------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~s 193 (266)
T cd05033 161 ATY-----------------------------------------------TTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193 (266)
T ss_pred cce-----------------------------------------------eccCCCCCccccChhhhccCCCccccchHH
Confidence 000 000123567899999999999999999 99
Q ss_pred HHHHHHhhhc
Q 019953 320 VSVLHFNSYR 329 (333)
Q Consensus 320 ~g~il~~l~t 329 (333)
+|+++|+|++
T Consensus 194 lG~~l~~l~~ 203 (266)
T cd05033 194 FGIVMWEVMS 203 (266)
T ss_pred HHHHHHHHHc
Confidence 9999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=253.94 Aligned_cols=188 Identities=35% Similarity=0.604 Sum_probs=163.4
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCH
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 173 (333)
||+|+||+||+|.+..+|+.||+|.+.............+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999765433333344567799999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccC
Q 019953 174 MTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (333)
Q Consensus 174 ~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 251 (333)
.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---------- 150 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---------- 150 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----------
Confidence 99987655 799999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.....++..|+|||++.+..++.++| |++|+++|+|+++
T Consensus 151 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g 190 (277)
T cd05577 151 ----------------------------------------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190 (277)
T ss_pred ----------------------------------------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence 01235788999999999888999999 9999999999986
Q ss_pred c
Q 019953 331 L 331 (333)
Q Consensus 331 ~ 331 (333)
.
T Consensus 191 ~ 191 (277)
T cd05577 191 R 191 (277)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=265.32 Aligned_cols=198 Identities=30% Similarity=0.504 Sum_probs=166.3
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 160 (333)
.+....|+++++||+||.+.||++.. .+...||+|.+.... .+......+.+|+..|.+++ |.+|+.++++-..+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 44567799999999999999999985 345677888776543 34456778999999999994 6799999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
+|+|||+- ..+|..+|.+... .+...++.+..||+.++.++|.+||||.||||.|+|+ -.|.+||+|||+|..+...
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 99999975 5799999987653 4546889999999999999999999999999999999 6789999999999999877
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC--------
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-------- 311 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-------- 311 (333)
+..++.+ +.+||+.|||||++....
T Consensus 513 TTsI~kd-----------------------------------------------sQvGT~NYMsPEAl~~~~s~~~~~~~ 545 (677)
T KOG0596|consen 513 TTSIVKD-----------------------------------------------SQVGTVNYMSPEALTDMSSSRENGKS 545 (677)
T ss_pred ccceeec-----------------------------------------------cccCcccccCHHHHhhccccccCCCc
Confidence 6555432 568999999999996432
Q ss_pred ---CCcccc-hHHHHHHHhhhcc
Q 019953 312 ---YGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 312 ---~~~~~D-ws~g~il~~l~t~ 330 (333)
.++++| ||+|||+|+|+-+
T Consensus 546 k~Ki~r~SDvWSLGCILYqMvYg 568 (677)
T KOG0596|consen 546 KIKISRKSDVWSLGCILYQMVYG 568 (677)
T ss_pred ceeecCccchhhhhhHHHHHHhc
Confidence 578999 9999999998644
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=254.20 Aligned_cols=198 Identities=24% Similarity=0.369 Sum_probs=165.2
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ......+..|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345679999999999999999999877 778899998864321 2223457789999999999999999999998
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cEEE
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRED-------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKL 227 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~vkl 227 (333)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 889999999999999999986643 488899999999999999999999999999999999998765 6999
Q ss_pred EeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc
Q 019953 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (333)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 307 (333)
+|||+++.+....... ......++..|+|||++
T Consensus 161 ~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 161 ADFGMARDIYRASYYR-----------------------------------------------KGGRAMLPIKWMPPEAF 193 (277)
T ss_pred ccCccccccCCcccee-----------------------------------------------cCCCCCccHhhCCHHHH
Confidence 9999998763222100 00012345689999999
Q ss_pred cCCCCCcccc-hHHHHHHHhhhc
Q 019953 308 LKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 308 ~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.+..++.++| |++||++|+|++
T Consensus 194 ~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 194 LDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred hcCCcCchhHHHHHHHHHHHHHc
Confidence 9999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=254.47 Aligned_cols=197 Identities=34% Similarity=0.532 Sum_probs=170.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999865432 2334466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||++++.+..+......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~--- 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS--- 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc---
Confidence 99988777776666677999999999999999999999999999999999999999999999999998876533210
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~i 323 (333)
......+++.|+|||++.+. .++.++| |++|++
T Consensus 157 ---------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~ 191 (288)
T cd07833 157 ---------------------------------------------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191 (288)
T ss_pred ---------------------------------------------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHH
Confidence 01134688999999999888 8999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 192 l~~l~~g~ 199 (288)
T cd07833 192 MAELLDGE 199 (288)
T ss_pred HHHHHhCC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=257.28 Aligned_cols=200 Identities=24% Similarity=0.345 Sum_probs=168.0
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 154 (333)
+....++|.+.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.+ +|+||+++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4556678999999999999999999753 3456899998875421 23345678899999999 79999999999
Q ss_pred EeeCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 155 FQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 155 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
+...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999987543 389999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
++.+....... ......+++.|+|||++.+..+
T Consensus 188 ~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 220 (302)
T cd05055 188 ARDIMNDSNYV-----------------------------------------------VKGNARLPVKWMAPESIFNCVY 220 (302)
T ss_pred cccccCCCcee-----------------------------------------------ecCCCCcccccCCHhhhccCCC
Confidence 88654321100 0012346788999999999999
Q ss_pred Ccccc-hHHHHHHHhhhc
Q 019953 313 GMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t 329 (333)
+.++| |++||++|+|++
T Consensus 221 ~~~~DiwslGvil~el~t 238 (302)
T cd05055 221 TFESDVWSYGILLWEIFS 238 (302)
T ss_pred CcHhHHHHHHHHHHHHHh
Confidence 99999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=254.14 Aligned_cols=195 Identities=26% Similarity=0.386 Sum_probs=163.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|.+.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++++......++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999865422 12223456799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+. +++.+.+.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++........
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 99995 677766644 356788889999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
.....+++.|+|||++.+ ..++.++| |++|
T Consensus 160 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 191 (291)
T cd07870 160 ------------------------------------------------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAG 191 (291)
T ss_pred ------------------------------------------------CCCccccccccCCceeecCCCCCcHHHHHHHH
Confidence 012357899999999976 45889999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 192 ~~l~~l~~g~ 201 (291)
T cd07870 192 CIFIEMLQGQ 201 (291)
T ss_pred HHHHHHHhCC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=252.32 Aligned_cols=194 Identities=25% Similarity=0.395 Sum_probs=163.3
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.+..++|.+.+.||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++|+||+++++.+. ....
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI 75 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence 35567899999999999999999987655 4699999875322 2245778999999999999999998875 4568
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++||||+++++|.+++... ..++...+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||.+..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999999753 35788999999999999999999999999999999999999999999999999866432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
... ......++..|+|||++.+..++.++| |
T Consensus 156 ~~~------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dvw 187 (262)
T cd05071 156 EYT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (262)
T ss_pred ccc------------------------------------------------cccCCcccceecCHhHhccCCCCchhhHH
Confidence 210 001234677899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|+|
T Consensus 188 slG~~l~ellt 198 (262)
T cd05071 188 SFGILLTELTT 198 (262)
T ss_pred HHHHHHHHHHc
Confidence 99999999998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=260.10 Aligned_cols=199 Identities=21% Similarity=0.345 Sum_probs=163.2
Q ss_pred EeeeEeee--cceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 90 LLTIIGRG--AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 90 ~~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
++++||+| +|++||++.+..+|+.||+|.+..... .......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999875432 223345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 168 LPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 168 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~- 159 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR- 159 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc-
Confidence 9999999998653 4589999999999999999999999999999999999999999999999987654322110000
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCcccc-hHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD-WLVSV 322 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~D-ws~g~ 322 (333)
. .........++..|+|||++.+ ..++.++| ||+||
T Consensus 160 ------------------~-----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (327)
T cd08227 160 ------------------V-----------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198 (327)
T ss_pred ------------------c-----------------------cccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence 0 0000112357788999999976 46899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 199 il~el~~g~ 207 (327)
T cd08227 199 TACELANGH 207 (327)
T ss_pred HHHHHHHCC
Confidence 999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.34 Aligned_cols=188 Identities=43% Similarity=0.775 Sum_probs=167.3
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCH
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 173 (333)
||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999989999999999765444444556788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCcc
Q 019953 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253 (333)
Q Consensus 174 ~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~ 253 (333)
.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~------------ 148 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK------------ 148 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc------------
Confidence 99998877899999999999999999999999999999999999999999999999999886643210
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.....|++.|+|||.+.+..++.++| |++|+++|+|+++.
T Consensus 149 --------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~ 189 (262)
T cd05572 149 --------------------------------------TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189 (262)
T ss_pred --------------------------------------cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCC
Confidence 01336889999999999989999999 99999999998864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=254.76 Aligned_cols=195 Identities=27% Similarity=0.434 Sum_probs=164.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|++|.||+|.+..+++.||||.+..... ......+.+|+.+++.++|+||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999988999999999865421 11223356799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||++ ++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||+++........
T Consensus 82 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 82 FEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred EecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 99997 4899888653 46899999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
.....+++.|+|||++.+ ..++.++| |++|
T Consensus 160 ------------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG 191 (291)
T cd07844 160 ------------------------------------------------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVG 191 (291)
T ss_pred ------------------------------------------------ccccccccccCCcHHhhcCcccCcHHHHHHHH
Confidence 002246889999999876 56899999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
+++|+|+++.
T Consensus 192 ~il~~l~~g~ 201 (291)
T cd07844 192 CIFYEMATGR 201 (291)
T ss_pred HHHHHHHhCC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=256.16 Aligned_cols=196 Identities=27% Similarity=0.414 Sum_probs=167.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
......|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 33446799999999999999999999889999999998654332333445678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
++||||++ |++.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 99999996 577776653 4578999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCCCcccc
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECD 317 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~D 317 (333)
...|++.|+|||++. ...++.++|
T Consensus 170 -----------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~sD 196 (307)
T cd06607 170 -----------------------------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVD 196 (307)
T ss_pred -----------------------------------------------------CccCCccccCceeeeccCCCCCCcccc
Confidence 235888999999985 356899999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+|+.
T Consensus 197 v~s~G~il~el~tg~ 211 (307)
T cd06607 197 VWSLGITCIELAERK 211 (307)
T ss_pred hHHHHHHHHHHHcCC
Confidence 99999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=277.18 Aligned_cols=198 Identities=24% Similarity=0.392 Sum_probs=155.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCC-ceEEEE--------------ecchhHHhhhhhHHHHHHHHHHHHHhcCCce
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSG-NIYAMK--------------KLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 148 (333)
..++|++++.||+|+||+||+|...... ..+++| .+.+...........+.+|+.+++.++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998764322 222222 1111111112234457889999999999999
Q ss_pred eEEEEEEeeCCeEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE-----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 149 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
+++++++...+..|+|++++ +++|..++... .......++.++.|++.||.|||++|||||||||+|||++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999 45777776432 2234567788999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|||++..+...... .....+||+.|+|
T Consensus 305 ~vkL~DFGla~~~~~~~~~------------------------------------------------~~~~~~gt~~y~a 336 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREA------------------------------------------------FDYGWVGTVATNS 336 (501)
T ss_pred CEEEEeCCCceecCccccc------------------------------------------------ccccccCCcCCCC
Confidence 9999999999876432110 1113479999999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
||++.+..++.++| ||+||++|+|+++
T Consensus 337 PE~~~~~~~~~~~DiwSlGvil~ell~~ 364 (501)
T PHA03210 337 PEILAGDGYCEITDIWSCGLILLDMLSH 364 (501)
T ss_pred chhhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999999 9999999999975
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=250.69 Aligned_cols=195 Identities=25% Similarity=0.353 Sum_probs=166.2
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
++..++|++.+.||+|++|.||+|.+. +++.||+|.+..... ....+.+|+.+++.++|+||+++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 455678999999999999999999864 457899999875432 234477899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999997643 6899999999999999999999999999999999999999999999999999876422
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... .....++..|+|||++.+..++.++| |
T Consensus 157 ~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 188 (261)
T cd05068 157 IYEA------------------------------------------------REGAKFPIKWTAPEAALYNRFSIKSDVW 188 (261)
T ss_pred cccc------------------------------------------------cCCCcCceeccCccccccCCCCchhhHH
Confidence 1000 00112356899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|+|
T Consensus 189 slG~~l~el~t 199 (261)
T cd05068 189 SFGILLTEIVT 199 (261)
T ss_pred HHHHHHHHHHh
Confidence 99999999997
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=253.74 Aligned_cols=196 Identities=27% Similarity=0.509 Sum_probs=163.1
Q ss_pred CCceEeeeEeeecceEEEEEE----EecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee--CC
Q 019953 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TE 159 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 159 (333)
.+|++++.||+|+||.||+|. +..++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 478999999999999999987 34578899999986543 2334567889999999999999999987643 34
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999998654 4689999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
...... ......++..|+|||++.+..++.++|
T Consensus 161 ~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 194 (284)
T cd05081 161 DKEYYK----------------------------------------------VREPGESPIFWYAPESLTESKFSVASDV 194 (284)
T ss_pred CCccee----------------------------------------------ecCCCCCceEeeCHHHhccCCcChHHHH
Confidence 221000 000112455699999999999999999
Q ss_pred hHHHHHHHhhhcc
Q 019953 318 WLVSVLHFNSYRF 330 (333)
Q Consensus 318 ws~g~il~~l~t~ 330 (333)
|++||++|+|+++
T Consensus 195 ~slG~~l~el~~~ 207 (284)
T cd05081 195 WSFGVVLYELFTY 207 (284)
T ss_pred HHHHHHHHHHhhc
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=252.63 Aligned_cols=195 Identities=29% Similarity=0.520 Sum_probs=164.8
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeC----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDT---- 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~---- 158 (333)
+.+.|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|+||+++++.+...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3467888999999999999999999999999999986542 2234567789999988 699999999998653
Q ss_pred --CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 159 --EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 159 --~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4689999999999999998763 468999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----C
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----K 309 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~ 309 (333)
....... ......|++.|+|||++. +
T Consensus 160 ~~~~~~~-------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~ 190 (272)
T cd06637 160 QLDRTVG-------------------------------------------------RRNTFIGTPYWMAPEVIACDENPD 190 (272)
T ss_pred ecccccc-------------------------------------------------cCCcccccccccCHhHhccccCcC
Confidence 6532210 011346899999999986 3
Q ss_pred CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| |++||++|+|+++.
T Consensus 191 ~~~~~~~Dv~slGv~l~el~~g~ 213 (272)
T cd06637 191 ATYDFKSDLWSLGITAIEMAEGA 213 (272)
T ss_pred CCCCchhhHHHHHHHHHHHHhCC
Confidence 46889999 99999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=263.39 Aligned_cols=200 Identities=25% Similarity=0.371 Sum_probs=162.6
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEE-----ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCRE-----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS 154 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 154 (333)
|....++|++.+.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 455667899999999999999999985 34678999999865321 22345677899999999 67999999998
Q ss_pred Eee-CCeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 019953 155 FQD-TEYLYLIMEYLPGGDMMTLLMRE----------------------------------------------------- 180 (333)
Q Consensus 155 ~~~-~~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------- 180 (333)
+.. ...+++|||||++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 764 45689999999999999988642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 181 --------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 181 --------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
..++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--- 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh---
Confidence 125667778899999999999999999999999999999999999999999988653221000
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
......+++.|+|||++.+..++.++| |++|+++|
T Consensus 237 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 272 (343)
T cd05103 237 --------------------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 272 (343)
T ss_pred --------------------------------------------hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHH
Confidence 000223567899999999999999999 99999999
Q ss_pred hhhc
Q 019953 326 NSYR 329 (333)
Q Consensus 326 ~l~t 329 (333)
+|++
T Consensus 273 el~~ 276 (343)
T cd05103 273 EIFS 276 (343)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.32 Aligned_cols=195 Identities=19% Similarity=0.299 Sum_probs=161.2
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCc----eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
.++|++++.||+|+||.||+|.+..++. .+++|.+.... .......+..|+.++..+.||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 4678999999999999999999877776 47777775332 1223345667888889999999999999875 455
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++++||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999976 457899999999999999999999999999999999999999999999999999865422
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
... .......++..|+|||++.+..++.++| |
T Consensus 163 ~~~-----------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~ 195 (279)
T cd05111 163 DKK-----------------------------------------------YFYSEHKTPIKWMALESILFGRYTHQSDVW 195 (279)
T ss_pred Ccc-----------------------------------------------cccCCCCCcccccCHHHhccCCcCchhhHH
Confidence 110 0011234677899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|++
T Consensus 196 slG~il~el~t 206 (279)
T cd05111 196 SYGVTVWEMMS 206 (279)
T ss_pred HHHHHHHHHHc
Confidence 99999999987
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=257.65 Aligned_cols=196 Identities=20% Similarity=0.341 Sum_probs=163.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
..+|.+.+.||+|+||.||+|.+.. .+..||+|++.... .......+..|+.++..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4568888999999999999998754 35789999987542 1223456778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
..++++||+.+++|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998531 2477888899999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|||+++........ .......+++.|+|
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~a 194 (283)
T cd05091 162 NVKISDLGLFREVYAADYY-----------------------------------------------KLMGNSLLPIRWMS 194 (283)
T ss_pred ceEecccccccccccchhe-----------------------------------------------eeccCccCCccccC
Confidence 9999999998865432210 00112346789999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
||++.+..++.++| ||+||++|+|++
T Consensus 195 PE~~~~~~~~~~~Dv~slG~~l~el~~ 221 (283)
T cd05091 195 PEAIMYGKFSIDSDIWSYGVVLWEVFS 221 (283)
T ss_pred HHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence 99999889999999 999999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=267.68 Aligned_cols=202 Identities=24% Similarity=0.354 Sum_probs=167.3
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~ 152 (333)
..+.+..++|.+.+.||+|+||.||+|.+. .++..||+|++..... ......+..|+.++..+. ||||++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 346777788999999999999999999864 3456899999975421 223345788999999997 99999999
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhCC---------------------------------------------------
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRED--------------------------------------------------- 181 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------- 181 (333)
+++...+.+++||||+++|+|.+++....
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999899999999999999999986431
Q ss_pred -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCC
Q 019953 182 -----------------------------------------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (333)
Q Consensus 182 -----------------------------------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 214 (333)
.++...+..++.|++.||.|||+.+++||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 245566788899999999999999999999999
Q ss_pred CcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccc
Q 019953 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (333)
Q Consensus 215 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (333)
+|||++.++.++|+|||+++.+...... .....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~-----------------------------------------------~~~~~ 300 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNY-----------------------------------------------ISKGS 300 (401)
T ss_pred ceEEEeCCCEEEEEecCcceeccccccc-----------------------------------------------ccCCC
Confidence 9999999999999999999865322100 00013
Q ss_pred cCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 295 TVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 295 ~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
..+++.|+|||++.+..++.++| |++|+++|+|++
T Consensus 301 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred cCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 35788999999999999999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=258.78 Aligned_cols=190 Identities=23% Similarity=0.375 Sum_probs=153.0
Q ss_pred eeeEeeecceEEEEEEEec--CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe--eCCeEEEEEe
Q 019953 91 LTIIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DTEYLYLIME 166 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 166 (333)
...||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3689999999999998653 568899998865421 234667999999999999999999885 3567899999
Q ss_pred ccCCCCHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE----ccCCcEEEEeccCc
Q 019953 167 YLPGGDMMTLLMR---------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLC 233 (333)
Q Consensus 167 ~~~~g~L~~~l~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill----~~~~~vkl~DFGla 233 (333)
|+. ++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 995 577777642 1248889999999999999999999999999999999999 45678999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGY 312 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~ 312 (333)
+.+....... .......||+.|+|||++.+ ..+
T Consensus 160 ~~~~~~~~~~----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~ 193 (317)
T cd07867 160 RLFNSPLKPL----------------------------------------------ADLDPVVVTFWYRAPELLLGARHY 193 (317)
T ss_pred eccCCCcccc----------------------------------------------cccCcceecccccCcHHhcCCCcc
Confidence 8764322100 00113468999999999977 458
Q ss_pred Ccccc-hHHHHHHHhhhcccc
Q 019953 313 GMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~~ 332 (333)
+.++| ||+||++|+|+|+.+
T Consensus 194 ~~~~DiwSlG~il~el~tg~~ 214 (317)
T cd07867 194 TKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred CcHHHHHhHHHHHHHHHhCCC
Confidence 99999 999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=254.99 Aligned_cols=195 Identities=25% Similarity=0.421 Sum_probs=165.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
..+|.+.+.||+|+||.||+|.+. .++..+++|.+..... .....+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 457999999999999999999754 3456799998865432 22345778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999996532 378889999999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.++|+|||++.......... ......+++.|+|
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~a 193 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYR-----------------------------------------------VGGHTMLPIRWMP 193 (291)
T ss_pred cEEECCCCcccccCCCceee-----------------------------------------------cCCCCCcceeecC
Confidence 99999999998654322110 0112357889999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
||++.+..++.++| ||+|+++|+|+|
T Consensus 194 PE~~~~~~~~~~~Di~slG~il~el~t 220 (291)
T cd05094 194 PESIMYRKFTTESDVWSFGVILWEIFT 220 (291)
T ss_pred hHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999 999999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=252.43 Aligned_cols=196 Identities=26% Similarity=0.422 Sum_probs=161.6
Q ss_pred CCc-eEeeeEeeecceEEEEEE----EecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--
Q 019953 86 DDF-ELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-- 158 (333)
Q Consensus 86 ~~y-~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 158 (333)
++| ++++.||+|+||+||++. ...++..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 899999999999998764 345688999999875421 12335577899999999999999999987653
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..+++||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+..
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 4689999999999999998654 599999999999999999999999999999999999999999999999999986643
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
..... .......++..|+|||++.+..++.++|
T Consensus 160 ~~~~~----------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di 193 (283)
T cd05080 160 GHEYY----------------------------------------------RVREDGDSPVFWYAVECLKENKFSYASDV 193 (283)
T ss_pred cchhh----------------------------------------------ccCCCCCCCceeeCHhHhcccCCCccccc
Confidence 22100 0001123567799999999999999999
Q ss_pred hHHHHHHHhhhcc
Q 019953 318 WLVSVLHFNSYRF 330 (333)
Q Consensus 318 ws~g~il~~l~t~ 330 (333)
||+|+++|+|+|+
T Consensus 194 ~slG~~l~el~tg 206 (283)
T cd05080 194 WSFGVTLYELLTH 206 (283)
T ss_pred HHHHHHHHHHHhC
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=254.57 Aligned_cols=196 Identities=25% Similarity=0.460 Sum_probs=164.8
Q ss_pred CceEeeeEeeecceEEEEEEE----ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--Ce
Q 019953 87 DFELLTIIGRGAFGEVRLCRE----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EY 160 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 160 (333)
-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 478899999999999999974 4578899999987542 123345688899999999999999999988765 56
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++||||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999998654 36899999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... .......++..|+|||++.+..++.++| |
T Consensus 163 ~~~~----------------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 196 (284)
T cd05079 163 KEYY----------------------------------------------TVKDDLDSPVFWYAPECLIQSKFYIASDVW 196 (284)
T ss_pred ccce----------------------------------------------eecCCCCCCccccCHHHhccCCCCccccch
Confidence 2100 0001235777899999999999999999 9
Q ss_pred HHHHHHHhhhcc
Q 019953 319 LVSVLHFNSYRF 330 (333)
Q Consensus 319 s~g~il~~l~t~ 330 (333)
|+|+++|+|+|+
T Consensus 197 slG~il~ellt~ 208 (284)
T cd05079 197 SFGVTLYELLTY 208 (284)
T ss_pred hhhhhhhhhhcC
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=250.84 Aligned_cols=191 Identities=30% Similarity=0.529 Sum_probs=160.0
Q ss_pred CCCceEe-eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEee----C
Q 019953 85 VDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD----T 158 (333)
Q Consensus 85 ~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~ 158 (333)
+++|.+- .+||-|-.|+|..|.++.+|+.+|+|++.... ..++|+++--.. .|||||.++++|.+ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 5677764 68999999999999999999999999986442 244566664443 79999999998865 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CCcEEEEeccCc
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLC 233 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~~vkl~DFGla 233 (333)
..+.+|||.++||.|.+.+...+ .|++.++..|+.||+.|+.|||+.+|.||||||+|+|.+. |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 46889999999999999998765 5999999999999999999999999999999999999975 457999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
+....+. ...+.|-||+|.|||++....|+
T Consensus 212 K~t~~~~--------------------------------------------------~L~TPc~TPyYvaPevlg~eKyd 241 (400)
T KOG0604|consen 212 KETQEPG--------------------------------------------------DLMTPCFTPYYVAPEVLGPEKYD 241 (400)
T ss_pred cccCCCc--------------------------------------------------cccCCcccccccCHHHhCchhcC
Confidence 9754322 22256789999999999999999
Q ss_pred cccc-hHHHHHHHhhh-ccccC
Q 019953 314 MECD-WLVSVLHFNSY-RFLEF 333 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~-t~~~~ 333 (333)
.++| ||+||+||-|+ .|-||
T Consensus 242 kscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 242 KSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred CCCCccchhHHHHHhhcCCCcc
Confidence 9999 99999999664 44444
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=249.47 Aligned_cols=190 Identities=26% Similarity=0.421 Sum_probs=166.1
Q ss_pred eeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEecc
Q 019953 92 TIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (333)
+.||+|+||.||+|.+... +..||+|.+....... ....+..|+.++..++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999998866 8999999997654322 4567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 169 PGGDMMTLLMRE---------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 169 ~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 67999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... ......+++.|+|||.+.+..++.++| |
T Consensus 159 ~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 191 (262)
T cd00192 159 DYYR-----------------------------------------------KKTGGKLPIRWMAPESLKDGIFTSKSDVW 191 (262)
T ss_pred cccc-----------------------------------------------cccCCCcCccccCHHHhccCCcchhhccH
Confidence 2100 011335788999999999889999999 9
Q ss_pred HHHHHHHhhhcc
Q 019953 319 LVSVLHFNSYRF 330 (333)
Q Consensus 319 s~g~il~~l~t~ 330 (333)
++|+++|+|++.
T Consensus 192 slG~il~~l~~~ 203 (262)
T cd00192 192 SFGVLLWEIFTL 203 (262)
T ss_pred HHHHHHHHHHhc
Confidence 999999999974
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=250.39 Aligned_cols=198 Identities=28% Similarity=0.489 Sum_probs=168.4
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh-------hhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-------KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999889999999988643211 1112356778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
..++||||+++++|.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988788999999999999999999999999999999999999999999999999998754321
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC--CCcccc
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YGMECD 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~D 317 (333)
... .......|+..|+|||++.+.. ++.++|
T Consensus 162 ~~~-----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~D 194 (272)
T cd06629 162 YDN-----------------------------------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVD 194 (272)
T ss_pred ccc-----------------------------------------------cccccccCCccccCHHHhccccCCCCccch
Confidence 100 0011345889999999998754 899999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+++.
T Consensus 195 v~slG~~l~~l~~g~ 209 (272)
T cd06629 195 IWSLGCVVLEMFAGR 209 (272)
T ss_pred hHHHHHHHHHHHhCC
Confidence 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.99 Aligned_cols=202 Identities=22% Similarity=0.379 Sum_probs=166.4
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecC-------CceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKS-------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVK 150 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 150 (333)
+.+++...+|++++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 45566677899999999999999999986432 2368999887432 223345678899999999 8999999
Q ss_pred EEEEEeeCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCC
Q 019953 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (333)
Q Consensus 151 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 214 (333)
+++.+...+.++++|||+++|+|.+++... ..++...+..++.|++.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 999999999999999999999999998653 2367778888999999999999999999999999
Q ss_pred CcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccc
Q 019953 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (333)
Q Consensus 215 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (333)
+||+++.++.+||+|||+++.+....... ....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~ 195 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYK-----------------------------------------------KTTN 195 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccc-----------------------------------------------cccC
Confidence 99999999999999999988654321100 0001
Q ss_pred cCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 295 TVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 295 ~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
..++..|+|||++.+..++.++| |++|+++|+|++
T Consensus 196 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred CCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence 23456899999999999999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=257.41 Aligned_cols=201 Identities=23% Similarity=0.369 Sum_probs=165.8
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEec-------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEE
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKL 151 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 151 (333)
.+.+..++|.+.+.||+|+||.||+|.+.. ....+|+|.+..... ......+..|+.+++.+ .||||+++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 345666789999999999999999997632 345799999875321 22345577899999999 69999999
Q ss_pred EEEEeeCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCC
Q 019953 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (333)
Q Consensus 152 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 215 (333)
++++...+.+++||||+++|+|.+++... ..++...+..++.|++.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 99999888999999999999999999653 24788888999999999999999999999999999
Q ss_pred cEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccccc
Q 019953 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (333)
Q Consensus 216 Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (333)
||+++.++.+||+|||+++......... .....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~ 196 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYK-----------------------------------------------KTSNG 196 (314)
T ss_pred eEEEcCCCcEEEcccccccccccccccc-----------------------------------------------ccccC
Confidence 9999999999999999998654321100 00011
Q ss_pred CCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 296 VGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 296 ~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.+++.|+|||++.+..++.++| |++|+++|+|++
T Consensus 197 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 231 (314)
T cd05099 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231 (314)
T ss_pred CCCccccCHHHHccCCcCccchhhHHHHHHHHHHh
Confidence 2456899999999999999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=250.64 Aligned_cols=192 Identities=21% Similarity=0.375 Sum_probs=162.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+..|+.+++.++|+||+++++++...+..++|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 346889999999999999999875 466899999865422 123466799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 9999999999998653 46899999999999999999999999999999999999999999999999998765322100
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......++..|+|||.+.+..++.++| |++|+
T Consensus 157 -----------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~ 189 (256)
T cd05059 157 -----------------------------------------------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGV 189 (256)
T ss_pred -----------------------------------------------ccCCCCCCccccCHHHhccCCCCchhhHHHHHH
Confidence 000112456899999999999999999 99999
Q ss_pred HHHhhhc
Q 019953 323 LHFNSYR 329 (333)
Q Consensus 323 il~~l~t 329 (333)
++|+|++
T Consensus 190 il~~l~~ 196 (256)
T cd05059 190 LMWEVFS 196 (256)
T ss_pred HHHHHhc
Confidence 9999997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=251.37 Aligned_cols=197 Identities=22% Similarity=0.328 Sum_probs=165.2
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCc---eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+..... ......+..|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4679999999999999999998865543 799999865321 22345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
++||||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999998764321
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
... .......++..|+|||.+.+..++.++| |+
T Consensus 161 ~~~----------------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 194 (267)
T cd05066 161 EAA----------------------------------------------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWS 194 (267)
T ss_pred cee----------------------------------------------eecCCCccceeecCHhHhccCccCchhhhHH
Confidence 100 0000112456899999999999999999 99
Q ss_pred HHHHHHhhhc
Q 019953 320 VSVLHFNSYR 329 (333)
Q Consensus 320 ~g~il~~l~t 329 (333)
+|+++|++++
T Consensus 195 lG~~l~ell~ 204 (267)
T cd05066 195 YGIVMWEVMS 204 (267)
T ss_pred HHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=255.83 Aligned_cols=193 Identities=29% Similarity=0.501 Sum_probs=165.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++.+...+.+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46889999999999999999999899999999886431 1223456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 166 EYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 166 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
||+++++|..++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999888763 378999999999999999999997 599999999999999999999999999987653211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC------CCCcc
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK------GYGME 315 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~~ 315 (333)
.....|++.|+|||++.+. .++.+
T Consensus 158 --------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 187 (286)
T cd06622 158 --------------------------------------------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQ 187 (286)
T ss_pred --------------------------------------------------cccCCCccCccCcchhcCCCCCccCCCCcc
Confidence 0133588899999998543 35889
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| |++||++|+|+++.
T Consensus 188 ~DiwslG~il~~l~~g~ 204 (286)
T cd06622 188 SDVWSLGLSILEMALGR 204 (286)
T ss_pred cchHhHHHHHHHHHhCC
Confidence 99 99999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=234.58 Aligned_cols=191 Identities=27% Similarity=0.474 Sum_probs=165.6
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|.-.++||+|.||+|++|++..+++.||+|.++.... .........+|+.+++.++|.|||++++....++.+.+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 45667899999999999999999999999999987643 33445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 167 YLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 167 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||. .+|..+..+ ++.++...++.++.|++.||.|+|+++++|||+||.|.||+.+|.+|++|||+++.+.-+-
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv----- 155 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----- 155 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-----
Confidence 994 577777755 5679999999999999999999999999999999999999999999999999999765221
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~i 323 (333)
++...-+-|.+|.+|.++.|. -|+.+.| ||+|||
T Consensus 156 --------------------------------------------rcysaevvtlwyrppdvlfgakly~tsidmwsagci 191 (292)
T KOG0662|consen 156 --------------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191 (292)
T ss_pred --------------------------------------------EeeeceeeeeeccCcceeeeeehhccchHhhhcchH
Confidence 122244789999999999985 4899999 999999
Q ss_pred HHhhh
Q 019953 324 HFNSY 328 (333)
Q Consensus 324 l~~l~ 328 (333)
+-++-
T Consensus 192 faela 196 (292)
T KOG0662|consen 192 FAELA 196 (292)
T ss_pred HHHHh
Confidence 98763
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=248.85 Aligned_cols=187 Identities=45% Similarity=0.772 Sum_probs=160.1
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHH-HHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL-AEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+.||.|+||.||+|.+..+++.||+|++.............+..|..++ ....|+|++++++.+...+.+++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999999999999998765433222333344454443 445899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---------- 151 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK---------- 151 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccc----------
Confidence 9999999888889999999999999999999999999999999999999999999999999887532110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
...|++.|+|||.+.+..++.++| |++|+++|+|++
T Consensus 152 -------------------------------------------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~ 188 (260)
T cd05611 152 -------------------------------------------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188 (260)
T ss_pred -------------------------------------------cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH
Confidence 335889999999999888999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 189 g~ 190 (260)
T cd05611 189 GY 190 (260)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=284.83 Aligned_cols=199 Identities=24% Similarity=0.414 Sum_probs=171.5
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCC-----ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSG-----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
+.....++.+.||+|.||.||.|...... ..||||.+.... +.+....+.+|+.+|+.++|||||+++|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 44567889999999999999999765432 238999987653 45567789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEec
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRE-------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DF 230 (333)
....+|++|||+||+|..+|++. ..++......++.||+.|+.||+++++|||||..+|+|++....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999875 35889999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 310 (333)
|+|+.+....++.... ...-+..|||||.+..+
T Consensus 847 GlArDiy~~~yyr~~~-----------------------------------------------~a~lPvkWm~PEsl~d~ 879 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHG-----------------------------------------------EAMLPVKWMPPESLKDG 879 (1025)
T ss_pred chhHhhhhchheeccC-----------------------------------------------ccccceecCCHHHHhhc
Confidence 9999665555443111 01234689999999999
Q ss_pred CCCcccc-hHHHHHHHhhhcc
Q 019953 311 GYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t~ 330 (333)
.+|.++| ||+||++|+++|.
T Consensus 880 iFtskSDvWsFGVllWEifsl 900 (1025)
T KOG1095|consen 880 IFTSKSDVWSFGVLLWEIFSL 900 (1025)
T ss_pred ccccccchhhhHHHHHHHHhC
Confidence 9999999 9999999999985
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=251.52 Aligned_cols=200 Identities=29% Similarity=0.513 Sum_probs=166.4
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEe-
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ- 156 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~- 156 (333)
+......++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+..|+.+++.+ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3445567899999999999999999999999999999998764321 123466788999998 6999999999873
Q ss_pred ----eCCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEE
Q 019953 157 ----DTEYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228 (333)
Q Consensus 157 ----~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~ 228 (333)
.++.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 44679999999999999988753 3468888999999999999999999999999999999999999999999
Q ss_pred eccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc
Q 019953 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308 (333)
Q Consensus 229 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~ 308 (333)
|||++..+..... ......|++.|+|||++.
T Consensus 167 dfg~~~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 167 DFGVSAQLTSTRL-------------------------------------------------RRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred cCCceeecccCCC-------------------------------------------------ccccccCCCcccChhhhc
Confidence 9999886542210 001335899999999985
Q ss_pred -----CCCCCcccc-hHHHHHHHhhhccc
Q 019953 309 -----KKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 309 -----~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+..++.++| |++||++|+|+++.
T Consensus 198 ~~~~~~~~~~~~~Dv~slGvi~~el~~g~ 226 (286)
T cd06638 198 CEQQLDSTYDARCDVWSLGITAIELGDGD 226 (286)
T ss_pred hhhhccccccchhhhhhHHHHHHHHhcCC
Confidence 355899999 99999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=247.90 Aligned_cols=193 Identities=30% Similarity=0.515 Sum_probs=170.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.++|+||+++++.+......|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3679999999999999999999988899999999875432 45688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999865 45789999999999999999999999999999999999999999999999999887643210
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......|+..|+|||++.+..++.++| |++|+
T Consensus 155 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~ 187 (256)
T cd06612 155 -----------------------------------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187 (256)
T ss_pred -----------------------------------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHH
Confidence 001235888999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 188 il~~l~~g~ 196 (256)
T cd06612 188 TAIEMAEGK 196 (256)
T ss_pred HHHHHHhCC
Confidence 999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=247.56 Aligned_cols=189 Identities=26% Similarity=0.426 Sum_probs=166.2
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..++|++.+.||.|+||.||+|... |+.||+|.+..... ....+.+|+.+++.++|+||+++++++......+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 45678999999999999999999864 88999999976532 3456888999999999999999999999888999
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 163 LIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999997655 78999999999999999999999999999999999999999999999999998653211
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
. ...++..|+|||.+.+..++.++| |+
T Consensus 157 ~----------------------------------------------------~~~~~~~~~ape~~~~~~~~~~~Di~s 184 (256)
T cd05039 157 D----------------------------------------------------SGKLPVKWTAPEALREKKFSTKSDVWS 184 (256)
T ss_pred c----------------------------------------------------cCCCcccccCchhhcCCcCCcHHHHHH
Confidence 0 123456899999999889999999 99
Q ss_pred HHHHHHhhhc
Q 019953 320 VSVLHFNSYR 329 (333)
Q Consensus 320 ~g~il~~l~t 329 (333)
+|+++|+|++
T Consensus 185 lG~il~~l~~ 194 (256)
T cd05039 185 FGILLWEIYS 194 (256)
T ss_pred HHHHHHHHHh
Confidence 9999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=248.56 Aligned_cols=199 Identities=30% Similarity=0.509 Sum_probs=171.4
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999986543222 4566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 166 EYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 166 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
|++++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998876543211
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLV 320 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~ 320 (333)
. ........|+..|+|||++... .++.++| |++
T Consensus 159 ~---------------------------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl 193 (267)
T cd06610 159 T---------------------------------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193 (267)
T ss_pred c---------------------------------------------ccccccccCChhhcChHHHccccCcCcccchHhH
Confidence 0 0011134689999999999876 7899999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 194 G~i~~~l~~g~ 204 (267)
T cd06610 194 GITAIELATGA 204 (267)
T ss_pred hHHHHHHHhCC
Confidence 99999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=250.41 Aligned_cols=199 Identities=23% Similarity=0.344 Sum_probs=165.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCc---eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.++|++.+.||+|+||.||+|.+..++. .||||++.... .......+..|+.+++.+.||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4578999999999999999999877665 59999986532 223445688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
++||||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999998753 568999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
.... .........+..|+|||.+.+..++.++| |+
T Consensus 161 ~~~~--------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvws 196 (269)
T cd05065 161 SDPT--------------------------------------------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWS 196 (269)
T ss_pred cccc--------------------------------------------cccccCCCcceeecCHhHhccCcccchhhhhh
Confidence 1000 00000111345799999999999999999 99
Q ss_pred HHHHHHhhhc
Q 019953 320 VSVLHFNSYR 329 (333)
Q Consensus 320 ~g~il~~l~t 329 (333)
+||++|+|++
T Consensus 197 lG~~l~e~l~ 206 (269)
T cd05065 197 YGIVMWEVMS 206 (269)
T ss_pred hHHHHHHHhc
Confidence 9999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=248.13 Aligned_cols=195 Identities=31% Similarity=0.555 Sum_probs=169.4
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHH--hhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
+|+..+.||+|+||+||+|.+..++..|++|.+..... ........+..|+.+++.++|+||+++++++.....+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999988999999999865431 1123445688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--- 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc---
Confidence 99999999999998877899999999999999999999999999999999999999999999999999886532210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-CCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~D-ws~g~ 322 (333)
.....|++.|+|||.+.+.. ++.++| |++|+
T Consensus 158 -----------------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~ 190 (258)
T cd06632 158 -----------------------------------------------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190 (258)
T ss_pred -----------------------------------------------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHH
Confidence 01345889999999998776 999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 191 ~l~~l~~g~ 199 (258)
T cd06632 191 TVLEMATGK 199 (258)
T ss_pred HHHHHHhCC
Confidence 999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=260.83 Aligned_cols=193 Identities=27% Similarity=0.426 Sum_probs=164.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC------
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 158 (333)
.++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4789999999999999999999999999999999864321 222334566799999999999999999988643
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
...|+||||+. ++|.+.+... ++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999995 5888877544 88999999999999999999999999999999999999999999999999986542
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
... .....+++.|+|||++.+..++.++|
T Consensus 171 ~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv 200 (353)
T cd07850 171 SFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDI 200 (353)
T ss_pred CCC--------------------------------------------------CCCCcccccccCHHHHhCCCCCCchhh
Confidence 210 01235889999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 201 wslG~~l~~l~~g~ 214 (353)
T cd07850 201 WSVGCIMGEMIRGT 214 (353)
T ss_pred HhHHHHHHHHHHCC
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=250.19 Aligned_cols=194 Identities=22% Similarity=0.346 Sum_probs=160.1
Q ss_pred ceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe----
Q 019953 88 FELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY---- 160 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 160 (333)
|++.+.||+|+||.||.|.+..+ +..||+|.+..... .......+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56789999999999999987653 47899999875422 22334568889999999999999999998765443
Q ss_pred --EEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 161 --LYLIMEYLPGGDMMTLLMRE------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 161 --~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
.+++|||+++++|..++... ..+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999888432 3588999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
++......... ......++..|+|||++.+..+
T Consensus 160 ~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05035 160 SKKIYSGDYYR-----------------------------------------------QGRIAKMPVKWIAIESLADRVY 192 (273)
T ss_pred eeecccccccc-----------------------------------------------ccccccCCccccCHhhcccCCC
Confidence 98654332110 0001235678999999999999
Q ss_pred Ccccc-hHHHHHHHhhhc
Q 019953 313 GMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t 329 (333)
+.++| ||+||++|+|++
T Consensus 193 ~~~~Dv~SlG~il~el~~ 210 (273)
T cd05035 193 TSKSDVWAFGVTMWEIAT 210 (273)
T ss_pred CcccchHHHHHHHHHHHh
Confidence 99999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=254.59 Aligned_cols=196 Identities=23% Similarity=0.422 Sum_probs=162.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEec----------------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKK----------------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 148 (333)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999986432 34579999987542 22334567889999999999999
Q ss_pred eEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcE
Q 019953 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-----------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (333)
Q Consensus 149 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Ni 217 (333)
+++++++......++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999986532 356678999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC
Q 019953 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (333)
Q Consensus 218 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 297 (333)
+++.++.++|+|||++..+....... ......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~ 194 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR-----------------------------------------------IQGRAVL 194 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee-----------------------------------------------ccCcCcC
Confidence 99999999999999988654321100 0002235
Q ss_pred CCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 298 TPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 298 t~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
++.|+|||+..+..++.++| ||+||++|+|++
T Consensus 195 ~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 195 PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred ccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence 67899999998889999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=248.09 Aligned_cols=195 Identities=24% Similarity=0.370 Sum_probs=167.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
++..++|.+.+.||+|+||.||+|.+. ++..||||.+..... ....+..|+.+++.++|+||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 456789999999999999999999865 557899999875432 234577899999999999999999999988899
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++||||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999764 36899999999999999999999999999999999999999999999999998865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
... ......++..|+|||.+.+..++.++| |
T Consensus 157 ~~~------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 188 (261)
T cd05034 157 EYT------------------------------------------------AREGAKFPIKWTAPEAANYGRFTIKSDVW 188 (261)
T ss_pred hhh------------------------------------------------hhhccCCCccccCHHHhccCCcCchhHHH
Confidence 100 000223567899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|++
T Consensus 189 slG~il~~l~t 199 (261)
T cd05034 189 SFGILLTEIVT 199 (261)
T ss_pred HHHHHHHHHHh
Confidence 99999999997
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=248.05 Aligned_cols=189 Identities=26% Similarity=0.473 Sum_probs=161.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe-eCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 160 (333)
.+...+|++.+.||+|+||.||++... |..||+|.+.... ....+..|+.+++.++|++++++++++. ..+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 345578999999999999999999754 7889999986432 2345778999999999999999998754 4567
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 899999999999999987643 478899999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
... ...++..|+|||++.+..++.++|
T Consensus 155 ~~~----------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~Dv 182 (256)
T cd05082 155 TQD----------------------------------------------------TGKLPVKWTAPEALREKKFSTKSDV 182 (256)
T ss_pred cCC----------------------------------------------------CCccceeecCHHHHccCCCCchhhh
Confidence 110 223566899999999999999999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
|++||++|+|++
T Consensus 183 ~slG~i~~~l~~ 194 (256)
T cd05082 183 WSFGILLWEIYS 194 (256)
T ss_pred HHHHHHHHHHHh
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=248.92 Aligned_cols=192 Identities=23% Similarity=0.409 Sum_probs=163.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|+||.||.|.+.. +..||+|.+..... ....+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 3578999999999999999997653 45699998875432 224577899999999999999999999988889999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.++........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 9999999999998764 46899999999999999999999999999999999999999999999999998765322110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......++..|+|||++.+..++.++| |++|+
T Consensus 157 -----------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~ 189 (256)
T cd05113 157 -----------------------------------------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGV 189 (256)
T ss_pred -----------------------------------------------ecCCCccChhhCCHHHHhcCcccchhHHHHHHH
Confidence 000223567899999999889999999 99999
Q ss_pred HHHhhhc
Q 019953 323 LHFNSYR 329 (333)
Q Consensus 323 il~~l~t 329 (333)
++|+|++
T Consensus 190 ~l~~l~~ 196 (256)
T cd05113 190 LMWEVYS 196 (256)
T ss_pred HHHHHhc
Confidence 9999987
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=252.44 Aligned_cols=196 Identities=23% Similarity=0.396 Sum_probs=164.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
...+|.+.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3467889999999999999999643 356789999886542 23345688899999999999999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRED---------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
...+++|||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999986542 478889999999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.++|+|||++.......... ......+++.|+|
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~a 192 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYR-----------------------------------------------VGGRTMLPIRWMP 192 (280)
T ss_pred CEEECCCCceeEcCCCceee-----------------------------------------------cCCCccccccccC
Confidence 99999999987553221100 0012246788999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
||.+.+..++.++| ||+||++|+|++
T Consensus 193 PE~~~~~~~~~~~Di~slG~il~el~~ 219 (280)
T cd05092 193 PESILYRKFTTESDIWSFGVVLWEIFT 219 (280)
T ss_pred HHHhccCCcCchhhHHHHHHHHHHHHc
Confidence 99999999999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=251.21 Aligned_cols=196 Identities=28% Similarity=0.448 Sum_probs=168.8
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++.+.||+|+||.||+|.+..+|..||+|++...... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999989999999998764321 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 167 YLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 167 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|+ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999998865 45789999999999999999999999999999999999999999999999999886643221
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~i 323 (333)
.......|+..|+|||++.+. .++.++| |++|++
T Consensus 155 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~ 190 (286)
T cd07832 155 --------------------------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCI 190 (286)
T ss_pred --------------------------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHH
Confidence 001133689999999998764 4699999 999999
Q ss_pred HHhhhcccc
Q 019953 324 HFNSYRFLE 332 (333)
Q Consensus 324 l~~l~t~~~ 332 (333)
+|+|+++.+
T Consensus 191 l~~l~tg~~ 199 (286)
T cd07832 191 FAELLNGSP 199 (286)
T ss_pred HHHHHcCCc
Confidence 999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=250.15 Aligned_cols=193 Identities=34% Similarity=0.506 Sum_probs=161.3
Q ss_pred eEeeeEeeecceEEEEEEEe----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 89 ELLTIIGRGAFGEVRLCREK----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.+.+.||.|+||.||+|.+. ..+..|+||.+.... .....+.+.+|+..++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 456789999995432 223356788899999999999999999999988889999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 165 MEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
|||+++|+|.+++... ..++......++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 68999999999999999999999999999999999999999999999999999876322111
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
. ......+...|+|||++.+..++.++| |++|
T Consensus 160 ~-----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG 192 (259)
T PF07714_consen 160 K-----------------------------------------------NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFG 192 (259)
T ss_dssp E-----------------------------------------------ESTTSESGGGGS-HHHHHHSEESHHHHHHHHH
T ss_pred c-----------------------------------------------cccccccccccccccccccccccccccccccc
Confidence 0 011234677899999999999999999 9999
Q ss_pred HHHHhhhcc
Q 019953 322 VLHFNSYRF 330 (333)
Q Consensus 322 ~il~~l~t~ 330 (333)
+++|+|++.
T Consensus 193 ~~l~ei~~~ 201 (259)
T PF07714_consen 193 MLLYEILTL 201 (259)
T ss_dssp HHHHHHHTT
T ss_pred ccccccccc
Confidence 999999984
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=248.99 Aligned_cols=194 Identities=25% Similarity=0.410 Sum_probs=163.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.+..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|++++++++.+. ....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 456678999999999999999999765 566799999875432 2245778999999999999999998875 4568
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999999998753 35899999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... .....++..|+|||++.+..++.++| |
T Consensus 156 ~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 187 (260)
T cd05070 156 EYTA------------------------------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (260)
T ss_pred cccc------------------------------------------------ccCCCCCccccChHHHhcCCCcchhhhH
Confidence 2100 00223567899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|++
T Consensus 188 slG~~l~~l~~ 198 (260)
T cd05070 188 SFGILLTELVT 198 (260)
T ss_pred HHHHHHHHHHh
Confidence 99999999997
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=248.95 Aligned_cols=199 Identities=22% Similarity=0.324 Sum_probs=165.8
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCc---eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
+..++|...+.||+|+||.||+|.+..++. .+|+|.+..... ......+..|+.+++.++||||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 345689999999999999999999876554 799999865421 223455778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999998764 5789999999999999999999999999999999999999999999999999876542
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
..... ........++.|+|||++.+..++.++|
T Consensus 160 ~~~~~----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv 193 (268)
T cd05063 160 DPEGT----------------------------------------------YTTSGGKIPIRWTAPEAIAYRKFTSASDV 193 (268)
T ss_pred ccccc----------------------------------------------eeccCCCcCceecCHHHhhcCCcChHhHH
Confidence 21100 0000112356799999999989999999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
|++||++|+|++
T Consensus 194 ~slG~il~ell~ 205 (268)
T cd05063 194 WSFGIVMWEVMS 205 (268)
T ss_pred HHHHHHHHHHHh
Confidence 999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=251.78 Aligned_cols=193 Identities=22% Similarity=0.339 Sum_probs=166.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
...+|++++.||.|+||.||+|.+.. +..+|+|++..... .....+..|+.+++.++|+||+++++++......++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34578999999999999999999877 88999999876532 223457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 164 IMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
||||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999753 4688999999999999999999999999999999999999999999999999976542210
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
. .....++..|+|||++.+..++.++| |++
T Consensus 160 ~-------------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 190 (261)
T cd05148 160 L-------------------------------------------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSF 190 (261)
T ss_pred c-------------------------------------------------ccCCCCceEecCHHHHccCCCCchhhHHHH
Confidence 0 00223677899999999999999999 999
Q ss_pred HHHHHhhhc
Q 019953 321 SVLHFNSYR 329 (333)
Q Consensus 321 g~il~~l~t 329 (333)
|+++|+|++
T Consensus 191 G~~l~~l~~ 199 (261)
T cd05148 191 GILLYEMFT 199 (261)
T ss_pred HHHHHHHHc
Confidence 999999997
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=254.20 Aligned_cols=192 Identities=26% Similarity=0.411 Sum_probs=160.0
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCc--eEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGN--IYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 162 (333)
++|++.+.||+|+||.||+|.+..++. .+++|.++... .......+..|+.++.++ +||||+++++++...+.++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999998877664 46888876421 122335577899999999 7999999999999989999
Q ss_pred EEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEE
Q 019953 163 LIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vk 226 (333)
+||||+++++|.+++.... .++...+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999986532 478889999999999999999999999999999999999999999
Q ss_pred EEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccc
Q 019953 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (333)
Q Consensus 227 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~ 306 (333)
|+|||++........ ......+..|+|||+
T Consensus 160 l~dfg~~~~~~~~~~--------------------------------------------------~~~~~~~~~y~aPE~ 189 (297)
T cd05089 160 IADFGLSRGEEVYVK--------------------------------------------------KTMGRLPVRWMAIES 189 (297)
T ss_pred ECCcCCCccccceec--------------------------------------------------cCCCCcCccccCchh
Confidence 999999864321100 001123557999999
Q ss_pred ccCCCCCcccc-hHHHHHHHhhhc
Q 019953 307 LLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 307 ~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+.+..++.++| ||+||++|+|++
T Consensus 190 ~~~~~~~~~~DvwSlG~il~el~t 213 (297)
T cd05089 190 LNYSVYTTKSDVWSFGVLLWEIVS 213 (297)
T ss_pred hccCCCCchhhHHHHHHHHHHHHc
Confidence 99999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=246.04 Aligned_cols=193 Identities=31% Similarity=0.614 Sum_probs=168.0
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+..|+.+++.++|||++++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999876432 22345668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-CcEEEEeccCcccCCCCcccc
Q 019953 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 167 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DFGla~~~~~~~~~~ 243 (333)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999999763 358999999999999999999999999999999999999855 4689999999986543210
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.....|++.|+|||.+.+..++.++| |++|+
T Consensus 158 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 189 (256)
T cd08220 158 ------------------------------------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGC 189 (256)
T ss_pred ------------------------------------------------ccccccCCcccCchhccCCCCCcccchHHHHH
Confidence 01235889999999999989999999 99999
Q ss_pred HHHhhhcc
Q 019953 323 LHFNSYRF 330 (333)
Q Consensus 323 il~~l~t~ 330 (333)
++|+|+++
T Consensus 190 ~l~~l~~~ 197 (256)
T cd08220 190 VLYELASL 197 (256)
T ss_pred HHHHHHhC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=248.42 Aligned_cols=189 Identities=26% Similarity=0.395 Sum_probs=158.7
Q ss_pred eEeeecceEEEEEEE--ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 93 IIGRGAFGEVRLCRE--KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
.||+|+||.||+|.+ ..++..||+|++..... .....+.+..|+.+++.+.|+||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 45678999999865422 2234566888999999999999999999875 4567899999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~------- 152 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY------- 152 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-------
Confidence 9999999887889999999999999999999999999999999999999999999999999998764332110
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.......+++.|+|||.+.+..++.++| ||+||++|+|++
T Consensus 153 ---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 193 (257)
T cd05116 153 ---------------------------------------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193 (257)
T ss_pred ---------------------------------------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence 0000123567999999998889999999 999999999997
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.39 Aligned_cols=200 Identities=31% Similarity=0.494 Sum_probs=175.4
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
-+++-...||.|.||.||-|.+..+|...|+|-+...... ......+..|..++..++|||+|++||+-.+.+.++|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4567778999999999999999999999999998776544 344556788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|||++|+|.+.+...+..++...+.+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+..+....
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~-- 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM-- 1391 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC--
Confidence 999999999999988889999999999999999999999999999999999999999999999999999886542111
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CCCCcccc-hHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECD-WLVS 321 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~D-ws~g 321 (333)
++ ++ ....|||.|||||++.| .+...+.| ||+|
T Consensus 1392 ----------------~~----------------el-----------~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslG 1428 (1509)
T KOG4645|consen 1392 ----------------PG----------------EL-----------QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLG 1428 (1509)
T ss_pred ----------------CH----------------HH-----------HhhcCCchhcCchhhcccccCCCCcchhhhccc
Confidence 00 11 14579999999999975 56788999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|+..+|.|+.
T Consensus 1429 CVVlEM~tGk 1438 (1509)
T KOG4645|consen 1429 CVVLEMATGK 1438 (1509)
T ss_pred ceEEEeecCC
Confidence 9999999874
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=245.60 Aligned_cols=195 Identities=30% Similarity=0.578 Sum_probs=169.4
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++.+.||+|+||.||.+.+..+|+.||+|.+...... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998754322 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--- 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence 99999999988654 3578999999999999999999999999999999999999999999999999886542210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
......|++.|+|||++.+..++.++| |++||+
T Consensus 157 ----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i 190 (256)
T cd08218 157 ----------------------------------------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCV 190 (256)
T ss_pred ----------------------------------------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHH
Confidence 001235889999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 ~~~l~~g~ 198 (256)
T cd08218 191 LYEMCTLK 198 (256)
T ss_pred HHHHHcCC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=246.55 Aligned_cols=195 Identities=29% Similarity=0.505 Sum_probs=173.2
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|++|.||+|.+..+++.|++|++...... .....+..|+..+..++|+|++++++.+...+..++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4689999999999999999999999999999998765321 34466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+++++|.+++.....+++.....++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 999999999999888889999999999999999999999 99999999999999999999999999998866432210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....++..|+|||.+.+..++.++| |++|++
T Consensus 157 -----------------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i 189 (264)
T cd06623 157 -----------------------------------------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189 (264)
T ss_pred -----------------------------------------------ccceeecccccCHhhhCCCCCCchhhHHHHHHH
Confidence 01235888999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+|+.
T Consensus 190 l~~l~tg~ 197 (264)
T cd06623 190 LLECALGK 197 (264)
T ss_pred HHHHHhCC
Confidence 99999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=250.71 Aligned_cols=193 Identities=30% Similarity=0.515 Sum_probs=168.5
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|+..+.||.|+||.||.|.+..++..||+|++..... ......+.+|+.+++.+.|+||+++++.+..++..++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 57788899999999999999998999999999875422 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|.+++.. .++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-----
Confidence 9999999998864 5688999999999999999999999999999999999999999999999999876542210
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
......++..|+|||++.+..++.++| |++||++|
T Consensus 157 --------------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~ 192 (277)
T cd06640 157 --------------------------------------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAI 192 (277)
T ss_pred --------------------------------------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHH
Confidence 001235888999999999999999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 193 el~tg~ 198 (277)
T cd06640 193 ELAKGE 198 (277)
T ss_pred HHHHCC
Confidence 999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=249.89 Aligned_cols=196 Identities=22% Similarity=0.325 Sum_probs=165.2
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCc----eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
..++|++.+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.+.||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 34679999999999999999999876665 589998865432 2344567889999999999999999998876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++.+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 789999999999999999764 4689999999999999999999999999999999999999999999999999987653
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
..... ......++..|+|||.+.+..++.++|
T Consensus 162 ~~~~~-----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di 194 (279)
T cd05057 162 DEKEY-----------------------------------------------HAEGGKVPIKWMALESILHRIYTHKSDV 194 (279)
T ss_pred cccce-----------------------------------------------ecCCCcccccccCHHHhhcCCcCchhhH
Confidence 22100 000112456899999999899999999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
|++|+++|++++
T Consensus 195 ~slG~~l~el~~ 206 (279)
T cd05057 195 WSYGVTVWELMT 206 (279)
T ss_pred HHHHHHHHHHhc
Confidence 999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=248.94 Aligned_cols=185 Identities=32% Similarity=0.542 Sum_probs=157.9
Q ss_pred CCceEeeeE--eeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEE
Q 019953 86 DDFELLTII--GRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 86 ~~y~~~~~l--g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 162 (333)
++|.+.+.+ |+|+||.||++.+..++..+|+|.+........ |......+ +||||+++++.+...+..+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 355666555 999999999999999999999999875432111 22222222 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-cEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~~~~~~ 241 (333)
+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 164 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS- 164 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence 9999999999999998877899999999999999999999999999999999999999998 99999999987653221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
...|++.|+|||++.+..++.++| ||+
T Consensus 165 ----------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 192 (267)
T PHA03390 165 ----------------------------------------------------CYDGTLDYFSPEKIKGHNYDVSFDWWAV 192 (267)
T ss_pred ----------------------------------------------------cCCCCCcccChhhhcCCCCCchhhHHHH
Confidence 235889999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 193 G~il~~l~~g~ 203 (267)
T PHA03390 193 GVLTYELLTGK 203 (267)
T ss_pred HHHHHHHHHCC
Confidence 99999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=255.93 Aligned_cols=195 Identities=24% Similarity=0.402 Sum_probs=169.2
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC--C----ceeEEEE
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--H----CIVKLYY 153 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv~~~~ 153 (333)
......++|.++..+|+|.||+|..|.|..++..||||+++.-. ...+..+-|+.+|.++.+ | -++.+.+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 34455789999999999999999999999999999999997653 234556779999999943 3 3778888
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc----------
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---------- 221 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---------- 221 (333)
+|.-.++.|+|+|.+ |.|+.+++..++ +++...++.++.|++.++.|||+.+++|.||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 899999999999998 779999998764 7999999999999999999999999999999999999832
Q ss_pred ----------CCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcc
Q 019953 222 ----------NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291 (333)
Q Consensus 222 ----------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (333)
+..++|+|||.|......+.
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-------------------------------------------------- 267 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHHS-------------------------------------------------- 267 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCcc--------------------------------------------------
Confidence 23589999999987654442
Q ss_pred ccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 292 AFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 292 ~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+.+.|..|+|||+++|-+++..|| ||.||||+++||+.
T Consensus 268 --~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 268 --TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred --eeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 567999999999999999999999 99999999999986
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=249.54 Aligned_cols=193 Identities=27% Similarity=0.462 Sum_probs=158.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHH-HHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
++|++.+.||+|+||.||+|.+..+|+.||||.+...... ... ..+..|.. .++.+.||||+++++++..++.+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 4799999999999999999999999999999998754221 112 22334554 46677899999999999999999999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 165 MEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
|||++ ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99995 678777643 34689999999999999999999997 9999999999999999999999999998765321
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC----CCCCcc
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK----KGYGME 315 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~ 315 (333)
.. .....|+..|+|||++.+ ..++.+
T Consensus 158 ~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 187 (283)
T cd06617 158 VA--------------------------------------------------KTIDAGCKPYMAPERINPELNQKGYDVK 187 (283)
T ss_pred cc--------------------------------------------------cccccCCccccChhhcCCcccccccCcc
Confidence 10 002358889999999865 557899
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| |++||++|+|+++.
T Consensus 188 ~Di~slG~~l~~l~~g~ 204 (283)
T cd06617 188 SDVWSLGITMIELATGR 204 (283)
T ss_pred ccchhhHHHHHHHHhCC
Confidence 99 99999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=252.67 Aligned_cols=198 Identities=24% Similarity=0.394 Sum_probs=164.9
Q ss_pred cCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..++|++.+.||+|+||.||+|.+. .++..||+|++..... ......+.+|+.+++.+.||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4578999999999999999999874 3678899999875421 22345577899999999999999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCc
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRED----------------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDN 216 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~N 216 (333)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 89999999999999999986432 36777888999999999999999999999999999
Q ss_pred EEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccC
Q 019953 217 LLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (333)
Q Consensus 217 ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (333)
|+++.++.++|+|||++..+....... ......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~ 193 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYK-----------------------------------------------ASENDA 193 (288)
T ss_pred eEecCCCceEECccccceecccCcccc-----------------------------------------------ccCCCc
Confidence 999999999999999987653221100 000123
Q ss_pred CCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 297 GTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 297 gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
++..|+|||++.+..++.++| ||+||++|+|+++
T Consensus 194 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~ 228 (288)
T cd05050 194 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 228 (288)
T ss_pred cChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhC
Confidence 466799999999999999999 9999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=247.04 Aligned_cols=194 Identities=27% Similarity=0.419 Sum_probs=164.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.+..++|++++.||+|+||.||+|.+ .+++.||+|.+..... ....+.+|+.+++.++|+||+++++++. ....
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 45667899999999999999999985 4578899999875432 2345778999999999999999998874 4568
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
+++|||+.+++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999999998653 36888999999999999999999999999999999999999999999999998765422
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... .....++..|+|||++.+..++.++| |
T Consensus 156 ~~~~------------------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~ 187 (260)
T cd05067 156 EYTA------------------------------------------------REGAKFPIKWTAPEAINYGTFTIKSDVW 187 (260)
T ss_pred Cccc------------------------------------------------ccCCcccccccCHHHhccCCcCcccchH
Confidence 1100 00224677899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|++
T Consensus 188 slG~~l~el~~ 198 (260)
T cd05067 188 SFGILLTEIVT 198 (260)
T ss_pred HHHHHHHHHHh
Confidence 99999999997
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=245.72 Aligned_cols=189 Identities=23% Similarity=0.385 Sum_probs=158.8
Q ss_pred eeEeeecceEEEEEEEecCC---ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEecc
Q 019953 92 TIIGRGAFGEVRLCREKKSG---NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (333)
+.||+|+||.||+|.+..++ ..||+|.+...... .....+..|+.+++.+.|+||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46899999999999876544 78999998765432 33456788999999999999999999876 45689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccc
Q 019953 169 PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248 (333)
Q Consensus 169 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 248 (333)
++++|.+++.....+++..+..++.|++.||.|||..+++|+||||+||+++.++.++|+|||+++.+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~----- 152 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY----- 152 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-----
Confidence 999999999887789999999999999999999999999999999999999999999999999988664322100
Q ss_pred ccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhh
Q 019953 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNS 327 (333)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l 327 (333)
.......++..|+|||.+.+..++.++| |++|+++|+|
T Consensus 153 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~ 191 (257)
T cd05060 153 -----------------------------------------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEA 191 (257)
T ss_pred -----------------------------------------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHH
Confidence 0000112456899999999999999999 9999999999
Q ss_pred hc
Q 019953 328 YR 329 (333)
Q Consensus 328 ~t 329 (333)
++
T Consensus 192 ~~ 193 (257)
T cd05060 192 FS 193 (257)
T ss_pred Hc
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=264.74 Aligned_cols=193 Identities=32% Similarity=0.512 Sum_probs=168.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhH-----HHHHHHHHHHHHhc---CCceeEEEEEEe
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQV-----EHVRAERNLLAEVA---SHCIVKLYYSFQ 156 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~e~~~l~~l~---h~~iv~~~~~~~ 156 (333)
..+|..++.+|+|+||+|++|.++.+...|+||.+.+....-...+ ..+-.|+.||..++ |+||++++++|.
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4569999999999999999999999999999999987643222221 12456999999997 999999999999
Q ss_pred eCCeEEEEEecc-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYL-PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
+++++||+||-. +|-+|.+++..+..+++..++.|+.|++-|+++||++||||||||-+||+++.+|.+||+|||.+..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999986 4679999999999999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Cc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GM 314 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ 314 (333)
...+.. ..++||.+|.|||++.|.+| +.
T Consensus 720 ~ksgpf---------------------------------------------------d~f~gtv~~aapevl~g~~y~gk 748 (772)
T KOG1152|consen 720 TKSGPF---------------------------------------------------DVFVGTVDYAAPEVLGGEKYLGK 748 (772)
T ss_pred hcCCCc---------------------------------------------------ceeeeeccccchhhhCCCccCCC
Confidence 654432 26789999999999999988 55
Q ss_pred ccc-hHHHHHHHhhh
Q 019953 315 ECD-WLVSVLHFNSY 328 (333)
Q Consensus 315 ~~D-ws~g~il~~l~ 328 (333)
.-| |++|+++|.+.
T Consensus 749 ~qdiwalgillytiv 763 (772)
T KOG1152|consen 749 PQDIWALGILLYTIV 763 (772)
T ss_pred cchhhhhhheeeEEE
Confidence 678 99999999764
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=251.27 Aligned_cols=194 Identities=25% Similarity=0.361 Sum_probs=161.5
Q ss_pred CceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.+.||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 235689998865432 22345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcE
Q 019953 162 YLIMEYLPGGDMMTLLMRE------------------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Ni 217 (333)
++||||+.+++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988542 2477888899999999999999999999999999999
Q ss_pred EEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC
Q 019953 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (333)
Q Consensus 218 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 297 (333)
+++.++.++|+|||++.......... ......+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~ 191 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYV-----------------------------------------------KRSKGRI 191 (290)
T ss_pred EEcCCCcEEeccccccccccCccchh-----------------------------------------------cccCCCC
Confidence 99999999999999988653221100 0002235
Q ss_pred CCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 298 TPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 298 t~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+..|+|||++.+..++.++| |++|+++|+|+|
T Consensus 192 ~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t 224 (290)
T cd05045 192 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224 (290)
T ss_pred CccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence 67899999999999999999 999999999997
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=284.16 Aligned_cols=212 Identities=29% Similarity=0.438 Sum_probs=164.7
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-------
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------- 157 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 157 (333)
..+|+.+..||+||||.||+++++-+|+.||||.|+... .......+.+|+.+|.+++|||||++|..+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 457889999999999999999999999999999998765 33344568889999999999999999865500
Q ss_pred --------------------------------------------------------------------------------
Q 019953 158 -------------------------------------------------------------------------------- 157 (333)
Q Consensus 158 -------------------------------------------------------------------------------- 157 (333)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEeccCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 019953 158 ------------------------T--------EYLYLIMEYLPGGDMMTLLMREDTL-TENVARFYIAQSVLAIESIHK 204 (333)
Q Consensus 158 ------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~qi~~~L~~LH~ 204 (333)
. ..+||-||||+...+.+++..+... ....++++++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1368999999988888888766544 477888999999999999999
Q ss_pred CCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHH
Q 019953 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHW 284 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (333)
+|||||||||.||+++.++.|||+|||+|........... .......+.. ++
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d--~~~~~~~~~~---------------g~----------- 767 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESID--QDLSFSTNRA---------------GS----------- 767 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHh--hccCcccccc---------------CC-----------
Confidence 9999999999999999999999999999987331110000 0000000000 00
Q ss_pred HhhhhccccccCCCCCCcccccccCCC---CCcccc-hHHHHHHHhhhc
Q 019953 285 QMNRRKLAFSTVGTPDYIAPEVLLKKG---YGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 285 ~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~~D-ws~g~il~~l~t 329 (333)
...-.++.+||..|+|||++.+.. |+.|+| ||+|+++|+|+-
T Consensus 768 ---~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 768 ---NDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ---CCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence 001123668999999999998755 999999 999999999974
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=247.32 Aligned_cols=181 Identities=19% Similarity=0.252 Sum_probs=155.6
Q ss_pred eeEeeecceEEEEEEEecCC----------ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 92 TIIGRGAFGEVRLCREKKSG----------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999987766 35788877644321 4567789999999999999999999887 778
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-------cEEEEeccCc
Q 019953 162 YLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-------HMKLSDFGLC 233 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-------~vkl~DFGla 233 (333)
++||||+++++|.+++.... .++...+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999997755 789999999999999999999999999999999999999887 7999999998
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC--C
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--G 311 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~ 311 (333)
....... ...++..|+|||++.+. .
T Consensus 156 ~~~~~~~-----------------------------------------------------~~~~~~~y~aPE~~~~~~~~ 182 (259)
T cd05037 156 ITVLSRE-----------------------------------------------------ERVERIPWIAPECIRNGQAS 182 (259)
T ss_pred ccccccc-----------------------------------------------------ccccCCCccChhhhcCCCCC
Confidence 8653211 23477889999999876 7
Q ss_pred CCcccc-hHHHHHHHhhhcc
Q 019953 312 YGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~ 330 (333)
++.++| |++|+++|+|+++
T Consensus 183 ~~~~~Di~slG~~~~~l~~~ 202 (259)
T cd05037 183 LTIAADKWSFGTTLLEICSN 202 (259)
T ss_pred cchhhHHHHHHHHHHHHHhC
Confidence 899999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=247.27 Aligned_cols=200 Identities=30% Similarity=0.522 Sum_probs=166.8
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEee
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD 157 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 157 (333)
.......++|.+.+.||+|+||.||+|.+..+++.+|+|++..... ....+..|+.+++.+ +|||++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4444567899999999999999999999999999999999865321 223466788899988 89999999998865
Q ss_pred C-----CeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEE
Q 019953 158 T-----EYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228 (333)
Q Consensus 158 ~-----~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~ 228 (333)
. ...++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 368999999999999988753 4578999999999999999999999999999999999999999999999
Q ss_pred eccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc
Q 019953 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308 (333)
Q Consensus 229 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~ 308 (333)
|||++..+...... .....|+..|+|||++.
T Consensus 171 dfg~~~~~~~~~~~-------------------------------------------------~~~~~~~~~y~aPE~~~ 201 (291)
T cd06639 171 DFGVSAQLTSTRLR-------------------------------------------------RNTSVGTPFWMAPEVIA 201 (291)
T ss_pred ecccchhccccccc-------------------------------------------------ccCccCCccccChhhhc
Confidence 99998865432110 01235889999999986
Q ss_pred CC-----CCCcccc-hHHHHHHHhhhccc
Q 019953 309 KK-----GYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 309 ~~-----~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+. .++.++| |++||++|+|+++.
T Consensus 202 ~~~~~~~~~~~~~Di~slGvi~~el~~g~ 230 (291)
T cd06639 202 CEQQYDYSYDARCDVWSLGITAIELGDGD 230 (291)
T ss_pred CCCCcccccCCccchHHHHHHHHHHhhCC
Confidence 43 3789999 99999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=249.08 Aligned_cols=197 Identities=40% Similarity=0.688 Sum_probs=167.5
Q ss_pred CceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHhh-hhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeE
Q 019953 87 DFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 161 (333)
+|++.+.||.|+||.||.|.+. .+|..||+|++....... ....+.+..|+.++..+ +|++|+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 478999999987643322 22345577899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999886532211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCcccc-h
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD-W 318 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~D-w 318 (333)
. ......|+..|+|||.+.+ ..++.++| |
T Consensus 161 ~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~ 192 (290)
T cd05613 161 E------------------------------------------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWW 192 (290)
T ss_pred c------------------------------------------------ccccccCCcccCChhhccCCCCCCCccccHH
Confidence 0 0113468899999999975 35788999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
++|+++|+|+++.
T Consensus 193 slG~~l~~ll~g~ 205 (290)
T cd05613 193 SMGVLMYELLTGA 205 (290)
T ss_pred HHHHHHHHHhcCC
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=248.59 Aligned_cols=194 Identities=21% Similarity=0.336 Sum_probs=158.4
Q ss_pred ceEeeeEeeecceEEEEEEEecCCc--eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee------CC
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGN--IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------TE 159 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 159 (333)
|.+.+.||+|+||.||+|.+..++. .||+|.+..... .......+..|..+++.++|+||+++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3467899999999999999877665 689998865421 23345667889999999999999999987632 12
Q ss_pred eEEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCc
Q 019953 160 YLYLIMEYLPGGDMMTLLMR------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
..+++|||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 47899999999999988742 234789999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
+.+....... ......+++.|+|||++.+..++
T Consensus 160 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~ 192 (272)
T cd05075 160 KKIYNGDYYR-----------------------------------------------QGRIAKMPVKWIAIESLADRVYT 192 (272)
T ss_pred cccCccccee-----------------------------------------------cCCcccCCcccCCHHHccCCCcC
Confidence 8764322100 00022467789999999999999
Q ss_pred cccc-hHHHHHHHhhhc
Q 019953 314 MECD-WLVSVLHFNSYR 329 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t 329 (333)
.++| |++|+++|+|++
T Consensus 193 ~~~Di~slG~il~el~~ 209 (272)
T cd05075 193 TKSDVWSFGVTMWEIAT 209 (272)
T ss_pred hHHHHHHHHHHHHHHHc
Confidence 9999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=253.75 Aligned_cols=198 Identities=26% Similarity=0.421 Sum_probs=163.4
Q ss_pred CceEeeeEeeecceEEEEEEEec--CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--CeEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLY 162 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 162 (333)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.............+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999764322223335567799999999999999999999888 7899
Q ss_pred EEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc----CCcEEEEeccCc
Q 019953 163 LIMEYLPGGDMMTLLMRE-----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK----NGHMKLSDFGLC 233 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~----~~~vkl~DFGla 233 (333)
+||||+++ ++.+.+... ..+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 677666432 36889999999999999999999999999999999999999 899999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGY 312 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~ 312 (333)
..+....... .......+++.|+|||++.+ ..+
T Consensus 160 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 193 (316)
T cd07842 160 RLFNAPLKPL----------------------------------------------ADLDPVVVTIWYRAPELLLGARHY 193 (316)
T ss_pred cccCCCcccc----------------------------------------------cccCCccccccccCHHHHhCCCCC
Confidence 8764322100 00013368899999999876 458
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| |++||++|+|+++.
T Consensus 194 ~~~~Dv~slG~~l~~l~~~~ 213 (316)
T cd07842 194 TKAIDIWAIGCIFAELLTLE 213 (316)
T ss_pred CcHHHHHHHHHHHHHHHhcC
Confidence 99999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=253.16 Aligned_cols=195 Identities=18% Similarity=0.287 Sum_probs=162.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCc----eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
.++|+..+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.+.||||+++++.+... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4678999999999999999999877776 478888865422 22234577899999999999999999988654 4
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 679999999999999987643 6889999999999999999999999999999999999999999999999999865422
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... ......++..|+|||++.+..++.++| |
T Consensus 163 ~~~~-----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Diw 195 (303)
T cd05110 163 EKEY-----------------------------------------------NADGGKMPIKWMALECIHYRKFTHQSDVW 195 (303)
T ss_pred cccc-----------------------------------------------ccCCCccccccCCHHHhccCCCChHHHHH
Confidence 1100 000224677899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
|+|+++|+|++
T Consensus 196 slG~~l~el~t 206 (303)
T cd05110 196 SYGVTIWELMT 206 (303)
T ss_pred HHHHHHHHHHh
Confidence 99999999987
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=244.82 Aligned_cols=199 Identities=31% Similarity=0.477 Sum_probs=172.5
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++.+.||+|+||.||+|.+..++..||+|.+...... ......+..|+.+++.++|+||+++++.+...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 588999999999999999999889999999998765432 3456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~-- 157 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG-- 157 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc--
Confidence 999999999998877789999999999999999999999999999999999999999999999999887653321100
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC---CCcccc-hHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG---YGMECD-WLVSV 322 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~~D-ws~g~ 322 (333)
.......+++.|+|||++.+.. ++.++| |++|+
T Consensus 158 -------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~ 194 (264)
T cd06626 158 -------------------------------------------EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC 194 (264)
T ss_pred -------------------------------------------ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHH
Confidence 0001235788999999998766 899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 195 il~~l~~g~ 203 (264)
T cd06626 195 VVLEMATGK 203 (264)
T ss_pred HHHHHHhCC
Confidence 999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=269.81 Aligned_cols=189 Identities=29% Similarity=0.505 Sum_probs=166.0
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 171 (333)
-+||+|.||+||-|+|..+....|||-+..... ....-+..|+.+-+.++|.|||+++|++..++++-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 379999999999999999999999999976532 34455788999999999999999999999999999999999999
Q ss_pred CHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc-cCCcEEEEeccCcccCCCCcccccccc
Q 019953 172 DMMTLLMRE-DTL--TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEH 247 (333)
Q Consensus 172 ~L~~~l~~~-~~~--~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~-~~~~vkl~DFGla~~~~~~~~~~~~~~ 247 (333)
+|.+++... +++ .+..+.++..||++||.|||.+.|||||||-+||||+ -.|.+||+|||.++.+..-.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------- 730 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------- 730 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-------
Confidence 999999875 566 8889999999999999999999999999999999997 56899999999998764211
Q ss_pred cccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC--CCCcccc-hHHHHHH
Q 019953 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--GYGMECD-WLVSVLH 324 (333)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~~D-ws~g~il 324 (333)
..+.++.||..|||||++..+ +|+.++| ||+||.+
T Consensus 731 ------------------------------------------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~ 768 (1226)
T KOG4279|consen 731 ------------------------------------------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTM 768 (1226)
T ss_pred ------------------------------------------ccccccccchhhhChHhhccCCcCCCchhhhhhcccee
Confidence 223367899999999999754 5999999 9999999
Q ss_pred Hhhhcccc
Q 019953 325 FNSYRFLE 332 (333)
Q Consensus 325 ~~l~t~~~ 332 (333)
-+|-|+.|
T Consensus 769 vEMATGrP 776 (1226)
T KOG4279|consen 769 VEMATGRP 776 (1226)
T ss_pred EeeccCCC
Confidence 99999865
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=248.15 Aligned_cols=188 Identities=20% Similarity=0.288 Sum_probs=151.8
Q ss_pred eEeeecceEEEEEEEec--CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 93 IIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+......++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999996432 44578888875432 122345577899999999999999999999999999999999999
Q ss_pred CCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 171 GDMMTLLMRED-----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 171 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|+|.+++.... ..++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-- 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI-- 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee--
Confidence 99999997643 24577788999999999999999999999999999999999999999999987543221100
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-------CCCCCcccc-
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-------KKGYGMECD- 317 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~~~~~D- 317 (333)
......+++.|+|||++. +..++.++|
T Consensus 158 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di 192 (269)
T cd05042 158 ---------------------------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNI 192 (269)
T ss_pred ---------------------------------------------ccCCCCCcccccCHHHHhhccccccccccchhhHH
Confidence 001234677899999974 345788999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
|++||++|+|++
T Consensus 193 wslG~~l~el~~ 204 (269)
T cd05042 193 WSLGVTMWELFT 204 (269)
T ss_pred HHHHHHHHHHHh
Confidence 999999999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=252.82 Aligned_cols=193 Identities=31% Similarity=0.530 Sum_probs=167.4
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|+..+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 46677889999999999999988999999999875432 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---- 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---- 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh----
Confidence 9999999988854 56899999999999999999999999999999999999999999999999998765422100
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
.....|+..|+|||++.+..++.++| |++|+++|
T Consensus 158 ---------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 192 (277)
T cd06642 158 ---------------------------------------------RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAI 192 (277)
T ss_pred ---------------------------------------------hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHH
Confidence 01235889999999999999999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 193 el~tg~ 198 (277)
T cd06642 193 ELAKGE 198 (277)
T ss_pred HHHhCC
Confidence 999875
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=244.98 Aligned_cols=188 Identities=24% Similarity=0.387 Sum_probs=155.5
Q ss_pred eEeeecceEEEEEEEe--cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 93 IIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++|+||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999765 345679999986542 22334568889999999999999999998764 568999999999
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccc
Q 019953 171 GDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (333)
Q Consensus 171 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 249 (333)
++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~----- 153 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----- 153 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee-----
Confidence 999999875 45789999999999999999999999999999999999999999999999999986543221000
Q ss_pred cCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhh
Q 019953 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSY 328 (333)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~ 328 (333)
......+++.|+|||++.+..++.++| |++||++|+|+
T Consensus 154 -----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05115 154 -----------------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192 (257)
T ss_pred -----------------------------------------ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHh
Confidence 000112467899999999889999999 99999999998
Q ss_pred c
Q 019953 329 R 329 (333)
Q Consensus 329 t 329 (333)
+
T Consensus 193 ~ 193 (257)
T cd05115 193 S 193 (257)
T ss_pred c
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=249.92 Aligned_cols=217 Identities=37% Similarity=0.658 Sum_probs=176.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 164 (333)
++|.+.+.||+|+||.||+|.+..+++.||+|++.............+..|..+++.+. |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999997654433344466788999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||++++++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999987653321100
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
... ..+ ....... ..........|+..|+|||++.+..++.++| |++|++
T Consensus 161 ~~~--------------~~~---~~~~~~~------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~ 211 (280)
T cd05581 161 NKG--------------DAT---NIDSQIE------------KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCI 211 (280)
T ss_pred CCC--------------CCc---ccccccc------------ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHH
Confidence 000 000 0000000 0011122456899999999999988999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+++++.
T Consensus 212 l~~l~~g~ 219 (280)
T cd05581 212 IYQMLTGK 219 (280)
T ss_pred HHHHHhCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=251.12 Aligned_cols=196 Identities=29% Similarity=0.442 Sum_probs=165.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--CeEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLYL 163 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 163 (333)
++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 5789999999999999999999999999999999754322 22233456799999999999999999998877 88999
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 164 IMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
||||++ ++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 161 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK- 161 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-
Confidence 999996 5898888664 3589999999999999999999999999999999999999999999999999886643210
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLV 320 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~ 320 (333)
......+++.|+|||++.+. .++.++| |++
T Consensus 162 ------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 193 (293)
T cd07843 162 ------------------------------------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193 (293)
T ss_pred ------------------------------------------------ccccccccccccCchhhcCCccccchhhHHHH
Confidence 00123578899999998764 4689999 999
Q ss_pred HHHHHhhhcccc
Q 019953 321 SVLHFNSYRFLE 332 (333)
Q Consensus 321 g~il~~l~t~~~ 332 (333)
|+++|+|+++.+
T Consensus 194 G~~l~~l~~g~~ 205 (293)
T cd07843 194 GCIFAELLTKKP 205 (293)
T ss_pred HHHHHHHHhCCC
Confidence 999999998753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=247.80 Aligned_cols=195 Identities=29% Similarity=0.516 Sum_probs=164.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEee-----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD----- 157 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----- 157 (333)
..+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4578999999999999999999999999999999986542 2234467788888888 69999999998853
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 158 -TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 158 -~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
...++++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 45789999999999999998653 458888899999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----C
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----K 309 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~ 309 (333)
....... ......|++.|+|||++. +
T Consensus 170 ~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~l~~~~~~~ 200 (282)
T cd06636 170 QLDRTVG-------------------------------------------------RRNTFIGTPYWMAPEVIACDENPD 200 (282)
T ss_pred hhhcccc-------------------------------------------------CCCcccccccccCHhhcCcccCcC
Confidence 5432110 011346899999999986 4
Q ss_pred CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| |++||++|+|+++.
T Consensus 201 ~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 201 ATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred cCCCcccchhHHHHHHHHHHhCC
Confidence 56899999 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=249.72 Aligned_cols=193 Identities=28% Similarity=0.478 Sum_probs=169.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+.||||+++++.+...+..++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 367888999999999999999999999999999876532 233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 166 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+..+....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999776 789999999999999999999999 999999999999999999999999999987543111
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.....++..|+|||.+.+..++.++| |++|+
T Consensus 156 ------------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 187 (265)
T cd06605 156 ------------------------------------------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGL 187 (265)
T ss_pred ------------------------------------------------hhcccCChhccCHHHHcCCCCCchhhHHHHHH
Confidence 00146889999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 188 ~l~~l~~g~ 196 (265)
T cd06605 188 SLIELATGR 196 (265)
T ss_pred HHHHHHhCC
Confidence 999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=249.04 Aligned_cols=183 Identities=17% Similarity=0.262 Sum_probs=154.2
Q ss_pred eeEeeecceEEEEEEEecCCc-------eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 92 TIIGRGAFGEVRLCREKKSGN-------IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
+.||+|+||.||+|.+...+. .||+|.+.... ....+.+..|..+++.+.|||++++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999998765443 48888875432 23345677799999999999999999999998899999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc--------EEEEeccCccc
Q 019953 165 MEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--------MKLSDFGLCKP 235 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~--------vkl~DFGla~~ 235 (333)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 5889999999999999999999999999999999999987764 68999998765
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGM 314 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ 314 (333)
..... ...+++.|+|||++.+ ..++.
T Consensus 158 ~~~~~-----------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~ 184 (258)
T cd05078 158 VLPKE-----------------------------------------------------ILLERIPWVPPECIENPQNLSL 184 (258)
T ss_pred cCCch-----------------------------------------------------hccccCCccCchhccCCCCCCc
Confidence 43211 2357889999999987 45899
Q ss_pred ccc-hHHHHHHHhhhcc
Q 019953 315 ECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~ 330 (333)
++| ||+|+++|+|+++
T Consensus 185 ~~DiwslG~~l~~l~~g 201 (258)
T cd05078 185 AADKWSFGTTLWEIFSG 201 (258)
T ss_pred hhhHHHHHHHHHHHHcC
Confidence 999 9999999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=246.37 Aligned_cols=193 Identities=31% Similarity=0.525 Sum_probs=167.2
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
-|++.+.||+|+||.||+|.+..++..||||.+..... ......+.+|+.++..++||||+++++.+......++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 36788899999999999999988999999998864432 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|..++.. ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-----
Confidence 9999999988854 4688999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
......|+..|+|||.+.+..++.++| |++||++|
T Consensus 157 --------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~ 192 (277)
T cd06641 157 --------------------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 192 (277)
T ss_pred --------------------------------------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHH
Confidence 001235888999999999888999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 193 ~l~~g~ 198 (277)
T cd06641 193 ELAKGE 198 (277)
T ss_pred HHHcCC
Confidence 999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=244.88 Aligned_cols=194 Identities=25% Similarity=0.378 Sum_probs=161.8
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
++..++|.+.+.||+|++|.||+|.+..+ ..+|+|.+..... ....+.+|+.+++.+.|+|++++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI 75 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence 34557899999999999999999987654 4699998765422 2245677999999999999999998875 4568
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++||||+.+++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999999999653 34788899999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
... ......++..|+|||++.+..++.++| |
T Consensus 156 ~~~------------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~ 187 (260)
T cd05069 156 EYT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (260)
T ss_pred ccc------------------------------------------------ccCCCccchhhCCHHHhccCCcChHHHHH
Confidence 210 000223667899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|+|
T Consensus 188 slG~~l~el~t 198 (260)
T cd05069 188 SFGILLTELVT 198 (260)
T ss_pred HHHHHHHHHHh
Confidence 99999999997
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=247.75 Aligned_cols=195 Identities=24% Similarity=0.431 Sum_probs=165.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
.++|+++..||.|+||.||+|.+.. +.+.|++|.+.... .......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3679999999999999999998653 35679999886532 1223456888999999999999999999999888
Q ss_pred eEEEEEeccCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEec
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED---------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DF 230 (333)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997655 6899999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 310 (333)
|++......... ......++..|+|||.+.+.
T Consensus 162 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~y~~PE~~~~~ 193 (275)
T cd05046 162 SLSKDVYNSEYY------------------------------------------------KLRNALIPLRWLAPEAVQED 193 (275)
T ss_pred ccccccCccccc------------------------------------------------ccCCceeEEeecChhhhccC
Confidence 998754221100 00123467789999999988
Q ss_pred CCCcccc-hHHHHHHHhhhc
Q 019953 311 GYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t 329 (333)
.++.++| |++|+++|+|++
T Consensus 194 ~~~~~~Di~slG~~l~~l~~ 213 (275)
T cd05046 194 DFSTKSDVWSFGVLMWEVFT 213 (275)
T ss_pred CCCchhhHHHHHHHHHHHHh
Confidence 8999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=246.38 Aligned_cols=189 Identities=22% Similarity=0.290 Sum_probs=152.7
Q ss_pred eeEeeecceEEEEEEEe--cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccC
Q 019953 92 TIIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (333)
+.||+|+||.||+|.+. .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+......++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999764 3456799998865432 1223457789999999999999999999998889999999999
Q ss_pred CCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 170 GGDMMTLLMRED-----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 170 ~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
+|+|.+++.... ..+...+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~- 157 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV- 157 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee-
Confidence 999999986432 35667778899999999999999999999999999999999999999999987533211000
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-------CCCcccc
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-------GYGMECD 317 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~~~~~D 317 (333)
......|++.|+|||++.+. .++.++|
T Consensus 158 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 191 (269)
T cd05087 158 ----------------------------------------------TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191 (269)
T ss_pred ----------------------------------------------cCCCcCCcccccCHhHhccccccccccCCCccch
Confidence 00123578899999998642 4688999
Q ss_pred -hHHHHHHHhhhc
Q 019953 318 -WLVSVLHFNSYR 329 (333)
Q Consensus 318 -ws~g~il~~l~t 329 (333)
||+|+++|+|++
T Consensus 192 iwslG~~l~el~~ 204 (269)
T cd05087 192 VWSLGVTIWELFE 204 (269)
T ss_pred hHHHHHHHHHHHh
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=255.73 Aligned_cols=197 Identities=27% Similarity=0.441 Sum_probs=163.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----C
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----E 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 159 (333)
.++|++.+.||+|+||.||+|.+..+|+.||||.+.... .......+..|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 478999999999999999999999999999999986422 122344567799999999999999999876543 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+++|+||+. ++|..++. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999995 58887774 457999999999999999999999999999999999999999999999999998865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D- 317 (333)
.... .......|++.|+|||++.+ ..++.++|
T Consensus 160 ~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 193 (336)
T cd07849 160 HDHT----------------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKAIDI 193 (336)
T ss_pred cccc----------------------------------------------CCcCCcCcCCCccChHHhhCCCCCCcHHHH
Confidence 2100 00113468999999998765 56899999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 194 wslGvil~el~~G~ 207 (336)
T cd07849 194 WSVGCILAEMLSNR 207 (336)
T ss_pred HHHHHHHHHHHhCC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=248.59 Aligned_cols=205 Identities=17% Similarity=0.150 Sum_probs=154.0
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhh--------HHHHHHHHHHHHHhcCCceeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQ--------VEHVRAERNLLAEVASHCIVKL 151 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~ 151 (333)
+..++|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..+.|++++.+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4557899999999999999999998777 6677888643221100000 0111223344556789999999
Q ss_pred EEEEeeCC----eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEE
Q 019953 152 YYSFQDTE----YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKL 227 (333)
Q Consensus 152 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl 227 (333)
++.+.... ..+++++++ ..++.+.+......++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 457888887 4567777665555788889999999999999999999999999999999999999999
Q ss_pred EeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc
Q 019953 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (333)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 307 (333)
+|||+|+.+......... .........||+.|+|||++
T Consensus 168 ~DFGla~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~ape~~ 205 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEY------------------------------------------SKEQKDLHRGTLYYAGLDAH 205 (294)
T ss_pred EEcCCceeeccCCccccc------------------------------------------ccccccccCCCccccCHHHh
Confidence 999999876432211000 00011134699999999999
Q ss_pred cCCCCCcccc-hHHHHHHHhhhcc
Q 019953 308 LKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 308 ~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.+..++.++| ||+||++|+|+++
T Consensus 206 ~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 206 NGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999 9999999999886
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=243.64 Aligned_cols=196 Identities=28% Similarity=0.434 Sum_probs=164.1
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..+++.....||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34555556789999999999999998999999998865432 234567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-CCcEEEEeccCcccCCCC
Q 019953 164 IMEYLPGGDMMTLLMRE-DTL--TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~-~~~--~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~~~ 239 (333)
|+||+++++|.+++... ..+ ++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++..+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999998764 445 78888899999999999999999999999999999986 679999999998765321
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC--CCcccc
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YGMECD 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~D 317 (333)
.. ......|++.|+|||++.+.. ++.++|
T Consensus 163 ~~-------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 193 (268)
T cd06624 163 NP-------------------------------------------------CTETFTGTLQYMAPEVIDKGPRGYGAPAD 193 (268)
T ss_pred CC-------------------------------------------------ccccCCCCccccChhhhccccccCCchhh
Confidence 10 001235889999999987643 889999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+|+++|+|+++.
T Consensus 194 v~slGvvl~~l~~g~ 208 (268)
T cd06624 194 IWSLGCTIVEMATGK 208 (268)
T ss_pred hHHHHHHHHHHHhCC
Confidence 99999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=243.93 Aligned_cols=195 Identities=35% Similarity=0.624 Sum_probs=167.6
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee--CCeEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TEYLYLI 164 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 164 (333)
+|++++.||.|+||.||+|.+..++..||+|.+..... .......+..|+.+++.++|+||+++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999865432 22334567789999999999999999987753 4568999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 165 MEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIH-----KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH-----~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
|||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 357899999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
....... .....|++.|+|||++.+..++.+
T Consensus 160 ~~~~~~~-------------------------------------------------~~~~~~~~~~~~pE~~~~~~~~~~ 190 (265)
T cd08217 160 LGHDSSF-------------------------------------------------AKTYVGTPYYMSPEQLNHMSYDEK 190 (265)
T ss_pred ccCCccc-------------------------------------------------ccccccCCCccChhhhcCCCCCch
Confidence 6432210 013368999999999999999999
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| |++|+++|+|+++.
T Consensus 191 ~Dv~slG~il~~l~~g~ 207 (265)
T cd08217 191 SDIWSLGCLIYELCALS 207 (265)
T ss_pred hHHHHHHHHHHHHHHCC
Confidence 99 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=243.34 Aligned_cols=195 Identities=25% Similarity=0.395 Sum_probs=164.5
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
|++..++|++.+.||+|+||.||++.+. .+..+|+|.+..... ....+.+|+.+++.++|+||+++++.+.. ..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP 74 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence 4566789999999999999999999754 456799998865422 23557789999999999999999999887 77
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.+++|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 89999999999999999763 3578888899999999999999999999999999999999999999999999876543
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
..... .....++..|+|||++.+..++.++|
T Consensus 155 ~~~~~------------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di 186 (260)
T cd05073 155 NEYTA------------------------------------------------REGAKFPIKWTAPEAINFGSFTIKSDV 186 (260)
T ss_pred CCccc------------------------------------------------ccCCcccccccCHhHhccCCcCccccc
Confidence 21100 00123567899999999999999999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
|++||++|+++|
T Consensus 187 ~slG~~l~~l~t 198 (260)
T cd05073 187 WSFGILLMEIVT 198 (260)
T ss_pred hHHHHHHHHHHh
Confidence 999999999997
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=246.74 Aligned_cols=193 Identities=32% Similarity=0.532 Sum_probs=165.8
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc---CCceeEEEEEEeeCCeEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 163 (333)
.|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.+. |||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4778899999999999999999999999999986532 1223455778999999986 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 9999999999998865 47899999999999999999999999999999999999999999999999998876432200
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
.....|+..|+|||.+.+ ..++.++| |++|
T Consensus 158 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 189 (277)
T cd06917 158 ------------------------------------------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLG 189 (277)
T ss_pred ------------------------------------------------cccccCCcceeCHHHhccCCccccchhHHHHH
Confidence 013368899999999865 55799999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 190 ~~l~~ll~g~ 199 (277)
T cd06917 190 ITIYEMATGN 199 (277)
T ss_pred HHHHHHHhCC
Confidence 9999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=246.51 Aligned_cols=186 Identities=26% Similarity=0.440 Sum_probs=154.6
Q ss_pred eeEeeecceEEEEEEEecCCc--eEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEecc
Q 019953 92 TIIGRGAFGEVRLCREKKSGN--IYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (333)
+.||+|+||.||+|.+..++. .+++|.+.... .......+..|+.++..+ .||||+++++++...+..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999887775 46888876421 122334577899999999 8999999999999999999999999
Q ss_pred CCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 169 PGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 169 ~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999986532 378889999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
+........ ......+..|+|||++.+..+
T Consensus 159 ~~~~~~~~~--------------------------------------------------~~~~~~~~~y~apE~~~~~~~ 188 (270)
T cd05047 159 SRGQEVYVK--------------------------------------------------KTMGRLPVRWMAIESLNYSVY 188 (270)
T ss_pred ccccchhhh--------------------------------------------------ccCCCCccccCChHHHccCCC
Confidence 763211000 001124567999999999999
Q ss_pred Ccccc-hHHHHHHHhhhc
Q 019953 313 GMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t 329 (333)
+.++| |++|+++|+|++
T Consensus 189 ~~~~Di~slG~il~el~~ 206 (270)
T cd05047 189 TTNSDVWSYGVLLWEIVS 206 (270)
T ss_pred CchhhHHHHHHHHHHHHc
Confidence 99999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=253.39 Aligned_cols=192 Identities=31% Similarity=0.502 Sum_probs=165.1
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|.....||+|+||.||+|.+..++..||+|.+..... .....+.+|+.++..+.||||+++++.+...+..++|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 34455689999999999999988999999999865322 233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|..++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..+.....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----- 172 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 172 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-----
Confidence 9999999987744 5689999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
......|++.|+|||++.+..++.++| |++||++|
T Consensus 173 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 208 (297)
T cd06659 173 --------------------------------------------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVI 208 (297)
T ss_pred --------------------------------------------cccceecCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 011346899999999999999999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 209 el~~g~ 214 (297)
T cd06659 209 EMVDGE 214 (297)
T ss_pred HHHhCC
Confidence 999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=246.31 Aligned_cols=193 Identities=30% Similarity=0.467 Sum_probs=165.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--CeEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLYL 163 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 163 (333)
++|...+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++... +.+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 478999999999999999999998999999999875422 13345678899999999999999999988643 46899
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 164 IMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887643 346889999999999999999999999999999999999999999999999998754321
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.. ....++..|+|||.+.+..++.++| |
T Consensus 159 ~~---------------------------------------------------~~~~~~~~y~~pE~~~~~~~~~~~Dv~ 187 (287)
T cd06621 159 LA---------------------------------------------------GTFTGTSFYMAPERIQGKPYSITSDVW 187 (287)
T ss_pred cc---------------------------------------------------ccccCCccccCHHHhcCCCCCchhhHH
Confidence 10 0234788999999999999999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
++|+++|+|+++.
T Consensus 188 slG~il~~l~~g~ 200 (287)
T cd06621 188 SLGLTLLEVAQNR 200 (287)
T ss_pred HHHHHHHHHHhCC
Confidence 9999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=253.28 Aligned_cols=192 Identities=29% Similarity=0.509 Sum_probs=165.2
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3445567999999999999998899999999986543 2234557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~----- 173 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP----- 173 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-----
Confidence 9999999988744 4688999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
......|++.|+|||.+.+..++.++| ||+|+++|
T Consensus 174 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~ 209 (292)
T cd06658 174 --------------------------------------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 209 (292)
T ss_pred --------------------------------------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 011346899999999999999999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 210 el~~g~ 215 (292)
T cd06658 210 EMIDGE 215 (292)
T ss_pred HHHhCC
Confidence 999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=246.78 Aligned_cols=193 Identities=28% Similarity=0.460 Sum_probs=164.1
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++.+.||.|++|.||+|.+..+|..||||.+..... ......+..|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875432 2223456679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 167 YLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 167 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9974 888887653 3689999999999999999999999999999999999999999999999999875432210
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
......+++.|+|||++.+ ..++.++| |++|
T Consensus 156 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG 188 (284)
T cd07836 156 -----------------------------------------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG 188 (284)
T ss_pred -----------------------------------------------ccccccccccccChHHhcCCCCCCcHHHHHHHH
Confidence 0012357889999999876 45789999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
+++|+|+++.
T Consensus 189 ~~l~~l~~g~ 198 (284)
T cd07836 189 CIMAEMITGR 198 (284)
T ss_pred HHHHHHHhCC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=250.83 Aligned_cols=192 Identities=29% Similarity=0.444 Sum_probs=164.3
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
..|...+.||+|+||.||+|.+..++..||+|.+.............+..|+.+++.++|+|++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778899999999999999999899999999987543333334456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+. |++.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~---- 179 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---- 179 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcc----
Confidence 9996 477777644 5578999999999999999999999999999999999999999999999999886543211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCCCcccc-hHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECD-WLV 320 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~D-ws~ 320 (333)
...|++.|+|||++. +..++.++| |++
T Consensus 180 -------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~sl 210 (317)
T cd06635 180 -------------------------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 210 (317)
T ss_pred -------------------------------------------------cccCCccccChhhhhcCCCCCCCccccHHHH
Confidence 235888999999984 456899999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 211 Gvil~el~~g~ 221 (317)
T cd06635 211 GITCIELAERK 221 (317)
T ss_pred HHHHHHHHhCC
Confidence 99999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=245.17 Aligned_cols=195 Identities=31% Similarity=0.515 Sum_probs=165.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC---
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE--- 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~--- 159 (333)
..++|++.+.||+|++|.||+|.+..+++.|++|++..... ....+..|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45789999999999999999999988899999999875432 235578899999998 7999999999986544
Q ss_pred ---eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 160 ---YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 160 ---~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
.+++||||+++++|.+++.. +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999988864 35789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--- 309 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--- 309 (333)
+........ ......|++.|+|||++.+
T Consensus 160 ~~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 190 (275)
T cd06608 160 SAQLDSTLG-------------------------------------------------RRNTFIGTPYWMAPEVIACDEQ 190 (275)
T ss_pred ceecccchh-------------------------------------------------hhcCccccccccCHhHhccccc
Confidence 876542210 0013358999999999854
Q ss_pred --CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 --KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 --~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| |++|+++|+|+++.
T Consensus 191 ~~~~~~~~~Dv~slG~il~~l~~g~ 215 (275)
T cd06608 191 PDASYDARSDVWSLGITAIELADGK 215 (275)
T ss_pred ccCCccccccHHHhHHHHHHHHhCC
Confidence 34788999 99999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=247.27 Aligned_cols=195 Identities=30% Similarity=0.472 Sum_probs=162.7
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||.|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++|+||+++++++......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999865432 1223355778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-CCcEEEEeccCcccCCCCccc
Q 019953 166 EYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~~~~~~ 242 (333)
||++ ++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++. ++.+||+|||++........
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 9995 57877775543 3578888899999999999999999999999999999985 56799999999976532110
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLV 320 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~ 320 (333)
......+++.|+|||++.+ ..++.++| |++
T Consensus 159 ------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 190 (294)
T PLN00009 159 ------------------------------------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV 190 (294)
T ss_pred ------------------------------------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHH
Confidence 0012357889999999876 46899999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+|+.
T Consensus 191 G~i~~~l~tg~ 201 (294)
T PLN00009 191 GCIFAEMVNQK 201 (294)
T ss_pred HHHHHHHHhCC
Confidence 99999999975
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=243.81 Aligned_cols=189 Identities=22% Similarity=0.365 Sum_probs=160.6
Q ss_pred eeEeeecceEEEEEEEec-CC--ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEecc
Q 019953 92 TIIGRGAFGEVRLCREKK-SG--NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (333)
+.||+|++|.||+|.+.. .+ ..||||.+...... .....+..|+.+++.++||||+++++.+.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999998865 33 36999999776432 455678889999999999999999999888 8899999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 169 PGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 169 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
++++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--- 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence 9999999997654 68899999999999999999999999999999999999999999999999998765322100
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
.......++..|+|||.+.+..++.++| |++||++|
T Consensus 155 -------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~ 191 (257)
T cd05040 155 -------------------------------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLW 191 (257)
T ss_pred -------------------------------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHH
Confidence 0000234778899999999999999999 99999999
Q ss_pred hhhc
Q 019953 326 NSYR 329 (333)
Q Consensus 326 ~l~t 329 (333)
+|++
T Consensus 192 el~t 195 (257)
T cd05040 192 EMFT 195 (257)
T ss_pred HHHh
Confidence 9987
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=246.72 Aligned_cols=198 Identities=21% Similarity=0.285 Sum_probs=165.9
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEec----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKK----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD- 157 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 157 (333)
+..++|++.+.||+|+||.||.|.+.. ++..|++|.+.... .......+.+|+.+++.+.|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999875 36889999886432 23345667889999999999999999998665
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEe
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRE--------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSD 229 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~D 229 (333)
....+++++|+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 46789999999999999998653 4588999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||+++.+........ .....++..|+|||++.+
T Consensus 161 ~g~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~y~apE~~~~ 193 (280)
T cd05043 161 NALSRDLFPMDYHCL-----------------------------------------------GDNENRPVKWMALESLVN 193 (280)
T ss_pred CCCcccccCCceEEe-----------------------------------------------CCCCCcchhccCHHHHhc
Confidence 999986643321100 002236778999999999
Q ss_pred CCCCcccc-hHHHHHHHhhhc
Q 019953 310 KGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t 329 (333)
..++.++| |++|+++|++++
T Consensus 194 ~~~~~~~Di~slG~~l~el~~ 214 (280)
T cd05043 194 KEYSSASDVWSFGVLLWELMT 214 (280)
T ss_pred CCCCchhhHHHhHHHHHHHhc
Confidence 99999999 999999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=248.61 Aligned_cols=195 Identities=29% Similarity=0.485 Sum_probs=169.1
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|.+.+.||+|+||.||++.+..++..||+|.+.... ....+.+..|+.+++.++|||++++++.+...+..++
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 3478999999999999999999988889999999986432 2233557789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|+||+++++|.+++... .++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence 99999999999998653 5788899999999999999999999999999999999999999999999988755422110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.....|++.|+|||.+.+..++.++| |++|+
T Consensus 172 ------------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 203 (293)
T cd06647 172 ------------------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203 (293)
T ss_pred ------------------------------------------------cccccCChhhcCchhhccCCCCchhhHHHHHH
Confidence 01235889999999999888999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 204 ll~~ll~g~ 212 (293)
T cd06647 204 MAIEMVEGE 212 (293)
T ss_pred HHHHHHhCC
Confidence 999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=261.49 Aligned_cols=198 Identities=23% Similarity=0.370 Sum_probs=170.5
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..+...+.++||+|-||.|.+|+- ..+..||+|.++.... ......+.+|+.+|.+|+||||+.++|+|..++.++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 3446677899999999999999984 3468999999987642 334577999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 163 LIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+++||+++|+|.+++..+. .........++.|++.|++||.+.++|||||.+.|+|++.++++||+|||+++.+.+..
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999999998763 33445556699999999999999999999999999999999999999999999887666
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
++.+. ...+-+..|||||.+.-+.+|.++| |+
T Consensus 692 yy~vq-----------------------------------------------gr~vlpiRwmawEsillgkFttaSDvWa 724 (807)
T KOG1094|consen 692 YYRVQ-----------------------------------------------GRAVLPIRWMAWESILLGKFTTASDVWA 724 (807)
T ss_pred ceeee-----------------------------------------------cceeeeeeehhHHHHHhccccchhhhhh
Confidence 54321 0235678999999999999999999 99
Q ss_pred HHHHHHhhhcc
Q 019953 320 VSVLHFNSYRF 330 (333)
Q Consensus 320 ~g~il~~l~t~ 330 (333)
+|+.+|+++++
T Consensus 725 fgvTlwE~~~~ 735 (807)
T KOG1094|consen 725 FGVTLWEVFML 735 (807)
T ss_pred hHHHHHHHHHH
Confidence 99999998764
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=242.66 Aligned_cols=192 Identities=29% Similarity=0.424 Sum_probs=165.4
Q ss_pred ceEeeeEeeecceEEEEEEEecCC----ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSG----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
+++.+.||.|+||.||+|.+...+ ..||+|++..... ......+..|+.++..++|+||+++++.+...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999988766 8999999965532 1245668889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 164 IMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+|||+++++|.+++..... +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 89999999999999999999999999999999999999999999999999887653321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.. .....+++.|+|||.+.+..++.++| |++
T Consensus 159 ~~------------------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 190 (258)
T smart00219 159 YK------------------------------------------------KKGGKLPIRWMAPESLKDGKFTSKSDVWSF 190 (258)
T ss_pred cc------------------------------------------------cccCCCcccccChHHhccCCCCcchhHHHH
Confidence 10 00112678999999998888999999 999
Q ss_pred HHHHHhhhc
Q 019953 321 SVLHFNSYR 329 (333)
Q Consensus 321 g~il~~l~t 329 (333)
|+++|+|++
T Consensus 191 G~i~~~l~~ 199 (258)
T smart00219 191 GVLLWEIFT 199 (258)
T ss_pred HHHHHHHHh
Confidence 999999987
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=249.53 Aligned_cols=201 Identities=29% Similarity=0.412 Sum_probs=163.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC-----
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 159 (333)
.++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4679999999999999999999999999999998864322 1122234567999999999999999999876543
Q ss_pred ---eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 160 ---YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 160 ---~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
..++||||+. ++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4699999995 5788777654 3689999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGM 314 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ 314 (333)
+....... ........++..|+|||++.+. .++.
T Consensus 169 ~~~~~~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (310)
T cd07865 169 FSLSKNSK---------------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGP 203 (310)
T ss_pred ccCCcccC---------------------------------------------CCCccCcccCccccCcHHhcCCcccCc
Confidence 64322100 0001123578899999998764 4789
Q ss_pred ccc-hHHHHHHHhhhcccc
Q 019953 315 ECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~~ 332 (333)
++| |++|+++|+|+++.+
T Consensus 204 ~~Di~slG~~l~el~t~~~ 222 (310)
T cd07865 204 PIDMWGAGCIMAEMWTRSP 222 (310)
T ss_pred hhhhHHHHHHHHHHHhCCC
Confidence 999 999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=247.17 Aligned_cols=195 Identities=32% Similarity=0.495 Sum_probs=161.4
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCe----
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEY---- 160 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~---- 160 (333)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999998865422 2223345777999999995 5999999998876655
Q ss_pred -EEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-CCcEEEEeccCc
Q 019953 161 -LYLIMEYLPGGDMMTLLMRE-----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLC 233 (333)
Q Consensus 161 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-~~~vkl~DFGla 233 (333)
.|+||||+++ +|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 788887542 35799999999999999999999999999999999999998 889999999998
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGY 312 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~ 312 (333)
..+..... ......+++.|+|||++.+ ..+
T Consensus 159 ~~~~~~~~-------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~ 189 (295)
T cd07837 159 RAFSIPVK-------------------------------------------------SYTHEIVTLWYRAPEVLLGSTHY 189 (295)
T ss_pred eecCCCcc-------------------------------------------------ccCCcccccCCCChHHhhCCCCC
Confidence 86532110 0012247889999999875 457
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| |++|+++|+|+++.
T Consensus 190 ~~~~Di~slG~~l~~l~~g~ 209 (295)
T cd07837 190 STPVDIWSVGCIFAEMSRKQ 209 (295)
T ss_pred CchHHHHHHHHHHHHHHcCC
Confidence 99999 99999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=250.36 Aligned_cols=198 Identities=30% Similarity=0.445 Sum_probs=164.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--CeE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYL 161 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 161 (333)
..++|++.+.||.|+||.||+|.+..+|..||+|.+...... ........+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 457899999999999999999999999999999998654321 12223355699999999999999999998654 568
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999996 578888765 3578999999999999999999999999999999999999999999999999988654321
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-h
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-W 318 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-w 318 (333)
.. .....+++.|+|||++.+ ..++.++| |
T Consensus 163 ~~-------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw 193 (309)
T cd07845 163 KP-------------------------------------------------MTPKVVTLWYRAPELLLGCTTYTTAIDMW 193 (309)
T ss_pred CC-------------------------------------------------CCcccccccccChhhhcCCCCcCchHHHH
Confidence 00 002246788999999876 56899999 9
Q ss_pred HHHHHHHhhhcccc
Q 019953 319 LVSVLHFNSYRFLE 332 (333)
Q Consensus 319 s~g~il~~l~t~~~ 332 (333)
++|+++|+|+++.+
T Consensus 194 slG~il~el~~g~~ 207 (309)
T cd07845 194 AVGCILAELLAHKP 207 (309)
T ss_pred HHHHHHHHHHhCCC
Confidence 99999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=245.05 Aligned_cols=197 Identities=47% Similarity=0.818 Sum_probs=167.3
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCH
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 173 (333)
||.|+||.||+|.+..+|+.|++|++.............+..|+.+++.++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999766544445566788899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCcc
Q 019953 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253 (333)
Q Consensus 174 ~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~ 253 (333)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~------- 153 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND------- 153 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc-------
Confidence 9999887789999999999999999999999999999999999999999999999999987643221100000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.........+++.|+|||++.+..++.++| |++|+++|+|+++.
T Consensus 154 ----------------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~ 198 (265)
T cd05579 154 ----------------------------------DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGI 198 (265)
T ss_pred ----------------------------------ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence 000111346888999999999988999999 99999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=243.67 Aligned_cols=182 Identities=21% Similarity=0.251 Sum_probs=151.7
Q ss_pred eeEeeecceEEEEEEEec------------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 92 TIIGRGAFGEVRLCREKK------------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
+.||+|+||.||+|.... ....|++|++.... ......+..|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999997432 23358999876542 223345777889999999999999999999888
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc-------EEEEecc
Q 019953 160 YLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-------MKLSDFG 231 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~-------vkl~DFG 231 (333)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999988865 356899999999999999999999999999999999999987664 8999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-CC
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KK 310 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~ 310 (333)
++....... ...++..|+|||++. +.
T Consensus 158 ~~~~~~~~~-----------------------------------------------------~~~~~~~y~aPE~~~~~~ 184 (262)
T cd05077 158 IPITVLSRQ-----------------------------------------------------ECVERIPWIAPECVEDSK 184 (262)
T ss_pred CCccccCcc-----------------------------------------------------cccccccccChhhhcCCC
Confidence 887543211 235788999999987 56
Q ss_pred CCCcccc-hHHHHHHHhhhc
Q 019953 311 GYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t 329 (333)
.++.++| |++||++|+|++
T Consensus 185 ~~~~~~DiwslG~~l~el~~ 204 (262)
T cd05077 185 NLSIAADKWSFGTTLWEICY 204 (262)
T ss_pred CCCchhHHHHHHHHHHHHHh
Confidence 7999999 999999999973
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=245.27 Aligned_cols=196 Identities=31% Similarity=0.508 Sum_probs=172.0
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
-..+.|++...||+|++|.||.|.+..++..|++|++..... ....+..|+.+++.++|+|++++++.+......+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 345679999999999999999999988899999999975432 3455778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+|+||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999998876 899999999999999999999999999999999999999999999999998875542210
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
......+++.|+|||++.+..++.++| |++
T Consensus 172 -------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 202 (286)
T cd06614 172 -------------------------------------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202 (286)
T ss_pred -------------------------------------------------hhccccCCcccCCHhHhcCCCCCCccccHHH
Confidence 001235788999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 203 Gvil~~l~~g~ 213 (286)
T cd06614 203 GIMCIEMAEGE 213 (286)
T ss_pred HHHHHHHHhCC
Confidence 99999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=240.79 Aligned_cols=188 Identities=26% Similarity=0.378 Sum_probs=159.8
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 171 (333)
+.||.|+||.||+|.+.. ++.||+|.+...... .....+..|+.+++.+.|+||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999877 999999988754322 23456888999999999999999999999999999999999999
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 172 DMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 172 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
+|.+++.. ...++...+..++.+++.||.|||+++++||||+|+||+++.++.++|+|||++...........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~------ 151 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS------ 151 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec------
Confidence 99999865 34688899999999999999999999999999999999999999999999999886542211000
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....++..|+|||++.+..++.++| |++|+++|+|+|
T Consensus 152 -----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 152 -----------------------------------------DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190 (251)
T ss_pred -----------------------------------------cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence 00112456799999999999999999 999999999997
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=246.55 Aligned_cols=199 Identities=25% Similarity=0.381 Sum_probs=163.2
Q ss_pred CCceEeeeEeeecceEEEEEEEecCC----ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-CCe
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSG----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-TEY 160 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 160 (333)
..|++...||+|+||.||+|....+. +.+|||.++..... ........+|+.+++.++|+|++.+..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 35889999999999999999654332 36899999765321 2222346679999999999999999988876 889
Q ss_pred EEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC----CcEEEEecc
Q 019953 161 LYLIMEYLPGGDMMTLLMRE-----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN----GHMKLSDFG 231 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~----~~vkl~DFG 231 (333)
+++++||.+. +|+.++.-+ ..++...++.++.|++.|+.|||++=|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999965 888888543 468999999999999999999999999999999999999988 899999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 311 (333)
+++.+..+-.+-. .....+-|.+|+|||.+.|..
T Consensus 182 laR~~~~plkpl~----------------------------------------------s~d~VVVTiWYRAPELLLGa~ 215 (438)
T KOG0666|consen 182 LARLFNNPLKPLA----------------------------------------------SLDPVVVTIWYRAPELLLGAR 215 (438)
T ss_pred HHHHhhccccccc----------------------------------------------cCCceEEEEEecChHHhcccc
Confidence 9998764321100 001346799999999999854
Q ss_pred -CCcccc-hHHHHHHHhhhcccc
Q 019953 312 -YGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 312 -~~~~~D-ws~g~il~~l~t~~~ 332 (333)
||.+.| |+.|||+-+|+|-.|
T Consensus 216 hYT~AiDvWAiGCIfaElLtl~P 238 (438)
T KOG0666|consen 216 HYTKAIDVWAIGCIFAELLTLEP 238 (438)
T ss_pred cccchhhhHHHHHHHHHHHccCc
Confidence 999999 999999999998765
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=247.12 Aligned_cols=194 Identities=29% Similarity=0.472 Sum_probs=164.4
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++++.||.|++|.||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999999999999998865432 22233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+. ++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence 995 688888755 35689999999999999999999999999999999999999999999999999876532210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-CCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~D-ws~g~ 322 (333)
......+++.|+|||++.+.. ++.++| |++|+
T Consensus 156 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 189 (284)
T cd07860 156 ----------------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 189 (284)
T ss_pred ----------------------------------------------ccccccccccccCCeEEecCCCCCcHHHHHHHHH
Confidence 001224788999999987644 688999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+|+.
T Consensus 190 il~~l~tg~ 198 (284)
T cd07860 190 IFAEMVTRR 198 (284)
T ss_pred HHHHHHHCC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=240.86 Aligned_cols=192 Identities=22% Similarity=0.336 Sum_probs=163.6
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+..|+.+++.+.||+++++++++......++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999875 467899998865432 123477799999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 9999999999998764 46889999999999999999999999999999999999999999999999998765322100
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......++..|+|||++.+..++.++| |++|+
T Consensus 157 -----------------------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~ 189 (256)
T cd05112 157 -----------------------------------------------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGV 189 (256)
T ss_pred -----------------------------------------------ccCCCccchhhcCHhHhccCCcChHHHHHHHHH
Confidence 001223567899999999999999999 99999
Q ss_pred HHHhhhc
Q 019953 323 LHFNSYR 329 (333)
Q Consensus 323 il~~l~t 329 (333)
++|+|++
T Consensus 190 ~l~el~~ 196 (256)
T cd05112 190 LMWEVFS 196 (256)
T ss_pred HHHHHHc
Confidence 9999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=245.50 Aligned_cols=198 Identities=27% Similarity=0.445 Sum_probs=165.8
Q ss_pred CCceEeeeEeeecceEEEEEEEe----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee--CC
Q 019953 86 DDFELLTIIGRGAFGEVRLCREK----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TE 159 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 159 (333)
.+|++.+.||+|+||.||+|.+. .++..||||++...... .....+.+|+.+++.+.|+||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46888899999999999999864 34789999998765322 245668889999999999999999998876 55
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 7999999999999999997654 689999999999999999999999999999999999999999999999999987653
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
...... ......++..|+|||.+.+..++.++|
T Consensus 162 ~~~~~~----------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Di 195 (284)
T cd05038 162 DKDYYY----------------------------------------------VKEPGESPIFWYAPECLRTSKFSSASDV 195 (284)
T ss_pred CCccee----------------------------------------------ccCCCCCcccccCcHHHccCCCCcccch
Confidence 221100 000123556799999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+|+.
T Consensus 196 ~slG~~l~el~tg~ 209 (284)
T cd05038 196 WSFGVTLYELFTYG 209 (284)
T ss_pred HHHhhhhheeeccC
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=252.61 Aligned_cols=215 Identities=30% Similarity=0.441 Sum_probs=177.7
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh----hhhhHHHHHHHHHHHHHhcCCceeEEE
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV----KRGQVEHVRAERNLLAEVASHCIVKLY 152 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~ 152 (333)
.++.+....++|.++..||+|||+.||+|.|....+.||||+-..+... .....+...+|..|-+.|.||.||++|
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 4566777889999999999999999999999999999999987544322 334456778899999999999999999
Q ss_pred EEEee-CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--CcEecccCCCcEEEcc---CCcEE
Q 019953 153 YSFQD-TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--NYIHRDIKPDNLLLDK---NGHMK 226 (333)
Q Consensus 153 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~Nill~~---~~~vk 226 (333)
++|.- ...+|-|+|||+|.+|..|++.+..+++..++.|+.||+.||.||... .|||.||||.|||+-. -|.+|
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 99965 456899999999999999999999999999999999999999999975 6999999999999953 46899
Q ss_pred EEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccc
Q 019953 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (333)
Q Consensus 227 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~ 306 (333)
|+|||+++.++...+..+. -..++....||.+|++||.
T Consensus 614 ITDFGLSKIMdddSy~~vd------------------------------------------GmeLTSQgAGTYWYLPPEc 651 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVD------------------------------------------GMELTSQGAGTYWYLPPEC 651 (775)
T ss_pred eeecchhhhccCCccCccc------------------------------------------ceeeecccCceeeecCcce
Confidence 9999999998765433110 1123335679999999999
Q ss_pred cc-C---CCCCcccc-hHHHHHHHhh-hccccC
Q 019953 307 LL-K---KGYGMECD-WLVSVLHFNS-YRFLEF 333 (333)
Q Consensus 307 ~~-~---~~~~~~~D-ws~g~il~~l-~t~~~~ 333 (333)
+. + ...+.++| ||.|||+|.. |...||
T Consensus 652 FvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF 684 (775)
T KOG1151|consen 652 FVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF 684 (775)
T ss_pred eecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence 85 3 34789999 9999999965 444444
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=263.02 Aligned_cols=195 Identities=25% Similarity=0.427 Sum_probs=171.1
Q ss_pred CCCc-eEeeeEeeecceEEEEEEEecCCceEEEEecchhHH-hhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe--
Q 019953 85 VDDF-ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY-- 160 (333)
Q Consensus 85 ~~~y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 160 (333)
.++| +....||+|+|-+||+|.|..+|..||--.++.... ..+...+.+..|+.+|+.|+||||+++|+++.+...
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 4555 567899999999999999999999998665554433 234456789999999999999999999999987665
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--CcEecccCCCcEEEccC-CcEEEEeccCcccCC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--NYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLD 237 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~Nill~~~-~~vkl~DFGla~~~~ 237 (333)
+-+|+|++..|+|..|+++.+.++...++.|++||+.||.|||++ .|||||||=+||+|+.+ |.|||+|+|||....
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 889999999999999999999999999999999999999999998 59999999999999865 899999999999765
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.+. +.+.+|||.|||||+.- ..|+..+|
T Consensus 198 ~s~---------------------------------------------------aksvIGTPEFMAPEmYE-E~YnE~VD 225 (632)
T KOG0584|consen 198 KSH---------------------------------------------------AKSVIGTPEFMAPEMYE-ENYNELVD 225 (632)
T ss_pred ccc---------------------------------------------------cceeccCccccChHHHh-hhcchhhh
Confidence 433 34678999999999997 88999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++|++|.+|.|+.
T Consensus 226 VYaFGMCmLEMvT~e 240 (632)
T KOG0584|consen 226 VYAFGMCMLEMVTSE 240 (632)
T ss_pred hhhhhHHHHHHHhcc
Confidence 99999999999874
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=244.77 Aligned_cols=192 Identities=29% Similarity=0.499 Sum_probs=165.7
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|...+.||+|++|.||++.+..++..+++|.+.... ......+.+|+.+++.+.|||++++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3555679999999999999998899999999886432 2233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|.+++.. ..++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~----- 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP----- 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-----
Confidence 9999999999876 5789999999999999999999999999999999999999999999999998775432110
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
......|++.|+|||.+.+..++.++| |++|+++|
T Consensus 171 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ 206 (285)
T cd06648 171 --------------------------------------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206 (285)
T ss_pred --------------------------------------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHH
Confidence 001345899999999999999999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 207 ell~g~ 212 (285)
T cd06648 207 EMVDGE 212 (285)
T ss_pred HHHhCC
Confidence 999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=254.62 Aligned_cols=199 Identities=26% Similarity=0.445 Sum_probs=166.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe----eCCeE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----DTEYL 161 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~ 161 (333)
++|++.+.||.|+||.||+|.+..+|..||+|++..... .......+..|+.+++.++||||+++++++. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875422 2233456778999999999999999988775 33578
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++||||+. ++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 68999987777899999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws 319 (333)
.. .......+|+..|+|||++.+ ..++.++| |+
T Consensus 163 ~~---------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 197 (334)
T cd07855 163 EH---------------------------------------------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS 197 (334)
T ss_pred CC---------------------------------------------CcccccccccccccChHHhcCCcccccccchHH
Confidence 00 001113468999999999876 56899999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 198 lG~~l~el~~g~ 209 (334)
T cd07855 198 VGCIFAEMLGRR 209 (334)
T ss_pred HHHHHHHHHcCC
Confidence 999999998765
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=239.79 Aligned_cols=187 Identities=26% Similarity=0.416 Sum_probs=157.3
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 171 (333)
+.||+|+||.||+|.. .++..||+|.+..... ......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 3689999999999985 4688999999865421 222345778999999999999999999999999999999999999
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccccc
Q 019953 172 DMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 172 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
+|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------- 150 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc-------
Confidence 999988653 467899999999999999999999999999999999999999999999999987543221100
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.....+++.|+|||++.+..++.++| |++|+++|+|++
T Consensus 151 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 151 -----------------------------------------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred -----------------------------------------CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 00113467899999999889999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=237.95 Aligned_cols=195 Identities=29% Similarity=0.498 Sum_probs=172.8
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|.+.+.||+|++|.||++.+..+++.|++|.+...... ......+.+|+.++..++|+|++++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588999999999999999999889999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|.+++.....+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence 9999999999988788999999999999999999999999999999999999999999999999999876533210
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
.....++..|+|||.+.+..++.++| |++|+++|
T Consensus 156 ---------------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~ 190 (254)
T cd06627 156 ---------------------------------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVI 190 (254)
T ss_pred ---------------------------------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHH
Confidence 01235888999999998888999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 191 ~l~~g~ 196 (254)
T cd06627 191 ELLTGN 196 (254)
T ss_pred HHHhCC
Confidence 999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=242.39 Aligned_cols=195 Identities=24% Similarity=0.352 Sum_probs=162.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
...+|.+.+.||+|+||.||+|.+... ...||||....... ....+.+.+|+.+++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346789999999999999999987543 45689998865431 2334567889999999999999999998875 45
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997643 5899999999999999999999999999999999999999999999999998865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... .....+++.|+|||.+.+..++.++| |
T Consensus 161 ~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 192 (270)
T cd05056 161 SYYK------------------------------------------------ASKGKLPIKWMAPESINFRRFTSASDVW 192 (270)
T ss_pred ccee------------------------------------------------cCCCCccccccChhhhccCCCCchhhhH
Confidence 1100 00123567899999999899999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|++
T Consensus 193 slG~il~el~~ 203 (270)
T cd05056 193 MFGVCMWEILM 203 (270)
T ss_pred HHHHHHHHHHH
Confidence 99999999885
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=244.26 Aligned_cols=180 Identities=17% Similarity=0.191 Sum_probs=149.6
Q ss_pred eEeeecceEEEEEEEecC------------------------CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce
Q 019953 93 IIGRGAFGEVRLCREKKS------------------------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI 148 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 148 (333)
.||+|+||.||+|....+ ...|++|++..... .....+..|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999875322 24589998865432 233457778899999999999
Q ss_pred eEEEEEEeeCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC----
Q 019953 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---- 223 (333)
Q Consensus 149 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---- 223 (333)
+++++++......++||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998865 45789999999999999999999999999999999999997654
Q ss_pred ---cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCC
Q 019953 224 ---HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPD 300 (333)
Q Consensus 224 ---~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 300 (333)
.++++|||++....... ...+++.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~-----------------------------------------------------~~~~~~~ 185 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE-----------------------------------------------------ERVERIP 185 (274)
T ss_pred ccceeeecCCcccccccccc-----------------------------------------------------ccccCCc
Confidence 48999999876432111 2247788
Q ss_pred CcccccccC-CCCCcccc-hHHHHHHHhhh
Q 019953 301 YIAPEVLLK-KGYGMECD-WLVSVLHFNSY 328 (333)
Q Consensus 301 y~APE~~~~-~~~~~~~D-ws~g~il~~l~ 328 (333)
|+|||.+.+ ..++.++| |++|+++|+|+
T Consensus 186 ~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 186 WIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred ccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999875 56899999 99999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=242.14 Aligned_cols=186 Identities=23% Similarity=0.399 Sum_probs=158.9
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|++.+.||+|+||.||.+. .+++.||+|.+.... ....+.+|+.+++.++|||++++++++..+ ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 34679999999999999999886 468889999986532 234577899999999999999999998765 4799
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 164 IMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
||||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 999999999999997643 578999999999999999999999999999999999999999999999999875431110
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
....+..|+|||.+.+..++.++| |++
T Consensus 156 ----------------------------------------------------~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 183 (254)
T cd05083 156 ----------------------------------------------------NSKLPVKWTAPEALKHKKFSSKSDVWSY 183 (254)
T ss_pred ----------------------------------------------------CCCCCceecCHHHhccCCcCchhhHHHH
Confidence 123456899999999999999999 999
Q ss_pred HHHHHhhhc
Q 019953 321 SVLHFNSYR 329 (333)
Q Consensus 321 g~il~~l~t 329 (333)
|+++|+|++
T Consensus 184 G~~l~el~~ 192 (254)
T cd05083 184 GVLLWEVFS 192 (254)
T ss_pred HHHHHHHHh
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=250.59 Aligned_cols=193 Identities=27% Similarity=0.442 Sum_probs=162.8
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT----- 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 158 (333)
..++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 35789999999999999999999999999999999875321 122334577899999999999999999987543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478899987 7899887754 468999999999999999999999999999999999999999999999999987543
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~ 316 (333)
... ....|++.|+|||++.+ ..++.++
T Consensus 172 ~~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (345)
T cd07877 172 DEM----------------------------------------------------TGYVATRWYRAPEIMLNWMHYNQTV 199 (345)
T ss_pred ccc----------------------------------------------------cccccCCCccCHHHHhCccCCCchh
Confidence 211 12358899999999876 5789999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| |++||++|+|+++.
T Consensus 200 DvwslG~il~el~~g~ 215 (345)
T cd07877 200 DIWSVGCIMAELLTGR 215 (345)
T ss_pred hHHHHHHHHHHHHhCC
Confidence 9 99999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=246.83 Aligned_cols=193 Identities=27% Similarity=0.451 Sum_probs=160.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 164 (333)
++|...+.||+|+||.||++.+..+++.||+|.+...... .....+..|+.++.++. |+||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4567778999999999999999999999999998754322 33455778999999996 99999999999988899999
Q ss_pred EeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 165 MEYLPGGDMMTLLM-----REDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 165 ~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
|||+. +++.++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..+..
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99985 45554332 245799999999999999999999975 999999999999999999999999999876532
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC---CCCcc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK---GYGME 315 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~ 315 (333)
+.. .....|++.|+|||++.+. .++.+
T Consensus 161 ~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~ 190 (288)
T cd06616 161 SIA--------------------------------------------------KTRDAGCRPYMAPERIDPSARDGYDVR 190 (288)
T ss_pred CCc--------------------------------------------------cccccCccCccCHHHhccccccCCcch
Confidence 210 0123588899999999876 68999
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| |++||++|+|+++.
T Consensus 191 ~Di~slG~il~el~~g~ 207 (288)
T cd06616 191 SDVWSLGITLYEVATGK 207 (288)
T ss_pred hhhhHHHHHHHHHHhCC
Confidence 99 99999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=252.39 Aligned_cols=197 Identities=25% Similarity=0.415 Sum_probs=166.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----C
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----E 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 159 (333)
.++|.+.+.||+|+||.||.|.+..+++.||||.+..... .......+..|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3579999999999999999999999999999999865322 222334566799999999999999999877543 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+|+||||+. ++|.+++.....+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999995 789999988888999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D- 317 (333)
.. ......++..|+|||.+.+ ..++.++|
T Consensus 162 ~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 192 (337)
T cd07858 162 GD-------------------------------------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDV 192 (337)
T ss_pred cc-------------------------------------------------cccccccccCccChHHHhcCCCCCCcccH
Confidence 10 0012357889999999875 56899999
Q ss_pred hHHHHHHHhhhcccc
Q 019953 318 WLVSVLHFNSYRFLE 332 (333)
Q Consensus 318 ws~g~il~~l~t~~~ 332 (333)
|++||++|+|+++.+
T Consensus 193 wslG~il~~l~~g~~ 207 (337)
T cd07858 193 WSVGCIFAELLGRKP 207 (337)
T ss_pred HHHHHHHHHHHcCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=241.64 Aligned_cols=192 Identities=20% Similarity=0.304 Sum_probs=154.8
Q ss_pred eeEeeecceEEEEEEEec---CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe-eCCeEEEEEec
Q 019953 92 TIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DTEYLYLIMEY 167 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 167 (333)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+..|+.+++.++||||+++++.+. .++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998653 34679999875421 2233456778999999999999999999765 45568999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 168 LPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 168 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
+.+++|.+++... ...+...+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~-- 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV-- 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee--
Confidence 9999999998764 3567777888999999999999999999999999999999999999999999886543211000
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
.......+++.|+|||++.+..++.++| |++||++|
T Consensus 157 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 193 (262)
T cd05058 157 -------------------------------------------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 193 (262)
T ss_pred -------------------------------------------cccccCcCCccccChhHhccCccchHHHHHHHHHHHH
Confidence 0001224677899999999999999999 99999999
Q ss_pred hhhcc
Q 019953 326 NSYRF 330 (333)
Q Consensus 326 ~l~t~ 330 (333)
+|+++
T Consensus 194 el~~~ 198 (262)
T cd05058 194 ELMTR 198 (262)
T ss_pred HHHcC
Confidence 99983
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=246.66 Aligned_cols=190 Identities=28% Similarity=0.436 Sum_probs=162.2
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
|...+.||+|+||.||+|.+..++..|++|.+.............+..|+.+++.++|||++++++++......++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999998754333333445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 168 LPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 168 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
+. +++.+++.. ..++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~------- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-------
Confidence 95 577777654 457899999999999999999999999999999999999999999999999987632111
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCCCcccc-hHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECD-WLVSV 322 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~D-ws~g~ 322 (333)
....|+..|+|||++. +..++.++| |++|+
T Consensus 175 ----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGv 208 (313)
T cd06633 175 ----------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 208 (313)
T ss_pred ----------------------------------------------CCccccccccChhhccccCCCCCCchhhHHHHHH
Confidence 0335889999999984 466899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 209 il~el~~g~ 217 (313)
T cd06633 209 TCIELAERK 217 (313)
T ss_pred HHHHHHhCC
Confidence 999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=235.72 Aligned_cols=192 Identities=34% Similarity=0.555 Sum_probs=170.5
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|.+.+.||+|++|.||++.+..++..+++|++..... .....+.+|+.+++.++|++++++++.+..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 47889999999999999999988999999999976532 244567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 167 YLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 167 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|+++++|.+++... ..+++..+..++.|++.||.+||..|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999998775 5799999999999999999999999999999999999999999999999999887643220
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
.....|+..|+|||.+.+..++.++| |++|+++
T Consensus 154 ----------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il 187 (253)
T cd05122 154 ----------------------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187 (253)
T ss_pred ----------------------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHH
Confidence 01345889999999999888999999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 188 ~~l~~g~ 194 (253)
T cd05122 188 IELAEGK 194 (253)
T ss_pred HHHHhCC
Confidence 9999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=250.64 Aligned_cols=193 Identities=28% Similarity=0.451 Sum_probs=163.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE---- 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 159 (333)
..++|++.+.||+|+||.||+|.+..++..||||.+.... ........+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3578999999999999999999999999999999986432 12223345778999999999999999999887553
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 --YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.+++||||+ +++|.+++. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999999 778888775 4578999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~ 316 (333)
... ....+++.|+|||++.+ ..++.++
T Consensus 170 ~~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~ 197 (343)
T cd07880 170 SEM----------------------------------------------------TGYVVTRWYRAPEVILNWMHYTQTV 197 (343)
T ss_pred cCc----------------------------------------------------cccccCCcccCHHHHhCCCCCCcHH
Confidence 211 02357889999999876 4589999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| |++|+++|+|+++.
T Consensus 198 Di~slG~ll~~l~~g~ 213 (343)
T cd07880 198 DIWSVGCIMAEMLTGK 213 (343)
T ss_pred HHHHHHHHHHHHHhCC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=243.12 Aligned_cols=194 Identities=31% Similarity=0.491 Sum_probs=165.1
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--CeEEEEE
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLYLIM 165 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 165 (333)
|++.+.||.|+||.||+|.+..+++.+|+|.+.... ........+..|+.+++.+.|+|++++++++... +..++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999999999999999998653 2223345577899999999999999999999887 8899999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 9996 4888888665 57999999999999999999999999999999999999999999999999998866433210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~ 322 (333)
......++..|+|||.+.+ ..++.++| |++|+
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~ 190 (287)
T cd07840 157 ----------------------------------------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGC 190 (287)
T ss_pred ----------------------------------------------cccccccccccCCceeeEccccCChHHHHHHHHH
Confidence 0012346789999998765 46899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 191 ~l~el~t~~ 199 (287)
T cd07840 191 ILAELFLGK 199 (287)
T ss_pred HHHHHHhCC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=242.04 Aligned_cols=190 Identities=29% Similarity=0.493 Sum_probs=157.9
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeC--CeEEEE
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDT--EYLYLI 164 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv 164 (333)
|++.+.||+|+||.||+|.+..++..||+|.+..... .... .....|+.++..+. |+|++++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999865421 1111 22346888888885 99999999999887 889999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||++ +++.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++. +.++|+|||++..+.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 99996 578777765 357899999999999999999999999999999999999999 9999999999986542211
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g 321 (333)
.....+++.|+|||++.+ ..++.++| |++|
T Consensus 155 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 186 (282)
T cd07831 155 ------------------------------------------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVG 186 (282)
T ss_pred ------------------------------------------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHH
Confidence 012357889999998754 55789999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 187 v~l~el~~~~ 196 (282)
T cd07831 187 CVFFEILSLF 196 (282)
T ss_pred HHHHHHHcCC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=248.88 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=163.0
Q ss_pred CceEeeeEeeecceEEEEEEEecC--CceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEee----CC
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKS--GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD----TE 159 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~ 159 (333)
+|.+.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++.+ .||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999887 8999999986432 1222344567799999999 59999999986432 24
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++++++|+. ++|.+.+.....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5889999984 689999988888999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D- 317 (333)
.... ........|++.|+|||++.+ ..++.++|
T Consensus 159 ~~~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di 193 (332)
T cd07857 159 PGEN---------------------------------------------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193 (332)
T ss_pred cccc---------------------------------------------cccccCcccCccccCcHHHhCCCCCCcHHHH
Confidence 2100 000113468999999998765 57899999
Q ss_pred hHHHHHHHhhhcccc
Q 019953 318 WLVSVLHFNSYRFLE 332 (333)
Q Consensus 318 ws~g~il~~l~t~~~ 332 (333)
|++||++|+|+++.+
T Consensus 194 ~slGv~l~~l~~g~~ 208 (332)
T cd07857 194 WSVGCILAELLGRKP 208 (332)
T ss_pred HHHHHHHHHHHhCCc
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=241.24 Aligned_cols=193 Identities=30% Similarity=0.464 Sum_probs=161.3
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh---cCCceeEEEEEEeeCCe----
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQDTEY---- 160 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~---- 160 (333)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ .|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999988899999999975432 112223455677777666 59999999999987776
Q ss_pred -EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 161 -LYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 161 -~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
++++|||+. ++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 5888888653 358999999999999999999999999999999999999999999999999988754
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... .....+++.|+|||++.+..++.++|
T Consensus 159 ~~~~--------------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~D 188 (287)
T cd07838 159 FEMA--------------------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVD 188 (287)
T ss_pred CCcc--------------------------------------------------cccccccccccChHHhccCCCCCcch
Confidence 3211 00234788999999999999999999
Q ss_pred -hHHHHHHHhhhcccc
Q 019953 318 -WLVSVLHFNSYRFLE 332 (333)
Q Consensus 318 -ws~g~il~~l~t~~~ 332 (333)
|++||++|+|+++.+
T Consensus 189 i~s~G~~l~~l~~~~~ 204 (287)
T cd07838 189 MWSVGCIFAELFRRRP 204 (287)
T ss_pred hhhHHHHHHHHHhCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=235.61 Aligned_cols=197 Identities=31% Similarity=0.495 Sum_probs=172.6
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--CeEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EYLYLI 164 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 164 (333)
+|.+.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.+++.++|+||+++++.+... ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 478889999999999999999989999999998765422 33456788899999999999999999999888 889999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
+||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988778999999999999999999999999999999999999999999999999998876543210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.......++..|+|||.+.+..++.++| |++|++
T Consensus 158 ---------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i 192 (260)
T cd06606 158 ---------------------------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCT 192 (260)
T ss_pred ---------------------------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHH
Confidence 0011346889999999999888999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 193 l~~l~~g~ 200 (260)
T cd06606 193 VIEMATGK 200 (260)
T ss_pred HHHHHhCC
Confidence 99999843
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=239.04 Aligned_cols=194 Identities=32% Similarity=0.607 Sum_probs=167.3
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|.+.+.||+|+||.||++.+..+|..||+|.+...... ....+.+.+|+.+++.++|+||+++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 588999999999999999999999999999998765322 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-cEEEEeccCcccCCCCcccc
Q 019953 167 YLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~~~~~~~~ 243 (333)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~- 158 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL- 158 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc-
Confidence 999999999986543 578999999999999999999999999999999999999886 5699999988765432110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.....|++.|+|||++.+..++.++| |++|+
T Consensus 159 ------------------------------------------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08225 159 ------------------------------------------------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGC 190 (257)
T ss_pred ------------------------------------------------ccccCCCccccCHHHHcCCCCCchhhHHHHHH
Confidence 01235889999999999889999999 99999
Q ss_pred HHHhhhcc
Q 019953 323 LHFNSYRF 330 (333)
Q Consensus 323 il~~l~t~ 330 (333)
++|+|+++
T Consensus 191 il~~l~~g 198 (257)
T cd08225 191 VLYELCTL 198 (257)
T ss_pred HHHHHHhC
Confidence 99999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=236.86 Aligned_cols=195 Identities=33% Similarity=0.628 Sum_probs=170.7
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|.+.+.||.|+||.||++.+..++..|++|++..... .......+..|+.+++.++|+|++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999998999999999876432 12344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 167 YLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 167 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
|+++++|.+++... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD- 158 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc-
Confidence 99999999998763 6799999999999999999999999999999999999999999999999999886543210
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
......|++.|+|||.+.+..++.++| |++|
T Consensus 159 ------------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG 190 (258)
T cd08215 159 ------------------------------------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLG 190 (258)
T ss_pred ------------------------------------------------eecceeeeecccChhHhccCCCCccccHHHHH
Confidence 011346889999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
+++|+|+++.
T Consensus 191 ~~~~~l~~g~ 200 (258)
T cd08215 191 CVLYELCTLK 200 (258)
T ss_pred HHHHHHHcCC
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=237.92 Aligned_cols=175 Identities=23% Similarity=0.380 Sum_probs=152.4
Q ss_pred ecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCHHHH
Q 019953 97 GAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176 (333)
Q Consensus 97 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 176 (333)
|.+|.||+|.+..+++.||+|.+..... ...+...+....||||+++++++......++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976532 22244445556799999999999999999999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccC
Q 019953 177 LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256 (333)
Q Consensus 177 l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 256 (333)
+.....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||++.......
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------------- 139 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------------- 139 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----------------
Confidence 9887789999999999999999999999999999999999999999999999999876543211
Q ss_pred CCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
....++..|+|||.+.+.+++.++| |++|+++|+|+++.
T Consensus 140 ------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~ 179 (237)
T cd05576 140 ------------------------------------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179 (237)
T ss_pred ------------------------------------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCc
Confidence 0224677899999999889999999 99999999999875
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=242.32 Aligned_cols=197 Identities=42% Similarity=0.686 Sum_probs=166.7
Q ss_pred CceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHh-hhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeE
Q 019953 87 DFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMV-KRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 161 (333)
+|++.+.||+|++|.||+|.+. .++..||||++...... .......+..|+.++..+ +|++|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46788999998754322 223345677899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998777899999999999999999999999999999999999999999999999999876532210
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC--CCcccc-h
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YGMECD-W 318 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~D-w 318 (333)
. ......|++.|+|||.+.+.. ++.++| |
T Consensus 161 ~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~ 192 (288)
T cd05583 161 E------------------------------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192 (288)
T ss_pred c------------------------------------------------ccccccCCccccCHHHhcCCCCCCcchhhhH
Confidence 0 011345889999999987755 788999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
++|+++|+|+++.
T Consensus 193 slG~il~el~tg~ 205 (288)
T cd05583 193 SLGVLTFELLTGA 205 (288)
T ss_pred HHHHHHHHHHhCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=227.38 Aligned_cols=196 Identities=27% Similarity=0.469 Sum_probs=163.5
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHH-hcCCceeEEEEEEeeCC
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDTE 159 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~ 159 (333)
.++..++..-+..||+|++|.|-+.++..+|...|+|.+..... ......+..|+++... ..+|.+|.+||......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 45556667778899999999999999999999999999976532 2334556667776554 47899999999999999
Q ss_pred eEEEEEeccCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 160 YLYLIMEYLPGGDMMTLL----MREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
.+++.||.| ..||..+. ..+..+++..+-+++..++.||.|||++ .+||||+||+||||+.+|.|||||||++.
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999999 45776554 4567899999999999999999999986 89999999999999999999999999998
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccc-cCCCCCCcccccccC----
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS-TVGTPDYIAPEVLLK---- 309 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~gt~~y~APE~~~~---- 309 (333)
.+..+- +.+ ..|+..|||||.+..
T Consensus 198 ~L~dSi---------------------------------------------------Akt~daGCkpYmaPEri~~e~n~ 226 (282)
T KOG0984|consen 198 YLVDSI---------------------------------------------------AKTMDAGCKPYMAPERINPELNQ 226 (282)
T ss_pred eehhhh---------------------------------------------------HHHHhcCCCccCChhhcCcccCc
Confidence 775442 112 369999999999853
Q ss_pred CCCCcccc-hHHHHHHHhhhcc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.+|+.++| ||+|+.+++|-+.
T Consensus 227 ~gY~vksDvWSLGItmiElA~l 248 (282)
T KOG0984|consen 227 KGYSVKSDVWSLGITMIEMAIL 248 (282)
T ss_pred ccceeehhhhhhhhhhhhhhhc
Confidence 57999999 9999999998553
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=247.34 Aligned_cols=193 Identities=28% Similarity=0.466 Sum_probs=163.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-CCeEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-TEYLY 162 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 162 (333)
..++|++.+.||.|+||.||+|.+..+++.||||.+..... .......+..|+.+++.++||||+++++++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46789999999999999999999999999999998864321 22233557789999999999999999998865 55789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+||||+ +++|..++. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-- 162 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-- 162 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence 999999 668888775 3468888899999999999999999999999999999999999999999999987543111
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLV 320 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~ 320 (333)
....+++.|+|||++.+ ..++.++| |++
T Consensus 163 --------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 192 (328)
T cd07856 163 --------------------------------------------------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192 (328)
T ss_pred --------------------------------------------------CCCcccccccCceeeeccCCcCcHHHHHHH
Confidence 12357889999999866 67899999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 193 G~il~el~tg~ 203 (328)
T cd07856 193 GCIFAEMLEGK 203 (328)
T ss_pred HHHHHHHHhCC
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=243.51 Aligned_cols=193 Identities=31% Similarity=0.492 Sum_probs=164.1
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
|++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++|+|++++++++...+..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6778899999999999999999999999999875432 222334577799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 168 LPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 168 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---- 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence 94 68999887655 789999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~i 323 (333)
......+++.|+|||++.+. .++.++| |++|++
T Consensus 155 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 189 (283)
T cd07835 155 ---------------------------------------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI 189 (283)
T ss_pred ---------------------------------------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHH
Confidence 00122468899999998764 5799999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 190 l~~l~~g~ 197 (283)
T cd07835 190 FAEMVNRR 197 (283)
T ss_pred HHHHHhCC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=237.75 Aligned_cols=193 Identities=29% Similarity=0.527 Sum_probs=168.9
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+|++.+.||.|+||.||++.+..++..+|+|.+...... ......+..|+.+++.++|+||+++++++......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 588999999999999999999999999999998765432 2334556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 167 YLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 167 ~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 9999999998865 3568999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
.....|++.|+|||.+.+..++.++| |++|
T Consensus 158 -------------------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG 188 (256)
T cd08530 158 -------------------------------------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLG 188 (256)
T ss_pred -------------------------------------------------cccccCCccccCHHHHCCCCCCchhhHHHHH
Confidence 00235788999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
+++|+|+++.
T Consensus 189 ~~~~~l~~g~ 198 (256)
T cd08530 189 CLLYEMATFA 198 (256)
T ss_pred HHHHHHHhCC
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=246.74 Aligned_cols=208 Identities=28% Similarity=0.439 Sum_probs=164.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC------
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 158 (333)
.++|.+.+.||+|+||.||+|.+..+++.||||.+...... ........+|+.+++.++||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 57999999999999999999999999999999998654321 11223456799999999999999999876433
Q ss_pred --CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 159 --EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 159 --~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
..+++||||+.+ ++...+.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999954 67766654 45799999999999999999999999999999999999999999999999999986
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGM 314 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ 314 (333)
............ ...........|++.|+|||++.+ ..++.
T Consensus 165 ~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (311)
T cd07866 165 YDGPPPNPKGGG--------------------------------------GGGTRKYTNLVVTRWYRPPELLLGERRYTT 206 (311)
T ss_pred ccCCCcccccCC--------------------------------------cccccccccceeccCcCChHHhhCCCccCc
Confidence 543221100000 000011124468899999999865 45899
Q ss_pred ccc-hHHHHHHHhhhcccc
Q 019953 315 ECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~~ 332 (333)
++| |++|+++|+|+++.+
T Consensus 207 ~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 207 AVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred hhHhHHHHHHHHHHHhCCC
Confidence 999 999999999998854
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=245.51 Aligned_cols=192 Identities=28% Similarity=0.439 Sum_probs=163.0
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
..|...+.||+|+||.||+|.+..++..||+|.+.............+..|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999999999999999986432222233455778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+. |++.+.+.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---- 169 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---- 169 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc----
Confidence 9996 577776644 4568999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCCCcccc-hHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECD-WLV 320 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~D-ws~ 320 (333)
...|++.|+|||++. +..++.++| |++
T Consensus 170 -------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl 200 (308)
T cd06634 170 -------------------------------------------------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (308)
T ss_pred -------------------------------------------------cccCCccccCHHHHhhcccCCCCcccchHHH
Confidence 235888999999985 356888999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 201 G~il~el~~g~ 211 (308)
T cd06634 201 GITCIELAERK 211 (308)
T ss_pred HHHHHHHHcCC
Confidence 99999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=240.13 Aligned_cols=188 Identities=18% Similarity=0.257 Sum_probs=150.1
Q ss_pred eEeeecceEEEEEEEecC--CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCC
Q 019953 93 IIGRGAFGEVRLCREKKS--GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
.||+|+||.||++..... ...+++|.+..... ......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999999999975433 33466776654321 22345688899999999999999999999999999999999999
Q ss_pred CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 171 GDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 171 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+|.+++... ...+...+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~---- 155 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI---- 155 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh----
Confidence 9999998653 24566777889999999999999999999999999999999999999999987643211100
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-------CCCCcccc-h
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-------KGYGMECD-W 318 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~~~~D-w 318 (333)
.......|++.|+|||++.+ ..++.++| |
T Consensus 156 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw 192 (268)
T cd05086 156 -------------------------------------------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVW 192 (268)
T ss_pred -------------------------------------------hcccCCcCcccccCchhcccccCccccCCCCCcchhH
Confidence 00113468899999999853 34678999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
|+|+++|+|++
T Consensus 193 slG~~l~el~~ 203 (268)
T cd05086 193 ALGVTLWELFE 203 (268)
T ss_pred HHHHHHHHHHh
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=236.67 Aligned_cols=196 Identities=26% Similarity=0.434 Sum_probs=164.1
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 161 (333)
...++.+.+..||+|+.|+||+++.+.+|...|||.+.... ..+..+.++..++++.... +|+||+++|+|..+..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 34456777889999999999999999999999999998764 3345566777777776664 89999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++.||.| +..+..++.. ..++++..+-.+...++.||.||-. +||+|||+||+|||+|..|++|+||||++..+..+
T Consensus 167 ~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9999998 4445555543 5679999999999999999999975 69999999999999999999999999999887655
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CCCCccc
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMEC 316 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~ 316 (333)
.-+. ...|++.|||||-+.. ..|+-++
T Consensus 246 kAht--------------------------------------------------rsAGC~~YMaPERidp~~~~kYDiRa 275 (391)
T KOG0983|consen 246 KAHT--------------------------------------------------RSAGCAAYMAPERIDPPDKPKYDIRA 275 (391)
T ss_pred cccc--------------------------------------------------cccCCccccCccccCCCCCCccchhh
Confidence 4221 2369999999999964 4699999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| ||+|+.+++|.|+.
T Consensus 276 DVWSlGITlveLaTg~ 291 (391)
T KOG0983|consen 276 DVWSLGITLVELATGQ 291 (391)
T ss_pred hhhhhccchhhhhccc
Confidence 9 99999999998863
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=249.84 Aligned_cols=197 Identities=27% Similarity=0.441 Sum_probs=168.5
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC-----eE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-----YL 161 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 161 (333)
+|++.+.||.|++|.||+|.+..++..||||.+.... ........+..|+.+++.++|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999998889999999987542 12234456788999999999999999999987765 78
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+||||++ ++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999996 58988888777899999999999999999999999999999999999999999999999999987653321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws 319 (333)
. ........+++.|+|||++.+. .++.++| |+
T Consensus 159 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s 192 (330)
T cd07834 159 E----------------------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWS 192 (330)
T ss_pred c----------------------------------------------cccccccccccCcCCceeeecccCCCcchhHHH
Confidence 0 0011133588999999999887 8999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+|+++|+|+++.
T Consensus 193 lG~il~~l~~g~ 204 (330)
T cd07834 193 VGCIFAELLTRK 204 (330)
T ss_pred HHHHHHHHHcCC
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=249.56 Aligned_cols=200 Identities=29% Similarity=0.447 Sum_probs=163.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeC--CeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDT--EYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 161 (333)
.++|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+++.+ +|+||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4679999999999999999999988999999998854311 112234466799999999 999999999988643 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++||||++ ++|..++... .+++.....++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999996 5898888665 788889999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws 319 (333)
.. .........|++.|+|||++.+ ..++.++| |+
T Consensus 163 ~~--------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s 198 (337)
T cd07852 163 NP--------------------------------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWS 198 (337)
T ss_pred cc--------------------------------------------cCcchhcccccccccCceeeeccccccccchHHH
Confidence 00 0001113468999999998865 56889999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+|+++|+|+++.
T Consensus 199 lG~~l~el~tg~ 210 (337)
T cd07852 199 VGCILGEMLLGK 210 (337)
T ss_pred HHHHHHHHHhCC
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=240.85 Aligned_cols=189 Identities=27% Similarity=0.379 Sum_probs=156.8
Q ss_pred eeEeeecceEEEEEEEecCC------ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 92 TIIGRGAFGEVRLCREKKSG------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
+.||+|+||.||+|.+.... ..+|||.+.... .......+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876443 689999886432 1233456778999999999999999999999889999999
Q ss_pred eccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-----cEEEEeccCc
Q 019953 166 EYLPGGDMMTLLMRE-------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-----HMKLSDFGLC 233 (333)
Q Consensus 166 e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-----~vkl~DFGla 233 (333)
||+++++|.+++... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 2477888899999999999999999999999999999999877 8999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
..+....... ......++..|+|||++.+..++
T Consensus 159 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~ 191 (269)
T cd05044 159 RDIYKSDYYR-----------------------------------------------KEGEGLLPVRWMAPESLLDGKFT 191 (269)
T ss_pred cccccccccc-----------------------------------------------cCcccCCCccccCHHHHccCCcc
Confidence 8654221100 00022467789999999999999
Q ss_pred cccc-hHHHHHHHhhhc
Q 019953 314 MECD-WLVSVLHFNSYR 329 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t 329 (333)
.++| |++|+++|+|+|
T Consensus 192 ~~~Dv~slG~il~ellt 208 (269)
T cd05044 192 TQSDVWSFGVLMWEILT 208 (269)
T ss_pred cchhHHHHHHHHHHHHH
Confidence 9999 999999999987
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=244.16 Aligned_cols=199 Identities=31% Similarity=0.521 Sum_probs=164.3
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC---
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE--- 159 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 159 (333)
...++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 446789999999999999999999999999999999875432 1222345667999999999999999999886644
Q ss_pred -------eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEecc
Q 019953 160 -------YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231 (333)
Q Consensus 160 -------~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFG 231 (333)
.+++|+||+++ ++...+... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999975 777777553 468999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-C
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-K 310 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~ 310 (333)
++..+...... ......++..|+|||.+.+ .
T Consensus 162 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~y~~PE~~~~~~ 193 (302)
T cd07864 162 LARLYNSEESR------------------------------------------------PYTNKVITLWYRPPELLLGEE 193 (302)
T ss_pred ccccccCCccc------------------------------------------------ccccceeccCccChHHhcCCC
Confidence 98866432210 0002246788999998865 4
Q ss_pred CCCcccc-hHHHHHHHhhhccc
Q 019953 311 GYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.++.++| |++||++|+|+++.
T Consensus 194 ~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 194 RYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred CCCchhHHHHHHHHHHHHHhCC
Confidence 5789999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=243.15 Aligned_cols=189 Identities=29% Similarity=0.504 Sum_probs=162.7
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccC
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (333)
....||+|+||.||++.+..++..||||.+.... ......+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3467999999999999999999999999875432 2234557889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccc
Q 019953 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (333)
Q Consensus 170 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 249 (333)
+++|.+++. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-------- 171 (292)
T cd06657 101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-------- 171 (292)
T ss_pred CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--------
Confidence 999998774 44689999999999999999999999999999999999999999999999998875432110
Q ss_pred cCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhh
Q 019953 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSY 328 (333)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~ 328 (333)
......|++.|+|||.+.+..++.++| |++|+++|+|+
T Consensus 172 -----------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~ 210 (292)
T cd06657 172 -----------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210 (292)
T ss_pred -----------------------------------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 001345889999999999888999999 99999999999
Q ss_pred ccc
Q 019953 329 RFL 331 (333)
Q Consensus 329 t~~ 331 (333)
++.
T Consensus 211 tg~ 213 (292)
T cd06657 211 DGE 213 (292)
T ss_pred hCC
Confidence 864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=236.01 Aligned_cols=189 Identities=48% Similarity=0.844 Sum_probs=167.7
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCH
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 173 (333)
||.|+||.||.+.+..+++.||+|++.............+..|+.+++.++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999999876554444566788899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCcc
Q 019953 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253 (333)
Q Consensus 174 ~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~ 253 (333)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------------ 148 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------------ 148 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------------
Confidence 99998887899999999999999999999999999999999999999999999999999886543210
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
......++..|+|||.+.+..++.++| |++|+++|+|+++.
T Consensus 149 -------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~ 190 (250)
T cd05123 149 -------------------------------------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190 (250)
T ss_pred -------------------------------------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 011345888999999999988999999 99999999999865
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-34 Score=242.57 Aligned_cols=204 Identities=27% Similarity=0.389 Sum_probs=168.7
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee----
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD---- 157 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 157 (333)
-+..+.|+-..+||+|.||.||+|+...+|+.||+|++--... +........+|+.+|..++|+|++.++..|..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 3445678888899999999999999999999999987644322 23444556779999999999999888766632
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 158 ----TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 158 ----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
...+|+||.+|+. +|..++.+. ..++...+..++.++++||.|+|+..|+|||+||+|+||+.+|.+||+|||+
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 2358999999964 788888664 5799999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KG 311 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~ 311 (333)
++.+..+.... +.+....+-|.+|++||.+.| ..
T Consensus 171 ar~fs~~~n~~---------------------------------------------kprytnrvvTLwYrppEllLG~r~ 205 (376)
T KOG0669|consen 171 ARAFSTSKNVV---------------------------------------------KPRYTNRVVTLWYRPPELLLGDRE 205 (376)
T ss_pred ccceecccccC---------------------------------------------CCCcccceeeeecCCHHHhhcccc
Confidence 99876554221 111224578999999999988 56
Q ss_pred CCcccc-hHHHHHHHhhhcccc
Q 019953 312 YGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~~~ 332 (333)
|+.+.| |.+||||-+|+|+.+
T Consensus 206 yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 206 YGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred cCCcchhHhHHHHHHHHHccCc
Confidence 999999 999999999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=246.70 Aligned_cols=211 Identities=24% Similarity=0.401 Sum_probs=166.7
Q ss_pred CCce-EeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhh-----------hHHHHHHHHHHHHHhcCCceeEEEE
Q 019953 86 DDFE-LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-----------QVEHVRAERNLLAEVASHCIVKLYY 153 (333)
Q Consensus 86 ~~y~-~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~ 153 (333)
++|. +.+.||.|+||.||+|.+..+++.||||.+......... ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 457899999999999999999999999998654321100 0123667999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCc
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
++......++||||+. ++|.+++.....+++.....++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 689999987778999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GY 312 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~ 312 (333)
.....+........ .... ..........+++.|+|||++.+. .+
T Consensus 167 ~~~~~~~~~~~~~~--------------------~~~~---------------~~~~~~~~~~~~~~y~aPE~~~~~~~~ 211 (335)
T PTZ00024 167 RRYGYPPYSDTLSK--------------------DETM---------------QRREEMTSKVVTLWYRAPELLMGAEKY 211 (335)
T ss_pred eecccccccccccc--------------------cccc---------------cccccccccccccCCCCChhcccCCCC
Confidence 87653321100000 0000 000011123578899999999764 47
Q ss_pred Ccccc-hHHHHHHHhhhcccc
Q 019953 313 GMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~~ 332 (333)
+.++| |++||++|+|+++.+
T Consensus 212 ~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 212 HFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CcHHHHHHHHHHHHHHHhCCC
Confidence 99999 999999999998753
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=239.10 Aligned_cols=194 Identities=25% Similarity=0.376 Sum_probs=158.0
Q ss_pred ceEeeeEeeecceEEEEEEEec---CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC-----
Q 019953 88 FELLTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 159 (333)
|.+.+.||+|+||.||+|.+.. ++..||||++..... .....+.+.+|+.+++.+.||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998643 578999999865422 2234556788999999999999999999876432
Q ss_pred -eEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 160 -YLYLIMEYLPGGDMMTLLMRE------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 160 -~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
..+++++|+.+|+|.+++... ..++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 357899999999998877432 2478889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
++......... ......+++.|++||.+.+..+
T Consensus 160 ~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05074 160 SKKIYSGDYYR-----------------------------------------------QGCASKLPVKWLALESLADNVY 192 (273)
T ss_pred cccccCCccee-----------------------------------------------cCCCccCchhhcCHhHHhcCcc
Confidence 88654321100 0002245678999999999999
Q ss_pred Ccccc-hHHHHHHHhhhc
Q 019953 313 GMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t 329 (333)
+.++| ||+||++|+|++
T Consensus 193 ~~~sDi~slG~il~el~~ 210 (273)
T cd05074 193 TTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred chhhhhHHHHHHHHHHhh
Confidence 99999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=237.85 Aligned_cols=195 Identities=27% Similarity=0.519 Sum_probs=163.6
Q ss_pred CceEeeeEeeecceEEEEEEEec-CCceEEEEecchhHH-------hhhhhHHHHHHHHHHHHH-hcCCceeEEEEEEee
Q 019953 87 DFELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEM-------VKRGQVEHVRAERNLLAE-VASHCIVKLYYSFQD 157 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 157 (333)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+..|+.++.. ++|+||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999877 688999998864321 112233456678887765 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
+....... ......|+..|+|||.+.+..+
T Consensus 161 ~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~ 190 (269)
T cd08528 161 AKQKQPES--------------------------------------------------KLTSVVGTILYSCPEIVKNEPY 190 (269)
T ss_pred eeeccccc--------------------------------------------------ccccccCcccCcChhhhcCCCC
Confidence 88654221 0113468899999999999899
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| |++|+++|+|+++.
T Consensus 191 ~~~~Dv~slG~ll~~l~~g~ 210 (269)
T cd08528 191 GEKADVWAFGCILYQMCTLQ 210 (269)
T ss_pred chHHHHHHHHHHHHHHHhCC
Confidence 99999 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=240.81 Aligned_cols=198 Identities=27% Similarity=0.433 Sum_probs=162.4
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 159 (333)
+.+..++|++.+.||+|+||.||+|.+..+++.||||.+...... .....+..|+.++... .|+||+++++++....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 455678899999999999999999999888999999998754221 1223345566666666 5999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
..++||||+ ++++.+++.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++..+.
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999999998 4577777655 4578999999999999999999997 699999999999999999999999999987653
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC----CC
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG----YG 313 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~ 313 (333)
..... ....+++.|+|||.+.+.. ++
T Consensus 167 ~~~~~--------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~ 196 (296)
T cd06618 167 DSKAK--------------------------------------------------TRSAGCAAYMAPERIDPPDPNPKYD 196 (296)
T ss_pred CCCcc--------------------------------------------------cCCCCCccccCHhhcCCCCCccccc
Confidence 22100 0224788999999997654 88
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| ||+|+++|+|+++.
T Consensus 197 ~~~Di~slG~il~el~~g~ 215 (296)
T cd06618 197 IRADVWSLGISLVELATGQ 215 (296)
T ss_pred cchhHHHHHHHHHHHHhCC
Confidence 9999 99999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=245.62 Aligned_cols=197 Identities=19% Similarity=0.313 Sum_probs=158.1
Q ss_pred eeEeee--cceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccC
Q 019953 92 TIIGRG--AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (333)
Q Consensus 92 ~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (333)
..||.| +||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|......++||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 9999999999999999999998754322 2344678889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccc
Q 019953 170 GGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247 (333)
Q Consensus 170 ~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~ 247 (333)
++++.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~--- 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK--- 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc---
Confidence 99999988764 3589999999999999999999999999999999999999999999999986544322110000
Q ss_pred cccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCcccc-hHHHHHH
Q 019953 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD-WLVSVLH 324 (333)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~D-ws~g~il 324 (333)
.. ........++..|+|||++.+ ..++.++| |++||++
T Consensus 160 ------~~---------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l 200 (328)
T cd08226 160 ------VV---------------------------------YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITA 200 (328)
T ss_pred ------cc---------------------------------ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHH
Confidence 00 000001235677999999976 45789999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 201 ~el~~g~ 207 (328)
T cd08226 201 CELATGR 207 (328)
T ss_pred HHHHhCC
Confidence 9999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=256.16 Aligned_cols=189 Identities=29% Similarity=0.504 Sum_probs=163.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 162 (333)
..+.|.+...+|.|+|+.|-.+.+..+++..++|++..... ...+|+.++... +|+||+++.+.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 36789999999999999999999999999999999976521 133366555544 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE-ccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL-DKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill-~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+|||.+.|+-+.+.+.....+. ..+..|+++|+.|+.|||++|+|||||||+|||+ +..++++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999888887766555 7888899999999999999999999999999999 58999999999999876533
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
..+.+-|..|.|||++...+||.+|| ||+
T Consensus 470 --------------------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSL 499 (612)
T KOG0603|consen 470 --------------------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSL 499 (612)
T ss_pred --------------------------------------------------hcccchhhcccChhhhccCCCCcchhhHHH
Confidence 11346788999999999999999999 999
Q ss_pred HHHHHhhhcccc
Q 019953 321 SVLHFNSYRFLE 332 (333)
Q Consensus 321 g~il~~l~t~~~ 332 (333)
|++||+||++..
T Consensus 500 GvlLy~ML~G~t 511 (612)
T KOG0603|consen 500 GVLLYEMLTGRT 511 (612)
T ss_pred HHHHHHHHhCCC
Confidence 999999999853
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=246.15 Aligned_cols=191 Identities=28% Similarity=0.468 Sum_probs=160.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC------
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 158 (333)
.++|.+.+.||+|+||.||+|.+..+|+.||||.+..... .......+.+|+.+++.+.|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3689999999999999999999998999999999865321 122334577899999999999999999988654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
...++|+||+. .+|..+. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....
T Consensus 93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 34699999995 4676655 34689999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D 317 (333)
.. ....+++.|+|||++.+ ..++.++|
T Consensus 170 ~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~D 197 (342)
T cd07879 170 EM----------------------------------------------------TGYVVTRWYRAPEVILNWMHYNQTVD 197 (342)
T ss_pred CC----------------------------------------------------CCceeeecccChhhhcCccccCchHH
Confidence 11 02357889999999876 46899999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 198 v~slGvil~el~~g~ 212 (342)
T cd07879 198 IWSVGCIMAEMLTGK 212 (342)
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=257.99 Aligned_cols=200 Identities=21% Similarity=0.346 Sum_probs=170.1
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
......+.+.||+|+||.|++|.|... ...||||++...... ...+.|++|+.+|.+|+|+|++++||+..+ ..
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 345567788999999999999988643 345899999876432 266789999999999999999999999987 66
Q ss_pred EEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
+.+|||+++.|+|.+.|.+ ...|.......++.||+.|+.||..+++|||||..+|+|+.....|||+||||.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 8899999999999999987 34688888899999999999999999999999999999999999999999999999887
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
+....+.. + ...-...|+|||.+....++.++|
T Consensus 265 ned~Yvm~----------------p------------------------------~rkvPfAWCaPEsLrh~kFShaSDv 298 (1039)
T KOG0199|consen 265 NEDMYVMA----------------P------------------------------QRKVPFAWCAPESLRHRKFSHASDV 298 (1039)
T ss_pred CCcceEec----------------C------------------------------CCcCcccccCHhHhccccccccchh
Confidence 65432100 0 112456899999999999999999
Q ss_pred hHHHHHHHhhhcccc
Q 019953 318 WLVSVLHFNSYRFLE 332 (333)
Q Consensus 318 ws~g~il~~l~t~~~ 332 (333)
|+.||.+|+||||-+
T Consensus 299 WmyGVTiWEMFtyGE 313 (1039)
T KOG0199|consen 299 WMYGVTIWEMFTYGE 313 (1039)
T ss_pred hhhhhhHHhhhccCC
Confidence 999999999999843
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=238.58 Aligned_cols=191 Identities=32% Similarity=0.553 Sum_probs=161.9
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeEEEEEe
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 166 (333)
|.+.+.||+|++|.||+|.+..+++.|+||.+...... .......+|+..++.+. |+|++++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999888999999998654221 11222446888999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 167 YLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|+ +++|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 789998887654 789999999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-CCCCCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~~D-ws~g~ 322 (333)
.....++..|+|||++. +..++.++| |++|+
T Consensus 155 -----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~ 187 (283)
T cd07830 155 -----------------------------------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGC 187 (283)
T ss_pred -----------------------------------------------cCCCCCcccccCceeeecCcCcCCccchhhHHH
Confidence 01235788999999885 456899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 188 ~l~el~~g~ 196 (283)
T cd07830 188 IMAELYTLR 196 (283)
T ss_pred HHHHHHhCC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=261.07 Aligned_cols=201 Identities=23% Similarity=0.350 Sum_probs=173.9
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCC---ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSG---NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
.++..+...+.++||.|.||.|+.|+.+..| ..||||.++.... ..+...|+.|+.||-++.||||+++-|+...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 3667788999999999999999999887666 5699999986532 3345668999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
...++||.|||++|+|..+|+.+ +.|+.-+..-+++.|+.|+.||-+++.|||||.++|||++.+..+|++|||+++.+
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999999875 57888888999999999999999999999999999999999999999999999987
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC--CCCCcccccccCCCCCc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG--TPDYIAPEVLLKKGYGM 314 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~ 314 (333)
.+..... ..+.-| +..|.|||++.-..+|.
T Consensus 782 edd~~~~------------------------------------------------ytt~GGKIPiRWTAPEAIa~RKFTs 813 (996)
T KOG0196|consen 782 EDDPEAA------------------------------------------------YTTLGGKIPIRWTAPEAIAYRKFTS 813 (996)
T ss_pred ccCCCcc------------------------------------------------ccccCCccceeecChhHhhhcccCc
Confidence 5443111 001122 45899999999999999
Q ss_pred ccc-hHHHHHHHhhhccc
Q 019953 315 ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~ 331 (333)
+|| ||.|++||+.++|=
T Consensus 814 ASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 814 ASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred hhhccccceEEEEecccC
Confidence 999 99999999998874
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=238.21 Aligned_cols=193 Identities=32% Similarity=0.497 Sum_probs=165.9
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
|++.+.||+|++|.||+|.+..+++.||+|++.... ........+..|+.+++.++|+|++++++++......++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 567889999999999999999999999999997653 1223345567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 168 LPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 168 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----- 153 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR----- 153 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-----
Confidence 96 5899999776 5799999999999999999999999999999999999999999999999999886543211
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVLH 324 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~il 324 (333)
......++..|+|||++.+. .++.++| |++|+++
T Consensus 154 --------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l 189 (282)
T cd07829 154 --------------------------------------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIF 189 (282)
T ss_pred --------------------------------------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHH
Confidence 00122467889999999876 8899999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 190 ~~l~~~~ 196 (282)
T cd07829 190 AEMITGK 196 (282)
T ss_pred HHHHhCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=245.49 Aligned_cols=196 Identities=24% Similarity=0.390 Sum_probs=160.6
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC------
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT------ 158 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 158 (333)
.++|.+.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 4689999999999999999999999999999999865432 3445677899999999999999998766543
Q ss_pred --------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-CCcEEEEe
Q 019953 159 --------EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSD 229 (333)
Q Consensus 159 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-~~~vkl~D 229 (333)
...++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35799999996 588887753 46899999999999999999999999999999999999974 56789999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||++..+....... .......|+..|+|||++.+
T Consensus 159 fg~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 159 FGLARIVDPHYSHK----------------------------------------------GYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred cccceecCCccccc----------------------------------------------cccccccccccccCHHHHhC
Confidence 99987653221100 00012257889999998754
Q ss_pred -CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 -KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 -~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| ||+||++|+|+++.
T Consensus 193 ~~~~~~~~DiwSlGvil~el~~g~ 216 (342)
T cd07854 193 PNNYTKAIDMWAAGCIFAEMLTGK 216 (342)
T ss_pred ccccCchhhHHHHHHHHHHHHhCC
Confidence 56889999 99999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=245.86 Aligned_cols=193 Identities=26% Similarity=0.448 Sum_probs=164.1
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe---
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY--- 160 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 160 (333)
..++|++.+.||+|++|.||+|.+..++..||||++..... .......+.+|+.+++.+.|+||+++.+++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35789999999999999999999999999999999865322 12233456779999999999999999887765544
Q ss_pred ---EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 161 ---LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 161 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799888865 569999999999999999999999999999999999999999999999999988653
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~ 316 (333)
... ....+++.|+|||++.+ ..++.++
T Consensus 170 ~~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~ 197 (343)
T cd07851 170 DEM----------------------------------------------------TGYVATRWYRAPEIMLNWMHYNQTV 197 (343)
T ss_pred ccc----------------------------------------------------cCCcccccccCHHHHhCCCCCCchH
Confidence 210 12357889999999866 4688999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| |++|+++|+|+++.
T Consensus 198 DvwslGv~l~elltg~ 213 (343)
T cd07851 198 DIWSVGCIMAELLTGK 213 (343)
T ss_pred hHHHHHHHHHHHHhCC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-33 Score=239.59 Aligned_cols=195 Identities=28% Similarity=0.430 Sum_probs=165.9
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC-----eE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-----YL 161 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 161 (333)
+.+-.+.||-|+||.||.+.|..+|+.||+|.+... .......+.+.+|+.+|..++|.|+...+++.+..+ .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 455567999999999999999999999999998754 333344566778999999999999999988877654 47
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+++|++ ..+|..++-+.+.++...++-+.+||+.||+|||+.+|+||||||.|.|+++|..+||||||+++.......
T Consensus 133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 8899999 569999999999999999999999999999999999999999999999999999999999999997654321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-CCcccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~D-ws 319 (333)
.....-+-|.+|+|||+++|.. |+.+.| ||
T Consensus 212 ------------------------------------------------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWS 243 (449)
T KOG0664|consen 212 ------------------------------------------------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWS 243 (449)
T ss_pred ------------------------------------------------hhhHHHHHHHHhccHHHhhcchhhcCccceeh
Confidence 0111236788999999999854 999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
.|||+-+|+...
T Consensus 244 VGCIFaELLgRr 255 (449)
T KOG0664|consen 244 VGCIFAELLQRK 255 (449)
T ss_pred hhHHHHHHHhhh
Confidence 999999998754
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=240.18 Aligned_cols=191 Identities=21% Similarity=0.299 Sum_probs=155.7
Q ss_pred cceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCHHHHH
Q 019953 98 AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL 177 (333)
Q Consensus 98 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 177 (333)
++|.||.+.+..+++.||||++..... .......+..|+.+++.++|+||+++++++...+..+++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445566667777999999999876422 2335567889999999999999999999999999999999999999999998
Q ss_pred HhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCcccc
Q 019953 178 MRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255 (333)
Q Consensus 178 ~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~ 255 (333)
... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||.+..+.........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~---------- 160 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV---------- 160 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc----------
Confidence 753 46889999999999999999999999999999999999999999999999988765432211000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCcccc-hHHHHHHHhhhccc
Q 019953 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.........++..|+|||++.+ ..++.++| |++||++|+|+++.
T Consensus 161 --------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~ 207 (314)
T cd08216 161 --------------------------------VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207 (314)
T ss_pred --------------------------------cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCC
Confidence 0001113457889999999976 46899999 99999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=236.76 Aligned_cols=193 Identities=33% Similarity=0.522 Sum_probs=165.2
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
|.+.+.||.|++|.||+|.+..+++.+++|.+...... ......+..|+.+++.++|+||+++++.+......++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 56788999999999999999889999999998755322 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 168 LPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 168 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
+++ ++.+++.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----
Confidence 965 88877765 45789999999999999999999999999999999999999999999999999876643220
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVLH 324 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~il 324 (333)
......++..|+|||.+.+. .++.++| |++|+++
T Consensus 154 --------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l 189 (283)
T cd05118 154 --------------------------------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF 189 (283)
T ss_pred --------------------------------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHH
Confidence 00123578899999999876 7899999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+|+.
T Consensus 190 ~~l~tg~ 196 (283)
T cd05118 190 AELLSRR 196 (283)
T ss_pred HHHHhCC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=249.63 Aligned_cols=194 Identities=23% Similarity=0.379 Sum_probs=164.6
Q ss_pred CCceEeeeEeeecceEEEEEEEecC----CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKS----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
....+.+.||.|-||.||.|..... .-.||||..+.+.. ....+.+..|+.+|++++||||++++|++... ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 3445668899999999999975432 34589999887542 34467799999999999999999999999754 58
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
|+|||+++.|.|..|+..++ .++......++.|++.||.|||+..+|||||..+|||+.+...|||+|||+++.+....
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999999997754 68888999999999999999999999999999999999999999999999999988766
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
++... ...-+.-|||||-+.-..++.+|| |.
T Consensus 546 yYkaS------------------------------------------------~~kLPIKWmaPESINfRrFTtASDVWM 577 (974)
T KOG4257|consen 546 YYKAS------------------------------------------------RGKLPIKWMAPESINFRRFTTASDVWM 577 (974)
T ss_pred hhhcc------------------------------------------------ccccceeecCccccchhcccchhhHHH
Confidence 54210 112345799999999999999999 99
Q ss_pred HHHHHHhhhcc
Q 019953 320 VSVLHFNSYRF 330 (333)
Q Consensus 320 ~g~il~~l~t~ 330 (333)
+||+||+++.+
T Consensus 578 FgVCmWEIl~l 588 (974)
T KOG4257|consen 578 FGVCMWEILSL 588 (974)
T ss_pred HHHHHHHHHHh
Confidence 99999998764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=253.07 Aligned_cols=199 Identities=29% Similarity=0.502 Sum_probs=168.3
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEe-
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ- 156 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~- 156 (333)
.......+-|++.+.||.|.+|+||++.++.+|+..|+|+....... -+.+..|.++++.. .|||++.+|++|.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34456678899999999999999999999999999999998765322 23455578888876 6899999999884
Q ss_pred ----eCCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEec
Q 019953 157 ----DTEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (333)
Q Consensus 157 ----~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DF 230 (333)
.++.+|||||||.+|+.-+++++ ...+.+..+..|++.++.|+.+||++.++|||||-.|||++.++.|||+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 35689999999999999999976 457899999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK- 309 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~- 309 (333)
|.+..++..- ....+.+|||.||||||+.-
T Consensus 168 GvSaQldsT~-------------------------------------------------grRnT~iGtP~WMAPEViac~ 198 (953)
T KOG0587|consen 168 GVSAQLDSTV-------------------------------------------------GRRNTFIGTPYWMAPEVIACD 198 (953)
T ss_pred eeeeeeeccc-------------------------------------------------ccccCcCCCcccccceeeecc
Confidence 9999876321 12226689999999999963
Q ss_pred ----CCCCcccc-hHHHHHHHhhhcc
Q 019953 310 ----KGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 310 ----~~~~~~~D-ws~g~il~~l~t~ 330 (333)
..|+..+| ||+|++..+|=.+
T Consensus 199 e~~d~tyd~R~D~WsLGITaIEladG 224 (953)
T KOG0587|consen 199 ESPDATYDYRSDLWSLGITAIEMAEG 224 (953)
T ss_pred cCCCCCcccccchhhccceeehhcCC
Confidence 45888999 9999998877443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=248.32 Aligned_cols=200 Identities=26% Similarity=0.383 Sum_probs=175.7
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
+.|+....+..+..+||-|-||.||.|.|+.-...||||.++.+. -..+.|+.|+.+|+.++|||+|+++|+|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 456777778888999999999999999999999999999997654 3456799999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
..+|||+|||..|+|.+|++... .++.-....++.||..|+.||..+++|||||.++|+|+.++..|||+|||+++.+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999997643 4677777778889999999999999999999999999999999999999999998
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
...++.+.. ..--+.-|.|||-+.-..++-++
T Consensus 416 tgDTYTAHA------------------------------------------------GAKFPIKWTAPEsLAyNtFSiKS 447 (1157)
T KOG4278|consen 416 TGDTYTAHA------------------------------------------------GAKFPIKWTAPESLAYNTFSIKS 447 (1157)
T ss_pred cCCceeccc------------------------------------------------CccCcccccCcccccccccccch
Confidence 766543210 12245689999999999999999
Q ss_pred c-hHHHHHHHhhhcc
Q 019953 317 D-WLVSVLHFNSYRF 330 (333)
Q Consensus 317 D-ws~g~il~~l~t~ 330 (333)
| |++||+||++-||
T Consensus 448 DVWAFGVLLWEIATY 462 (1157)
T KOG4278|consen 448 DVWAFGVLLWEIATY 462 (1157)
T ss_pred hhHHHHHHHHHHHhc
Confidence 9 9999999999775
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-33 Score=235.66 Aligned_cols=198 Identities=28% Similarity=0.492 Sum_probs=162.4
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHH-HHHhcCCceeEEEEEEeeCC
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~ 159 (333)
+.+..++.+-+..||.|+||+|++..++.+|+..|||.++.... .....+++.|.+. ++.-+.||||++||..-.++
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 44556778888999999999999999999999999999987654 2233445556654 55568899999999998899
Q ss_pred eEEEEEeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCc
Q 019953 160 YLYLIMEYLPGGDMMTLLM-----REDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
..|+.||+| ..||..+.+ .+..+++.....+....+.||.||-. ..|||||+||+|||++..|.+||||||++
T Consensus 137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 999999999 456554432 35679999999999999999999975 58999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KG 311 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~ 311 (333)
..+..+--.+ .-.|+..|||||-+.. .+
T Consensus 216 GqLv~SiAkT--------------------------------------------------~daGCrpYmAPERi~p~~~g 245 (361)
T KOG1006|consen 216 GQLVDSIAKT--------------------------------------------------VDAGCRPYMAPERIDPSDKG 245 (361)
T ss_pred HhHHHHHHhh--------------------------------------------------hccCCccccChhccCCccCC
Confidence 8765432111 2369999999999964 56
Q ss_pred CCcccc-hHHHHHHHhhhccc
Q 019953 312 YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~~ 331 (333)
|+-+|| ||+|+.||++-|+.
T Consensus 246 yDiRSDvWSLGITL~EvAtG~ 266 (361)
T KOG1006|consen 246 YDIRSDVWSLGITLYEVATGN 266 (361)
T ss_pred cchhhhhhhhcceEeeeecCC
Confidence 999999 99999999987763
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=232.72 Aligned_cols=195 Identities=30% Similarity=0.498 Sum_probs=161.5
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh--hhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+..|+.+++.++||||+++++.+......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588999999999999999999887777777776542211 112233456688999999999999999999888899999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 165 MEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988753 356899999999999999999999999999999999999975 579999999987653221
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
. ......|++.|+|||.+.+..++.++| |+
T Consensus 160 ~-------------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s 190 (260)
T cd08222 160 D-------------------------------------------------LATTFTGTPYYMSPEALKHQGYDSKSDIWS 190 (260)
T ss_pred c-------------------------------------------------cccCCCCCcCccCHHHHccCCCCchhhHHH
Confidence 1 001235888999999999889999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+|+++|+|+++.
T Consensus 191 lG~~~~~l~~~~ 202 (260)
T cd08222 191 LGCILYEMCCLA 202 (260)
T ss_pred HHHHHHHHHhCC
Confidence 999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=236.76 Aligned_cols=195 Identities=26% Similarity=0.356 Sum_probs=156.6
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHH--HHhcCCceeEEEEEEeeCC
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL--AEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l--~~l~h~~iv~~~~~~~~~~ 159 (333)
........+.+.||+|.||.||+|.|+ |..||||++...... ...+|.+|. ..++|+||..+++.-..++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~------SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDER------SWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEecccchh------hhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 344678899999999999999999987 889999999765322 133355554 4679999999987654332
Q ss_pred ----eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEecccCCCcEEEccCCcEEE
Q 019953 160 ----YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDKNGHMKL 227 (333)
Q Consensus 160 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlkp~Nill~~~~~vkl 227 (333)
+++||++|.+.|||.|+|.. ..++.....+++..++.||.+||.. .|.|||||..|||+..++.+.|
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 68999999999999999976 7799999999999999999999942 4999999999999999999999
Q ss_pred EeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc
Q 019953 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (333)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 307 (333)
+|+|||...+...+.. ++.+ ...+||..|||||++
T Consensus 358 ADLGLAv~h~~~t~~i----------------di~~-----------------------------N~rVGTKRYMAPEvL 392 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTI----------------DIPP-----------------------------NPRVGTKRYMAPEVL 392 (513)
T ss_pred eeceeeEEecccCCcc----------------cCCC-----------------------------CCccceeeccChHHh
Confidence 9999999877654321 1111 145899999999999
Q ss_pred cCCC----C--Ccccc-hHHHHHHHhhhcc
Q 019953 308 LKKG----Y--GMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 308 ~~~~----~--~~~~D-ws~g~il~~l~t~ 330 (333)
...- + =..+| |++|+++|++...
T Consensus 393 detin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 393 DETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred hhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 6432 1 22578 9999999998654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=240.77 Aligned_cols=191 Identities=24% Similarity=0.358 Sum_probs=156.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHH--hcCCceeEEEEEEeeCC---
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDTE--- 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~--- 159 (333)
....++.++||+|.||.||+|.. +++.||||+++... ...+..|.+|... +.|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 45677889999999999999974 47999999997653 3446667777664 58999999997765444
Q ss_pred -eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEecccCCCcEEEccCCcEEEEe
Q 019953 160 -YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH---------NYIHRDIKPDNLLLDKNGHMKLSD 229 (333)
Q Consensus 160 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~---------~ivHrDlkp~Nill~~~~~vkl~D 229 (333)
.++||++|.+.|+|.++|.. ..+++....+++..|+.||.|||+. .|+|||||..|||+..|++..|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 78999999999999999954 5689999999999999999999952 499999999999999999999999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||+|..+...... .-+..-+||..|||||++-|
T Consensus 360 FGLAl~~~p~~~~-----------------------------------------------~d~~~qVGT~RYMAPEvLEg 392 (534)
T KOG3653|consen 360 FGLALRLEPGKPQ-----------------------------------------------GDTHGQVGTRRYMAPEVLEG 392 (534)
T ss_pred cceeEEecCCCCC-----------------------------------------------cchhhhhhhhhhcCHHHHhh
Confidence 9999988743211 11124589999999999976
Q ss_pred CC-CC-----cccc-hHHHHHHHhhhccc
Q 019953 310 KG-YG-----MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~-~~-----~~~D-ws~g~il~~l~t~~ 331 (333)
.- +. .+.| |++|.++|+|.+.-
T Consensus 393 ainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 393 AINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred hcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 32 22 3689 99999999998764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=251.12 Aligned_cols=192 Identities=21% Similarity=0.266 Sum_probs=164.7
Q ss_pred eEeeeEeeecceEEEEEEEecCC----ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 89 ELLTIIGRGAFGEVRLCREKKSG----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
+..++||+|+||+||+|.+.-.| .+||||++.... .......+..|+.+|.+++|||++++++++..+. +.||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34679999999999999886554 468999886543 2334567889999999999999999999998776 8899
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
++|+++|.|.++++.+ .++.......|+.||++||.|||.+++|||||.++|||+.....+||+|||+++.+...+...
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999999875 578999999999999999999999999999999999999999999999999999887554221
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
. +....-.+.|||=|.+....|+..+| |++||
T Consensus 856 ~-----------------------------------------------~~~gK~pikwmale~i~~~~~thqSDVWsfGV 888 (1177)
T KOG1025|consen 856 S-----------------------------------------------APGGKVPIKWMALESIRIRKYTHQSDVWSFGV 888 (1177)
T ss_pred c-----------------------------------------------ccccccCcHHHHHHHhhccCCCchhhhhhhhh
Confidence 0 01223466899999999999999999 99999
Q ss_pred HHHhhhcc
Q 019953 323 LHFNSYRF 330 (333)
Q Consensus 323 il~~l~t~ 330 (333)
.+|+++||
T Consensus 889 tiWElmTF 896 (1177)
T KOG1025|consen 889 TIWELMTF 896 (1177)
T ss_pred hHHHHHhc
Confidence 99999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=244.20 Aligned_cols=195 Identities=25% Similarity=0.408 Sum_probs=166.4
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC------CceeEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS------HCIVKLYYS 154 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~ 154 (333)
+++.-++|.+....|+|-||+|..|.+...|..||||+|..+.... +.=+.|+++|+.|+. .++++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3445678999999999999999999999999999999998875432 224569999999963 278999999
Q ss_pred EeeCCeEEEEEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-CcEEEEec
Q 019953 155 FQDTEYLYLIMEYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDF 230 (333)
Q Consensus 155 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DF 230 (333)
|...+++|||+|-+ ..+|..++.+- -.+....++.++.|++.||..|-..||+|.||||+|||+++. ..+|||||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 99999999999988 67999999763 357888999999999999999999999999999999999865 46899999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 310 (333)
|.|......... ...-+..|.|||++.|.
T Consensus 582 GSA~~~~eneit---------------------------------------------------PYLVSRFYRaPEIiLG~ 610 (752)
T KOG0670|consen 582 GSASFASENEIT---------------------------------------------------PYLVSRFYRAPEIILGL 610 (752)
T ss_pred cccccccccccc---------------------------------------------------HHHHHHhccCcceeecC
Confidence 999876544311 12356689999999999
Q ss_pred CCCcccc-hHHHHHHHhhhccc
Q 019953 311 GYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+|+...| ||.||.||+|||+-
T Consensus 611 ~yd~~iD~WSvgctLYElYtGk 632 (752)
T KOG0670|consen 611 PYDYPIDTWSVGCTLYELYTGK 632 (752)
T ss_pred cccCCccceeeceeeEEeeccc
Confidence 9999999 99999999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=248.01 Aligned_cols=194 Identities=21% Similarity=0.363 Sum_probs=138.7
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecC----CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEE--
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKS----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS-- 154 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-- 154 (333)
.....++|.+.+.||+|+||.||+|.+..+ +..||+|.+...... +....+ .+....+.++..+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhh
Confidence 345678999999999999999999999888 899999987643211 111111 1111122222211111
Q ss_pred ----EeeCCeEEEEEeccCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcEec
Q 019953 155 ----FQDTEYLYLIMEYLPGGDMMTLLMREDT--------------------LTENVARFYIAQSVLAIESIHKHNYIHR 210 (333)
Q Consensus 155 ----~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~qi~~~L~~LH~~~ivHr 210 (333)
.......++||||+.+++|.+++..... .....+..++.|++.||.|||+++|+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2345679999999999999998864321 1123456789999999999999999999
Q ss_pred ccCCCcEEEcc-CCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhh
Q 019953 211 DIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (333)
Q Consensus 211 Dlkp~Nill~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
||||+|||++. ++.+||+|||+++.+.....+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~----------------------------------------------- 312 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY----------------------------------------------- 312 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCcccccccccc-----------------------------------------------
Confidence 99999999986 579999999999865432211
Q ss_pred ccccccCCCCCCcccccccCC----------------------CCCcccc-hHHHHHHHhhhc
Q 019953 290 KLAFSTVGTPDYIAPEVLLKK----------------------GYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 290 ~~~~~~~gt~~y~APE~~~~~----------------------~~~~~~D-ws~g~il~~l~t 329 (333)
.....+|++.|+|||.+... .++.++| ||+||++|+|++
T Consensus 313 -~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~ 374 (566)
T PLN03225 313 -IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAF 374 (566)
T ss_pred -CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHh
Confidence 11145789999999976422 2445679 999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=252.19 Aligned_cols=153 Identities=45% Similarity=0.777 Sum_probs=140.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|.+++.||+|+||.||+|.+..+++.||||++.............+..|+.++..++|+||+++++.+.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999765444444456688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
|||+.+++|.+++.....+++..++.++.|++.||.|||.++|+||||||+|||++.++.++|+|||+++...
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 9999999999999887789999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=263.77 Aligned_cols=181 Identities=19% Similarity=0.256 Sum_probs=154.2
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|.....||+|+||.||+|.+..++..||||.+...... ...|+..++.++||||+++++++......++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 456678999999999999999889999999998643211 1235788999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH---KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|+++|+|.+++. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++..++. ||.........
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~--- 836 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT--- 836 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC---
Confidence 999999999995 3788899999999999999999 6699999999999999999888875 66544321110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
...|++.|+|||++.+..++.++| ||+||
T Consensus 837 --------------------------------------------------~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gv 866 (968)
T PLN00113 837 --------------------------------------------------KCFISSAYVAPETRETKDITEKSDIYGFGL 866 (968)
T ss_pred --------------------------------------------------CccccccccCcccccCCCCCcccchhhHHH
Confidence 225889999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+|+.
T Consensus 867 vl~el~tg~ 875 (968)
T PLN00113 867 ILIELLTGK 875 (968)
T ss_pred HHHHHHhCC
Confidence 999999874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=215.21 Aligned_cols=187 Identities=27% Similarity=0.459 Sum_probs=160.9
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCC--e
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTE--Y 160 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~ 160 (333)
..++|++.+++|+|.++.|+.|.+..+.+.++||++++.. .+.+.+|+.||..+. ||||++++++..++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3578999999999999999999999999999999997653 244788999999996 999999999987654 4
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-CcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DFGla~~~~~~ 239 (333)
..+++||+++.+...+. ..++...++.++.+++.||.|+|++||+|||+||.|++||.. ..++|+|+|+|..+.++
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 77999999988777665 568888999999999999999999999999999999999954 57999999999988765
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D- 317 (333)
..+- ..+.+..|--||.+.. ..|+++-|
T Consensus 187 ~eYn--------------------------------------------------VRVASRyfKGPELLVdy~~YDYSLD~ 216 (338)
T KOG0668|consen 187 KEYN--------------------------------------------------VRVASRYFKGPELLVDYQMYDYSLDM 216 (338)
T ss_pred ceee--------------------------------------------------eeeehhhcCCchheeechhccccHHH
Confidence 4321 3467788889999976 56999999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
||+|||+-.|..
T Consensus 217 WS~GcmlA~miF 228 (338)
T KOG0668|consen 217 WSLGCMLASMIF 228 (338)
T ss_pred HHHHHHHHHHHh
Confidence 999999987753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=244.63 Aligned_cols=201 Identities=26% Similarity=0.424 Sum_probs=170.6
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEec-------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEE
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKL 151 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 151 (333)
.+++...+..+.+.||+|.||+|++|.-.. ....||||.++..... ...+.+..|+.+|+.+ .|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 577777778888899999999999986421 1467999999865432 5567789999999999 59999999
Q ss_pred EEEEeeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCC
Q 019953 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (333)
Q Consensus 152 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 215 (333)
+|.+...+.+++|+||+..|+|..++...+ .++......++.||+.|++||++..+|||||.++
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999997655 4888889999999999999999999999999999
Q ss_pred cEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccccc
Q 019953 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (333)
Q Consensus 216 Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (333)
|||++.+..+||+|||+|+.......+... ..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~------------------------------------------------~~ 479 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTK------------------------------------------------SS 479 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEec------------------------------------------------CC
Confidence 999999999999999999976654433210 11
Q ss_pred CC--CCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 296 VG--TPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 296 ~g--t~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.| +..|||||.+....|+.++| ||.|++||+++|.
T Consensus 480 ~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsL 517 (609)
T KOG0200|consen 480 AGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTL 517 (609)
T ss_pred CCccceeecCHHHhccCcccccchhhHHHHHHHHHhhC
Confidence 12 33599999999999999999 9999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=223.69 Aligned_cols=132 Identities=24% Similarity=0.435 Sum_probs=114.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-----CC---ceeEEEEEEe
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-----SH---CIVKLYYSFQ 156 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~---~iv~~~~~~~ 156 (333)
.++|.+.++||+|-|++||+|.|..+.+.||+|+.+... ...+....|+.+|++++ ++ +||++++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 389999999999999999999999999999999997653 34556777999999884 22 6999999996
Q ss_pred e----CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEcc
Q 019953 157 D----TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDK 221 (333)
Q Consensus 157 ~----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~ 221 (333)
. ..++|||+|++ |.+|..+|... +.++...++.|++||+.||.|||.. ||||.||||+|||+..
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence 5 45899999999 78888888653 4699999999999999999999975 9999999999999953
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=234.61 Aligned_cols=201 Identities=23% Similarity=0.337 Sum_probs=146.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEe----------------cCCceEEEEecchhHHhhh-----------hhHHHHH
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREK----------------KSGNIYAMKKLKKSEMVKR-----------GQVEHVR 134 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~----------------~~~~~vaiK~~~~~~~~~~-----------~~~~~~~ 134 (333)
.+..++|.+.++||+|+||.||+|.+. ..++.||||.+........ ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 345789999999999999999999652 2456799999864321100 0112233
Q ss_pred HHHHHHHHhcCCce-----eEEEEEEee--------CCeEEEEEeccCCCCHHHHHHhC---------------------
Q 019953 135 AERNLLAEVASHCI-----VKLYYSFQD--------TEYLYLIMEYLPGGDMMTLLMRE--------------------- 180 (333)
Q Consensus 135 ~e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~--------------------- 180 (333)
.|+.++..++|.++ ++++++|.. .+..++||||+++++|.+++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46777777776654 556665532 35689999999999999888532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCC
Q 019953 181 ---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257 (333)
Q Consensus 181 ---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 257 (333)
..++...++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--------------- 365 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--------------- 365 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---------------
Confidence 12345677889999999999999999999999999999999999999999998754322100
Q ss_pred CCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC--------------------CC--cc
Q 019953 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--------------------YG--ME 315 (333)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--------------------~~--~~ 315 (333)
......+++.|+|||++.... |+ .+
T Consensus 366 ---------------------------------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~ 412 (507)
T PLN03224 366 ---------------------------------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDL 412 (507)
T ss_pred ---------------------------------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCc
Confidence 000123588999999986432 22 24
Q ss_pred cc-hHHHHHHHhhhcc
Q 019953 316 CD-WLVSVLHFNSYRF 330 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~ 330 (333)
.| ||+||++|+|+++
T Consensus 413 ~DvwSlGvil~em~~~ 428 (507)
T PLN03224 413 FDSYTAGVLLMQMCVP 428 (507)
T ss_pred cchhhHHHHHHHHHhC
Confidence 79 9999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=209.79 Aligned_cols=194 Identities=42% Similarity=0.670 Sum_probs=167.7
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
|.+.+.||+|++|.||++.+..++..+|+|.+...... .....+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999888999999999765322 2456688899999999999999999999988999999999
Q ss_pred cCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 168 LPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 168 ~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
+++++|.+++..... +++.....++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~----- 153 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA----- 153 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-----
Confidence 999999999987666 89999999999999999999999999999999999999999999999999887643210
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc-cCCCCCcccc-hHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-LKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-~~~~~~~~~D-ws~g~il 324 (333)
.......++..|++||.+ .+.+++.++| |++|+++
T Consensus 154 -------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~ 190 (225)
T smart00221 154 -------------------------------------------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVIL 190 (225)
T ss_pred -------------------------------------------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHH
Confidence 001134578899999999 7778888999 9999999
Q ss_pred Hhhhccc
Q 019953 325 FNSYRFL 331 (333)
Q Consensus 325 ~~l~t~~ 331 (333)
|+|+++.
T Consensus 191 ~~l~~g~ 197 (225)
T smart00221 191 YELLWGP 197 (225)
T ss_pred HHHHHCC
Confidence 9998864
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=247.12 Aligned_cols=193 Identities=31% Similarity=0.547 Sum_probs=171.5
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
-..++|.++..+|+|+||.||+|++..+++..|+|+++... ......+++|+-+++.++||||+.+++.+.....++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 34578999999999999999999999999999999997653 234455778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+.||||.+|+|.+...-.+++++.++...+++.+.||+|||++|-+|||||-.||++++.|.+|+.|||.+..++..
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--- 165 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--- 165 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh---
Confidence 99999999999999988899999999999999999999999999999999999999999999999999998876522
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc---cCCCCCcccc-h
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKGYGMECD-W 318 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~---~~~~~~~~~D-w 318 (333)
....+++.|||+|||||+. ..++|+..|| |
T Consensus 166 ----------------------------------------------i~KrksfiGtpywmapEvaaverkggynqlcdiw 199 (829)
T KOG0576|consen 166 ----------------------------------------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIW 199 (829)
T ss_pred ----------------------------------------------hhhhhcccCCccccchhHHHHHhccccccccccc
Confidence 2234478999999999996 4678999999 9
Q ss_pred HHHHHHHhh
Q 019953 319 LVSVLHFNS 327 (333)
Q Consensus 319 s~g~il~~l 327 (333)
++|+...++
T Consensus 200 a~gitAiel 208 (829)
T KOG0576|consen 200 ALGITAIEL 208 (829)
T ss_pred ccccchhhh
Confidence 999765543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=221.88 Aligned_cols=149 Identities=17% Similarity=0.164 Sum_probs=118.2
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEec-CCceEEEEecchhHH--hhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
......++|.+.+.||+|+||+||+|.+.. +++.||||++..... ........+.+|+.+|+.+.|+|++..+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 344567889999999999999999998876 678889998753211 1122345688999999999999988533222
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccc-CCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI-KPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDl-kp~Nill~~~~~vkl~DFGla~~ 235 (333)
+..|+|||||+|++|.. +.. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 45799999999999963 211 11 1457889999999999999999999 99999999999999999999998
Q ss_pred CCC
Q 019953 236 LDC 238 (333)
Q Consensus 236 ~~~ 238 (333)
+..
T Consensus 162 ~~~ 164 (365)
T PRK09188 162 FRR 164 (365)
T ss_pred ccc
Confidence 754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=209.22 Aligned_cols=182 Identities=45% Similarity=0.796 Sum_probs=159.9
Q ss_pred cceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCHHHHH
Q 019953 98 AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL 177 (333)
Q Consensus 98 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 177 (333)
+||.||+|.+..+++.+|+|++........ ...+.+|+..++.++|+|++++++.+......++++||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988899999999976543221 466888999999999999999999999989999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCC
Q 019953 178 MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257 (333)
Q Consensus 178 ~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 257 (333)
.....++...+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---------------- 142 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---------------- 142 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc----------------
Confidence 7766689999999999999999999999999999999999999999999999999987653310
Q ss_pred CCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.....++..|+|||.+.+..++.++| |++|+++|+|+++.
T Consensus 143 ----------------------------------~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~ 183 (244)
T smart00220 143 ----------------------------------LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGK 183 (244)
T ss_pred ----------------------------------cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 11345888999999999889999999 99999999999863
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-29 Score=215.92 Aligned_cols=193 Identities=26% Similarity=0.412 Sum_probs=163.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE---- 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 159 (333)
...+|.-+..+|.|.- .|..|-|.-.+++||+|..... ...........+|..++..+.|+||++++.+|....
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 4567888999999998 7888888899999999988665 333334456778999999999999999999997653
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 --YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.+|+|||++ ..+|.+.+. -.++-..+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+.-+
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 589999999 568888776 346777889999999999999999999999999999999999999999999998644
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
..- ..+..+.+..|.|||++.+.+|...+|
T Consensus 170 ~~~--------------------------------------------------~mtpyVvtRyyrapevil~~~~ke~vd 199 (369)
T KOG0665|consen 170 TDF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVD 199 (369)
T ss_pred ccc--------------------------------------------------ccCchhheeeccCchheeccCCcccch
Confidence 220 111457899999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||.||++-+|+++.
T Consensus 200 iwSvGci~gEli~~~ 214 (369)
T KOG0665|consen 200 IWSVGCIMGELILGT 214 (369)
T ss_pred hhhhhhHHHHHhhce
Confidence 99999999998864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-26 Score=194.06 Aligned_cols=183 Identities=42% Similarity=0.687 Sum_probs=159.1
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCH
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 173 (333)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++++++++++......+++||++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654321 345688899999999999999999999998999999999998999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-CCcEEEEeccCcccCCCCcccccccccccC
Q 019953 174 MTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251 (333)
Q Consensus 174 ~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 251 (333)
.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9999765 57899999999999999999999999999999999999999 89999999999987653321
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHHHHhh
Q 019953 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVLHFNS 327 (333)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~il~~l 327 (333)
......+...|++||.+... .++.+.| |++|+++|+|
T Consensus 149 ---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 ---------------------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ---------------------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 00123588899999999887 8899999 9999999986
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=218.47 Aligned_cols=223 Identities=22% Similarity=0.378 Sum_probs=163.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEec---CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCe
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEY 160 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 160 (333)
...|.++.+||+|+|+.||+|.+.. ....||+|.+..... ...+..|+++|..+. +.||+++.+++...+.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3568899999999999999998877 788999999876543 234778999999984 6799999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-CCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~~~ 239 (333)
+.+|+||++.....++.. .++-..++.+++.++.||.++|.+|||||||||+|||.+. .+.-.|+|||+|...+..
T Consensus 110 v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999999999998888884 3668889999999999999999999999999999999984 578899999999843211
Q ss_pred ccccccc-----cccc-Cccc-cCCCC---CCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 240 TLYAIHE-----HKTI-DDEN-MAEPM---DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 240 ~~~~~~~-----~~~~-~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
....... +..+ .+.. .+... +.+.++.. .+ ...++...-...||++|+|||++..
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~--------~~-------~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYR--------RC-------NDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCcee--------cc-------CCCccceecccCCCCCCCchHHHhh
Confidence 1000000 0000 0000 00000 00111110 00 0011122224579999999999987
Q ss_pred CC-CCcccc-hHHHHHHHhhhcc
Q 019953 310 KG-YGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 310 ~~-~~~~~D-ws~g~il~~l~t~ 330 (333)
.+ .+.++| ||.|||+.-+++.
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~ 274 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSR 274 (418)
T ss_pred ccCcCCccceeeccceeehhhcc
Confidence 55 688999 9999999877764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=229.00 Aligned_cols=185 Identities=25% Similarity=0.362 Sum_probs=151.3
Q ss_pred eeeEeeecceE-EEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEEecc
Q 019953 91 LTIIGRGAFGE-VRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 91 ~~~lg~G~~g~-V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (333)
.+.+|.|+-|+ ||+|. ..|+.||||.+-.. ......+|+..|+.. .||||+++|+.-.+....||..|+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 46788998876 78776 45889999987543 334577899999988 6999999999999999999999999
Q ss_pred CCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CC--cEEEEeccCcccCCCC
Q 019953 169 PGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NG--HMKLSDFGLCKPLDCS 239 (333)
Q Consensus 169 ~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~--~vkl~DFGla~~~~~~ 239 (333)
..+|.+++.... .......+..+.|++.||.+||+.+||||||||.||||+. ++ .++|+|||+++.+..+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 569999997641 1111345677899999999999999999999999999986 33 6899999999998755
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
...- +...+..||-+|+|||++.+..-+.++| +
T Consensus 665 ~sS~----------------------------------------------~r~s~~sGt~GW~APE~L~~~~~~~avDiF 698 (903)
T KOG1027|consen 665 KSSF----------------------------------------------SRLSGGSGTSGWQAPEQLREDRKTQAVDIF 698 (903)
T ss_pred cchh----------------------------------------------hcccCCCCcccccCHHHHhccccCcccchh
Confidence 4211 1123557999999999999999999999 9
Q ss_pred HHHHHHHhhhcc
Q 019953 319 LVSVLHFNSYRF 330 (333)
Q Consensus 319 s~g~il~~l~t~ 330 (333)
++||++|+.+++
T Consensus 699 slGCvfyYvltg 710 (903)
T KOG1027|consen 699 SLGCVFYYVLTG 710 (903)
T ss_pred hcCceEEEEecC
Confidence 999999998876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=202.44 Aligned_cols=190 Identities=23% Similarity=0.371 Sum_probs=154.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEE-EEeeCCeEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYY-SFQDTEYLY 162 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~-~~~~~~~~~ 162 (333)
.+.|.+.+.||+|.||.+-+|+++.+.+.+++|.++..... ...+.+|...--.| .|.||+..|+ .|+..+.+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 46799999999999999999999999999999999876432 34466676665555 4679998885 578888899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc--CCcEEEEeccCcccCCCCc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~~~~~~ 240 (333)
++|||++.|+|.+-+.. ..+.+...+.++.|+++||.|+|+.++||||||.+||||.. ...|||||||+++..+.--
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999999999888744 45888889999999999999999999999999999999963 3489999999998754211
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CC--CCcc
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KG--YGME 315 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~--~~~~ 315 (333)
. ..--+..|.|||+... +. .+++
T Consensus 178 ~----------------------------------------------------~~~~~~~y~~pe~~~~~~ne~~~~~ps 205 (378)
T KOG1345|consen 178 K----------------------------------------------------YLEYVNNYHAPELCDTVVNEKLVVNPS 205 (378)
T ss_pred h----------------------------------------------------hhhhhcccCCcHHHhhccccceEeccc
Confidence 0 1124678999999753 22 5889
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| |.+|+++|..+|+.
T Consensus 206 ~D~WqfGIi~f~cltG~ 222 (378)
T KOG1345|consen 206 TDIWQFGIIFFYCLTGK 222 (378)
T ss_pred ccchheeeeeeeeecCC
Confidence 99 99999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=198.15 Aligned_cols=204 Identities=25% Similarity=0.315 Sum_probs=159.9
Q ss_pred CceEeeeEeeecceEEEEEEEecCC-ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC----CceeEEEEEE-eeCCe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSG-NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS----HCIVKLYYSF-QDTEY 160 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~ 160 (333)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+......... ..+..|..++..+.. ++++.+++.+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 6789998765432211 136668888888863 5899999998 47778
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-----CcEEEEeccCc
Q 019953 161 LYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-----GHMKLSDFGLC 233 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-----~~vkl~DFGla 233 (333)
-++||+.+ |.+|.++.... +.++...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 88999988543 579999999999999999999999999999999999999865 46999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
+........... . . ..+.....+.||..|+++.++.+...+
T Consensus 175 r~~~~~~~~~~~-~-~-------------------------------------~~r~~~~~~rGT~ry~S~~~H~~~e~~ 215 (322)
T KOG1164|consen 175 RRFKYVGDSGGN-L-R-------------------------------------PPRPQKGLFRGTLRYASINVHLGIEQG 215 (322)
T ss_pred ccccccCCCCcc-c-c-------------------------------------cCCCCccCCCCccccccHHHhCCCccC
Confidence 943321110000 0 0 000001245699999999999999999
Q ss_pred cccc-hHHHHHHHhhhcc-ccC
Q 019953 314 MECD-WLVSVLHFNSYRF-LEF 333 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~-~~~ 333 (333)
++.| ||++-++.+++.+ .||
T Consensus 216 r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 216 RRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred CchhhhhHHHHHHHHhcCCCCC
Confidence 9999 9998888888766 554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=185.24 Aligned_cols=204 Identities=25% Similarity=0.317 Sum_probs=164.6
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC-CceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 160 (333)
.+..+.|.+++.||+|+||.+|+|....+|..||||+-.... ....+.-|..+...+++ +.|+.+..++.+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 356789999999999999999999999999999999875442 12336668899999876 588888888888888
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC---CcEEEEeccCcccC
Q 019953 161 LYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN---GHMKLSDFGLCKPL 236 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~---~~vkl~DFGla~~~ 236 (333)
-.+||+++ |.+|.++..- ...++...+.-++-||+.-++|+|.+++|||||||+|+|..-+ ..+.++|||+|+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 8899998854 5679999999999999999999999999999999999998643 46999999999988
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
-+...... +|. ..-....||..|.+--++.+...++..
T Consensus 165 ~d~~t~~H--------------------Ipy----------------------re~r~ltGTaRYASinAh~g~eqSRRD 202 (341)
T KOG1163|consen 165 RDIRTRQH--------------------IPY----------------------REDRNLTGTARYASINAHLGIEQSRRD 202 (341)
T ss_pred cccccccc--------------------Ccc----------------------ccCCccceeeeehhhhhhhhhhhhhhh
Confidence 65443221 100 011245799999999999999999999
Q ss_pred c-hHHH-HHHHhhhccccC
Q 019953 317 D-WLVS-VLHFNSYRFLEF 333 (333)
Q Consensus 317 D-ws~g-~il~~l~t~~~~ 333 (333)
| =|+| |+||..-+-.||
T Consensus 203 DmeSvgYvLmYfnrG~LPW 221 (341)
T KOG1163|consen 203 DMESVGYVLMYFNRGSLPW 221 (341)
T ss_pred hhhhhcceeeeeecCCCcc
Confidence 9 9998 566654444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=186.51 Aligned_cols=143 Identities=20% Similarity=0.212 Sum_probs=111.9
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhh-----------------------hHHHHHHHHHHHHHhcCCc
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-----------------------QVEHVRAERNLLAEVASHC 147 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~~ 147 (333)
...||+|+||.||+|.+. +|+.||||+++........ .......|..++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999764211100 0123345899999998877
Q ss_pred eeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEecccCCCcEEEccCCcEE
Q 019953 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLLLDKNGHMK 226 (333)
Q Consensus 148 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~L-H~~~ivHrDlkp~Nill~~~~~vk 226 (333)
+.......... .++||||++|+++.........++...+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 64433322222 389999998887766544566899999999999999999999 799999999999999998 57899
Q ss_pred EEeccCcccCC
Q 019953 227 LSDFGLCKPLD 237 (333)
Q Consensus 227 l~DFGla~~~~ 237 (333)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=180.42 Aligned_cols=145 Identities=19% Similarity=0.167 Sum_probs=113.8
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhh-----------------------hhhHHHHHHHHHHHHHhcCCc
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-----------------------RGQVEHVRAERNLLAEVASHC 147 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~h~~ 147 (333)
.+.||+|+||+||+|.+. +|+.||||+++...... ......+..|...+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 89999999987642110 001223457889999999998
Q ss_pred eeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEE
Q 019953 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMK 226 (333)
Q Consensus 148 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vk 226 (333)
+.......... .++||||++|+++.........++...+..++.|++.++.++|+ .||+||||||+||+++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75444333322 48999999887654443344567888999999999999999999 9999999999999998 89999
Q ss_pred EEeccCcccCCCC
Q 019953 227 LSDFGLCKPLDCS 239 (333)
Q Consensus 227 l~DFGla~~~~~~ 239 (333)
|+|||++...+..
T Consensus 158 liDFG~a~~~~~~ 170 (190)
T cd05145 158 IIDVSQAVELDHP 170 (190)
T ss_pred EEEcccceecCCC
Confidence 9999999977543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=186.60 Aligned_cols=198 Identities=22% Similarity=0.332 Sum_probs=163.8
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 161 (333)
+..-+|+++++||+|+||+++.|.+..++++||||.-+... ...++..|-...+.|. .++|+..|.+..+..+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 45568999999999999999999999999999999765432 2234677888888885 57999999988888888
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-----cEEEEeccCccc
Q 019953 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-----HMKLSDFGLCKP 235 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-----~vkl~DFGla~~ 235 (333)
.||||++ |-||.++..- ...|+...+..++.||+.-++++|++.+|.|||||+|+||...+ .+.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 8899998864 56899999999999999999999999999999999999997543 689999999998
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
+-++..... .++ ...++..||..||+---++|...+++
T Consensus 179 YrDp~TkqH---------------------------IPY---------------rE~KSLsGTARYMSINTHlGrEQSRR 216 (449)
T KOG1165|consen 179 YRDPKTKQH---------------------------IPY---------------REHKSLSGTARYMSINTHLGREQSRR 216 (449)
T ss_pred hcCcccccc---------------------------Ccc---------------ccccccccceeeeEeeccccchhhhh
Confidence 765543221 111 12336789999999999999999999
Q ss_pred cc-hHHH-HHHHhhh
Q 019953 316 CD-WLVS-VLHFNSY 328 (333)
Q Consensus 316 ~D-ws~g-~il~~l~ 328 (333)
.| =++| |+||.|=
T Consensus 217 DDLEaLGHvFmYFLR 231 (449)
T KOG1165|consen 217 DDLEALGHVFMYFLR 231 (449)
T ss_pred hhHHHhhhhhhhhcc
Confidence 99 9999 5555543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=192.76 Aligned_cols=204 Identities=19% Similarity=0.272 Sum_probs=166.3
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCC-----ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEE
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSG-----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 152 (333)
.....+...++++...+-+|.||.||.|.++..+ +.|-+|.++... ++-+...+..|.-.+..+.|||+..+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 3445566678899999999999999999876543 345566665432 334556788899999999999999999
Q ss_pred EEEeeC-CeEEEEEeccCCCCHHHHHH-----h---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 153 YSFQDT-EYLYLIMEYLPGGDMMTLLM-----R---EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 153 ~~~~~~-~~~~lv~e~~~~g~L~~~l~-----~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
++...+ ...++++.+..-|+|..++. + .+.++..+...++.|++.|+.|||++|+||.||.++|++|++.-
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence 887654 46788899998899999996 2 23577778888899999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|=.+++-+-+.+++-.+. .-..+..|||
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGD-----------------------------------------------nEnRPvkWMs 466 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGD-----------------------------------------------NENRPVKWMS 466 (563)
T ss_pred eEEeccchhccccCcccccccCC-----------------------------------------------CCCCcccccC
Confidence 99999999999887666543222 1125678999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
||.+.+..|+.++| |++||+||+|+|-
T Consensus 467 lEal~n~~yssasDvWsfGVllWELmtl 494 (563)
T KOG1024|consen 467 LEALQNSHYSSASDVWSFGVLLWELMTL 494 (563)
T ss_pred HHHHhhhhhcchhhhHHHHHHHHHHHhc
Confidence 99999999999999 9999999999873
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-22 Score=184.07 Aligned_cols=198 Identities=41% Similarity=0.627 Sum_probs=165.4
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC-ceeEEEEEEeeCCeEEEEEe
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 166 (333)
|.+...||.|+||.||.+.+. ..+++|.+.............+.+|+.++..+.|+ +|+.+.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999877 78999999876543333456788899999999998 79999999987777899999
Q ss_pred ccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-cEEEEeccCcccCCCCccc
Q 019953 167 YLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~~~~~~~ 242 (333)
++.++++.+++.... .+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776664 799999999999999999999999999999999999999998 7999999999855433211
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CCCCcccc-h
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECD-W 318 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~D-w 318 (333)
.... ......+|+..|+|||.+.+ ..++...| |
T Consensus 159 ~~~~-------------------------------------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~ 195 (384)
T COG0515 159 SSIP-------------------------------------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW 195 (384)
T ss_pred cccc-------------------------------------------ccccccccccccCCHHHhcCCCCCCCCchHhHH
Confidence 0000 01225679999999999988 57899999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
++|++++.+++..
T Consensus 196 s~g~~~~~~~~~~ 208 (384)
T COG0515 196 SLGITLYELLTGL 208 (384)
T ss_pred HHHHHHHHHHhCC
Confidence 9999999877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=182.38 Aligned_cols=142 Identities=16% Similarity=0.188 Sum_probs=115.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHH------HHHHHHHHHHhcCCceeEEEEEEee
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH------VRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
..++|++++.+|.|+||.||++.+ ++..+|||++.......+..... +.+|+..+.++.|++|+.+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 357999999999999999999755 46689999997654333333222 5789999999999999999887653
Q ss_pred C--------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEe
Q 019953 158 T--------EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSD 229 (333)
Q Consensus 158 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~D 229 (333)
. +..++||||++|.+|.+... +++ ....+++.+|..+|+.|++|||+||+||+++.+| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3 35889999999999987732 333 2456999999999999999999999999999988 99999
Q ss_pred ccCcccC
Q 019953 230 FGLCKPL 236 (333)
Q Consensus 230 FGla~~~ 236 (333)
||..+..
T Consensus 178 fg~~~~~ 184 (232)
T PRK10359 178 LSGKRCT 184 (232)
T ss_pred CCCcccc
Confidence 9988754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=214.38 Aligned_cols=164 Identities=12% Similarity=0.122 Sum_probs=112.7
Q ss_pred CceeEEEEEE-------eeCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcE
Q 019953 146 HCIVKLYYSF-------QDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (333)
Q Consensus 146 ~~iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Ni 217 (333)
+||..++++| .....++.+||++ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 3666666666 2234577888987 67999999653 4699999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchH---HhHHHHhh----hhc
Q 019953 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHE---QLQHWQMN----RRK 290 (333)
Q Consensus 218 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----~~~ 290 (333)
||+..+.+|++|||++......... ..-..|++.+...... ........ ...
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~---------------------~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 170 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDA---------------------TTKSREIGSSRREEILSERRIEKLEEVKKQPFPM 170 (793)
T ss_pred EEcccCcEEEeeccccCcccccccC---------------------cccccccccccccccccccchhhhhccccCCCcc
Confidence 9998888888888887654321110 0000111111100000 00000000 000
Q ss_pred cccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 291 LAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 291 ~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.....+||+.|||||++.+..|+.++| |++||++|+|++..
T Consensus 171 ~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~ 212 (793)
T PLN00181 171 KQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPV 212 (793)
T ss_pred cccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCC
Confidence 011246899999999999999999999 99999999999754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=166.77 Aligned_cols=136 Identities=15% Similarity=0.233 Sum_probs=107.1
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-----cCCceeEEEEEEeeCC---eEE
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-----ASHCIVKLYYSFQDTE---YLY 162 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~~~ 162 (333)
...||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||+++++++.++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 6666665 6998865421 2335688899999999 5799999999998873 444
Q ss_pred -EEEec--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCcEecccCCCcEEEccC----CcEEEEe-ccCc
Q 019953 163 -LIMEY--LPGGDMMTLLMREDTLTENVARFYIAQSVLAI-ESIHKHNYIHRDIKPDNLLLDKN----GHMKLSD-FGLC 233 (333)
Q Consensus 163 -lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L-~~LH~~~ivHrDlkp~Nill~~~----~~vkl~D-FGla 233 (333)
+|||| +.+++|.+++... .+++. ..++.|++.++ .|||+++|+||||||+|||++.. +.++|+| ||..
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 5579999999664 46555 35678888888 89999999999999999999743 3799999 5554
Q ss_pred cc
Q 019953 234 KP 235 (333)
Q Consensus 234 ~~ 235 (333)
..
T Consensus 158 ~~ 159 (210)
T PRK10345 158 TF 159 (210)
T ss_pred ce
Confidence 44
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-21 Score=162.47 Aligned_cols=195 Identities=17% Similarity=0.165 Sum_probs=134.9
Q ss_pred eEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhh-hHHHHHHHHHHHHHhcC-CceeEEEEEEeeCCeEEEEEe
Q 019953 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG-QVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 166 (333)
.+...|++|+||+|+++.. .+..++.+.+......... ....+.+|+.+|+++.| ++++.++++ +..+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999997764 6778887777654332111 12247789999999965 679998875 34699999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccc-CCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDI-KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDl-kp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|+.|.+|...+.. ....++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++..........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~-- 149 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM-- 149 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH--
Confidence 9999888654321 11346789999999999999999999 7999999999999999999998644321000
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCC-cccch-HHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYG-MECDW-LVSV 322 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~-~~~Dw-s~g~ 322 (333)
.. .-..+-..-+.+| ...++.|++|+...-- ..+ .+.+| +.|+
T Consensus 150 r~------------------------L~~rDl~~llk~~----------~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~ 195 (218)
T PRK12274 150 RL------------------------LAREDLRHLLKHK----------RMYCPAALTPVERRVLKRTSWIRELWFATGK 195 (218)
T ss_pred HH------------------------HHHHHHHHHHHHH----------HhcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence 00 0000111111222 1378899999875432 333 45674 5699
Q ss_pred HHHhhhcccc
Q 019953 323 LHFNSYRFLE 332 (333)
Q Consensus 323 il~~l~t~~~ 332 (333)
.+|.++|..-
T Consensus 196 ~~~~~~~~~~ 205 (218)
T PRK12274 196 PVYRFVTRRV 205 (218)
T ss_pred hHHHHHhccC
Confidence 9999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=169.62 Aligned_cols=147 Identities=16% Similarity=0.123 Sum_probs=115.6
Q ss_pred CceEeeeEeeecceEEEEEE-EecCCceEEEEecchhHHhh---------------------hhhHHHHHHHHHHHHHhc
Q 019953 87 DFELLTIIGRGAFGEVRLCR-EKKSGNIYAMKKLKKSEMVK---------------------RGQVEHVRAERNLLAEVA 144 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~-~~~~~~~vaiK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~ 144 (333)
-|.+.+.||+|+||.||+|. +..+|+.||||+++...... ......+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 66789999999987542100 001123567999999997
Q ss_pred CC--ceeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-cEecccCCCcEEEcc
Q 019953 145 SH--CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN-YIHRDIKPDNLLLDK 221 (333)
Q Consensus 145 h~--~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlkp~Nill~~ 221 (333)
+. .++.++.. ...++||||++|.+|..............+..++.|++.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 63 34444442 234899999998888766544455666777889999999999999999 99999999999999
Q ss_pred CCcEEEEeccCcccCCC
Q 019953 222 NGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 222 ~~~vkl~DFGla~~~~~ 238 (333)
++.++|+|||.+.....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 88999999999886554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=196.30 Aligned_cols=196 Identities=20% Similarity=0.264 Sum_probs=154.3
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc---CCceeEEEEEEee
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQD 157 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 157 (333)
.++....|.|.+.||+|+||+||.|.+.. |+.||+|+-+...... +.--..++.+|+ -+.|..+...+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34456779999999999999999999876 9999999987654322 111233444444 2344555555555
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-------CCcEEEEec
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-------NGHMKLSDF 230 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-------~~~vkl~DF 230 (333)
.+.-++|+||.+.|+|.++++..+.+++..+..++.||+..++.||.++|||+||||+|+||.. .-.++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 5667899999999999999998889999999999999999999999999999999999999952 236999999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 310 (333)
|-+.-+..-. ........++|-.+-.+|+..|.
T Consensus 846 G~siDm~lfp-----------------------------------------------~~~~F~~~~~td~f~C~EM~~gr 878 (974)
T KOG1166|consen 846 GRSIDMKLFP-----------------------------------------------DGTKFKAVWHTDLFDCIEMREGR 878 (974)
T ss_pred ccceeeeEcC-----------------------------------------------CCcEEeeeeccccchhHHHhcCC
Confidence 9876543211 01223356899999999999999
Q ss_pred CCCcccc-hHHHHHHHhhhcc
Q 019953 311 GYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t~ 330 (333)
+|++..| +-++-+++-||.+
T Consensus 879 pWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 879 PWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred CCchhhhhHHHHHHHHHHHHH
Confidence 9999999 9899888888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-23 Score=193.75 Aligned_cols=183 Identities=40% Similarity=0.640 Sum_probs=158.2
Q ss_pred eEeeecceEEEEEEE---ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeEEEEEecc
Q 019953 93 IIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 168 (333)
.+|.|+||.|++++- ...|..+|+|+..+......... ....|..++..++ ||.++++...++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 368999999997642 34578899999877654433333 5667888999987 899999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccccc
Q 019953 169 PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248 (333)
Q Consensus 169 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 248 (333)
.||.|...+.....+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence 999999999888889999999999999999999999999999999999999999999999999998653221
Q ss_pred ccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhh
Q 019953 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNS 327 (333)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l 327 (333)
-.|||..|||||++. +...++| |++|+++|+|
T Consensus 152 ---------------------------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~fel 184 (612)
T KOG0603|consen 152 ---------------------------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFEL 184 (612)
T ss_pred ---------------------------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHH
Confidence 128999999999998 7889999 8889999999
Q ss_pred hccc
Q 019953 328 YRFL 331 (333)
Q Consensus 328 ~t~~ 331 (333)
+|+.
T Consensus 185 ltg~ 188 (612)
T KOG0603|consen 185 LTGT 188 (612)
T ss_pred hhCC
Confidence 9874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=195.59 Aligned_cols=196 Identities=24% Similarity=0.384 Sum_probs=154.2
Q ss_pred eEeeeEeeecceEEEEEEEecCCceEEEEecch---hHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK---SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
.....+|.|++|.|+.+........++.|.+.. ...........+..|..+-..+.|+|++.....+.......-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 467889999999888887766666666665431 11112222223666777888899999887766655544445559
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|||++ +|..++.....+....+..++.|++.|+.|+|..||.|||+||+|++++.+|.+||+|||.+..+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~--- 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK--- 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch---
Confidence 99999 99999988878999999999999999999999999999999999999999999999999998876533211
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCc-ccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM-ECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~-~~D-ws~g~i 323 (333)
.......++|+..|+|||++.+..|++ ..| |++|++
T Consensus 477 ------------------------------------------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii 514 (601)
T KOG0590|consen 477 ------------------------------------------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGII 514 (601)
T ss_pred ------------------------------------------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccce
Confidence 112334678999999999999999976 688 999999
Q ss_pred HHhhhcc
Q 019953 324 HFNSYRF 330 (333)
Q Consensus 324 l~~l~t~ 330 (333)
++.|.++
T Consensus 515 ~~~m~~~ 521 (601)
T KOG0590|consen 515 YICMILG 521 (601)
T ss_pred EEEEecC
Confidence 9988765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-20 Score=158.80 Aligned_cols=138 Identities=23% Similarity=0.293 Sum_probs=114.0
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHH-----hhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-----VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
+.||+|++|.||+|.+ .|..|++|+...... ........+.+|+.++..+.|++++....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999986 677899998654221 112223457789999999999988777767666777899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||++...
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999998865432 7778899999999999999999999999999999 889999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=155.33 Aligned_cols=134 Identities=21% Similarity=0.273 Sum_probs=107.0
Q ss_pred eEeeecceEEEEEEEecCCceEEEEecchhHH-----hhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-----VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
.||+|+||.||+|.+ +|..|++|....... ........+.+|+.++..+.++++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999984 578899998653221 1122235577899999999988655554455556667899999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 168 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988754321 7789999999999999999999999999999 899999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.5e-20 Score=152.94 Aligned_cols=99 Identities=21% Similarity=0.322 Sum_probs=88.0
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccc
Q 019953 171 GDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (333)
Q Consensus 171 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 249 (333)
|+|.+++.. ...+++..+..++.|++.||.|||+++ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 689999976 456999999999999999999999999 999999999999999 9998764321
Q ss_pred cCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhh
Q 019953 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSY 328 (333)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~ 328 (333)
...|++.|||||++.+..++.++| ||+||++|+|+
T Consensus 63 --------------------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 98 (176)
T smart00750 63 --------------------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL 98 (176)
T ss_pred --------------------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHH
Confidence 125889999999999999999999 99999999999
Q ss_pred ccc
Q 019953 329 RFL 331 (333)
Q Consensus 329 t~~ 331 (333)
|+.
T Consensus 99 tg~ 101 (176)
T smart00750 99 DYE 101 (176)
T ss_pred hCC
Confidence 875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=154.33 Aligned_cols=141 Identities=20% Similarity=0.172 Sum_probs=108.9
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh-------------------hhhHHHHHHHHHHHHHhcCC--
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-------------------RGQVEHVRAERNLLAEVASH-- 146 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-------------------~~~~~~~~~e~~~l~~l~h~-- 146 (333)
|.+.+.||+|+||.||+|.+. +|+.||||++....... .........|..++..+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777899999999999999864 79999999876432000 00112356688888888777
Q ss_pred ceeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEE
Q 019953 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (333)
Q Consensus 147 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vk 226 (333)
.++..++ ....++||||++|++|...... .....++.+++.++.++|+.|++||||+|+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4444443 2345899999999988765421 23566788999999999999999999999999999999999
Q ss_pred EEeccCcccCCCC
Q 019953 227 LSDFGLCKPLDCS 239 (333)
Q Consensus 227 l~DFGla~~~~~~ 239 (333)
|+|||++......
T Consensus 166 liDfg~~~~~~~~ 178 (198)
T cd05144 166 IIDWPQMVSTDHP 178 (198)
T ss_pred EEECCccccCCCc
Confidence 9999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.9e-19 Score=171.73 Aligned_cols=140 Identities=24% Similarity=0.294 Sum_probs=111.7
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchh-----HHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS-----EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
|...+.||+|+||.||++.+.. ..+++|+.... ..........+.+|+.++..++|++++....++......+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 4567899999999999988653 34444432211 1112223456788999999999999988777776667789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
+||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++....
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~~ 479 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSDL 479 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCCc
Confidence 9999999999998885 346788999999999999999999999999999 678999999999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-19 Score=159.14 Aligned_cols=191 Identities=19% Similarity=0.269 Sum_probs=123.5
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC----------CceeEEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS----------HCIVKLYYSFQ 156 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~~iv~~~~~~~ 156 (333)
.+...+.||.|+++.||.+.|..+++.+|+|++...........+.+.+|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35677899999999999999999999999999876554444455666665544333221 12222222221
Q ss_pred ---------eC---C-----eEEEEEeccCCCCHHHHHH---hCCCC----CHHHHHHHHHHHHHHHHHHHhCCcEeccc
Q 019953 157 ---------DT---E-----YLYLIMEYLPGGDMMTLLM---REDTL----TENVARFYIAQSVLAIESIHKHNYIHRDI 212 (333)
Q Consensus 157 ---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~----~~~~~~~~~~qi~~~L~~LH~~~ivHrDl 212 (333)
.. . +.+++|+-+ .++|.+++. ..... .......+..|++..+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 246778877 568887753 22222 12222345579999999999999999999
Q ss_pred CCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccc
Q 019953 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLA 292 (333)
Q Consensus 213 kp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (333)
+|+|++++.+|.+.|+||+.....+....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--------------------------------------------------- 200 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR--------------------------------------------------- 200 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE---------------------------------------------------
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee---------------------------------------------------
Confidence 99999999999999999998776542210
Q ss_pred cccCCCCCCcccccccC--------CCCCcccc-hHHHHHHHhhhcc
Q 019953 293 FSTVGTPDYIAPEVLLK--------KGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 293 ~~~~gt~~y~APE~~~~--------~~~~~~~D-ws~g~il~~l~t~ 330 (333)
....+..|.+||.... ..++.+.| |.+|+++|.|+-.
T Consensus 201 -~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 201 -CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred -ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 0134578999998743 35899999 9999999988643
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=147.59 Aligned_cols=141 Identities=18% Similarity=0.214 Sum_probs=100.2
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHH---------------------HHHHHHHHHHHhcCCc--
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE---------------------HVRAERNLLAEVASHC-- 147 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~h~~-- 147 (333)
.+.||+|+||.||+|.+. +++.||||++............ ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 8999999998753211111111 1134566666665443
Q ss_pred eeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEE
Q 019953 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMK 226 (333)
Q Consensus 148 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vk 226 (333)
++++++. ...++||||++++.+........... ..+..++.+++.++.++|. .||+|+||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4444443 23589999998854322111111111 5677889999999999999 9999999999999999 99999
Q ss_pred EEeccCcccCCC
Q 019953 227 LSDFGLCKPLDC 238 (333)
Q Consensus 227 l~DFGla~~~~~ 238 (333)
|+|||.+.....
T Consensus 155 liDfg~a~~~~~ 166 (187)
T cd05119 155 IIDVPQAVEIDH 166 (187)
T ss_pred EEECcccccccC
Confidence 999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.5e-19 Score=174.04 Aligned_cols=172 Identities=38% Similarity=0.654 Sum_probs=123.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
.-++|..++.|..|+||.||.++|+.+.+.+|+| +++....-+ .++....+|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR----------nilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR----------NILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh----------ccccccCCccee--------------
Confidence 3468999999999999999999999999999995 444322111 022222333333
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|+-...++.-++++... +.+++|||+-||+|||+||+|.+|+.-|++|++|||+++..--+-..-
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 45555665555555433 778999999999999999999999999999999999998754221110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.++ +.+. . ..+.-..+..||||.|+||||+..++|+..+| |++|+
T Consensus 201 l~e----------------g~I~---------------k---~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGi 246 (1205)
T KOG0606|consen 201 LKE----------------GHIE---------------K---DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGI 246 (1205)
T ss_pred hhh----------------cchH---------------H---HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHH
Confidence 000 0000 0 11223344679999999999999999999999 77899
Q ss_pred HHHhhhc
Q 019953 323 LHFNSYR 329 (333)
Q Consensus 323 il~~l~t 329 (333)
|+|+.+-
T Consensus 247 IlyeFLV 253 (1205)
T KOG0606|consen 247 ILYEFLV 253 (1205)
T ss_pred HHHHHhe
Confidence 9997653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.9e-18 Score=153.75 Aligned_cols=143 Identities=26% Similarity=0.428 Sum_probs=105.5
Q ss_pred cCCceeEEEEEEee---------------------------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 019953 144 ASHCIVKLYYSFQD---------------------------TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196 (333)
Q Consensus 144 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~ 196 (333)
+|||||++++.|.+ ...+|+||...+ -+|..++-.+ ..+....+.++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999988853 235899999874 4888888554 466777888899999
Q ss_pred HHHHHHHhCCcEecccCCCcEEEc--cCC--cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCC
Q 019953 197 LAIESIHKHNYIHRDIKPDNLLLD--KNG--HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272 (333)
Q Consensus 197 ~~L~~LH~~~ivHrDlkp~Nill~--~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (333)
+|+.|||++||.|||+|.+|||+. +|+ .+.|+|||.+-..+..+.. .+. .+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlq-lpy---------------~S--------- 406 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQ-LPY---------------ES--------- 406 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccc-ccc---------------cc---------
Confidence 999999999999999999999984 343 5889999987644322211 110 00
Q ss_pred CCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-----CC-cccc-hHHHHHHHhhhccc
Q 019953 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-----YG-MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~~-~~~D-ws~g~il~~l~t~~ 331 (333)
| ....-|.-.-||||+....+ .+ .++| |+.|.+.|++++..
T Consensus 407 -----------~-------~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~ 454 (598)
T KOG4158|consen 407 -----------D-------EVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRS 454 (598)
T ss_pred -----------c-------cccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccC
Confidence 0 00224778889999986433 23 3789 99999999999764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.2e-17 Score=141.27 Aligned_cols=139 Identities=19% Similarity=0.275 Sum_probs=104.4
Q ss_pred eeEe-eecceEEEEEEEecCCceEEEEecchhHH----------hhhhhHHHHHHHHHHHHHhcCCce--eEEEEEEeeC
Q 019953 92 TIIG-RGAFGEVRLCREKKSGNIYAMKKLKKSEM----------VKRGQVEHVRAERNLLAEVASHCI--VKLYYSFQDT 158 (333)
Q Consensus 92 ~~lg-~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~ 158 (333)
..|| .||.|+||.+... +..++||.+..... ........+.+|+.++..+.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888888887653 77899998854211 011233557789999999998774 6666654332
Q ss_pred -C---eEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCc
Q 019953 159 -E---YLYLIMEYLPG-GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 159 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
. ..++|||+++| .+|.+++.. ..+++.. +.+++.+|.+||+.||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999997 688888754 3455443 578999999999999999999999999999999999999998
Q ss_pred ccCC
Q 019953 234 KPLD 237 (333)
Q Consensus 234 ~~~~ 237 (333)
....
T Consensus 190 ~~~~ 193 (239)
T PRK01723 190 ELRT 193 (239)
T ss_pred ccCC
Confidence 8644
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-18 Score=172.25 Aligned_cols=197 Identities=18% Similarity=0.229 Sum_probs=149.4
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhH-HhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE-MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++...+.||++.|=+|.+|++. .|. |+||++.+.. ........+...++. ....++||.+++.-+-..+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888999999999999999875 344 8899987653 222222333333444 66779999999877777777888999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
+|. ..+|+|.+....-+..-+.++|+.|++.||.-+|..||+|||||.+||||+.-+-+.|+||..-++..-+++
T Consensus 101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD---- 175 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED---- 175 (1431)
T ss_pred HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC----
Confidence 998 559999998777788889999999999999999999999999999999999999999999997765433222
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC----------C-CCc
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK----------G-YGM 314 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------~-~~~ 314 (333)
+.+++.. ...+...-.+|+|||-+... + .++
T Consensus 176 ------------------------NPadf~f--------------FFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~p 217 (1431)
T KOG1240|consen 176 ------------------------NPADFTF--------------FFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTP 217 (1431)
T ss_pred ------------------------CcccceE--------------EEecCCceeeecChHhhhccccccccCCcccccCh
Confidence 1111100 00011233479999998642 2 678
Q ss_pred ccc-hHHHHHHHhhhc
Q 019953 315 ECD-WLVSVLHFNSYR 329 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t 329 (333)
+-| +|+||++.+|++
T Consensus 218 aMDIFS~GCViaELf~ 233 (1431)
T KOG1240|consen 218 AMDIFSAGCVIAELFL 233 (1431)
T ss_pred hhhhhhhhHHHHHHHh
Confidence 899 999999999976
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=129.57 Aligned_cols=135 Identities=20% Similarity=0.244 Sum_probs=112.2
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC--CceeEEEEEEeeCCeEEEEEec
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
+++.||.|.++.||++.+. +..+++|....... ...+..|..++..+.+ .++++++..+...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999864 37899999865432 3457779999999977 4889998888877889999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH---NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 168 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
++++.+..+ +......++.+++.+|..+|.. +++|+|++|.||+++..+.++++|||.+...+.
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~ 141 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCCh
Confidence 988777544 4556677889999999999985 799999999999999989999999999986543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.5e-17 Score=139.51 Aligned_cols=190 Identities=18% Similarity=0.253 Sum_probs=147.9
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..++..++.+|.+...|..|+|+|. |..+++|++.-.....+ ....+..|.-.|+-+.||||+.+++.|....++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 44556667888999999999999987 55577788765543322 2234667888899999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEccCCcEEEE--eccCcccC
Q 019953 163 LIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLS--DFGLCKPL 236 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~~~~~vkl~--DFGla~~~ 236 (333)
++..|++.|+|+..+..... .+..++..++.+++.|+.|||+.. |.---|....++||++.+.+|+ |--++...
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 99999999999999977543 677889999999999999999874 4444788999999999877764 32222110
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC---
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG--- 313 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~--- 313 (333)
. ...-.|.|||||.+...+-+
T Consensus 344 ~--------------------------------------------------------gr~y~pawmspealqrkped~n~ 367 (448)
T KOG0195|consen 344 V--------------------------------------------------------GRAYSPAWMSPEALQRKPEDLNI 367 (448)
T ss_pred c--------------------------------------------------------ccccCcccCCHHHHhcCchhcch
Confidence 0 22357899999999887654
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
+++| ||+++++|+|-|..
T Consensus 368 raadmwsfaillwel~tre 386 (448)
T KOG0195|consen 368 RAADMWSFAILLWELNTRE 386 (448)
T ss_pred hhhhHHHHHHHHHHhhccc
Confidence 4799 99999999998763
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-15 Score=147.01 Aligned_cols=145 Identities=17% Similarity=0.341 Sum_probs=96.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh-------------------------------hhhHHHH
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-------------------------------RGQVEHV 133 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-------------------------------~~~~~~~ 133 (333)
..+|.. +.||+|++|+||.|+...+|+.||||++++..... .+....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455766 79999999999999988779999999997542100 0111222
Q ss_pred ------HHHHHHHHHhc----CCc---eeEEEEEEeeCCeEEEEEeccCCCCHHHHH--HhCC----CCCHHHHHHHHHH
Q 019953 134 ------RAERNLLAEVA----SHC---IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MRED----TLTENVARFYIAQ 194 (333)
Q Consensus 134 ------~~e~~~l~~l~----h~~---iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~----~~~~~~~~~~~~q 194 (333)
.+|+..+.++. +.. |++++.-+ ....++||||++|+++.++. ...+ .+.+..+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~--st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY--CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc--CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 33333333332 222 33333322 34568999999999997742 2222 1333333444444
Q ss_pred HHHHHHHHHhCCcEecccCCCcEEEccCC----cEEEEeccCcccCCCC
Q 019953 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLDCS 239 (333)
Q Consensus 195 i~~~L~~LH~~~ivHrDlkp~Nill~~~~----~vkl~DFGla~~~~~~ 239 (333)
+...|++|+|+||.||+++.++ .++++|||++..++..
T Consensus 276 -------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 -------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 4469999999999999999888 9999999999988654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=138.49 Aligned_cols=142 Identities=18% Similarity=0.284 Sum_probs=97.8
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhh-------------------------------hhHH------HHH
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR-------------------------------GQVE------HVR 134 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-------------------------------~~~~------~~~ 134 (333)
+.||+|++|+||+|+. .+|+.||||+.++.....- +... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999985 5799999999865421000 0000 133
Q ss_pred HHHHHHHHhc-----CCc--eeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 019953 135 AERNLLAEVA-----SHC--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVL-AIESIHKH 205 (333)
Q Consensus 135 ~e~~~l~~l~-----h~~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~-~L~~LH~~ 205 (333)
.|+..+..+. +++ +++++..+ ....++||||++|++|.+..... .... ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555542 233 33333322 33468999999999998876432 1222 2334555555 46789999
Q ss_pred CcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 206 ~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
|++|+|++|.||+++.++.++++|||++..++..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 9999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.1e-16 Score=144.81 Aligned_cols=125 Identities=24% Similarity=0.369 Sum_probs=103.6
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
.++|+.|++|...+|.+.+.... ..+......++.|+..|++| ++.+|+|+||.||+...+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999999999996443 46677888899999999999 9999999999999999999999999999886
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
....... .+ +-.....-+||+.||+||.+.|..|+.+
T Consensus 406 ~~~~~~~--~~-----------------------------------------~~a~~t~~~gt~~YmsPEQi~g~~y~~k 442 (516)
T KOG1033|consen 406 QDKDETV--AP-----------------------------------------AAASHTQQVGTLLYMSPEQIRGQQYSEK 442 (516)
T ss_pred cccCCcc--cc-----------------------------------------hhhhhhhcccccccCCHHHHhhhhhhhh
Confidence 5433200 00 0001124479999999999999999999
Q ss_pred cc-hHHHHHHHhhhc
Q 019953 316 CD-WLVSVLHFNSYR 329 (333)
Q Consensus 316 ~D-ws~g~il~~l~t 329 (333)
+| |++|+|++++++
T Consensus 443 vdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 443 VDIYALGLILAELLI 457 (516)
T ss_pred cchhhHHHHHHHHHH
Confidence 99 999999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-16 Score=156.44 Aligned_cols=199 Identities=24% Similarity=0.409 Sum_probs=159.4
Q ss_pred CCCceEeeeEeeecceEEEEEEEe-cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREK-KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 162 (333)
...|.+.+.||+|+|+.|-.+... .....+|.|.+.... ........+..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 456888999999999999887653 334456667665443 22334455666777777776 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEecccCCCcEEEccCC-cEEEEeccCcccCCC
Q 019953 163 LIMEYLPGGDMMTLL-MRED-TLTENVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDC 238 (333)
Q Consensus 163 lv~e~~~~g~L~~~l-~~~~-~~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~~~ 238 (333)
+++++..|+++...+ .... ..+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++.|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999888 5554 6788889999999999999999 99999999999999999999 999999999987654
Q ss_pred -CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC-CCCCcccccccCCCC-Ccc
Q 019953 239 -STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG-TPDYIAPEVLLKKGY-GME 315 (333)
Q Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~APE~~~~~~~-~~~ 315 (333)
.+ ........+| ++.|+|||...+..| ...
T Consensus 178 ~~g-----------------------------------------------~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~ 210 (601)
T KOG0590|consen 178 KNG-----------------------------------------------AERSLKDRCGSSPPYGAPEHLSGKAYRGPS 210 (601)
T ss_pred cCC-----------------------------------------------cceeeecccCCCCCCCCcccccchhhcCCC
Confidence 21 1112224478 999999999998654 557
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
.| |++|+++.-++++.
T Consensus 211 ~d~~S~g~~l~~~~~g~ 227 (601)
T KOG0590|consen 211 VDVWSLGIVLSAMLTGE 227 (601)
T ss_pred cccccccccccccccCC
Confidence 77 99999999887753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-13 Score=115.91 Aligned_cols=142 Identities=14% Similarity=0.133 Sum_probs=102.8
Q ss_pred eeeEeeecceEEEEEEEec------CCceEEEEecchhHH--------h-----------hhh----hHHHHHHHHHHHH
Q 019953 91 LTIIGRGAFGEVRLCREKK------SGNIYAMKKLKKSEM--------V-----------KRG----QVEHVRAERNLLA 141 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~--------~-----------~~~----~~~~~~~e~~~l~ 141 (333)
...||.|.=+.||.|.... .+..+|||+.+.... . ... ...+..+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997543 357899999854210 0 011 1223458999999
Q ss_pred HhcCC--ceeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEecccCCCcEE
Q 019953 142 EVASH--CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLL 218 (333)
Q Consensus 142 ~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~L-H~~~ivHrDlkp~Nil 218 (333)
++... +++.++++ ..-++||||+.++.+.........++......+..+++.+|..| |+.|+||+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 98654 66677654 34589999997654432222233455566677789999999998 8999999999999999
Q ss_pred EccCCcEEEEeccCcccCC
Q 019953 219 LDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 219 l~~~~~vkl~DFGla~~~~ 237 (333)
++ ++.+.|+|||.+...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 5789999999988765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-13 Score=114.05 Aligned_cols=130 Identities=22% Similarity=0.266 Sum_probs=95.6
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce-eEEEEEEeeCCeEEEEEeccC
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDTEYLYLIMEYLP 169 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~ 169 (333)
++.|+.|.++.||++... +..|++|+...... .......|+.+++.+.+.++ ++++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 457889999999998754 78899998765421 11234568888888865544 44544432 23479999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY-----IHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 170 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i-----vHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
|.++... . .....++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+...+
T Consensus 75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 9877543 0 1123456789999999999885 9999999999998 6789999999988643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.9e-14 Score=130.90 Aligned_cols=145 Identities=19% Similarity=0.230 Sum_probs=117.9
Q ss_pred HHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-EecccCCCcE
Q 019953 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNY-IHRDIKPDNL 217 (333)
Q Consensus 140 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i-vHrDlkp~Ni 217 (333)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ...++......++++++.||.|||...| .|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999987 3467777788889999999999998765 9999999999
Q ss_pred EEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC
Q 019953 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (333)
Q Consensus 218 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 297 (333)
+++....+||+|||+........... ......-
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~-----------------------------------------------~~~~~~~ 113 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPE-----------------------------------------------AHHPIRK 113 (484)
T ss_pred eeeeeEEEEechhhhccccccccccc-----------------------------------------------ccchhHH
Confidence 99999999999999988764310000 0001123
Q ss_pred CCCCcccccccCCC-------CCcccc-hHHHHHHHhhhccc
Q 019953 298 TPDYIAPEVLLKKG-------YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 298 t~~y~APE~~~~~~-------~~~~~D-ws~g~il~~l~t~~ 331 (333)
..-|.|||.+.+.. .+.+.| |++|++++++++..
T Consensus 114 ~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 114 ALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred HHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 45789999997632 467799 99999999998753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-12 Score=107.20 Aligned_cols=138 Identities=21% Similarity=0.236 Sum_probs=103.7
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecch-----hHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKK-----SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
..+++|+-+.|+.+.+. |..+++|.-.+ ......-......+|+.++..+.--.|+...-++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35778999999988653 54566765432 334444445667889999999877666555555666677789999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
|++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++|||++..-...
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~ 144 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEV 144 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccccH
Confidence 99998898888665 134566677777789999999999999999996655 999999999865433
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-11 Score=101.45 Aligned_cols=146 Identities=23% Similarity=0.269 Sum_probs=110.6
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecch-----hHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK-----SEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.+..|-+|+-+.|+.+.+ .|+.+.||.-.. ......-......+|+..|.++.--.|.-.--+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567888999999998875 488888875432 3344444456678899999998766666555567777777899
Q ss_pred EeccCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cEEEEeccCcccCC
Q 019953 165 MEYLPG-GDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLD 237 (333)
Q Consensus 165 ~e~~~~-g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~~ 237 (333)
|||++| .++.+++... ....+.....++.++-..|.-||..+|+|+||..+||++..++ .+.++|||++..-.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~ 167 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR 167 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence 999976 4777777553 2333333467888999999999999999999999999998765 46899999987643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-13 Score=136.43 Aligned_cols=231 Identities=29% Similarity=0.403 Sum_probs=165.0
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
...+.+.+.+.+-+|+++.++.+.-..+|...++|+............+....+-.++-...+|.++..+..+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45678889999999999999998877788777888766554443333444444444444456677776666666667799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
||++|..+++|...+.+....++..++.+...+..++++||...++|+|++|.|.++..++..+++|||.......-...
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999999988888888889999999999999999999999999999999999999999999966654322110
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCC-CCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDN-KSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
. +..++...... .-+......+++. ..-......+||+.|.|||...+......+| |++
T Consensus 961 ~----------------~~sg~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 961 T----------------DLSGPSSSGTPRRLSRSERRPQLSA---DEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred C----------------CcccccccCcccccccccccccccc---chhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence 0 00000000000 0000000111111 0112233568999999999999999999999 889
Q ss_pred HHHHHhhhcccc
Q 019953 321 SVLHFNSYRFLE 332 (333)
Q Consensus 321 g~il~~l~t~~~ 332 (333)
|+++++.+++.+
T Consensus 1022 g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIP 1033 (1205)
T ss_pred hhhhhhhhcCCC
Confidence 999999988754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-11 Score=118.56 Aligned_cols=167 Identities=17% Similarity=0.189 Sum_probs=127.1
Q ss_pred EEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCC
Q 019953 105 CREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLT 184 (333)
Q Consensus 105 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 184 (333)
|..+.++.+|.|...+.... .......+.+.-|+.++||||+++++.+..++.+|+|+|-+ ..|..++..-.
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~--- 102 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG--- 102 (690)
T ss_pred cceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH---
Confidence 45567788899888876543 33445666788899999999999999999999999999998 36666775433
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCC
Q 019953 185 ENVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263 (333)
Q Consensus 185 ~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (333)
.......+.||+.||.||| +.+++|++|..+.|+++..|..||.+|.++...+....
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---------------------- 160 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---------------------- 160 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----------------------
Confidence 6677778899999999998 56899999999999999999999999998765432210
Q ss_pred CCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
.+....---.|..|+.+.... -+.| |-+||++|+++.+
T Consensus 161 ---------------------------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 ---------------------------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---------------------------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 000112233466676664332 4579 9999999999987
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.6e-11 Score=103.24 Aligned_cols=142 Identities=17% Similarity=0.232 Sum_probs=101.5
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC--ceeEEEEEEeeC---CeEEEEEe
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYSFQDT---EYLYLIME 166 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e 166 (333)
+.|+.|..+.||++... +|..+++|+....... .....+..|..+++.+.+. .+++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 57899999999998763 3678999987654321 1234577899999999764 456677666543 35689999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK------------------------------------------ 204 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~------------------------------------------ 204 (333)
|++|.++...+.. ..++......++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9998877664421 235555555556666666666652
Q ss_pred --------------CCcEecccCCCcEEEcc--CCcEEEEeccCcccCC
Q 019953 205 --------------HNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLD 237 (333)
Q Consensus 205 --------------~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~~~ 237 (333)
..++|+|++|.||+++. ++.+.|+||+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~ 208 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGD 208 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCC
Confidence 34699999999999998 6678999999887544
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=3e-12 Score=121.18 Aligned_cols=195 Identities=19% Similarity=0.246 Sum_probs=149.6
Q ss_pred CCCceEeeeEee--ecceEEEEEEE--ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC
Q 019953 85 VDDFELLTIIGR--GAFGEVRLCRE--KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~--G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 159 (333)
...|.+...+|. |.+|.||.+.. ..++..+|+|.-+.... .......-.+++...+.+ .|++.++.+..+...+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCC
Confidence 345678889999 99999999988 88899999997432211 111112223455555555 4779999888999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCcEecccCCCcEEEccC-CcEEEEeccCc
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVL----AIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLC 233 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~----~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DFGla 233 (333)
..++-+|+| +.+|..+...... +++..+.....+... ||.++|..+++|-|+||.||++..+ ...+++|||+.
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 999999999 5788888766554 888888888888888 9999999999999999999999999 88999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
..+.......... ......|..-|++||+..+ -++
T Consensus 271 ~~i~~~~~~~~~~--------------------------------------------~~~r~~~~~~Y~~ke~~~~-l~~ 305 (524)
T KOG0601|consen 271 SKISDGNFSSVFK--------------------------------------------VSKRPEGDCIYAAKELLNG-LAT 305 (524)
T ss_pred EEccCCcccccee--------------------------------------------eeecCCCCceEeChhhhcc-ccc
Confidence 9987665322111 0112357888999999864 478
Q ss_pred cccc-hHHHHHHHh
Q 019953 314 MECD-WLVSVLHFN 326 (333)
Q Consensus 314 ~~~D-ws~g~il~~ 326 (333)
.++| +++|.+..+
T Consensus 306 ~~~di~sl~ev~l~ 319 (524)
T KOG0601|consen 306 FASDIFSLGEVILE 319 (524)
T ss_pred hHhhhcchhhhhHh
Confidence 8899 999966554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.2e-11 Score=117.05 Aligned_cols=154 Identities=26% Similarity=0.322 Sum_probs=123.2
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEe-cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREK-KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 159 (333)
.....+|.++..||.|.|+.|+.+... .++..|++|-...........+. -..|+.+...+ .|.+++..+..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccc
Confidence 345678999999999999999987654 67888999987665433322222 23355555555 5778888887777777
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-CcEEEEeccCcccC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPL 236 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DFGla~~~ 236 (333)
..|+--|||+++++...+.....+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||....+
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 788999999999988777666678888899999999999999999999999999999999886 78899999988753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.7e-10 Score=94.97 Aligned_cols=129 Identities=20% Similarity=0.239 Sum_probs=82.9
Q ss_pred EEEEEEEecCCceEEEEecchhH-----------------------HhhhhhHHHHHHHHHHHHHhcCC--ceeEEEEEE
Q 019953 101 EVRLCREKKSGNIYAMKKLKKSE-----------------------MVKRGQVEHVRAERNLLAEVASH--CIVKLYYSF 155 (333)
Q Consensus 101 ~V~~a~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~ 155 (333)
.||.|.. .+|..+|+|+.+... ...........+|...|..+..- ++++++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888875 467799999875421 01111235678899999999776 567766443
Q ss_pred eeCCeEEEEEeccC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 156 QDTEYLYLIMEYLP--GGDMMTLLMREDTLTENVARFYIAQSVLAIES-IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 156 ~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~-LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
. -++||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.||+++.+ .+.|+|||.
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred --C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2 369999997 55554433222 1133456667777775555 589999999999999999877 999999998
Q ss_pred cccCC
Q 019953 233 CKPLD 237 (333)
Q Consensus 233 a~~~~ 237 (333)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 88654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.9e-09 Score=95.88 Aligned_cols=132 Identities=14% Similarity=0.099 Sum_probs=92.7
Q ss_pred EEEEEEecCCceEEEEecchhHHh---hh-----hhHHHHHHHHHHHHHhcCCc--eeEEEEEEee-----CCeEEEEEe
Q 019953 102 VRLCREKKSGNIYAMKKLKKSEMV---KR-----GQVEHVRAERNLLAEVASHC--IVKLYYSFQD-----TEYLYLIME 166 (333)
Q Consensus 102 V~~a~~~~~~~~vaiK~~~~~~~~---~~-----~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~-----~~~~~lv~e 166 (333)
|..+. ..|+.|.||........ .. .....+.+|...+..+...+ .+.++.++.. ....++|||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44543 35778889976443211 00 11113667888888875443 3333444432 235789999
Q ss_pred ccCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-------CCcEEEEeccCccc
Q 019953 167 YLPGG-DMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-------NGHMKLSDFGLCKP 235 (333)
Q Consensus 167 ~~~~g-~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-------~~~vkl~DFGla~~ 235 (333)
++++. +|.+++.. ..+.+......++.+++..+.-||..||+|+|++++|||++. +..+.++||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99875 78888753 345566777889999999999999999999999999999985 46899999998864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.8e-09 Score=90.34 Aligned_cols=140 Identities=17% Similarity=0.198 Sum_probs=102.7
Q ss_pred eEeeeEeeecceEEEEEEEecCCceEEEEecchhHH-------------------hhhhhHHHHHHHHHHHHHhcCC--c
Q 019953 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-------------------VKRGQVEHVRAERNLLAEVASH--C 147 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~~~~~e~~~l~~l~h~--~ 147 (333)
.+...||.|.-|.||.|.+. .|.++|||.-+.... ..-.......+|..+|..+... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46789999999999999865 688999996532110 0011234567899999999766 6
Q ss_pred eeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEE
Q 019953 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKL 227 (333)
Q Consensus 148 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl 227 (333)
+++.+++ +...+|||+++|..|...- ++...+..++..|+.-+.-+-..|+||+|+.+=||+++.+|.+.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 7777653 4568999999886664332 123344555666666666666899999999999999999999999
Q ss_pred EeccCcccCCC
Q 019953 228 SDFGLCKPLDC 238 (333)
Q Consensus 228 ~DFGla~~~~~ 238 (333)
+||--+...+.
T Consensus 244 IDwPQ~v~~~h 254 (304)
T COG0478 244 IDWPQAVPISH 254 (304)
T ss_pred EeCcccccCCC
Confidence 99987776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.3e-08 Score=85.84 Aligned_cols=107 Identities=22% Similarity=0.270 Sum_probs=83.6
Q ss_pred HHHHHHHHHHHHhcCC--ceeEEEEEEeeC----CeEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 019953 131 EHVRAERNLLAEVASH--CIVKLYYSFQDT----EYLYLIMEYLPGG-DMMTLLMREDTLTENVARFYIAQSVLAIESIH 203 (333)
Q Consensus 131 ~~~~~e~~~l~~l~h~--~iv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH 203 (333)
....+|...+..+... ..+..+.+.... ...++|+|++++. +|.+++......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 3466788877777543 344444444332 2458999999874 78888876555777778889999999999999
Q ss_pred hCCcEecccCCCcEEEccCC---cEEEEeccCcccCC
Q 019953 204 KHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLD 237 (333)
Q Consensus 204 ~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~~ 237 (333)
..||+|+|++|.|||++.++ .+.++||+-++...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999999999999887 89999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.3e-08 Score=96.33 Aligned_cols=144 Identities=19% Similarity=0.277 Sum_probs=93.6
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhh---------------------------h----hhHH------HHH
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK---------------------------R----GQVE------HVR 134 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---------------------------~----~~~~------~~~ 134 (333)
..|+.++-|+||.|+.. +|+.||||+.++.-... . +..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67899999999999964 59999999987631000 0 0001 133
Q ss_pred HHHHHHHHhc-----CCc--eeEEEEEEeeCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019953 135 AERNLLAEVA-----SHC--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHN 206 (333)
Q Consensus 135 ~e~~~l~~l~-----h~~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ 206 (333)
+|+..+..+. .++ |++++ +.-.+.-.|+|||++|..+.+.... ...++...+.....++. +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 4444444442 333 33433 3334456899999999888887422 23444333222222211 23344589
Q ss_pred cEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 207 ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
++|.|.+|.||+++.+|.+.+.|||+...++...
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 9999999999999999999999999999887543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.4e-08 Score=92.58 Aligned_cols=138 Identities=18% Similarity=0.249 Sum_probs=111.1
Q ss_pred eEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee----CCeEEEEEeccCC-CCHH
Q 019953 100 GEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----TEYLYLIMEYLPG-GDMM 174 (333)
Q Consensus 100 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~-g~L~ 174 (333)
.+.|+|....+|..|++|.++....... .....-.++++++.|+|+|++..+|.. +..+++|++|.++ ++|.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 5688999999999999999954432222 122335788999999999999988863 4579999999876 5777
Q ss_pred HHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 175 TLLMR---------------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 175 ~~l~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++... +...++..++.++.|+..||.++|+.|+.-+-|.|.+||++.+..++|+..|+...+...
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 76532 224678889999999999999999999999999999999999999999999987776544
Q ss_pred c
Q 019953 240 T 240 (333)
Q Consensus 240 ~ 240 (333)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 3
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.7e-08 Score=82.40 Aligned_cols=142 Identities=20% Similarity=0.307 Sum_probs=91.4
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHH------HHHHHHHHHHHhcC---CceeEEEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE------HVRAERNLLAEVAS---HCIVKLYY 153 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~------~~~~e~~~l~~l~h---~~iv~~~~ 153 (333)
+..++|.+.+.+-......|.+-. .+|..+++|..+........... ...+.+..+..+.. .....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 345789999999887777776543 56788999988764322111111 12333343444432 22222222
Q ss_pred EE-----eeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEE
Q 019953 154 SF-----QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228 (333)
Q Consensus 154 ~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~ 228 (333)
+. .-....+++|||++|..|.+... +++. +...+..++.-||+.|++|+|.+|+|++++.+ .++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence 22 22344679999999987766542 2222 34556778899999999999999999999855 59999
Q ss_pred eccCccc
Q 019953 229 DFGLCKP 235 (333)
Q Consensus 229 DFGla~~ 235 (333)
||+-.+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9986654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-08 Score=90.33 Aligned_cols=146 Identities=20% Similarity=0.312 Sum_probs=108.3
Q ss_pred HHHHHHhcCCceeEEEEEEeeCC-----eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 019953 137 RNLLAEVASHCIVKLYYSFQDTE-----YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKH-- 205 (333)
Q Consensus 137 ~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~-- 205 (333)
...+-.+-|.||++++.++.+.. ...++.||+..|++.++|+. ...+....-.+|+.||++||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 44566678999999998886544 47889999999999999965 34577888889999999999999987
Q ss_pred CcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHH
Q 019953 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQ 285 (333)
Q Consensus 206 ~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (333)
-|+|+++.-+.|++..+|-+||.- +.+ ++..+.+ .
T Consensus 198 piihgnlTc~tifiq~ngLIkig~---~ap--~s~h~s~---------------------~------------------- 232 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS---VAP--DSTHPSV---------------------N------------------- 232 (458)
T ss_pred ccccCCcchhheeecCCceEEecc---cCc--cccchhh---------------------h-------------------
Confidence 599999999999999999888752 111 0000000 0
Q ss_pred hhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhh
Q 019953 286 MNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNS 327 (333)
Q Consensus 286 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l 327 (333)
..+........+-++|.|||.-.....+.++| |.+|+...+|
T Consensus 233 ~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 233 STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 00000111224788999999988788889999 9999877766
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-07 Score=80.79 Aligned_cols=140 Identities=19% Similarity=0.180 Sum_probs=97.7
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhh---------------------hhhHHHHHHHHHHHHHhcC--Cc
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK---------------------RGQVEHVRAERNLLAEVAS--HC 147 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h--~~ 147 (333)
...|++|.-+.||+|.. .++..+|+|++......- .....+..+|...|.++.. -.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34777788889999874 568899999986542211 1112356677777877743 35
Q ss_pred eeEEEEEEeeCCeEEEEEeccCCCCHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcE
Q 019953 148 IVKLYYSFQDTEYLYLIMEYLPGGDMM-TLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHM 225 (333)
Q Consensus 148 iv~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~v 225 (333)
+++.+.+.. -.|||||+.....- -.| +.-.+....+..+..+++..+.-|-. .++||+||..=|||+. ++.+
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 556655543 36999999443111 111 12233343677778889998888766 8999999999999998 8999
Q ss_pred EEEeccCcccCC
Q 019953 226 KLSDFGLCKPLD 237 (333)
Q Consensus 226 kl~DFGla~~~~ 237 (333)
.|+|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999998765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.7e-07 Score=79.56 Aligned_cols=140 Identities=13% Similarity=0.170 Sum_probs=98.8
Q ss_pred eeecceEEEEEEEecCCceEEEEecchhHHhh---hhhHHHHHHHHHHHHHhcCCc--eeEEEEEE--ee--CCeEEEEE
Q 019953 95 GRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK---RGQVEHVRAERNLLAEVASHC--IVKLYYSF--QD--TEYLYLIM 165 (333)
Q Consensus 95 g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~--~~--~~~~~lv~ 165 (333)
|+||.|-|+.... .|+.+=+|.-....... +.....+.+|...+..+...+ ++++.... .. .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688888987653 34567778764211111 223456888999998886543 34443111 11 12468999
Q ss_pred eccCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc--EEEEeccCcccC
Q 019953 166 EYLPG-GDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--MKLSDFGLCKPL 236 (333)
Q Consensus 166 e~~~~-g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~--vkl~DFGla~~~ 236 (333)
|-+++ .+|.+++... .+.+......+..+++..+.-||+.|+.|+|+.+.||+++.++. +.++||.-++.-
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 97754 5788877553 34577777889999999999999999999999999999987777 999999977754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.7e-08 Score=101.66 Aligned_cols=77 Identities=26% Similarity=0.331 Sum_probs=58.2
Q ss_pred EecccCCC-cEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHh
Q 019953 208 IHRDIKPD-NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQM 286 (333)
Q Consensus 208 vHrDlkp~-Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (333)
-+++..|. |++++..+.+++.|||.++........
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~-------------------------------------------- 534 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAP-------------------------------------------- 534 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhccccc--------------------------------------------
Confidence 34555666 666777777889999988765432210
Q ss_pred hhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 287 NRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 287 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
......+||+.|+|||++.+..++.++| |++||++|+|+|+.
T Consensus 535 ---~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~ 577 (669)
T cd05610 535 ---VEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGI 577 (669)
T ss_pred ---ccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 0112457999999999999999999999 99999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.2e-06 Score=76.33 Aligned_cols=135 Identities=19% Similarity=0.161 Sum_probs=85.2
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc--eeEEEEEEeeCCeEEEEEeccC
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLYYSFQDTEYLYLIMEYLP 169 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~ 169 (333)
..||+|..+.||+. .+..+++|...... ....+.+|..+++.+.... +++.+.+....+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 24567889876432 2234677999999886543 5677777777777889999998
Q ss_pred CCC-HH--------------HHHHh-----CC------CCCHHHHHHHHH----------HHHH-HHHHHHh----CCcE
Q 019953 170 GGD-MM--------------TLLMR-----ED------TLTENVARFYIA----------QSVL-AIESIHK----HNYI 208 (333)
Q Consensus 170 ~g~-L~--------------~~l~~-----~~------~~~~~~~~~~~~----------qi~~-~L~~LH~----~~iv 208 (333)
|.+ +. ..+.. +. .+.... ..+.. .+.. ...+|.. ..++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 853 11 11100 00 111100 00100 0111 1222321 2478
Q ss_pred ecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 209 HRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 209 HrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
|+|+.|.||+++.++ +.|+||+.+...+
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGYGN 184 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCcCC
Confidence 999999999999888 9999999887654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=6.9e-07 Score=86.02 Aligned_cols=142 Identities=22% Similarity=0.302 Sum_probs=89.6
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhh----------------------------hhhHHH------HHHHH
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK----------------------------RGQVEH------VRAER 137 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------------------------~~~~~~------~~~e~ 137 (333)
+.||..+.|+|++|+.. +|+.||||+-++.-... .+..+. +.+|+
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 57899999999999965 59999999976531100 000111 22233
Q ss_pred HH----HHHhcCCc------eeEEEEEEeeCCeEEEEEeccCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHH-HHHHh
Q 019953 138 NL----LAEVASHC------IVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDTLTENVARFYIAQSVLAI-ESIHK 204 (333)
Q Consensus 138 ~~----l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~qi~~~L-~~LH~ 204 (333)
.. .+.+.|-+ |+++|-.+ .....|+||||+|..+.+. +.+. .++...+ +..+.++. .-+-.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i---~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDI---LNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHH---HHHHHHHHHHHHHh
Confidence 22 22333434 55554433 3346899999999766654 3333 3444433 33333332 22346
Q ss_pred CCcEecccCCCcEEEcc----CCcEEEEeccCcccCCCCc
Q 019953 205 HNYIHRDIKPDNLLLDK----NGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~----~~~vkl~DFGla~~~~~~~ 240 (333)
.|++|+|-+|.||+++. ++.+.+.|||+...++...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 79999999999999984 5689999999998876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.52 E-value=3e-06 Score=73.43 Aligned_cols=139 Identities=21% Similarity=0.333 Sum_probs=81.6
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC--ceeEEEEEE---eeCCeEEEEE
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYSF---QDTEYLYLIM 165 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~---~~~~~~~lv~ 165 (333)
++.|+.|..+.||.+.... ..+++|..... .....+..|..+++.+... .++.++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4678999999999987543 58999997654 1234466788888887544 355666533 2334579999
Q ss_pred eccCCCCHHH----------------HHH---hC----CCCCHHH---H---HHH---------------HHHHHH-HHH
Q 019953 166 EYLPGGDMMT----------------LLM---RE----DTLTENV---A---RFY---------------IAQSVL-AIE 200 (333)
Q Consensus 166 e~~~~g~L~~----------------~l~---~~----~~~~~~~---~---~~~---------------~~qi~~-~L~ 200 (333)
++++|..+.. .+. .. ....... . ... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999887776 111 11 1111100 0 000 011222 233
Q ss_pred HHH-------hCCcEecccCCCcEEEc-cCCcEEEEeccCcccC
Q 019953 201 SIH-------KHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPL 236 (333)
Q Consensus 201 ~LH-------~~~ivHrDlkp~Nill~-~~~~vkl~DFGla~~~ 236 (333)
.++ ..+++|+|+.|.|||++ .++.+-|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 333 23599999999999999 6677789999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.9e-06 Score=69.07 Aligned_cols=138 Identities=16% Similarity=0.208 Sum_probs=95.7
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHH-------------hhhhhHHHHHHHHHHHHHhc------CCceeEEE
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-------------VKRGQVEHVRAERNLLAEVA------SHCIVKLY 152 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~------h~~iv~~~ 152 (333)
..||+|+.-.||. |.. ....+||+...... ..........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5799999999994 433 34567899876540 01112345666776666665 67899999
Q ss_pred EEEeeCCeEEEEEeccCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---
Q 019953 153 YSFQDTEYLYLIMEYLPG------GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG--- 223 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~--- 223 (333)
|+..++....+|+|.+.. -+|.+++.. +.+++ .. ...+-.-..||-+++|+.+|++|.||++..+.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998732 357777743 34555 22 22333445678899999999999999997433
Q ss_pred -cEEEEe-ccCcccCC
Q 019953 224 -HMKLSD-FGLCKPLD 237 (333)
Q Consensus 224 -~vkl~D-FGla~~~~ 237 (333)
.+.|+| ||....++
T Consensus 159 ~~lvlIDG~G~~~~ip 174 (199)
T PF10707_consen 159 FRLVLIDGLGEKELIP 174 (199)
T ss_pred eEEEEEeCCCCccccc
Confidence 578888 77665543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2e-06 Score=70.48 Aligned_cols=130 Identities=16% Similarity=0.234 Sum_probs=92.9
Q ss_pred eEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeE-EEEEEeeCCeEEEEEec
Q 019953 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK-LYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~ 167 (333)
+..+.|++|++|.||++.+. |..+|+|+-..+. ....+..|+.+|..+...++.+ +|.+.. .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 45678999999999999876 6689999876543 3455888999999998776644 333332 2455999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccC-CCcEEEccCCcEEEEeccCcccC
Q 019953 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIK-PDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 168 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlk-p~Nill~~~~~vkl~DFGla~~~ 236 (333)
+.|-.|...-... + +.-...+++.-.-|-..||-|..|. |...+|..++.+.|+||..|+.-
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9887886655322 1 2223445555445677899999986 66666667779999999998843
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=5e-08 Score=93.58 Aligned_cols=173 Identities=20% Similarity=0.270 Sum_probs=127.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc-eeEEEEEEeeCCeEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 164 (333)
..+....-.++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++.+..+.+.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 44556667889999999998876665554 5555432 22444889999999999 77777788888899999
Q ss_pred EeccCCC-CHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 165 MEYLPGG-DMMT-LLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 165 ~e~~~~g-~L~~-~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
|+++.++ +... .-...-.+.+.....+++.-+.+++++|+.-=+|+| ||+..+ +..+..||+....++...
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999776 2221 111222355556666777888899999998778998 776644 788999999877664321
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
...+..+++.++|||+.....++...| |+.+
T Consensus 386 ------------------------------------------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~ 417 (829)
T KOG0576|consen 386 ------------------------------------------------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLA 417 (829)
T ss_pred ------------------------------------------------ccccCCCCCCCCCchhhcccccccCCCccCCC
Confidence 112567999999999999999999999 9987
Q ss_pred H
Q 019953 322 V 322 (333)
Q Consensus 322 ~ 322 (333)
+
T Consensus 418 ~ 418 (829)
T KOG0576|consen 418 V 418 (829)
T ss_pred c
Confidence 5
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.1e-06 Score=70.16 Aligned_cols=129 Identities=25% Similarity=0.343 Sum_probs=89.9
Q ss_pred CCCceEeeeEeeecc-eEEEEEEEecCCceEEEEecchhHHhhh------------------hhHHHHHHHHHHHHHhcC
Q 019953 85 VDDFELLTIIGRGAF-GEVRLCREKKSGNIYAMKKLKKSEMVKR------------------GQVEHVRAERNLLAEVAS 145 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~~~e~~~l~~l~h 145 (333)
..+++.++.||.|.- |.||++.. .|..||+|++........ ....-+..|.+...+++.
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 99999874 588999999432110000 122346667777666643
Q ss_pred ---Cce--eEEEEEEeeC------------------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 019953 146 ---HCI--VKLYYSFQDT------------------EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202 (333)
Q Consensus 146 ---~~i--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~L 202 (333)
.++ |+++|+..-. ....||.||++... .+... -+.+|..-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHH
Confidence 345 8999887322 12467888876543 22222 356777778889
Q ss_pred HhCCcEecccCCCcEEEccCCcEEEEeccCc
Q 019953 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 203 H~~~ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
|..||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999985 4588999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.2e-07 Score=91.82 Aligned_cols=96 Identities=21% Similarity=0.350 Sum_probs=74.4
Q ss_pred HHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCC
Q 019953 194 QSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKS 272 (333)
Q Consensus 194 qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (333)
+++.|+.|+|+. ++||++|.|++|.++.++..||+.|+++.....+.. .++..++...+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--------------------~p~~~yd~~lp 166 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--------------------YPFSEYDPPLP 166 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--------------------cccccCCCCCC
Confidence 344899999976 899999999999999999999999999887654332 12222222211
Q ss_pred CCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 273 SWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+ ...-...|.|||++.+...+.++| +++||++|.++.
T Consensus 167 ~--------------------~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~ 204 (700)
T KOG2137|consen 167 L--------------------LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYN 204 (700)
T ss_pred h--------------------hhccCcccccchhhccccccccccceeeeeEEEEEec
Confidence 1 224567899999999988899999 999999998873
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.7e-06 Score=77.44 Aligned_cols=182 Identities=13% Similarity=0.100 Sum_probs=117.9
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEE------E-eeCCeE
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYS------F-QDTEYL 161 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~------~-~~~~~~ 161 (333)
..+.||+|+-+.+|-.-.. +. .+.|++......- -.+....|... .||-+-.-+.+ . .....+
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchh--hc-hhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 4578999999999954321 22 3457776542111 11123333333 34422110111 1 122337
Q ss_pred EEEEeccCCC-CHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 162 YLIMEYLPGG-DMMTLLMR------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 162 ~lv~e~~~~g-~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
.++|..+.+. .+..++.- -..+.+..+....+.++.+...||..|-+-+|++++|+|+.+++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 8888888664 22233311 1246777888899999999999999999999999999999999999999854332
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----C
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----K 309 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~ 309 (333)
....+ ......+|.+.|.+||... +
T Consensus 166 i~~ng--------------------------------------------------~~~~cpVg~~eftPPElQ~~~sf~g 195 (637)
T COG4248 166 INANG--------------------------------------------------TLHLCPVGVSEFTPPELQTLPSFVG 195 (637)
T ss_pred eccCC--------------------------------------------------ceEecccCccccCCHHHhccccccc
Confidence 22111 1222458999999999865 4
Q ss_pred CCCCcccc-hHHHHHHHhhhcc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~ 330 (333)
..-+...| +-+||++|++|-+
T Consensus 196 ~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 196 FERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred cCCCccccchhHHHHHHHHHhc
Confidence 55678899 9999999998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=7e-06 Score=72.20 Aligned_cols=137 Identities=14% Similarity=0.076 Sum_probs=83.1
Q ss_pred eEeeecc-eEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC-CceeEEEEEEeeCCeEEEEEeccCC
Q 019953 93 IIGRGAF-GEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 93 ~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
.|..|.. ..||+... .+..+.+|+..... ...+.+|+.+++.+.. --+++++++....+..++||++++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444555 67898753 34678889876542 1235568888888743 4566777777666678999999998
Q ss_pred CCHHHHHH----------------h-CC------CCCHH---HHHHH---HH----------------HHHHHHHHHH--
Q 019953 171 GDMMTLLM----------------R-ED------TLTEN---VARFY---IA----------------QSVLAIESIH-- 203 (333)
Q Consensus 171 g~L~~~l~----------------~-~~------~~~~~---~~~~~---~~----------------qi~~~L~~LH-- 203 (333)
.++..... . +. ++... ..... +. .....+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 76653310 0 00 11100 00000 00 0111122221
Q ss_pred -----hCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 204 -----KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 204 -----~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
...++|+|+.|.|||++.++.+.|+||+.+...+
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd 195 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD 195 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence 2348999999999999998888999999887544
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.19 E-value=3e-05 Score=80.11 Aligned_cols=147 Identities=20% Similarity=0.319 Sum_probs=90.6
Q ss_pred eeeEeeecceEEEEEEEecCC--ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCc--eeEEEEEEeeC---CeEE
Q 019953 91 LTIIGRGAFGEVRLCREKKSG--NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHC--IVKLYYSFQDT---EYLY 162 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~---~~~~ 162 (333)
++.++.|.+..+|+......+ ..+++|+.+..... .....+.+|..+++.+. |++ +++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577889999999987654322 46778876543211 11234778999999995 565 47777776553 4678
Q ss_pred EEEeccCCCCHHH--------------------HH---Hh-C-C---------C--CCHHHHHHHHHH------------
Q 019953 163 LIMEYLPGGDMMT--------------------LL---MR-E-D---------T--LTENVARFYIAQ------------ 194 (333)
Q Consensus 163 lv~e~~~~g~L~~--------------------~l---~~-~-~---------~--~~~~~~~~~~~q------------ 194 (333)
+||||++|..+.+ .+ .. . . + .....+..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998754221 11 01 0 0 0 111122222111
Q ss_pred ---HHHHHHHHHh-----------CCcEecccCCCcEEEccC--CcEEEEeccCcccCCCC
Q 019953 195 ---SVLAIESIHK-----------HNYIHRDIKPDNLLLDKN--GHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 195 ---i~~~L~~LH~-----------~~ivHrDlkp~Nill~~~--~~vkl~DFGla~~~~~~ 239 (333)
+...+.+|.. ..+||+|++|.|||++.+ ..+-|.||+++...++-
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdPl 261 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQM 261 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCChH
Confidence 2233556632 249999999999999853 34689999998876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.1e-05 Score=68.81 Aligned_cols=137 Identities=17% Similarity=0.187 Sum_probs=76.7
Q ss_pred eeEeeecce-EEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC---ceeEEEEEEeeC---CeEEEE
Q 019953 92 TIIGRGAFG-EVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH---CIVKLYYSFQDT---EYLYLI 164 (333)
Q Consensus 92 ~~lg~G~~g-~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv 164 (333)
+.|+.|+.. .||.. +..+++|..+... ....+..|..++..+... .++.++...... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457777776 48865 2357788755321 223577799999888532 455555544332 235889
Q ss_pred EeccCCCCHHHH---------------HHh-CC----CCC------------H--H--HH----HHHH----HHHHHHH-
Q 019953 165 MEYLPGGDMMTL---------------LMR-ED----TLT------------E--N--VA----RFYI----AQSVLAI- 199 (333)
Q Consensus 165 ~e~~~~g~L~~~---------------l~~-~~----~~~------------~--~--~~----~~~~----~qi~~~L- 199 (333)
|++++|.++... +.. +. ... . . .. ..+. .+.+..+
T Consensus 73 ~~~i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 152 (235)
T cd05155 73 YRWLEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALW 152 (235)
T ss_pred EEeecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHH
Confidence 999988655321 110 00 000 0 0 00 0000 0111111
Q ss_pred HHH------HhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 200 ESI------HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 200 ~~L------H~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..+ ...+++|+|+.|.||+++.++..-|+||+.+...+.
T Consensus 153 ~~~~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gDp 197 (235)
T cd05155 153 EAALRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGDP 197 (235)
T ss_pred HHHhcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCcCCh
Confidence 111 123589999999999998776678999999876543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.6e-05 Score=71.33 Aligned_cols=137 Identities=15% Similarity=0.137 Sum_probs=95.3
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh-----------------hhh--hHHHHHHHHHHHHHhcCC--
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----------------KRG--QVEHVRAERNLLAEVASH-- 146 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----------------~~~--~~~~~~~e~~~l~~l~h~-- 146 (333)
+.++.+||-|.-+.||.+-+ ..|++.++|.-+..... .+. ..-...+|...|+.+...
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56788999999999999875 46888888864321100 011 122356788888888653
Q ss_pred ceeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEE
Q 019953 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (333)
Q Consensus 147 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vk 226 (333)
-+++.++ .+..++|||++.|-.|...-.-. .+..+...+..-+--|..+|+||+|..-=||++++++.++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 3555544 34578999999887775543211 1223444555556678899999999999999999999999
Q ss_pred EEeccCccc
Q 019953 227 LSDFGLCKP 235 (333)
Q Consensus 227 l~DFGla~~ 235 (333)
++||--...
T Consensus 243 vIDFPQmvS 251 (465)
T KOG2268|consen 243 VIDFPQMVS 251 (465)
T ss_pred EeechHhhc
Confidence 999975543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00011 Score=67.04 Aligned_cols=145 Identities=21% Similarity=0.243 Sum_probs=100.2
Q ss_pred eEeeeEeeecceEEEEEEEecCCceEEEEecchhHH-----------------------hhhhhHHHHHHHHHHHHHhcC
Q 019953 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-----------------------VKRGQVEHVRAERNLLAEVAS 145 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~~~~~e~~~l~~l~h 145 (333)
.+-.+|..|.-+.||.|.. .+|..+|||+++..-+ ...-...+...|+..|.++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3557888999999999874 5788899999854210 000112356778888888876
Q ss_pred CceeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEecccCCCcEEEccCCc
Q 019953 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLLLDKNGH 224 (333)
Q Consensus 146 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~L-H~~~ivHrDlkp~Nill~~~~~ 224 (333)
..|+..--+.. ....|||+|+....-..-..+.-.++...+..+-.|++.-+.-| +..++||.||.-=|+|+ .+|.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 66543222221 12469999994322222222344677777888878888888776 56799999999999999 6789
Q ss_pred EEEEeccCcccCC
Q 019953 225 MKLSDFGLCKPLD 237 (333)
Q Consensus 225 vkl~DFGla~~~~ 237 (333)
+.|+|-+-+...+
T Consensus 303 lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 303 LYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEccccccCC
Confidence 9999998877654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00033 Score=65.81 Aligned_cols=79 Identities=22% Similarity=0.187 Sum_probs=52.2
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHh--h--hhhHHHHHHHHHHHHHhc---CCceeEEEEEEeeCCeEEE
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--K--RGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 163 (333)
.+.||.|.+..||++.+...++.|+||.-...... . +...+....|...|..+. ..++++++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 46789999999999987543358999985422100 0 123445666788887763 23567776653 345789
Q ss_pred EEeccCCC
Q 019953 164 IMEYLPGG 171 (333)
Q Consensus 164 v~e~~~~g 171 (333)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.89 E-value=5.3e-05 Score=63.91 Aligned_cols=100 Identities=21% Similarity=0.224 Sum_probs=79.1
Q ss_pred HHHHHHHHhcC-CceeEEEEEEeeCCeEEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 019953 135 AERNLLAEVAS-HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL---LMREDTLTENVARFYIAQSVLAIESIHK---HNY 207 (333)
Q Consensus 135 ~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i 207 (333)
.|.-+++.+.+ +++++++|+|.. ++|.||...+++... +..-...++..+..++.+++..+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 37778888876 599999999843 678899977666422 1122346788899999999999999987 347
Q ss_pred EecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 208 vHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.-.|++|+|+-+++++.+|++|...+...+.
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~ 114 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK 114 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence 7799999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00037 Score=60.79 Aligned_cols=139 Identities=17% Similarity=0.204 Sum_probs=78.8
Q ss_pred eeeEeeecceEEEEEEEec-CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc-eeEEEEEEeeCCeEEEEEecc
Q 019953 91 LTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~ 168 (333)
++.|..|-...+|++.... .+..|++|+...... .. ....+|..++..+...+ .++++..+. . .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LI-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ce-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEee
Confidence 3567777778999886432 356788997754311 11 12335888888885443 344444332 2 4799999
Q ss_pred CCCCHHHH--------------HH---h-CCCC----------CH-HHHHHHHH----------------------HHH-
Q 019953 169 PGGDMMTL--------------LM---R-EDTL----------TE-NVARFYIA----------------------QSV- 196 (333)
Q Consensus 169 ~~g~L~~~--------------l~---~-~~~~----------~~-~~~~~~~~----------------------qi~- 196 (333)
+|.++... +. . .... .. ..+..+.. .+.
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 88654211 11 0 0011 11 11111111 111
Q ss_pred --HHHHH-HH----hCCcEecccCCCcEEEcc-CCcEEEEeccCcccCC
Q 019953 197 --LAIES-IH----KHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLD 237 (333)
Q Consensus 197 --~~L~~-LH----~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~ 237 (333)
..|.. +- ..+++|+|+.|.|||++. ++.+.|+||..|....
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~ 203 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNY 203 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCc
Confidence 11111 11 135999999999999998 5789999999887544
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00057 Score=62.07 Aligned_cols=77 Identities=13% Similarity=0.069 Sum_probs=53.6
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC---CceeEEEEEEee---CCeEEE
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS---HCIVKLYYSFQD---TEYLYL 163 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~l 163 (333)
-.+.||.|..+.||..... ++ .+.+|..+.. .....+..|+..|+.+.. ..++++++.+.. .+..++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-QG-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcC-CC-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 4568999999999986532 23 4667774321 012347779999988854 367888877654 366899
Q ss_pred EEeccCCCCH
Q 019953 164 IMEYLPGGDM 173 (333)
Q Consensus 164 v~e~~~~g~L 173 (333)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999988654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00022 Score=63.23 Aligned_cols=135 Identities=18% Similarity=0.216 Sum_probs=76.1
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce-eEEEEEEeeCCeEEEEEeccCCCC
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDTEYLYLIMEYLPGGD 172 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~ 172 (333)
+..|-.+.+|+.. .++..+++|........- .. ....|..+++.+....+ ++++... . -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence 4456777889775 456778888765432110 01 24568888888865433 3444333 2 268999998865
Q ss_pred HHH--------------HHHh-C------CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcEecccC
Q 019953 173 MMT--------------LLMR-E------DTLTEN-VARFYIAQS---------VLAIESIHK--------HNYIHRDIK 213 (333)
Q Consensus 173 L~~--------------~l~~-~------~~~~~~-~~~~~~~qi---------~~~L~~LH~--------~~ivHrDlk 213 (333)
+.. .+.. + .+++.. .+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 431 1110 0 111111 111211111 111222221 258999999
Q ss_pred CCcEEEccCCcEEEEeccCcccCCC
Q 019953 214 PDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 214 p~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
|.||+++.++ +.|+||..+...++
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~gdp 178 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDGDI 178 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcCCH
Confidence 9999999877 78999998876543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00056 Score=61.90 Aligned_cols=138 Identities=16% Similarity=0.143 Sum_probs=81.5
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc--eeEEEEE------EeeCCeEE
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLYYS------FQDTEYLY 162 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~ 162 (333)
.+.|..|....+|+... ++..+++|+.... ....+..|+.++..+...+ +++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 55677777788998753 3457889987641 1233556777777775432 4444432 12345678
Q ss_pred EEEeccCCCCHHH-----------HH---Hh-CCCCC---------HHHH---H--------HHHHHHHHHHHHHHh---
Q 019953 163 LIMEYLPGGDMMT-----------LL---MR-EDTLT---------ENVA---R--------FYIAQSVLAIESIHK--- 204 (333)
Q Consensus 163 lv~e~~~~g~L~~-----------~l---~~-~~~~~---------~~~~---~--------~~~~qi~~~L~~LH~--- 204 (333)
+|++|++|..+.. .+ .. ...+. .... . .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998865421 01 00 00000 0000 0 001112233444443
Q ss_pred ----CCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 205 ----HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 205 ----~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.+++|+|+.|.||+++.++.+.|+||+.+..-
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 47999999999999999877899999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00074 Score=61.56 Aligned_cols=142 Identities=19% Similarity=0.167 Sum_probs=80.8
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc--eeEEEEEE------eeCC
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLYYSF------QDTE 159 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~------~~~~ 159 (333)
..-++.++.|....+|++.. .+| .+++|+..... ....+..+..++..+.... +++++... ...+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 44466777777788998753 334 57789765421 1122444667777764332 44444321 2245
Q ss_pred eEEEEEeccCCCCHH-----------HHH---Hh-CCCC--------CHHH-----HH----------HHHHHHHHHHHH
Q 019953 160 YLYLIMEYLPGGDMM-----------TLL---MR-EDTL--------TENV-----AR----------FYIAQSVLAIES 201 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~-----------~~l---~~-~~~~--------~~~~-----~~----------~~~~qi~~~L~~ 201 (333)
..+++++|++|..+. ..+ .. ...+ .... .. .....+...+.+
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999885421 111 10 0000 0000 00 001112334444
Q ss_pred HH-------hCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 202 IH-------KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 202 LH-------~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+. ..+++|+|+++.||+++.++.+.|+||+.+..-
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~ 218 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTD 218 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccCc
Confidence 43 258999999999999999887799999988653
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0014 Score=59.49 Aligned_cols=33 Identities=24% Similarity=0.308 Sum_probs=29.0
Q ss_pred CcEecccCCCcEEEccC----CcEEEEeccCcccCCC
Q 019953 206 NYIHRDIKPDNLLLDKN----GHMKLSDFGLCKPLDC 238 (333)
Q Consensus 206 ~ivHrDlkp~Nill~~~----~~vkl~DFGla~~~~~ 238 (333)
+++|+|+.|.|||++.+ +.+.++||..|..-..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p 216 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYR 216 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCc
Confidence 58999999999999985 8899999999886554
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0017 Score=67.21 Aligned_cols=150 Identities=17% Similarity=0.183 Sum_probs=110.8
Q ss_pred HHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE----EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019953 131 EHVRAERNLLAEVASHCIVKLYYSFQDTEYLY----LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206 (333)
Q Consensus 131 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 206 (333)
.....|...+..+.|+|++.++.+........ +..++|...++...+..-..++....+.+..+...||.++|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34455778888999999999988876544333 45577888888888888888999999999999999999999997
Q ss_pred cEecccCCC---cEEEccCCcEEEE--eccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHh
Q 019953 207 YIHRDIKPD---NLLLDKNGHMKLS--DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQL 281 (333)
Q Consensus 207 ivHrDlkp~---Nill~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (333)
..|.-+..+ +...+..+.+.++ ||+.++.+.....
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---------------------------------------- 346 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---------------------------------------- 346 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCccc----------------------------------------
Confidence 766666655 4445566677777 8888776653321
Q ss_pred HHHHhhhhccccccCCCCCCcccccccCCCCCcc--cc-hHHHHHHHhhhcc
Q 019953 282 QHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME--CD-WLVSVLHFNSYRF 330 (333)
Q Consensus 282 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~--~D-ws~g~il~~l~t~ 330 (333)
..+..-+..+.|||......++.+ .| |.+|.....+..+
T Consensus 347 ----------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 347 ----------SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred ----------chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhc
Confidence 113345667888998877666554 69 9999888766543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0037 Score=58.80 Aligned_cols=77 Identities=17% Similarity=0.144 Sum_probs=49.7
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh----hhhHHHHHHHHHHHHHhc---CCceeEEEEEEeeCCeEE
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK----RGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 162 (333)
..+.||.|....||+..+ .+..++||.-....... +........|...|+.+. ...+++++.++. ...+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 367889999999999875 34568999865321100 012333444666776654 247788877776 3357
Q ss_pred EEEeccCC
Q 019953 163 LIMEYLPG 170 (333)
Q Consensus 163 lv~e~~~~ 170 (333)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.012 Score=53.94 Aligned_cols=32 Identities=25% Similarity=0.314 Sum_probs=27.6
Q ss_pred CCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.+++|+|++|.||+++.+...-|+||+.+..-
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 38999999999999987666689999988753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0068 Score=56.05 Aligned_cols=76 Identities=18% Similarity=0.175 Sum_probs=47.4
Q ss_pred eEeeecceEEEEEEEecCCceEEEEecchhHHh----hhhhHHHHHHHHHHHHHhc--CC-ceeEEEEEEeeCCeEEEEE
Q 019953 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV----KRGQVEHVRAERNLLAEVA--SH-CIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 93 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~ 165 (333)
.||.|....||++.+...++.|+||.-....-. -+...++...|...|+... .| .++++|. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 478899999999987543468999976432211 1223445556777777653 23 4555543 2344567999
Q ss_pred eccCC
Q 019953 166 EYLPG 170 (333)
Q Consensus 166 e~~~~ 170 (333)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00019 Score=75.80 Aligned_cols=195 Identities=14% Similarity=0.057 Sum_probs=126.0
Q ss_pred CCceEeeeEeeecceEEEEEEEecCC-ceEEEEecchhHHhhh--hhHHHHHHHHHHHHHhcCCceeEEEEEEeeC--Ce
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSG-NIYAMKKLKKSEMVKR--GQVEHVRAERNLLAEVASHCIVKLYYSFQDT--EY 160 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 160 (333)
..+++.--+|-|.++ ++.+.... -.+.+++.+......- ...+-...|.+.++...|+++...+.-..+. ..
T Consensus 1229 e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 345554445544443 33333221 1245565544332211 1122334455566677899887766544332 34
Q ss_pred EEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC-----CcEecccCCCcEEEccCCcEEEEecc
Q 019953 161 LYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHKH-----NYIHRDIKPDNLLLDKNGHMKLSDFG 231 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~LH~~-----~ivHrDlkp~Nill~~~~~vkl~DFG 231 (333)
.+.+++++.+|.+.+.+.++- ......+.....+.+....-+|+. -.+|+++|+-|.+|..+..+|+.++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 688999999999999986642 233333333333436666666653 27899999999999999999999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 311 (333)
+.+...... ......++++.|++|++...-.
T Consensus 1386 LdKIknp~~-------------------------------------------------sf~Gl~l~sp~~v~qli~N~ik 1416 (2724)
T KOG1826|consen 1386 LDKIKNPVL-------------------------------------------------SFFGLELCSPIYVLQLIKNEIK 1416 (2724)
T ss_pred cccccCchH-------------------------------------------------hhhhhhhCCHHHHHHHHHHHHh
Confidence 999432211 1122457889999999999888
Q ss_pred CCcccc-hHHHHHHHhhhcccc
Q 019953 312 YGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~~~ 332 (333)
++.++| |..++-+|....+++
T Consensus 1417 ~t~rsdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1417 FTKRSDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred hhhHHHHHHHHHHHHHHhcccH
Confidence 999999 888999998877654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.007 Score=54.32 Aligned_cols=34 Identities=26% Similarity=0.460 Sum_probs=27.9
Q ss_pred CcEecccCCCcEEEccCCc-EEEEeccCcccCCCC
Q 019953 206 NYIHRDIKPDNLLLDKNGH-MKLSDFGLCKPLDCS 239 (333)
Q Consensus 206 ~ivHrDlkp~Nill~~~~~-vkl~DFGla~~~~~~ 239 (333)
.++|+|++|.|||++.++. .-|+||+.+...++.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDPa 220 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDPA 220 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCHH
Confidence 4899999999999997554 579999998876543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0082 Score=54.67 Aligned_cols=150 Identities=13% Similarity=0.156 Sum_probs=85.1
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC--ceeEEEEEEeeCC--eEEE
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYSFQDTE--YLYL 163 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~--~~~l 163 (333)
..+++.+..|---.+|...+. ++.+++. .+.. ...........+|..+++.+..- -+...++.+.++. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~-~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPR-GDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCc-cccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 444555533433445554433 7788888 3321 11222334456688888877543 3445555555544 6799
Q ss_pred EEeccCCCCHH------------------HHHHh--------------CCCCCHHHHHHHHHHH--------------HH
Q 019953 164 IMEYLPGGDMM------------------TLLMR--------------EDTLTENVARFYIAQS--------------VL 197 (333)
Q Consensus 164 v~e~~~~g~L~------------------~~l~~--------------~~~~~~~~~~~~~~qi--------------~~ 197 (333)
||+|++|..+. ++|.. .+.....+...+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 99999873221 11110 0001111122222222 11
Q ss_pred HHHHHHhC--------CcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 198 AIESIHKH--------NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 198 ~L~~LH~~--------~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
-..||+.+ .++|+|+++.|++++..+-+-|.||+++...++..+
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~D 234 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLED 234 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHHH
Confidence 23455432 489999999999999998899999999998776544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.012 Score=54.65 Aligned_cols=140 Identities=11% Similarity=0.149 Sum_probs=79.9
Q ss_pred eeeEeeecceEEEEEEEec----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCcee-EEEEEEeeCCeEEEEE
Q 019953 91 LTIIGRGAFGEVRLCREKK----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV-KLYYSFQDTEYLYLIM 165 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~ 165 (333)
+..|..|-...+|++.... .++.|++|+..... ...++ ...|..+++.+...++. ++++.+.. + .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 3455457778899876432 24678999876532 12222 35688888888655443 45555532 2 578
Q ss_pred eccCCCCHHHH----------H----H---h-C---C--CCCHHHHHHHHHHH-----------------HHHHHHH---
Q 019953 166 EYLPGGDMMTL----------L----M---R-E---D--TLTENVARFYIAQS-----------------VLAIESI--- 202 (333)
Q Consensus 166 e~~~~g~L~~~----------l----~---~-~---~--~~~~~~~~~~~~qi-----------------~~~L~~L--- 202 (333)
+|+++.++... + . . . . ......+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99876554311 0 0 0 0 0 01111222222111 1111122
Q ss_pred -H----hCCcEecccCCCcEEEcc-CCcEEEEeccCcccCCC
Q 019953 203 -H----KHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 203 -H----~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~~ 238 (333)
. ...++|+|+++.|||++. ++.+.++||..+...+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~~ 234 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNPV 234 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccch
Confidence 1 235899999999999986 47899999999886543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.015 Score=52.52 Aligned_cols=75 Identities=19% Similarity=0.207 Sum_probs=46.6
Q ss_pred eEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc---CCceeEEEEEEeeCCeEEEEE
Q 019953 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 165 (333)
+-.+.|+.|....+|+.. .+++.+-||+-... ....+..|+.-|+.|. .-.+++++.+....+..++||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345688889999999866 67888999987622 1123566888888883 336888888887777779999
Q ss_pred eccCCC
Q 019953 166 EYLPGG 171 (333)
Q Consensus 166 e~~~~g 171 (333)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.015 Score=54.54 Aligned_cols=78 Identities=18% Similarity=0.204 Sum_probs=50.2
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHh---hhhhHHHHHHHHHHHHHhc--CC-ceeEEEEEEeeCCeEEEE
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV---KRGQVEHVRAERNLLAEVA--SH-CIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv 164 (333)
.+.||-|.-.-||++.+...+..|+||.-....-. -+...++..-|...|+... .| .++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 67889999999999987434567999975432111 1223455666888887663 24 45555433 34456789
Q ss_pred EeccCC
Q 019953 165 MEYLPG 170 (333)
Q Consensus 165 ~e~~~~ 170 (333)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998853
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.037 Score=51.01 Aligned_cols=144 Identities=14% Similarity=0.134 Sum_probs=78.6
Q ss_pred CCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce-eEEEEEEeeCCeE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDTEYL 161 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~ 161 (333)
+.+.+... ..|=...+|++..... +..|++|+...... .. -...+|..+++.+...++ +++++++. .+
T Consensus 15 ~~i~i~~l-~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G-- 86 (330)
T PLN02421 15 SDFSVERI-SGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG-- 86 (330)
T ss_pred CceEEEEe-CCcccceEEEEEecCCCCCCceEEEEEecCCcC---eE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc--
Confidence 34444444 3366677888754322 23788998754321 11 123458888888876555 34555553 22
Q ss_pred EEEEeccCCCCHHH----------HH----H---hCC-C----C-CHHHHHHHHHHH----------------------H
Q 019953 162 YLIMEYLPGGDMMT----------LL----M---RED-T----L-TENVARFYIAQS----------------------V 196 (333)
Q Consensus 162 ~lv~e~~~~g~L~~----------~l----~---~~~-~----~-~~~~~~~~~~qi----------------------~ 196 (333)
+|.+|+++..+.. .+ . ... + . ....+..+..++ .
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5889987654321 01 0 100 0 1 111222222111 1
Q ss_pred HHHHHH---H-hC----CcEecccCCCcEEEcc-CCcEEEEeccCcccCCC
Q 019953 197 LAIESI---H-KH----NYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 197 ~~L~~L---H-~~----~ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~~ 238 (333)
.-+..+ . .. -++|.|+.|.|||++. ++.++++||..|..-+.
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~ 216 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYR 216 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCcc
Confidence 112222 1 11 3799999999999975 57899999998876543
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.015 Score=53.43 Aligned_cols=73 Identities=25% Similarity=0.459 Sum_probs=56.1
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
...+.|++|++. |+++.-. ......++..++.+.+..++-+... .+-|||+.-.||||+ +|+|.|+||-+++.
T Consensus 297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 345678888886 5555322 2234566777788877777777655 789999999999999 99999999999994
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.093 Score=49.36 Aligned_cols=32 Identities=22% Similarity=0.142 Sum_probs=26.2
Q ss_pred CCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
..++|.|+-+.||+.+ ++.+.++||.-|..-.
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~n~ 258 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGFNY 258 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEeccccCCc
Confidence 4689999999999875 4569999999887544
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.46 Score=43.65 Aligned_cols=30 Identities=20% Similarity=0.244 Sum_probs=25.5
Q ss_pred CCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.++||+|+.+.|||++ + .+.|+||+.+..-
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~g 225 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARMG 225 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCCC
Confidence 3689999999999995 4 5789999988754
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.06 Score=50.41 Aligned_cols=61 Identities=23% Similarity=0.384 Sum_probs=41.5
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCcEecccCCCcEEEccC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES-IHKHNYIHRDIKPDNLLLDKN 222 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~-LH~~~ivHrDlkp~Nill~~~ 222 (333)
..++=+|..|-++..++... ..++.....++.-...|+-- |--.+++|.|++|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 34566677788888777543 34555556666555666544 345689999999999999543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.073 Score=45.82 Aligned_cols=83 Identities=22% Similarity=0.270 Sum_probs=56.4
Q ss_pred HHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--CCcEec
Q 019953 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK--HNYIHR 210 (333)
Q Consensus 133 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivHr 210 (333)
+..+.+++.++. .|+++..- +...+.++.|.|-.-.. ....++.--+.+|.-.|+ .+.+|+
T Consensus 105 y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N~i~agi~~L~~fH~~~~~~lHG 167 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NFSNFITAGIKDLMDFHSENQHCLHG 167 (308)
T ss_pred hhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------chhHHHHHhHHHHHHhhccCCCeecC
Confidence 455677777653 67777622 34457899999842111 011122223566777884 479999
Q ss_pred ccCCCcEEEccCCcEEEEeccC
Q 019953 211 DIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 211 Dlkp~Nill~~~~~vkl~DFGl 232 (333)
|..|+||+.|..|.+||.|-+.
T Consensus 168 D~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 168 DCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCChhheeecCCCCEEecChhh
Confidence 9999999999999999999874
|
The function of this family is unknown. |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.43 Score=43.60 Aligned_cols=137 Identities=18% Similarity=0.165 Sum_probs=85.2
Q ss_pred eeeEeeecceEEEEEEE-------ec---CCceEEEEecchhHH--hh-------------------hhhH--HHHHHHH
Q 019953 91 LTIIGRGAFGEVRLCRE-------KK---SGNIYAMKKLKKSEM--VK-------------------RGQV--EHVRAER 137 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~-------~~---~~~~vaiK~~~~~~~--~~-------------------~~~~--~~~~~e~ 137 (333)
...|..|.-+.|+.|.- .. .-..+|||+++..-. .. +..+ -+..+|.
T Consensus 257 ~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkEm 336 (531)
T KOG2269|consen 257 DGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKEM 336 (531)
T ss_pred hhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHHH
Confidence 34677788888887731 11 235689998854210 00 0001 1233455
Q ss_pred HHHHHhc-----CCceeEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEecc
Q 019953 138 NLLAEVA-----SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI-HKHNYIHRD 211 (333)
Q Consensus 138 ~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~L-H~~~ivHrD 211 (333)
..|.+++ +|-+|.+ ....|||.|+...-+..--.++-.++....+..-.|+..++.-| |..-+||.|
T Consensus 337 hNL~RMq~~GlpcP~vV~l-------kkhvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHAD 409 (531)
T KOG2269|consen 337 HNLSRMQKHGLPCPQVVKL-------KKHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHAD 409 (531)
T ss_pred HHHHHHHhcCCCCCceeee-------ecceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecc
Confidence 5555543 4555554 23578999984322222112334577788777777888888776 677899999
Q ss_pred cCCCcEEEccCCcEEEEeccCccc
Q 019953 212 IKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 212 lkp~Nill~~~~~vkl~DFGla~~ 235 (333)
+.--|+|...+ .+.++|-.-+..
T Consensus 410 lSEyN~Lw~~g-Kvw~IDVsQsve 432 (531)
T KOG2269|consen 410 LSEYNLLWTPG-KVWVIDVSQSVE 432 (531)
T ss_pred hhhhhheecCC-ceEEEechhccC
Confidence 99999999766 899999776554
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.058 Score=48.98 Aligned_cols=30 Identities=27% Similarity=0.557 Sum_probs=26.4
Q ss_pred CCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47999999999999987 6789999997764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.03 Score=46.95 Aligned_cols=32 Identities=25% Similarity=0.427 Sum_probs=27.5
Q ss_pred CcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 206 ~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..+|+|+.|.||+++.++ ++|+||+.+...++
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp 109 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGDI 109 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCCCH
Confidence 479999999999998877 88999998886543
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.81 Score=43.97 Aligned_cols=78 Identities=18% Similarity=0.091 Sum_probs=45.6
Q ss_pred CCceEeeeEeeecceEEEEEEEec--------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCcee-EEEEEEe
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKK--------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV-KLYYSFQ 156 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~ 156 (333)
++. -++.|..|=.-.+|++.... .++.|.+++.-.... ..+ ....|..+++.+...+|. ++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te---~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~ 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD---ELY-NPISEFEVYKTMSKYRIAPQLLNTFS 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc---cee-CHHHHHHHHHHHHHCCCCCceEEEeC
Confidence 344 45566556667788876432 156788898754321 111 234577788777655543 4445442
Q ss_pred eCCeEEEEEeccCCCC
Q 019953 157 DTEYLYLIMEYLPGGD 172 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~ 172 (333)
-+.|.+|++|..
T Consensus 181 ----gg~I~efi~g~~ 192 (442)
T PTZ00296 181 ----GGRIEEWLYGDP 192 (442)
T ss_pred ----CCEEEEeeCCcc
Confidence 246789998753
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.48 E-value=0.18 Score=42.76 Aligned_cols=35 Identities=20% Similarity=0.287 Sum_probs=28.9
Q ss_pred CCcEecccCCCcEEEccCC-----cEEEEeccCcccCCCC
Q 019953 205 HNYIHRDIKPDNLLLDKNG-----HMKLSDFGLCKPLDCS 239 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~~-----~vkl~DFGla~~~~~~ 239 (333)
..++|||+.+.||++..++ .+.|+||..+....+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g~p~ 159 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYGSPA 159 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCcCChH
Confidence 4699999999999998554 6899999999865543
|
subfamily of choline kinases |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.92 Score=39.45 Aligned_cols=75 Identities=21% Similarity=0.301 Sum_probs=47.9
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh---cCCceeEEEEEEeeCCeEEEEEecc
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (333)
+.+.-|.--..|...+ ...++-+|+-... ....+..|+.-|..+ +.-.+++++.+.....+.|+||||+
T Consensus 22 ~~v~gG~inea~~v~d--g~~~~FvK~n~~~------~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRD--GTDPFFVKCNQRE------QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeec--CCcceEEEecchh------hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 4454555555555443 3456778864332 223355566666655 3456888888888899999999999
Q ss_pred CCCCHH
Q 019953 169 PGGDMM 174 (333)
Q Consensus 169 ~~g~L~ 174 (333)
+.+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 875443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 333 | ||||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-48 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-48 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-48 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-46 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-46 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-45 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-45 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-43 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-38 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-38 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-38 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-37 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-37 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-37 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-37 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-37 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-37 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-37 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-37 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-37 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-37 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-37 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-37 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-37 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-37 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-37 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-37 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-37 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-37 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-37 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-37 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-37 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-36 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-36 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-36 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-36 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-36 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-36 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-36 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-36 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-36 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-36 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-36 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-36 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-36 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-36 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-36 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-36 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-36 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-36 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-36 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-36 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-36 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-36 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-36 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-36 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-36 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-36 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-36 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-36 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-35 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-34 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-34 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-34 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-34 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-34 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-34 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-33 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-33 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-33 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-33 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-33 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-33 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-33 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-33 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-32 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-32 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-32 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-31 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-31 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-31 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-31 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-31 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-31 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-31 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-31 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-30 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-29 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-28 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-27 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-27 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-27 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-27 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-27 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-27 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-27 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-27 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-27 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-27 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-27 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-27 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-27 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-27 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-27 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-27 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-27 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-26 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-26 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-26 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-26 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-26 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-26 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-24 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-24 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-24 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-24 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-23 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-23 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-23 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-23 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-23 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-23 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-23 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-23 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-22 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-22 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-21 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-21 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-21 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-21 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-20 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-18 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-18 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-18 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-17 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-17 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 4e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 7e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 8e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 4ax8_A | 569 | Medium Resolution Structure Of The Bifunctional Kin | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-05 | ||
| 4azs_A | 569 | High Resolution (2.2 A) Crystal Structure Of Wbdd. | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 4azw_A | 471 | Crystal Structure Of Monomeric Wbdd Length = 471 | 3e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-04 |
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AX8|A Chain A, Medium Resolution Structure Of The Bifunctional Kinase- Methyltransferase Wbdd Length = 569 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4AZS|A Chain A, High Resolution (2.2 A) Crystal Structure Of Wbdd. Length = 569 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AZW|A Chain A, Crystal Structure Of Monomeric Wbdd Length = 471 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 300 bits (769), Expect = e-100
Identities = 98/270 (36%), Positives = 146/270 (54%), Gaps = 56/270 (20%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
+ + + L+ E +RLK ++ DDFE+L +IGRGAF EV + + K++G +YAM
Sbjct: 32 ELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 117 KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
K + K +M+KRG+V R ER++L I +L+++FQD YLYL+MEY GGD++TL
Sbjct: 92 KIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTL 151
Query: 177 LMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235
L + + + +ARFY+A+ V+AI+S+H+ Y+HRDIKPDN+LLD+ GH++L+DFG C
Sbjct: 152 LSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295
L + +
Sbjct: 212 LR------------------------------------------------ADGTVRSLVA 223
Query: 296 VGTPDYIAPEVLLKKG-------YGMECDW 318
VGTPDY++PE+L G YG ECDW
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDW 253
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 292 bits (748), Expect = 1e-96
Identities = 104/272 (38%), Positives = 153/272 (56%), Gaps = 54/272 (19%)
Query: 53 SSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN 112
++ P+ + N+++ LE + ++K+ ++ +DFE+L +IGRGAFGEV + + K +
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK 100
Query: 113 IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD 172
++AMK L K EM+KR + R ER++L S I L+Y+FQD LYL+M+Y GGD
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160
Query: 173 MMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
++TLL + ED L E +ARFY+A+ V+AI+S+H+ +Y+HRDIKPDN+L+D NGH++L+DFG
Sbjct: 161 LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 220
Query: 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291
C L D +SS
Sbjct: 221 SCLKLM----------------------------EDGTVQSS------------------ 234
Query: 292 AFSTVGTPDYIAPEVLL-----KKGYGMECDW 318
VGTPDYI+PE+L K YG ECDW
Sbjct: 235 --VAVGTPDYISPEILQAMEGGKGRYGPECDW 264
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 3e-96
Identities = 98/266 (36%), Positives = 145/266 (54%), Gaps = 53/266 (19%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
+ + N+ L R + +++ ++ +D+E++ +IGRGAFGEV+L R K + +YAM
Sbjct: 40 ALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 117 KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
K L K EM+KR ER+++A S +V+L+Y+FQD YLY++MEY+PGGD++ L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 177 LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
+ D + E ARFY A+ VLA+++IH +IHRD+KPDN+LLDK+GH+KL+DFG C +
Sbjct: 160 MSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218
Query: 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296
+ + V
Sbjct: 219 N------------------------------------------------KEGMVRCDTAV 230
Query: 297 GTPDYIAPEVLLKKG----YGMECDW 318
GTPDYI+PEVL +G YG ECDW
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDW 256
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 2e-84
Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 47/247 (19%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
+ + K +DF+ I+G G+F V L RE + YA+K L+K ++K +V
Sbjct: 16 QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75
Query: 132 HVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
+V ER++++ + VKLY++FQD E LY + Y G+++ + + + E RFY
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
A+ V A+E +H IHRD+KP+N+LL+++ H++++DFG K L
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------------- 181
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+++ A S VGT Y++PE+L +K
Sbjct: 182 ---------------------------------PESKQARANSFVGTAQYVSPELLTEKS 208
Query: 312 YGMECDW 318
D
Sbjct: 209 ACKSSDL 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 6e-80
Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 53/243 (21%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+ + D FE+L IG+G+FG+V + ++ + +YAMK + K + V+R +V +V E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
++ + +V L+YSFQD E ++++++ L GGD+ L + E + +I + V+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
++ + IHRD+KPDN+LLD++GH+ ++DF +
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------------ 163
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK---GYGME 315
+ R + GT Y+APE+ + GY
Sbjct: 164 --------------------------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 316 CDW 318
DW
Sbjct: 198 VDW 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 8e-79
Identities = 78/251 (31%), Positives = 120/251 (47%), Gaps = 50/251 (19%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
++ DF L +IG+G+FG+V L R K YA+K L+K ++K+
Sbjct: 21 PSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK 80
Query: 129 QVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
+ +H+ +ERN+L + H +V L++SFQ + LY +++Y+ GG++ L RE E
Sbjct: 81 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 140
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
ARFY A+ A+ +H N ++RD+KP+N+LLD GH+ L+DFGLCK
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK------------- 187
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
EN+ + GTP+Y+APEVL
Sbjct: 188 -----ENIEH-------------------------------NSTTSTFCGTPEYLAPEVL 211
Query: 308 LKKGYGMECDW 318
K+ Y DW
Sbjct: 212 HKQPYDRTVDW 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 3e-78
Identities = 74/241 (30%), Positives = 117/241 (48%), Gaps = 50/241 (20%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+ K+ ++DF L ++G+G+FG+V L KK+ +A+K LKK ++ VE E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 139 LLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
+L+ H + ++ +FQ E L+ +MEYL GGD+M + + A FY A+ +L
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
++ +H ++RD+K DN+LLDK+GH+K++DFG+CK ENM
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK------------------ENMLG 171
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ GTPDYIAPE+LL + Y D
Sbjct: 172 D-------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVD 200
Query: 318 W 318
W
Sbjct: 201 W 201
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 8e-78
Identities = 75/254 (29%), Positives = 125/254 (49%), Gaps = 50/254 (19%)
Query: 66 KDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV 125
K+ ++ +++ +D+FE + ++G+G+FG+V L R K++G++YA+K LKK ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 126 KRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLT 184
+ VE E+ +L+ +H + +L+ FQ + L+ +ME++ GGD+M + +
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
E ARFY A+ + A+ +H I+RD+K DN+LLD GH KL+DFG+CK
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---------- 172
Query: 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304
E + + GTPDYIAP
Sbjct: 173 --------EGICN-------------------------------GVTTATFCGTPDYIAP 193
Query: 305 EVLLKKGYGMECDW 318
E+L + YG DW
Sbjct: 194 EILQEMLYGPAVDW 207
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-77
Identities = 81/246 (32%), Positives = 125/246 (50%), Gaps = 53/246 (21%)
Query: 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRG-QVEH 132
KI + FELL ++G+G +G+V R+ +G I+AMK LKK+ +V+ H
Sbjct: 8 NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
+AERN+L EV IV L Y+FQ LYLI+EYL GG++ L RE E+ A FY+
Sbjct: 68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
A+ +A+ +H+ I+RD+KP+N++L+ GH+KL+DFGLCK
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK------------------ 169
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
E++ + + + GT +Y+APE+L++ G+
Sbjct: 170 ESIHDG-------------------------------TVTHTFCGTIEYMAPEILMRSGH 198
Query: 313 GMECDW 318
DW
Sbjct: 199 NRAVDW 204
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 5e-77
Identities = 70/241 (29%), Positives = 113/241 (46%), Gaps = 50/241 (20%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
R ++ + DF L ++G+G+FG+V L K + +YA+K LKK +++ VE E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 139 LLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
+LA + +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ +
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
+ + I+RD+K DN++LD GH+K++DFG+CK EN+ +
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------ENIWD 174
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ GTPDYIAPE++ + YG D
Sbjct: 175 -------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVD 203
Query: 318 W 318
W
Sbjct: 204 W 204
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-76
Identities = 80/237 (33%), Positives = 119/237 (50%), Gaps = 49/237 (20%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K+ ++DF+ L ++G+G FG+V L REK +G YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ L Y+FQ + L +MEY GG++ L RE TE ARFY A+ V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H + ++RDIK +NL+LDK+GH+K++DFGLCK E +++
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK------------------EGISD---- 158
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTP+Y+APEVL YG DW
Sbjct: 159 ---------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 1e-76
Identities = 80/267 (29%), Positives = 132/267 (49%), Gaps = 55/267 (20%)
Query: 59 EEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCRE---KKSGNIYA 115
+ L+ T + K+ +++FELL ++G GA+G+V L R+ +G +YA
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 116 MKKLKKSEMVKRG-QVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDM 173
MK LKK+ +V++ EH R ER +L + +V L+Y+FQ L+LI++Y+ GG++
Sbjct: 87 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 146
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
T L + + TE+ + Y+ + VLA+E +HK I+RDIK +N+LLD NGH+ L+DFGL
Sbjct: 147 FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
K E +A+ + A+
Sbjct: 207 K------------------EFVADETE------------------------------RAY 218
Query: 294 STVGTPDYIAPEVLL--KKGYGMECDW 318
GT +Y+AP+++ G+ DW
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDW 245
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 6e-76
Identities = 67/159 (42%), Positives = 106/159 (66%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K + DF++L +G G+FG V L R + +G YAMK LKK +V+ QVEH ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
V I++++ +FQD + +++IM+Y+ GG++ +LL + VA+FY A+ LA+E
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
+H + I+RD+KP+N+LLDKNGH+K++DFG K + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 14/22 (63%), Positives = 15/22 (68%)
Query: 297 GTPDYIAPEVLLKKGYGMECDW 318
GTPDYIAPEV+ K Y DW
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDW 186
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 7e-76
Identities = 76/238 (31%), Positives = 120/238 (50%), Gaps = 50/238 (21%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ + DF+LL +IGRG++ +V L R KK+ IYAMK +KK + ++ V+ E+++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 142 EVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
+ ++H +V L+ FQ L+ ++EY+ GGD+M + R+ L E ARFY A+ LA+
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H+ I+RD+K DN+LLD GH+KL+D+G+CK E +
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------------------EGLRP--- 163
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTP+YIAPE+L + YG DW
Sbjct: 164 ----------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 9e-76
Identities = 84/249 (33%), Positives = 130/249 (52%), Gaps = 53/249 (21%)
Query: 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQ 129
T ++ K FELL ++G+G+FG+V L ++ + +YAMK LKK+ + R +
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 130 VEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVAR 189
V + ER++L EV IVKL+Y+FQ LYLI+++L GGD+ T L +E TE +
Sbjct: 71 V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
FY+A+ LA++ +H I+RD+KP+N+LLD+ GH+KL+DFGL K
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------------- 174
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309
E++ K A+S GT +Y+APEV+ +
Sbjct: 175 ---ESIDHE-------------------------------KKAYSFCGTVEYMAPEVVNR 200
Query: 310 KGYGMECDW 318
+G+ DW
Sbjct: 201 RGHTQSADW 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-74
Identities = 77/254 (30%), Positives = 124/254 (48%), Gaps = 50/254 (19%)
Query: 66 KDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV 125
++ E T + + DF+LL +IGRG++ +V L R KK+ IYAM+ +KK +
Sbjct: 32 EEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN 91
Query: 126 KRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLT 184
++ V+ E+++ + ++H +V L+ FQ L+ ++EY+ GGD+M + R+ L
Sbjct: 92 DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP 151
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
E ARFY A+ LA+ +H+ I+RD+K DN+LLD GH+KL+D+G+CK
Sbjct: 152 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---------- 201
Query: 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304
E + + GTP+YIAP
Sbjct: 202 --------EGLRP-------------------------------GDTTSTFCGTPNYIAP 222
Query: 305 EVLLKKGYGMECDW 318
E+L + YG DW
Sbjct: 223 EILRGEDYGFSVDW 236
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 9e-74
Identities = 71/177 (40%), Positives = 109/177 (61%)
Query: 64 LIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE 123
L K E ++ ++ +D F+ + +G G+FG V L + K+SGN YAMK L K +
Sbjct: 19 LAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 124 MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTL 183
+VK Q+EH E+ +L V +VKL +SF+D LY++MEY+ GG+M + L R
Sbjct: 79 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 184 TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
+E ARFY AQ VL E +H + I+RD+KP+NLL+D+ G+++++DFG K + T
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 12/22 (54%), Positives = 16/22 (72%)
Query: 297 GTPDYIAPEVLLKKGYGMECDW 318
GTP+ +APE++L KGY DW
Sbjct: 200 GTPEALAPEIILSKGYNKAVDW 221
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-72
Identities = 78/336 (23%), Positives = 131/336 (38%), Gaps = 70/336 (20%)
Query: 1 MEEAEEEEVLGSKLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPMEE 60
++ E+ + + A+ + Q + + V + + D +
Sbjct: 89 WKDIEDYDTADDA---LRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQP 145
Query: 61 QINLIKDLERKE--------------TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR 106
+ + + ++ L+ + D F ++GRG FGEV C+
Sbjct: 146 LLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQ 205
Query: 107 EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166
K +G +YA KKL K + KR + E+ +LA+V S IV L Y+F+ L L+M
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265
Query: 167 YLPGGDMM----TLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN 222
+ GGD+ + E A FY AQ V +E +H+ N I+RD+KP+N+LLD +
Sbjct: 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD 325
Query: 223 GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQ 282
G++++SD GL E A
Sbjct: 326 GNVRISDLGLAV------------------ELKAG------------------------- 342
Query: 283 HWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTP ++APE+LL + Y D+
Sbjct: 343 ------QTKTKGYAGTPGFMAPELLLGEEYDFSVDY 372
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 3e-72
Identities = 80/241 (33%), Positives = 122/241 (50%), Gaps = 50/241 (20%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+H++ +++FE L ++G+G FG+V L +EK +G YAMK LKK +V + +V H E
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
+L + L YSFQ + L +MEY GG++ L RE +E+ ARFY A+ V A
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 199 IESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
++ +H + N ++RD+K +NL+LDK+GH+K++DFGLCK E + +
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK------------------EGIKD 302
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ GTP+Y+APEVL YG D
Sbjct: 303 G-------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 318 W 318
W
Sbjct: 332 W 332
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 4e-71
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 54/267 (20%)
Query: 54 SDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNI 113
S P + ++ I + ++ L+R + + F ++G+G FGEV C+ + +G +
Sbjct: 154 SVAPFADYLDSIY--FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKM 211
Query: 114 YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDM 173
YA KKL+K + KR E+ +L +V S +V L Y+++ + L L++ + GGD+
Sbjct: 212 YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL 271
Query: 174 MTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
+ M + E A FY A+ +E +H+ ++RD+KP+N+LLD +GH+++SD G
Sbjct: 272 KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291
L + +
Sbjct: 332 LAV--------------------------------------------------HVPEGQT 341
Query: 292 AFSTVGTPDYIAPEVLLKKGYGMECDW 318
VGT Y+APEV+ + Y DW
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDW 368
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 6e-71
Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 50/267 (18%)
Query: 53 SSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN 112
+ + + K R ++ + DF L ++G+G+FG+V L K +
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 113 IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGG 171
+YA+K LKK +++ VE E+ +LA + +L+ FQ + LY +MEY+ GG
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 172 DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231
D+M + + E A FY A+ + + + I+RD+K DN++LD GH+K++DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291
+CK EN+ +
Sbjct: 488 MCK------------------ENIWD-------------------------------GVT 498
Query: 292 AFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTPDYIAPE++ + YG DW
Sbjct: 499 TKTFCGTPDYIAPEIIAYQPYGKSVDW 525
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 227 bits (579), Expect = 6e-69
Identities = 70/244 (28%), Positives = 109/244 (44%), Gaps = 55/244 (22%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+ ++DF + IIGRG FGEV CR+ +G +YAMK L K + + ER
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 139 LLAEVASHC---IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQS 195
+L+ V++ IV + Y+F + L I++ + GGD+ L + +E RFY A+
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+L +E +H ++RD+KP N+LLD++GH+++SD GL
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--------------------- 340
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGM 314
+K ++VGT Y+APEVL K Y
Sbjct: 341 ------------------------------DFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 315 ECDW 318
DW
Sbjct: 371 SADW 374
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-66
Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 51/246 (20%)
Query: 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH 132
T + + K +DDF++ +G+G FG V L REK++ I A+K L KS++ K G
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
+R E + + + I+++Y F D + +YL++E+ P G++ L + E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+ A+ H+ IHRDIKP+NLL+ G +K++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
H RR+ + GT DY+ PE++ K +
Sbjct: 163 ------------------------------HAPSLRRR---TMCGTLDYLPPEMIEGKTH 189
Query: 313 GMECDW 318
+ D
Sbjct: 190 DEKVDL 195
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 5e-66
Identities = 66/240 (27%), Positives = 101/240 (42%), Gaps = 51/240 (21%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
K+ + ++DFE+ +G+G FG V L REK+S I A+K L K+++ K G +R E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
+ + + I++LY F D +YLI+EY P G + L + E YI + A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
+ H IHRDIKP+NLLL G +K++DFG S +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR------RTDL-------- 167
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
C GT DY+ PE++ + + + D
Sbjct: 168 -----C--------------------------------GTLDYLPPEMIEGRMHDEKVDL 190
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-58
Identities = 54/235 (22%), Positives = 85/235 (36%), Gaps = 55/235 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F+ L+ +G G++GEV R K+ G +YA+K+ + AE +V
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQ 115
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIH 203
H C V+L ++++ LYL E G + +L E Y+ ++LA+ +H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+H D+KP N+ L G KL DFGL
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV----------------------------- 205
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
++ G P Y+APE+ L+ YG D
Sbjct: 206 ---------------------ELGTAGAGEVQEGDPRYMAPEL-LQGSYGTAADV 238
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-57
Identities = 58/248 (23%), Positives = 101/248 (40%), Gaps = 54/248 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DFE + ++G+GAFG+V R YA+KK++ +E ++ + +E LLA +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNH 61
Query: 146 HCIVKLYYSFQDTE-------------YLYLIMEYLPGGDMMTLLMREDTLT-ENVARFY 191
+V+ Y ++ + L++ MEY G + L+ E+ +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 192 IAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
Q + A+ IH IHRD+KP N+ +D++ ++K+ DFGL K + S + + +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+ S +GT Y+A EVL G
Sbjct: 182 GSS-----------------------------------DNLTSAIGTAMYVATEVLDGTG 206
Query: 312 -YGMECDW 318
Y + D
Sbjct: 207 HYNEKIDM 214
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-53
Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 50/235 (21%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+ +G+G F + + + ++A K + KS ++K Q E + E ++ +A
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+V + F+D +++++++E ++ L R LTE AR+Y+ Q VL + +H+
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+ IHRD+K NL L+++ +K+ DFGL ++ K + C
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVL-------------C 176
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
GTP+YIAPEVL KKG+ E D W
Sbjct: 177 --------------------------------GTPNYIAPEVLSKKGHSFEVDVW 199
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 8e-53
Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 50/235 (21%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+ +G+G F + + + ++A K + KS ++K Q E + E ++ +A
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+V + F+D +++++++E ++ L R LTE AR+Y+ Q VL + +H+
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+ IHRD+K NL L+++ +K+ DFGL ++ K + C
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVL-------------C 202
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
GTP+YIAPEVL KKG+ E D W
Sbjct: 203 --------------------------------GTPNYIAPEVLSKKGHSFEVDVW 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 1e-52
Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 53/237 (22%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
++DF++ ++G+G+F V +G A+K + K M K G V+ V+ E + ++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIH 203
I++LY F+D+ Y+YL++E G+M L R +EN AR ++ Q + + +H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
H +HRD+ NLLL +N ++K++DFGL +T
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGL------ATQ---------------------- 161
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV-GTPDYIAPEVLLKKGYGMECD-W 318
+ + T+ GTP+YI+PE+ + +G+E D W
Sbjct: 162 --LKMPH----------------EKHY----TLCGTPNYISPEIATRSAHGLESDVW 196
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-52
Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 53/236 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + L IG G+FG+ L + + G Y +K++ S M + + E R E +LA +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKH 82
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIH 203
IV+ SF++ LY++M+Y GGD+ + + E+ + Q LA++ +H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+HRDIK N+ L K+G ++L DFG+ + L+ +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV----------------------- 179
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
+LA + +GTP Y++PE+ K Y + D W
Sbjct: 180 --------------------------ELARACIGTPYYLSPEICENKPYNNKSDIW 209
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-49
Identities = 50/287 (17%), Positives = 101/287 (35%), Gaps = 78/287 (27%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
P+ +++ + +K ++D+ ++ + +G F ++ LC + YA+
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYAL 59
Query: 117 KKLKKSEMVK--------------RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162
KK +KS + K + + + + E ++ ++ + + + + +Y
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY 119
Query: 163 LIMEYLPGGDMMTLLMREDTL--------TENVARFYIAQSVLAIESIHKHNYI-HRDIK 213
+I EY+ ++ L V + I + + IH I HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSS 273
P N+L+DKNG +KLSDFG + D
Sbjct: 180 PSNILMDKNGRVKLSDFGESE-----------------------------YMVD------ 204
Query: 274 WKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YGMECDW 318
+ K + GT +++ PE + G + D
Sbjct: 205 -------------KKIK---GSRGTYEFMPPEFFSNESSYNGAKVDI 235
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-48
Identities = 56/238 (23%), Positives = 91/238 (38%), Gaps = 54/238 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+F + IGRG F EV G A+KK++ +++ E +LL ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL----MREDTLTENVARFYIAQSVLAIES 201
++K Y SF + L +++E GD+ ++ ++ + E Y Q A+E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H +HRDIKP N+ + G +KL D GL + T
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------------------- 190
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
A S VGTP Y++PE + + GY + D W
Sbjct: 191 ----------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-48
Identities = 49/252 (19%), Positives = 85/252 (33%), Gaps = 76/252 (30%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DF+ + +IG G FG+V + + G Y +K++K + E E LA++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63
Query: 146 HCIVKLYYSFQDTE----------------YLYLIMEYLPGGDMMTLL--MREDTLTENV 187
IV + + L++ ME+ G + + R + L + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
A Q ++ IH I+RD+KP N+ L +K+ DFGL
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT------------- 170
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
+ + GT Y++PE +
Sbjct: 171 -------------------------------------SLKNDGKRTRSKGTLRYMSPEQI 193
Query: 308 LKKGYGMECD-W 318
+ YG E D +
Sbjct: 194 SSQDYGKEVDLY 205
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-47
Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 62/245 (25%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+D+E+L IG G++G + R K G I K+L M + + + + +E NLL E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 146 HCIVKLYYSFQDTE--YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAI 199
IV+ Y D LY++MEY GGD+ +++ + L E + Q LA+
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 200 ESIHKHNY-----IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
+ H+ + +HRD+KP N+ LD ++KL DFGL + L+ T +A KT
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KTF---- 176
Query: 255 MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314
VGTP Y++PE + + Y
Sbjct: 177 -----------------------------------------VGTPYYMSPEQMNRMSYNE 195
Query: 315 ECD-W 318
+ D W
Sbjct: 196 KSDIW 200
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-46
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 55/237 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D++++ +G+GAF VR C K +G +A K + ++ R + + E + ++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV+L+ S Q+ + YL+ + + GG++ ++ + +E A I Q + +I H +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HR++KP+NLLL K +KL+DFGL ++ D E
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-------------DSEAW------- 164
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
GTP Y++PEVL K Y D W
Sbjct: 165 ------------------------------HGFAGTPGYLSPEVLKKDPYSKPVDIW 191
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-46
Identities = 62/252 (24%), Positives = 106/252 (42%), Gaps = 56/252 (22%)
Query: 71 KETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQV 130
+ +EFM K D++++ +G+GAF VR C K +G +A K + ++ R
Sbjct: 15 RGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DF 72
Query: 131 EHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF 190
+ + E + ++ IV+L+ S Q+ + YL+ + + GG++ ++ + +E A
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
I Q + +I H + +HR++KP+NLLL K +KL+DFGL ++
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---------- 182
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
D E GTP Y++PEVL
Sbjct: 183 ---DSEAW-------------------------------------HGFAGTPGYLSPEVL 202
Query: 308 LKKGYGMECD-W 318
K Y D W
Sbjct: 203 KKDPYSKPVDIW 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-46
Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 58/246 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEHVRAERNLLAE 142
D +E+ +G G F VR CR+K +G YA K +KK + + E + E N+L E
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ I+ L+ F++ + LI+E + GG++ L +++LTE+ A ++ Q + + +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 203 HKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H H D+KP+N++L N +KL DFG+ ++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-------------AGNEFKN- 170
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317
GTP+++APE++ + G+E D
Sbjct: 171 ------------------------------------IFGTPEFVAPEIVNYEPLGLEADM 194
Query: 318 WLVSVL 323
W + V+
Sbjct: 195 WSIGVI 200
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-46
Identities = 59/256 (23%), Positives = 110/256 (42%), Gaps = 58/256 (22%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEH 132
M + + D +++ +G G F V+ CREK +G YA K +KK + + E
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
+ E ++L +V H ++ L+ +++ + LI+E + GG++ L ++++L+E A +I
Sbjct: 62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
Q + + +H H D+KP+N++L H+KL DFGL ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----------- 170
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
D GTP+++APE++
Sbjct: 171 --DGVEFKN-------------------------------------IFGTPEFVAPEIVN 191
Query: 309 KKGYGMECD-WLVSVL 323
+ G+E D W + V+
Sbjct: 192 YEPLGLEADMWSIGVI 207
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 51/247 (20%), Positives = 86/247 (34%), Gaps = 54/247 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DFE + +GRG FG V + K YA+K+++ E V E LA++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62
Query: 146 HCIVKLYYSFQD------------TEYLYLIMEYLPGGDMMTLLMREDTLT---ENVARF 190
IV+ + ++ + YLY+ M+ ++ + T+ +V
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
Q A+E +H +HRD+KP N+ + +K+ DFGL +D
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ------- 175
Query: 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310
+ H VGT Y++PE +
Sbjct: 176 ----------------TVLTPMPAYARHT--------------GQVGTKLYMSPEQIHGN 205
Query: 311 GYGMECD 317
Y + D
Sbjct: 206 SYSHKVD 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-45
Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 58/237 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F + ++G GAF EV L +++ +G ++A+K +KKS + + E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV L ++ T + YL+M+ + GG++ ++ TE A I Q + A++ +H++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HRD+KP+NLL ++N + ++DFGL K + M
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLS--------------KMEQNGIM------- 164
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
+ GTP Y+APEVL +K Y D W
Sbjct: 165 ------------------------------STACGTPGYVAPEVLAQKPYSKAVDCW 191
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-45
Identities = 55/263 (20%), Positives = 99/263 (37%), Gaps = 65/263 (24%)
Query: 70 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ 129
TE + + + + +L IG G +V + IYA+K + E +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQ-T 69
Query: 130 VEHVRAERNLLAEVASHC--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
++ R E L ++ H I++LY +Y+Y++ME D+ + L ++ ++
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE 128
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ Y + A+ +IH+H +H D+KP N L+ +G +KL DFG+ +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ---------- 177
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
PDT + + S VGT +Y+ PE +
Sbjct: 178 ------------------PDTTS-------------------VVKDSQVGTVNYMPPEAI 200
Query: 308 L-----------KKGYGMECD-W 318
K + D W
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVW 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-45
Identities = 62/246 (25%), Positives = 103/246 (41%), Gaps = 63/246 (25%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK-----KLKKSEMVKRGQVEHVRAERNLL 140
++ +IGRG VR C + +G+ +A+K + S E R E ++L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 141 AEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+VA H I+ L S++ + +++L+ + + G++ L + L+E R + + A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPM 259
+H +N +HRD+KP+N+LLD N ++LSDFG L+ E + E
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-------------PGEKLRE-- 258
Query: 260 DIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL------LKKGYG 313
GTP Y+APE+L GYG
Sbjct: 259 -----------------------------------LCGTPGYLAPEILKCSMDETHPGYG 283
Query: 314 MECD-W 318
E D W
Sbjct: 284 KEVDLW 289
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 59/237 (24%), Positives = 105/237 (44%), Gaps = 56/237 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + ++ ++G+G+FGEV C+++ + YA+K + K+ + + E LL ++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I+KL+ +D+ Y++ E GG++ +++ +E+ A I Q I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
N +HRD+KP+N+LL +K+ +K+ DFGL + M +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-------------QNTKMKD----- 182
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
+GT YIAPEV L+ Y +CD W
Sbjct: 183 --------------------------------RIGTAYYIAPEV-LRGTYDEKCDVW 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 64/247 (25%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA- 144
+++E I+GRG VR C K + YA+K + + E L EV
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 145 -----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
H I++L +++ + +L+ + + G++ L + TL+E R + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
I ++HK N +HRD+KP+N+LLD + ++KL+DFG LD E + E
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-------------PGEKLRE- 182
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL------LKKGY 312
GTP Y+APE++ GY
Sbjct: 183 ------------------------------------VCGTPSYLAPEIIECSMNDNHPGY 206
Query: 313 GMECD-W 318
G E D W
Sbjct: 207 GKEVDMW 213
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-45
Identities = 57/246 (23%), Positives = 96/246 (39%), Gaps = 65/246 (26%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ--VEHVRAERNLLAEV 143
D +EL +IG+G F VR C +++G +A+K + ++ E ++ E ++ +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-------EDTLTENVARFYIAQSV 196
IV+L ++ LY++ E++ G D L +E VA Y+ Q +
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGAD---LCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 197 LAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
A+ H +N IHRD+KP +LL + + +KL FG+ L
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE------------SGL 188
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313
VGTP ++APEV+ ++ YG
Sbjct: 189 VAGG-------------------------------------RVGTPHFMAPEVVKREPYG 211
Query: 314 MECD-W 318
D W
Sbjct: 212 KPVDVW 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-45
Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 58/256 (22%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEH 132
M + + D +++ +G G F V+ CREK +G YA K +KK + + E
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 133 VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYI 192
+ E ++L +V I+ L+ +++ + LI+E + GG++ L ++++L+E A +I
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
Q + + +H H D+KP+N++L H+KL DFGL ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----------- 170
Query: 249 TIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308
D GTP+++APE++
Sbjct: 171 --DGVEFKN-------------------------------------IFGTPEFVAPEIVN 191
Query: 309 KKGYGMECD-WLVSVL 323
+ G+E D W + V+
Sbjct: 192 YEPLGLEADMWSIGVI 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 55/246 (22%), Positives = 101/246 (41%), Gaps = 58/246 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEHVRAERNLLAE 142
D ++ +G G F V+ CREK +G YA K +KK + E + E ++L E
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ ++ L+ +++ + LI+E + GG++ L +++LTE A ++ Q + + +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 203 HKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H H D+KP+N++L +K+ DFGL +D
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-------------FGNEFKN- 176
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317
GTP+++APE++ + G+E D
Sbjct: 177 ------------------------------------IFGTPEFVAPEIVNYEPLGLEADM 200
Query: 318 WLVSVL 323
W + V+
Sbjct: 201 WSIGVI 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 4e-44
Identities = 64/298 (21%), Positives = 121/298 (40%), Gaps = 60/298 (20%)
Query: 33 QMKNIQERKERRWVLERKLASSDVPMEEQIN---LIKDLERKETEFMRLKRHKICVDDFE 89
+ + ++ R + ++ + N + D+ ++ +H +D ++
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+ +G GAFG V E+ +GN +A K + E VR E ++ + +V
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLV 217
Query: 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYI 208
L+ +F+D + +I E++ GG++ + E ++E+ A Y+ Q + +H++NY+
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 209 HRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
H D+KP+N++ ++ +KL DFGL LD
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLD----------------------------- 308
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
P + ++ T GT ++ APEV K G D W V VL
Sbjct: 309 ----------PKQSVKV-----------TTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-44
Identities = 51/231 (22%), Positives = 91/231 (39%), Gaps = 53/231 (22%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +L IG G +V + IYA+K + E + ++ R E L ++ H
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 67
Query: 147 C--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
I++LY +Y+Y++ME D+ + L ++ ++ + Y + A+ +IH+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
H +H D+KP N L+ +G +KL DFG+ +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ--------------------------- 158
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
PDT + + S VGT +Y+ PE + E
Sbjct: 159 -PDTTS-------------------VVKDSQVGTVNYMPPEAIKDMSSSRE 189
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-44
Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 58/237 (24%)
Query: 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLY 152
+GRG F VR C K +G YA K LKK + + E +L S ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKHNYIHR 210
+++T + LI+EY GG++ +L + E ++EN I Q + + +H++N +H
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 211 DIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
D+KP N+LL G +K+ DFG+ + + + E
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG-------------HACELRE---------- 192
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
+GTP+Y+APE+L D W + ++
Sbjct: 193 ---------------------------IMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 56/260 (21%)
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
+++ L F++ D ++ ++G+G+FGEV LC++K +G A+K + K
Sbjct: 4 SMMDHLHATPGMFVQHSTAIF-SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT 182
++ ++ E + E LL ++ I+KLY F+D Y YL+ E GG++ ++
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCS 239
+E A I Q + I +HK+ +HRD+KP+NLLL K+ ++++ DFGL +
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-- 180
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
+ M + +GT
Sbjct: 181 -----------ASKKMKD-------------------------------------KIGTA 192
Query: 300 DYIAPEVLLKKGYGMECD-W 318
YIAPEV L Y +CD W
Sbjct: 193 YYIAPEV-LHGTYDEKCDVW 211
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 57/255 (22%), Positives = 96/255 (37%), Gaps = 70/255 (27%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ L I+G+GA V R KK+G+++A+K ++ V+ E +L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLK 62
Query: 142 EVASHCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLM---REDTLTENVARFYIAQSV 196
++ IVKL+ ++ T + LIME+ P G + T+L L E+ + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 197 LAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+ + ++ +HR+IKP N++ D KL+DFG + L+ DD
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------------DD 169
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL----- 307
E S GT +Y+ P++
Sbjct: 170 EQFV-------------------------------------SLYGTEEYLHPDMYERAVL 192
Query: 308 ---LKKGYGMECD-W 318
+K YG D W
Sbjct: 193 RKDHQKKYGATVDLW 207
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 57/251 (22%), Positives = 96/251 (38%), Gaps = 70/251 (27%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L I+G+GA V R KK+G+++A+K ++ V+ E +L ++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 146 HCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLM---REDTLTENVARFYIAQSVLAIE 200
IVKL+ ++ T + LIME+ P G + T+L L E+ + V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 201 SIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ ++ +HR+IKP N++ D KL+DFG + L+ DDE
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------------DDEQFV 173
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL--------L 308
S GT +Y+ P++
Sbjct: 174 -------------------------------------SLYGTEEYLHPDMYERAVLRKDH 196
Query: 309 KKGYGMECD-W 318
+K YG D W
Sbjct: 197 QKKYGATVDLW 207
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-43
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 63/242 (26%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D F +G GAFG+V L E+ SG +K + K + +E + AE +L +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSL-D 78
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGD----MMTLLMREDTLTENVARFYIAQSVLAIE 200
H I+K++ F+D +Y++ME GG+ +++ R L+E + Q + A+
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 201 SIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
H + +H+D+KP+N+L + +K+ DFGL
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL------------------------- 173
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ E + GT Y+APEV K+ +CD
Sbjct: 174 --------------AELFKSDEHST-----------NAAGTALYMAPEV-FKRDVTFKCD 207
Query: 318 -W 318
W
Sbjct: 208 IW 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 58/275 (21%), Positives = 114/275 (41%), Gaps = 57/275 (20%)
Query: 53 SSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN 112
+ + +D+ +K + D +++L +G GAFG V C EK +G
Sbjct: 18 YDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGR 77
Query: 113 IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD 172
++ K + V+ E +++ ++ ++ L+ +F+D + LI+E+L GG+
Sbjct: 78 VFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 173 MMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL--DKNGHMKLSD 229
+ + ED ++E Y+ Q+ ++ +H+H+ +H DIKP+N++ K +K+ D
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194
Query: 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289
FGL L+ P E ++
Sbjct: 195 FGLATKLN---------------------------------------PDEIVK------- 208
Query: 290 KLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323
T T ++ APE++ ++ G D W + VL
Sbjct: 209 ----VTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-43
Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 65/246 (26%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA- 144
D++ + +G GA GEV+L E+K+ A++ + K + E A + E+
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN-VETEIEI 193
Query: 145 ----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+H CI+K+ F D E Y+++E + GG++ ++ L E + Y Q +LA+
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 200 ESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ +H++ IHRD+KP+N+LL +++ +K++DFG K L
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG------------------- 293
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKGYG 313
+ T GTP Y+APEVL GY
Sbjct: 294 -----ETSLMRT--------------------------LCGTPTYLAPEVLVSVGTAGYN 322
Query: 314 MECD-W 318
D W
Sbjct: 323 RAVDCW 328
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-43
Identities = 53/242 (21%), Positives = 87/242 (35%), Gaps = 58/242 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + + +GRG FG V C E S Y K +K K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMM-TLLMREDTLTENVARFYIAQSVLAIESIHK 204
I+ L+ SF+ E L +I E++ G D+ + L E Y+ Q A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 205 HNYIHRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
HN H DI+P+N++ ++ +K+ +FG + L
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------------------------- 155
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321
P + + P+Y APEV D W +
Sbjct: 156 --------------PGDNFR-----------LLFTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 322 VL 323
L
Sbjct: 191 TL 192
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-43
Identities = 63/246 (25%), Positives = 104/246 (42%), Gaps = 65/246 (26%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA- 144
D++ + +G GA GEV+L E+K+ A+K + K + E A + E+
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN-VETEIEI 68
Query: 145 ----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+H CI+K+ F D E Y+++E + GG++ ++ L E + Y Q +LA+
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 200 ESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ +H++ IHRD+KP+N+LL +++ +K++DFG K L + M
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-------------ETSLMR 174
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKGYG 313
GTP Y+APEVL GY
Sbjct: 175 T-------------------------------------LCGTPTYLAPEVLVSVGTAGYN 197
Query: 314 MECD-W 318
D W
Sbjct: 198 RAVDCW 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-43
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 58/237 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L IGRG++GEV++ +K + A KK+ K + V+ + E ++ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDH 65
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I++LY +F+D +YL+ME GG++ ++ + E+ A + + A+ HK
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
N HRD+KP+N L + +KL DFGL + M
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-------------PGKMMRT----- 167
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
VGTP Y++P+V L+ YG ECD W
Sbjct: 168 --------------------------------KVGTPYYVSPQV-LEGLYGPECDEW 191
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-43
Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 54/237 (22%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
++++L +G+GAF VR C + +G YA + ++ + + E + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKH 69
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV+L+ S + + YLI + + GG++ ++ + +E A I Q + A+ H+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HR++KP+NLLL K +KL+DFGL +
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-------------------------- 163
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
+ + F GTP Y++PEVL K YG D W
Sbjct: 164 ------------EGEQQAW-----------FGFAGTPGYLSPEVLRKDPYGKPVDLW 197
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-42
Identities = 50/231 (21%), Positives = 90/231 (38%), Gaps = 53/231 (22%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ +L IG G +V + IYA+K + E + ++ R E L ++ H
Sbjct: 57 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 114
Query: 147 C--IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
I++LY +Y+Y++ME D+ + L ++ ++ + Y + A+ +IH+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
H +H D+KP N L+ +G +KL DFG+ +
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ--------------------------- 205
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
PDT + + S VG +Y+ PE + E
Sbjct: 206 -PDTTS-------------------VVKDSQVGAVNYMPPEAIKDMSSSRE 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-42
Identities = 60/249 (24%), Positives = 97/249 (38%), Gaps = 64/249 (25%)
Query: 78 LKRHKICVDDFELLT---IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVR 134
+K ++L +G G+F R C KKS +A+K + K + +
Sbjct: 1 MKDSPF-YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQ 53
Query: 135 AERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA 193
E L H IVKL+ F D + +L+ME L GG++ + ++ +E A + +
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR 113
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+ V A+ +H +HRD+KP+NLL + N +K+ DFG + K
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR------------LKPP 161
Query: 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310
D++ + P T Y APE+L +
Sbjct: 162 DNQPLKTP-------------------------------------CFTLHYAAPELLNQN 184
Query: 311 GYGMECD-W 318
GY CD W
Sbjct: 185 GYDESCDLW 193
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 59/237 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D FE+ + +GRGA V C++K + YA+K LKK+ + VR E +L ++
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSH 107
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I+KL F+ + L++E + GG++ ++ + +E A + Q + A+ +H++
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HRD+KP+NLL + +K++DFGL K ++ M
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-------------HQVLM------- 207
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
+ GTP Y APE+L YG E D W
Sbjct: 208 ------------------------------KTVCGTPGYCAPEILRGCAYGPEVDMW 234
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 6e-42
Identities = 70/266 (26%), Positives = 114/266 (42%), Gaps = 57/266 (21%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
E + DL+ F+ K+ + + ++ + +G GA+GEV LCR+K + A+
Sbjct: 9 SGRENLYFQGDLQATPGMFITSKKGHL-SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67
Query: 117 KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
K ++K+ + + E +L + I+KLY F+D YL+ME GG++
Sbjct: 68 KIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126
Query: 177 LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLC 233
++ E A I Q + + +HKHN +HRD+KP+NLLL +K+ +K+ DFGL
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
+ + + M
Sbjct: 187 AVFE-------------NQKKM-------------------------------------K 196
Query: 294 STVGTPDYIAPEVLLKKGYGMECD-W 318
+GT YIAPEV L+K Y +CD W
Sbjct: 197 ERLGTAYYIAPEV-LRKKYDEKCDVW 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 7e-42
Identities = 46/308 (14%), Positives = 90/308 (29%), Gaps = 77/308 (25%)
Query: 51 LASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREK-- 108
L+ P+ N + + K ++ + ++G GAF +V +
Sbjct: 31 LSGLSKPVSSYPN-TFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89
Query: 109 ---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165
K+ + +K K + + L H +K Y + L+
Sbjct: 90 NDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146
Query: 166 EYLPGGDMMTLLMR-----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL- 219
E G ++ + E + + + + + + IE +H IH DIKPDN +L
Sbjct: 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206
Query: 220 ----------DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTD 269
D + + L D G + FP
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMK--------------------------LFPKGT 240
Query: 270 NKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW-----LVSVLH 324
+ + T + E+L K + + D+ V +
Sbjct: 241 ---------------------IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279
Query: 325 FNSYRFLE 332
F +Y ++
Sbjct: 280 FGTYMKVK 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-42
Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 58/238 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + ++ ++G+G+FGEV C+++ + YA+K + K+ + + E LL ++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-D 79
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
H I+KL+ +D+ Y++ E GG++ +++ +E+ A I Q I +HK
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 205 HNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
HN +HRD+KP+N+LL +K+ +K+ DFGL + M
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-------------QNTKM------ 180
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
+GT YIAPEV L+ Y +CD W
Sbjct: 181 -------------------------------KDRIGTAYYIAPEV-LRGTYDEKCDVW 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 57/241 (23%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
I+G G FG+V C E +G A K +K M + E V+ E +++ ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKH 205
+++LY +F+ + L+MEY+ GG++ ++ E LTE ++ Q I +H+
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 206 NYIHRDIKPDNLLL-DKNGH-MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
+H D+KP+N+L +++ +K+ DFGL + E +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-------------PREKLKV------ 247
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322
GTP+++APEV+ D W V V
Sbjct: 248 -------------------------------NFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
Query: 323 L 323
+
Sbjct: 277 I 277
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 61/297 (20%), Positives = 105/297 (35%), Gaps = 92/297 (30%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VK 126
+E + + + L IG+G++G VR+ E ++ I A+K + K+++ +
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 127 RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD-------------- 172
VE ++ E L+ ++ I +LY ++D +Y+ L+ME GG
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 173 --------------------------MMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
+ E + + Q A+ +H
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188
Query: 207 YIHRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
HRDIKP+N L +K+ +KL DFGL
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGL-------------------------------- 216
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL--LKKGYGMECD-W 318
S +++ M + GTP ++APEVL + YG +CD W
Sbjct: 217 -------SKEFYKLNNGEYYGMT------TKAGTPYFVAPEVLNTTNESYGPKCDAW 260
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 71/275 (25%), Positives = 114/275 (41%), Gaps = 66/275 (24%)
Query: 58 MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK 117
+ + + ++R K KI + + + +G GA+GEV LC+EK + A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKI-GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67
Query: 118 KLKKSEMVKRGQVEHVRA----ERNLLAEVA-----SH-CIVKLYYSFQDTEYLYLIMEY 167
+KKS+ K + + + E++ H I+KL+ F+D +Y YL+ E+
Sbjct: 68 VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127
Query: 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGH 224
GG++ ++ E A + Q + I +HKHN +HRDIKP+N+LL + +
Sbjct: 128 YEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187
Query: 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHW 284
+K+ DFGL D +
Sbjct: 188 IKIVDFGLSSFFS-------------KDYKL----------------------------- 205
Query: 285 QMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
+GT YIAPEV LKK Y +CD W
Sbjct: 206 --------RDRLGTAYYIAPEV-LKKKYNEKCDVW 231
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 56/262 (21%), Positives = 106/262 (40%), Gaps = 71/262 (27%)
Query: 63 NLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS 122
++++ L R +F D +E+ IG G++ + C K + +A+K + KS
Sbjct: 8 SIVQQLHRNSIQFT---------DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS 58
Query: 123 EMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED 181
+ E +L H I+ L + D +Y+Y++ E + GG+++ ++R+
Sbjct: 59 K-------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK 111
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL-DKNGH---MKLSDFGLCKPLD 237
+E A + +E +H +HRD+KP N+L D++G+ +++ DFG K L
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297
++ + P
Sbjct: 172 A------------ENGLLMTP-------------------------------------CY 182
Query: 298 TPDYIAPEVLLKKGYGMECD-W 318
T +++APEVL ++GY CD W
Sbjct: 183 TANFVAPEVLERQGYDAACDIW 204
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-41
Identities = 48/236 (20%), Positives = 89/236 (37%), Gaps = 55/236 (23%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKL 151
++G GA V+ C + YA+K ++K R V E +L + H +++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRD 211
F++ + YL+ E + GG +++ + + E A + A++ +H HRD
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 212 IKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDT 268
+KP+N+L ++ +K+ DF L + + + I + P
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLN-----GDCSPISTPELLTP---------- 181
Query: 269 DNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYGMECD-W 318
G+ +Y+APEV+ Y CD W
Sbjct: 182 ---------------------------CGSAEYMAPEVVEAFSEEASIYDKRCDLW 210
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-40
Identities = 46/234 (19%), Positives = 78/234 (33%), Gaps = 51/234 (21%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+ + +G G F V L G+ YA+K++ E R E + E ++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHP 86
Query: 147 CIVKLYYSFQD----TEYLYLIMEYLPGGD----MMTLLMREDTLTENVARFYIAQSVLA 198
I++L +L++ + G + L + + LTE+ + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
+E+IH Y HRD+KP N+LL G L D G ++ A
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA----------CIHVEGSRQA-- 194
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
LQ W + T Y APE+ + +
Sbjct: 195 --------------------LTLQDW--------AAQRCTISYRAPELFSVQSH 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-40
Identities = 60/265 (22%), Positives = 103/265 (38%), Gaps = 77/265 (29%)
Query: 69 ERKETEFMRLKRHKICVDDFELLT-IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR 127
+ +++K++ I +DD+++ + ++G G G+V K++ +A+K L+ +R
Sbjct: 45 QFHVKSGLQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR 103
Query: 128 GQVEHVRAERNLLAEVASH-CIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR--- 179
E L + IV++ +++ + L ++ME L GG+ L R
Sbjct: 104 --------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQD 152
Query: 180 --EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCK 234
+ TE A + AI+ +H N HRD+KP+NLL N +KL+DFG
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-- 210
Query: 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294
+ + H L +
Sbjct: 211 -------------------------------------AKETTSHNSLT-----------T 222
Query: 295 TVGTPDYIAPEVLLKKGYGMECD-W 318
TP Y+APEVL + Y CD W
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMW 247
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-40
Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 52/242 (21%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
++ + + L +G G FG+V++ + +G+ A+K L + ++ V ++ E
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
L I+KLY +++MEY+ GG++ + + + E AR Q + A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
++ H+H +HRD+KP+N+LLD + + K++DFGL NM
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS--------------------NMMS- 162
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD 317
DG F T + G+P+Y APEV+ + Y G E D
Sbjct: 163 ---DGEFLRT--------------------------SCGSPNYAAPEVISGRLYAGPEVD 193
Query: 318 -W 318
W
Sbjct: 194 IW 195
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 60/248 (24%), Positives = 95/248 (38%), Gaps = 77/248 (31%)
Query: 86 DDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
DD++L ++G G G+V C +++G A+K L S ++ E + + +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQAS 79
Query: 145 SH-CIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR-----EDTLTENVARFYIAQ 194
IV + +++ L +IME + GG+ L R + TE A +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQERGDQAFTEREAAEIMRD 136
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
AI+ +H HN HRD+KP+NLL +K+ +KL+DFG K + L
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---------- 186
Query: 252 DENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311
+ TP Y+APEVL +
Sbjct: 187 -----------------------------------------QTPCYTPYYVAPEVLGPEK 205
Query: 312 YGMECD-W 318
Y CD W
Sbjct: 206 YDKSCDMW 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-39
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 58/247 (23%)
Query: 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK-----KLKKSEMVKRGQVEHVR 134
+ ++ +G GAFG V +K+ +K K+ + ++ ++ V
Sbjct: 18 CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 135 AERNLLAEVASHCIVKLYYSFQDTEYLYLIME-YLPGGDMMTLLMREDTLTENVARFYIA 193
E +L+ V I+K+ F++ + L+ME + G D+ + R L E +A +
Sbjct: 78 LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
Q V A+ + + IHRDIK +N+++ ++ +KL DFG L+
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---------------- 181
Query: 254 NMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY- 312
G T GT +Y APEVL+ Y
Sbjct: 182 --------RGKLFYT--------------------------FCGTIEYCAPEVLMGNPYR 207
Query: 313 GMECD-W 318
G E + W
Sbjct: 208 GPELEMW 214
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-39
Identities = 50/251 (19%), Positives = 85/251 (33%), Gaps = 62/251 (24%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH-VRAER 137
K + ++ L ++G+G FG V A+K + ++ ++ + V
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 138 -----NLLAEVASH-CIVKLYYSFQDTEYLYLIMEY-LPGGDMMTLLMREDTLTENVARF 190
+ H +++L F+ E L++E LP D+ + + L E +R
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
+ Q V AI+ H +HRDIK +N+L+D + G KL DFG L
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG------SGALLH------ 191
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309
D + GT Y PE + +
Sbjct: 192 ------------DEPY-TD--------------------------FDGTRVYSPPEWISR 212
Query: 310 KGY-GMECD-W 318
Y + W
Sbjct: 213 HQYHALPATVW 223
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-39
Identities = 47/238 (19%), Positives = 82/238 (34%), Gaps = 41/238 (17%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+F L IG G FG V C ++ G IYA+K+ KK + +R E A +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQ 69
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL----MREDTLTENVARFYIAQSVLAIE 200
H +V+ + ++ + +++ + EY GG + + E + + Q +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
IH + +H DIKP N+ + + + + S K I D
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF---K-IGDLGHV---- 181
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD 317
+ SP G ++A EVL + + D
Sbjct: 182 -----------TRISSPQ---------------VEEGDSRFLANEVLQENYTHLPKAD 213
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 54/247 (21%), Positives = 85/247 (34%), Gaps = 65/247 (26%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+E+ +G G FG V + +G A+K+ ++ K E E ++ ++
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLN 70
Query: 145 SHCIVKLYYSFQDTEYL------YLIMEYLPGGDMMTLLM---REDTLTENVARFYIAQS 195
+V + L L MEY GGD+ L L E R ++
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
A+ +H++ IHRD+KP+N++L K+ D G K LD
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-------------QG 177
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
E VGT Y+APE+L +K Y
Sbjct: 178 ELCT-------------------------------------EFVGTLQYLAPELLEQKKY 200
Query: 313 GMECD-W 318
+ D W
Sbjct: 201 TVTVDYW 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-38
Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 51/236 (21%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
V+D++L+ +G GA+GEV+L + + A+K + V E+++ E + +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+VK Y ++ YL +EY GG++ + + + E A+ + Q + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
HRDIKP+NLLLD+ ++K+SDFGL + + +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA--------------------TVFRYNNRER- 162
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-W 318
L GT Y+APE+L ++ + D W
Sbjct: 163 --------------------------LLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-38
Identities = 57/272 (20%), Positives = 101/272 (37%), Gaps = 54/272 (19%)
Query: 49 RKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREK 108
++ + + + + E ++ V +GRG+FGEV ++K
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 109 KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYL 168
++G A+KK++ E A ++S IV LY + ++ ++ + ME L
Sbjct: 81 QTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 169 PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKL 227
GG + L+ + L E+ A +Y+ Q++ +E +H +H D+K DN+LL +G L
Sbjct: 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAAL 192
Query: 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMN 287
DFG L L
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGD-------------------------------------- 214
Query: 288 RRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
GT ++APEV++ K + D W
Sbjct: 215 ------YIPGTETHMAPEVVMGKPCDAKVDIW 240
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 63/244 (25%), Positives = 95/244 (38%), Gaps = 58/244 (23%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
D ++ + IG G FG RL R+K + + A+K +++ + E+V+ E
Sbjct: 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREII 68
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
+ IV+ +L +IMEY GG++ + +E+ ARF+ Q +
Sbjct: 69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG 128
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHM--KLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ H HRD+K +N LLD + K+ DFG
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY------------------------ 164
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GME 315
S H Q + STVGTP YIAPEVLL++ Y G
Sbjct: 165 ---------------SKSSVLHSQPK-----------STVGTPAYIAPEVLLRQEYDGKI 198
Query: 316 CD-W 318
D W
Sbjct: 199 ADVW 202
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 66/269 (24%), Positives = 107/269 (39%), Gaps = 79/269 (29%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
+ ++ + L IG+G++G V+L + YAMK L K +++++ R
Sbjct: 6 SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRG 65
Query: 139 LLA-----------------EVA-----SH-CIVKLY--YSFQDTEYLYLIMEYLPGGDM 173
E+A H +VKL + ++LY++ E + G +
Sbjct: 66 TRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV 125
Query: 174 MTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
M + L+E+ ARFY + IE +H IHRDIKP NLL+ ++GH+K++DFG+
Sbjct: 126 MEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293
N + D L
Sbjct: 185 --------------------NEFKGSD-----------------------------ALLS 195
Query: 294 STVGTPDYIAPEVL--LKKGY-GMECD-W 318
+TVGTP ++APE L +K + G D W
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVW 224
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-37
Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 51/236 (21%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
V+D++L+ +G GA+GEV+L + + A+K + V E+++ E + +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
+VK Y ++ YL +EY GG++ + + + E A+ + Q + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
HRDIKP+NLLLD+ ++K+SDFGL + + +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA--------------------TVFRYNNRER- 162
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-W 318
L GT Y+APE+L ++ + D W
Sbjct: 163 --------------------------LLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-37
Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 52/242 (21%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
++ + + L +G G FG+V++ + + +G+ A+K L + ++ V +R E
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
L I+KLY ++++MEY+ GG++ + + L E +R Q +
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
++ H+H +HRD+KP+N+LLD + + K++DFGL NM
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS--------------------NMMS- 167
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD 317
DG F T + G+P+Y APEV+ + Y G E D
Sbjct: 168 ---DGEFLRT--------------------------SCGSPNYAAPEVISGRLYAGPEVD 198
Query: 318 -W 318
W
Sbjct: 199 IW 200
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 58/259 (22%), Positives = 94/259 (36%), Gaps = 60/259 (23%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
+ T+ K + +++ ++G G FG V A+K ++K + G
Sbjct: 26 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85
Query: 129 QVEH---VRAERNLLAEVASHC--IVKLYYSFQDTEYLYLIMEY-LPGGDMMTLLMREDT 182
++ + V E LL +V+S +++L F+ + LI+E P D+ +
Sbjct: 86 ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 145
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCSTL 241
L E +AR + Q + A+ H +HRDIK +N+L+D N G +KL DFG L
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG------SGAL 199
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
D + D D GT Y
Sbjct: 200 LK------------------DTVYTDFD---------------------------GTRVY 214
Query: 302 IAPEVLLKKGY-GMECD-W 318
PE + Y G W
Sbjct: 215 SPPEWIRYHRYHGRSAAVW 233
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 53/236 (22%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+ ++ LL IG+G F +V+L R +G A+K + K+++ ++ + E ++ +
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN 72
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
IVKL+ + + LYLIMEY GG++ L+ + E AR Q V A++ H+
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
+HRD+K +NLLLD + ++K++DFG
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGF-------------------------------- 160
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-W 318
S+ + +L + G P Y APE+ K Y G E D W
Sbjct: 161 -------SNEFTVGGKLDAF-----------CGAPPYAAPELFQGKKYDGPEVDVW 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 62/243 (25%), Positives = 107/243 (44%), Gaps = 53/243 (21%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER 137
+ K + + + +G G+FG+V+L K+ A+K + + + K V E
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 138 NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
+ L + I+KLY + +++EY GG++ ++ + +TE+ R + Q +
Sbjct: 61 SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAE 257
AIE H+H +HRD+KP+NLLLD N ++K++DFGL
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL------------------------- 154
Query: 258 PMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMEC 316
S+ + L+ ++ G+P+Y APEV+ K Y G E
Sbjct: 155 --------------SNIMTDGNFLK-----------TSCGSPNYAAPEVINGKLYAGPEV 189
Query: 317 D-W 318
D W
Sbjct: 190 DVW 192
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 57/236 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEV 143
+ F L IG+G+FGEV + ++ + A+K L+++E ++E ++ E +L++
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQC 77
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
S + K Y S+ L++IMEYL GG + L + L E + + + ++ +H
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLH 136
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
IHRDIK N+LL ++G +KL+DFG+
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAG----------------------------- 167
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
QL +R + VGTP ++APEV+ + Y + D W
Sbjct: 168 ----------------QLTD-TQIKRN---TFVGTPFWMAPEVIKQSAYDSKADIW 203
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 70/272 (25%), Positives = 111/272 (40%), Gaps = 58/272 (21%)
Query: 52 ASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDD----FELLTIIGRGAFGEVRLCRE 107
SS V + + + +F R + D + IG G+ G V L RE
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLARE 66
Query: 108 KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167
K SG A+K + + +R E + E ++ + +V++Y S+ E L+++ME+
Sbjct: 67 KHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKL 227
L GG + T ++ + L E + A+ +H IHRDIK D++LL +G +KL
Sbjct: 124 LQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182
Query: 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMN 287
SDFG C Q+ +
Sbjct: 183 SDFGFCA---------------------------------------------QISK-DVP 196
Query: 288 RRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
+RK S VGTP ++APEV+ + Y E D W
Sbjct: 197 KRK---SLVGTPYWMAPEVISRSLYATEVDIW 225
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 62/238 (26%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ IG+GA G V + +G A++++ + K+ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA----QSVLAIES 201
IV S+ + L+++MEYL GG + T ++ E + E IA + + A+E
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEG----QIAAVCRECLQALEF 131
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H + IHRDIK DN+LL +G +KL+DFG C
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--------------------------- 164
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
Q+ + ++R + VGTP ++APEV+ +K YG + D W
Sbjct: 165 ------------------QITP-EQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIW 200
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-34
Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 60/237 (25%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ F++L +G G++G V K++G I A+K++ ++ + E +++ + S
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+VK Y S+ L+++MEY G D++ L R TLTE+ + ++ +E +
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYL 141
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
H IHRDIK N+LL+ GH KL+DFG+
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAG---------------------------- 173
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
QL M +R + +GTP ++APEV+ + GY D W
Sbjct: 174 -----------------QLTD-TMAKRN---TVIGTPFWMAPEVIQEIGYNCVADIW 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 26/173 (15%)
Query: 74 EFMRLKRHKICVDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH 132
+++K++ I +DD+++ ++G G G+V K++ +A+K L+ +R
Sbjct: 6 SGLQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----- 59
Query: 133 VRAERNLLAEVASH-CIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR-----EDT 182
E L + IV++ +++ + L ++ME L GG+ L R +
Sbjct: 60 ---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQA 113
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGL 232
TE A + AI+ +H N HRD+KP+NLL N +KL+DFG
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 54/235 (22%), Positives = 91/235 (38%), Gaps = 63/235 (26%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
++G+G +G V R+ + A+K + S + + E L + IV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-----LHEEIALHKHLKHKNIVQ 83
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNY 207
SF + ++ + ME +PGG + LL + E FY Q + ++ +H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 208 IHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFP 266
+HRDIK DN+L++ +G +K+SDFG K
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSK-------------------------------- 171
Query: 267 DTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD-W 318
+L + GT Y+APE++ K +GYG D W
Sbjct: 172 -------------RLAGINPCTE----TFTGTLQYMAPEIIDKGPRGYGKAADIW 209
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 49/241 (20%), Positives = 93/241 (38%), Gaps = 54/241 (22%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE-HVRAERNLLAEV 143
+ + + ++G G++G+V+ + ++ A+K LKK ++ + E +V+ E LL +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 144 ASHCIVKLY--YSFQDTEYLYLIMEYLPGGDM-MTLLMREDTLTENVARFYIAQSVLAIE 200
+++L ++ + +Y++MEY G M + E A Y Q + +E
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+H +H+DIKP NLLL G +K+S G+ P
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA--------------------EALHPFA 163
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGY-GMECD- 317
D ++ G+P + PE+ + G + D
Sbjct: 164 ADD---------------------------TCRTSQGSPAFQPPEIANGLDTFSGFKVDI 196
Query: 318 W 318
W
Sbjct: 197 W 197
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 65/265 (24%)
Query: 65 IKDLERKETEFMRL--------KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAM 116
+++LE E + RL K ++ DDFE ++ +G G G V K SG + A
Sbjct: 4 LEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMAR 63
Query: 117 KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
K + K + E +L E S IV Y +F + + ME++ GG + +
Sbjct: 64 KLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121
Query: 177 LMREDTLTENVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
L + + E + ++ +V+ + + KH +HRD+KP N+L++ G +KL DFG+
Sbjct: 122 LKKAGRIPEQILG-KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294
L S +A S
Sbjct: 181 QLIDS---------------------------------------------------MANS 189
Query: 295 TVGTPDYIAPEVLLKKGYGMECD-W 318
VGT Y++PE L Y ++ D W
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIW 214
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-33
Identities = 48/259 (18%), Positives = 75/259 (28%), Gaps = 79/259 (30%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ I+G G+ G V G A+K++ + E LL E
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDD 67
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGG--DMM----TLLMREDTLTENVARFYIAQSVLA 198
H +++ Y S +LY+ +E D++ E + Q
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 199 IESIHKHNYIHRDIKPDNLLLD-------------KNGHMKLSDFGLCKPLDCSTLYAIH 245
+ +H IHRD+KP N+L+ +N + +SDFGLCK LD
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305
GT + APE
Sbjct: 188 NLNNP---------------------------------------------SGTSGWRAPE 202
Query: 306 VLL-------KKGYGMECD 317
+L K+ D
Sbjct: 203 LLEESNNLQTKRRLTRSID 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-33
Identities = 50/269 (18%), Positives = 89/269 (33%), Gaps = 67/269 (24%)
Query: 58 MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK 117
M +L +D +ET + + + C D ++G GA G + + R A+K
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKD-----VLGHGAEGTI-VYRGMFDNRDVAVK 54
Query: 118 KLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTL 176
++ E LL E H +++ + + +D ++ Y+ +E +
Sbjct: 55 RILPE------CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV 108
Query: 177 LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-----MKLSDFG 231
++ + Q+ + +H N +HRD+KP N+L+ +SDFG
Sbjct: 109 EQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291
LCK L + S
Sbjct: 169 LCKKLA----------------------------VGRHSFSRRSGV-------------- 186
Query: 292 AFSTVGTPDYIAPEVL---LKKGYGMECD 317
GT +IAPE+L K+ D
Sbjct: 187 ----PGTEGWIAPEMLSEDCKENPTYTVD 211
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 57/245 (23%), Positives = 104/245 (42%), Gaps = 60/245 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMK--KLKKSEMVKRGQVEHVRAERNLLAEV 143
DD+EL +IG GA V+ A+K L+K + ++ + E +++
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQC 70
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMRED-----TLTENVARFYIAQS 195
IV Y SF + L+L+M+ L GG D++ ++ + L E+ + +
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+ +E +HK+ IHRD+K N+LL ++G ++++DFG+
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS---------------------- 168
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGM 314
+ + + RK + VGTP ++APEV+ + +GY
Sbjct: 169 -------AFLATGGDIT------------RNKVRK---TFVGTPCWMAPEVMEQVRGYDF 206
Query: 315 ECD-W 318
+ D W
Sbjct: 207 KADIW 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 47/248 (18%), Positives = 86/248 (34%), Gaps = 57/248 (22%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH- 146
+ ++ G F V ++ SG YA+K+L +E K + E + +++ H
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHP 86
Query: 147 CIVKLYYSF-------QDTEYLYLIMEYLPGGDMMTLLMR---EDTLTENVARFYIAQSV 196
IV+ + + +L++ L G ++ L + L+ + Q+
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 197 LAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
A++ +H+ IHRD+K +NLLL G +KL DFG +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS----------------- 189
Query: 255 MAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---LKKG 311
P + + + TP Y PE++
Sbjct: 190 --------------------HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP 229
Query: 312 YGMECD-W 318
G + D W
Sbjct: 230 IGEKQDIW 237
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 43/238 (18%), Positives = 82/238 (34%), Gaps = 49/238 (20%)
Query: 86 DDFELLTIIGRGA--FGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+ELLT+IG+G V L R K +G ++++ E V ++ E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIES 201
IV +F L+++ ++ G L+ D + E + + + A++
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
IH Y+HR +K ++L+ +G + LS
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSN---------------------------- 175
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL--LKKGYGMECD 317
+ Q +V +++PEVL +GY + D
Sbjct: 176 -LSMISHGQR-------------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 19/178 (10%), Positives = 61/178 (34%), Gaps = 33/178 (18%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--------------- 137
++G+ ++++G + + +E ++ ++ E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 138 ----------NLLAEVASHCIVKLYYSFQDTEYL--YLIME------YLPGGDMMTLLMR 179
+L+ + ++++ +D L + + G +++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 180 EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+L + Q + + S+H + +H ++P +++LD+ G + L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 24/195 (12%), Positives = 48/195 (24%), Gaps = 40/195 (20%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
+L+ + G V L R+ + +A+K R ++E + A +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 147 CIVKLY--------------------------YSFQDTEYLYLIMEYLPGGDMMTLL--- 177
+ L+M D+ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTL 181
Query: 178 ----MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
+ AQ + ++ +H PDNL + +G + L D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 234 KPLD------CSTLY 242
+ +
Sbjct: 242 WKVGTRGPASSVPVT 256
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 61/259 (23%), Positives = 107/259 (41%), Gaps = 63/259 (24%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG 128
RK E+ ++R + +E++ +G GAFG+V + K++G + A K ++ +
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-- 59
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTE 185
+E E +LA IVKL ++ L++++E+ PGG +M L R LTE
Sbjct: 60 -LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTE 116
Query: 186 NVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
+ Q + A+ +H IHRD+K N+L+ G ++L+DFG+
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS------------ 164
Query: 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305
+ + +R S +GTP ++APE
Sbjct: 165 ---------------------------------AKNLK-TLQKRD---SFIGTPYWMAPE 187
Query: 306 VLL-----KKGYGMECD-W 318
V++ Y + D W
Sbjct: 188 VVMCETMKDTPYDYKADIW 206
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRAER 137
++ DD E + +GRGA+G V R SG I A+K+++ S+ KR ++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL----D 57
Query: 138 NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG---DMMTLLMREDTLTENVARFYIAQ 194
+ V V Y + +++ ME + ++ + T+ E++ IA
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-KIAV 116
Query: 195 SVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
S++ A+E +H K + IHRD+KP N+L++ G +K+ DFG+ L
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 40/148 (27%), Positives = 67/148 (45%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F L IG G+FG V R+ ++ + A+KK+ S + + + E L ++
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
++ + +L+MEY G L + + L E ++ + +H H
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
N IHRD+K N+LL + G +KL DFG
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 66/263 (25%)
Query: 67 DLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSE 123
++ + +R++ ++D E L +G G G+V R +K+G++ A+K+++ E
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 124 MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTL 183
KR ++ +L IV+ + +F +++ ME + + +
Sbjct: 66 ENKRILMDL----DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121
Query: 184 TENVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
E + + +++ A+ + KH IHRD+KP N+LLD+ G +KL DFG
Sbjct: 122 PERILG-KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG---------- 170
Query: 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301
I G D K + G Y
Sbjct: 171 -------------------ISGRLVDDKAKD---------------------RSAGCAAY 190
Query: 302 IAPEVL-----LKKGYGMECD-W 318
+APE + K Y + D W
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVW 213
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 1e-30
Identities = 26/264 (9%), Positives = 65/264 (24%), Gaps = 86/264 (32%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA----------- 141
++G+ ++++G + + +E ++ ++ E L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 142 ----------EVASHCIVKLYYSFQDTEYLYLIMEY-----LPGGDMMTLL------MRE 180
++ K + E ++ ++ T
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 181 DTLTENVARFYIA-QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
+ AR + Q + + S+H + +H ++P +++LD+ G + L+ F S
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299
+ I P
Sbjct: 265 AVSPIG------------------------------------------------RGFAPP 276
Query: 300 DYIAPEVLL-----KKGYGMECDW 318
+ A +L D
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDT 300
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 49/290 (16%), Positives = 85/290 (29%), Gaps = 95/290 (32%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----------------------EKKSGNIYAMKKLKKSE 123
DFE + +GRG FG V + EK + A+ KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 124 MVK---------------------------------RGQVEHVRAERNLLAEVASHCIVK 150
+V+ ++ + + ++ V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLT---ENVARFYIAQSVLAIESIHKHNY 207
YLY+ M+ ++ + R +L V Q A+E +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPD 267
+HRD+KP N+ + +K+ DFGL +D D
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMD----------------------------QD 217
Query: 268 TDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ ++ H VGT Y++PE + Y + D
Sbjct: 218 EEEQTVLTPMPAYATH---------TGQVGTKLYMSPEQIHGNNYSHKVD 258
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 68/248 (27%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
FEL+ ++G G +G+V R K+G + A+K + V + E ++ E N+L + +
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 146 HC-IVKLYYSF------QDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSV 196
H I Y +F + L+L+ME+ G + L+ + +TL E + + +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ +H+H IHRDIK N+LL +N +KL DFG+
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 177
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-----G 311
QL + RR + +GTP ++APEV+
Sbjct: 178 -----------------------QLDR-TVGRRN---TFIGTPYWMAPEVIACDENPDAT 210
Query: 312 YGMECD-W 318
Y + D W
Sbjct: 211 YDFKSDLW 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-30
Identities = 53/254 (20%), Positives = 94/254 (37%), Gaps = 69/254 (27%)
Query: 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKRGQVEHVRA 135
+ +D + L IGRGA+G V K SG I A+K+++ + K+ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--- 71
Query: 136 ERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG--DMMTLLM--REDTLTENVARFY 191
++ IV+ Y + ++ ME + + +D + E +
Sbjct: 72 -DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-K 129
Query: 192 IAQSVL-AIESIH-KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
I + + A+ + IHRDIKP N+LLD++G++KL DFG+ L S
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---------- 179
Query: 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-- 307
+ + + G Y+APE +
Sbjct: 180 ------------------------------------IAKTR----DAGCRPYMAPERIDP 199
Query: 308 --LKKGYGMECD-W 318
++GY + D W
Sbjct: 200 SASRQGYDVRSDVW 213
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 46/153 (30%), Positives = 81/153 (52%), Gaps = 11/153 (7%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRA----ERNLL 140
++ +E + IG G++G V CR + +G I A+KK +SE ++ E +L
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRML 56
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAI 199
++ +V L F+ L+L+ EY ++ L + + E++ + Q++ A+
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
HKHN IHRD+KP+N+L+ K+ +KL DFG
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRA----ERNL 139
++ +E L ++G G++G V CR K +G I A+KK +S+ + V+ E L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMVKKIAMREIKL 77
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLA 198
L ++ +V L + + YL+ E++ ++ L + + L V + Y+ Q +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
I H HN IHRDIKP+N+L+ ++G +KL DFG
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 48/232 (20%), Positives = 89/232 (38%), Gaps = 60/232 (25%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLY 152
IGRG+F V + ++ A +L+ ++ K + + + E +L + IV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 153 YSFQDT----EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY- 207
S++ T + + L+ E + G + T L R + V R + Q + ++ +H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 208 -IHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
IHRD+K DN+ + G +K+ D GL
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLAT------------------------------- 180
Query: 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ R A + +GTP+++APE+ ++ Y D
Sbjct: 181 --------------------LKRASFAKAVIGTPEFMAPEM-YEEKYDESVD 211
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEV 143
+++F+ + IG G +G V R K +G + A+KK++ + G +R E +LL E+
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIR-EISLLKEL 59
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIES 201
IVKL LYL+ E+L D+ + + + + Y+ Q + +
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H H +HRD+KP NLL++ G +KL+DFGL
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-27
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH----VRAERNL 139
+E + IG GA+G V R+ SG+ A+K ++ G VR E L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR-EVAL 64
Query: 140 LAE--VASH-CIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVAR 189
L H +V+L + L+ E++ D+ T L L +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 190 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ Q + ++ +H + +HRD+KP+N+L+ G +KL+DFGL
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 49/164 (29%), Positives = 87/164 (53%), Gaps = 15/164 (9%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH--- 132
+ +K +E L +G G F V R+K + I A+KK+K + R + +
Sbjct: 3 LDVKSR---AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGIN 56
Query: 133 ---VRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVA 188
+R E LL E++ I+ L +F + L+ +++ D+ ++ LT +
Sbjct: 57 RTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHI 114
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ Y+ ++ +E +H+H +HRD+KP+NLLLD+NG +KL+DFGL
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEV 143
+ +E L IG G +G V + +++ I A+K+++ + G +R E LL E+
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALR-EICLLKEL 58
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESI 202
IV+L+ + L L+ E+ D+ L + + ++ Q + +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H N +HRD+KP NLL+++NG +KL++FGL
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGL 147
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 20/157 (12%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH--------VRAE 136
++ + L +G G + V + K + N+ A+K+++ +EH +R E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIR-E 50
Query: 137 RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQS 195
+LL ++ IV L+ + L L+ EYL D+ L + + + + ++ Q
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + H+ +HRD+KP NLL+++ G +KL+DFGL
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL 146
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 25/162 (15%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH--------VRAE 136
F+ L +G G + V K +G A+K++K ++ +R E
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIR-E 53
Query: 137 RNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL------MREDTLTENVARF 190
+L+ E+ IV+LY L L+ E++ D+ + L N+ ++
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ Q + + H++ +HRD+KP NLL++K G +KL DFGL
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL 154
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 27/165 (16%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ +IG G+FG V + SG + A+KK+ + + K R E ++ ++ HC
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NR-ELQIMRKL-DHC 107
Query: 148 -IVKLYYSF------QDTEYLYLIMEYLPGGDMMTL--LMRE-----DTLTENVARFYIA 193
IV+L Y F +D YL L+++Y+P T+ + R TL + Y+
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLD 237
Q ++ IH HRDIKP NLLLD + +KL DFG K L
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-25
Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 6/151 (3%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAE 142
++ ++ L +G G +G V ++ G I A+K+++ + G +R E +LL E
Sbjct: 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIR-EISLLKE 75
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIES 201
+ IV L L L+ E++ D+ +L + L ++ + Y+ Q + +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H+H +HRD+KP NLL++ +G +KL+DFGL
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGL 165
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-25
Identities = 42/173 (24%), Positives = 80/173 (46%), Gaps = 20/173 (11%)
Query: 69 ERKETEFMRLKRHKI---CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV 125
+ E+ + H + DD++L+ +GRG + EV + +K LK
Sbjct: 16 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---- 71
Query: 126 KRGQVEHVRAER--NLLAEVASH-CIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMRE 180
V+ + +R +L + I+ L +D + L+ E++ D L
Sbjct: 72 ----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--- 124
Query: 181 DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGL 232
TLT+ RFY+ + + A++ H +HRD+KP N+++D ++ ++L D+GL
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH---------VR 134
+D + +T +G G +GEV + + A+K+++ +EH +R
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---------LEHEEEGVPGTAIR 82
Query: 135 AERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQ 194
E +LL E+ I++L L+LI EY D+ + + ++ V + ++ Q
Sbjct: 83 -EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKN-----GHMKLSDFGL 232
+ + H +HRD+KP NLLL + +K+ DFGL
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 48/150 (32%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLAEV 143
++ + L IG G +G V + G +A+KK++ E G +R E ++L E+
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIR-EISILKEL 57
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESI 202
IVKLY + L L+ E+L D+ LL + E L A+ ++ Q + I
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H +HRD+KP NLL+++ G +K++DFGL
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGL 146
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 19/179 (10%)
Query: 64 LIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE 123
+ K + E F V +E L IG+G FGEV R +K+G A+KK+ E
Sbjct: 1 MAKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-ME 53
Query: 124 MVKRG-QVEHVRAERNLLAEVASHCIVKLY--------YSFQDTEYLYLIMEYLPGGDMM 174
K G + +R E +L + +V L + +YL+ ++ D+
Sbjct: 54 NEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLA 111
Query: 175 TLL-MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
LL T + + + + + IH++ +HRD+K N+L+ ++G +KL+DFGL
Sbjct: 112 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-24
Identities = 51/242 (21%), Positives = 93/242 (38%), Gaps = 51/242 (21%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
D ++G+G FG+ +++G + MK+L + + +R L E
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE---------ETQRTFLKE 57
Query: 143 VA-----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
V H ++K + L I EY+ GG + ++ D+ R A+ +
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117
Query: 197 -LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+ +H N IHRD+ N L+ +N ++ ++DFGL + L
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL------ARL-------------- 157
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
+ + S K P RK ++ VG P ++APE++ + Y +
Sbjct: 158 -----MVDEKTQPEGLRSLKKP----------DRKKRYTVVGNPYWMAPEMINGRSYDEK 202
Query: 316 CD 317
D
Sbjct: 203 VD 204
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-24
Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 31/169 (18%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKS-GNIYAMKKLKKSEMVKRGQVEH---------V 133
+E + IG GA+G+V R+ K+ G A+K+++ V+ +
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---------VQTGEEGMPLSTI 59
Query: 134 RAERNLLAE--VASH-CIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL--MREDTL 183
R E +L H +V+L+ L L+ E++ D+ T L + E +
Sbjct: 60 R-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 184 TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + Q + ++ +H H +HRD+KP N+L+ +G +KL+DFGL
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-24
Identities = 38/154 (24%), Positives = 74/154 (48%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
++++ +G G V L + A+K + K ++ E + ++++
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
IV + ++ + YL+MEY+ G + + L+ + A + Q + I+ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
+HRDIKP N+L+D N +K+ DFG+ K L ++L
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 56/239 (23%), Positives = 82/239 (34%), Gaps = 68/239 (28%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ E+ ++GRGAFG V C+ K A+K+++ K E L+ V
Sbjct: 8 KEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESERK-----AFIVELRQLSRVNH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTE--NVARFYIAQSV-LAIESI 202
IVKLY + + L+MEY GG + +L + L + +
Sbjct: 61 PNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 203 HKHNY---IHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H IHRD+KP NLLL G +K+ DFG I H T
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--------DIQTHMT--------- 161
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317
+ G+ ++APEV Y +CD
Sbjct: 162 -----------------------------------NNKGSAAWMAPEVFEGSNYSEKCD 185
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 28/165 (16%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ +IG G+FG V + +S + A+KK V + + R E ++ V H
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV-AIKK------VLQDKRFKNR-ELQIMRIV-KHP 92
Query: 148 -IVKLYYSF------QDTEYLYLIMEYLPGGDMMTL--LMR-----EDTLTENVARFYIA 193
+V L F +D +L L++EY+P T+ R + T+ + + Y+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLD 237
Q + ++ IH HRDIKP NLLLD G +KL DFG K L
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 35/155 (22%), Positives = 65/155 (41%), Gaps = 2/155 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVASH 146
+ L ++GRG G+V + I A+K + + ++ E +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
+V ++ + LY+ M + G D+ +L R+ L A + Q A+++ H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
HRD+KP+N+L+ + L DFG+ L
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-22
Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 4/157 (2%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+EL I+G G EV L R+ + A+K L+ R E A +
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 148 IVKLY----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
IV +Y Y++MEY+ G + ++ E +T A IA + A+ H
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
++ IHRD+KP N+++ +K+ DFG+ + + S
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 16/192 (8%)
Query: 48 ERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCRE 107
++ D+P E + ++ + + I D + IG G+FG V R
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMD--------IPWCDLNIKEKIGAGSFGTV--HRA 56
Query: 108 KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167
+ G+ A+K L + + +V E ++ + IV + L ++ EY
Sbjct: 57 EWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115
Query: 168 LPGGDMMTLLMREDTLTE--NVARFYIAQSV-LAIESIHKHNY--IHRDIKPDNLLLDKN 222
L G + LL + + R +A V + +H N +HR++K NLL+DK
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175
Query: 223 GHMKLSDFGLCK 234
+K+ DFGL +
Sbjct: 176 YTVKVCDFGLSR 187
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 11/188 (5%)
Query: 52 ASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSG 111
S E Q + R D +E+ +IG G++G V +K
Sbjct: 19 TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEK 78
Query: 112 NIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEVASHCIVKLY-----YSFQDTEYLYLI 164
+ A+KK+ + V ++ R R +L + +VK+ + + LY++
Sbjct: 79 RVVAIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135
Query: 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH 224
+E D L LTE + + ++ ++ +H +HRD+KP N L++++
Sbjct: 136 LEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS 194
Query: 225 MKLSDFGL 232
+K+ DFGL
Sbjct: 195 VKVCDFGL 202
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 15/158 (9%), Positives = 50/158 (31%), Gaps = 3/158 (1%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ LL G + + A+ + ++ ++ + L+ +
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
+ ++ ++ E++ GG + + + + + A + A ++ H+
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST-LYAI 244
P + + +G + L+ + + I
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIRGI 188
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK----SEMVKR 127
+EF + + + ++ E IG+G FG V R K ++ A+K L E
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 128 GQVEHVRAERNLLAEVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN 186
+ + + E +++ + IVKLY ++ME++P GD+ L+ + +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLM---HNPPRMVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 187 VARFYIAQSV-LAIESIHKHNY--IHRDIKPDNLLLDKNG-----HMKLSDFGLCK 234
+ + + L IE + N +HRD++ N+ L K++DFGL +
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-21
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
+D F++ + G+G FG V+L +EK +G A+KK+ + + +++ ++ LA +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLH 77
Query: 145 SHCIVKLYYSFQDTE-------YLYLIMEYLPGGD----MMTLLMREDTLTENVARFYIA 193
IV+L F YL ++MEY+P R+ + + ++
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 194 QSVLAIESIHK--HNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLD 237
Q + +I +H N HRDIKP N+L+++ +G +KL DFG K L
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 17/159 (10%)
Query: 88 FELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKS---EMVKRGQVEHVRAERNLLAEV 143
+E+ I G G + L ++ +G +K L S E AER LAEV
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-----AMAERQFLAEV 136
Query: 144 ASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
IV+++ Y++MEY+ G + L A Y+ + + A
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +H ++ D+KP+N++L + +KL D G ++
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRIN 232
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 32/153 (20%), Positives = 66/153 (43%), Gaps = 6/153 (3%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
I + E+ +IG+G FG+V + G + A++ + + Q++ + E +
Sbjct: 30 IPFEQLEIGELIGKGRFGQV--YHGRWHGEV-AIRLIDIERDNED-QLKAFKREVMAYRQ 85
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIES 201
+V + +L +I G + +++ + L N R + V +
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+H +H+D+K N+ D NG + ++DFGL
Sbjct: 146 LHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 9/163 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ + +G G FG+V L + + A+K LK + + E ++L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILR 88
Query: 142 EVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+ I+K L L+MEY+P G + L ++ + Q +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGM 147
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+H +YIHRD+ N+LLD + +K+ DFGL K + Y
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-20
Identities = 52/247 (21%), Positives = 84/247 (34%), Gaps = 66/247 (26%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ-VEHVRAERNLLA 141
I + L IIG G FG+V R G+ A+K + Q +E+VR E L A
Sbjct: 4 IDFAELTLEEIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ I+ L L L+ME+ GG + +L + ++ + Q +
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNY 120
Query: 202 IHKHNY---IHRDIKPDNLLLDK--------NGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+H IHRD+K N+L+ + N +K++DFGL + +T
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-------- 172
Query: 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310
S G ++APEV+
Sbjct: 173 -------------------------------------------SAAGAYAWMAPEVIRAS 189
Query: 311 GYGMECD 317
+ D
Sbjct: 190 MFSKGSD 196
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 10/164 (6%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ L +G+G FG V +CR + +G + A+KKL+ S + E +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILK 66
Query: 142 EVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLA 198
+ IVK L LIMEYLP G + L + ++ + Y +Q
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+E + YIHRD+ N+L++ +K+ DFGL K L +
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-20
Identities = 50/181 (27%), Positives = 77/181 (42%), Gaps = 18/181 (9%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEM 124
+R T+F + L +G+G FG V +CR + +G + A+KKL+ S
Sbjct: 32 DRDPTQFEE--------RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 83
Query: 125 VKRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMT-LLMRED 181
+ E +L + IVK L LIMEYLP G + L ++
Sbjct: 84 ---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 140
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
+ Y +Q +E + YIHRD+ N+L++ +K+ DFGL K L
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
Query: 242 Y 242
Y
Sbjct: 201 Y 201
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-20
Identities = 36/151 (23%), Positives = 68/151 (45%), Gaps = 6/151 (3%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
I + IG G+FG V + K G++ A+K L + + Q++ + E +L +
Sbjct: 21 IPDGQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK 76
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV-LAIES 201
I+ L ++ ++ G + L +T E IA+ ++
Sbjct: 77 TRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+H + IHRD+K +N+ L ++ +K+ DFGL
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-20
Identities = 23/162 (14%), Positives = 56/162 (34%), Gaps = 10/162 (6%)
Query: 78 LKRHK-ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAE 136
+ +H I LT + GE+ + + GN +K LK + R + E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEE 57
Query: 137 RNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA-RFYIA 193
L + ++ + + LI ++P G + +L + + A
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 194 QSV-LAIESIHKHNY--IHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + +H + ++++D++ ++S +
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 17/181 (9%)
Query: 69 ERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEM 124
E T F + + + +G G FG+V LCR G+ A+K LK
Sbjct: 12 EVDPTHFEK--------RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG 63
Query: 125 VKRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMT-LLMRED 181
+ ++ E +L + IVK + + LIME+LP G + L ++
Sbjct: 64 GN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
+ Y Q ++ + Y+HRD+ N+L++ +K+ DFGL K ++
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 242 Y 242
Y
Sbjct: 182 Y 182
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 45/186 (24%), Positives = 72/186 (38%), Gaps = 37/186 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKL---------------------------- 119
+ L +G G+FG V + +SG +A+KK+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 120 ---KKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGD---- 172
E K Q + ++ + + +YL +IMEY+P
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 173 MMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFG 231
+ + + ++ N+ YI Q A+ IH HRDIKP NLL++ K+ +KL DFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 232 LCKPLD 237
K L
Sbjct: 188 SAKKLI 193
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 46/185 (24%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
D++ + +IGRG++G V L +K + A+KK+ + + ++ R R +L +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNRL 82
Query: 144 ASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
S I++LY + LY+++E D+ L LTE + + +L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
IH+ IHRD+KP N LL+++ +K+ DFGL + ++ I ++E
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 259 MDIDG 263
++
Sbjct: 202 KNLKK 206
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 49/180 (27%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 70 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEMV 125
+ T F + ++ +G+G FG V LCR G+ A+K+L+ S
Sbjct: 15 QDPTIFEE--------RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD 66
Query: 126 KRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMT-LLMREDT 182
Q + E +L + S IVK + L L+MEYLP G + L
Sbjct: 67 ---QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR 123
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
L + Y +Q +E + +HRD+ N+L++ H+K++DFGL K L Y
Sbjct: 124 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 3/166 (1%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+D L IGRG FGEV R + + A+K +++ E +L + +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSH 171
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESIHK 204
IV+L + +Y++ME + GGD +T L L + + +E +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
IHRD+ N L+ + +K+SDFG+ + A + +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV 277
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 39/179 (21%), Positives = 71/179 (39%), Gaps = 40/179 (22%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRA 135
M + + + +++ IG G+FG + + A+K E R+
Sbjct: 1 MSGQNNVVG-VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRS 47
Query: 136 ERNLLAE--------VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
+ L + I +YY Q+ + L+++ L G + ED L
Sbjct: 48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL------EDLLDLCG 100
Query: 188 ARF------YIA-QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK-----LSDFGLCK 234
+F A Q + ++SIH+ + ++RDIKPDN L+ + + DFG+ K
Sbjct: 101 RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 33/164 (20%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE----- 142
F + IG G FGE+RL + + A+K +E +++ L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFY 58
Query: 143 ---VASHCIVKLYYSFQDTEYLYLIMEYLPGG----DMMTLLMREDTLTENVARFYIAQS 195
+ I ++YY +Y +++E L G D+ L R +L + V I Q
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL-KTVLMIAI-QL 114
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMK-----LSDFGLCK 234
+ +E +H N I+RD+KP+N L+ + G+ + DF L K
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 22/158 (13%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+EL+ +G+GA+G V ++++G + A+KK+ + + R R +L E+
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILTEL 65
Query: 144 ASH-CIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQ 194
+ H IV L + +D +YL+ +Y M T L +R + L ++ + Q
Sbjct: 66 SGHENIVNLLNVLRADNDRD---VYLVFDY-----METDLHAVIRANILEPVHKQYVVYQ 117
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ I+ +H +HRD+KP N+LL+ H+K++DFGL
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGL 155
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 29/161 (18%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER-NLLAEVA-- 144
+ L IG G+FG++ L + +G A+K E V+ + L E
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIY 58
Query: 145 -----SHCIVKLYYSFQDTEYLYLIMEYLPG---GDMMTLLMREDTLTENVARFYIAQSV 196
I + + + +Y ++ME L G D+ R+ +L + V Q +
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL-KTVLLLAD-QMI 115
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMK---LSDFGLCK 234
IE IH N+IHRD+KPDN L+ + DFGL K
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-18
Identities = 37/169 (21%), Positives = 71/169 (42%), Gaps = 22/169 (13%)
Query: 86 DDFELLTIIGRGAFGEV---RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLA 141
+F+ + ++G GAFG V E + I A+K+L+++ K A + +L
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--------ANKEILD 66
Query: 142 EVA-----SH-CIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIA 193
E + + +L T + LI + +P G ++ + +D + +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 194 QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
Q + + +HRD+ N+L+ H+K++DFGL K L
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 29/162 (17%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAE-RNLLAEVA-- 144
F L IG G+FGE+ L ++ A+K E+V+ + LL E
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIY 56
Query: 145 -----SHCIVKLYYSFQDTEYLYLIMEYLPG---GDMMTLLMREDTLTENVARFYIAQSV 196
I + + + +Y L+M+ L G D+ R+ +L + V Q +
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL-KTVLMLAD-QMI 113
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMK---LSDFGLCKP 235
+E +H +++HRDIKPDN L+ + DFGL K
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ D + +G G +GEV KK A+K LK+ M +VE E ++ E
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 272
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIE 200
+ +V+L Y+I E++ G+++ L ++ V + Q A+E
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ K N+IHR++ N L+ +N +K++DFGL
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 44/195 (22%), Positives = 83/195 (42%), Gaps = 16/195 (8%)
Query: 56 VPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYA 115
+ L + E R + L +G+G FGEV + + + A
Sbjct: 245 TVCPTSKPQTQGLAKDAWEIPR--------ESLRLEVKLGQGCFGEVWMGTWNGTTRV-A 295
Query: 116 MKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT 175
+K LK M E E ++ ++ +V+LY + E +Y++ EY+ G ++
Sbjct: 296 IKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 350
Query: 176 LLMREDTLTENVARF--YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
L E + + AQ + + + NY+HRD++ N+L+ +N K++DFGL
Sbjct: 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
Query: 234 KPLDCSTLYAIHEHK 248
+ ++ + A K
Sbjct: 411 RLIEDNEYTARQGAK 425
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 28/173 (16%)
Query: 71 KETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK---KSEMVKR 127
K + F+L +++G GA+G V K +G I A+KK++ K R
Sbjct: 3 KRIVYNISSD-------FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR 55
Query: 128 GQVEHVRAERNLLAEVASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL---MR 179
+R E +L I+ ++ SF++ +Y+I E M T L +
Sbjct: 56 T----LR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVIS 105
Query: 180 EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
L+++ +++I Q++ A++ +H N IHRD+KP NLL++ N +K+ DFGL
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 47/242 (19%), Positives = 79/242 (32%), Gaps = 68/242 (28%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN--LL 140
+ +D+ +LL +IGRG +G V + A+K + ++ E+N +
Sbjct: 10 LDLDNLKLLELIGRGRYGAV--YKGSLDERPVAVKVFSFANR------QNFINEKNIYRV 61
Query: 141 AEVASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQS 195
+ I + + L+MEY P G + L + + R +A S
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR--LAHS 119
Query: 196 V----------LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
V L +K HRD+ N+L+ +G +SDFGL
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL------------- 166
Query: 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305
+ + + + VGT Y+APE
Sbjct: 167 ----------------------SMRLTGNRLVRPGEEDNAAISE------VGTIRYMAPE 198
Query: 306 VL 307
VL
Sbjct: 199 VL 200
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-17
Identities = 40/184 (21%), Positives = 78/184 (42%), Gaps = 27/184 (14%)
Query: 67 DLERKETEFMRLKRHKICVDDFELLTI-IGRGAFGEVRLCREK--KSGNIYAMKKLKKSE 123
D + K +R D FE +GRG +G V + K K YA+K+++ +
Sbjct: 4 DYDFKVKLSSERER---VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG 60
Query: 124 MVKRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLL---- 177
+ + R E LL E+ ++ L + ++L+ +Y D+ ++
Sbjct: 61 I----SMSACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHR 114
Query: 178 -----MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLS 228
+ L + + + Q + I +H + +HRD+KP N+L+ + G +K++
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 229 DFGL 232
D G
Sbjct: 175 DMGF 178
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-17
Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 10/168 (5%)
Query: 86 DDFELLTIIGRGAFGEV---RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLA 141
+F+ + ++G GAFG V E + I A+K+L+++ K + + E ++A
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 72
Query: 142 EVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLAI 199
V + + +L T + LI + +P G ++ + +D + + Q +
Sbjct: 73 SVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ +HRD+ N+L+ H+K++DFGL K L E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-17
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+ L +G GA+G V + ++G A+KKL + + ++ RA R LL +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHM 81
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQ 194
++ L + D YL+M + M T L M+ + L E+ +F + Q
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ + IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+ ++ L+ +G GA+G V + K+G A+KKL + + + R R LL +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLKHM 85
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQ 194
++ L S ++ +YL+ M L ++ LT++ +F I Q
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ ++ IH + IHRD+KP NL ++++ +K+ DFGL +
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 44/195 (22%), Positives = 83/195 (42%), Gaps = 16/195 (8%)
Query: 56 VPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYA 115
+ L + E R + L +G+G FGEV + + + A
Sbjct: 162 TVCPTSKPQTQGLAKDAWEIPR--------ESLRLEVKLGQGCFGEVWMGTWNGTTRV-A 212
Query: 116 MKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT 175
+K LK M E E ++ ++ +V+LY + E +Y++ EY+ G ++
Sbjct: 213 IKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 267
Query: 176 LLMREDTLTENVARF--YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233
L E + + AQ + + + NY+HRD++ N+L+ +N K++DFGL
Sbjct: 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
Query: 234 KPLDCSTLYAIHEHK 248
+ ++ + A K
Sbjct: 328 RLIEDNEYTARQGAK 342
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 38/156 (24%), Positives = 64/156 (41%), Gaps = 5/156 (3%)
Query: 86 DDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAE 142
D LL +G G+FG VR + A+K LK + + ++ E N +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLAIES 201
+ +++LY T + ++ E P G ++ L + Y Q +
Sbjct: 78 LDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +IHRD+ NLLL +K+ DFGL + L
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 45/250 (18%), Positives = 76/250 (30%), Gaps = 80/250 (32%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKS---------EMVKRG 128
+ +LL + RG FG V + A+K E+
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLP 73
Query: 129 QVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
++H N+L + + L+LI + G + L + + ++ N
Sbjct: 74 GMKH----ENILQFIGA-EKRGTSVDVD----LWLITAFHEKGSLSDFL-KANVVSWN-E 122
Query: 189 RFYIAQSV-----------LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+IA+++ ++ HK HRDIK N+LL N ++DFGL +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297
+ + VG
Sbjct: 183 -----------------------------------------AGKSAGDTHGQ------VG 195
Query: 298 TPDYIAPEVL 307
T Y+APEVL
Sbjct: 196 TRRYMAPEVL 205
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 46/240 (19%), Positives = 71/240 (29%), Gaps = 66/240 (27%)
Query: 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ +++ IG+G +GEV + + + G A+K +E E
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE----ASWFRETEIYQT 85
Query: 141 AEVASHCIVKLY----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ I+ LYLI +Y G + L + TL +A S
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKS-MLKLAYSS 143
Query: 197 ---------LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ K HRD+K N+L+ KNG ++D GL T
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT------- 196
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
+D VGT Y+ PEVL
Sbjct: 197 NEVDIPPNTR--------------------------------------VGTKRYMPPEVL 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 41/160 (25%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+ T +G GA+G V +K+SG A+KKL + + ++ RA R LL +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLKHM 80
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
++ L S ++ YL+M ++ D+ ++ + +E ++ + Q +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLK 137
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
++ IH +HRD+KP NL ++++ +K+ DFGL + D
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 4/147 (2%)
Query: 93 IIGRGAFGEVR--LCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150
+G G FG V+ + KK A+K LK + E + E N++ ++ + IV+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVR 82
Query: 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHR 210
+ + E L+ME G + L + + + + Q + ++ + + N++HR
Sbjct: 83 MI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 211 DIKPDNLLLDKNGHMKLSDFGLCKPLD 237
D+ N+LL + K+SDFGL K L
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALR 168
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 28/169 (16%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ L IG G FG + L A +K E + G + E VA
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFS---ELKFYQRVAKKD 94
Query: 148 IV---------------KLYYS----FQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVA 188
+ Y S F+ Y +++ME L G D+ + + T ++
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV 153
Query: 189 RFYIA-QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK--LSDFGLCK 234
+ + + +E IH++ Y+H DIK NLLL + L+D+GL
Sbjct: 154 -LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 14/160 (8%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
++ L IG GA G V + A+KKL + + Q RA R L+ V
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVLMKCV 118
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
I+ L + ++ + +YL+ME + ++ ++ E L + + Q +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 175
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 36/173 (20%), Positives = 66/173 (38%), Gaps = 33/173 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNI-----YAMKKLKK--------SEMVKRGQVEHVR 134
+++ IG+G FG + L S ++ +K + +R
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 135 AERNLLAEVASHCIVKLYYS----FQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF 190
+ ++ + K + S Y ++IM+ G D+ + N RF
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL------QKIYEANAKRF 149
Query: 191 ------YIA-QSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK--LSDFGLCK 234
++ + + +E IH+H Y+H DIK NLLL+ + L D+GL
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
+ L+ IG GA+G V + + A+KK+ E Q R R +L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRF 82
Query: 144 ASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQS 195
I+ + + + + +Y++ + M T L ++ L+ + +++ Q
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQI 137
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ ++ IH N +HRD+KP NLLL+ +K+ DFGL + D
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-16
Identities = 31/148 (20%), Positives = 61/148 (41%), Gaps = 6/148 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + IG G FG V L + A+K +++ M E E ++ +++
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHK 204
+V+LY + + L+ E++ G + L + + + +
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
IHRD+ N L+ +N +K+SDFG+
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGM 150
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 32/168 (19%), Positives = 66/168 (39%), Gaps = 10/168 (5%)
Query: 86 DDFELLTIIGRGAFGEVR---LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ L ++G G FG V E +S I +K ++ + + V +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIG 70
Query: 142 EVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLAI 199
+ IV+L + L L+ +YLP G ++ + L + + Q +
Sbjct: 71 SLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ +H +HR++ N+LL ++++DFG+ L ++
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-16
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 14/160 (8%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER--NLLAEV 143
++ L IG GA G V + A+KKL + + Q RA R L+ V
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---PFQNQTHAKRAYRELVLMKCV 81
Query: 144 ASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
I+ L S ++ + +Y++ME + ++ ++ E L + + Q +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 138
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-16
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D + +G G +GEV KK A+K LK+ M +VE E ++ E+
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIH 203
+V+L Y+I E++ G+++ L ++ V + Q A+E +
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
K N+IHRD+ N L+ +N +K++DFGL
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGL 157
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 9e-16
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 7/165 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNL 139
I + EL IG G FG+V + ++ + A+K K E E
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALT 444
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLA 198
+ + IVKL + +++IME G++ + L +R+ +L Y Q A
Sbjct: 445 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+ + ++HRDI N+L+ N +KL DFGL + ++ ST Y
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 30/186 (16%)
Query: 56 VPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYA 115
ME + + R + +LL IG+G FG+V L + GN A
Sbjct: 171 KVMEGTVAAQDEFYRSGWALNM--------KELKLLQTIGKGEFGDVMLGDYR--GNKVA 220
Query: 116 MKKLKKSEMVKRGQVEHVRAERNLLAEVA-----SH-CIVKLY-YSFQDTEYLYLIMEYL 168
+K +K + LAE + H +V+L ++ LY++ EY+
Sbjct: 221 VKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 169 PGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226
G ++ L L + + A+E + +N++HRD+ N+L+ ++ K
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 329
Query: 227 LSDFGL 232
+SDFGL
Sbjct: 330 VSDFGL 335
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 32/162 (19%), Positives = 65/162 (40%), Gaps = 18/162 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREK-KSGNIYAMKKLKKSEMVKRGQV---EHVRAER---- 137
+ + I G++G V C G A+K++ + R + +R
Sbjct: 22 SPYTVQRFISSGSYGAV--CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 138 -NLLAEVASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARF 190
LL I+ L + LYL+ E + D+ ++ + ++ ++
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY 138
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++ +L + +H+ +HRD+ P N+LL N + + DF L
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 18/160 (11%)
Query: 83 ICVDDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNL 139
I + IIG G GEV R ++ A+K LK + R+
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--------QRRDF 97
Query: 140 LAEVA-----SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYI 192
L+E + H I++L ++ EY+ G + T L + T +
Sbjct: 98 LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + Y+HRD+ N+L+D N K+SDFGL
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 7/165 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNL 139
I + EL IG G FG+V N A+K K E E
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALT 69
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVLA 198
+ + IVKL + +++IME G++ + L +R+ +L Y Q A
Sbjct: 70 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+ + ++HRDI N+L+ N +KL DFGL + ++ ST Y
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 49/235 (20%), Positives = 71/235 (30%), Gaps = 68/235 (28%)
Query: 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH 146
D LL +G+G +GEV + G A+K + + + L H
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVML-----RH 61
Query: 147 -CIVKLY----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV----- 196
I+ S + L+LI Y G + L + TL I S+
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVS-CLRIVLSIASGLA 119
Query: 197 ----LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
+ K HRD+K N+L+ KNG ++D GL +D
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS-------QSTNQLDV 172
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
N VGT Y+APEVL
Sbjct: 173 GNNPR--------------------------------------VGTKRYMAPEVL 189
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 30/184 (16%)
Query: 58 MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK 117
M + + R + +LL IG+G FG+V L + GN A+K
Sbjct: 1 MGGSVAAQDEFYRSGWALNM--------KELKLLQTIGKGEFGDVMLGDYR--GNKVAVK 50
Query: 118 KLKKSEMVKRGQVEHVRAERNLLAEVA-----SHC-IVKLY-YSFQDTEYLYLIMEYLPG 170
+K + LAE + H +V+L ++ LY++ EY+
Sbjct: 51 CIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99
Query: 171 GDMMTLL--MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228
G ++ L L + + A+E + +N++HRD+ N+L+ ++ K+S
Sbjct: 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS 159
Query: 229 DFGL 232
DFGL
Sbjct: 160 DFGL 163
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 53/240 (22%), Positives = 74/240 (30%), Gaps = 66/240 (27%)
Query: 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L IG+G FGEV R K G A+K E + AE
Sbjct: 37 QRTIARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQT 90
Query: 141 AEVASHCIVKLYYSFQDTEY----LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ I+ + L+L+ +Y G + L R T+T +A S
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEG-MIKLALST 148
Query: 197 ---------LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ + K HRD+K N+L+ KNG ++D GL D
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD-------SAT 201
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
TID VGT Y+APEVL
Sbjct: 202 DTIDIAPNHR--------------------------------------VGTKRYMAPEVL 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 8/163 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
I + +L +G G FGEV + K + A+K +K M VE AE N++
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKT 239
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARF--YIAQSVLAIE 200
+ +VKL+ E +Y+I E++ G ++ L ++ + + + + AQ +
Sbjct: 240 LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
I + NYIHRD++ N+L+ + K++DFGL + ++ + A
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 30/170 (17%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKL--KKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L +G G G V + A+KK+ + VK +R E ++ +
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA----LR-EIKIIRRLDH 67
Query: 146 HCIVKLY--------------YSFQDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVA 188
IVK++ S + +Y++ EY M T L + + L E A
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHA 122
Query: 189 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLD 237
R ++ Q + ++ IH N +HRD+KP NL ++ ++ +K+ DFGL + +D
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 47/154 (30%), Positives = 70/154 (45%), Gaps = 7/154 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNL 139
I +D L I+G G FGEV + K I A+K KK + E +E +
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVI 66
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLA 198
+ + IVKL + E ++IME P G++ L R +++L Y Q A
Sbjct: 67 MKNLDHPHIVKLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ + N +HRDI N+L+ +KL DFGL
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 12/176 (6%)
Query: 66 KDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVR---LCREKKSGNIYAMKKLKKS 122
D E + + + LKR + + D EL G G FG VR KK ++ A+K LK+
Sbjct: 320 SDPEELKDKKLFLKRDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDV-AIKVLKQG 374
Query: 123 EMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMRED 181
E + E ++ ++ + IV+L E L L+ME GG + L+ + +
Sbjct: 375 TEKA--DTEEMMREAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKRE 431
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ + + Q + ++ + + N++HR++ N+LL + K+SDFGL K L
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 35/151 (23%), Positives = 68/151 (45%), Gaps = 12/151 (7%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D L +G G FG V+ + + ++ A+K +K+ M + E ++ ++
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA----IES 201
+V+LY +++I EY+ G ++ L + + + V +ES
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++HRD+ N L++ G +K+SDFGL
Sbjct: 139 ---KQFLHRDLAARNCLVNDQGVVKVSDFGL 166
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-15
Identities = 37/148 (25%), Positives = 70/148 (47%), Gaps = 6/148 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
++ LL +G G FG V+L + K ++ A+K +K+ M + E + +++
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV-LAIESIHK 204
+VK Y +Y++ EY+ G ++ L E + V + +
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H +IHRD+ N L+D++ +K+SDFG+
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGM 150
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 6/151 (3%)
Query: 86 DDFELLTIIGRGAFGEVR--LCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ + ++G G FGEV + I A+K LK K Q E +++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIMGQ 102
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIES 201
I++L ++ + ++ EY+ G + + L + T + ++
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ Y+HRD+ N+L++ N K+SDFGL
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-15
Identities = 38/155 (24%), Positives = 65/155 (41%), Gaps = 7/155 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEV---RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERN 138
I +IG G FGEV L + A+K LK K Q E
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAG 98
Query: 139 LLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVL 197
++ + + H I++L + + +I EY+ G + L ++ + +
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++ + NY+HRD+ N+L++ N K+SDFGL
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 21/171 (12%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY--AMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
+D + +IG G FG+V R KK G A+K++K+ E +L ++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 82
Query: 144 ASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIE 200
H I+ L + + YLYL +EY P G+++ L R A S L+ +
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 201 SIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +IHRD+ N+L+ +N K++DFGL + +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 193
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 34/205 (16%)
Query: 51 LASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR---- 106
+ ++P++E + + + EF R D +L +GRGAFG+V
Sbjct: 1 MDPDELPLDEHCERLP-YDASKWEFPR--------DRLKLGKPLGRGAFGQVIEADAFGI 51
Query: 107 -EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLY-YSFQDTEYLYL 163
+ + A+K LK+ + + +E +L + H +V L + L +
Sbjct: 52 DKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 109
Query: 164 IMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESIHK--------------HNY 207
I+E+ G++ T L R + + VA + + L +E +
Sbjct: 110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC 169
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGL 232
IHRD+ N+LL + +K+ DFGL
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGL 194
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 28/173 (16%), Positives = 59/173 (34%), Gaps = 33/173 (19%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNI--------YAMKKLKKSEMVKRGQVEHVRAERNL 139
++L + R G + + +++K K + Q RA + L
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 140 -------LAEVASHCIVKLYYS-FQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFY 191
L I +Y +L++ L G + + L +
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSL------QSALDVSPKHVL 156
Query: 192 IAQSVL--------AIESIHKHNYIHRDIKPDNLLLDKNGHMK--LSDFGLCK 234
+SVL A+E +H++ Y+H ++ +N+ +D + L+ +G
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 34/208 (16%)
Query: 49 RKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEV------ 102
R +++D PM ++ + E + EF R D L +G G FG+V
Sbjct: 52 RLSSTADTPMLAGVSEYELPEDPKWEFPR--------DKLTLGKPLGEGCFGQVVMAEAV 103
Query: 103 RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEY 160
+ ++K + A+K LK K + + +E ++ + H I+ L +
Sbjct: 104 GIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161
Query: 161 LYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIESIHK-------------- 204
LY+I+EY G++ L R + + + + + + +
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
IHRD+ N+L+ +N MK++DFGL
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGL 249
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 22/167 (13%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLL 140
++ + +G GAFG+V K+ + A+K LK + + E + +E ++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIM 103
Query: 141 AEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
+ + H IV L + + +I EY GD++ L R+ + E F IA S +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 200 ESIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ N IHRD+ N+LL K+ DFGL
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 32/171 (18%), Positives = 69/171 (40%), Gaps = 25/171 (14%)
Query: 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY-------AMKKLKKSEMVKRGQVEHV 133
HKI +D +G+G F ++ ++ G+ +K L K+ E
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESF 59
Query: 134 RAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA 193
+++++++ +V Y + L+ E++ G + T L + + + +A
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 194 QSVLA----IESIHKHNYIHRDIKPDNLLLDK--------NGHMKLSDFGL 232
+ + A +E + IH ++ N+LL + +KLSD G+
Sbjct: 120 KQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 34/209 (16%)
Query: 48 ERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEV----- 102
S PM ++ + E + EF R D L +G GAFG+V
Sbjct: 5 HHHHHHSQDPMLAGVSEYELPEDPKWEFPR--------DKLTLGKPLGEGAFGQVVMAEA 56
Query: 103 -RLCREKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTE 159
+ ++K + A+K LK K + + +E ++ + H I+ L +
Sbjct: 57 VGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 160 YLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIHK------------- 204
LY+I+EY G++ L R + + + + + + +
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 174
Query: 205 -HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
IHRD+ N+L+ +N MK++DFGL
Sbjct: 175 SQKCIHRDLAARNVLVTENNVMKIADFGL 203
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY--AMKKLKKSEMVKRGQVEHVRA 135
LKR + + D EL G G FG VR + A+K LK+ E +
Sbjct: 6 LKRDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 59
Query: 136 ERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQ 194
E ++ ++ + IV+L E L L+ME GG + L+ + + + + Q
Sbjct: 60 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ ++ + + N++HRD+ N+LL + K+SDFGL K L
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ +L+ +G G FGEV + + A+K LK+ M + AE NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLAIESIH 203
+V+LY + E +Y+I EY+ G ++ L LT N AQ + I
Sbjct: 68 QRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ NYIHRD++ N+L+ K++DFGL
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGL 155
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 32/165 (19%), Positives = 67/165 (40%), Gaps = 7/165 (4%)
Query: 89 ELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+IGRG FG V + A+K L + + +V E ++ + +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 85
Query: 146 HCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIH 203
++ L + +++ Y+ GD+ + E T + Q ++ +
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHK 248
++HRD+ N +LD+ +K++DFGL + + Y++H
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 35/184 (19%), Positives = 78/184 (42%), Gaps = 10/184 (5%)
Query: 70 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVK 126
E + + + ++ +IG+G FG V A+K L + ++
Sbjct: 8 LAEVKDVLIPHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 127 RGQVEHVRAERNLLAEVASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLT 184
QVE E L+ + ++ L ++++ Y+ GD++ + + T
Sbjct: 65 --QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244
+ Q +E + + ++HRD+ N +LD++ +K++DFGL + + Y++
Sbjct: 123 VKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182
Query: 245 HEHK 248
+H+
Sbjct: 183 QQHR 186
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 26/171 (15%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLL 140
+ +G GAFG+V K + A+K LK S + + E + +E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 141 AEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVL 197
+ + +H IV L + +I EY GD++ L R+ + + + L
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 198 AIES----------------IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
A++ + N IHRD+ N+LL K+ DFGL
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 18/163 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAE 142
F L ++G+G FG VR + K+ + A+K LK + +E E + E
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKE 81
Query: 143 VASHCIVKLY------YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+ KL + +I+ ++ GD+ L + EN + V
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLV 140
Query: 197 LAIESIHK-------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ I N+IHRD+ N +L ++ + ++DFGL
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 51/224 (22%), Positives = 85/224 (37%), Gaps = 40/224 (17%)
Query: 38 QERKERRWVLERKLASSDVPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRG 97
Q R E + + + SSD ++ + + EF R + E ++G G
Sbjct: 6 QFRYESQLQMVQVTGSSD-NEYFYVDFREYEYDLKWEF---PRENL-----EFGKVLGSG 56
Query: 98 AFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKL 151
AFG+V K +I A+K LK+ + E + +E ++ ++ SH IV L
Sbjct: 57 AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNL 114
Query: 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK------- 204
+ + +YLI EY GD++ L + Y Q L E
Sbjct: 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174
Query: 205 ----------------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ +HRD+ N+L+ +K+ DFGL
Sbjct: 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 3e-13
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 26/156 (16%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA----- 144
+G G FG V + + A+KKL + + ++ E+
Sbjct: 38 KMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEE-----LKQQFDQEIKVMAKC 87
Query: 145 SH-CIVKLY-YSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTEN-VARFYIAQSVLA-- 198
H +V+L +S + L+ Y+P G ++ L + T + R IAQ A
Sbjct: 88 QHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA-ANG 145
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
I +H++++IHRDIK N+LLD+ K+SDFGL +
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR 181
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 30/149 (20%), Positives = 61/149 (40%), Gaps = 7/149 (4%)
Query: 89 ELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+IGRG FG V + A+K L + + +V E ++ + +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 149
Query: 146 HCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIH 203
++ L + +++ Y+ GD+ + E T + Q ++ +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
++HRD+ N +LD+ +K++DFGL
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGL 238
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 36/154 (23%), Positives = 79/154 (51%), Gaps = 15/154 (9%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVA-- 144
+E+L +IG+G+FG+V + K A+K ++ + ++ E +R +L +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDN 157
Query: 145 SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQSVLAI 199
+ ++ + +F ++ + E L M L L++++ + + R + + +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGH--MKLSDFG 231
+++HK+ IH D+KP+N+LL + G +K+ DFG
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 8e-13
Identities = 51/254 (20%), Positives = 87/254 (34%), Gaps = 24/254 (9%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-- 145
+ ++ +G G F V L + + AMK +K +E E E LL V +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSD 94
Query: 146 ------HCIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIA 193
+V+L F+ + ++ ++ E L G ++ +++ L + I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 194 QSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDD 252
Q + ++ +H IH DIKP+N+LL N S
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 253 ENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
A ++ P K K W + T Y + EVL+ GY
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT---EDIQTRQYRSLEVLIGSGY 270
Query: 313 GMECD-WLVSVLHF 325
D W + + F
Sbjct: 271 NTPADIWSTACMAF 284
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 36/177 (20%), Positives = 66/177 (37%), Gaps = 17/177 (9%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIY---AMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ L I+G G FG V K+ A+K +K +R E + E + +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKD 92
Query: 143 VASHCIVKLY-----YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
+ +++L S Q +I+ ++ GD+ T L L + +
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLK 151
Query: 198 AIESIHK-------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ I N++HRD+ N +L + + ++DFGL K + Y
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI 208
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 40/206 (19%), Positives = 77/206 (37%), Gaps = 29/206 (14%)
Query: 48 ERKLASSDVPMEEQINLIKDLERKETEFMR-LKRHKICVDDFELLTIIGRGAFGEVRLCR 106
+ Q ++I++ + + +KR I L +G GAFG+V L
Sbjct: 7 SSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDI-----VLKWELGEGAFGKVFLAE 61
Query: 107 ----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161
+ + A+K LK++ R + + E LL + IV+ + + L
Sbjct: 62 CHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 162 YLIMEYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESIHK--------------HN 206
++ EY+ GD+ L +A L + + +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGL 232
++HRD+ N L+ + +K+ DFG+
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGM 204
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 28/162 (17%), Positives = 69/162 (42%), Gaps = 17/162 (10%)
Query: 86 DDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ + +G+G+FG V + + A+K + ++ ++ + E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMT-LLMREDTLTENVARFYIAQSVL-- 197
E H +V+L + +IME + GD+ + L + N + S +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 198 -------AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
+ ++ + ++HRD+ N ++ ++ +K+ DFG+
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 26/171 (15%)
Query: 86 DDFELLTIIGRGAFGEVRLCR-------EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
D L +G GAFG+V L + A+K LK K + + +E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 139 LLAEVASHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQS 195
++ + H I+ L + LY+I+EY G++ L R L + + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 196 VLAIESIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
L+ + + IHRD+ N+L+ ++ MK++DFGL
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 42/182 (23%), Positives = 68/182 (37%), Gaps = 41/182 (22%)
Query: 78 LKRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEH 132
+KR I L +G GAFG+V L + A+K LK +
Sbjct: 12 IKRRDI-----VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-------- 58
Query: 133 VRAERNLLAEVA-----SHC-IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLT 184
A ++ E H IVK Y D + L ++ EY+ GD+ L D +
Sbjct: 59 -AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 117
Query: 185 ENVARFYIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDF 230
+ A+ L + + +++HRD+ N L+ N +K+ DF
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 231 GL 232
G+
Sbjct: 178 GM 179
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 86 DDFELLTIIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
++F+ +IG G FG+V L + G A+K+ +G E E L+
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVL----RDGAKVALKRRTPES--SQGIEE-FETEIETLSF 91
Query: 143 VASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTEN---VARFYIA-QSVL 197
+V L + + E + LI +Y+ G++ L D T + R I +
Sbjct: 92 CRHPHLVSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ +H IHRD+K N+LLD+N K++DFG+ K
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 47/205 (22%), Positives = 79/205 (38%), Gaps = 39/205 (19%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGN 112
P+ ++ K LE + EF R + L +G G FG+V + ++G
Sbjct: 2 PLSLSVDAFKILEDPKWEFPR--------KNLVLGKTLGEGEFGKVVKATAFHLKGRAGY 53
Query: 113 IY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171
A+K LK++ ++ + +E N+L +V ++KLY + L LI+EY G
Sbjct: 54 TTVAVKMLKENASPS--ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 172 DMMTLLM--REDTLTENVARFYIAQSVLAIESIHK----------------------HNY 207
+ L R+ + S L
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGL 232
+HRD+ N+L+ + MK+SDFGL
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGL 196
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 51/170 (30%), Positives = 73/170 (42%), Gaps = 32/170 (18%)
Query: 86 DDFELLTIIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
D+F I+GRG FG+V RL G + A+K+LK +R Q E E
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRL----ADGTLVAVKRLK----EERTQ----GGELQFQTE 77
Query: 143 V-----ASH-CIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV---ARFYI 192
V A H +++L + TE L L+ Y+ G + + L + R I
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 193 AQSV---LAI--ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
A LA + IHRD+K N+LLD+ + DFGL K +D
Sbjct: 137 ALGSARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 33/168 (19%), Positives = 54/168 (32%), Gaps = 23/168 (13%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLL 140
+ +G FG+V A+K LK E R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEAMLR 66
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL--MREDTLTENVARFYIAQSVLA 198
A + +V L + L +I Y GD+ L + + +S L
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 199 IESIHK--------------HNYIHRDIKPDNLLLDKNGHMKLSDFGL 232
H+ +H+D+ N+L+ ++K+SD GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 39/205 (19%)
Query: 57 PMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGN 112
PM +++ L+ + + E+ R+ I E + IG GAFG V R
Sbjct: 26 PMYQRMPLLLNPKLLSLEY---PRNNI-----EYVRDIGEGAFGRVFQARAPGLLPYEPF 77
Query: 113 IY-AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGG 171
A+K LK+ + E L+AE + IVKL + + L+ EY+ G
Sbjct: 78 TMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYG 135
Query: 172 DMMTLLM--REDTLTENVARFYIAQSVLAIESIHK----------------------HNY 207
D+ L T+ ++ ++ +
Sbjct: 136 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 195
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGL 232
+HRD+ N L+ +N +K++DFGL
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGL 220
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 34/162 (20%), Positives = 66/162 (40%), Gaps = 17/162 (10%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L+ +G GAFGEV + + A+K L + + E ++
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV-LAI 199
++ IV+ + +++ME + GGD+ + L + + + +A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 200 ------ESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGL 232
+ + ++++IHRDI N LL G K+ DFG+
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 33/162 (20%), Positives = 62/162 (38%), Gaps = 17/162 (10%)
Query: 86 DDFELLTIIGRGAFGEVRLCR----EKKSGNIY-AMKKLKKSEMVKRGQVEHVRAERNLL 140
+ L+ +G GAFGEV + + A+K L + + E ++
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
++ IV+ + ++++E + GGD+ + L + + +
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 201 SIHK-------HNYIHRDIKPDNLLLDKNGH---MKLSDFGL 232
I +++IHRDI N LL G K+ DFG+
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 50/239 (20%), Positives = 91/239 (38%), Gaps = 40/239 (16%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVEHVRAERNL-LAEVAS 145
F ++ +G G FG V LC+ + YA+K ++ + + ++E + + ++ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-ADILKKIQNDDINN 95
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIH 203
+ IVK + F +++ LI E L G + ++ R + + Y + + A+ +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID- 262
K + H D+KP+N+LLD K + I ID
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI--------KLIDF 206
Query: 263 --GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318
F +D S + T Y APEV+L G+ + D W
Sbjct: 207 GCATF-KSDYHGSI---------------------INTRQYRAPEVILNLGWDVSSDMW 243
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 45/252 (17%), Positives = 92/252 (36%), Gaps = 74/252 (29%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVE-----HVR-AERNLL 140
+ L+ +G G F V L ++ + AMK ++ + + E V A+
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 141 AEVASHCIVKLYYSFQ----DTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQ 194
+ ++ I+KL F + ++ ++ E L G +++ L+ + + + + Q
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 195 SVLAIESIHKH-NYIHRDIKPDNLLLD------KNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+L ++ +H+ IH DIKP+N+L++ +K++D G A
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN----------ACWYD 189
Query: 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307
+ +++ T +Y +PEVL
Sbjct: 190 EHY------------------------------------------TNSIQTREYRSPEVL 207
Query: 308 LKKGYGMECD-W 318
L +G D W
Sbjct: 208 LGAPWGCGADIW 219
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 15/155 (9%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK-KSEMVKRGQVE-HVRAERNLLAEVAS 145
+E+ ++IG+G+FG+V ++ A+K +K K + + Q+E + N
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQSVLAIE 200
+ IV L F +L L+ E L L L+R ++ N+ R + Q A+
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS----YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 201 SIH--KHNYIHRDIKPDNLLL--DKNGHMKLSDFG 231
+ + + IH D+KP+N+LL K +K+ DFG
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 37/191 (19%), Positives = 68/191 (35%), Gaps = 22/191 (11%)
Query: 56 VPMEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR-----EKKS 110
+P++E + + + EF R D +L +GRGAFG+V + +
Sbjct: 1 LPLDEHCERL-PYDASKWEFPR--------DRLKLGKPLGRGAFGQVIEADAFGIDKTAT 51
Query: 111 GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLY-YSFQDTEYLYLIMEYL 168
A+K LK+ + + +E +L + H +V L + L +I+E+
Sbjct: 52 CRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 109
Query: 169 PGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228
G++ T L + Y + + I D+K + + S
Sbjct: 110 KFGNLSTYLRSKRNEFVP----YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165
Query: 229 DFGLCKPLDCS 239
F K L
Sbjct: 166 GFVEEKSLSDV 176
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 45/247 (18%), Positives = 86/247 (34%), Gaps = 60/247 (24%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIY-AMKKLK-KSEMVKRGQVEHVRAERNLLAEVA- 144
+E++ +G G FG+V C + G A+K ++ + + ++E N+L ++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-----INVLKKIKE 75
Query: 145 -----SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQ 194
V + F ++ + E L ++E+ R Q
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLG----KNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDEN 254
A+ +H++ H D+KP+N+L + L + +I + D
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI---RVAD--- 185
Query: 255 MAEPMDIDG--CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312
G F D ++ ++ V T Y PEV+L+ G+
Sbjct: 186 -------FGSATF-DHEHHTTI---------------------VATRHYRPPEVILELGW 216
Query: 313 GMECD-W 318
CD W
Sbjct: 217 AQPCDVW 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 32/177 (18%), Positives = 74/177 (41%), Gaps = 25/177 (14%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGN-IYAMKKLK-KSEMVKRGQVEHVRAERNLLAEVA- 144
+E++ +G GAFG+V C + K+G A+K +K + + E +L +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNT 70
Query: 145 -----SHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTL--LMREDT---LTENVARFYIAQ 194
+ V++ F+ ++ ++ E L ++ ++E+ + R Q
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELLG----LSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTID 251
++ +H + H D+KP+N+L ++ + + + + + I K +D
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI---KVVD 180
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 7e-09
Identities = 34/200 (17%), Positives = 60/200 (30%), Gaps = 48/200 (24%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKL-----KKSEMVKRGQVEHVRAERNLL 140
+ + IG G FGEV A+K + + E + E +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 141 AEVA-----------------SHCIVKLYY----------------------SFQDTEYL 161
E++ S V+ Y F + L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLD 220
++++E+ GG + MR + A+ + Q ++ + HRD+ N+LL
Sbjct: 138 FIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 221 KNGHMKLSDFGLCKPLDCST 240
K KL K +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPS 216
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 31/147 (21%), Positives = 57/147 (38%), Gaps = 17/147 (11%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKK-LKKS----EMVKRGQVEHVRAERNLLAEVASHC 147
+IG+GA E + R+ +K+ +KK + + + E LA V
Sbjct: 343 LIGKGA--EADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFG 400
Query: 148 IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNY 207
I Y D + ++M Y+ G ++ + + + +HK++
Sbjct: 401 IPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGE--------IVGKLHKNDV 452
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCK 234
IH D+ N + D + + DFGL K
Sbjct: 453 IHNDLTTSNFIFD--KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 333 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.66 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.57 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.46 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.48 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.6 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.25 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.81 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.78 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.72 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.87 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=389.66 Aligned_cols=201 Identities=34% Similarity=0.616 Sum_probs=184.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+++.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34689999999999999999999999999999999988766666667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~-- 187 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-- 187 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT--
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC--
Confidence 999999999999999888999999999999999999999999999999999999999999999999999997753321
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.....+.+||+.|||||++.+.+|+.++| ||+||
T Consensus 188 ---------------------------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGv 222 (311)
T 4aw0_A 188 ---------------------------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 222 (311)
T ss_dssp ---------------------------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHH
T ss_pred ---------------------------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHH
Confidence 11233678999999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 223 ilyeml~G~ 231 (311)
T 4aw0_A 223 IIYQLVAGL 231 (311)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHhCC
Confidence 999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=383.12 Aligned_cols=197 Identities=30% Similarity=0.581 Sum_probs=171.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999765432 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 165 MEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
||||+||+|.+++... ..+++..++.++.|++.||.|||++|||||||||+||||+.++.+||+|||+|+.+....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-- 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--
Confidence 9999999999999654 357999999999999999999999999999999999999999999999999999764321
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
....+.+||+.|||||++.+.+|+.++| ||+|
T Consensus 180 -----------------------------------------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlG 212 (350)
T 4b9d_A 180 -----------------------------------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALG 212 (350)
T ss_dssp -----------------------------------------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred -----------------------------------------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHH
Confidence 1122568999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+|+.
T Consensus 213 vilyemltG~ 222 (350)
T 4b9d_A 213 CVLYELCTLK 222 (350)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHHCC
Confidence 9999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=368.12 Aligned_cols=196 Identities=30% Similarity=0.587 Sum_probs=162.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||+||+|.+..+|+.||||++.............+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999876555555566788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||| +|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---- 166 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence 9999 78999999998999999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D-ws~g~ 322 (333)
...+.+||+.|||||++.+.+| +.++| ||+||
T Consensus 167 ----------------------------------------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGv 200 (275)
T 3hyh_A 167 ----------------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 200 (275)
T ss_dssp ------------------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHH
T ss_pred ----------------------------------------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHH
Confidence 1125689999999999999887 57999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+|+.
T Consensus 201 ily~lltg~ 209 (275)
T 3hyh_A 201 ILYVMLCRR 209 (275)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHHCC
Confidence 999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=377.29 Aligned_cols=194 Identities=28% Similarity=0.488 Sum_probs=175.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
...|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999999976532 2234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||||+||+|.+++.. ..+++..++.++.|++.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--- 225 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--- 225 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC---
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC---
Confidence 999999999999865 5699999999999999999999999999999999999999999999999999997653321
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
...+.+||+.|||||++.+.+|+.++| ||+||+
T Consensus 226 ----------------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvi 259 (346)
T 4fih_A 226 ----------------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM 259 (346)
T ss_dssp ----------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred ----------------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHH
Confidence 122568999999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 260 lyeml~G~ 267 (346)
T 4fih_A 260 VIEMVDGE 267 (346)
T ss_dssp HHHHHHSS
T ss_pred HHHHHHCC
Confidence 99999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=372.92 Aligned_cols=196 Identities=29% Similarity=0.413 Sum_probs=171.2
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..+.|++.+.||+|+||+||+|++..+|+.||||+++.... ..+|+.+++.++|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34678999999999999999999999999999999976432 2359999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-cEEEEeccCcccCCCCccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~~~~~~~ 242 (333)
|||||+||+|.+++...+.+++..++.++.|++.||.|||++|||||||||+||||+.+| .+||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999888999999999999999999999999999999999999999988 6999999999977543211
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
. ......+.+||+.|||||++.+.+|+.++| ||+|
T Consensus 208 ~--------------------------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlG 243 (336)
T 4g3f_A 208 K--------------------------------------------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243 (336)
T ss_dssp --------------------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHH
T ss_pred c--------------------------------------------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHH
Confidence 0 001122468999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+|+.
T Consensus 244 vilyemltG~ 253 (336)
T 4g3f_A 244 CMMLHMLNGC 253 (336)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHHCc
Confidence 9999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=378.22 Aligned_cols=195 Identities=28% Similarity=0.480 Sum_probs=175.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..+.|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 34679999999999999999999999999999999976532 223457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||||+||+|.+++.. ..+++..++.++.|++.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence 9999999999999865 4699999999999999999999999999999999999999999999999999987653321
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
...+.+||+.|||||++.+.+|+.++| ||+||
T Consensus 303 -----------------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGv 335 (423)
T 4fie_A 303 -----------------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 335 (423)
T ss_dssp -----------------------------------------------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHH
T ss_pred -----------------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHH
Confidence 122568999999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 336 ilyeml~G~ 344 (423)
T 4fie_A 336 MVIEMVDGE 344 (423)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHHCC
Confidence 999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=373.09 Aligned_cols=199 Identities=42% Similarity=0.696 Sum_probs=169.5
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
+..++|++++.||+|+||+||+|++. .+++.||||+++....... ....+.+|+.+|+.++|||||++++++.+++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34578999999999999999999874 4678999999976533221 2234677999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+|+|||||+||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999865322
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
. ....+.+||+.|||||++.+.+|+.++| |
T Consensus 180 ~-------------------------------------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~Diw 210 (304)
T 3ubd_A 180 E-------------------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210 (304)
T ss_dssp --------------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHH
T ss_pred C-------------------------------------------------ccccccccCcccCCHHHhccCCCCCCCccc
Confidence 1 1122568999999999999999999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++|+|+|+.
T Consensus 211 SlGvilyemltG~ 223 (304)
T 3ubd_A 211 SFGVLMFEMLTGT 223 (304)
T ss_dssp HHHHHHHHHHHSS
T ss_pred chHHHHHHHHhCC
Confidence 9999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=358.39 Aligned_cols=193 Identities=24% Similarity=0.424 Sum_probs=170.0
Q ss_pred CCc-eEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee----CCe
Q 019953 86 DDF-ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----TEY 160 (333)
Q Consensus 86 ~~y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 160 (333)
++| ++.+.||+|+||+||+|.+..++..||+|++...... ......+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 455 7888999999999999999999999999999765432 3345678899999999999999999999865 356
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEcc-CCcEEEEeccCcccCC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDK-NGHMKLSDFGLCKPLD 237 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~~-~~~vkl~DFGla~~~~ 237 (333)
+|+|||||+||+|.+++.....+++..++.++.|++.||.|||++| ||||||||+||||+. ++.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 8999999999999999998889999999999999999999999998 999999999999984 7999999999997543
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.. ...+.+|||.|||||++.+ +|+.++|
T Consensus 184 ~~---------------------------------------------------~~~~~~GTp~YmAPE~~~~-~y~~~~D 211 (290)
T 3fpq_A 184 AS---------------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVD 211 (290)
T ss_dssp TT---------------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHH
T ss_pred CC---------------------------------------------------ccCCcccCccccCHHHcCC-CCCcHHH
Confidence 21 1225689999999999875 6999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+|+.
T Consensus 212 iwSlGvilyelltg~ 226 (290)
T 3fpq_A 212 VYAFGMCMLEMATSE 226 (290)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHHCC
Confidence 99999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=364.09 Aligned_cols=205 Identities=25% Similarity=0.411 Sum_probs=160.1
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC------
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE------ 159 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 159 (333)
++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 36999999999999999999999999999999997543 2233456889999999999999999999986543
Q ss_pred ------eEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEec
Q 019953 160 ------YLYLIMEYLPGGDMMTLLMREDT---LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (333)
Q Consensus 160 ------~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DF 230 (333)
++|+|||||++|+|.+++..... .....+..++.|++.||.|||++|||||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999987654 455668899999999999999999999999999999999999999999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 310 (333)
|+|+.+........... .........+.+||+.|||||++.+.
T Consensus 163 Gla~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~GT~~YmAPE~~~~~ 205 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLT-------------------------------------PMPAYARHTGQVGTKLYMSPEQIHGN 205 (299)
T ss_dssp CCC---------------------------------------------------------------CCCTTSCHHHHTTC
T ss_pred ccceecCCCcccccccc-------------------------------------ccccccccCCcccCccccCHHHHcCC
Confidence 99998764432110000 00001122356899999999999999
Q ss_pred CCCcccc-hHHHHHHHhhhc
Q 019953 311 GYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t 329 (333)
+|+.++| ||+||++|+|++
T Consensus 206 ~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 206 SYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCCTHHHHHHHHHHHHHHHS
T ss_pred CCCCHHHHHHHHHHHHHHcc
Confidence 9999999 999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=359.78 Aligned_cols=198 Identities=24% Similarity=0.424 Sum_probs=170.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
.+..++|.+.+.||+|+||+||+|.+. .++..||||+++... ....+.+.+|+.+|++++|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 455678999999999999999999874 357889999997543 234566889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRE-------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
+.+.+|+|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999753 3699999999999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|||+|+........ ......+||+.|||
T Consensus 166 ~~Ki~DFGla~~~~~~~~~-----------------------------------------------~~~~~~~gt~~ymA 198 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYY-----------------------------------------------RVGGHTMLPIRWMP 198 (299)
T ss_dssp CEEECCCSCHHHHTGGGCE-----------------------------------------------EETTTEEECGGGCC
T ss_pred cEEECCcccceecCCCCce-----------------------------------------------eecCceecChhhcC
Confidence 9999999999876433211 11123469999999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
||++.+..|+.++| ||+||++|+|+|
T Consensus 199 PE~~~~~~~~~k~DVwS~Gvvl~Ellt 225 (299)
T 4asz_A 199 PESIMYRKFTTESDVWSLGVVLWEIFT 225 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHc
Confidence 99999999999999 999999999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=357.69 Aligned_cols=199 Identities=23% Similarity=0.402 Sum_probs=166.4
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
..+..++|.+.+.||+|+||+||+|.+. .++..||||+++... ....+.+.+|+.+|+.++|||||++++++
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4566678999999999999999999864 368899999997543 23456788999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc
Q 019953 156 QDTEYLYLIMEYLPGGDMMTLLMRE---------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 220 (333)
Q Consensus 156 ~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~ 220 (333)
.+.+.+|||||||++|+|.+++... .++++..+..++.|++.||.|||+++||||||||+|||++
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999999653 3589999999999999999999999999999999999999
Q ss_pred cCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCC
Q 019953 221 KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPD 300 (333)
Q Consensus 221 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 300 (333)
.++.+||+|||+|+.+...... ......+||+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~-----------------------------------------------~~~~~~~gt~~ 225 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY-----------------------------------------------RVGGRTMLPIR 225 (329)
T ss_dssp TTTEEEECCCC---------------------------------------------------------------CCCCGG
T ss_pred CCCcEEEcccccceeccCCCcc-----------------------------------------------eecCccccccc
Confidence 9999999999999876433211 11124579999
Q ss_pred CcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 301 YIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 301 y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
|||||++.+..|+.++| ||+||++|+|+|
T Consensus 226 ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt 255 (329)
T 4aoj_A 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255 (329)
T ss_dssp GCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccChhhhcCCCCCccccccchHHHHHHHHc
Confidence 99999999999999999 999999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=382.21 Aligned_cols=199 Identities=34% Similarity=0.594 Sum_probs=176.7
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHH---HHHHHHhcCCceeEEEEEEeeC
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAE---RNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
.+..++|++++.||+|+||+||+|++..+|+.||||++.+..............| +.+++.++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 5667899999999999999999999999999999999987665444444444455 4455566899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
+.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-CCCCCcccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~~D 317 (333)
.. ..+.+||+.|||||++. +.+|+.++|
T Consensus 345 ~~---------------------------------------------------~~t~~GTp~YmAPEvl~~~~~y~~~vD 373 (689)
T 3v5w_A 345 KK---------------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSAD 373 (689)
T ss_dssp CC---------------------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHH
T ss_pred CC---------------------------------------------------CCCccCCcCccCHHHHhCCCCCCcHHH
Confidence 21 12568999999999997 468999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 374 iWSLGvilYEmLtG~ 388 (689)
T 3v5w_A 374 WFSLGCMLFKLLRGH 388 (689)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=354.34 Aligned_cols=201 Identities=21% Similarity=0.269 Sum_probs=169.0
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..|++..+++++.+.||+|+||+||+|.+. ..||||+++.... .....+.+.+|+.+|+.++|||||++++++..
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 103 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK- 103 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence 457899999999999999999999999854 3599999875432 23445678999999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+.++||||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+|||++.++.+||+|||+|+...
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 5689999999999999999764 579999999999999999999999999999999999999999999999999998754
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CCCCc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGM 314 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~ 314 (333)
..... ....+.+||+.|||||++.+ .+|+.
T Consensus 184 ~~~~~-----------------------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ 216 (307)
T 3omv_A 184 RWSGS-----------------------------------------------QQVEQPTGSVLWMAPEVIRMQDNNPFSF 216 (307)
T ss_dssp ---------------------------------------------------------CCCCTTSCCHHHHHCCSSCCCCH
T ss_pred cCCcc-----------------------------------------------eeecccccCCCccCHHHhhccCCCCCCc
Confidence 32210 11225589999999999964 46999
Q ss_pred ccc-hHHHHHHHhhhccc
Q 019953 315 ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~ 331 (333)
++| ||+||++|+|+|+.
T Consensus 217 ksDVwS~Gvvl~Elltg~ 234 (307)
T 3omv_A 217 QSDVYSYGIVLYELMTGE 234 (307)
T ss_dssp HHHHHHHHHHHHHHHHSS
T ss_pred HHHhHhHHHHHHHHHHCC
Confidence 999 99999999999974
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=354.83 Aligned_cols=200 Identities=23% Similarity=0.369 Sum_probs=171.8
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
.++..+++++++.||+|+||+||+|.+. .+++.||||+++... .....+.+.+|+.++++++|||||+++|++
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3566778999999999999999999863 467899999997542 223456789999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE
Q 019953 156 QDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 219 (333)
Q Consensus 156 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill 219 (333)
..++.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+|||+
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999642 358999999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCC
Q 019953 220 DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTP 299 (333)
Q Consensus 220 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 299 (333)
+.++.+||+|||+|+.+...... ......+||+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~-----------------------------------------------~~~~~~~gt~ 211 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY-----------------------------------------------KLLGNSLLPI 211 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB-----------------------------------------------CSSSSSCBCG
T ss_pred CCCCCEEECCcccceeccCCCce-----------------------------------------------eEecccccCC
Confidence 99999999999999876433211 1112457999
Q ss_pred CCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 300 DYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 300 ~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.|||||++.+..|+.++| ||+||++|+|+|
T Consensus 212 ~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t 242 (308)
T 4gt4_A 212 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242 (308)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccCHHHHhCCCCCccchhhhHHHHHHHHHh
Confidence 999999999999999999 999999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=359.54 Aligned_cols=201 Identities=25% Similarity=0.432 Sum_probs=171.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee------C
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------T 158 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 158 (333)
.++|++++.||+|+||+||+|.+..+|+.||||+++.... .......+.+|+.+|+.++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 4689999999999999999999999999999999975432 22344567889999999999999999998764 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
+.+|+|||||+ |+|.+++...+.+++..++.++.|++.||.|||++|||||||||+|||++.++.+||+|||+|+.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 57999999995 68999998888999999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D 317 (333)
+... ......+.+||+.|||||++.+. .|+.++|
T Consensus 211 ~~~~---------------------------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~D 245 (398)
T 4b99_A 211 SPAE---------------------------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAID 245 (398)
T ss_dssp --------------------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHH
T ss_pred Cccc---------------------------------------------cccccccceeChHhcCHHHhcCCCCCCChhh
Confidence 3211 01122366899999999999885 5699999
Q ss_pred -hHHHHHHHhhhcccc
Q 019953 318 -WLVSVLHFNSYRFLE 332 (333)
Q Consensus 318 -ws~g~il~~l~t~~~ 332 (333)
||+||++|+|+++.+
T Consensus 246 iWSlG~il~ell~G~~ 261 (398)
T 4b99_A 246 LWSVGCIFGEMLARRQ 261 (398)
T ss_dssp HHHHHHHHHHHHHTSC
T ss_pred eehhHHHHHHHHHCCC
Confidence 999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=353.62 Aligned_cols=203 Identities=25% Similarity=0.363 Sum_probs=174.4
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecC-----CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC-CceeEE
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKL 151 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~ 151 (333)
...|++..++|++++.||+|+||+||+|.+..+ ++.||||.+..... ......+.+|+.+|.++.| ||||++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 356889999999999999999999999998654 36799999975432 2334668899999999976 799999
Q ss_pred EEEEeeC-CeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCC
Q 019953 152 YYSFQDT-EYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (333)
Q Consensus 152 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 214 (333)
+++|..+ +.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~ 213 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence 9998664 5689999999999999999653 3488999999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccc
Q 019953 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (333)
Q Consensus 215 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (333)
+|||++.++.+||+|||+|+.+....... ...+
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~-----------------------------------------------~~~~ 246 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYV-----------------------------------------------RKGD 246 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSE-----------------------------------------------EETT
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCce-----------------------------------------------eecc
Confidence 99999999999999999999765432111 1124
Q ss_pred cCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 295 TVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 295 ~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.+||+.|||||++.+..|+.++| ||+||++|+|+|
T Consensus 247 ~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh
Confidence 57999999999999999999999 999999999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=347.35 Aligned_cols=220 Identities=24% Similarity=0.390 Sum_probs=168.6
Q ss_pred CCCceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCe
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 160 (333)
.++|++++.||+|+||+||+|.+. .+++.||||.+.... ....+.+|+.+|+.+ +||||++++++|.+.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 468999999999999999999875 457889999886542 234467899999998 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-CcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DFGla~~~~~~ 239 (333)
+|+|||||+||+|.+++ +.+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999998 359999999999999999999999999999999999999877 79999999999877654
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D- 317 (333)
......................+. ...+.....+.+||+.|||||++.+. .|+.++|
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di 230 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSI---------------------CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM 230 (361)
T ss_dssp SCGGGGGC-----------------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHH
T ss_pred cccccccccccccccccccccccc---------------------cccccccccccccCccccCHHHHcCCCCCCCccch
Confidence 322211100000000000000000 00112223456899999999999886 4899999
Q ss_pred hHHHHHHHhhhccc-cC
Q 019953 318 WLVSVLHFNSYRFL-EF 333 (333)
Q Consensus 318 ws~g~il~~l~t~~-~~ 333 (333)
||+||++|+|+++. ||
T Consensus 231 WSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 231 WSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp HHHHHHHHHHHHTCSSS
T ss_pred hhhHHHHHHHHHCCCCC
Confidence 99999999999975 45
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=338.80 Aligned_cols=194 Identities=25% Similarity=0.299 Sum_probs=158.4
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC----eE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----YL 161 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~ 161 (333)
.+|.+.+.||+|+||+||+|.+ +|+.||||++...... ......|+..+..++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999986 5899999999754321 112334566667889999999999997653 68
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEecccCCCcEEEccCCcEEEEeccCc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
|||||||++|+|.+++.. ..+++..+..++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999965 4688999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC---
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--- 310 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--- 310 (333)
+......... .....+.+||+.|||||++.+.
T Consensus 156 ~~~~~~~~~~---------------------------------------------~~~~~~~~GT~~ymAPE~l~~~~~~ 190 (303)
T 3hmm_A 156 VRHDSATDTI---------------------------------------------DIAPNHRVGTKRYMAPEVLDDSINM 190 (303)
T ss_dssp EEEETTTTEE---------------------------------------------SCC-----CCGGGCCHHHHTTCSCT
T ss_pred ccccCCCCce---------------------------------------------eeecccccccccccCHHHhcccccc
Confidence 8765432211 0011245799999999999764
Q ss_pred ---CCCcccc-hHHHHHHHhhhccc
Q 019953 311 ---GYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 311 ---~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.|+.++| ||+||++|+|+|+.
T Consensus 191 ~~~~~~~k~DVwS~Gvvl~El~tg~ 215 (303)
T 3hmm_A 191 KHFESFKRADIYAMGLVFWEIARRC 215 (303)
T ss_dssp TCHHHHHHHHHHHHHHHHHHHHHTB
T ss_pred cCCccChhHhhhhHHHHHHHHHHCC
Confidence 4788999 99999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=359.13 Aligned_cols=194 Identities=30% Similarity=0.525 Sum_probs=174.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||.||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999876432 2345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC--CcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN--GHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~--~~vkl~DFGla~~~~~~~~ 241 (333)
||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 999999999999864 4579999999999999999999999999999999999999854 8999999999998754321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
..+.+||+.|||||++.+.+|+.++| ||+
T Consensus 313 --------------------------------------------------~~~~~GT~~y~APEv~~~~~y~~~~DiWSl 342 (573)
T 3uto_A 313 --------------------------------------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342 (573)
T ss_dssp --------------------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred --------------------------------------------------eeeeEECccccCHHHhCCCCCCcHHHHHHH
Confidence 22568999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 343 Gvilyeml~G~ 353 (573)
T 3uto_A 343 GVLSYILLSGL 353 (573)
T ss_dssp HHHHHHHHHSC
T ss_pred HHHHHHHHHCC
Confidence 99999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=323.32 Aligned_cols=200 Identities=40% Similarity=0.694 Sum_probs=180.5
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..++|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 34578999999999999999999999999999999998765545556677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+||||++||+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999986432210
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
...+.+||+.|+|||++.+..++.++| ||+|
T Consensus 161 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 192 (337)
T 1o6l_A 161 ------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192 (337)
T ss_dssp ------------------------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHH
T ss_pred ------------------------------------------------cccccccChhhCChhhhcCCCCCchhhcccch
Confidence 112457999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 193 ~il~ell~g~ 202 (337)
T 1o6l_A 193 VVMYEMMCGR 202 (337)
T ss_dssp HHHHHHHHSS
T ss_pred hHHHHHhcCC
Confidence 9999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=326.41 Aligned_cols=201 Identities=37% Similarity=0.707 Sum_probs=176.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 160 (333)
.+..++|++++.||+|+||.||+|++..+|+.||||++.............+..|..++..+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999877655556667788899999988 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|+||||+++|+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998543221
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
. ...+.+||+.|+|||++.+..|+.++| ||
T Consensus 179 ~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 209 (353)
T 3txo_A 179 V-------------------------------------------------TTATFCGTPDYIAPEILQEMLYGPAVDWWA 209 (353)
T ss_dssp --------------------------------------------------------CCGGGCCHHHHHHHHCTTHHHHHH
T ss_pred c-------------------------------------------------cccccCCCcCeEChhhcCCCCcCCccCCCc
Confidence 1 112558999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 210 lG~il~ell~G~ 221 (353)
T 3txo_A 210 MGVLLYEMLCGH 221 (353)
T ss_dssp HHHHHHHHHHSS
T ss_pred chHHHHHHHhCC
Confidence 999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=318.89 Aligned_cols=197 Identities=41% Similarity=0.768 Sum_probs=179.9
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|..+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34578999999999999999999999999999999998765555556677888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-- 160 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCcc--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999998654211
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
.+.+||+.|+|||++.+.+++.++| ||+|
T Consensus 161 --------------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 190 (318)
T 1fot_A 161 --------------------------------------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFG 190 (318)
T ss_dssp --------------------------------------------------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHH
T ss_pred --------------------------------------------------ccccCCccccCHhHhcCCCCCcccchhhhH
Confidence 1457999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 191 ~il~ell~g~ 200 (318)
T 1fot_A 191 ILIYEMLAGY 200 (318)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHhCC
Confidence 9999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.74 Aligned_cols=201 Identities=36% Similarity=0.644 Sum_probs=178.8
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 160 (333)
.+..++|++.+.||+|+||.||+|++..+|+.||||++.............+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999999876554455566778899999887 99999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998643221
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
. ...+.+||+.|+|||++.+..++.++| ||
T Consensus 173 ~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 203 (345)
T 1xjd_A 173 A-------------------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWS 203 (345)
T ss_dssp C-------------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred C-------------------------------------------------cccCCCCCcccCChhhhcCCCCCChhhhHH
Confidence 0 112568999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 204 lG~il~ell~g~ 215 (345)
T 1xjd_A 204 FGVLLYEMLIGQ 215 (345)
T ss_dssp HHHHHHHHHHSS
T ss_pred HHHHHHHHhcCC
Confidence 999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=328.01 Aligned_cols=201 Identities=38% Similarity=0.678 Sum_probs=177.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 160 (333)
.+..++|++++.||+|+||.||+|++..+++.||||++.+...........+..|..++..+ +||||+++++++.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45567899999999999999999999999999999999876544444455677899999887 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|+||||+++|+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998532211
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
....+.+||+.|+|||++.+..|+.++| ||
T Consensus 208 -------------------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diws 238 (396)
T 4dc2_A 208 -------------------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 238 (396)
T ss_dssp -------------------------------------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred -------------------------------------------------CccccccCCcccCCchhhcCCCCChHHHHHH
Confidence 1122568999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 239 lGvllyell~G~ 250 (396)
T 4dc2_A 239 LGVLMFEMMAGR 250 (396)
T ss_dssp HHHHHHHHHHSS
T ss_pred HHHHHHHHHhCC
Confidence 999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.85 Aligned_cols=202 Identities=33% Similarity=0.652 Sum_probs=182.7
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
...+..++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34566789999999999999999999999999999999998776556666778889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+|+||||+.||+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CCCCccc
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMEC 316 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~ 316 (333)
. ...+.+||+.|+|||++.+ .+|+.++
T Consensus 169 ~--------------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 198 (384)
T 4fr4_A 169 T--------------------------------------------------QITTMAGTKPYMAPEMFSSRKGAGYSFAV 198 (384)
T ss_dssp C--------------------------------------------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTH
T ss_pred C--------------------------------------------------ceeccCCCccccCCeeeccCCCCCCCccc
Confidence 2 1125579999999999974 5699999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| ||+||++|+|+++.
T Consensus 199 DiwSlG~il~elltG~ 214 (384)
T 4fr4_A 199 DWWSLGVTAYELLRGR 214 (384)
T ss_dssp HHHHHHHHHHHHHHSS
T ss_pred eeechHHHHHHHHhCC
Confidence 9 99999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=328.33 Aligned_cols=207 Identities=46% Similarity=0.868 Sum_probs=182.2
Q ss_pred hhhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 76 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
..+....+..++|++++.||+|+||.||+|.+..+++.||+|++.............+..|+.+++.++||||+++++++
T Consensus 59 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 138 (410)
T 3v8s_A 59 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 138 (410)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34456677889999999999999999999999999999999999876554444455677899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 156 QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 156 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
.+...+|+|||||+||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 139 ~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 139 QDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 999999999999999999999865 4699999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC----
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG---- 311 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---- 311 (333)
+..... ....+.+||+.|+|||++.+.+
T Consensus 218 ~~~~~~------------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~ 249 (410)
T 3v8s_A 218 MNKEGM------------------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGY 249 (410)
T ss_dssp CCTTSE------------------------------------------------EECCSCCSCGGGCCHHHHHTTTTTCE
T ss_pred eccCCc------------------------------------------------ccccCCcCCccccCHHHhhccCCCcC
Confidence 653321 1122568999999999998766
Q ss_pred CCcccc-hHHHHHHHhhhccc
Q 019953 312 YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~~ 331 (333)
|+.++| ||+||++|+|+++.
T Consensus 250 ~~~~~DiwSlGvilyell~G~ 270 (410)
T 3v8s_A 250 YGRECDWWSVGVFLYEMLVGD 270 (410)
T ss_dssp EETHHHHHHHHHHHHHHHHSS
T ss_pred CCCcceEecchHHHHHHHhCC
Confidence 889999 99999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.27 Aligned_cols=207 Identities=47% Similarity=0.839 Sum_probs=182.5
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
......+..++|++++.||+|+||+||+|.+..+++.||+|++.............+..|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556677899999999999999999999999999999999998765544444455788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
+.+.+|+|||||++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999999987 56899999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----CC
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KK 310 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~ 310 (333)
....... .....+||+.|+|||++. +.
T Consensus 225 ~~~~~~~------------------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~ 256 (437)
T 4aw2_A 225 LMEDGTV------------------------------------------------QSSVAVGTPDYISPEILQAMEGGKG 256 (437)
T ss_dssp CCTTSCE------------------------------------------------ECCSCCSCGGGCCHHHHHHHHTSCC
T ss_pred cccCCCc------------------------------------------------ccccccCCcCeeChHHHhhcccCCC
Confidence 6433211 112457999999999997 56
Q ss_pred CCCcccc-hHHHHHHHhhhccc
Q 019953 311 GYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.|+.++| ||+||++|+|+++.
T Consensus 257 ~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 257 RYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp EECTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCcCeeHHHHHHHHHHHhCC
Confidence 7999999 99999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=319.28 Aligned_cols=200 Identities=39% Similarity=0.674 Sum_probs=179.1
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 161 (333)
+..++|++++.||+|+||.||+|++..+++.||||++.............+..|..++..+ +||||+++++++.+.+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4467899999999999999999999999999999999876544445566788899999988 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
...+.+||+.|+|||++.+..++.++| ||+
T Consensus 166 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 196 (345)
T 3a8x_A 166 -------------------------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196 (345)
T ss_dssp -------------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred -------------------------------------------------cccccCCCccccCccccCCCCCChHHhHHHH
Confidence 112458999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 197 G~il~ell~g~ 207 (345)
T 3a8x_A 197 GVLMFEMMAGR 207 (345)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=319.31 Aligned_cols=198 Identities=41% Similarity=0.732 Sum_probs=181.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
....++|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999877655555667788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~- 195 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.+.+||+.|+|||++.+..++.++| |++
T Consensus 196 ---------------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 224 (350)
T 1rdq_E 196 ---------------------------------------------------WTLCGTPEALAPEIILSKGYNKAVDWWAL 224 (350)
T ss_dssp ---------------------------------------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred ---------------------------------------------------ccccCCccccCHHHhcCCCCCCcCCEecc
Confidence 1457999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 225 G~il~ell~g~ 235 (350)
T 1rdq_E 225 GVLIYEMAAGY 235 (350)
T ss_dssp HHHHHHHHHSS
T ss_pred cHhHhHHhhCC
Confidence 99999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=326.13 Aligned_cols=208 Identities=46% Similarity=0.879 Sum_probs=183.1
Q ss_pred hhhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 76 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
..++...+..++|++++.||+|+||.||+|++..+|+.||||++.+...........+..|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 44566677889999999999999999999999999999999999876544444555678899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 156 QDTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 156 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
.+.+.+|+||||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999999999764 479999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc------
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------ 308 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~------ 308 (333)
.+...... .....+||+.|+|||++.
T Consensus 211 ~~~~~~~~------------------------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~ 242 (412)
T 2vd5_A 211 KLRADGTV------------------------------------------------RSLVAVGTPDYLSPEILQAVGGGP 242 (412)
T ss_dssp ECCTTSCE------------------------------------------------ECSSCCSCGGGCCHHHHHHHHTCT
T ss_pred eccCCCcc------------------------------------------------ccceeccccCcCCHHHHhhcccCc
Confidence 76533210 112458999999999997
Q ss_pred -CCCCCcccc-hHHHHHHHhhhccc
Q 019953 309 -KKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 309 -~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+..|+.++| ||+||++|+|+++.
T Consensus 243 ~~~~~~~~~DiwSlGvilyelltG~ 267 (412)
T 2vd5_A 243 GTGSYGPECDWWALGVFAYEMFYGQ 267 (412)
T ss_dssp TCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCCChHHhhhHHhHHHHHHHhCC
Confidence 467999999 99999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=319.98 Aligned_cols=201 Identities=34% Similarity=0.624 Sum_probs=179.0
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 160 (333)
.+..++|++++.||+|+||.||+|.+..+++.||||++.............+..|..++..+ .||+|+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 35578999999999999999999999999999999999877655555667788899999887 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999998643221
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
. ...+.+||+.|+|||++.+.+++.++| |+
T Consensus 176 ~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 206 (353)
T 2i0e_A 176 V-------------------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 206 (353)
T ss_dssp C-------------------------------------------------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHH
T ss_pred c-------------------------------------------------ccccccCCccccChhhhcCCCcCCcccccc
Confidence 0 112568999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 207 lG~il~ell~G~ 218 (353)
T 2i0e_A 207 FGVLLYEMLAGQ 218 (353)
T ss_dssp HHHHHHHHHHSS
T ss_pred hHHHHHHHHcCC
Confidence 999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=315.15 Aligned_cols=199 Identities=30% Similarity=0.532 Sum_probs=177.8
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
....++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 4456899999999999999999999999999999999976532 233456678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999986543321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC-cccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG-MECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~~D-ws 319 (333)
....+||+.|+|||++.+..++ .++| ||
T Consensus 170 --------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 199 (328)
T 3fe3_A 170 --------------------------------------------------LDAFCGAPPYAAPELFQGKKYDGPEVDVWS 199 (328)
T ss_dssp --------------------------------------------------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHH
T ss_pred --------------------------------------------------cccccCCcceeCcccccCCCcCCchhhhhh
Confidence 1145799999999999988875 7999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 200 lG~il~ell~g~ 211 (328)
T 3fe3_A 200 LGVILYTLVSGS 211 (328)
T ss_dssp HHHHHHHHHHSS
T ss_pred hHHHHHHHHhCC
Confidence 999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=307.95 Aligned_cols=202 Identities=23% Similarity=0.366 Sum_probs=175.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.+..++|++++.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 45568999999999999999999999999999999998654433444556788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++||||+++++|.+++....++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
. .....+||+.|+|||++.+..++.++| |++
T Consensus 167 ~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 198 (294)
T 4eqm_A 167 T------------------------------------------------QTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198 (294)
T ss_dssp --------------------------------------------------------CCSSCCHHHHHTCCCCTTHHHHHH
T ss_pred c------------------------------------------------ccCccccCccccCHhHhcCCCCCchHhHHHH
Confidence 0 111346999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 199 G~~l~~ll~g~ 209 (294)
T 4eqm_A 199 GIVLYEMLVGE 209 (294)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=320.50 Aligned_cols=201 Identities=38% Similarity=0.684 Sum_probs=169.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHH-HHHhcCCceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~ 160 (333)
.+..++|++++.||+|+||.||+|++..+++.||||++.............+..|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4556889999999999999999999999999999999987654333444556667766 567899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998532211
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
....+.+||+.|+|||++.+..|+.++| |+
T Consensus 194 -------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 224 (373)
T 2r5t_A 194 -------------------------------------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224 (373)
T ss_dssp -------------------------------------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHH
T ss_pred -------------------------------------------------CccccccCCccccCHHHhCCCCCCchhhhHH
Confidence 0122568999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 225 lG~il~ell~G~ 236 (373)
T 2r5t_A 225 LGAVLYEMLYGL 236 (373)
T ss_dssp HHHHHHHHHHSS
T ss_pred HHHHHHHHHcCC
Confidence 999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.26 Aligned_cols=202 Identities=31% Similarity=0.592 Sum_probs=181.6
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
...+..++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.+.+
T Consensus 178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 44567789999999999999999999999999999999998766555555667888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999999997654 49999999999999999999999999999999999999999999999999998764
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... ..+.+||+.|+|||++.+..|+.++|
T Consensus 338 ~~~~--------------------------------------------------~~~~~GT~~Y~APEvl~~~~~~~~~D 367 (576)
T 2acx_A 338 EGQT--------------------------------------------------IKGRVGTVGYMAPEVVKNERYTFSPD 367 (576)
T ss_dssp TTCC--------------------------------------------------EECCCSCGGGCCHHHHTTCEESSHHH
T ss_pred cCcc--------------------------------------------------ccccCCCccccCHHHHcCCCCCccch
Confidence 3221 11457999999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 368 iwSLGvilyeLltG~ 382 (576)
T 2acx_A 368 WWALGCLLYEMIAGQ 382 (576)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.22 Aligned_cols=198 Identities=30% Similarity=0.530 Sum_probs=177.0
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
...++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++...+.++
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999998765444444566888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+||||+ +|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~- 163 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF- 163 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT-
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc-
Confidence 999999 789999998888899999999999999999999999999999999999999999999999999986543221
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-hHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-WLV 320 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D-ws~ 320 (333)
..+.+||+.|+|||++.+..+ +.++| ||+
T Consensus 164 -------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (336)
T 3h4j_B 164 -------------------------------------------------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194 (336)
T ss_dssp -------------------------------------------------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred -------------------------------------------------cccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence 114579999999999998886 78999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 195 G~il~~ll~g~ 205 (336)
T 3h4j_B 195 GIVLYVMLVGR 205 (336)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=314.06 Aligned_cols=198 Identities=29% Similarity=0.512 Sum_probs=176.2
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh---hhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
..++|++++.||+|+||.||+|.+..+|+.||+|++........ .....+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 45689999999999999999999999999999999976532211 134568889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC----cEEEEeccCcccC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPL 236 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~----~vkl~DFGla~~~ 236 (333)
+++||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999998888899999999999999999999999999999999999998877 7999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
..... ....+||+.|+|||++.+.+++.++
T Consensus 170 ~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 199 (361)
T 2yab_A 170 EDGVE--------------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEA 199 (361)
T ss_dssp CTTCC--------------------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred CCCCc--------------------------------------------------cccCCCCccEECchHHcCCCCCccc
Confidence 53221 1145799999999999999999999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| |++||++|+|+++.
T Consensus 200 DiwslGvil~~ll~g~ 215 (361)
T 2yab_A 200 DMWSIGVITYILLSGA 215 (361)
T ss_dssp HHHHHHHHHHHHHHSC
T ss_pred cHHHHHHHHHHHHhCC
Confidence 9 99999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=302.69 Aligned_cols=196 Identities=28% Similarity=0.474 Sum_probs=174.7
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence 345789999999999999999999999999999999875432 23456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 999999999999999664 699999999999999999999999999999999999999999999999999987653321
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
.....+||+.|+|||++.+..++.++| |++|
T Consensus 172 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 203 (297)
T 3fxz_A 172 ------------------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203 (297)
T ss_dssp ------------------------------------------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHH
T ss_pred ------------------------------------------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHH
Confidence 111457999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 204 ~il~ell~g~ 213 (297)
T 3fxz_A 204 IMAIEMIEGE 213 (297)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHhCC
Confidence 9999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=325.58 Aligned_cols=202 Identities=36% Similarity=0.592 Sum_probs=181.3
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
..+..++|.+.+.||+|+||.||+|++..+|+.||||++.............+..|+.+++.++||||+++++++.....
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 45667899999999999999999999999999999999987765555556778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 161 LYLIMEYLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999998763 36999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
..... ...+.+||+.|+|||++.+.+|+.++
T Consensus 340 ~~~~~-------------------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~ 370 (543)
T 3c4z_A 340 KAGQT-------------------------------------------------KTKGYAGTPGFMAPELLLGEEYDFSV 370 (543)
T ss_dssp CTTCC-------------------------------------------------CBCCCCSCTTTSCHHHHTTCCBCTHH
T ss_pred cCCCc-------------------------------------------------ccccccCCccccChhhhcCCCCChHH
Confidence 43221 11145799999999999999999999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| ||+||++|+|+++.
T Consensus 371 DiwSlGvilyelltG~ 386 (543)
T 3c4z_A 371 DYFALGVTLYEMIAAR 386 (543)
T ss_dssp HHHHHHHHHHHHHHSS
T ss_pred hcCcchHHHHHHHhCC
Confidence 9 99999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=309.94 Aligned_cols=196 Identities=29% Similarity=0.518 Sum_probs=174.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4579999999999999999999999999999999976532 223446688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~~~~~~ 241 (333)
|||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999999999998888899999999999999999999999999999999999998654 599999999987643221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
....+||+.|+|||++.+..++.++| ||+
T Consensus 187 --------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 216 (362)
T 2bdw_A 187 --------------------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216 (362)
T ss_dssp --------------------------------------------------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred --------------------------------------------------cccCCCCccccCHHHHccCCCCchhhHHHH
Confidence 11457999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 217 G~il~~ll~g~ 227 (362)
T 2bdw_A 217 GVILYILLVGY 227 (362)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHHCC
Confidence 99999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.64 Aligned_cols=203 Identities=39% Similarity=0.694 Sum_probs=170.2
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
...+..++|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 34566788999999999999999999999999999999998765444445566778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.+++||||+++|+|.+++.....+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999888899999999999999999999998 9999999999999999999999999999985432
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
... .....+||+.|+|||++.+..|+.++|
T Consensus 302 ~~~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 332 (446)
T 4ejn_A 302 DGA-------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDW 332 (446)
T ss_dssp ------------------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHH
T ss_pred CCc-------------------------------------------------ccccccCCccccCHhhcCCCCCCCccch
Confidence 211 112457999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 333 wslG~il~ell~g~ 346 (446)
T 4ejn_A 333 WGLGVVMYEMMCGR 346 (446)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred hhhHHHHHHHhhCC
Confidence 99999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=320.15 Aligned_cols=202 Identities=28% Similarity=0.526 Sum_probs=181.7
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
...+..++|.+++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45566789999999999999999999999999999999998765544455667889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+++||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D- 317 (333)
.. ..+.+||+.|+|||++.+..+ +.++|
T Consensus 170 ~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di 199 (476)
T 2y94_A 170 EF--------------------------------------------------LRTSCGSPNYAAPEVISGRLYAGPEVDI 199 (476)
T ss_dssp CC--------------------------------------------------BCCCCSCSTTCCHHHHTTCCBCSHHHHH
T ss_pred cc--------------------------------------------------ccccCCCcCeEChhhccCCCCCCCccee
Confidence 21 114579999999999998876 78999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 200 wSlGvil~elltG~ 213 (476)
T 2y94_A 200 WSSGVILYALLCGT 213 (476)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred hhhHHHHHHHhhCC
Confidence 99999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.95 Aligned_cols=202 Identities=40% Similarity=0.726 Sum_probs=167.4
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHh-hhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMV-KRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
..+..++|++.+.||+|+||.||+|.+. .+++.||+|++...... .......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3456688999999999999999999985 68999999999765322 1223445778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
..+.+|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998754
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
.... ......+||+.|+|||++.+..++.++
T Consensus 172 ~~~~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 202 (327)
T 3a62_A 172 IHDG-------------------------------------------------TVTHTFCGTIEYMAPEILMRSGHNRAV 202 (327)
T ss_dssp --------------------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHH
T ss_pred ccCC-------------------------------------------------ccccccCCCcCccCHhhCcCCCCCCcc
Confidence 3211 011245799999999999999999999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| |++||++|+|+++.
T Consensus 203 DiwslG~il~el~~g~ 218 (327)
T 3a62_A 203 DWWSLGALMYDMLTGA 218 (327)
T ss_dssp HHHHHHHHHHHHHHSS
T ss_pred cchhHHHHHHHHHHCC
Confidence 9 99999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.71 Aligned_cols=197 Identities=29% Similarity=0.507 Sum_probs=173.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999765332 23345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc---cCCcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---KNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~---~~~~vkl~DFGla~~~~~~~~ 241 (333)
||||++|+|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999999999888999999999999999999999999999999999999998 457899999999987653221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.....+||+.|+|||++.+.+|+.++| ||+
T Consensus 169 -------------------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 199 (444)
T 3soa_A 169 -------------------------------------------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 199 (444)
T ss_dssp -------------------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred -------------------------------------------------eeecccCCcccCCHHHhcCCCCCCccccHHH
Confidence 111457999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 200 Gvilyell~G~ 210 (444)
T 3soa_A 200 GVILYILLVGY 210 (444)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=303.01 Aligned_cols=193 Identities=26% Similarity=0.403 Sum_probs=173.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 578999999999999999999999999999999987542 2334577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc--CCcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~~~~~~~ 241 (333)
||||++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++..+.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999999765 47999999999999999999999999999999999999987 78999999999987653321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
....+||+.|+|||++.+..++.++| ||+
T Consensus 160 --------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (321)
T 1tki_A 160 --------------------------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp --------------------------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred --------------------------------------------------cccccCChhhcCcHHhcCCCCCchhhHHHH
Confidence 11447999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 190 G~il~~ll~g~ 200 (321)
T 1tki_A 190 GTLVYVLLSGI 200 (321)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.41 Aligned_cols=197 Identities=28% Similarity=0.503 Sum_probs=175.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh---hhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK---RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.++|.+.+.||+|+||.||+|.+..+|..||+|++....... ......+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999999999999999987643221 11346688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC----cEEEEeccCcccCC
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLD 237 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~----~vkl~DFGla~~~~ 237 (333)
++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888899999999999999999999999999999999999999887 89999999998764
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... ....+||+.|+|||++.+..++.++|
T Consensus 170 ~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~D 199 (326)
T 2y0a_A 170 FGNE--------------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEAD 199 (326)
T ss_dssp TTSC--------------------------------------------------CCCCCSCTTTCCHHHHTTCCCCTHHH
T ss_pred CCCc--------------------------------------------------cccccCCcCcCCceeecCCCCCcHHH
Confidence 3221 11346999999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 200 iwslG~il~~ll~g~ 214 (326)
T 2y0a_A 200 MWSIGVITYILLSGA 214 (326)
T ss_dssp HHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHHHHCc
Confidence 99999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=300.55 Aligned_cols=212 Identities=19% Similarity=0.338 Sum_probs=175.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.+..++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++..++..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 345678999999999999999999999999999999885532 33456688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999987 5679999999999999999999999999999999999999999999999999998775433
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
....... .............+||+.|+|||++.+..++.++| |+
T Consensus 163 ~~~~~~~-----------------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 207 (310)
T 3s95_A 163 TQPEGLR-----------------------------------SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFS 207 (310)
T ss_dssp ----------------------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred ccccccc-----------------------------------cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHH
Confidence 2110000 00000111122557999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+|+++|+|+++.
T Consensus 208 lG~~l~el~~g~ 219 (310)
T 3s95_A 208 FGIVLCEIIGRV 219 (310)
T ss_dssp HHHHHHHHHHTC
T ss_pred HHHHHHHHhcCC
Confidence 999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=306.91 Aligned_cols=198 Identities=31% Similarity=0.541 Sum_probs=172.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh--hhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR--GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
.++|++.+.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.+++.++||||+++++++...+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4579999999999999999999999999999999976543221 13566889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc---EEEEeccCccc
Q 019953 163 LIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKP 235 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~---vkl~DFGla~~ 235 (333)
+|||||++++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999999887754 235899999999999999999999999999999999999987654 99999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
...... .....+||+.|+|||++.+..++.+
T Consensus 183 ~~~~~~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~ 213 (351)
T 3c0i_A 183 LGESGL-------------------------------------------------VAGGRVGTPHFMAPEVVKREPYGKP 213 (351)
T ss_dssp CCTTSC-------------------------------------------------BCCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred ecCCCe-------------------------------------------------eecCCcCCcCccCHHHHcCCCCCch
Confidence 653321 0114479999999999999999999
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| ||+||++|+|+++.
T Consensus 214 ~DiwslG~il~~ll~g~ 230 (351)
T 3c0i_A 214 VDVWGCGVILFILLSGC 230 (351)
T ss_dssp HHHHHHHHHHHHHHHSS
T ss_pred HhhHHHHHHHHHHHHCC
Confidence 99 99999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=309.00 Aligned_cols=199 Identities=19% Similarity=0.273 Sum_probs=168.4
Q ss_pred hccccCCCceEeeeEeeecceEEEEE-----EEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc---CCceeEE
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLC-----REKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKL 151 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~ 151 (333)
...+..++|.+.+.||+|+||.||+| .+..+++.||||++.... ...+..|..++..+. |+||+.+
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 34456688999999999999999999 467789999999987542 234566777777776 8999999
Q ss_pred EEEEeeCCeEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-----
Q 019953 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMR-----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK----- 221 (333)
Q Consensus 152 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~----- 221 (333)
++++...+..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999999973 467999999999999999999999999999999999999998
Q ss_pred ------CCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccccc
Q 019953 222 ------NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (333)
Q Consensus 222 ------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (333)
++.+||+|||+++.+..... .......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~-----------------------------------------------~~~~~~~ 245 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPK-----------------------------------------------GTIFTAK 245 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCT-----------------------------------------------TEEECCS
T ss_pred cccccccCCEEEeeCchhhhhhccCC-----------------------------------------------Cceeeee
Confidence 89999999999975432110 0112245
Q ss_pred CCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 296 VGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 296 ~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+||+.|+|||++.+..|+.++| ||+||++|+|+|+.
T Consensus 246 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282 (365)
T ss_dssp SCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 7999999999999999999999 99999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.80 Aligned_cols=194 Identities=26% Similarity=0.444 Sum_probs=168.2
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999999999999999999999999976532 2334466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLL-MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+++ ++.+.+ .....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 156 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--- 156 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS---
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc---
Confidence 99976 555555 4467899999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-CCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~D-ws~g~ 322 (333)
.....+||+.|+|||++.+.. ++.++| ||+||
T Consensus 157 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 190 (292)
T 3o0g_A 157 ----------------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190 (292)
T ss_dssp ----------------------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred ----------------------------------------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHH
Confidence 111346899999999998766 899999 99999
Q ss_pred HHHhhhcc
Q 019953 323 LHFNSYRF 330 (333)
Q Consensus 323 il~~l~t~ 330 (333)
++|+|+++
T Consensus 191 il~~l~~~ 198 (292)
T 3o0g_A 191 IFAELANA 198 (292)
T ss_dssp HHHHHTTT
T ss_pred HHHHHHHc
Confidence 99999954
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.58 Aligned_cols=201 Identities=34% Similarity=0.624 Sum_probs=179.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 160 (333)
.+..++|++++.||+|+||.||+|.+..+++.||||++.............+..|..++..+ .||+|+.+++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45578999999999999999999999999999999999876555555667788899999887 78999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|+||||+++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998643221
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
. ...+.+||+.|+|||++.+.+|+.++| ||
T Consensus 497 ~-------------------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwS 527 (674)
T 3pfq_A 497 V-------------------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 527 (674)
T ss_dssp C-------------------------------------------------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHH
T ss_pred c-------------------------------------------------ccccccCCCcccCHhhhcCCCCCccceEec
Confidence 1 122568999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 528 lGvilyelltG~ 539 (674)
T 3pfq_A 528 FGVLLYEMLAGQ 539 (674)
T ss_dssp HHHHHHHHHHSS
T ss_pred hHHHHHHHHcCC
Confidence 999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=306.56 Aligned_cols=204 Identities=24% Similarity=0.361 Sum_probs=170.8
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC--
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-- 159 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 159 (333)
....++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 445689999999999999999999999999999999998754444455567888999999999999999999987654
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 --YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
..|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 359999999999999999888889999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
...... ......+||+.|+|||++.+..++.++|
T Consensus 168 ~~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 201 (311)
T 3ork_A 168 DSGNSV----------------------------------------------TQTAAVIGTAQYLSPEQARGDSVDARSD 201 (311)
T ss_dssp ------------------------------------------------------------CCTTCCHHHHHTCCCCHHHH
T ss_pred cccccc----------------------------------------------ccccccCcCcccCCHHHhcCCCCCchHh
Confidence 432110 1111457999999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+++.
T Consensus 202 i~slG~~l~~ll~g~ 216 (311)
T 3ork_A 202 VYSLGCVLYEVLTGE 216 (311)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=294.38 Aligned_cols=199 Identities=34% Similarity=0.534 Sum_probs=177.3
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
....++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45678999999999999999999999999999999999776554555566788899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999886543221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.....|++.|+|||++.+..++.++| |++
T Consensus 164 --------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (279)
T 3fdn_A 164 --------------------------------------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193 (279)
T ss_dssp ------------------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred --------------------------------------------------ccccCCCCCccCHhHhccCCCCccchhHhH
Confidence 11346999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 194 G~il~~l~~g~ 204 (279)
T 3fdn_A 194 GVLCYEFLVGK 204 (279)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHHCC
Confidence 99999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.86 Aligned_cols=199 Identities=28% Similarity=0.476 Sum_probs=172.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 357899999999999999999999999999999998654321 223457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 161 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE- 161 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE-
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999865422210
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D-ws~g 321 (333)
......+||+.|+|||++.+..+ +.++| |++|
T Consensus 162 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 195 (323)
T 3tki_A 162 ----------------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195 (323)
T ss_dssp ----------------------------------------------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHH
T ss_pred ----------------------------------------------cccCCCccCcCccCcHHhccCCCCCCcccHHHHH
Confidence 11124579999999999988776 78999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 196 ~il~~ll~g~ 205 (323)
T 3tki_A 196 IVLTAMLAGE 205 (323)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHhCC
Confidence 9999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.72 Aligned_cols=208 Identities=20% Similarity=0.318 Sum_probs=177.9
Q ss_pred ccccCCCceEeeeEeee--cceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 81 HKICVDDFELLTIIGRG--AFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
.....++|++++.||+| +||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 33456789999999999 999999999999999999999976532 234556788899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+.+++|||||++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999999999775 67999999999999999999999999999999999999999999999999998765
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGM 314 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ 314 (333)
......... ........+||+.|+|||++.+ ..++.
T Consensus 179 ~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 216 (389)
T 3gni_B 179 ISHGQRQRV------------------------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDA 216 (389)
T ss_dssp EETTEECSC------------------------------------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCT
T ss_pred ccccccccc------------------------------------------cccccccccccccccCHHHHhccCCCCCc
Confidence 432211000 0001113479999999999988 67999
Q ss_pred ccc-hHHHHHHHhhhccc
Q 019953 315 ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~ 331 (333)
++| ||+||++|+|+++.
T Consensus 217 ~~DiwslG~il~el~~g~ 234 (389)
T 3gni_B 217 KSDIYSVGITACELANGH 234 (389)
T ss_dssp HHHHHHHHHHHHHHHHSS
T ss_pred HhHHHHHHHHHHHHHHCC
Confidence 999 99999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=291.92 Aligned_cols=201 Identities=31% Similarity=0.555 Sum_probs=179.1
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
...+..++|++.+.||+|+||.||+|.+..++..||||++.............+.+|+.+++.++||||+++++++...+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 34556688999999999999999999999999999999997765444445567888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
..++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
. .....|++.|+|||++.+..++.++| |
T Consensus 168 ~---------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 196 (284)
T 2vgo_A 168 R---------------------------------------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLW 196 (284)
T ss_dssp C---------------------------------------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHH
T ss_pred c---------------------------------------------------cccccCCCCcCCHHHhccCCCCcccchh
Confidence 1 01346999999999999999999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
++|+++|+|+++.
T Consensus 197 slG~il~~l~~g~ 209 (284)
T 2vgo_A 197 CAGVLCYEFLVGM 209 (284)
T ss_dssp HHHHHHHHHHHSS
T ss_pred hHHHHHHHHHHCC
Confidence 9999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=304.86 Aligned_cols=201 Identities=24% Similarity=0.400 Sum_probs=172.6
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEe-------cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEE
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREK-------KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKL 151 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 151 (333)
.+.+..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+ +||||+++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 34566789999999999999999999875 345679999997542 233456688999999999 89999999
Q ss_pred EEEEeeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCC
Q 019953 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (333)
Q Consensus 152 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 215 (333)
++++...+.+|+||||+++|+|.+++.... .++...+..++.|++.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999997643 4788999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccccc
Q 019953 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (333)
Q Consensus 216 Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (333)
|||++.++.+||+|||+++.+....... .....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~-----------------------------------------------~~~~~ 265 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYK-----------------------------------------------KTTNG 265 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTC-----------------------------------------------TTTTT
T ss_pred hEEECCCCCEEEccccCCcccCccccee-----------------------------------------------cccCC
Confidence 9999999999999999998664322110 01133
Q ss_pred CCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 296 VGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 296 ~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.||+.|+|||++.+..++.++| |++||++|+|+|
T Consensus 266 ~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 300 (370)
T 2psq_A 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300 (370)
T ss_dssp TSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 5788999999999999999999 999999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=297.71 Aligned_cols=198 Identities=28% Similarity=0.443 Sum_probs=172.0
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC--
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-- 159 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 159 (333)
.+..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 3456789999999999999999999999999999999976432 233456778999999999999999999987655
Q ss_pred eEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE----ccCCcEEEEeccC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGL 232 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill----~~~~~vkl~DFGl 232 (333)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 7899999999999999997643 39999999999999999999999999999999999999 7788899999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc----
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---- 308 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---- 308 (333)
++....... ..+..||+.|+|||++.
T Consensus 163 a~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~ 192 (319)
T 4euu_A 163 ARELEDDEQ--------------------------------------------------FVSLYGTEEYLHPDMYERAVL 192 (319)
T ss_dssp CEECCTTCC--------------------------------------------------BCCCCSCGGGCCHHHHHHHTS
T ss_pred ceecCCCCc--------------------------------------------------eeecccCCCccCHHHhhhccc
Confidence 987653321 11346999999999986
Q ss_pred ----CCCCCcccc-hHHHHHHHhhhccc
Q 019953 309 ----KKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 309 ----~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+..++.++| ||+||++|+|+++.
T Consensus 193 ~~~~~~~~~~~~DiwslG~il~el~~g~ 220 (319)
T 4euu_A 193 RKDHQKKYGATVDLWSIGVTFYHAATGS 220 (319)
T ss_dssp CCCCCCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred cccccCCCCcHHHHHHHHHHHHHHHhCC
Confidence 578999999 99999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=314.47 Aligned_cols=220 Identities=23% Similarity=0.356 Sum_probs=160.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT----- 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 158 (333)
..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3578999999999999999999999999999999986532 2233456688899999999999999999998433
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..+|+||||+ +++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 5799999998 679999998888899999999999999999999999999999999999999999999999999998754
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHH--HhhhhccccccCCCCCCcccccc-cCCCCCcc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHW--QMNRRKLAFSTVGTPDYIAPEVL-LKKGYGME 315 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~gt~~y~APE~~-~~~~~~~~ 315 (333)
......... ..+. .....+..+ ...........+||+.|+|||++ .+..|+.+
T Consensus 209 ~~~~~~~~~-------------~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 264 (458)
T 3rp9_A 209 PENGNSQLP-------------ISPR-----------EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA 264 (458)
T ss_dssp CTTCCCCCC---------------------------------------------------CCCTTCCHHHHTTCCCCCTH
T ss_pred ccccccccc-------------cCcc-----------ccccccccccccccccccccCCcccccccChHHhhCCCCCCcH
Confidence 321100000 0000 000000000 00011223356899999999987 46679999
Q ss_pred cc-hHHHHHHHhhhc
Q 019953 316 CD-WLVSVLHFNSYR 329 (333)
Q Consensus 316 ~D-ws~g~il~~l~t 329 (333)
+| ||+||++|+|++
T Consensus 265 ~DiwSlG~il~ellt 279 (458)
T 3rp9_A 265 IDVWSIGCIFAELLN 279 (458)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHH
Confidence 99 999999999997
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=304.84 Aligned_cols=196 Identities=31% Similarity=0.466 Sum_probs=165.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
....++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.++||||+++++++.....+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 3456899999999999999999999999999999999975432 224477899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc--EEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--MKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~--vkl~DFGla~~~~~~ 239 (333)
++||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999999988888999999999999999999999999999999999999987765 999999998743221
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc-cc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME-CD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~-~D- 317 (333)
. .....+||+.|+|||++.+..++.+ +|
T Consensus 172 ~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 201 (361)
T 3uc3_A 172 S--------------------------------------------------QPKSTVGTPAYIAPEVLLRQEYDGKIADV 201 (361)
T ss_dssp -----------------------------------------------------------CTTSCHHHHHCSSCCHHHHHH
T ss_pred C--------------------------------------------------CCCCCcCCCCcCChhhhcCCCCCCCeeee
Confidence 1 1114579999999999999888766 89
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 202 wslG~il~ell~g~ 215 (361)
T 3uc3_A 202 WSCGVTLYVMLVGA 215 (361)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred ehhHHHHHHHHhCC
Confidence 99999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=297.48 Aligned_cols=202 Identities=26% Similarity=0.378 Sum_probs=166.7
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
...+.+..++|++.+.||+|+||.||+|.+ +|..||||++..... .......+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 345667788999999999999999999976 588999999876432 23345668889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEccCCcEEEEeccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMREDT---LTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
...+++||||+++++|.+++..... +++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999999976553 999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
++....... ......||+.|+|||++.+..+
T Consensus 186 a~~~~~~~~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~ 216 (309)
T 3p86_A 186 SRLKASTFL-------------------------------------------------SSKSAAGTPEWMAPEVLRDEPS 216 (309)
T ss_dssp -----------------------------------------------------------------CCTTSCHHHHTTCCC
T ss_pred Ccccccccc-------------------------------------------------ccccCCCCccccChhhhcCCCC
Confidence 975432210 0114479999999999999999
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| ||+||++|+|+++.
T Consensus 217 ~~~~DiwslG~il~elltg~ 236 (309)
T 3p86_A 217 NEKSDVYSFGVILWELATLQ 236 (309)
T ss_dssp CTTHHHHHHHHHHHHHHHCC
T ss_pred CchhhHHHHHHHHHHHHhCC
Confidence 99999 99999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=298.48 Aligned_cols=207 Identities=26% Similarity=0.414 Sum_probs=167.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC------
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE------ 159 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 159 (333)
++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 57999999999999999999999999999999997543 2334566889999999999999999999885543
Q ss_pred ---------------------------------------------------eEEEEEeccCCCCHHHHHHhCC---CCCH
Q 019953 160 ---------------------------------------------------YLYLIMEYLPGGDMMTLLMRED---TLTE 185 (333)
Q Consensus 160 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~---~~~~ 185 (333)
.+++|||||++++|.+++.... ...+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 3899999999999999997754 3556
Q ss_pred HHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCC
Q 019953 186 NVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265 (333)
Q Consensus 186 ~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (333)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~------------------ 225 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT------------------ 225 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc------------------
Confidence 67889999999999999999999999999999999999999999999998764431110000
Q ss_pred CCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 266 PDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
...........+||+.|+|||++.+..++.++| |++||++|+|+++.
T Consensus 226 -------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~ 273 (332)
T 3qd2_B 226 -------------------PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273 (332)
T ss_dssp -------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCC
T ss_pred -------------------cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcC
Confidence 000001122457999999999999999999999 99999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=304.86 Aligned_cols=194 Identities=28% Similarity=0.531 Sum_probs=172.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.....+++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999875432 2234578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc--CCcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~~~~~~~ 241 (333)
|||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++..+.....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999999987653 7999999999999999999999999999999999999974 46799999999987653321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
....+||+.|+|||++.+..++.++| ||+
T Consensus 207 --------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 236 (387)
T 1kob_A 207 --------------------------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAI 236 (387)
T ss_dssp --------------------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred --------------------------------------------------eeeeccCCCccCchhccCCCCCCcccEeeH
Confidence 11347999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 237 G~il~elltg~ 247 (387)
T 1kob_A 237 GVLGYVLLSGL 247 (387)
T ss_dssp HHHHHHHHHSC
T ss_pred hHHHHHHHhCC
Confidence 99999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=299.35 Aligned_cols=199 Identities=26% Similarity=0.448 Sum_probs=175.4
Q ss_pred hhhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-----CCceeE
Q 019953 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-----SHCIVK 150 (333)
Q Consensus 76 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~ 150 (333)
..+....+..++|++++.||+|+||.||+|.+..+++.||||++.... ........|+.+++.+. ||||++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 455677788899999999999999999999999999999999997532 22344667999999987 999999
Q ss_pred EEEEEeeCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-------
Q 019953 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK------- 221 (333)
Q Consensus 151 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~------- 221 (333)
+++++...+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 899999997654 5999999999999999999999999999999999999975
Q ss_pred ------------------CCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHH
Q 019953 222 ------------------NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQH 283 (333)
Q Consensus 222 ------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (333)
++.+||+|||++.......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------------------------------------------- 216 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------------------------------------------- 216 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-------------------------------------------
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCCC-------------------------------------------
Confidence 7899999999998643211
Q ss_pred HHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 284 WQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 284 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
...+||+.|+|||++.+.+++.++| ||+||++|+|+++.
T Consensus 217 ---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 217 ---------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp ---------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ---------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 1347999999999999999999999 99999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=308.16 Aligned_cols=217 Identities=26% Similarity=0.392 Sum_probs=169.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT----- 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 158 (333)
..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3579999999999999999999999999999999997542 2233456688999999999999999999999766
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..+|+||||+. ++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999995 69999998888899999999999999999999999999999999999999999999999999998754
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc-cCCCCCcccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-LKKGYGMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-~~~~~~~~~D 317 (333)
........... . ... ...............+||+.|+|||++ .+..|+.++|
T Consensus 182 ~~~~~~~~~~~----~-----------------~~~------~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~D 234 (432)
T 3n9x_A 182 EKDTNIVNDLE----E-----------------NEE------PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234 (432)
T ss_dssp --------------------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHH
T ss_pred ccccccccccc----c-----------------ccc------ccccccchhccccCCCCCccccCHHHHhcCCCCCcccc
Confidence 32211000000 0 000 000000011223366899999999996 5667999999
Q ss_pred -hHHHHHHHhhhc
Q 019953 318 -WLVSVLHFNSYR 329 (333)
Q Consensus 318 -ws~g~il~~l~t 329 (333)
||+||++|+|++
T Consensus 235 iwSlG~il~ell~ 247 (432)
T 3n9x_A 235 IWSTGCIFAELLN 247 (432)
T ss_dssp HHHHHHHHHHHHT
T ss_pred cchHHHHHHHHHh
Confidence 999999999997
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=287.70 Aligned_cols=197 Identities=28% Similarity=0.517 Sum_probs=175.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999999976543 23344667889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc---EEEEeccCcccCCCCc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKPLDCST 240 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~---vkl~DFGla~~~~~~~ 240 (333)
||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999999999999988888999999999999999999999999999999999999987665 9999999998665332
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
. .....||+.|+|||++.+..++.++| |+
T Consensus 163 ~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 192 (284)
T 3kk8_A 163 A--------------------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWA 192 (284)
T ss_dssp B--------------------------------------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred c--------------------------------------------------ccCCCCCcCCcCchhhcCCCCCcccchHH
Confidence 1 11346999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+|+++|+|+++.
T Consensus 193 lG~~l~~l~~g~ 204 (284)
T 3kk8_A 193 CGVILYILLVGY 204 (284)
T ss_dssp HHHHHHHHHHSS
T ss_pred HHHHHHHHHHCC
Confidence 999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=294.43 Aligned_cols=200 Identities=27% Similarity=0.461 Sum_probs=169.1
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
..+...++|++++.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 44566789999999999999999999984 589999999976532 2334466788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.+++||||+++ +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99999999974 787777654 4699999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D 317 (333)
... .....+||+.|+|||++.+ ..++.++|
T Consensus 172 ~~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~D 202 (311)
T 3niz_A 172 PVR-------------------------------------------------SYTHEVVTLWYRAPDVLMGSKKYSTSVD 202 (311)
T ss_dssp CCC----------------------------------------------------CCCCCCTTCCHHHHTTCCSCCTHHH
T ss_pred Ccc-------------------------------------------------cccCCcccCCcCCHHHhcCCCCCCchHH
Confidence 211 0113468999999999987 56899999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 203 iwslG~il~~ll~g~ 217 (311)
T 3niz_A 203 IWSIGCIFAEMITGK 217 (311)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred hHHHHHHHHHHHhCC
Confidence 99999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=293.44 Aligned_cols=200 Identities=27% Similarity=0.415 Sum_probs=164.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh--hhhhHHHHHHHHHHHHHhc---CCceeEEEEEEe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQ 156 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~ 156 (333)
.+..++|++++.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.+. ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34568999999999999999999999999999999998643211 1111223556777766664 999999999997
Q ss_pred eCC-----eEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEe
Q 019953 157 DTE-----YLYLIMEYLPGGDMMTLLMREDT--LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSD 229 (333)
Q Consensus 157 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~D 229 (333)
... .+++||||+. ++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 755 5899999996 699999977654 99999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||++........ ....+||+.|+|||++.+
T Consensus 164 fg~a~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 164 FGLARIYSYQMA--------------------------------------------------LTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp CSCTTTSTTCCC--------------------------------------------------SGGGGCCCSSCCHHHHHT
T ss_pred CccccccCCCcc--------------------------------------------------cCCccccccccCchHHcC
Confidence 999986543221 114579999999999999
Q ss_pred CCCCcccc-hHHHHHHHhhhcccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~~ 332 (333)
..++.++| ||+||++|+|+++.+
T Consensus 194 ~~~~~~~DiwslG~il~~l~~g~~ 217 (308)
T 3g33_A 194 STYATPVDMWSVGCIFAEMFRRKP 217 (308)
T ss_dssp SCCCSTHHHHHHHHHHHHTTTSSC
T ss_pred CCCCchHHHHHHHHHHHHHHhCCC
Confidence 99999999 999999999998764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=288.55 Aligned_cols=198 Identities=30% Similarity=0.587 Sum_probs=156.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999999999999999999876544445567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 9999999999999765 5799999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......|++.|+|||++.+..++.++| |++|+
T Consensus 168 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 200 (278)
T 3cok_A 168 -----------------------------------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGC 200 (278)
T ss_dssp -----------------------------------------------------------------------CTHHHHHHH
T ss_pred -----------------------------------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHH
Confidence 011346899999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 201 il~~l~~g~ 209 (278)
T 3cok_A 201 MFYTLLIGR 209 (278)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHhCC
Confidence 999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.62 Aligned_cols=195 Identities=32% Similarity=0.524 Sum_probs=160.8
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
....++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++......
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 345678999999999999999999999999999999997542 224577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CCcEEEEeccCcccCCC
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~~vkl~DFGla~~~~~ 238 (333)
++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999999988888999999999999999999999999999999999999975 88999999999986542
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
.. .....+||+.|+|||++.+..++.++|
T Consensus 204 ~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 233 (349)
T 2w4o_A 204 QV--------------------------------------------------LMKTVCGTPGYCAPEILRGCAYGPEVDM 233 (349)
T ss_dssp -----------------------------------------------------------CGGGSCHHHHTTCCCCTHHHH
T ss_pred cc--------------------------------------------------ccccccCCCCccCHHHhcCCCCCcccch
Confidence 21 111446999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 234 wslG~il~ell~g~ 247 (349)
T 2w4o_A 234 WSVGIITYILLCGF 247 (349)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHhCC
Confidence 99999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.97 Aligned_cols=195 Identities=27% Similarity=0.405 Sum_probs=163.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT----- 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 158 (333)
..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4588999999999999999999999999999999997642 2334456678899999999999999999999654
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
..+|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 467999999965 5666664 348999999999999999999999999999999999999999999999999998654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
... .....+||+.|+|||++.+..|+.++|
T Consensus 216 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 245 (464)
T 3ttj_A 216 TSF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVD 245 (464)
T ss_dssp -CC--------------------------------------------------CC----CCCTTCCHHHHTTCCCCTTHH
T ss_pred CCc--------------------------------------------------ccCCCcccccccCHHHHcCCCCCHHHH
Confidence 321 111457999999999999999999999
Q ss_pred -hHHHHHHHhhhcccc
Q 019953 318 -WLVSVLHFNSYRFLE 332 (333)
Q Consensus 318 -ws~g~il~~l~t~~~ 332 (333)
||+||++|+|+++.+
T Consensus 246 iwSlG~il~ell~g~~ 261 (464)
T 3ttj_A 246 IWSVGCIMGEMVRHKI 261 (464)
T ss_dssp HHHHHHHHHHHHHSSC
T ss_pred HHHHHHHHHHHHhCCC
Confidence 999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=289.31 Aligned_cols=199 Identities=29% Similarity=0.484 Sum_probs=178.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+.||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 45689999999999999999999999999999999976544444456678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 170 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-- 170 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......|++.|+|||++.+..++.++| |++|+
T Consensus 171 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 203 (294)
T 2rku_A 171 -----------------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGC 203 (294)
T ss_dssp -----------------------------------------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHH
T ss_pred -----------------------------------------------ccccccCCCCcCCcchhccCCCCchhhHHHHHH
Confidence 011346999999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 204 ~l~~l~~g~ 212 (294)
T 2rku_A 204 IMYTLLVGK 212 (294)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHhCC
Confidence 999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=296.69 Aligned_cols=201 Identities=22% Similarity=0.296 Sum_probs=172.0
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 161 (333)
+..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+ +||||+++++++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 345789999999999999999999999999999999865422 12367799999999 999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc-----EEEEeccCccc
Q 019953 162 YLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-----MKLSDFGLCKP 235 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~-----vkl~DFGla~~ 235 (333)
++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 9999999976 468999999999999999999999999999999999999998887 99999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
+......... ........+||+.|+|||++.+..++.+
T Consensus 160 ~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 197 (330)
T 2izr_A 160 YIDPETKKHI------------------------------------------PYREHKSLTGTARYMSINTHLGKEQSRR 197 (330)
T ss_dssp SBCTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred eecCCCCccc------------------------------------------cccccCCcCCCccccChHHHcCCCCCch
Confidence 6433211000 0001125579999999999999999999
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| ||+||++|+|+++.
T Consensus 198 ~Di~slG~il~ell~g~ 214 (330)
T 2izr_A 198 DDLEALGHMFMYFLRGS 214 (330)
T ss_dssp HHHHHHHHHHHHHHHSS
T ss_pred hHHHHHHHHHHHHhcCC
Confidence 99 99999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=295.63 Aligned_cols=199 Identities=29% Similarity=0.484 Sum_probs=178.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35689999999999999999999999999999999976544344456678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-- 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-- 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
......|++.|+|||++.+..++.++| |++|+
T Consensus 197 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 229 (335)
T 2owb_A 197 -----------------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGC 229 (335)
T ss_dssp -----------------------------------------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHH
T ss_pred -----------------------------------------------cccccCCCccccCHHHhccCCCCchhhHHHHHH
Confidence 011346999999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 230 il~~l~~g~ 238 (335)
T 2owb_A 230 IMYTLLVGK 238 (335)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHHCc
Confidence 999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=296.40 Aligned_cols=190 Identities=29% Similarity=0.498 Sum_probs=151.5
Q ss_pred CceEe---eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeEE
Q 019953 87 DFELL---TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 87 ~y~~~---~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 162 (333)
+|++. +.||+|+||.||+|.+..+++.||||++.... .....+|+.+++.+. ||||+++++++.+....|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 46654 78999999999999999999999999986542 234667999999997 999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cEEEEeccCcccCCCC
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPLDCS 239 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~~~~ 239 (333)
+||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999999988999999999999999999999999999999999999998766 8999999999865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.. .....+||+.|+|||++.+..++.++| |
T Consensus 163 ~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 193 (325)
T 3kn6_A 163 NQ-------------------------------------------------PLKTPCFTLHYAAPELLNQNGYDESCDLW 193 (325)
T ss_dssp ----------------------------------------------------------------------CCCCHHHHHH
T ss_pred CC-------------------------------------------------cccccCCCcCccCHHHhcCCCCCCccchH
Confidence 21 111446899999999999999999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
++||++|+|+++.
T Consensus 194 slG~il~~ll~g~ 206 (325)
T 3kn6_A 194 SLGVILYTMLSGQ 206 (325)
T ss_dssp HHHHHHHHHHHSS
T ss_pred HHHHHHHHHHhCC
Confidence 9999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=295.52 Aligned_cols=197 Identities=29% Similarity=0.530 Sum_probs=174.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh---hhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.++|++.+.||+|+||.||+|.+..+|+.||+|++........ .....+.+|+.+++.+.||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4579999999999999999999999999999999976432211 1345688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC----cEEEEeccCcccCC
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLD 237 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~----~vkl~DFGla~~~~ 237 (333)
++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999998888899999999999999999999999999999999999999888 79999999998764
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... .....||+.|+|||++.+..++.++|
T Consensus 171 ~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~D 200 (321)
T 2a2a_A 171 DGVE--------------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEAD 200 (321)
T ss_dssp TTCC--------------------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred cccc--------------------------------------------------ccccCCCCCccCcccccCCCCCCccc
Confidence 3211 11346999999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+++.
T Consensus 201 i~slG~il~~l~~g~ 215 (321)
T 2a2a_A 201 MWSIGVITYILLSGA 215 (321)
T ss_dssp HHHHHHHHHHHHHSC
T ss_pred cHHHHHHHHHHHHCC
Confidence 99999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=294.37 Aligned_cols=195 Identities=28% Similarity=0.452 Sum_probs=162.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 162 (333)
..++|++++.||+|+||+||+|.+..+|+.||||++......... ......|+..+..+ .||||+++++++...+.++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 346799999999999999999999999999999987653222222 22344455555555 9999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 999999 6788888765 45699999999999999999999999999999999999999999999999999886643221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.....||+.|+|||++.+ .++.++| |++
T Consensus 213 --------------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl 241 (311)
T 3p1a_A 213 --------------------------------------------------GEVQEGDPRYMAPELLQG-SYGTAADVFSL 241 (311)
T ss_dssp ----------------------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHH
T ss_pred --------------------------------------------------CcccCCCccccCHhHhcC-CCCchhhHHHH
Confidence 113469999999999986 7999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 242 G~il~el~~g~ 252 (311)
T 3p1a_A 242 GLTILEVACNM 252 (311)
T ss_dssp HHHHHHHHHTC
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=297.79 Aligned_cols=192 Identities=28% Similarity=0.446 Sum_probs=169.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
+.|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999987543333344566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+. |+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---- 208 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---- 208 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC----
Confidence 9996 67877775 45689999999999999999999999999999999999999999999999999998654221
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCCCcccc-hHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGMECD-WLV 320 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~~D-ws~ 320 (333)
..+||+.|+|||++. +..++.++| ||+
T Consensus 209 -------------------------------------------------~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 239 (348)
T 1u5q_A 209 -------------------------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239 (348)
T ss_dssp -------------------------------------------------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHH
T ss_pred -------------------------------------------------cccCCcceeCHhhhccccCCCCCcHHHHHHH
Confidence 346999999999985 567999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 240 G~il~ell~g~ 250 (348)
T 1u5q_A 240 GITCIELAERK 250 (348)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=315.29 Aligned_cols=199 Identities=34% Similarity=0.599 Sum_probs=176.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.+..++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34457899999999999999999999999999999999765443344567788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE---ccCCcEEEEeccCcccCCC
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill---~~~~~vkl~DFGla~~~~~ 238 (333)
++|||||.+++|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..+..
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999999888899999999999999999999999999999999999999 4678999999999987653
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
... ....+||+.|+|||++.+ .|+.++|
T Consensus 182 ~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Di 210 (484)
T 3nyv_A 182 SKK--------------------------------------------------MKDKIGTAYYIAPEVLHG-TYDEKCDV 210 (484)
T ss_dssp CCS--------------------------------------------------HHHHTTGGGTCCHHHHHT-CCCTHHHH
T ss_pred ccc--------------------------------------------------cccCCCCccccCceeecC-CCCCccee
Confidence 321 113479999999999976 6999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 211 wslG~il~~ll~g~ 224 (484)
T 3nyv_A 211 WSTGVILYILLSGC 224 (484)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHCC
Confidence 99999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.26 Aligned_cols=199 Identities=34% Similarity=0.605 Sum_probs=166.4
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh-----------------------hhhHHHHHHHHHH
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-----------------------RGQVEHVRAERNL 139 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~~~e~~~ 139 (333)
+..++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45689999999999999999999999999999999997643211 1123457889999
Q ss_pred HHHhcCCceeEEEEEEee--CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcE
Q 019953 140 LAEVASHCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 217 (333)
Q Consensus 140 l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Ni 217 (333)
++.++||||+++++++.. ...+++||||+++++|.+++ ....+++..+..++.|++.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999986 56899999999999998765 345799999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC
Q 019953 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (333)
Q Consensus 218 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 297 (333)
|++.++.+||+|||++........ ......|
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------~~~~~~g 199 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-------------------------------------------------LLSNTVG 199 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-------------------------------------------------EECCCCS
T ss_pred EECCCCCEEEecCCCccccccccc-------------------------------------------------cccCCcC
Confidence 999999999999999987653321 0113479
Q ss_pred CCCCcccccccCCC---CCcccc-hHHHHHHHhhhccc
Q 019953 298 TPDYIAPEVLLKKG---YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 298 t~~y~APE~~~~~~---~~~~~D-ws~g~il~~l~t~~ 331 (333)
|+.|+|||++.+.. ++.++| |++||++|+|+++.
T Consensus 200 t~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp CGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred CccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 99999999998765 478899 99999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=301.27 Aligned_cols=191 Identities=27% Similarity=0.537 Sum_probs=167.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 163 (333)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.++..+ +||||+++++++.+...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3579999999999999999999999999999999976431 133578888887 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC----CcEEEEeccCcccCCCC
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN----GHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~----~~vkl~DFGla~~~~~~ 239 (333)
|||||++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+..+ +.+||+|||++..+...
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999999888899999999999999999999999999999999999998543 35999999999865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.. ...+.+||+.|+|||++.+.+|+.++| |
T Consensus 174 ~~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 204 (342)
T 2qr7_A 174 NG-------------------------------------------------LLMTPCYTANFVAPEVLERQGYDAACDIW 204 (342)
T ss_dssp TC-------------------------------------------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHH
T ss_pred CC-------------------------------------------------ceeccCCCccccCHHHhcCCCCCCccCee
Confidence 11 112457999999999999988999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
++||++|+|+++.
T Consensus 205 slG~il~ell~g~ 217 (342)
T 2qr7_A 205 SLGVLLYTMLTGY 217 (342)
T ss_dssp HHHHHHHHHHHSS
T ss_pred eHhHHHHHHhcCC
Confidence 9999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=292.20 Aligned_cols=197 Identities=29% Similarity=0.450 Sum_probs=168.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 4689999999999999999999999999999998865432 233345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--- 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---
Confidence 99999999999988888899999999999999999999999999999999999999999999999999987653221
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~ 322 (333)
.....+||+.|+|||++.+ ..++.++| |++|+
T Consensus 158 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 191 (311)
T 4agu_A 158 ----------------------------------------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGC 191 (311)
T ss_dssp ------------------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHH
T ss_pred ----------------------------------------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHH
Confidence 0113468999999999986 67899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 192 il~~l~~g~ 200 (311)
T 4agu_A 192 VFAELLSGV 200 (311)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHhCC
Confidence 999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=286.59 Aligned_cols=202 Identities=28% Similarity=0.518 Sum_probs=172.0
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
...+..++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34566789999999999999999999999999999999998765544555667889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
..++||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D- 317 (333)
.. .....|++.|+|||++.+..+ +.++|
T Consensus 165 ~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di 194 (276)
T 2h6d_A 165 EF--------------------------------------------------LRTSCGSPNYAAPEVISGRLYAGPEVDI 194 (276)
T ss_dssp --------------------------------------------------------------CCTGGGTTSCCCHHHHHH
T ss_pred cc--------------------------------------------------eecccCCccccCHHHHcCCCCCCccchH
Confidence 11 113468999999999998776 68999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+++.
T Consensus 195 ~slG~~l~~l~~g~ 208 (276)
T 2h6d_A 195 WSCGVILYALLCGT 208 (276)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHhCC
Confidence 99999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.69 Aligned_cols=203 Identities=24% Similarity=0.370 Sum_probs=172.6
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEE-----EecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEE
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKL 151 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 151 (333)
...+.+..++|++.+.||+|+||.||+|. +..+++.||||++.... .......+.+|+.++..+ +||||+++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 35667888999999999999999999998 44567899999997542 223345688899999999 78999999
Q ss_pred EEEEeeCC-eEEEEEeccCCCCHHHHHHhCCC------------------------------------------------
Q 019953 152 YYSFQDTE-YLYLIMEYLPGGDMMTLLMREDT------------------------------------------------ 182 (333)
Q Consensus 152 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------ 182 (333)
++++...+ .+++|||||++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99987754 48999999999999999976432
Q ss_pred ------------------CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 183 ------------------LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 183 ------------------~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 249 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-- 249 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC--
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc--
Confidence 889999999999999999999999999999999999999999999999999866432211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.......||+.|+|||++.+..++.++| ||+||+
T Consensus 250 ---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 284 (359)
T 3vhe_A 250 ---------------------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284 (359)
T ss_dssp ---------------------------------------------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred ---------------------------------------------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHH
Confidence 0111346899999999999999999999 999999
Q ss_pred HHhhhc
Q 019953 324 HFNSYR 329 (333)
Q Consensus 324 l~~l~t 329 (333)
+|+|+|
T Consensus 285 l~ellt 290 (359)
T 3vhe_A 285 LWEIFS 290 (359)
T ss_dssp HHHHTT
T ss_pred HHHHHh
Confidence 999997
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=295.88 Aligned_cols=195 Identities=27% Similarity=0.447 Sum_probs=155.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999987543 122334577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 165 MEYLPGGDMMTLLMRE------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
|||++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5899888643 3589999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D 317 (333)
... .....+||+.|+|||++.+ ..++.++|
T Consensus 161 ~~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~D 191 (317)
T 2pmi_A 161 PVN-------------------------------------------------TFSSEVVTLWYRAPDVLMGSRTYSTSID 191 (317)
T ss_dssp CCC-------------------------------------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHH
T ss_pred Ccc-------------------------------------------------cCCCCcccccccCchHhhCCCCCCcHHH
Confidence 211 0113468999999999987 46899999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 192 iwslG~il~el~~g~ 206 (317)
T 2pmi_A 192 IWSCGCILAEMITGK 206 (317)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=291.59 Aligned_cols=201 Identities=22% Similarity=0.299 Sum_probs=167.7
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
...++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34688999999999999999999999999999999998665444445577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999998865432110
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
......|++.|+|||++.+..++.++| |++|
T Consensus 191 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 222 (309)
T 2h34_A 191 ------------------------------------------------QLGNTVGTLYYMAPERFSESHATYRADIYALT 222 (309)
T ss_dssp ------------------------------------------------------CCGGGCCGGGTCC----CCCHHHHHH
T ss_pred ------------------------------------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHH
Confidence 011346999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
+++|+|+++.
T Consensus 223 ~il~~l~~g~ 232 (309)
T 2h34_A 223 CVLYECLTGS 232 (309)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHHCC
Confidence 9999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=302.46 Aligned_cols=190 Identities=29% Similarity=0.485 Sum_probs=158.7
Q ss_pred cCCCceEe-eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHH-HhcCCceeEEEEEEee----
Q 019953 84 CVDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA-EVASHCIVKLYYSFQD---- 157 (333)
Q Consensus 84 ~~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~---- 157 (333)
..++|.+. +.||+|+||+||+|.+..+|+.||||++.... .+.+|+.++. ..+||||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch--------hHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 34678776 78999999999999999999999999986432 2456777764 4589999999998875
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CCcEEEEeccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGL 232 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~~vkl~DFGl 232 (333)
...+|+|||||++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 567999999999999999997643 5999999999999999999999999999999999999997 78999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
++....... ..+.+||+.|+|||++.+..|
T Consensus 211 a~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~ 240 (400)
T 1nxk_A 211 AKETTSHNS--------------------------------------------------LTTPCYTPYYVAPEVLGPEKY 240 (400)
T ss_dssp CEECC-------------------------------------------------------------CTTCCGGGSCCCCS
T ss_pred ccccCCCCc--------------------------------------------------cccCCCCCCccCHhhcCCCCC
Confidence 986542210 114579999999999999999
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| ||+||++|+|+++.
T Consensus 241 ~~~~DiwslG~il~ell~g~ 260 (400)
T 1nxk_A 241 DKSCDMWSLGVIMYILLCGY 260 (400)
T ss_dssp SSHHHHHHHHHHHHHHHHSS
T ss_pred CCcccHHHHHHHHHHHHhCC
Confidence 99999 99999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=302.25 Aligned_cols=217 Identities=24% Similarity=0.428 Sum_probs=161.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCC--eE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTE--YL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~ 161 (333)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 478999999999999999999999999999999986432 22334456778999999997 999999999997544 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|+|||||+ ++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999996 689888865 5799999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws 319 (333)
.... .+.... .....+. .........+||+.|+|||++.+ ..|+.++| ||
T Consensus 165 ~~~~-------------------~~~~~~--------~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 216 (388)
T 3oz6_A 165 VTNN-------------------IPLSIN--------ENTENFD-DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216 (388)
T ss_dssp CCCC-------------------GGGCCC------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred cccc-------------------cccccc--------ccccccc-cccccccCCcccCCcCCHHHhcCCCCCCChhhHHH
Confidence 1000 000000 0000000 00112235689999999999987 67999999 99
Q ss_pred HHHHHHhhhcccc
Q 019953 320 VSVLHFNSYRFLE 332 (333)
Q Consensus 320 ~g~il~~l~t~~~ 332 (333)
+||++|+|+++.+
T Consensus 217 lG~il~ell~g~~ 229 (388)
T 3oz6_A 217 LGCILGEILCGKP 229 (388)
T ss_dssp HHHHHHHHHHSSC
T ss_pred HHHHHHHHHhCCC
Confidence 9999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=296.80 Aligned_cols=201 Identities=23% Similarity=0.313 Sum_probs=171.1
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCc---eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
..+..++|++.+.||+|+||.||+|.+..++. .||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45667899999999999999999999976555 49999997542 22344568889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999654 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
....... .......+|+.|+|||++.+..++.++
T Consensus 202 ~~~~~~~----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~ 235 (325)
T 3kul_A 202 EDDPDAA----------------------------------------------YTTTGGKIPIRWTAPEAIAFRTFSSAS 235 (325)
T ss_dssp C----CC----------------------------------------------EECC---CCGGGSCHHHHHHCEECHHH
T ss_pred ccCccce----------------------------------------------eeccCCCCcccccCHhHhcCCCCCcHH
Confidence 5432110 001123468889999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| |++|+++|+|++
T Consensus 236 Di~slG~il~ell~ 249 (325)
T 3kul_A 236 DVWSFGVVMWEVLA 249 (325)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHc
Confidence 9 999999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=290.37 Aligned_cols=193 Identities=19% Similarity=0.247 Sum_probs=170.2
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCC-------ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSG-------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 154 (333)
++..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 355678999999999999999999998777 469999986543 2344668889999999999999999999
Q ss_pred EeeCCeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc--------E
Q 019953 155 FQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--------M 225 (333)
Q Consensus 155 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~--------v 225 (333)
+...+..++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 999999999999999999999999999999999999998887 9
Q ss_pred EEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccc
Q 019953 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (333)
Q Consensus 226 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE 305 (333)
||+|||++....... ...|++.|+|||
T Consensus 161 kl~Dfg~~~~~~~~~-----------------------------------------------------~~~~~~~y~aPE 187 (289)
T 4fvq_A 161 KLSDPGISITVLPKD-----------------------------------------------------ILQERIPWVPPE 187 (289)
T ss_dssp EECCCCSCTTTSCHH-----------------------------------------------------HHHHTTTTSCHH
T ss_pred eeccCcccccccCcc-----------------------------------------------------ccCCcCcccCHH
Confidence 999999987543221 235788999999
Q ss_pred cccC-CCCCcccc-hHHHHHHHhhhcc
Q 019953 306 VLLK-KGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 306 ~~~~-~~~~~~~D-ws~g~il~~l~t~ 330 (333)
++.+ ..++.++| ||+|+++|+|+++
T Consensus 188 ~~~~~~~~~~~~DiwslG~il~el~~g 214 (289)
T 4fvq_A 188 CIENPKNLNLATDKWSFGTTLWEICSG 214 (289)
T ss_dssp HHHCGGGCCHHHHHHHHHHHHHHHHTT
T ss_pred HhCCCCCCCchhHHHHHHHHHHHHHcC
Confidence 9988 77999999 9999999999984
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=291.99 Aligned_cols=192 Identities=31% Similarity=0.491 Sum_probs=170.5
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3778889999999999999999899999999987543 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
|+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+.....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----- 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-----
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-----
Confidence 9999999998854 5699999999999999999999999999999999999999999999999999987653211
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHF 325 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~ 325 (333)
.....+||+.|+|||++.+..++.++| ||+|+++|
T Consensus 197 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ 232 (321)
T 2c30_A 197 --------------------------------------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232 (321)
T ss_dssp --------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred --------------------------------------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHH
Confidence 011447999999999999999999999 99999999
Q ss_pred hhhccc
Q 019953 326 NSYRFL 331 (333)
Q Consensus 326 ~l~t~~ 331 (333)
+|+++.
T Consensus 233 el~~g~ 238 (321)
T 2c30_A 233 EMVDGE 238 (321)
T ss_dssp HHHHSS
T ss_pred HHHhCC
Confidence 999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.77 Aligned_cols=193 Identities=31% Similarity=0.552 Sum_probs=172.2
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 3579999999999999999999999999999999876432 3345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE---ccCCcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill---~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 9999999999999888889999999999999999999999999999999999999 7888999999999987653321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.....||+.|+|||++.+. ++.++| |++
T Consensus 165 --------------------------------------------------~~~~~~t~~y~aPE~~~~~-~~~~~Di~sl 193 (277)
T 3f3z_A 165 --------------------------------------------------MRTKVGTPYYVSPQVLEGL-YGPECDEWSA 193 (277)
T ss_dssp --------------------------------------------------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHH
T ss_pred --------------------------------------------------hhccCCCCCccChHHhccc-CCchhhehhH
Confidence 1134699999999998765 999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 194 G~~l~~l~~g~ 204 (277)
T 3f3z_A 194 GVMMYVLLCGY 204 (277)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHHCC
Confidence 99999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=310.17 Aligned_cols=195 Identities=31% Similarity=0.593 Sum_probs=172.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.....+++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4579999999999999999999999999999999976543 223456688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc---cCCcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---KNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~---~~~~vkl~DFGla~~~~~~~~ 241 (333)
||||.+++|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++..+.....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 99999999999998888899999999999999999999999999999999999995 456799999999986543221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
....+||+.|+|||++.+ .|+.++| ||+
T Consensus 180 --------------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl 208 (486)
T 3mwu_A 180 --------------------------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSA 208 (486)
T ss_dssp ----------------------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHH
T ss_pred --------------------------------------------------cCCCcCCCCCCCHHHhCC-CCCchhhHHHH
Confidence 113479999999999976 5999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 209 G~il~~ll~g~ 219 (486)
T 3mwu_A 209 GVILYILLSGT 219 (486)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=286.72 Aligned_cols=194 Identities=22% Similarity=0.349 Sum_probs=168.6
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 164 (333)
++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+..+..+ +||||+++++++...+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 5799999999999999999999999999999998754222 22345577889999998 999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC------------------
Q 019953 165 MEYLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN------------------ 222 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~------------------ 222 (333)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999764 679999999999999999999999999999999999999844
Q ss_pred -CcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCC
Q 019953 223 -GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301 (333)
Q Consensus 223 -~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 301 (333)
..+||+|||++....... ...||+.|
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~-----------------------------------------------------~~~gt~~y 196 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQ-----------------------------------------------------VEEGDSRF 196 (289)
T ss_dssp CCCEEECCCTTCEETTCSC-----------------------------------------------------CCCCCGGG
T ss_pred ceEEEEcccccccccCCcc-----------------------------------------------------ccCCCccc
Confidence 479999999998764322 23599999
Q ss_pred cccccccCC-CCCcccc-hHHHHHHHhhhccccC
Q 019953 302 IAPEVLLKK-GYGMECD-WLVSVLHFNSYRFLEF 333 (333)
Q Consensus 302 ~APE~~~~~-~~~~~~D-ws~g~il~~l~t~~~~ 333 (333)
+|||++.+. .++.++| |++||++|+|+++.++
T Consensus 197 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 197 LANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp CCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 999999876 6778999 9999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=290.14 Aligned_cols=194 Identities=29% Similarity=0.456 Sum_probs=165.3
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5899999999999999999998 6789999999865432 2223355778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--- 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc---
Confidence 99965 898888764 6799999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~ 322 (333)
......||+.|+|||++.+ ..++.++| ||+||
T Consensus 156 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 189 (288)
T 1ob3_A 156 ----------------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189 (288)
T ss_dssp ----------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred ----------------------------------------------ccccccccccccCchheeCCCCCCcHHHHHHHHH
Confidence 0113468999999999976 45899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 190 il~~l~~g~ 198 (288)
T 1ob3_A 190 IFAEMVNGT 198 (288)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHhCC
Confidence 999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=301.18 Aligned_cols=197 Identities=28% Similarity=0.470 Sum_probs=172.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh-----hhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR-----GQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
.++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3579999999999999999999999999999999976532111 12234566999999999999999999999999
Q ss_pred eEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGG-DMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.+++||||+.+| +|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 999999998766 9999998888999999999999999999999999999999999999999999999999999987653
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D 317 (333)
... ..+.+||+.|+|||++.+..+ +.++|
T Consensus 183 ~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~D 212 (335)
T 3dls_A 183 GKL--------------------------------------------------FYTFCGTIEYCAPEVLMGNPYRGPELE 212 (335)
T ss_dssp TCC--------------------------------------------------BCEECSCGGGCCHHHHTTCCBCSHHHH
T ss_pred CCc--------------------------------------------------eeccCCCccccChhhhcCCCCCCCccc
Confidence 321 114579999999999998887 88999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 213 iwslG~il~el~~g~ 227 (335)
T 3dls_A 213 MWSLGVTLYTLVFEE 227 (335)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred chhHHHHHHHHHhCC
Confidence 99999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=291.99 Aligned_cols=202 Identities=27% Similarity=0.486 Sum_probs=168.1
Q ss_pred ccccCCCceEeeeEeeecceEEEEEE----EecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
..+..++|++++.||+|+||.||+|. +..+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35567889999999999999999998 56789999999987542 233456888999999999999999999985
Q ss_pred e--CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCc
Q 019953 157 D--TEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 157 ~--~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
. ...+++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4 346899999999999999997754 5999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
.......... .......|++.|+|||++.+..++
T Consensus 162 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 195 (295)
T 3ugc_A 162 KVLPQDKEFF----------------------------------------------KVKEPGESPIFWYAPESLTESKFS 195 (295)
T ss_dssp C-----------------------------------------------------------CTTCGGGGCCHHHHHHCCCC
T ss_pred ccccCCccee----------------------------------------------eeccCCCCccceeCcHHhcCCCCC
Confidence 8765332110 011123577889999999999999
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| ||+|+++|+|+|+.
T Consensus 196 ~~~Di~slG~~l~~l~~g~ 214 (295)
T 3ugc_A 196 VASDVWSFGVVLYELFTYI 214 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHHHhcc
Confidence 9999 99999999999853
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=309.28 Aligned_cols=198 Identities=34% Similarity=0.571 Sum_probs=170.8
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh----------hhHHHHHHHHHHHHHhcCCceeEEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR----------GQVEHVRAERNLLAEVASHCIVKLY 152 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~ 152 (333)
...++|.+++.||+|+||.||+|.+..++..||||++........ .....+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 346789999999999999999999999999999999976543211 3346688899999999999999999
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cEEEEe
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSD 229 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~vkl~D 229 (333)
+++.+...+++|||||++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999999998888899999999999999999999999999999999999999776 699999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||++..+..... ....+||+.|+|||++.
T Consensus 193 fg~a~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~- 221 (504)
T 3q5i_A 193 FGLSSFFSKDYK--------------------------------------------------LRDRLGTAYYIAPEVLK- 221 (504)
T ss_dssp CTTCEECCTTSC--------------------------------------------------BCCCCSCTTTCCHHHHT-
T ss_pred CCCCEEcCCCCc--------------------------------------------------cccccCCcCCCCHHHhc-
Confidence 999987653221 11447999999999987
Q ss_pred CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| ||+||++|+|+++.
T Consensus 222 ~~~~~~~DiwslG~il~~ll~g~ 244 (504)
T 3q5i_A 222 KKYNEKCDVWSCGVIMYILLCGY 244 (504)
T ss_dssp TCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCchHHHHHHHHHHHHHHhCC
Confidence 46999999 99999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=293.28 Aligned_cols=205 Identities=23% Similarity=0.330 Sum_probs=175.8
Q ss_pred hhhhhccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeE
Q 019953 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK 150 (333)
Q Consensus 76 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 150 (333)
.....+.+..++|.+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceee
Confidence 344566777899999999999999999999884 455889999997542 2334566888999999999999999
Q ss_pred EEEEEeeCCeEEEEEeccCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCC
Q 019953 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT------------------------LTENVARFYIAQSVLAIESIHKHN 206 (333)
Q Consensus 151 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------~~~~~~~~~~~qi~~~L~~LH~~~ 206 (333)
+++++...+..++||||+++++|.+++..... +++..+..++.|++.||.|||++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999976543 889999999999999999999999
Q ss_pred cEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHh
Q 019953 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQM 286 (333)
Q Consensus 207 ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (333)
|+||||||+||+++.++.+||+|||++..........
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~------------------------------------------- 207 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV------------------------------------------- 207 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE-------------------------------------------
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccce-------------------------------------------
Confidence 9999999999999999999999999998765332110
Q ss_pred hhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 287 NRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 287 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
......+++.|+|||++.+..++.++| |++|+++|+|++
T Consensus 208 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 208 ----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp ----CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred ----eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 011335788999999999999999999 999999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=296.65 Aligned_cols=202 Identities=24% Similarity=0.361 Sum_probs=174.2
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 153 (333)
....+..++|++++.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 345677889999999999999999999987 355899999997543 2234566889999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE------------------------DTLTENVARFYIAQSVLAIESIHKHNYIH 209 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 209 (333)
++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999999999999999999999763 56899999999999999999999999999
Q ss_pred cccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhh
Q 019953 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (333)
Q Consensus 210 rDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
|||||+||+++.++.+||+|||++..+.......
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------------- 231 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYK---------------------------------------------- 231 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------------------------------------------
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCcccc----------------------------------------------
Confidence 9999999999999999999999998654322100
Q ss_pred ccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 290 KLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 290 ~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
......||+.|+|||++.+..++.++| |++|+++|+|+|
T Consensus 232 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 271 (343)
T 1luf_A 232 -ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271 (343)
T ss_dssp -----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence 011346889999999999999999999 999999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=297.39 Aligned_cols=203 Identities=24% Similarity=0.380 Sum_probs=174.9
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecC-------CceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCcee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKS-------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIV 149 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 149 (333)
...+.+..++|.+.+.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.+++.+ +||||+
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhh
Confidence 345677889999999999999999999997643 3579999997642 233446688899999999 999999
Q ss_pred EEEEEEeeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccC
Q 019953 150 KLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIK 213 (333)
Q Consensus 150 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlk 213 (333)
++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|||||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999999999999999999999999997643 48999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccc
Q 019953 214 PDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAF 293 (333)
Q Consensus 214 p~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (333)
|+|||++.++.+||+|||+++......... ...
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~-----------------------------------------------~~~ 251 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYK-----------------------------------------------KTT 251 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTC-----------------------------------------------CCT
T ss_pred cceEEEcCCCcEEEcccCcccccccccccc-----------------------------------------------ccc
Confidence 999999999999999999998765332110 011
Q ss_pred ccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 294 STVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 294 ~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
...||+.|+|||++.+..++.++| ||+||++|+|++
T Consensus 252 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 288 (382)
T 3tt0_A 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288 (382)
T ss_dssp TCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence 335788999999999999999999 999999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.44 Aligned_cols=202 Identities=25% Similarity=0.383 Sum_probs=173.9
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..+.+..++|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 346677789999999999999999999999899999999987542 222334577899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+.+++||||+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999999999764 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
...... ......+++.|+|||++.+..++.++|
T Consensus 265 ~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 297 (377)
T 3cbl_A 265 DGVYAA-----------------------------------------------SGGLRQVPVKWTAPEALNYGRYSSESD 297 (377)
T ss_dssp TSEEEC-----------------------------------------------CSSCCEEEGGGSCHHHHHHCEEEHHHH
T ss_pred CCceee-----------------------------------------------cCCCCCCCcCcCCHhHhccCCCCchhh
Confidence 322110 000123577899999999999999999
Q ss_pred -hHHHHHHHhhhc
Q 019953 318 -WLVSVLHFNSYR 329 (333)
Q Consensus 318 -ws~g~il~~l~t 329 (333)
||+||++|+|+|
T Consensus 298 vwslG~il~el~t 310 (377)
T 3cbl_A 298 VWSFGILLWETFS 310 (377)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHh
Confidence 999999999997
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=295.67 Aligned_cols=201 Identities=24% Similarity=0.406 Sum_probs=164.6
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
.....++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34556789999999999999999999999999999999975432 22334456789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc-----cCCcEEEEeccCccc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-----KNGHMKLSDFGLCKP 235 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~-----~~~~vkl~DFGla~~ 235 (333)
+++||||++ ++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999999996 59999999888899999999999999999999999999999999999994 455699999999986
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGM 314 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ 314 (333)
+..... .....+||+.|+|||++.+. .++.
T Consensus 187 ~~~~~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~ 217 (329)
T 3gbz_A 187 FGIPIR-------------------------------------------------QFTHEIITLWYRPPEILLGSRHYST 217 (329)
T ss_dssp HC------------------------------------------------------------CCTTCCHHHHTTCCCCCT
T ss_pred cCCccc-------------------------------------------------ccCCCcCCccccCHHHhcCCCCCCc
Confidence 542211 11134689999999999874 4899
Q ss_pred ccc-hHHHHHHHhhhcccc
Q 019953 315 ECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~~ 332 (333)
++| ||+||++|+|+++.+
T Consensus 218 ~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 218 SVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp HHHHHHHHHHHHHHHHSSC
T ss_pred HHHHHHHHHHHHHHHHCCC
Confidence 999 999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=294.43 Aligned_cols=197 Identities=30% Similarity=0.551 Sum_probs=172.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhH-----HhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE-----MVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDT 158 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 158 (333)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .........+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 357999999999999999999998899999999986542 11223345678899999999 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
...++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999987653
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC------CCC
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK------KGY 312 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~ 312 (333)
... ....+||+.|+|||++.+ ..+
T Consensus 253 ~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~ 282 (365)
T 2y7j_A 253 GEK--------------------------------------------------LRELCGTPGYLAPEILKCSMDETHPGY 282 (365)
T ss_dssp TCC--------------------------------------------------BCCCCSCGGGCCHHHHHHTTCTTSCCB
T ss_pred Ccc--------------------------------------------------cccCCCCCCccChhhccccccccCcCC
Confidence 321 114579999999999863 468
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| ||+||++|+|+++.
T Consensus 283 ~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 283 GKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp CTTHHHHHHHHHHHHHHHSS
T ss_pred CchhhHHhHHHHHHHHHHCC
Confidence 99999 99999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=294.45 Aligned_cols=202 Identities=23% Similarity=0.376 Sum_probs=171.1
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 152 (333)
..+.+..++|.+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+ .||||++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 356777899999999999999999999973 356789999997543 223345688899999999 899999999
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRED-----------------------TLTENVARFYIAQSVLAIESIHKHNYIH 209 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH 209 (333)
+++...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 99999999999999999999999997643 2789999999999999999999999999
Q ss_pred cccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhh
Q 019953 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (333)
Q Consensus 210 rDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
|||||+|||++.++.+||+|||++..+......
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~----------------------------------------------- 228 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNY----------------------------------------------- 228 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-----------------------------------------------
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccc-----------------------------------------------
Confidence 999999999999999999999999865432211
Q ss_pred ccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 290 KLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 290 ~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.......||+.|+|||++.+..++.++| |++|+++|+|+|
T Consensus 229 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 269 (344)
T 1rjb_A 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269 (344)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence 0111345788999999999999999999 999999999997
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=293.39 Aligned_cols=205 Identities=22% Similarity=0.363 Sum_probs=156.7
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEecCCc---eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEE
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 153 (333)
.++...+..++|++.+.||+|+||.||+|.+..++. .||||++..... .......+.+|+.+++.++||||+++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 345667778899999999999999999999877665 899999976532 2334567889999999999999999999
Q ss_pred EEeeCCeE------EEEEeccCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc
Q 019953 154 SFQDTEYL------YLIMEYLPGGDMMTLLMRED------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK 221 (333)
Q Consensus 154 ~~~~~~~~------~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~ 221 (333)
++...... ++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC
Confidence 99876654 99999999999999986432 5999999999999999999999999999999999999999
Q ss_pred CCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCC
Q 019953 222 NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDY 301 (333)
Q Consensus 222 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 301 (333)
++.+||+|||++.......... ......+++.|
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y 205 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYR-----------------------------------------------QGCASKLPVKW 205 (323)
T ss_dssp TSCEEECCCCC----------------------------------------------------------------CCGGG
T ss_pred CCCEEEeecccccccccccccc-----------------------------------------------ccccccCcccc
Confidence 9999999999998764332110 01123578899
Q ss_pred cccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 302 IAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 302 ~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+|||++.+..++.++| ||+||++|+|++
T Consensus 206 ~aPE~~~~~~~~~~~Di~slG~il~ell~ 234 (323)
T 3qup_A 206 LALESLADNLYTVHSDVWAFGVTMWEIMT 234 (323)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCchhhcCCCCCCccchhhHHHHHHHHHh
Confidence 9999999999999999 999999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=302.38 Aligned_cols=196 Identities=32% Similarity=0.599 Sum_probs=162.2
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh-----hhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-----RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... ......+.+|+.+++.++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 478999999999999999999999999999999997653211 1122346789999999999999999999854 5
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cEEEEeccCcccC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HMKLSDFGLCKPL 236 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~vkl~DFGla~~~ 236 (333)
..++||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5899999999999999998888999999999999999999999999999999999999997544 5999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CCCC
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYG 313 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~ 313 (333)
.... .....+||+.|+|||++.+ ..++
T Consensus 293 ~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 322 (419)
T 3i6u_A 293 GETS--------------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYN 322 (419)
T ss_dssp C-------------------------------------------------------------CTTCCTTTTC----CTTH
T ss_pred CCCc--------------------------------------------------cccccCCCCCccCceeeecCCCCCCC
Confidence 4321 1114579999999999864 6788
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| ||+||++|+|+++.
T Consensus 323 ~~~DiwslG~il~~lltg~ 341 (419)
T 3i6u_A 323 RAVDCWSLGVILFICLSGY 341 (419)
T ss_dssp HHHHHHHHHHHHHHHHHSS
T ss_pred chhhhHhHHHHHHHHHHCC
Confidence 9999 99999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=284.48 Aligned_cols=196 Identities=30% Similarity=0.553 Sum_probs=171.6
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh---hhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 569999999999999999999999999999999876432211 13566888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC----cEEEEeccCcccCCC
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLDC 238 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~----~vkl~DFGla~~~~~ 238 (333)
+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999998877 899999999987543
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
... .....|++.|+|||++.+..++.++|
T Consensus 165 ~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di 194 (283)
T 3bhy_A 165 GNE--------------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADM 194 (283)
T ss_dssp ---------------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred CCc--------------------------------------------------ccccCCCcCccCcceecCCCCCcchhh
Confidence 211 11346999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+++.
T Consensus 195 ~slG~il~~l~~g~ 208 (283)
T 3bhy_A 195 WSIGVITYILLSGA 208 (283)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred hhHHHHHHHHHHCC
Confidence 99999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=293.52 Aligned_cols=199 Identities=25% Similarity=0.415 Sum_probs=166.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC--CceeEEEEEEeeCC
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDTE 159 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~ 159 (333)
.+..++|++++.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.++..+.| +||+++++++...+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 45567899999999999999999987 5688999999875432 23345668889999999987 89999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+++|||+ .+++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++..+...
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99999994 5889999999988999999999999999999999999999999999999996 688999999999876533
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC----------
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---------- 309 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---------- 309 (333)
... ......+||+.|+|||++.+
T Consensus 161 ~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 193 (343)
T 3dbq_A 161 TTS-----------------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193 (343)
T ss_dssp --------------------------------------------------------CCCCSSCCHHHHHHCC--------
T ss_pred ccc-----------------------------------------------ccCCCCcCCcCcCCHHHHhhcccccccccc
Confidence 211 01114579999999999965
Q ss_pred -CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 -KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 -~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| ||+||++|+|+++.
T Consensus 194 ~~~~~~~~DiwslG~il~ell~g~ 217 (343)
T 3dbq_A 194 KSKISPKSDVWSLGCILYYMTYGK 217 (343)
T ss_dssp ---CCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCchhhHHHHHHHHHHHHhCC
Confidence 67899999 99999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.40 Aligned_cols=195 Identities=33% Similarity=0.568 Sum_probs=166.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||.||+|.+..++..||||++....... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 346999999999999999999999999999999997654322 2345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC---CcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN---GHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~---~~vkl~DFGla~~~~~~~~ 241 (333)
||||++|+|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..+.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 9999999999999888889999999999999999999999999999999999999764 4599999999987543221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
....+||+.|+|||++. ..|+.++| ||+
T Consensus 195 --------------------------------------------------~~~~~gt~~y~aPE~l~-~~~~~~~Diwsl 223 (494)
T 3lij_A 195 --------------------------------------------------MKERLGTAYYIAPEVLR-KKYDEKCDVWSI 223 (494)
T ss_dssp --------------------------------------------------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHH
T ss_pred --------------------------------------------------ccccCCCcCeeCHHHHc-ccCCCchhHHHH
Confidence 11457999999999986 56999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 224 G~il~~ll~g~ 234 (494)
T 3lij_A 224 GVILFILLAGY 234 (494)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=283.95 Aligned_cols=197 Identities=21% Similarity=0.321 Sum_probs=171.5
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
.+.+..++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 45667789999999999999999999976 577899999976432 2345788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999999654 4689999999999999999999999999999999999999999999999999986543
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
.... ......+++.|+|||++.+..++.++|
T Consensus 159 ~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 190 (269)
T 4hcu_A 159 DQYT------------------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDV 190 (269)
T ss_dssp HHHH------------------------------------------------STTSTTCCGGGCCHHHHHHCCCCHHHHH
T ss_pred cccc------------------------------------------------cccCcccccccCCHHHhcCCCCCchhhh
Confidence 2210 111345788999999999999999999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
|++|+++|+|++
T Consensus 191 ~slG~~l~~ll~ 202 (269)
T 4hcu_A 191 WSFGVLMWEVFS 202 (269)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHhc
Confidence 999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=297.89 Aligned_cols=194 Identities=28% Similarity=0.433 Sum_probs=163.7
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE---- 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 159 (333)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 3578999999999999999999999999999999986532 22334566888999999999999999999997653
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 --YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 8899999876 579999999999999999999999999999999999999999999999999998654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~ 316 (333)
... ...+||+.|+|||++.+ ..++.++
T Consensus 180 ~~~----------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~ 207 (367)
T 1cm8_A 180 SEM----------------------------------------------------TGYVVTRWYRAPEVILNWMRYTQTV 207 (367)
T ss_dssp SSC----------------------------------------------------CSSCSCGGGCCTHHHHTTTCCCTTH
T ss_pred ccc----------------------------------------------------CcCcCCCCcCCHHHHhCCCCCChhh
Confidence 211 13478999999999987 7899999
Q ss_pred c-hHHHHHHHhhhcccc
Q 019953 317 D-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 317 D-ws~g~il~~l~t~~~ 332 (333)
| ||+||++|+|+++.+
T Consensus 208 DiwslG~il~ell~g~~ 224 (367)
T 1cm8_A 208 DIWSVGCIMAEMITGKT 224 (367)
T ss_dssp HHHHHHHHHHHHHHSSC
T ss_pred hHHHHHHHHHHHHhCCC
Confidence 9 999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=302.14 Aligned_cols=198 Identities=28% Similarity=0.445 Sum_probs=171.2
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC--
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE-- 159 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 159 (333)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 3456789999999999999999999999999999999976432 233456778999999999999999999988655
Q ss_pred eEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE----ccCCcEEEEeccC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKLSDFGL 232 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill----~~~~~vkl~DFGl 232 (333)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 7899999999999999997543 39999999999999999999999999999999999999 7778899999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--- 309 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--- 309 (333)
++....... ..+.+||+.|+|||++.+
T Consensus 163 a~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~ 192 (396)
T 4eut_A 163 ARELEDDEQ--------------------------------------------------FVSLYGTEEYLHPDMYERAVL 192 (396)
T ss_dssp CEECCCGGG--------------------------------------------------SSCSSSCCTTCCHHHHHHHCC
T ss_pred ceEccCCCc--------------------------------------------------cccccCCccccCHHHhhcccc
Confidence 987653321 114579999999999875
Q ss_pred -----CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 -----KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 -----~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| ||+||++|+|+++.
T Consensus 193 ~~~~~~~~~~~~DiwSlG~il~el~tg~ 220 (396)
T 4eut_A 193 RKDHQKKYGATVDLWSIGVTFYHAATGS 220 (396)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred ccccccCCCcHHHHHHHHHHHHHHHHCC
Confidence 56889999 99999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=295.82 Aligned_cols=200 Identities=28% Similarity=0.404 Sum_probs=176.9
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
....+..++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 345667789999999999999999999999999999999987542 233446688899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+..++||||+++++|.+++.....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++....
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999999999998888899999999999999999999996 99999999999999999999999999987542
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.. ......||+.|+|||++.+..++.++|
T Consensus 184 ~~---------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 212 (360)
T 3eqc_A 184 DS---------------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSD 212 (360)
T ss_dssp HH---------------------------------------------------C----CCCCTTCCHHHHTTCCCSHHHH
T ss_pred cc---------------------------------------------------cccCCCCCCCeECHHHHcCCCCCchhh
Confidence 11 111447999999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 213 i~slG~il~~l~~g~ 227 (360)
T 3eqc_A 213 IWSMGLSLVEMAVGR 227 (360)
T ss_dssp HHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.37 Aligned_cols=192 Identities=29% Similarity=0.517 Sum_probs=163.4
Q ss_pred CceE--eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 87 DFEL--LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 87 ~y~~--~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.|.+ .+.||+|+||.||+|.+..+|..||+|++..... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4554 6789999999999999999999999999976432 2345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE--ccCCcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill--~~~~~vkl~DFGla~~~~~~~~ 241 (333)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 9999999999888654 469999999999999999999999999999999999999 5677999999999987653321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
....+||+.|+|||++.+..++.++| |++
T Consensus 245 --------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 274 (373)
T 2x4f_A 245 --------------------------------------------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274 (373)
T ss_dssp --------------------------------------------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHH
T ss_pred --------------------------------------------------cccccCCCcEeChhhccCCCCCcHHhHHHH
Confidence 11346999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 275 G~il~elltg~ 285 (373)
T 2x4f_A 275 GVIAYMLLSGL 285 (373)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=282.80 Aligned_cols=203 Identities=20% Similarity=0.227 Sum_probs=172.5
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 159 (333)
..+..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+ .|++++.+++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 34567889999999999999999999999999999999865432 12367799999999 7899999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc-----EEEEeccCc
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH-----MKLSDFGLC 233 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~-----vkl~DFGla 233 (333)
..++||||+ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 99999999865 46999999999999999999999999999999999999987776 999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
............ .........||+.|+|||++.+..++
T Consensus 159 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (298)
T 1csn_A 159 KFYRDPVTKQHI------------------------------------------PYREKKNLSGTARYMSINTHLGREQS 196 (298)
T ss_dssp EESBCTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred cccccccccccc------------------------------------------cccCccCCCCCcccCCchhhcCCCCC
Confidence 876543211000 00011245799999999999999999
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| ||+|+++|+|+++.
T Consensus 197 ~~~Di~slG~il~el~~g~ 215 (298)
T 1csn_A 197 RRDDLEALGHVFMYFLRGS 215 (298)
T ss_dssp HHHHHHHHHHHHHHHHHSS
T ss_pred hHHHHHHHHHHHHHHHcCC
Confidence 9999 99999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.76 Aligned_cols=202 Identities=23% Similarity=0.337 Sum_probs=174.5
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEE-----ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCRE-----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 152 (333)
..+.+..++|++.+.||+|+||.||+|.+ ..++..||||++..... ......+.+|+.+++.+ +||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 44667778999999999999999999985 35678999999975432 23346688899999999 999999999
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCC
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRED------------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 214 (333)
+++...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 99999999999999999999999997653 489999999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccc
Q 019953 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (333)
Q Consensus 215 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (333)
+||+++.++.+||+|||++.......... ....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~ 206 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYV-----------------------------------------------VKGN 206 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSE-----------------------------------------------ECSS
T ss_pred ceEEEcCCCCEEEccccccccccccccce-----------------------------------------------eccC
Confidence 99999999999999999998765432110 1113
Q ss_pred cCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 295 TVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 295 ~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
..||+.|+|||++.+..++.++| |++|+++|+|+|
T Consensus 207 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 242 (313)
T 1t46_A 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (313)
T ss_dssp SEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 35788999999999999999999 999999999997
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.30 Aligned_cols=200 Identities=21% Similarity=0.330 Sum_probs=167.5
Q ss_pred ccccCCCceEeeeEeeecceEEEEEE-----EecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
..+..++|++++.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35567889999999999999999999 44577899999986432 122334577899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---cE
Q 019953 156 QDTEYLYLIMEYLPGGDMMTLLMRE-------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG---HM 225 (333)
Q Consensus 156 ~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~---~v 225 (333)
......++||||+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999999763 3589999999999999999999999999999999999999555 59
Q ss_pred EEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccc
Q 019953 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (333)
Q Consensus 226 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE 305 (333)
||+|||+++.+...... .......||+.|+|||
T Consensus 224 kL~DFG~a~~~~~~~~~-----------------------------------------------~~~~~~~~t~~y~aPE 256 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-----------------------------------------------RKGGCAMLPVKWMPPE 256 (367)
T ss_dssp EECCCHHHHHHHHHSSC-----------------------------------------------TTCCGGGSCGGGCCHH
T ss_pred EECCCcccccccccccc-----------------------------------------------ccCCCcCCcccEECHH
Confidence 99999999754321100 0111346899999999
Q ss_pred cccCCCCCcccc-hHHHHHHHhhhc
Q 019953 306 VLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 306 ~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
++.+..++.++| ||+||++|+|++
T Consensus 257 ~~~~~~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 257 AFMEGIFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred HhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999 999999999997
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=286.99 Aligned_cols=192 Identities=31% Similarity=0.573 Sum_probs=169.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 579999999999999999999999999999999976432 12345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE---ccCCcEEEEeccCcccCCCCccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill---~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-- 163 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--
Confidence 999999999999888889999999999999999999999999999999999999 778899999999987543211
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
....+|++.|+|||++.+..++.++| |++|
T Consensus 164 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 194 (304)
T 2jam_A 164 -------------------------------------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIG 194 (304)
T ss_dssp -------------------------------------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHH
T ss_pred -------------------------------------------------cccccCCCCccChHHhccCCCCchhhHHHHH
Confidence 11346999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
+++|+|+++.
T Consensus 195 ~il~~l~~g~ 204 (304)
T 2jam_A 195 VITYILLCGY 204 (304)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHHCC
Confidence 9999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=291.43 Aligned_cols=198 Identities=30% Similarity=0.489 Sum_probs=170.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45789999999999999999999999999999999865432 22334557789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+.....
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence 999999999988887778899999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g 321 (333)
......|++.|+|||++.+. .++.++| |++|
T Consensus 180 -----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG 212 (331)
T 4aaa_A 180 -----------------------------------------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIG 212 (331)
T ss_dssp ---------------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHH
T ss_pred -----------------------------------------------ccCCCcCCccccCcccccCCCCcchHHHHHHHH
Confidence 01134699999999999875 7899999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 213 ~il~~l~~g~ 222 (331)
T 4aaa_A 213 CLVTEMFMGE 222 (331)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHhCC
Confidence 9999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.02 Aligned_cols=203 Identities=24% Similarity=0.430 Sum_probs=171.4
Q ss_pred hccccCCCceEeeeEeeecceEEEEEE----EecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
...+...+|++++.||+|+||.||+|. +..+++.||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 334455679999999999999999998 56789999999997653 233456688899999999999999999999
Q ss_pred eeC--CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 156 QDT--EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 156 ~~~--~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
... ..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 876 668999999999999999954 46799999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
+.......... .......||+.|+|||++.+..+
T Consensus 173 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 206 (302)
T 4e5w_A 173 TKAIETDKEYY----------------------------------------------TVKDDRDSPVFWYAPECLMQSKF 206 (302)
T ss_dssp CEECCTTCCEE----------------------------------------------ECCCCTTCCGGGCCHHHHHHCEE
T ss_pred cccccCCCcce----------------------------------------------eccCCCCCCccccCCeeecCCCC
Confidence 98765433110 01113468889999999999999
Q ss_pred Ccccc-hHHHHHHHhhhcc
Q 019953 313 GMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~ 330 (333)
+.++| |++|+++|+|+++
T Consensus 207 ~~~~Di~slG~il~~l~~g 225 (302)
T 4e5w_A 207 YIASDVWSFGVTLHELLTY 225 (302)
T ss_dssp EHHHHHHHHHHHHHHHHTT
T ss_pred CcchhHHHHHHHHHHHHHc
Confidence 99999 9999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.45 Aligned_cols=196 Identities=23% Similarity=0.374 Sum_probs=170.7
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
+.+..++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 3556788999999999999999999765 577899999976432 23457889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999999764 45999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
... ......+|+.|+|||++.+..++.++| |
T Consensus 158 ~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 189 (268)
T 3sxs_A 158 QYV------------------------------------------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189 (268)
T ss_dssp CEE------------------------------------------------ECCSCCCCGGGCCHHHHHHSEEETTHHHH
T ss_pred hhh------------------------------------------------cccCCCcCcccCCHHHHhccCCchhhhhH
Confidence 211 011335778899999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|++
T Consensus 190 slG~il~~l~~ 200 (268)
T 3sxs_A 190 AFGILMWEVFS 200 (268)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHc
Confidence 99999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=293.86 Aligned_cols=194 Identities=26% Similarity=0.389 Sum_probs=160.8
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE---- 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 159 (333)
..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4579999999999999999999999999999999987542 12334456788999999999999999999997654
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 --YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.+|+||||++ ++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7899999996 57888875 458999999999999999999999999999999999999999999999999998654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
... .....+||+.|+|||++.+..++.++|
T Consensus 179 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 208 (371)
T 2xrw_A 179 TSF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVD 208 (371)
T ss_dssp -------------------------------------------------------------CTTCCHHHHTTCCCCTTHH
T ss_pred ccc--------------------------------------------------ccCCceecCCccCHHHhcCCCCCchHh
Confidence 221 011347999999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 209 iwslG~il~el~~g~ 223 (371)
T 2xrw_A 209 IWSVGCIMGEMIKGG 223 (371)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=297.03 Aligned_cols=201 Identities=39% Similarity=0.701 Sum_probs=169.6
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHh-hhhhHHHHHHHHHHHHHh-cCCceeEEEEEEee
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMV-KRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD 157 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 157 (333)
+..++|++++.||+|+||.||+|.+. .+++.||||++...... .......+.+|+.+++.+ .||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34478999999999999999999984 48999999998754211 111223356689999999 69999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
...+++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999998654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCcc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGME 315 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~ 315 (333)
.... ......+||+.|+|||++.+ ..++.+
T Consensus 211 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 242 (355)
T 1vzo_A 211 ADET------------------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKA 242 (355)
T ss_dssp GGGG------------------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTH
T ss_pred cCCC------------------------------------------------CcccCcccCcCccChhhhcCCCCCCCch
Confidence 3221 11124579999999999986 457899
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| |++||++|+|+++.
T Consensus 243 ~DvwslG~il~ell~g~ 259 (355)
T 1vzo_A 243 VDWWSLGVLMYELLTGA 259 (355)
T ss_dssp HHHHHHHHHHHHHHHSS
T ss_pred hhHHHHHHHHHHHHHCC
Confidence 99 99999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=305.80 Aligned_cols=194 Identities=13% Similarity=0.192 Sum_probs=162.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHH---HHHHHhcCCceeEEE-------E
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAER---NLLAEVASHCIVKLY-------Y 153 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~ 153 (333)
..++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+ .+++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999999999999999999754433444556788899 455566899999988 6
Q ss_pred EEeeCC-----------------eEEEEEeccCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCcEe
Q 019953 154 SFQDTE-----------------YLYLIMEYLPGGDMMTLLMREDTLTE-------NVARFYIAQSVLAIESIHKHNYIH 209 (333)
Q Consensus 154 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~qi~~~L~~LH~~~ivH 209 (333)
++...+ ..|+||||+ +|+|.+++.....+++ ..+..++.|++.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 665543 289999999 6899999976554554 777789999999999999999999
Q ss_pred cccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhh
Q 019953 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (333)
Q Consensus 210 rDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
|||||+|||++.++.+||+|||+++.....
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-------------------------------------------------- 259 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-------------------------------------------------- 259 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTCE--------------------------------------------------
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCCc--------------------------------------------------
Confidence 999999999999999999999999854321
Q ss_pred ccccccCCCCCCcccccccCC-----------CCCcccc-hHHHHHHHhhhccc
Q 019953 290 KLAFSTVGTPDYIAPEVLLKK-----------GYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 290 ~~~~~~~gt~~y~APE~~~~~-----------~~~~~~D-ws~g~il~~l~t~~ 331 (333)
....+| +.|+|||++.+. .++.++| ||+||++|+|+++.
T Consensus 260 --~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 260 --VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp --EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred --ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 114468 999999999987 8999999 99999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=281.55 Aligned_cols=199 Identities=30% Similarity=0.518 Sum_probs=173.8
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhH------HhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE------MVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSF 155 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 155 (333)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... .........+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34679999999999999999999999999999999986542 111233456788999999995 99999999999
Q ss_pred eeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 156 QDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 156 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
...+..++||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc------C
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL------K 309 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~------~ 309 (333)
...... .....|++.|+|||++. +
T Consensus 174 ~~~~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 203 (298)
T 1phk_A 174 LDPGEK--------------------------------------------------LREVCGTPSYLAPEIIECSMNDNH 203 (298)
T ss_dssp CCTTCC--------------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTS
T ss_pred cCCCcc--------------------------------------------------cccccCCccccCHHHhcccccccc
Confidence 643221 11346999999999985 4
Q ss_pred CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| |++|+++|+|+++.
T Consensus 204 ~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 204 PGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCcccccHhHHHHHHHHHHCC
Confidence 67899999 99999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=293.34 Aligned_cols=201 Identities=31% Similarity=0.506 Sum_probs=167.1
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh--hhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV--KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
++|++.+.||+|+||.||+|.+..++..||+|++...... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999999999999999999765432 23445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 019953 164 IMEYLPGGDMMTLLMR----------------------------------------EDTLTENVARFYIAQSVLAIESIH 203 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~----------------------------------------~~~~~~~~~~~~~~qi~~~L~~LH 203 (333)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998842 112357778889999999999999
Q ss_pred hCCcEecccCCCcEEEccCC--cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHh
Q 019953 204 KHNYIHRDIKPDNLLLDKNG--HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQL 281 (333)
Q Consensus 204 ~~~ivHrDlkp~Nill~~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (333)
++||+||||||+||+++.++ .+||+|||++..+.......
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-------------------------------------- 227 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-------------------------------------- 227 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc--------------------------------------
Confidence 99999999999999998776 89999999998654321100
Q ss_pred HHHHhhhhccccccCCCCCCcccccccC--CCCCcccc-hHHHHHHHhhhccc
Q 019953 282 QHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 282 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
........||+.|+|||++.+ ..++.++| |++||++|+|+++.
T Consensus 228 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~ 273 (345)
T 3hko_A 228 -------YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273 (345)
T ss_dssp --------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred -------cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 001114479999999999975 67899999 99999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=293.91 Aligned_cols=202 Identities=27% Similarity=0.398 Sum_probs=168.5
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee------
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------ 157 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 157 (333)
..++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 35789999999999999999999999999999999865432 22223456789999999999999999999876
Q ss_pred --CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 158 --TEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 158 --~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
.+.+++||||+++ +|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4568999999965 67766654 3579999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCC
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYG 313 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~ 313 (333)
.+....... .......+||+.|+|||++.+ ..++
T Consensus 173 ~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (351)
T 3mi9_A 173 AFSLAKNSQ---------------------------------------------PNRYTNRVVTLWYRPPELLLGERDYG 207 (351)
T ss_dssp ECCCCSSSS---------------------------------------------CCCCCSSCSCGGGCCHHHHTTCCSCC
T ss_pred ccccccccc---------------------------------------------ccccCCcccccCccCchhhcCCCCCC
Confidence 765322110 011124579999999999986 5689
Q ss_pred cccc-hHHHHHHHhhhcccc
Q 019953 314 MECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~~ 332 (333)
.++| ||+||++|+|+++.+
T Consensus 208 ~~~DiwslG~il~ell~g~~ 227 (351)
T 3mi9_A 208 PPIDLWGAGCIMAEMWTRSP 227 (351)
T ss_dssp THHHHHHHHHHHHHHHHSSC
T ss_pred cHhHHHHHHHHHHHHHhCCC
Confidence 9999 999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=286.83 Aligned_cols=200 Identities=25% Similarity=0.373 Sum_probs=177.2
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
+..+.+..++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3567788899999999999999999999999999999999987542 234567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999999763 4599999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
....... ......+++.|+|||++.+..++.+
T Consensus 161 ~~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 192 (288)
T 3kfa_A 161 MTGDTYT------------------------------------------------AHAGAKFPIKWTAPESLAYNKFSIK 192 (288)
T ss_dssp SCSSSSE------------------------------------------------EETTEEECGGGCCHHHHHHCCCCHH
T ss_pred ccCCccc------------------------------------------------cccCCccccCcCChhhhccCCCCch
Confidence 6533211 1113357889999999999999999
Q ss_pred cc-hHHHHHHHhhhc
Q 019953 316 CD-WLVSVLHFNSYR 329 (333)
Q Consensus 316 ~D-ws~g~il~~l~t 329 (333)
+| |++|+++|+|++
T Consensus 193 ~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 193 SDVWAFGVLLWEIAT 207 (288)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHh
Confidence 99 999999999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=282.52 Aligned_cols=197 Identities=27% Similarity=0.468 Sum_probs=172.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 579999999999999999999999999999999875432 234466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--- 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE---
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch---
Confidence 99999999999987778999999999999999999999999999999999999999999999999999865422110
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D-ws~g~i 323 (333)
.......|++.|+|||++.+..+ +.++| |++|++
T Consensus 162 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 197 (276)
T 2yex_A 162 --------------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197 (276)
T ss_dssp --------------------------------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHH
T ss_pred --------------------------------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHH
Confidence 01114469999999999988775 78999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 198 l~~l~~g~ 205 (276)
T 2yex_A 198 LTAMLAGE 205 (276)
T ss_dssp HHHHHHSS
T ss_pred HHHHHhCC
Confidence 99999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=293.19 Aligned_cols=199 Identities=31% Similarity=0.506 Sum_probs=163.7
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh--hhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK--RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
.++|++++.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 578999999999999999999999999999999997543211 111235678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999975 888888654 4689999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WL 319 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws 319 (333)
.....+||+.|+|||++.+. .++.++| ||
T Consensus 168 -------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 198 (346)
T 1ua2_A 168 -------------------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWA 198 (346)
T ss_dssp -------------------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred -------------------------------------------------cCCcccccccccCchHhhCCCCCCchhhhHh
Confidence 01134799999999999764 5899999 99
Q ss_pred HHHHHHhhhccccC
Q 019953 320 VSVLHFNSYRFLEF 333 (333)
Q Consensus 320 ~g~il~~l~t~~~~ 333 (333)
+||++|+|+++.++
T Consensus 199 lG~il~ell~g~~~ 212 (346)
T 1ua2_A 199 VGCILAELLLRVPF 212 (346)
T ss_dssp HHHHHHHHHHSSCS
T ss_pred HHHHHHHHHHCCCC
Confidence 99999999987653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=293.14 Aligned_cols=199 Identities=22% Similarity=0.260 Sum_probs=167.4
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
+.+.+..++|++.+.||+|+||.||+|.+. ++.||||++..... .......|+.+++.++||||+++++++...
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 445566789999999999999999999865 88999999975432 223345588889999999999999999874
Q ss_pred C----eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEecccCCCcEEEccCCc
Q 019953 159 E----YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH----------NYIHRDIKPDNLLLDKNGH 224 (333)
Q Consensus 159 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~----------~ivHrDlkp~Nill~~~~~ 224 (333)
. .+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 3 47999999999999999966 4599999999999999999999999 9999999999999999999
Q ss_pred EEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccc
Q 019953 225 MKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304 (333)
Q Consensus 225 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~AP 304 (333)
+||+|||+++.+...... ......+||+.|+||
T Consensus 170 ~kL~DFg~a~~~~~~~~~-----------------------------------------------~~~~~~~gt~~y~aP 202 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSA-----------------------------------------------GDTHGQVGTRRYMAP 202 (322)
T ss_dssp EEECCCTTCEEECTTSCC-----------------------------------------------CCCTTCCCCGGGCCH
T ss_pred EEEccCCcccccccccCc-----------------------------------------------cccccCccCccccCH
Confidence 999999999876533211 011134799999999
Q ss_pred ccccC-----CCCCcccc-hHHHHHHHhhhccc
Q 019953 305 EVLLK-----KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 305 E~~~~-----~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
|++.+ ..++.++| ||+||++|+|+|+.
T Consensus 203 E~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 235 (322)
T 3soc_A 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235 (322)
T ss_dssp HHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence 99987 45677899 99999999999963
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=295.19 Aligned_cols=205 Identities=17% Similarity=0.172 Sum_probs=165.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecC-----CceEEEEecchhHHhhhhh--------HHHHHHHHHHHHHhcCCceeE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKS-----GNIYAMKKLKKSEMVKRGQ--------VEHVRAERNLLAEVASHCIVK 150 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~ 150 (333)
..++|++.+.||+|+||.||+|.+..+ ++.||||++.......... ......|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999988664 5889999987543211111 112334555667778999999
Q ss_pred EEEEEeeC----CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc--cCC
Q 019953 151 LYYSFQDT----EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--KNG 223 (333)
Q Consensus 151 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~--~~~ 223 (333)
+++++... ...++||||+ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 5689999999 99999999775 6799999999999999999999999999999999999999 889
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|||+++.+......... ........+||+.|+|
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~a 229 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAY------------------------------------------AADPKRCHDGTIEFTS 229 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCS------------------------------------------SCCSSCCCCCCTTTCC
T ss_pred eEEEEECCcceecccCCccccc------------------------------------------ccCcccccCCCCCccC
Confidence 9999999999876543211100 0001124569999999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
||++.+..++.++| ||+||++|+|+|+.
T Consensus 230 PE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 230 IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred HHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999 99999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=283.28 Aligned_cols=194 Identities=28% Similarity=0.524 Sum_probs=166.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++......++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 467999999999999999999999999999999997653 223456688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE---ccCCcEEEEeccCcccCC
Q 019953 165 MEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill---~~~~~vkl~DFGla~~~~ 237 (333)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999998854 3679999999999999999999999999999999999999 456789999999998654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... .....||+.|+|||++. ..++.++|
T Consensus 179 ~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~D 207 (285)
T 3is5_A 179 SDEH--------------------------------------------------STNAAGTALYMAPEVFK-RDVTFKCD 207 (285)
T ss_dssp ----------------------------------------------------------CTTGGGCCHHHHT-TCCCHHHH
T ss_pred Cccc--------------------------------------------------CcCcccccCcCChHHhc-cCCCcccC
Confidence 3211 11346999999999986 56899999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+++.
T Consensus 208 i~slG~il~~ll~g~ 222 (285)
T 3is5_A 208 IWSAGVVMYFLLTGC 222 (285)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred eehHHHHHHHHHhCC
Confidence 99999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=290.64 Aligned_cols=197 Identities=21% Similarity=0.336 Sum_probs=161.5
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceE----EEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
+..++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 34578999999999999999999988777654 777775432 223446688899999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
. .++|++|+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999977 4579999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
...... ......||+.|+|||++.+..++.++|
T Consensus 169 ~~~~~~-----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3poz_A 169 AEEKEY-----------------------------------------------HAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp TTCC------------------------------------------------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred CCcccc-----------------------------------------------cccCCCccccccChHHhccCCCCchhh
Confidence 332110 011335788999999999999999999
Q ss_pred -hHHHHHHHhhhc
Q 019953 318 -WLVSVLHFNSYR 329 (333)
Q Consensus 318 -ws~g~il~~l~t 329 (333)
||+||++|+|+|
T Consensus 202 i~slG~il~ellt 214 (327)
T 3poz_A 202 VWSYGVTVWELMT 214 (327)
T ss_dssp HHHHHHHHHHHHT
T ss_pred hhhhHHHHHHHHh
Confidence 999999999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=290.43 Aligned_cols=204 Identities=24% Similarity=0.390 Sum_probs=173.8
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEe-------cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCce
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREK-------KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCI 148 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 148 (333)
..+.+.+..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+ +||||
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCE
Confidence 34567778899999999999999999999875 457789999997542 223456688899999999 89999
Q ss_pred eEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccc
Q 019953 149 VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDI 212 (333)
Q Consensus 149 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDl 212 (333)
+++++++...+.+++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 183 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 999999999999999999999999999997643 3889999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccc
Q 019953 213 KPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLA 292 (333)
Q Consensus 213 kp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (333)
||+||+++.++.+||+|||++.......... ..
T Consensus 184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-----------------------------------------------~~ 216 (334)
T 2pvf_A 184 AARNVLVTENNVMKIADFGLARDINNIDYYK-----------------------------------------------KT 216 (334)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECTTTSSEE-----------------------------------------------CC
T ss_pred ccceEEEcCCCCEEEcccccccccccccccc-----------------------------------------------cc
Confidence 9999999999999999999998765332110 01
Q ss_pred cccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 293 FSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 293 ~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
....+++.|+|||++.+..++.++| |++|+++|+|++
T Consensus 217 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp SCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred CCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence 1235788999999999999999999 999999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.48 Aligned_cols=193 Identities=30% Similarity=0.432 Sum_probs=161.0
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee----
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD---- 157 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 157 (333)
....++|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 3456789999999999999999999999999999999865421 12359999999999999999999843
Q ss_pred ----------------------------------CCeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHH
Q 019953 158 ----------------------------------TEYLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAI 199 (333)
Q Consensus 158 ----------------------------------~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~L 199 (333)
..++++||||++ ++|.+.+. ....+++..+..++.|++.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 345899999997 57666654 457899999999999999999
Q ss_pred HHHHhCCcEecccCCCcEEEc-cCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCch
Q 019953 200 ESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPH 278 (333)
Q Consensus 200 ~~LH~~~ivHrDlkp~Nill~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (333)
.|||++||+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~------------------------------------- 197 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP------------------------------------- 197 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-------------------------------------
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-------------------------------------
Confidence 999999999999999999998 688999999999987643321
Q ss_pred HHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-hHHHHHHHhhhcccc
Q 019953 279 EQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-ws~g~il~~l~t~~~ 332 (333)
.....||+.|+|||++.+. .++.++| ||+||++|+|+++.+
T Consensus 198 -------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 198 -------------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp -------------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 1134689999999999875 4999999 999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=284.79 Aligned_cols=201 Identities=28% Similarity=0.483 Sum_probs=165.3
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
....++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34557899999999999999999999999999999998754333344556688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 162 YLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998864 4579999999999999999999999999999999999999999999999999988654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... ......|++.|+|||++.+..++.++|
T Consensus 188 ~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (310)
T 2wqm_A 188 SKTT-------------------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSD 218 (310)
T ss_dssp ------------------------------------------------------------CCSSCCHHHHTTCCCCHHHH
T ss_pred CCCc-------------------------------------------------cccccCCCeeEeChHHhCCCCCCchhh
Confidence 3211 011346899999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+++.
T Consensus 219 v~slG~il~~l~~g~ 233 (310)
T 2wqm_A 219 IWSLGCLLYEMAALQ 233 (310)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=296.19 Aligned_cols=198 Identities=25% Similarity=0.420 Sum_probs=165.9
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc--CCceeEEEEEEeeCCe
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA--SHCIVKLYYSFQDTEY 160 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~ 160 (333)
+...+|++++.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.+. ||||+++++++...+.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 344569999999999999999998764 89999999975432 2334567889999999997 4899999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|+||| +.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999999 56889999999888999999999999999999999999999999999999995 6899999999998764322
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-----------
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK----------- 309 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----------- 309 (333)
.. ......+||+.|+|||++.+
T Consensus 209 ~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 241 (390)
T 2zmd_A 209 TS-----------------------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241 (390)
T ss_dssp ----------------------------------------------------CCSCCCGGGCCHHHHHCC----------
T ss_pred cc-----------------------------------------------ccCCCCCcCCCccChHHhhhccccccccccc
Confidence 10 01124579999999999975
Q ss_pred CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| ||+||++|+|+++.
T Consensus 242 ~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 242 SKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp --CCHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCChhhHHHHHHHHHHHHHCC
Confidence 46899999 99999999999865
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=292.15 Aligned_cols=202 Identities=24% Similarity=0.317 Sum_probs=174.0
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
.......++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34455678999999999999999999996 468999999887542 23456688899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999999986543 58999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCc
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ 314 (333)
........ .......||+.|+|||++.+..++.
T Consensus 188 ~~~~~~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 220 (321)
T 2qkw_B 188 KGTELDQT-----------------------------------------------HLSTVVKGTLGYIDPEYFIKGRLTE 220 (321)
T ss_dssp ECSSSSCC-----------------------------------------------CCBCCCEEETTTCCHHHHHHCBCCT
T ss_pred cccccccc-----------------------------------------------ccccccCCCccccCHHHhcCCCCCc
Confidence 65422110 0011346899999999999999999
Q ss_pred ccc-hHHHHHHHhhhccc
Q 019953 315 ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~ 331 (333)
++| |++|+++|+|+++.
T Consensus 221 ~~Di~slG~il~ell~g~ 238 (321)
T 2qkw_B 221 KSDVYSFGVVLFEVLCAR 238 (321)
T ss_dssp HHHHHHHHHHHHHHHHCC
T ss_pred ccchHhHHHHHHHHHhCC
Confidence 999 99999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=283.57 Aligned_cols=199 Identities=22% Similarity=0.392 Sum_probs=171.1
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
...+.+..++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 4567788899999999999999999999875 677899999976432 23457889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999976 467999999999999999999999999999999999999999999999999999865
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
...... ......+|+.|+|||++.+..++.++
T Consensus 171 ~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 202 (283)
T 3gen_A 171 LDDEYT------------------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKS 202 (283)
T ss_dssp CCHHHH------------------------------------------------STTSTTSCGGGCCHHHHHHCCCSHHH
T ss_pred cccccc------------------------------------------------cccCCccCcccCCHHHhccCCCCchh
Confidence 432110 11133578899999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| |++|+++|+|+|
T Consensus 203 Dv~slG~~l~~l~t 216 (283)
T 3gen_A 203 DIWAFGVLMWEIYS 216 (283)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHh
Confidence 9 999999999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=296.77 Aligned_cols=193 Identities=23% Similarity=0.425 Sum_probs=168.2
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh------cCCceeEEEEEEe
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV------ASHCIVKLYYSFQ 156 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~ 156 (333)
....+|++++.||+|+||.||+|.+..+++.||||++.... .....+..|+.+++.+ .|+||+.+++.+.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 34578999999999999999999999999999999997643 2234466788888887 4669999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc--EEEEeccC
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH--MKLSDFGL 232 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~--vkl~DFGl 232 (333)
..+.+++||||+. ++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999995 68999887654 5999999999999999999999999999999999999999887 99999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
+....... .+.+||+.|+|||++.+..+
T Consensus 249 a~~~~~~~----------------------------------------------------~~~~gt~~y~aPE~~~~~~~ 276 (429)
T 3kvw_A 249 SCYEHQRV----------------------------------------------------YTYIQSRFYRAPEVILGARY 276 (429)
T ss_dssp CEETTCCC----------------------------------------------------CSSCSCGGGCCHHHHHTBCC
T ss_pred ceecCCcc----------------------------------------------------cccCCCCCccChHHHhCCCC
Confidence 97543211 14479999999999999999
Q ss_pred Ccccc-hHHHHHHHhhhcccc
Q 019953 313 GMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~~ 332 (333)
+.++| ||+||++|+|+++.+
T Consensus 277 ~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 277 GMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp CTHHHHHHHHHHHHHHHHSSC
T ss_pred CchHHHHhHHHHHHHHHhCCC
Confidence 99999 999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.35 Aligned_cols=203 Identities=23% Similarity=0.438 Sum_probs=166.9
Q ss_pred cCCCceEe-eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeE
Q 019953 84 CVDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 84 ~~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 161 (333)
..+.|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..+ +||||+++++++...+.+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34679885 78999999999999999999999999997542 23345678899999985 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc---EEEEeccCcccCCC
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKPLDC 238 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~---vkl~DFGla~~~~~ 238 (333)
++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999998776 99999999986643
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-----CCCC
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-----KGYG 313 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~ 313 (333)
....... ........+||+.|+|||++.+ ..++
T Consensus 167 ~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 204 (316)
T 2ac3_A 167 NGDCSPI------------------------------------------STPELLTPCGSAEYMAPEVVEAFSEEASIYD 204 (316)
T ss_dssp ---------------------------------------------------------CCSGGGCCHHHHHHTSHHHHHHT
T ss_pred CCccccc------------------------------------------cccccccccCCcCccChHHhhcccccccCCC
Confidence 2210000 0001113469999999999975 5689
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| |++||++|+|+++.
T Consensus 205 ~~~DiwslG~il~~l~~g~ 223 (316)
T 2ac3_A 205 KRCDLWSLGVILYILLSGY 223 (316)
T ss_dssp TTHHHHHHHHHHHHHHHSS
T ss_pred cccccHhHHHHHHHHHHCC
Confidence 9999 99999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=283.35 Aligned_cols=200 Identities=25% Similarity=0.348 Sum_probs=160.7
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
..+.+..++|++.+.||+|+||.||+|.+..+ +..||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 34567778999999999999999999998653 4579999987542 223455688899999999999999999998
Q ss_pred eeCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 156 QDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 156 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
. ++..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 5 556899999999999999997654 79999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCc
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ 314 (333)
........ ......+++.|+|||++.+..++.
T Consensus 165 ~~~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ 196 (281)
T 1mp8_A 165 YMEDSTYY------------------------------------------------KASKGKLPIKWMAPESINFRRFTS 196 (281)
T ss_dssp --------------------------------------------------------------CCGGGCCHHHHHHCCCSH
T ss_pred ccCccccc------------------------------------------------ccccCCCcccccChhhcccCCCCC
Confidence 76433211 011235788999999999999999
Q ss_pred ccc-hHHHHHHHhhhc
Q 019953 315 ECD-WLVSVLHFNSYR 329 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t 329 (333)
++| ||+|+++|+|++
T Consensus 197 ~~Di~slG~~l~ell~ 212 (281)
T 1mp8_A 197 ASDVWMFGVCMWEILM 212 (281)
T ss_dssp HHHHHHHHHHHHHHHT
T ss_pred ccCchHHHHHHHHHHh
Confidence 999 999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=289.67 Aligned_cols=202 Identities=23% Similarity=0.374 Sum_probs=173.2
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCc-----eEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN-----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 152 (333)
..+.+..++|++.+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 3567778999999999999999999999876654 79999987543 223446688899999999 899999999
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEE
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMR--------------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL 218 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nil 218 (333)
+++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 999999999999999999999999864 235799999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCC
Q 019953 219 LDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGT 298 (333)
Q Consensus 219 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 298 (333)
++.++.+||+|||++......... .......||
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~ 229 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNY-----------------------------------------------IVKGNARLP 229 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTS-----------------------------------------------EECSSCEEC
T ss_pred ECCCCeEEECccccccccccccce-----------------------------------------------eecCCCCCC
Confidence 999999999999999865432210 011133578
Q ss_pred CCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 299 PDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 299 ~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+.|+|||++.+..++.++| ||+|+++|+|+|
T Consensus 230 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 261 (333)
T 2i1m_A 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261 (333)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred ccccCHHHhccCCCChHHHHHHHHHHHHHHHc
Confidence 8999999999999999999 999999999997
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=300.07 Aligned_cols=192 Identities=26% Similarity=0.464 Sum_probs=168.3
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..+.+..++|++.+.||+|+||.||+|.+. |+.||||+++... ....+.+|+.+|+.++||||+++++++...
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 567888899999999999999999999864 7899999997643 235588899999999999999999998765
Q ss_pred C-eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 159 E-YLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 159 ~-~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
. .+++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 4 7999999999999999997654 379999999999999999999999999999999999999999999999999985
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
..... ....+++.|+|||++.+..++.+
T Consensus 339 ~~~~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~ 366 (450)
T 1k9a_A 339 ASSTQ----------------------------------------------------DTGKLPVKWTAPEALREKKFSTK 366 (450)
T ss_dssp CC----------------------------------------------------------CCCTTTSCHHHHHSSCCCHH
T ss_pred ccccc----------------------------------------------------cCCCCCcceeCHHHhcCCCCCcH
Confidence 43211 02257889999999999999999
Q ss_pred cc-hHHHHHHHhhhc
Q 019953 316 CD-WLVSVLHFNSYR 329 (333)
Q Consensus 316 ~D-ws~g~il~~l~t 329 (333)
+| ||+||++|+|+|
T Consensus 367 sDvwslG~~l~el~t 381 (450)
T 1k9a_A 367 SDVWSFGILLWEIYS 381 (450)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHh
Confidence 99 999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=278.80 Aligned_cols=195 Identities=24% Similarity=0.386 Sum_probs=170.1
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee----CC
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----TE 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~ 159 (333)
....|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34568999999999999999999999999999999876533 23345678889999999999999999998865 45
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEc-cCCcEEEEeccCcccC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLD-KNGHMKLSDFGLCKPL 236 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~-~~~~vkl~DFGla~~~ 236 (333)
.+++||||+++++|.+++.....+++..+..++.|++.||.|||++| |+||||||+||+++ .++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 68999999999999999988888999999999999999999999999 99999999999998 7899999999999754
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
.... .....||+.|+|||++.+ .++.++
T Consensus 183 ~~~~---------------------------------------------------~~~~~~t~~y~aPE~~~~-~~~~~~ 210 (290)
T 1t4h_A 183 RASF---------------------------------------------------AKAVIGTPEFMAPEMYEE-KYDESV 210 (290)
T ss_dssp CTTS---------------------------------------------------BEESCSSCCCCCGGGGGT-CCCTHH
T ss_pred cccc---------------------------------------------------cccccCCcCcCCHHHHhc-cCCCcc
Confidence 3221 113469999999998874 599999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| |++|+++|+|+++.
T Consensus 211 Di~slG~~l~~l~~g~ 226 (290)
T 1t4h_A 211 DVYAFGMCMLEMATSE 226 (290)
T ss_dssp HHHHHHHHHHHHHHSS
T ss_pred hHHHHHHHHHHHHhCC
Confidence 9 99999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=296.39 Aligned_cols=200 Identities=21% Similarity=0.324 Sum_probs=161.5
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
.+..++|.+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 456678999999999999999999876 467789999997542 223445688999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999997654 69999999999999999999999999999999999999999999999999998764
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
...... .......+++.|+|||++.+..++.++|
T Consensus 199 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 232 (373)
T 2qol_A 199 DDPEAA----------------------------------------------YTTRGGKIPIRWTSPEAIAYRKFTSASD 232 (373)
T ss_dssp -------------------------------------------------------------CTTSCHHHHHHCCCCHHHH
T ss_pred cCCccc----------------------------------------------eeccCCCcCCCccChhhhccCCcCchhc
Confidence 322100 0001224678999999999999999999
Q ss_pred -hHHHHHHHhhhc
Q 019953 318 -WLVSVLHFNSYR 329 (333)
Q Consensus 318 -ws~g~il~~l~t 329 (333)
||+|+++|+|++
T Consensus 233 v~SlG~il~ellt 245 (373)
T 2qol_A 233 VWSYGIVLWEVMS 245 (373)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHh
Confidence 999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=280.97 Aligned_cols=189 Identities=26% Similarity=0.475 Sum_probs=166.7
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee--------
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-------- 157 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 157 (333)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 57999999999999999999999899999999987542 125579999999999999999998854
Q ss_pred --------CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEE
Q 019953 158 --------TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKL 227 (333)
Q Consensus 158 --------~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl 227 (333)
...+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 44589999999999999999654 57999999999999999999999999999999999999999999999
Q ss_pred EeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc
Q 019953 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (333)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 307 (333)
+|||++........ .....|++.|+|||++
T Consensus 164 ~Dfg~~~~~~~~~~--------------------------------------------------~~~~~~~~~y~aPE~~ 193 (284)
T 2a19_B 164 GDFGLVTSLKNDGK--------------------------------------------------RTRSKGTLRYMSPEQI 193 (284)
T ss_dssp CCCTTCEESSCCSC--------------------------------------------------CCCCCSCCTTSCHHHH
T ss_pred Ccchhheecccccc--------------------------------------------------ccccCCcccccChhhh
Confidence 99999987653221 0134699999999999
Q ss_pred cCCCCCcccc-hHHHHHHHhhhccc
Q 019953 308 LKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 308 ~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.+..++.++| |++|+++|+|+++.
T Consensus 194 ~~~~~~~~~Di~slG~il~~l~~~~ 218 (284)
T 2a19_B 194 SSQDYGKEVDLYALGLILAELLHVC 218 (284)
T ss_dssp HCSCCCTHHHHHHHHHHHHHHHSCC
T ss_pred ccCCCcchhhhHHHHHHHHHHHhcC
Confidence 9999999999 99999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=288.28 Aligned_cols=195 Identities=32% Similarity=0.619 Sum_probs=165.1
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh-----hhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----KRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999998754321 1122334778999999999999999999987655
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc---EEEEeccCcccCC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFGLCKPLD 237 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~---vkl~DFGla~~~~ 237 (333)
.++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987664 9999999998764
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCCCc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGYGM 314 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~ 314 (333)
.... .....||+.|+|||++. +..++.
T Consensus 169 ~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~ 198 (322)
T 2ycf_A 169 ETSL--------------------------------------------------MRTLCGTPTYLAPEVLVSVGTAGYNR 198 (322)
T ss_dssp CCHH--------------------------------------------------HHHHHSCCTTCCHHHHHHTTTTTCTT
T ss_pred cccc--------------------------------------------------cccccCCcCccCchhhccCCCCCCCc
Confidence 3211 11346999999999974 567899
Q ss_pred ccc-hHHHHHHHhhhccc
Q 019953 315 ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~ 331 (333)
++| |++||++|+|+++.
T Consensus 199 ~~Di~slG~il~~l~~g~ 216 (322)
T 2ycf_A 199 AVDCWSLGVILFICLSGY 216 (322)
T ss_dssp HHHHHHHHHHHHHHHHSS
T ss_pred hhhHHHHHHHHHHHHhCC
Confidence 999 99999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=294.30 Aligned_cols=200 Identities=25% Similarity=0.402 Sum_probs=170.3
Q ss_pred hhhhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc--------CC
Q 019953 75 FMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA--------SH 146 (333)
Q Consensus 75 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~ 146 (333)
+..+....+..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+. |+
T Consensus 26 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~ 101 (397)
T 1wak_A 26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNRE 101 (397)
T ss_dssp CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred ceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcc
Confidence 3344555666789999999999999999999999999999999997542 23455778999999986 77
Q ss_pred ceeEEEEEEe----eCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEE
Q 019953 147 CIVKLYYSFQ----DTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLL 219 (333)
Q Consensus 147 ~iv~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill 219 (333)
||+++++++. ....+++||||+ +++|.+.+... ..+++..+..++.|++.||.|||++ ||+||||||+|||+
T Consensus 102 ~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll 180 (397)
T 1wak_A 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180 (397)
T ss_dssp GBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred eeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence 8999999987 556899999999 56666666543 4699999999999999999999998 99999999999999
Q ss_pred ccCC-------------------------------------------------cEEEEeccCcccCCCCccccccccccc
Q 019953 220 DKNG-------------------------------------------------HMKLSDFGLCKPLDCSTLYAIHEHKTI 250 (333)
Q Consensus 220 ~~~~-------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~~ 250 (333)
+.++ .+||+|||++.......
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~---------- 250 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---------- 250 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------
Confidence 9775 79999999998654221
Q ss_pred CccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 251 DDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
...+||+.|+|||++.+..++.++| ||+||++|+|++
T Consensus 251 ------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 288 (397)
T 1wak_A 251 ------------------------------------------TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288 (397)
T ss_dssp ------------------------------------------CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhh
Confidence 1346999999999999999999999 999999999998
Q ss_pred cc
Q 019953 330 FL 331 (333)
Q Consensus 330 ~~ 331 (333)
+.
T Consensus 289 g~ 290 (397)
T 1wak_A 289 GD 290 (397)
T ss_dssp SS
T ss_pred CC
Confidence 75
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=278.91 Aligned_cols=196 Identities=27% Similarity=0.405 Sum_probs=159.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh-hhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
++..++|++.+.||+|+||.||+|.+. +..||||++....... ......+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 355789999999999999999999874 8899999987643222 2334668889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---cEecccCCCcEEEcc--------CCcEEEEe
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN---YIHRDIKPDNLLLDK--------NGHMKLSD 229 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~Nill~~--------~~~vkl~D 229 (333)
.++||||+++++|.+++. ...+++..+..++.|++.||.|||++| |+||||||+||+++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999884 557999999999999999999999999 999999999999986 77899999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||++........ ....|++.|+|||++.+
T Consensus 160 fg~~~~~~~~~~---------------------------------------------------~~~~~~~~y~aPE~~~~ 188 (271)
T 3dtc_A 160 FGLAREWHRTTK---------------------------------------------------MSAAGAYAWMAPEVIRA 188 (271)
T ss_dssp CCC----------------------------------------------------------------CCGGGSCHHHHHH
T ss_pred CCcccccccccc---------------------------------------------------cCCCCccceeCHHHhcc
Confidence 999986542210 13469999999999999
Q ss_pred CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| |++|+++|+|+++.
T Consensus 189 ~~~~~~~Di~slG~~l~~l~~g~ 211 (271)
T 3dtc_A 189 SMFSKGSDVWSYGVLLWELLTGE 211 (271)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999 99999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=306.85 Aligned_cols=199 Identities=25% Similarity=0.371 Sum_probs=175.3
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..+++..++|++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456677788999999999999999999999889999999997542 2345688899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
..+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999999999763 46899999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
...... ......+++.|+|||++.+..++.++
T Consensus 369 ~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~s 400 (495)
T 1opk_A 369 TGDTYT------------------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKS 400 (495)
T ss_dssp TTCCEE------------------------------------------------CCTTCCCCGGGCCHHHHHHCEECHHH
T ss_pred cCCcee------------------------------------------------ecCCCcCCcceeCHhHHhcCCCCcHH
Confidence 432211 01123467899999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| ||+||++|+|+|
T Consensus 401 DvwSlG~~l~el~t 414 (495)
T 1opk_A 401 DVWAFGVLLWEIAT 414 (495)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred hHHhHHHHHHHHHh
Confidence 9 999999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=291.61 Aligned_cols=194 Identities=26% Similarity=0.419 Sum_probs=161.2
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 6899999999999999999999999999999998754321 11112446899999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--- 155 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--- 155 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---
Confidence 9996 5888888764 4699999999999999999999999999999999999999999999999999986542211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~ 322 (333)
.....+||+.|+|||++.+ ..++.++| ||+||
T Consensus 156 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 189 (324)
T 3mtl_A 156 ----------------------------------------------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGC 189 (324)
T ss_dssp -----------------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred ----------------------------------------------ccccccCcccccChhhhcCCCCCCcHHHHHHHHH
Confidence 0113468999999999987 67899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 190 il~~l~~g~ 198 (324)
T 3mtl_A 190 IFYEMATGR 198 (324)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHhCC
Confidence 999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=290.82 Aligned_cols=198 Identities=19% Similarity=0.289 Sum_probs=165.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCce----EEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNI----YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
.+..++|++++.||+|+||.||+|.+..++.. ||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34567899999999999999999999888876 6777664332 1122234567899999999999999999886
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+...++||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 45689999999999999999764 57899999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
....... ......|++.|+|||++.+..++.++
T Consensus 166 ~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 198 (325)
T 3kex_A 166 PPDDKQL-----------------------------------------------LYSEAKTPIKWMALESIHFGKYTHQS 198 (325)
T ss_dssp CCCTTCC-----------------------------------------------C-----CCTTTSCHHHHHHCCCCHHH
T ss_pred Ccccccc-----------------------------------------------cccCCCCcccccChHHhccCCCChhh
Confidence 5432110 11134688899999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| ||+|+++|+|+|
T Consensus 199 Di~slG~~l~el~~ 212 (325)
T 3kex_A 199 DVWSYGVTVWELMT 212 (325)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HhHHhHHHHHHHHh
Confidence 9 999999999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=284.22 Aligned_cols=195 Identities=26% Similarity=0.331 Sum_probs=161.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHH--hcCCceeEEEEEEee--
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE--VASHCIVKLYYSFQD-- 157 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~-- 157 (333)
.+..++|++.+.||+|+||.||+|.+ +++.||||++.... ......|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567899999999999999999986 68999999986542 2334556777766 799999999998654
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEecccCCCcEEEccCCcEEE
Q 019953 158 --TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH--------KHNYIHRDIKPDNLLLDKNGHMKL 227 (333)
Q Consensus 158 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH--------~~~ivHrDlkp~Nill~~~~~vkl 227 (333)
...+++||||+++|+|.+++. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 346899999999999999994 457999999999999999999999 999999999999999999999999
Q ss_pred EeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc
Q 019953 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (333)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 307 (333)
+|||++........... ......+||+.|+|||++
T Consensus 155 ~Dfg~a~~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~ 189 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLD---------------------------------------------VGNNPRVGTKRYMAPEVL 189 (301)
T ss_dssp CCCTTCEEEETTTTEEE---------------------------------------------CCCCCCCCCGGGCCHHHH
T ss_pred eeCCCeeeccccccccc---------------------------------------------ccccccccccceeChhhh
Confidence 99999986543321110 011134799999999999
Q ss_pred cCC------CCCcccc-hHHHHHHHhhhcc
Q 019953 308 LKK------GYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 308 ~~~------~~~~~~D-ws~g~il~~l~t~ 330 (333)
.+. .++.++| ||+||++|+|+|+
T Consensus 190 ~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp TTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 877 5668999 9999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.92 Aligned_cols=195 Identities=31% Similarity=0.524 Sum_probs=173.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.+.|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+.||||+++++++......++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4579999999999999999999999999999999975532 23456688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 174 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--- 174 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC---
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc---
Confidence 999999999999854 5799999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
......|++.|+|||++.+..++.++| |++|++
T Consensus 175 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 208 (303)
T 3a7i_A 175 ----------------------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 208 (303)
T ss_dssp ----------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred ----------------------------------------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHH
Confidence 011346999999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 209 l~~l~~g~ 216 (303)
T 3a7i_A 209 AIELARGE 216 (303)
T ss_dssp HHHHHHSS
T ss_pred HHHHccCC
Confidence 99999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=283.63 Aligned_cols=196 Identities=26% Similarity=0.445 Sum_probs=170.6
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEE-ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc------eeEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCRE-KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC------IVKL 151 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~ 151 (333)
....+..++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+|+.+++.++|++ ++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 45566678999999999999999999998 5688999999997542 23455778999999887664 9999
Q ss_pred EEEEeeCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc--------
Q 019953 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-------- 221 (333)
Q Consensus 152 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-------- 221 (333)
++++...+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 889999997765 6899999999999999999999999999999999999987
Q ss_pred -----------CCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhc
Q 019953 222 -----------NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRK 290 (333)
Q Consensus 222 -----------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (333)
++.+||+|||++.......
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------- 191 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHH-------------------------------------------------- 191 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCC--------------------------------------------------
T ss_pred CccccccccccCCCceEeeCcccccCcccc--------------------------------------------------
Confidence 6689999999998643221
Q ss_pred cccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 291 LAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 291 ~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
...+||+.|+|||++.+..++.++| |++||++|+|+++.
T Consensus 192 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 231 (339)
T 1z57_A 192 --STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231 (339)
T ss_dssp --CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred --ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence 1346999999999999999999999 99999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=283.69 Aligned_cols=188 Identities=24% Similarity=0.396 Sum_probs=166.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEee--CCeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD--TEYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~ 161 (333)
.++|++++.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.+. ||||+++++++.. ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 578999999999999999999999999999999986432 245778999999997 9999999999987 6679
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-cEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~~~~~ 240 (333)
++||||+++++|.+++. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999884 488999999999999999999999999999999999999777 89999999998664332
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-h
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-W 318 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-w 318 (333)
. .....|++.|+|||++.+ ..++.++| |
T Consensus 186 ~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 215 (330)
T 3nsz_A 186 E--------------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMW 215 (330)
T ss_dssp C--------------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHH
T ss_pred c--------------------------------------------------cccccccccccChhhhcCCCcCCchhhHH
Confidence 1 113468999999999987 67999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++|+|+++.
T Consensus 216 slG~il~~ll~g~ 228 (330)
T 3nsz_A 216 SLGCMLASMIFRK 228 (330)
T ss_dssp HHHHHHHHHHHTC
T ss_pred HHHHHHHHHHhCC
Confidence 9999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=280.02 Aligned_cols=197 Identities=23% Similarity=0.400 Sum_probs=168.0
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhh----hHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG----QVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
..+..++|++.+.||+|+||.||+|.+..+++.||+|++......... ....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 346678999999999999999999999999999999998654322111 1256888999999999999999999997
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEccCCc-----EEEE
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGH-----MKLS 228 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~~~~~-----vkl~ 228 (333)
+.. ++||||+++++|.+.+... ..+++..+..++.|++.||.|||++| |+||||||+||+++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 665 6999999999999888654 47999999999999999999999999 999999999999988776 9999
Q ss_pred eccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc-
Q 019953 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL- 307 (333)
Q Consensus 229 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~- 307 (333)
|||++....... ....||+.|+|||++
T Consensus 172 Dfg~~~~~~~~~----------------------------------------------------~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 172 DFGLSQQSVHSV----------------------------------------------------SGLLGNFQWMAPETIG 199 (287)
T ss_dssp CCTTCBCCSSCE----------------------------------------------------ECCCCCCTTSCGGGSS
T ss_pred CCCccccccccc----------------------------------------------------cccCCCccccCchhhc
Confidence 999987543211 134699999999999
Q ss_pred -cCCCCCcccc-hHHHHHHHhhhccc
Q 019953 308 -LKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 308 -~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.+..++.++| |++||++|+|+++.
T Consensus 200 ~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 200 AEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp CSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 4566899999 99999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=294.75 Aligned_cols=194 Identities=15% Similarity=0.174 Sum_probs=150.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh--cCCceeEEE-------EEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV--ASHCIVKLY-------YSF 155 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~ 155 (333)
...|++.+.||+|+||.||+|.+..+|+.||||++.............+..|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 44599999999999999999999999999999999876543444556677886666666 599988765 444
Q ss_pred eeC-----------------CeEEEEEeccCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCcEecc
Q 019953 156 QDT-----------------EYLYLIMEYLPGGDMMTLLMRE-DTLTENVA------RFYIAQSVLAIESIHKHNYIHRD 211 (333)
Q Consensus 156 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~------~~~~~qi~~~L~~LH~~~ivHrD 211 (333)
... ..+|+||||++ ++|.+++... ..+..... ..++.|++.||.|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 332 34899999998 8999999763 23444444 56669999999999999999999
Q ss_pred cCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcc
Q 019953 212 IKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKL 291 (333)
Q Consensus 212 lkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (333)
|||+|||++.++.+||+|||+++.......
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~-------------------------------------------------- 249 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGP-------------------------------------------------- 249 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEEE--------------------------------------------------
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCcc--------------------------------------------------
Confidence 999999999999999999999986542210
Q ss_pred ccccCCCCCCcccccccC--CCCCcccc-hHHHHHHHhhhccc
Q 019953 292 AFSTVGTPDYIAPEVLLK--KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 292 ~~~~~gt~~y~APE~~~~--~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
...+|+.|+|||++.+ ..++.++| ||+||++|+|+++.
T Consensus 250 --~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 250 --ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp --GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred --CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 2346799999999988 78999999 99999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=294.39 Aligned_cols=193 Identities=27% Similarity=0.432 Sum_probs=152.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT----- 158 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 158 (333)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3478999999999999999999999999999999986532 1223445677899999999999999999998654
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
..+|+|||++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 7899888865 679999999999999999999999999999999999999999999999999998643
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~ 316 (333)
... ...+||+.|+|||++.+ ..++.++
T Consensus 184 ~~~----------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~ 211 (367)
T 2fst_X 184 DEM----------------------------------------------------TGYVATRWYRAPEIMLNWMHYNQTV 211 (367)
T ss_dssp -----------------------------------------------------------CCCTTCCHHHHTTCCSCCTTH
T ss_pred ccC----------------------------------------------------CCcCcCcCccChHHHcCCcCCCchh
Confidence 211 13479999999999987 7799999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| ||+||++|+|+++.
T Consensus 212 DiwslG~il~ell~g~ 227 (367)
T 2fst_X 212 DIWSVGCIMAELLTGR 227 (367)
T ss_dssp HHHHHHHHHHHHHHSS
T ss_pred hHHHHHHHHHHHHhCC
Confidence 9 99999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=287.27 Aligned_cols=202 Identities=17% Similarity=0.282 Sum_probs=173.3
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 153 (333)
..+.+..++|++.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 456777889999999999999999999876 4678899999975432 223455788999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE----------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
++...+..++||||+++++|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999998652 4578999999999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|||++.......... ......||+.|+|
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~a 208 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYR-----------------------------------------------KGGKGLLPVRWMS 208 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEE-----------------------------------------------GGGSSEECGGGCC
T ss_pred eEEECcCccccccccccccc-----------------------------------------------cccCCCCCCCccC
Confidence 99999999998654322110 1113357889999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
||++.+..++.++| |++|+++|+|++
T Consensus 209 PE~~~~~~~~~~~Di~slG~il~el~~ 235 (322)
T 1p4o_A 209 PESLKDGVFTTYSDVWSFGVVLWEIAT 235 (322)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHH
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999 999999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=288.25 Aligned_cols=197 Identities=28% Similarity=0.491 Sum_probs=168.9
Q ss_pred cCCCceEe-eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeE
Q 019953 84 CVDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 84 ~~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 161 (333)
..++|.+. +.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+. ||||+++++++...+.+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 34568777 899999999999999999999999999976532 2233456788999999995 59999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CCcEEEEeccCcccC
Q 019953 162 YLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPL 236 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~~vkl~DFGla~~~ 236 (333)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999999998553 67999999999999999999999999999999999999987 789999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
..... ....+||+.|+|||++.+.+++.++
T Consensus 185 ~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 214 (327)
T 3lm5_A 185 GHACE--------------------------------------------------LREIMGTPEYLAPEILNYDPITTAT 214 (327)
T ss_dssp -----------------------------------------------------------CCCGGGCCHHHHTTCCCCTHH
T ss_pred CCccc--------------------------------------------------cccccCCcCccCCeeecCCCCCchh
Confidence 43221 1134799999999999999999999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| |++|+++|+|+++.
T Consensus 215 DiwslG~il~~ll~g~ 230 (327)
T 3lm5_A 215 DMWNIGIIAYMLLTHT 230 (327)
T ss_dssp HHHHHHHHHHHHHHSS
T ss_pred hHHHHHHHHHHHHhCC
Confidence 9 99999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.70 Aligned_cols=204 Identities=25% Similarity=0.337 Sum_probs=173.9
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
.........++|++.+.||+|+||.||+|.+ .+|+.||||++....... ....+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 3455667789999999999999999999974 468999999997653221 1224778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcEecccCCCcEEEccCCcEEEEe
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRED----TLTENVARFYIAQSVLAIESIHKH---NYIHRDIKPDNLLLDKNGHMKLSD 229 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~Nill~~~~~vkl~D 229 (333)
..+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997643 499999999999999999999999 999999999999999999999999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||++......... ......||+.|+|||++.+
T Consensus 178 fg~~~~~~~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~ 209 (326)
T 3uim_A 178 FGLAKLMDYKDTH------------------------------------------------VTTAVRGTIGHIAPEYLST 209 (326)
T ss_dssp CSSCEECCSSSSC------------------------------------------------EECCCCSCGGGCCHHHHHH
T ss_pred CccccccCccccc------------------------------------------------ccccccCCcCccCHHHhcc
Confidence 9999876533211 1113469999999999999
Q ss_pred CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| ||+|+++|+|+++.
T Consensus 210 ~~~~~~~Di~slG~il~~l~~g~ 232 (326)
T 3uim_A 210 GKSSEKTDVFGYGVMLLELITGQ 232 (326)
T ss_dssp SEECHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCccccchhHHHHHHHHHhCC
Confidence 99999999 99999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=286.44 Aligned_cols=202 Identities=24% Similarity=0.365 Sum_probs=171.7
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 152 (333)
..+.+..++|++.+.||+|+||.||+|.+. .+++.||||++..... ......+.+|+.++..+ +||||++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 455677889999999999999999999853 4678999999976432 23345688899999999 789999999
Q ss_pred EEEeeCC-eEEEEEeccCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEecccCCC
Q 019953 153 YSFQDTE-YLYLIMEYLPGGDMMTLLMREDT----------------LTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (333)
Q Consensus 153 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 215 (333)
+++...+ .+++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9987654 58999999999999999976543 889999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccccc
Q 019953 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (333)
Q Consensus 216 Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (333)
||+++.++.+||+|||++......... ......
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~ 210 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDY-----------------------------------------------VRKGDA 210 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTS-----------------------------------------------EEETTE
T ss_pred eEEECCCCCEEECCCccccccccCccc-----------------------------------------------eeccCC
Confidence 999999999999999999876432211 011134
Q ss_pred CCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 296 VGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 296 ~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
.||+.|+|||++.+..++.++| |++|+++|+|+|
T Consensus 211 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 5789999999999999999999 999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=280.72 Aligned_cols=199 Identities=26% Similarity=0.423 Sum_probs=157.4
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
+++..++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+..+...++.+.||||+++++++...+.
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 35667899999999999999999999999999999999976432 22233344455566788899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 161 LYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
.++||||++ |+|.+++. ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999999996 58777664 356899999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc----cCCC
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL----LKKG 311 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~ 311 (333)
...... .....||+.|+|||++ .+..
T Consensus 160 ~~~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~ 189 (290)
T 3fme_A 160 LVDDVA--------------------------------------------------KDIDAGCKPYMAPERINPELNQKG 189 (290)
T ss_dssp ------------------------------------------------------------CCCCCCSCHHHHSCCTTC--
T ss_pred cccccc--------------------------------------------------ccccCCCccccChhhcChhhcCcC
Confidence 543221 1133699999999996 5677
Q ss_pred CCcccc-hHHHHHHHhhhccc
Q 019953 312 YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~~ 331 (333)
++.++| |++|+++|+|+++.
T Consensus 190 ~~~~~Di~slG~il~~l~~g~ 210 (290)
T 3fme_A 190 YSVKSDIWSLGITMIELAILR 210 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHTS
T ss_pred CCcHHHHHHHHHHHHHHHHCC
Confidence 999999 99999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=282.51 Aligned_cols=201 Identities=29% Similarity=0.506 Sum_probs=167.1
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEe
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ 156 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 156 (333)
+.......++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+ .||||+++++++.
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3445566789999999999999999999999999999999986542 2234577899999999 7999999999997
Q ss_pred e------CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEE
Q 019953 157 D------TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228 (333)
Q Consensus 157 ~------~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~ 228 (333)
. .+.+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 6 46899999999999999999764 579999999999999999999999999999999999999999999999
Q ss_pred eccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc
Q 019953 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL 308 (333)
Q Consensus 229 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~ 308 (333)
|||++........ ......|++.|+|||++.
T Consensus 172 Dfg~~~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-------------------------------------------------RRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp CCTTTC--------------------------------------------------------------CCGGGCCHHHHC
T ss_pred eCcCceecCcCcc-------------------------------------------------ccccccCCccccChhhhc
Confidence 9999886542210 011346999999999997
Q ss_pred -----CCCCCcccc-hHHHHHHHhhhccc
Q 019953 309 -----KKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 309 -----~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+..++.++| |++||++|+|+++.
T Consensus 203 ~~~~~~~~~~~~~Di~slG~il~~l~~g~ 231 (326)
T 2x7f_A 203 CDENPDATYDFKSDLWSLGITAIEMAEGA 231 (326)
T ss_dssp --------CCTTHHHHHHHHHHHHHHHSS
T ss_pred cccccCcCCCccchHHHHHHHHHHHHhCC
Confidence 567899999 99999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=276.82 Aligned_cols=196 Identities=21% Similarity=0.317 Sum_probs=171.4
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
+.+..++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4566789999999999999999999975 678899999976532 22457889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999765 56899999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.. .......|++.|+|||++.+..++.++| |
T Consensus 158 ~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 189 (267)
T 3t9t_A 158 QY------------------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189 (267)
T ss_dssp HH------------------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred cc------------------------------------------------cccccccccccccChhhhcCCCccchhchh
Confidence 11 0111335788999999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|++
T Consensus 190 slG~il~~l~~ 200 (267)
T 3t9t_A 190 SFGVLMWEVFS 200 (267)
T ss_dssp HHHHHHHHHHT
T ss_pred hhHHHHHHHhc
Confidence 99999999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=281.43 Aligned_cols=195 Identities=29% Similarity=0.509 Sum_probs=167.0
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.++||||+++++++...+..+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999987542 2345778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+||||+++++|.+++. ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999999986 456899999999999999999999999999999999999999999999999999986543210
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
......|++.|+|||++.+..++.++| |++
T Consensus 181 -------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (314)
T 3com_A 181 -------------------------------------------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSL 211 (314)
T ss_dssp -------------------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHH
T ss_pred -------------------------------------------------ccCccCCCCCccChhhcCCCCCCccccHHHH
Confidence 011346999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
|+++|+|+++.
T Consensus 212 G~il~~l~~g~ 222 (314)
T 3com_A 212 GITAIEMAEGK 222 (314)
T ss_dssp HHHHHHHHHSS
T ss_pred HHHHHHHHhCC
Confidence 99999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=289.36 Aligned_cols=205 Identities=19% Similarity=0.158 Sum_probs=165.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEec---CCceEEEEecchhHHhh--------hhhHHHHHHHHHHHHHhcCCceeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVK--------RGQVEHVRAERNLLAEVASHCIVKLY 152 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~ 152 (333)
..++|++.+.||+|+||.||+|.+.. ++..||||++....... ......+.+|+..+..+.||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999999987 78899999987543111 11122355688889999999999999
Q ss_pred EEEee----CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC--cEE
Q 019953 153 YSFQD----TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG--HMK 226 (333)
Q Consensus 153 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~--~vk 226 (333)
+++.. ....++||||+ +++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99987 77899999999 999999998777899999999999999999999999999999999999999887 999
Q ss_pred EEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccc
Q 019953 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (333)
Q Consensus 227 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~ 306 (333)
|+|||+++.+......... .........||+.|+|||+
T Consensus 194 L~Dfg~a~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~ 231 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQY------------------------------------------QENPRKGHNGTIEFTSLDA 231 (345)
T ss_dssp ECCCTTCEESSGGGCCCCC------------------------------------------CCCGGGCSCSCTTTCCHHH
T ss_pred EEeCCCceecccccccccc------------------------------------------hhccccccCCCccccCHHH
Confidence 9999999877543211000 0011124579999999999
Q ss_pred ccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 307 LLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 307 ~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+.+..++.++| ||+||++|+|+++.
T Consensus 232 ~~~~~~~~~~Di~slG~il~ell~g~ 257 (345)
T 2v62_A 232 HKGVALSRRSDVEILGYCMLRWLCGK 257 (345)
T ss_dssp HHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999 99999999999865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=280.45 Aligned_cols=202 Identities=24% Similarity=0.338 Sum_probs=169.4
Q ss_pred hccccCCCceEee-eEeeecceEEEEEEE--ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 80 RHKICVDDFELLT-IIGRGAFGEVRLCRE--KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 80 ~~~~~~~~y~~~~-~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
...+..++|.+.+ .||+|+||.||+|.+ ..+++.||||++..... .......+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 3455567899998 999999999999954 55678999999976532 233456788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
..+..++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 56678999999999999999998888999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
....... .......+++.|+|||++.+..++.++
T Consensus 168 ~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 201 (291)
T 1xbb_A 168 RADENYY----------------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKS 201 (291)
T ss_dssp CTTCSEE----------------------------------------------EC----CCCGGGCCHHHHHHCEEEHHH
T ss_pred ccCCCcc----------------------------------------------cccccCCCCceeeChHHhccCCCChhh
Confidence 5432110 001123477899999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| |++|+++|+|++
T Consensus 202 Di~slG~il~~l~~ 215 (291)
T 1xbb_A 202 DVWSFGVLMWEAFS 215 (291)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHh
Confidence 9 999999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=284.95 Aligned_cols=199 Identities=28% Similarity=0.475 Sum_probs=171.4
Q ss_pred ccCCCceEeeeEeeecceEEEEEE----EecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe--
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-- 156 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-- 156 (333)
+..++|++++.||+|+||.||+|. +..++..||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 345789999999999999999998 56789999999987653 233456888999999999999999999886
Q ss_pred eCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
....+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 45679999999999999999976 45699999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
........ .......||+.|+|||++.+..++.+
T Consensus 177 ~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 210 (327)
T 3lxl_A 177 LPLDKDYY----------------------------------------------VVREPGQSPIFWYAPESLSDNIFSRQ 210 (327)
T ss_dssp CCTTCSEE----------------------------------------------ECSSCCCSCGGGSCHHHHHHCEEEHH
T ss_pred cccCCccc----------------------------------------------eeeccCCccccccCHHHhccCCCChH
Confidence 65432111 01113358889999999999999999
Q ss_pred cc-hHHHHHHHhhhcc
Q 019953 316 CD-WLVSVLHFNSYRF 330 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~ 330 (333)
+| |++|+++|+|+++
T Consensus 211 ~Di~slG~il~~ll~g 226 (327)
T 3lxl_A 211 SDVWSFGVVLYELFTY 226 (327)
T ss_dssp HHHHHHHHHHHHHHTT
T ss_pred HhHHHHHHHHHHHHhC
Confidence 99 9999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=281.20 Aligned_cols=201 Identities=27% Similarity=0.467 Sum_probs=169.2
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
.......++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp BSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 344455678999999999999999999999999999999987542 23456678899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999998865 5679999999999999999999999999999999999999999999999999876321
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc-----cCCCC
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL-----LKKGY 312 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-----~~~~~ 312 (333)
.. ........|++.|+|||++ .+..+
T Consensus 169 ~~-------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (302)
T 2j7t_A 169 KT-------------------------------------------------LQKRDSFIGTPYWMAPEVVMCETMKDTPY 199 (302)
T ss_dssp HH-------------------------------------------------HHC-----CCGGGCCHHHHHHHHTTSTTT
T ss_pred cc-------------------------------------------------ccccccccCChhhcCCeeeccccCCCCCC
Confidence 10 0011134699999999998 46789
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| |++|+++|+|+++.
T Consensus 200 ~~~~Di~slG~il~~l~~g~ 219 (302)
T 2j7t_A 200 DYKADIWSLGITLIEMAQIE 219 (302)
T ss_dssp TTHHHHHHHHHHHHHHHHSS
T ss_pred chhhhHHHHHHHHHHHhcCC
Confidence 99999 99999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=286.01 Aligned_cols=207 Identities=27% Similarity=0.467 Sum_probs=154.1
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
.++.+..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 3456778999999999999999999999988999999999875432 22345677899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEec
Q 019953 159 EYLYLIMEYLPGGDMMTLLMR--------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DF 230 (333)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999999863 456999999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK- 309 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~- 309 (333)
|++.......... .........||+.|+|||++.+
T Consensus 166 g~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~ 201 (303)
T 2vwi_A 166 GVSAFLATGGDIT--------------------------------------------RNKVRKTFVGTPCWMAPEVMEQV 201 (303)
T ss_dssp HHHHHCC-----------------------------------------------------------CCCTTCCHHHHHHH
T ss_pred cchheeccCCCcc--------------------------------------------chhhhcccCCCccccCHHHhccc
Confidence 9998765332100 0011124479999999999976
Q ss_pred CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| |++|+++|+|+++.
T Consensus 202 ~~~~~~~Di~slG~il~~l~~g~ 224 (303)
T 2vwi_A 202 RGYDFKADIWSFGITAIELATGA 224 (303)
T ss_dssp HCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCchhhHHHHHHHHHHHHhCC
Confidence 57899999 99999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=286.89 Aligned_cols=197 Identities=26% Similarity=0.408 Sum_probs=168.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----C
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----E 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 159 (333)
.++|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 468999999999999999999999999999999987532 223345678899999999999999999998654 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
..++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 6899999996 589998865 46999999999999999999999999999999999999999999999999999876533
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D- 317 (333)
.... ......+||+.|+|||++.+ ..++.++|
T Consensus 182 ~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 215 (364)
T 3qyz_A 182 HDHT----------------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215 (364)
T ss_dssp GCBC----------------------------------------------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHH
T ss_pred CCcc----------------------------------------------ccccccccccCCCCCHHhcCCCCCCcchhH
Confidence 2110 01124579999999998765 55899999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 216 wslG~il~ell~g~ 229 (364)
T 3qyz_A 216 WSVGCILAEMLSNR 229 (364)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHCC
Confidence 99999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=278.11 Aligned_cols=196 Identities=21% Similarity=0.288 Sum_probs=166.3
Q ss_pred CceEeeeEeeecceEEEEEEEecCCc---eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE-E
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL-Y 162 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~ 162 (333)
.|.+.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++...+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46677999999999999999766554 79999986532 233456688899999999999999999999766654 9
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+.....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 45789999999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.. ........+++.|+|||++.+..++.++| |++
T Consensus 180 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 214 (298)
T 3pls_A 180 YS---------------------------------------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSF 214 (298)
T ss_dssp GC---------------------------------------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH
T ss_pred cc---------------------------------------------cccCcCCCCCccccChhhhccCCCChhhchhhH
Confidence 11 00111346889999999999999999999 999
Q ss_pred HHHHHhhhc
Q 019953 321 SVLHFNSYR 329 (333)
Q Consensus 321 g~il~~l~t 329 (333)
|+++|+|++
T Consensus 215 G~il~~l~~ 223 (298)
T 3pls_A 215 GVLLWELLT 223 (298)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhh
Confidence 999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=285.69 Aligned_cols=195 Identities=26% Similarity=0.436 Sum_probs=166.4
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceE--EEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIY--AMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 159 (333)
+..++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 44578999999999999999999999888865 999886532 223345578899999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED----------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997653 699999999999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|||++........ .....+++.|+|
T Consensus 180 ~~kL~Dfg~~~~~~~~~~--------------------------------------------------~~~~~~~~~y~a 209 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVK--------------------------------------------------KTMGRLPVRWMA 209 (327)
T ss_dssp CEEECCTTCEESSCEECC--------------------------------------------------C----CCTTTCC
T ss_pred eEEEcccCcCcccccccc--------------------------------------------------ccCCCCCccccC
Confidence 999999999874321110 012357889999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
||++.+..++.++| |++|+++|+|+|
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~ellt 236 (327)
T 1fvr_A 210 IESLNYSVYTTNSDVWSYGVLLWEIVS 236 (327)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred hhhhccccCCchhcchHHHHHHHHHHc
Confidence 99999999999999 999999999997
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=299.45 Aligned_cols=197 Identities=24% Similarity=0.371 Sum_probs=170.7
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..+.+..++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.+|+.++||||+++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 456788889999999999999999999875 47789999997643 23566889999999999999999999986 5
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+.+++||||+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 6789999999999999999753 36889999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
...... ......+++.|+|||++.+..++.++
T Consensus 335 ~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 366 (454)
T 1qcf_A 335 EDNEYT------------------------------------------------AREGAKFPIKWTAPEAINFGSFTIKS 366 (454)
T ss_dssp CCHHHH------------------------------------------------TTCSSSSCGGGSCHHHHHHCCCCHHH
T ss_pred CCCcee------------------------------------------------ccCCCcccccccCHHHhccCCCCcHH
Confidence 432210 01123477899999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| ||+||++|+|+|
T Consensus 367 DvwslG~~l~el~t 380 (454)
T 1qcf_A 367 DVWSFGILLMEIVT 380 (454)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHhHHHHHHHHHh
Confidence 9 999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=282.64 Aligned_cols=204 Identities=21% Similarity=0.325 Sum_probs=162.8
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEec---CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEE
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKK---SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 154 (333)
+....+..++|.+.+.||+|+||.||+|.+.. ++..||+|++..... .......+.+|+.+++.++||||++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 45566777899999999999999999998765 456899999875432 22344668889999999999999999999
Q ss_pred EeeCC-----eEEEEEeccCCCCHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 155 FQDTE-----YLYLIMEYLPGGDMMTLLM------REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 155 ~~~~~-----~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
+.... ..++||||+++++|.+++. ....+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 87654 3599999999999999984 335699999999999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|||++..+....... ......+++.|+|
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~a 217 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYR-----------------------------------------------QGRIAKMPVKWIA 217 (313)
T ss_dssp CEEECSCSCC---------------------------------------------------------------CCGGGSC
T ss_pred cEEEeecCcceecccccccC-----------------------------------------------cccccCCCccccC
Confidence 99999999998764332110 0112357889999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
||++.+..++.++| |++|+++|+|++
T Consensus 218 PE~~~~~~~~~~~Di~slG~il~el~~ 244 (313)
T 3brb_A 218 IESLADRVYTSKSDVWAFGVTMWEIAT 244 (313)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHT
T ss_pred chhhcCCCccchhhhHHHHHHHHHHHh
Confidence 99999999999999 999999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=285.33 Aligned_cols=197 Identities=21% Similarity=0.336 Sum_probs=161.6
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceE----EEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIY----AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
+..++|++++.||+|+||.||+|.+..+++.| |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 44688999999999999999999998888766 566554321 233456688899999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
. .++|++++.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 7899999999999999976 4579999999999999999999999999999999999999999999999999998764
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
..... .......||+.|+|||++.+..++.++|
T Consensus 169 ~~~~~-----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3lzb_A 169 AEEKE-----------------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp ----------------------------------------------------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred Ccccc-----------------------------------------------ccccCCCccccccCHHHHcCCCCChHHH
Confidence 33211 0111335788999999999999999999
Q ss_pred -hHHHHHHHhhhc
Q 019953 318 -WLVSVLHFNSYR 329 (333)
Q Consensus 318 -ws~g~il~~l~t 329 (333)
|++||++|+|++
T Consensus 202 i~slG~il~ell~ 214 (327)
T 3lzb_A 202 VWSYGVTVWELMT 214 (327)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHH
Confidence 999999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=278.38 Aligned_cols=205 Identities=29% Similarity=0.497 Sum_probs=162.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee--------
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-------- 157 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 157 (333)
++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 47999999999999999999999999999999996542 234567889999999999999999998754
Q ss_pred -----CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEecc
Q 019953 158 -----TEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231 (333)
Q Consensus 158 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFG 231 (333)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 457899999999999999997644 67889999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK- 310 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~- 310 (333)
++............... . . ...........|++.|+|||++.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~-----~----------~--------------------~~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQ-----N----------L--------------------PGSSDNLTSAIGTAMYVATEVLDGTG 206 (303)
T ss_dssp CCSCTTC------------------------------------------------------------CTTSCHHHHTSCS
T ss_pred chhhcccccchhccccc-----c----------c--------------------cccccccccCCCcccccCcccccCCC
Confidence 99876533211000000 0 0 0000112245799999999999865
Q ss_pred CCCcccc-hHHHHHHHhhhc
Q 019953 311 GYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t 329 (333)
.++.++| |++||++|+|++
T Consensus 207 ~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 207 HYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCTHHHHHHHHHHHHHHHS
T ss_pred CCcchhhHHHHHHHHHHHHh
Confidence 6899999 999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=280.61 Aligned_cols=197 Identities=32% Similarity=0.603 Sum_probs=168.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe--eCCeEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DTEYLY 162 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 162 (333)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4689999999999999999999999999999999975432 2234566888999999999999999999874 356899
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEecccCCCcEEEccCCcEEEEeccCc
Q 019953 163 LIMEYLPGGDMMTLLMRE----DTLTENVARFYIAQSVLAIESIHKHN-----YIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999998653 35999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
......... .....|++.|+|||++.+..++
T Consensus 164 ~~~~~~~~~-------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~ 194 (279)
T 2w5a_A 164 RILNHDTSF-------------------------------------------------AKTFVGTPYYMSPEQMNRMSYN 194 (279)
T ss_dssp HHC---CHH-------------------------------------------------HHHHHSCCTTCCHHHHHCC-CC
T ss_pred eeecccccc-------------------------------------------------ccccCCCccccChHHhccCCCC
Confidence 865432110 1134689999999999999999
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| |++|+++|+|+++.
T Consensus 195 ~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 195 EKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp HHHHHHHHHHHHHHHHHSS
T ss_pred chhhHHHHHHHHHHHHHCC
Confidence 9999 99999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=283.02 Aligned_cols=201 Identities=22% Similarity=0.306 Sum_probs=165.3
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCC----ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSG----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
.++..++|.+.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4667789999999999999999999886553 459999987542 2233456888999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999764 5799999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
........ .......+++.|+|||++.+..++.+
T Consensus 197 ~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 230 (333)
T 1mqb_A 197 LEDDPEAT----------------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSA 230 (333)
T ss_dssp ------------------------------------------------------------CCCGGGSCHHHHHSCCCCHH
T ss_pred hccccccc----------------------------------------------cccCCCCccccccCchhcccCCCCch
Confidence 64322100 00112346889999999999999999
Q ss_pred cc-hHHHHHHHhhhc
Q 019953 316 CD-WLVSVLHFNSYR 329 (333)
Q Consensus 316 ~D-ws~g~il~~l~t 329 (333)
+| |++|+++|+|++
T Consensus 231 ~Di~slG~il~ellt 245 (333)
T 1mqb_A 231 SDVWSFGIVMWEVMT 245 (333)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred hhhHHHHHHHHHHHc
Confidence 99 999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=279.74 Aligned_cols=203 Identities=19% Similarity=0.259 Sum_probs=159.5
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
....+++..++|++.+.||+|+||.||+|.+. ..||+|++..... .......+.+|+.+++.++||||++++++.
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 34667888999999999999999999999754 3599999875432 233456688899999999999999999965
Q ss_pred eCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
.....++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 45668999999999999999954 45799999999999999999999999999999999999999999999999999986
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CCCC
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KKGY 312 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~ 312 (333)
....... .......||+.|+|||++. +.++
T Consensus 170 ~~~~~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (289)
T 3og7_A 170 KSRWSGS-----------------------------------------------HQFEQLSGSILWMAPEVIRMQDSNPY 202 (289)
T ss_dssp -------------------------------------------------------------CCCTTCCHHHHC----CCS
T ss_pred ccccccc-----------------------------------------------ccccccCCCccccCchhhcccCCCCC
Confidence 5422110 0111346999999999997 6778
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| ||+|+++|+|+++.
T Consensus 203 ~~~~Di~slG~il~el~~g~ 222 (289)
T 3og7_A 203 SFQSDVYAFGIVLYELMTGQ 222 (289)
T ss_dssp CHHHHHHHHHHHHHHHHHSS
T ss_pred CcccchHHHHHHHHHHHHCC
Confidence 99999 99999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=293.21 Aligned_cols=189 Identities=29% Similarity=0.446 Sum_probs=158.6
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee------CC
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------TE 159 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 159 (333)
.+|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 469999999999999999999999999999999865421 12359999999999999999998843 22
Q ss_pred eEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-CcEEEEeccCcc
Q 019953 160 YLYLIMEYLPGGDMMTLLM----REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCK 234 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DFGla~ 234 (333)
++++||||+++ ++...+. ....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 47899999975 5655553 35679999999999999999999999999999999999999965 578999999998
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCC
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYG 313 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~ 313 (333)
.+..... ....+||+.|+|||++.+. .|+
T Consensus 206 ~~~~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~ 235 (420)
T 1j1b_A 206 QLVRGEP--------------------------------------------------NVSYICSRYYRAPELIFGATDYT 235 (420)
T ss_dssp ECCTTCC--------------------------------------------------CCSCCSCTTSCCHHHHTTCSSCC
T ss_pred hcccCCC--------------------------------------------------ceeeeeCCCcCCHHHHcCCCCCC
Confidence 7543221 1144799999999999775 799
Q ss_pred cccc-hHHHHHHHhhhcccc
Q 019953 314 MECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~~ 332 (333)
.++| |++||++|+|+++.+
T Consensus 236 ~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 236 SSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp THHHHHHHHHHHHHHHHSSC
T ss_pred chhhhHHHHHHHHHHHhCCC
Confidence 9999 999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=276.71 Aligned_cols=197 Identities=25% Similarity=0.401 Sum_probs=169.9
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..+.+..++|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 456778889999999999999999999864 56789999987543 224567889999999999999999998864
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 45899999999999999996543 6999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
...... ......+++.|+|||++.+..++.++
T Consensus 160 ~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 191 (279)
T 1qpc_A 160 EDNEYT------------------------------------------------AREGAKFPIKWTAPEAINYGTFTIKS 191 (279)
T ss_dssp SSSCEE------------------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHH
T ss_pred cCcccc------------------------------------------------cccCCCCccCccChhhhccCCCCchh
Confidence 543211 01133578899999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| |++|+++|+|++
T Consensus 192 Di~slG~il~el~~ 205 (279)
T 1qpc_A 192 DVWSFGILLTEIVT 205 (279)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHh
Confidence 9 999999999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=286.81 Aligned_cols=196 Identities=15% Similarity=0.177 Sum_probs=164.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEec--------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeE------
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKK--------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVK------ 150 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~------ 150 (333)
.++|++.+.||+|+||.||+|.+.. .++.||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4789999999999999999999987 4889999998754 23667999999999998887
Q ss_pred ---------EEEEEee-CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEE
Q 019953 151 ---------LYYSFQD-TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL 218 (333)
Q Consensus 151 ---------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nil 218 (333)
+++++.. ....++||||+ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5666665 67899999999 99999999876 68999999999999999999999999999999999999
Q ss_pred EccCC--cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccC
Q 019953 219 LDKNG--HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (333)
Q Consensus 219 l~~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (333)
++.++ .+||+|||+++.+......... .........
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~------------------------------------------~~~~~~~~~ 229 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY------------------------------------------VEGSRSPHE 229 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCC------------------------------------------CTTSSCTTC
T ss_pred EcCCCCceEEEecCcceeeccCCCccccc------------------------------------------ccccccccc
Confidence 99998 9999999999876543211000 000111347
Q ss_pred CCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 297 GTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 297 gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
||+.|+|||++.+..++.++| ||+||++|+|+++.
T Consensus 230 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 230 GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999 99999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=275.84 Aligned_cols=195 Identities=17% Similarity=0.238 Sum_probs=168.9
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT- 158 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 158 (333)
...+..++|++.+.||+|+||.||+|.+. +..||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 34567789999999999999999999874 88999999976532 223345688899999999999999999999876
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEccCCcEEEEeccCc
Q 019953 159 -EYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 159 -~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
...++||||+++|+|.+++.... .+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78899999999999999998755 4899999999999999999999999 999999999999999999999999987
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
...... ...||+.|+|||++.+..++
T Consensus 161 ~~~~~~------------------------------------------------------~~~~t~~y~aPE~~~~~~~~ 186 (271)
T 3kmu_A 161 FSFQSP------------------------------------------------------GRMYAPAWVAPEALQKKPED 186 (271)
T ss_dssp CTTSCT------------------------------------------------------TCBSCGGGSCHHHHHSCGGG
T ss_pred eeeccc------------------------------------------------------CccCCccccChhhhccCCCC
Confidence 643211 23689999999999887655
Q ss_pred c---ccc-hHHHHHHHhhhccc
Q 019953 314 M---ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~---~~D-ws~g~il~~l~t~~ 331 (333)
. ++| ||+|+++|+|+++.
T Consensus 187 ~~~~~~Di~slG~il~el~~g~ 208 (271)
T 3kmu_A 187 TNRRSADMWSFAVLLWELVTRE 208 (271)
T ss_dssp SCHHHHHHHHHHHHHHHHHHCS
T ss_pred CCCchhhHHHHHHHHHHHHhCC
Confidence 5 799 99999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=276.22 Aligned_cols=201 Identities=24% Similarity=0.381 Sum_probs=169.5
Q ss_pred hccccCCCceEee-eEeeecceEEEEEEEe--cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 80 RHKICVDDFELLT-IIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 80 ~~~~~~~~y~~~~-~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
.+.+..++|.+.+ .||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 3455667888887 9999999999999864 467889999997642 233456688899999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 456699999999999999998654 5699999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
........ .......||+.|+|||++.+..++.+
T Consensus 160 ~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 193 (287)
T 1u59_A 160 LGADDSYY----------------------------------------------TARSAGKWPLKWYAPECINFRKFSSR 193 (287)
T ss_dssp CTTCSCEE----------------------------------------------CCCCSSCCCGGGCCHHHHHHCEECHH
T ss_pred eccCccee----------------------------------------------eccccccccccccCHHHhccCCCCch
Confidence 65332110 00112357899999999999999999
Q ss_pred cc-hHHHHHHHhhhc
Q 019953 316 CD-WLVSVLHFNSYR 329 (333)
Q Consensus 316 ~D-ws~g~il~~l~t 329 (333)
+| |++|+++|+|++
T Consensus 194 ~Di~slG~il~ellt 208 (287)
T 1u59_A 194 SDVWSYGVTMWEALS 208 (287)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHc
Confidence 99 999999999997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=277.25 Aligned_cols=199 Identities=26% Similarity=0.449 Sum_probs=166.2
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh-hhhHHHHHHHHHHHHHhcCCceeEEEEEE--eeCCeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK-RGQVEHVRAERNLLAEVASHCIVKLYYSF--QDTEYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~ 161 (333)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ ......
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998754332 23456788999999999999999999998 445679
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 162 YLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
++||||++++ |.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999776 7777755 457999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC--CCcccc
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YGMECD 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~~D 317 (333)
... .......|++.|+|||++.+.. ++.++|
T Consensus 163 ~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 195 (305)
T 2wtk_C 163 AAD-----------------------------------------------DTCRTSQGSPAFQPPEIANGLDTFSGFKVD 195 (305)
T ss_dssp CSS-----------------------------------------------CEECCCCSCGGGCCHHHHTCCSCEESHHHH
T ss_pred ccc-----------------------------------------------cccccCCCCCCCcChhhccCcccCCcchhh
Confidence 110 0111346999999999998754 478999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++|+++|+|+++.
T Consensus 196 i~slG~il~~l~~g~ 210 (305)
T 2wtk_C 196 IWSAGVTLYNITTGL 210 (305)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=287.42 Aligned_cols=191 Identities=27% Similarity=0.422 Sum_probs=163.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE---
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL--- 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--- 161 (333)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4799999999999999999999999999999999975432 233456678899999999999999999999876654
Q ss_pred ---EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 162 ---YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 162 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999996 68887773 4599999999999999999999999999999999999999999999999999986432
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D 317 (333)
.. ...+||+.|+|||++.+ ..++.++|
T Consensus 197 ~~----------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (371)
T 4exu_A 197 EM----------------------------------------------------TGYVVTRWYRAPEVILSWMHYNQTVD 224 (371)
T ss_dssp -------------------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHH
T ss_pred Cc----------------------------------------------------CCcccCccccCHHHhcCCCCCCcHHh
Confidence 21 13468999999999987 78999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 225 iwslG~il~el~~g~ 239 (371)
T 4exu_A 225 IWSVGCIMAEMLTGK 239 (371)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=274.36 Aligned_cols=199 Identities=22% Similarity=0.248 Sum_probs=163.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEE-EeeCCeEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS-FQDTEYLYL 163 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~l 163 (333)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.+.|++++..+.. +......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 47899999999999999999999999999999987654322 236679999999998876666554 467788999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE---ccCCcEEEEeccCcccCCCC
Q 019953 164 IMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill---~~~~~vkl~DFGla~~~~~~ 239 (333)
||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999975 4579999999999999999999999999999999999999 78899999999999876543
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
...... .........||+.|+|||++.+..++.++| |
T Consensus 162 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 199 (296)
T 4hgt_A 162 RTHQHI------------------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLE 199 (296)
T ss_dssp TTCCBC------------------------------------------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHH
T ss_pred ccCccC------------------------------------------CCCcccccCCCccccchHHhcCCCCCchhHHH
Confidence 211000 000112457999999999999999999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++|+|+++.
T Consensus 200 slG~il~~l~~g~ 212 (296)
T 4hgt_A 200 SLGYVLMYFNLGS 212 (296)
T ss_dssp HHHHHHHHHHHSS
T ss_pred HHHHHHHHHhcCC
Confidence 9999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=278.74 Aligned_cols=198 Identities=19% Similarity=0.294 Sum_probs=164.9
Q ss_pred CCCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE-eeCCe
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF-QDTEY 160 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 160 (333)
..+|++.+.||+|+||.||+|.+..+ +..||+|.+.... .......+.+|+.+++.++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 45799999999999999999986543 3468999887532 233456688899999999999999999985 45667
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 8999999999999999976 456899999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
..... .......||+.|+|||++.+..++.++| |
T Consensus 182 ~~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 216 (298)
T 3f66_A 182 EYYSV---------------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVW 216 (298)
T ss_dssp GGCBC--------------------------------------------------CCBCGGGSCHHHHHHCCCCHHHHHH
T ss_pred chhcc---------------------------------------------ccccCCCCCccccChHHhcCCCCChHHHHH
Confidence 21110 0111346889999999999999999999 9
Q ss_pred HHHHHHHhhhc
Q 019953 319 LVSVLHFNSYR 329 (333)
Q Consensus 319 s~g~il~~l~t 329 (333)
++|+++|+|++
T Consensus 217 slG~il~~l~~ 227 (298)
T 3f66_A 217 SFGVLLWELMT 227 (298)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHh
Confidence 99999999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=274.66 Aligned_cols=199 Identities=26% Similarity=0.354 Sum_probs=166.9
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
.+.+..++|.+.+.||+|+||.||+|.+... +..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 3456678999999999999999999987543 3469999987642 2233466888999999999999999999987
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
.. ..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 54 568999999999999999764 4699999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
....... ......+++.|+|||++.+..++.+
T Consensus 163 ~~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 194 (281)
T 3cc6_A 163 IEDEDYY------------------------------------------------KASVTRLPIKWMSPESINFRRFTTA 194 (281)
T ss_dssp C---------------------------------------------------------CCCCCGGGCCHHHHHHCCCCHH
T ss_pred ccccccc------------------------------------------------ccccCCCCcceeCchhhccCCCCch
Confidence 6432210 0113357889999999999999999
Q ss_pred cc-hHHHHHHHhhhc
Q 019953 316 CD-WLVSVLHFNSYR 329 (333)
Q Consensus 316 ~D-ws~g~il~~l~t 329 (333)
+| |++|+++|+|++
T Consensus 195 ~Di~slG~il~~llt 209 (281)
T 3cc6_A 195 SDVWMFAVCMWEILS 209 (281)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred hccHHHHHHHHHHHh
Confidence 99 999999999997
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=282.70 Aligned_cols=207 Identities=27% Similarity=0.443 Sum_probs=168.4
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC----
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT---- 158 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 158 (333)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34679999999999999999999999999999999986432 223345577899999999999999999988654
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 -EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
...++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67999999996 689888865 579999999999999999999999999999999999999999999999999998775
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~ 316 (333)
......... ..........+||+.|+|||++.+ ..++.++
T Consensus 164 ~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 204 (353)
T 2b9h_A 164 ESAADNSEP---------------------------------------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204 (353)
T ss_dssp -------------------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHH
T ss_pred cccccccCc---------------------------------------cccccchhhccccccccCCeeeccCCCccchh
Confidence 432110000 000011224579999999999865 7799999
Q ss_pred c-hHHHHHHHhhhcccc
Q 019953 317 D-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 317 D-ws~g~il~~l~t~~~ 332 (333)
| ||+||++|+|+++.+
T Consensus 205 Di~slG~il~~l~~g~~ 221 (353)
T 2b9h_A 205 DVWSCGCILAELFLRRP 221 (353)
T ss_dssp HHHHHHHHHHHHHHSSC
T ss_pred hHHHHHHHHHHHHhCCC
Confidence 9 999999999998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=284.60 Aligned_cols=201 Identities=24% Similarity=0.351 Sum_probs=158.4
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHH--HHHhcCCceeEEEEEEee
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL--LAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~ 157 (333)
...+..++|++++.||+|+||.||+|.+ +++.||||++..... ..+..|..+ +..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccc
Confidence 3456788999999999999999999975 689999999975432 122334444 445899999999975532
Q ss_pred -----CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEecccCCCcEEEccCC
Q 019953 158 -----TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH---------NYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 158 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~---------~ivHrDlkp~Nill~~~~ 223 (333)
...+++||||+++|+|.+++.... .++..+..++.|++.||.|||+. ||+||||||+|||++.++
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 336799999999999999996544 58888999999999999999999 999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|||++..+.......... ........+||+.|+|
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~a 196 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGE-----------------------------------------EDNAAISEVGTIRYMA 196 (336)
T ss_dssp CEEECCCTTCEECSSSSCC--------------------------------------------------CCTTSCGGGCC
T ss_pred cEEEeeccceeecccccccCccc-----------------------------------------cccccccCCCccceeC
Confidence 99999999998765432110000 0011124579999999
Q ss_pred cccccC-------CCCCcccc-hHHHHHHHhhhcc
Q 019953 304 PEVLLK-------KGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 304 PE~~~~-------~~~~~~~D-ws~g~il~~l~t~ 330 (333)
||++.+ ..++.++| ||+||++|+|+++
T Consensus 197 PE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp HHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 999987 46778999 9999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=272.96 Aligned_cols=200 Identities=22% Similarity=0.247 Sum_probs=166.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEE-EeeCCeEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS-FQDTEYLY 162 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~ 162 (333)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.|++++..+.. +......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 35789999999999999999999999999999999865422 1247789999999999876555544 46677899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE---ccCCcEEEEeccCcccCCC
Q 019953 163 LIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill---~~~~~vkl~DFGla~~~~~ 238 (333)
+||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 9999999974 4579999999999999999999999999999999999999 4888999999999987654
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
....... .........||+.|+|||++.+..++.++|
T Consensus 161 ~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 198 (296)
T 3uzp_A 161 ARTHQHI------------------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDL 198 (296)
T ss_dssp TTTCCBC------------------------------------------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred ccccccc------------------------------------------ccccccccccccccCChhhhcCCCCCcchhh
Confidence 3211000 000112457999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 199 ~slG~il~~l~~g~ 212 (296)
T 3uzp_A 199 ESLGYVLMYFNLGS 212 (296)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHhCC
Confidence 99999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=279.69 Aligned_cols=208 Identities=22% Similarity=0.318 Sum_probs=169.2
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe----
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ---- 156 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---- 156 (333)
..+..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 3455678999999999999999999999999999999986532 234456788999999999999999999886
Q ss_pred eCCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
.....++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 34478999999999999999865 46799999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG- 311 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~- 311 (333)
+........... ....... .....||+.|+|||++.+..
T Consensus 181 ~~~~~~~~~~~~--------------------------------~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~ 220 (317)
T 2buj_A 181 MNQACIHVEGSR--------------------------------QALTLQD--------WAAQRCTISYRAPELFSVQSH 220 (317)
T ss_dssp CEESCEEEESHH--------------------------------HHHHHHH--------HHHHHSCGGGCCGGGSSCCSE
T ss_pred chhccccccccc--------------------------------ccccccc--------cccccCCcccCCHhHhccCCC
Confidence 886542210000 0000001 11335899999999998654
Q ss_pred --CCcccc-hHHHHHHHhhhccc
Q 019953 312 --YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 312 --~~~~~D-ws~g~il~~l~t~~ 331 (333)
++.++| |++|+++|+|+++.
T Consensus 221 ~~~~~~~Di~slG~il~el~~g~ 243 (317)
T 2buj_A 221 CVIDERTDVWSLGCVLYAMMFGE 243 (317)
T ss_dssp EEECTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCchhhHHHHHHHHHHHHhCC
Confidence 799999 99999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=284.23 Aligned_cols=197 Identities=26% Similarity=0.399 Sum_probs=168.6
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CC-----ceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SH-----CIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~ 152 (333)
.......++|++.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.+++.+. |+ +|+.++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 344556789999999999999999999999999999999997543 22345667888888885 44 499999
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcEecccCCCcEEEc--cCCcEE
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIH--KHNYIHRDIKPDNLLLD--KNGHMK 226 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~Nill~--~~~~vk 226 (333)
+.+...+..++||||++ ++|.+++... ..+++..+..++.|++.||.||| +.||+||||||+|||++ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999999995 5999998765 46999999999999999999999 57999999999999995 477899
Q ss_pred EEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccc
Q 019953 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (333)
Q Consensus 227 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~ 306 (333)
|+|||++....... ...+||+.|+|||+
T Consensus 202 L~DFG~a~~~~~~~----------------------------------------------------~~~~~t~~y~aPE~ 229 (382)
T 2vx3_A 202 IVDFGSSCQLGQRI----------------------------------------------------YQYIQSRFYRSPEV 229 (382)
T ss_dssp ECCCTTCEETTCCC----------------------------------------------------CSSCSCGGGCCHHH
T ss_pred EEeccCceeccccc----------------------------------------------------ccccCCccccChHH
Confidence 99999998654221 13479999999999
Q ss_pred ccCCCCCcccc-hHHHHHHHhhhcccc
Q 019953 307 LLKKGYGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 307 ~~~~~~~~~~D-ws~g~il~~l~t~~~ 332 (333)
+.+.+++.++| ||+||++|+|+++.+
T Consensus 230 ~~~~~~~~~~DiwSlG~il~elltg~~ 256 (382)
T 2vx3_A 230 LLGMPYDLAIDMWSLGCILVEMHTGEP 256 (382)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred HcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 999999999998753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=287.02 Aligned_cols=198 Identities=24% Similarity=0.496 Sum_probs=172.7
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhh--------------HHHHHHHHHHHHHhcCC
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ--------------VEHVRAERNLLAEVASH 146 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~--------------~~~~~~e~~~l~~l~h~ 146 (333)
.....++|++.+.||+|+||.||+|.+ +|+.||||++.......... ...+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 345568999999999999999999998 89999999998664332211 16688899999999999
Q ss_pred ceeEEEEEEeeCCeEEEEEeccCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcE
Q 019953 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTL------LMR--EDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNL 217 (333)
Q Consensus 147 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Ni 217 (333)
||+++++++...+..++||||+++++|.++ +.. ...+++..+..++.|++.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 655 5679999999999999999999999 9999999999999
Q ss_pred EEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC
Q 019953 218 LLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (333)
Q Consensus 218 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 297 (333)
+++.++.++|+|||++....... .....|
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~---------------------------------------------------~~~~~~ 212 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKK---------------------------------------------------IKGSRG 212 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTE---------------------------------------------------ECSSCS
T ss_pred EEcCCCcEEEecccccccccccc---------------------------------------------------ccCCCC
Confidence 99999999999999998653221 113469
Q ss_pred CCCCcccccccCC-CCCc-ccc-hHHHHHHHhhhccc
Q 019953 298 TPDYIAPEVLLKK-GYGM-ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 298 t~~y~APE~~~~~-~~~~-~~D-ws~g~il~~l~t~~ 331 (333)
++.|+|||++.+. .++. ++| |++|+++|+|+++.
T Consensus 213 ~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 249 (348)
T 2pml_X 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249 (348)
T ss_dssp CGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred CcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence 9999999999987 6776 999 99999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=280.60 Aligned_cols=198 Identities=25% Similarity=0.401 Sum_probs=166.9
Q ss_pred cCCCc-eEeeeEeeecceEEEEEEE----ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-
Q 019953 84 CVDDF-ELLTIIGRGAFGEVRLCRE----KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD- 157 (333)
Q Consensus 84 ~~~~y-~~~~~lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 157 (333)
..++| ++++.||+|+||.||++.. ..+++.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 34455 9999999999999988753 4578999999997642 22345668889999999999999999999987
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 158 -TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 158 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
...+++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 46799999999999999999654 4999999999999999999999999999999999999999999999999999877
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
....... .......|++.|+|||++.+..++.++
T Consensus 185 ~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 218 (318)
T 3lxp_A 185 PEGHEYY----------------------------------------------RVREDGDSPVFWYAPECLKEYKFYYAS 218 (318)
T ss_dssp CTTCSEE----------------------------------------------EC---CCCCGGGCCHHHHHHCEEEHHH
T ss_pred ccccccc----------------------------------------------ccccCCCCCceeeChHHhcCCCCCcHH
Confidence 5432110 011134588899999999999999999
Q ss_pred c-hHHHHHHHhhhcc
Q 019953 317 D-WLVSVLHFNSYRF 330 (333)
Q Consensus 317 D-ws~g~il~~l~t~ 330 (333)
| |++|+++|+|+++
T Consensus 219 Di~slG~il~~ll~g 233 (318)
T 3lxp_A 219 DVWSFGVTLYELLTH 233 (318)
T ss_dssp HHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhC
Confidence 9 9999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=275.64 Aligned_cols=194 Identities=31% Similarity=0.590 Sum_probs=169.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 579999999999999999999999999999999876532 2234566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC---CcEEEEeccCcccCCCCccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN---GHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~---~~vkl~DFGla~~~~~~~~~ 242 (333)
||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~- 179 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence 999999999999887889999999999999999999999999999999999999764 4799999999886543211
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
.....|++.|+|||++.+. ++.++| |++|
T Consensus 180 -------------------------------------------------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG 209 (287)
T 2wei_A 180 -------------------------------------------------MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAG 209 (287)
T ss_dssp -------------------------------------------------CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHH
T ss_pred -------------------------------------------------cccccCcccccChHHhcCC-CCCchhhHhHH
Confidence 0123588999999998764 899999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
+++|+|+++.
T Consensus 210 ~~l~~l~~g~ 219 (287)
T 2wei_A 210 VILYILLSGT 219 (287)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHHhCC
Confidence 9999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.62 Aligned_cols=196 Identities=26% Similarity=0.435 Sum_probs=167.9
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCC-ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc------eeEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSG-NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC------IVKL 151 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~ 151 (333)
.......++|++.+.||+|+||.||+|.+..++ ..||+|++.... .....+..|+.+++.+.|++ ++.+
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 344556789999999999999999999998776 789999997542 23345777999999998765 8999
Q ss_pred EEEEeeCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE----------
Q 019953 152 YYSFQDTEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---------- 219 (333)
Q Consensus 152 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill---------- 219 (333)
++++...+..++||||+ ++++.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 99999999999999999 66777777654 369999999999999999999999999999999999999
Q ss_pred ---------ccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhc
Q 019953 220 ---------DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRK 290 (333)
Q Consensus 220 ---------~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (333)
+.++.+||+|||++.......
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------- 196 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH-------------------------------------------------- 196 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSCC--------------------------------------------------
T ss_pred ccccccccccCCCcEEEeecCccccccccc--------------------------------------------------
Confidence 567899999999997643211
Q ss_pred cccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 291 LAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 291 ~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
...+||+.|+|||++.+..++.++| ||+||++|+|+++.
T Consensus 197 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 197 --TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236 (355)
T ss_dssp --CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred --cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence 1346999999999999999999999 99999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=281.61 Aligned_cols=204 Identities=27% Similarity=0.488 Sum_probs=171.2
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEE----EecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCR----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYS 154 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 154 (333)
....+..++|++++.||+|+||.||+|. +..+++.||||++.... ......+.+|+.+++.++||||++++++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3445566789999999999999999998 45689999999987542 3344568889999999999999999998
Q ss_pred EeeCC--eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEecc
Q 019953 155 FQDTE--YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFG 231 (333)
Q Consensus 155 ~~~~~--~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFG 231 (333)
+...+ .+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 86544 689999999999999999775 469999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 311 (333)
++.......... .......+++.|+|||++.+..
T Consensus 191 ~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~ 224 (326)
T 2w1i_A 191 LTKVLPQDKEYY----------------------------------------------KVKEPGESPIFWYAPESLTESK 224 (326)
T ss_dssp TCEECCSSCSEE----------------------------------------------ECSSCCSCCGGGCCHHHHHHCE
T ss_pred chhhcccccccc----------------------------------------------ccccCCCCceeEECchhhcCCC
Confidence 998765432110 0011235778899999999999
Q ss_pred CCcccc-hHHHHHHHhhhccc
Q 019953 312 YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~~ 331 (333)
++.++| |++|+++|+|+|+.
T Consensus 225 ~~~~~Di~slG~il~el~tg~ 245 (326)
T 2w1i_A 225 FSVASDVWSFGVVLYELFTYI 245 (326)
T ss_dssp EEHHHHHHHHHHHHHHHHHTT
T ss_pred CCchhhHHHHHHHHHHHHhcC
Confidence 999999 99999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=284.26 Aligned_cols=199 Identities=21% Similarity=0.355 Sum_probs=160.2
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHH--------hhhhhHHHHHHHHHHHHHhcCCceeEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--------VKRGQVEHVRAERNLLAEVASHCIVKLY 152 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 152 (333)
.....++|++.+.||+|+||.||+|.+.. |..||||++..... ........+.+|+.+++.++||||++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 34456899999999999999999998754 99999999865321 1222346688999999999999999999
Q ss_pred EEEee-----CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEE
Q 019953 153 YSFQD-----TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMK 226 (333)
Q Consensus 153 ~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vk 226 (333)
+++.. ...+|+||||++ |+|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 99843 347899999996 6788777654 4799999999999999999999999999999999999999999999
Q ss_pred EEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccc
Q 019953 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (333)
Q Consensus 227 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~ 306 (333)
|+|||++........ .....||+.|+|||+
T Consensus 175 l~Dfg~~~~~~~~~~--------------------------------------------------~~~~~~t~~y~aPE~ 204 (362)
T 3pg1_A 175 ICDFNLAREDTADAN--------------------------------------------------KTHYVTHRWYRAPEL 204 (362)
T ss_dssp ECCTTC-----------------------------------------------------------------CGGGCCHHH
T ss_pred EEecCcccccccccc--------------------------------------------------cceecccceecCcHH
Confidence 999999975432211 113468999999999
Q ss_pred ccC-CCCCcccc-hHHHHHHHhhhccc
Q 019953 307 LLK-KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 307 ~~~-~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+.+ ..++.++| |++||++|+|+++.
T Consensus 205 ~~~~~~~~~~~DiwslG~il~~l~~g~ 231 (362)
T 3pg1_A 205 VMQFKGFTKLVDMWSAGCVMAEMFNRK 231 (362)
T ss_dssp HTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred hcCCCCCCcHhHHHhHHHHHHHHHhCC
Confidence 987 77999999 99999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=280.13 Aligned_cols=211 Identities=21% Similarity=0.344 Sum_probs=156.9
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEe--
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQ-- 156 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-- 156 (333)
.+.+...+|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..+. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 34455668999999999999999999999999999999885542 233456788999999996 999999999983
Q ss_pred ------eCCeEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEccCCcE
Q 019953 157 ------DTEYLYLIMEYLPGGDMMTLLMR---EDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDKNGHM 225 (333)
Q Consensus 157 ------~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~~~~~v 225 (333)
....+++||||+. |+|.+++.. ...+++..+..++.|++.||.|||++| |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3456899999995 789888754 457999999999999999999999999 9999999999999999999
Q ss_pred EEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccc
Q 019953 226 KLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPE 305 (333)
Q Consensus 226 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE 305 (333)
||+|||++............... ...........||+.|+|||
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~t~~y~aPE 220 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQR-------------------------------------RALVEEEITRNTTPMYRTPE 220 (337)
T ss_dssp EBCCCTTCBCCSSCC-----------------------------------------------------------------
T ss_pred EEecCccceeccccCcccccccc-------------------------------------cccchhhccccCCCCcCChh
Confidence 99999999876543221100000 00000111446999999999
Q ss_pred cc---cCCCCCcccc-hHHHHHHHhhhccc
Q 019953 306 VL---LKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 306 ~~---~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
++ .+..++.++| |++||++|+|+++.
T Consensus 221 ~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 221 IIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp ---CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred hhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence 99 5778999999 99999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=289.14 Aligned_cols=191 Identities=27% Similarity=0.380 Sum_probs=157.2
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC---
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE--- 159 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 159 (333)
....+|.+.+.||+|+||.||+|.+..++. ||+|++...... ..+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 344679999999999999999999877665 888877543211 235899999999999999999985433
Q ss_pred ---eEEEEEeccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc-cCCcEEEEeccC
Q 019953 160 ---YLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGL 232 (333)
Q Consensus 160 ---~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~-~~~~vkl~DFGl 232 (333)
.+++||||++++.+.... .....+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 488999999765433322 2356899999999999999999999999999999999999999 799999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-C
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-G 311 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~ 311 (333)
++.+..... ..+.+||+.|+|||++.+. .
T Consensus 189 a~~~~~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~ 218 (394)
T 4e7w_A 189 AKILIAGEP--------------------------------------------------NVSYICSRYYRAPELIFGATN 218 (394)
T ss_dssp CEECCTTCC--------------------------------------------------CCSSCSCGGGCCHHHHTTCSS
T ss_pred cccccCCCC--------------------------------------------------CcccccCcCccCHHHHcCCCC
Confidence 987643321 1144789999999999775 5
Q ss_pred CCcccc-hHHHHHHHhhhccc
Q 019953 312 YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~~ 331 (333)
++.++| ||+||++|+|+++.
T Consensus 219 ~~~~~DiwSlG~il~ell~g~ 239 (394)
T 4e7w_A 219 YTTNIDIWSTGCVMAELMQGQ 239 (394)
T ss_dssp CCTHHHHHHHHHHHHHHHHSS
T ss_pred CCcHHHHHHHHHHHHHHHhCC
Confidence 999999 99999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=278.47 Aligned_cols=197 Identities=27% Similarity=0.439 Sum_probs=165.1
Q ss_pred cCCCceEeeeEeeecceEEEEEEEe-cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh---cCCceeEEEEEEe---
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREK-KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQ--- 156 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~--- 156 (333)
..++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3478999999999999999999985 678999999987543211 1112355677777766 8999999999987
Q ss_pred --eCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 157 --DTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 157 --~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
.....++||||++ |+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5567999999996 69999987643 499999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC
Q 019953 233 CKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY 312 (333)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 312 (333)
+....... ......|++.|+|||++.+..+
T Consensus 167 ~~~~~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 196 (326)
T 1blx_A 167 ARIYSFQM--------------------------------------------------ALTSVVVTLWYRAPEVLLQSSY 196 (326)
T ss_dssp CCCCCGGG--------------------------------------------------GGCCCCCCCTTCCHHHHTTCCC
T ss_pred cccccCCC--------------------------------------------------CccccccccceeCHHHHhcCCC
Confidence 98654221 0113469999999999999999
Q ss_pred Ccccc-hHHHHHHHhhhcccc
Q 019953 313 GMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~~ 332 (333)
+.++| |++|+++|+|+++.+
T Consensus 197 ~~~~Di~slG~il~~l~~g~~ 217 (326)
T 1blx_A 197 ATPVDLWSVGCIFAEMFRRKP 217 (326)
T ss_dssp CTHHHHHHHHHHHHHHHHSSC
T ss_pred CcchhHHHHHHHHHHHHcCCC
Confidence 99999 999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=283.38 Aligned_cols=199 Identities=21% Similarity=0.327 Sum_probs=163.9
Q ss_pred cccCCCceEeeeEeeecceEEEEEE-----EecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
.+..++|++.+.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4667899999999999999999998 55678899999996432 1223446788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CCcEE
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRE-------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMK 226 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~~vk 226 (333)
.....++||||+++++|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++. +..+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999999765 34889999999999999999999999999999999999984 44699
Q ss_pred EEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccc
Q 019953 227 LSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEV 306 (333)
Q Consensus 227 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~ 306 (333)
|+|||++......... .......|++.|+|||+
T Consensus 184 l~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~ 216 (327)
T 2yfx_A 184 IGDFGMARDIYRASYY-----------------------------------------------RKGGCAMLPVKWMPPEA 216 (327)
T ss_dssp ECCCHHHHHHHC-----------------------------------------------------CCGGGSCGGGCCHHH
T ss_pred ECcccccccccccccc-----------------------------------------------ccCCCcCCCcceeCHhH
Confidence 9999998754322110 01113468999999999
Q ss_pred ccCCCCCcccc-hHHHHHHHhhhc
Q 019953 307 LLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 307 ~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
+.+..++.++| |++|+++|+|+|
T Consensus 217 ~~~~~~~~~~Di~slG~il~ellt 240 (327)
T 2yfx_A 217 FMEGIFTSKTDTWSFGVLLWEIFS 240 (327)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred hcCCCCCchhhHHHHHHHHHHHHc
Confidence 99999999999 999999999997
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=294.98 Aligned_cols=197 Identities=24% Similarity=0.380 Sum_probs=165.6
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..+.+..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++..
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 4567778899999999999999999999864 46799999976432 23568889999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 678999999999999999964 356999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
...... ......+++.|+|||++.+..++.++
T Consensus 331 ~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~s 362 (452)
T 1fmk_A 331 EDNEYT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKS 362 (452)
T ss_dssp ------------------------------------------------------------CCGGGSCHHHHHHCCCCHHH
T ss_pred CCCcee------------------------------------------------cccCCcccccccCHhHHhcCCCCccc
Confidence 432110 00123478899999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| ||+|+++|+|+|
T Consensus 363 DvwslG~~l~el~t 376 (452)
T 1fmk_A 363 DVWSFGILLTELTT 376 (452)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred cHHhHHHHHHHHHh
Confidence 9 999999999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=277.16 Aligned_cols=188 Identities=28% Similarity=0.460 Sum_probs=158.4
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..++|++.+.||+|+||.||+|.+. ++.||||++... .....+.+|+.+++.++||||+++++++.+ ..+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999864 788999998643 234567889999999999999999998864 478
Q ss_pred EEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcEecccCCCcEEEccCCc-EEEEeccCccc
Q 019953 163 LIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHK---HNYIHRDIKPDNLLLDKNGH-MKLSDFGLCKP 235 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~Nill~~~~~-vkl~DFGla~~ 235 (333)
+||||+++++|.+++.... .++...+..++.|++.||.|||+ +||+||||||+||+++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999997654 47889999999999999999999 89999999999999998886 79999999875
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
..... ....||+.|+|||++.+..++.+
T Consensus 156 ~~~~~----------------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~ 183 (307)
T 2eva_A 156 IQTHM----------------------------------------------------TNNKGSAAWMAPEVFEGSNYSEK 183 (307)
T ss_dssp -------------------------------------------------------------CCTTSSCHHHHTCCCCCTH
T ss_pred ccccc----------------------------------------------------ccCCCCCceEChhhhCCCCCCcH
Confidence 43211 02359999999999999999999
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| |++|+++|+|+++.
T Consensus 184 ~Di~slG~il~el~~g~ 200 (307)
T 2eva_A 184 CDVFSWGIILWEVITRR 200 (307)
T ss_dssp HHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHHHHCC
Confidence 99 99999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=278.17 Aligned_cols=195 Identities=24% Similarity=0.340 Sum_probs=160.0
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHH--hcCCceeEEEEEEeeC-
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDT- 158 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~- 158 (333)
....++|++.+.||+|+||.||+|.+. ++.||||++..... .....|..++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 344568999999999999999999875 89999999865422 223345555554 4999999999999877
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEecccCCCcEEEccCCcEEE
Q 019953 159 ---EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDKNGHMKL 227 (333)
Q Consensus 159 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~ivHrDlkp~Nill~~~~~vkl 227 (333)
..+++||||+++|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999654 699999999999999999999998 9999999999999999999999
Q ss_pred EeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc
Q 019953 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (333)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 307 (333)
+|||++..+....... .......+||+.|+|||++
T Consensus 184 ~Dfg~a~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~ 218 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEV---------------------------------------------DIPPNTRVGTKRYMPPEVL 218 (337)
T ss_dssp CCCTTCEECC------------------------------------------------------CCSSCSCGGGCCHHHH
T ss_pred EeCCCceeeccccccc---------------------------------------------cCCCCCCccCcceeChhhc
Confidence 9999998765332110 0011144799999999999
Q ss_pred cCCCCCcc------cc-hHHHHHHHhhhcc
Q 019953 308 LKKGYGME------CD-WLVSVLHFNSYRF 330 (333)
Q Consensus 308 ~~~~~~~~------~D-ws~g~il~~l~t~ 330 (333)
.+..++.. +| ||+||++|+|+|+
T Consensus 219 ~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 219 DESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp TTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccCCccccCccccchHHHHHHHHHHHhc
Confidence 88777665 99 9999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=283.25 Aligned_cols=204 Identities=25% Similarity=0.365 Sum_probs=171.3
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh---hhHHHHHHHHHHHHHhc--CCceeEE
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEVA--SHCIVKL 151 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~iv~~ 151 (333)
.........++|++.+.||+|+||.||+|.+..+++.||||++........ .....+..|+.+++.+. |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 334556677899999999999999999999999999999999976532211 11123556899999996 5999999
Q ss_pred EEEEeeCCeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc-cCCcEEEEe
Q 019953 152 YYSFQDTEYLYLIMEYLPG-GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSD 229 (333)
Q Consensus 152 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~-~~~~vkl~D 229 (333)
++++...+..++|||++.+ ++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999999999976 89999998888899999999999999999999999999999999999999 789999999
Q ss_pred ccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC
Q 019953 230 FGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 309 (333)
Q Consensus 230 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 309 (333)
||++........ ....||+.|+|||++.+
T Consensus 194 fg~~~~~~~~~~---------------------------------------------------~~~~gt~~y~aPE~~~~ 222 (320)
T 3a99_A 194 FGSGALLKDTVY---------------------------------------------------TDFDGTRVYSPPEWIRY 222 (320)
T ss_dssp CTTCEECCSSCB---------------------------------------------------CCCCSCGGGSCHHHHHH
T ss_pred Cccccccccccc---------------------------------------------------cCCCCCccCCChHHhcc
Confidence 999987643211 13469999999999987
Q ss_pred CCC-Ccccc-hHHHHHHHhhhccc
Q 019953 310 KGY-GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ~~~-~~~~D-ws~g~il~~l~t~~ 331 (333)
..+ +.++| |++|+++|+|+++.
T Consensus 223 ~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 223 HRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp SCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred CCCCCccchHHhHHHHHHHHHHCC
Confidence 776 78899 99999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=275.92 Aligned_cols=192 Identities=26% Similarity=0.455 Sum_probs=160.8
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..+.+..++|++.+.||+|+||.||+|.+ +|..||||++.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34667788999999999999999999986 48899999997542 345578899999999999999999986544
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 159 -EYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 159 -~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccc
Confidence 47899999999999999997654 388999999999999999999999999999999999999999999999999875
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
..... ....+++.|+|||++.+..++.+
T Consensus 167 ~~~~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~ 194 (278)
T 1byg_A 167 ASSTQ----------------------------------------------------DTGKLPVKWTAPEALREKKFSTK 194 (278)
T ss_dssp -------------------------------------------------------------CCTTTSCHHHHHHCCCCHH
T ss_pred ccccc----------------------------------------------------cCCCccccccCHHHhCCCCCCch
Confidence 43221 02257889999999999999999
Q ss_pred cc-hHHHHHHHhhhc
Q 019953 316 CD-WLVSVLHFNSYR 329 (333)
Q Consensus 316 ~D-ws~g~il~~l~t 329 (333)
+| |++|+++|+|+|
T Consensus 195 ~Di~slG~il~~l~t 209 (278)
T 1byg_A 195 SDVWSFGILLWEIYS 209 (278)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred hcHHHHHHHHHHHHh
Confidence 99 999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=283.53 Aligned_cols=192 Identities=29% Similarity=0.443 Sum_probs=150.4
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC-----
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 159 (333)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......++..+..++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 4789999999999999999999999999999998865422 1223455778888999999999999986533
Q ss_pred --eEEEEEeccCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hCCcEecccCCCcEEEcc-CCcEEEEec
Q 019953 160 --YLYLIMEYLPGGDMMTLL----MREDTLTENVARFYIAQSVLAIESIH--KHNYIHRDIKPDNLLLDK-NGHMKLSDF 230 (333)
Q Consensus 160 --~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~Nill~~-~~~vkl~DF 230 (333)
.+++||||+++ +|...+ .....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 38999999976 444333 34567999999999999999999999 999999999999999996 899999999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 310 (333)
|++..+..... .....||+.|+|||++.+.
T Consensus 177 g~a~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~ 206 (360)
T 3e3p_A 177 GSAKKLSPSEP--------------------------------------------------NVAYICSRYYRAPELIFGN 206 (360)
T ss_dssp TTCBCCCTTSC--------------------------------------------------CCSTTSCGGGCCHHHHTTC
T ss_pred CCceecCCCCC--------------------------------------------------cccccCCcceeCHHHHcCC
Confidence 99987653321 1134689999999999765
Q ss_pred C-CCcccc-hHHHHHHHhhhccc
Q 019953 311 G-YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 311 ~-~~~~~D-ws~g~il~~l~t~~ 331 (333)
. ++.++| ||+||++|+|+++.
T Consensus 207 ~~~~~~~Di~slG~il~ell~g~ 229 (360)
T 3e3p_A 207 QHYTTAVDIWSVGCIFAEMMLGE 229 (360)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCcHHHHHHHHHHHHHHHhCC
Confidence 4 899999 99999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=291.34 Aligned_cols=189 Identities=17% Similarity=0.213 Sum_probs=156.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh-----hhhhHHHHHHHHHHHHHhc---------CCcee
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-----KRGQVEHVRAERNLLAEVA---------SHCIV 149 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~~iv 149 (333)
..++|++++.||+|+||+||+|.+ +|+.||||++...... .......+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346799999999999999999987 6899999999765321 2223456788999999886 77777
Q ss_pred EEEEEEe------------------------------eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 019953 150 KLYYSFQ------------------------------DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199 (333)
Q Consensus 150 ~~~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L 199 (333)
++.+.+. ..+.+|+|||||++|++.+.+.. ..+++..++.++.|++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 7777643 26789999999999977776643 6689999999999999999
Q ss_pred HHHH-hCCcEecccCCCcEEEccCC--------------------cEEEEeccCcccCCCCcccccccccccCccccCCC
Q 019953 200 ESIH-KHNYIHRDIKPDNLLLDKNG--------------------HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258 (333)
Q Consensus 200 ~~LH-~~~ivHrDlkp~Nill~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (333)
.||| ++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------- 235 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------- 235 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------------------
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------------------
Confidence 9999 99999999999999999887 8999999999865421
Q ss_pred CCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH-HHhhhcc
Q 019953 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL-HFNSYRF 330 (333)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i-l~~l~t~ 330 (333)
..+||+.|+|||++.+.. +.++| ||++++ .+.++++
T Consensus 236 -----------------------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g 273 (336)
T 2vuw_A 236 -----------------------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGE 273 (336)
T ss_dssp -----------------------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTS
T ss_pred -----------------------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccc
Confidence 336999999999999877 99999 998766 6666644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=273.96 Aligned_cols=194 Identities=26% Similarity=0.308 Sum_probs=164.6
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHH-hhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
|...+.||+|+||.||+|.+ ++..||||++..... ........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999985 688999999865321 123345668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 167 YLPGGDMMTLLMR---EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 167 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
|+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT- 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc-
Confidence 9999999999864 346999999999999999999999999999999999999999999999999999865432210
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.......||+.|+|||++.+ .++.++| |++|+
T Consensus 190 ----------------------------------------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~ 222 (307)
T 2nru_A 190 ----------------------------------------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGV 222 (307)
T ss_dssp ----------------------------------------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHH
T ss_pred ----------------------------------------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHH
Confidence 01113469999999999875 4899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 223 il~~l~~g~ 231 (307)
T 2nru_A 223 VLLEIITGL 231 (307)
T ss_dssp HHHHHHHCC
T ss_pred HHHHHHHCC
Confidence 999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=282.32 Aligned_cols=191 Identities=27% Similarity=0.417 Sum_probs=163.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe----
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY---- 160 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 160 (333)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999986542 223345567889999999999999999999987653
Q ss_pred --EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 161 --LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 161 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
+++||||+. ++|.+++. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999996 68877764 3599999999999999999999999999999999999999999999999999986432
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D 317 (333)
.. ...+||+.|+|||++.+ ..++.++|
T Consensus 179 ~~----------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~D 206 (353)
T 3coi_A 179 EM----------------------------------------------------TGYVVTRWYRAPEVILSWMHYNQTVD 206 (353)
T ss_dssp ---------------------------------------------------------CCSBCCSCHHHHSCCSCCCTTHH
T ss_pred Cc----------------------------------------------------cccccCcCcCCHHHHhCcCCCCchhh
Confidence 11 13468999999999987 77999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 207 i~slG~il~el~~g~ 221 (353)
T 3coi_A 207 IWSVGCIMAEMLTGK 221 (353)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhCC
Confidence 99999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=303.44 Aligned_cols=195 Identities=25% Similarity=0.356 Sum_probs=162.4
Q ss_pred CceEe-eeEeeecceEEEEEEE--ecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 87 DFELL-TIIGRGAFGEVRLCRE--KKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 87 ~y~~~-~~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
.+.+. +.||+|+||.||+|.+ ..+++.||||+++... ........+.+|+.+++.++||||+++++++.. +..++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999965 4567889999997653 233445678899999999999999999999864 45889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998765432110
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.......||+.|+|||++.+..++.++| ||+||
T Consensus 527 ----------------------------------------------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv 560 (635)
T 4fl3_A 527 ----------------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 560 (635)
T ss_dssp ------------------------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ----------------------------------------------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHH
Confidence 0011234788999999999999999999 99999
Q ss_pred HHHhhhc
Q 019953 323 LHFNSYR 329 (333)
Q Consensus 323 il~~l~t 329 (333)
++|+|++
T Consensus 561 ~l~ellt 567 (635)
T 4fl3_A 561 LMWEAFS 567 (635)
T ss_dssp HHHHHHT
T ss_pred HHHHHHh
Confidence 9999997
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=275.99 Aligned_cols=201 Identities=23% Similarity=0.365 Sum_probs=160.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEec-CCc--eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKK-SGN--IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
.+..++|++.+.||+|+||.||+|.+.. ++. .||||++.............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4456789999999999999999998653 333 6899999765444445567788999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
. .++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 88999999999999998764 579999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
...... .......+++.|+|||++.+..++.++|
T Consensus 173 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 206 (291)
T 1u46_A 173 QNDDHY----------------------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASD 206 (291)
T ss_dssp C-CCEE----------------------------------------------EC-----CCGGGCCHHHHHHCEEEHHHH
T ss_pred ccccch----------------------------------------------hhhccCCCCceeeCchhhcCCCCCchhh
Confidence 432110 0111335788999999999999999999
Q ss_pred -hHHHHHHHhhhc
Q 019953 318 -WLVSVLHFNSYR 329 (333)
Q Consensus 318 -ws~g~il~~l~t 329 (333)
|++|+++|+|++
T Consensus 207 i~slG~il~~l~~ 219 (291)
T 1u46_A 207 TWMFGVTLWEMFT 219 (291)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHh
Confidence 999999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=273.60 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=168.6
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
......++|.....||+|+||.||+|.+..++..||||.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 33444566666779999999999999999999999999987542 233456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-CCcEEEEeccCccc
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE---DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-NGHMKLSDFGLCKP 235 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-~~~vkl~DFGla~~ 235 (333)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 999999999999999999764 25678899999999999999999999999999999999987 89999999999986
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC--CC
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG--YG 313 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~ 313 (333)
...... ......|++.|+|||++.+.. ++
T Consensus 173 ~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (295)
T 2clq_A 173 LAGINP-------------------------------------------------CTETFTGTLQYMAPEIIDKGPRGYG 203 (295)
T ss_dssp SCC------------------------------------------------------CCCCCCGGGCCHHHHHHGGGGCS
T ss_pred cCCCCC-------------------------------------------------cccccCCCccccChhhhcCCCCCCC
Confidence 543210 011346999999999997654 89
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| |++|+++|+|+++.
T Consensus 204 ~~~Di~slG~il~~l~~g~ 222 (295)
T 2clq_A 204 KAADIWSLGCTIIEMATGK 222 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTS
T ss_pred cHHHHHHHHHHHHHHHHCC
Confidence 9999 99999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=275.09 Aligned_cols=198 Identities=24% Similarity=0.382 Sum_probs=160.7
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe------
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ------ 156 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 156 (333)
...++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 44679999999999999999999999999999999986542 234566788999999999999999998873
Q ss_pred --------eCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc-cCCcEEE
Q 019953 157 --------DTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKL 227 (333)
Q Consensus 157 --------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~-~~~~vkl 227 (333)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999996 699998854 5799999999999999999999999999999999999997 5679999
Q ss_pred EeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc
Q 019953 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (333)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 307 (333)
+|||++......... ........|++.|+|||++
T Consensus 163 ~Dfg~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~ 196 (320)
T 2i6l_A 163 GDFGLARIMDPHYSH----------------------------------------------KGHLSEGLVTKWYRSPRLL 196 (320)
T ss_dssp CCCTTCBCC------------------------------------------------------CCCGGGSCCTTCCHHHH
T ss_pred ccCccccccCCCccc----------------------------------------------ccccccccccccccCcHHh
Confidence 999999876432110 0011134689999999998
Q ss_pred cC-CCCCcccc-hHHHHHHHhhhccc
Q 019953 308 LK-KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 308 ~~-~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.+ ..++.++| |++|+++|+|+++.
T Consensus 197 ~~~~~~~~~~Di~slG~il~el~~g~ 222 (320)
T 2i6l_A 197 LSPNNYTKAIDMWAAGCIFAEMLTGK 222 (320)
T ss_dssp HCTTCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCcccCCchhhhHhHHHHHHHHHhCC
Confidence 76 77999999 99999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=277.72 Aligned_cols=200 Identities=26% Similarity=0.462 Sum_probs=151.0
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHH-HHHHhcCCceeEEEEEEee
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERN-LLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~ 157 (333)
..+.+..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+..|+. +++.++||||+++++++..
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4566778999999999999999999999999999999999975421 122233444554 6777899999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEecc
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMR-----EDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFG 231 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFG 231 (333)
.+..++||||+++ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999975 78777753 56799999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc----
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL---- 307 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~---- 307 (333)
++........ .....||+.|+|||++
T Consensus 172 ~~~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~ 201 (327)
T 3aln_A 172 ISGQLVDSIA--------------------------------------------------KTRDAGCRPYMAPERIDPSA 201 (327)
T ss_dssp SSCC----------------------------------------------------------------------------
T ss_pred Cceecccccc--------------------------------------------------cccCCCCccccCceeecccc
Confidence 9986543211 0123699999999999
Q ss_pred cCCCCCcccc-hHHHHHHHhhhccc
Q 019953 308 LKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 308 ~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
.+..++.++| |++|+++|+|+++.
T Consensus 202 ~~~~~~~~~Di~slG~il~~l~~g~ 226 (327)
T 3aln_A 202 SRQGYDVRSDVWSLGITLYELATGR 226 (327)
T ss_dssp ----CCSHHHHHHHHHHHHHHHHSC
T ss_pred CcCCCCchhhHHHHHHHHHHHHHCC
Confidence 5677999999 99999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=289.63 Aligned_cols=195 Identities=25% Similarity=0.383 Sum_probs=149.7
Q ss_pred CCceE-eeeEeeecceEEEEEEEe--cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee--CCe
Q 019953 86 DDFEL-LTIIGRGAFGEVRLCREK--KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TEY 160 (333)
Q Consensus 86 ~~y~~-~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 160 (333)
+.|.+ .++||+|+||.||+|.+. .+++.||||++..... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 44666 458999999999999965 5789999999975422 2346789999999999999999999954 678
Q ss_pred EEEEEeccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE----ccCCcEEE
Q 019953 161 LYLIMEYLPGGDMMTLLMRE---------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DKNGHMKL 227 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill----~~~~~vkl 227 (333)
+++||||+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 5888777531 249999999999999999999999999999999999999 67789999
Q ss_pred EeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccc
Q 019953 228 SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVL 307 (333)
Q Consensus 228 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~ 307 (333)
+|||+++.+...... .......+||+.|+|||++
T Consensus 174 ~Dfg~a~~~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~ 207 (405)
T 3rgf_A 174 ADMGFARLFNSPLKP----------------------------------------------LADLDPVVVTFWYRAPELL 207 (405)
T ss_dssp CCTTCCC--------------------------------------------------------------CCCTTCCHHHH
T ss_pred EECCCceecCCCCcc----------------------------------------------cccCCCceecCcccCchhh
Confidence 999999876432110 0011245799999999999
Q ss_pred cCC-CCCcccc-hHHHHHHHhhhcccc
Q 019953 308 LKK-GYGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 308 ~~~-~~~~~~D-ws~g~il~~l~t~~~ 332 (333)
.+. .++.++| ||+||++|+|+++.+
T Consensus 208 ~~~~~~~~~~DiwSlG~il~ell~g~~ 234 (405)
T 3rgf_A 208 LGARHYTKAIDIWAIGCIFAELLTSEP 234 (405)
T ss_dssp TTCCSCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcccchhhhHHHHHHHHHHHhCCC
Confidence 884 5999999 999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=300.22 Aligned_cols=199 Identities=24% Similarity=0.373 Sum_probs=163.8
Q ss_pred cccCCCceEee-eEeeecceEEEEEEEec--CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 82 KICVDDFELLT-IIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 82 ~~~~~~y~~~~-~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
.+..+++.+.+ .||+|+||.||+|.+.. ++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 34456677766 89999999999998763 56679999997642 23345678899999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 5699999999999999999654 469999999999999999999999999999999999999999999999999998764
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
...... .......+++.|+|||++.+..++.++|
T Consensus 488 ~~~~~~----------------------------------------------~~~~~~~~~~~y~APE~~~~~~~~~~sD 521 (613)
T 2ozo_A 488 ADDSYY----------------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSD 521 (613)
T ss_dssp ------------------------------------------------------------CCTTSCHHHHHHCCCCHHHH
T ss_pred CCCcee----------------------------------------------eeccCCCCccceeCHhhhcCCCCCcHHH
Confidence 322100 0001224678999999999999999999
Q ss_pred -hHHHHHHHhhhc
Q 019953 318 -WLVSVLHFNSYR 329 (333)
Q Consensus 318 -ws~g~il~~l~t 329 (333)
||+||++|+|+|
T Consensus 522 vwSlGv~l~ellt 534 (613)
T 2ozo_A 522 VWSYGVTMWEALS 534 (613)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHH
Confidence 999999999997
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=286.79 Aligned_cols=196 Identities=19% Similarity=0.284 Sum_probs=155.9
Q ss_pred CceEeeeEeeecceEEEEEEEecCC---ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe-eCCeEE
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSG---NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DTEYLY 162 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 162 (333)
.|.+.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+++++++. .++..+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4788999999999999999876433 468999986532 2344567888999999999999999999864 456789
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999999764 4688999999999999999999999999999999999999999999999999986643221
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
.. ........+|+.|+|||++.+..++.++| ||+
T Consensus 248 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 282 (373)
T 3c1x_A 248 DS---------------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282 (373)
T ss_dssp -------------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred cc---------------------------------------------ccccCCCCCcccccChHHhcCCCCCcHHHHHHH
Confidence 10 00011335788999999999999999999 999
Q ss_pred HHHHHhhhc
Q 019953 321 SVLHFNSYR 329 (333)
Q Consensus 321 g~il~~l~t 329 (333)
||++|+|+|
T Consensus 283 G~il~ellt 291 (373)
T 3c1x_A 283 GVLLWELMT 291 (373)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=281.64 Aligned_cols=193 Identities=25% Similarity=0.396 Sum_probs=166.1
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-----------CCceeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-----------SHCIVK 150 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~ 150 (333)
.+..++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.+. |+||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 3456799999999999999999999999999999999975432 2345677888888876 789999
Q ss_pred EEEEEeeCC----eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEcc--
Q 019953 151 LYYSFQDTE----YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDK-- 221 (333)
Q Consensus 151 ~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~-- 221 (333)
+++++...+ .+++|||++ +++|.+++... ..+++..+..++.|++.||.|||++ ||+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999987654 789999999 89999999763 4599999999999999999999998 9999999999999953
Q ss_pred ----CCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCC
Q 019953 222 ----NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVG 297 (333)
Q Consensus 222 ----~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 297 (333)
.+.+||+|||++....... ...+|
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~~----------------------------------------------------~~~~~ 197 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEHY----------------------------------------------------TNSIQ 197 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBCC----------------------------------------------------CSCCS
T ss_pred CCcCcceEEEcccccccccCCCC----------------------------------------------------CCCCC
Confidence 3489999999998654221 13468
Q ss_pred CCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 298 TPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 298 t~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
|+.|+|||++.+..++.++| ||+||++|+|+++.
T Consensus 198 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp CGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 99999999999999999999 99999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=278.46 Aligned_cols=200 Identities=26% Similarity=0.408 Sum_probs=162.1
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh---hhHHHHHHHHHHHHHh----cCCceeEEEE
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---GQVEHVRAERNLLAEV----ASHCIVKLYY 153 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~~iv~~~~ 153 (333)
.....++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.++..+ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34556789999999999999999999999999999999976432111 1122355689999998 8999999999
Q ss_pred EEeeCCeEEEEEec-cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc-cCCcEEEEecc
Q 019953 154 SFQDTEYLYLIMEY-LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFG 231 (333)
Q Consensus 154 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~-~~~~vkl~DFG 231 (333)
++...+..++|||+ +.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999999 78999999998888899999999999999999999999999999999999999 88999999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 311 (333)
++........ ....|++.|+|||++.+..
T Consensus 186 ~~~~~~~~~~---------------------------------------------------~~~~~~~~y~aPE~~~~~~ 214 (312)
T 2iwi_A 186 SGALLHDEPY---------------------------------------------------TDFDGTRVYSPPEWISRHQ 214 (312)
T ss_dssp SCEECCSSCB---------------------------------------------------CCCCSCTTTSCHHHHHHSC
T ss_pred hhhhcccCcc---------------------------------------------------cccCCcccccCceeeecCC
Confidence 9987653221 1346999999999998777
Q ss_pred CC-cccc-hHHHHHHHhhhccc
Q 019953 312 YG-MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 312 ~~-~~~D-ws~g~il~~l~t~~ 331 (333)
+. .++| |++|+++|+|+++.
T Consensus 215 ~~~~~~Di~slG~il~~l~~g~ 236 (312)
T 2iwi_A 215 YHALPATVWSLGILLYDMVCGD 236 (312)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSS
T ss_pred CCCccchHHHHHHHHHHHHHCC
Confidence 64 5899 99999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=278.25 Aligned_cols=192 Identities=29% Similarity=0.485 Sum_probs=145.7
Q ss_pred cccCCCceEee-eEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee---
Q 019953 82 KICVDDFELLT-IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--- 157 (333)
Q Consensus 82 ~~~~~~y~~~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 157 (333)
....++|.+.+ .||+|+||.||+|.+..+|+.||||++...... .......++.+.||||+++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-------RQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH-------HHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH-------HHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 34567899965 699999999999999999999999998654211 1223344667799999999999876
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CCcEEEEecc
Q 019953 158 -TEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFG 231 (333)
Q Consensus 158 -~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~~vkl~DFG 231 (333)
...+++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999997653 6999999999999999999999999999999999999986 4559999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 311 (333)
++....... ....+||+.|+|||++.+..
T Consensus 177 ~~~~~~~~~---------------------------------------------------~~~~~~t~~y~aPE~~~~~~ 205 (336)
T 3fhr_A 177 FAKETTQNA---------------------------------------------------LQTPCYTPYYVAPEVLGPEK 205 (336)
T ss_dssp TCEEC-------------------------------------------------------------------------CH
T ss_pred cceeccccc---------------------------------------------------cccCCCCcCccChhhhCCCC
Confidence 998654221 11346899999999999999
Q ss_pred CCcccc-hHHHHHHHhhhccc
Q 019953 312 YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~~ 331 (333)
++.++| |++|+++|+|+++.
T Consensus 206 ~~~~~Di~slG~il~~l~~g~ 226 (336)
T 3fhr_A 206 YDKSCDMWSLGVIMYILLCGF 226 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHSS
T ss_pred CCchhhHHHHHHHHHHHHHCC
Confidence 999999 99999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=297.98 Aligned_cols=197 Identities=24% Similarity=0.380 Sum_probs=170.0
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
..+++..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++|+||+++++++..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4577788899999999999999999999864 46799999976432 23568889999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+.+++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 678999999999999999964 356899999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
...... ......++..|+|||++.+..++.++
T Consensus 414 ~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~s 445 (535)
T 2h8h_A 414 EDNEYT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKS 445 (535)
T ss_dssp CCHHHH------------------------------------------------TTCSTTSCGGGSCHHHHHHCCCCHHH
T ss_pred CCCcee------------------------------------------------cccCCcCcccccCHHHhccCCCCchh
Confidence 432110 01123577899999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| |++||++|+|++
T Consensus 446 DvwSlGv~l~el~t 459 (535)
T 2h8h_A 446 DVWSFGILLTELTT 459 (535)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHh
Confidence 9 999999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=305.09 Aligned_cols=194 Identities=25% Similarity=0.371 Sum_probs=164.4
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEec-CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKK-SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
...+..++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.++..++||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 344566899999999999999999999976 78999999986532 223345678899999999999999999999876
Q ss_pred Ce-----EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCc
Q 019953 159 EY-----LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 159 ~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
+. .|+||||++|++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++.+ .+||+|||++
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccc
Confidence 55 7999999999999887754 79999999999999999999999999999999999999875 8999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
+...... ..+||+.|+|||++.+. ++
T Consensus 229 ~~~~~~~-----------------------------------------------------~~~gt~~y~aPE~~~~~-~~ 254 (681)
T 2pzi_A 229 SRINSFG-----------------------------------------------------YLYGTPGFQAPEIVRTG-PT 254 (681)
T ss_dssp EETTCCS-----------------------------------------------------CCCCCTTTSCTTHHHHC-SC
T ss_pred hhcccCC-----------------------------------------------------ccCCCccccCHHHHcCC-CC
Confidence 8654321 34699999999999765 48
Q ss_pred cccc-hHHHHHHHhhhcccc
Q 019953 314 MECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~~ 332 (333)
.++| ||+||++|+|+++.+
T Consensus 255 ~~sDi~slG~~l~~l~~g~~ 274 (681)
T 2pzi_A 255 VATDIYTVGRTLAALTLDLP 274 (681)
T ss_dssp HHHHHHHHHHHHHHHHSCCC
T ss_pred CceehhhhHHHHHHHHhCCC
Confidence 9999 999999999998653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=274.20 Aligned_cols=204 Identities=25% Similarity=0.407 Sum_probs=167.7
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc--CCceeEEEEE
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA--SHCIVKLYYS 154 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~ 154 (333)
.+....+..++|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.++..+. |+||++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34556667788999999999999999999875 588999999865432 2234566888999999997 4899999999
Q ss_pred EeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 155 FQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 155 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
+...+..++||| +.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++.
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 174 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccc
Confidence 999999999999 55889999999888999999999999999999999999999999999999996 5899999999998
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-----
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK----- 309 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----- 309 (333)
........ .......|++.|+|||++.+
T Consensus 175 ~~~~~~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (313)
T 3cek_A 175 QMQPDTTS-----------------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSR 207 (313)
T ss_dssp C-------------------------------------------------------------CCGGGCCHHHHTTCC---
T ss_pred cccCcccc-----------------------------------------------ccccCCCCCCCcCCHHHHhhccccc
Confidence 76432210 00113469999999999976
Q ss_pred ------CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 ------KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ------~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| |++|+++|+|+++.
T Consensus 208 ~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 208 ENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp -------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 47899999 99999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=287.17 Aligned_cols=200 Identities=22% Similarity=0.270 Sum_probs=167.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC-ceeEEEEEEeeCCeEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLY 162 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~ 162 (333)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.+.|+ +++.+..++......+
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 457899999999999999999999999999999987654321 2367799999999875 5666666677788899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEE---ccCCcEEEEeccCcccCCC
Q 019953 163 LIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill---~~~~~vkl~DFGla~~~~~ 238 (333)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 5679999999999999999999999999999999999999 6889999999999987654
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
....... ........+||+.|+|||++.+..++.++|
T Consensus 159 ~~~~~~~------------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDv 196 (483)
T 3sv0_A 159 TSTHQHI------------------------------------------PYRENKNLTGTARYASVNTHLGIEQSRRDDL 196 (483)
T ss_dssp TTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred Ccccccc------------------------------------------ccccccccCCCccccCHHHhcCCCCChHHHH
Confidence 3211000 000112457999999999999999999999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
|++||++|+|+++.
T Consensus 197 wSlGvil~elltG~ 210 (483)
T 3sv0_A 197 ESLGYVLMYFLRGS 210 (483)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHhCC
Confidence 99999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=275.71 Aligned_cols=192 Identities=26% Similarity=0.325 Sum_probs=162.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHH--hcCCceeEEEEEEeeCC---
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDTE--- 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~--- 159 (333)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..|..++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 46799999999999999999987 58999999986542 2346678888887 79999999999998775
Q ss_pred -eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEecccCCCcEEEccCCcEEEEec
Q 019953 160 -YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH--------KHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (333)
Q Consensus 160 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH--------~~~ivHrDlkp~Nill~~~~~vkl~DF 230 (333)
.+++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 79999999999999999965 46899999999999999999999 899999999999999999999999999
Q ss_pred cCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC
Q 019953 231 GLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK 310 (333)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 310 (333)
|++........... .......||+.|+|||++.+.
T Consensus 192 g~~~~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 192 GLAVRHDSATDTID---------------------------------------------IAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp TTCEEEETTTTEEE---------------------------------------------ECCCSCCCCGGGCCHHHHTSC
T ss_pred CCceeccccccccc---------------------------------------------cccccCCcCcccCCHhhhccc
Confidence 99987643321100 011144799999999999876
Q ss_pred ------CCCcccc-hHHHHHHHhhhcc
Q 019953 311 ------GYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 311 ------~~~~~~D-ws~g~il~~l~t~ 330 (333)
.++.++| |++||++|+|+|+
T Consensus 227 ~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 227 INMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp CCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCCcccHHHHHHHHHHHHhc
Confidence 3447899 9999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=296.51 Aligned_cols=199 Identities=25% Similarity=0.349 Sum_probs=166.9
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
...+..++|++.+.||+|+||.||+|.+..+ +..||||.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456668899999999999999999998643 4679999986542 2234466888999999999999999999985
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 456899999999999999997654 689999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
........ .....+++.|+|||++.+..++.+
T Consensus 541 ~~~~~~~~------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~ 572 (656)
T 2j0j_A 541 MEDSTYYK------------------------------------------------ASKGKLPIKWMAPESINFRRFTSA 572 (656)
T ss_dssp CCC----------------------------------------------------------CCGGGCCHHHHHHCCCCHH
T ss_pred cCCCccee------------------------------------------------ccCCCCCcceeCHHHhcCCCCCch
Confidence 64332110 112357889999999999999999
Q ss_pred cc-hHHHHHHHhhhc
Q 019953 316 CD-WLVSVLHFNSYR 329 (333)
Q Consensus 316 ~D-ws~g~il~~l~t 329 (333)
+| ||+||++|+|++
T Consensus 573 ~DiwSlG~il~ellt 587 (656)
T 2j0j_A 573 SDVWMFGVCMWEILM 587 (656)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHH
Confidence 99 999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=270.63 Aligned_cols=200 Identities=26% Similarity=0.405 Sum_probs=152.8
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
......++|++++.||+|+||.||+|.+..+|+.||||++...... ......+..+..+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 3455678899999999999999999999999999999999764321 222333445556788889999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
..++||||+ ++.+..+... ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++..+.
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 5566665543 56799999999999999999999995 99999999999999999999999999987654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----CCCC
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGY 312 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~ 312 (333)
.... .....|++.|+|||++. +..+
T Consensus 177 ~~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~ 206 (318)
T 2dyl_A 177 DDKA--------------------------------------------------KDRSAGCAAYMAPERIDPPDPTKPDY 206 (318)
T ss_dssp ------------------------------------------------------------CCTTCCHHHHC--------C
T ss_pred CCcc--------------------------------------------------ccccCCCccccChhhcccccccccCC
Confidence 3211 11346999999999994 5678
Q ss_pred Ccccc-hHHHHHHHhhhccc
Q 019953 313 GMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 313 ~~~~D-ws~g~il~~l~t~~ 331 (333)
+.++| |++|+++|+|+++.
T Consensus 207 ~~~~Di~slG~il~~l~~g~ 226 (318)
T 2dyl_A 207 DIRADVWSLGISLVELATGQ 226 (318)
T ss_dssp CTHHHHHHHHHHHHHHHHSS
T ss_pred ccccchhhHHHHHHHHHhCC
Confidence 99999 99999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=297.04 Aligned_cols=195 Identities=28% Similarity=0.431 Sum_probs=167.2
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee------
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------ 157 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 157 (333)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3478999999999999999999999999999999987542 23345668889999999999999999998755
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCc---EEEEecc
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGH---MKLSDFG 231 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~---vkl~DFG 231 (333)
.+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 667899999999999999997644 5899999999999999999999999999999999999997764 9999999
Q ss_pred CcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC
Q 019953 232 LCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG 311 (333)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 311 (333)
++........ .....||+.|+|||++.+..
T Consensus 170 ~a~~~~~~~~--------------------------------------------------~~~~~gt~~Y~APE~l~~~~ 199 (676)
T 3qa8_A 170 YAKELDQGEL--------------------------------------------------CTEFVGTLQYLAPELLEQKK 199 (676)
T ss_dssp CCCBTTSCCC--------------------------------------------------CCCCCSCCTTCSSCSSCCSC
T ss_pred cccccccccc--------------------------------------------------cccccCCcccCChHHhccCC
Confidence 9987653321 11347999999999999999
Q ss_pred CCcccc-hHHHHHHHhhhcc
Q 019953 312 YGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~ 330 (333)
++.++| |++|+++|+|+++
T Consensus 200 ~s~ksDIwSLGviLyeLltG 219 (676)
T 3qa8_A 200 YTVTVDYWSFGTLAFECITG 219 (676)
T ss_dssp CSTTHHHHHHHHHHHHHHSS
T ss_pred CCchhHHHHHHHHHHHHHHC
Confidence 999999 9999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=278.04 Aligned_cols=198 Identities=23% Similarity=0.342 Sum_probs=151.6
Q ss_pred hhccccC-CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEe
Q 019953 79 KRHKICV-DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ 156 (333)
Q Consensus 79 ~~~~~~~-~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 156 (333)
+..+... +.|.+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.
T Consensus 7 p~~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp -CCSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 3333333 44566789999999999875 45689999999986542 23466799999877 8999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-------
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMREDTL-------TENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN------- 222 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~------- 222 (333)
+.+.+++|||||. |+|.+++...... ++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999999995 6999999765432 222356799999999999999999999999999999754
Q ss_pred ------CcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccC
Q 019953 223 ------GHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTV 296 (333)
Q Consensus 223 ------~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (333)
+.+||+|||+++......... .......+
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~---------------------------------------------~~~~~~~~ 193 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSF---------------------------------------------RTNLNNPS 193 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC----------------------------------------------------------
T ss_pred ccCCCceEEEEcccccceecCCCCccc---------------------------------------------eeeecCCC
Confidence 489999999999765432110 00011347
Q ss_pred CCCCCcccccccC-------CCCCcccc-hHHHHHHHhhhc
Q 019953 297 GTPDYIAPEVLLK-------KGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 297 gt~~y~APE~~~~-------~~~~~~~D-ws~g~il~~l~t 329 (333)
||+.|+|||++.+ ..++.++| ||+||++|+|+|
T Consensus 194 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt 234 (434)
T 2rio_A 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234 (434)
T ss_dssp -CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred CCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence 9999999999976 67899999 999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=275.71 Aligned_cols=206 Identities=19% Similarity=0.267 Sum_probs=166.4
Q ss_pred hhhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEe
Q 019953 77 RLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 156 (333)
Q Consensus 77 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 156 (333)
....+.+..++|++.+.||+|+||.||+|.+.. .||+|++..... .......+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 457788889999999999999999999998753 499999875422 1122234567899999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 157 DTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 157 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
..+.+++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++ ++.++|+|||++..
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999999997654 699999999999999999999999999999999999998 78999999999876
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC------
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK------ 309 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------ 309 (333)
........ .........|++.|+|||++.+
T Consensus 179 ~~~~~~~~--------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 214 (319)
T 2y4i_B 179 SGVLQAGR--------------------------------------------REDKLRIQNGWLCHLAPEIIRQLSPDTE 214 (319)
T ss_dssp -----------------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--
T ss_pred cccccccc--------------------------------------------cccccccCCCcccccChHHhhhcccccc
Confidence 53221100 0011123468999999999975
Q ss_pred ---CCCCcccc-hHHHHHHHhhhccc
Q 019953 310 ---KGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 310 ---~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
..++.++| |++|+++|+|+++.
T Consensus 215 ~~~~~~~~~~Di~slG~il~el~~g~ 240 (319)
T 2y4i_B 215 EDKLPFSKHSDVFALGTIWYELHARE 240 (319)
T ss_dssp CCCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccCCCchhhHHHHHHHHHHHHhCC
Confidence 45899999 99999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=279.47 Aligned_cols=195 Identities=22% Similarity=0.340 Sum_probs=154.1
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 159 (333)
..+...+|.+.+.||+|+||+|+. ....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 334455799999999999999764 4567899999999865422 1245699999999 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-----CCcEEEEeccCc
Q 019953 160 YLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-----NGHMKLSDFGLC 233 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-----~~~vkl~DFGla 233 (333)
..|+|||||. |+|.+++.... ...+..+..++.|++.||.|||++||+||||||+|||++. ...+||+|||++
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999995 69999997654 4555567789999999999999999999999999999953 236889999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc---CC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL---KK 310 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~ 310 (333)
+.+....... ......+||+.|+|||++. +.
T Consensus 171 ~~~~~~~~~~----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~ 204 (432)
T 3p23_A 171 KKLAVGRHSF----------------------------------------------SRRSGVPGTEGWIAPEMLSEDCKE 204 (432)
T ss_dssp ECC----------------------------------------------------------CCSCTTSCCGGGTSCC---
T ss_pred eeccCCCcce----------------------------------------------eeccccCCCcCccChhhhhccccc
Confidence 8765332100 0112457999999999998 46
Q ss_pred CCCcccc-hHHHHHHHhhhc
Q 019953 311 GYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 311 ~~~~~~D-ws~g~il~~l~t 329 (333)
.++.++| ||+||++|+|++
T Consensus 205 ~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 205 NPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp CCCTHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHHHHHHHHHHHc
Confidence 6888999 999999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=257.82 Aligned_cols=150 Identities=10% Similarity=0.078 Sum_probs=132.5
Q ss_pred hhcc-ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 79 KRHK-ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 79 ~~~~-~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
..+. +..++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++++..
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 4444 566889999999999999999999999999999999986544334455678889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEec
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDF 230 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DF 230 (333)
.+..|+||||++|++|.+++... .....+..++.|++.||.|||++||+||||||+|||++.++.+||+++
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC
T ss_pred CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec
Confidence 99999999999999999998543 466678889999999999999999999999999999999999998743
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=273.89 Aligned_cols=194 Identities=14% Similarity=0.178 Sum_probs=149.6
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC-c---------e-----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-C---------I----- 148 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~---------i----- 148 (333)
....|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.|. + +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345688999999999999999999999999999998744333333456688899999888762 1 1
Q ss_pred -------eEEEEEEee-----CCeEEEEEeccCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 019953 149 -------VKLYYSFQD-----TEYLYLIMEYLPGGDMMTLLMR-------EDTLTENVARFYIAQSVLAIESIHKHNYIH 209 (333)
Q Consensus 149 -------v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 209 (333)
..+...+.. ...++++|+++ +++|.+++.. ...+++..+..++.|++.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111111111 22467888876 6899988841 234777788888999999999999999999
Q ss_pred cccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhh
Q 019953 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (333)
Q Consensus 210 rDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
|||||+|||++.++.+||+|||+++.....
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------------------------------------------------- 264 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------------------------------------------------- 264 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--------------------------------------------------
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--------------------------------------------------
Confidence 999999999999999999999998864322
Q ss_pred ccccccCCCCCCcccccc----------cCCCCCcccc-hHHHHHHHhhhccc
Q 019953 290 KLAFSTVGTPDYIAPEVL----------LKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 290 ~~~~~~~gt~~y~APE~~----------~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
....+| +.|+|||++ .+..++.++| ||+||++|+|+++.
T Consensus 265 --~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 265 --AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp --ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred --cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 114468 999999999 6667899999 99999999999863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=284.93 Aligned_cols=184 Identities=17% Similarity=0.160 Sum_probs=133.8
Q ss_pred EeeecceEEEEEEEecCCceEEEEecchhH-------HhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCCeEEEEE
Q 019953 94 IGRGAFGEVRLCREKKSGNIYAMKKLKKSE-------MVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 94 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
.+.|++|.+..++....|+.||+|++.... .........+.+|+.+|+++ .|+||+++++++.+++.+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 455666666666667789999999996531 12233456689999999999 6899999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|||+|++|.+++...+++++. .++.||+.||.|+|++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~---- 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS---- 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C----
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc----
Confidence 999999999999988888765 4789999999999999999999999999999999999999999987643221
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLH 324 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il 324 (333)
...+.+||+.|||||++.+. +..++| |++|+++
T Consensus 395 ---------------------------------------------~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~ 428 (569)
T 4azs_A 395 ---------------------------------------------WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHP 428 (569)
T ss_dssp ---------------------------------------------CSHHHHHHHHHHHHHHC------------------
T ss_pred ---------------------------------------------cccCceechhhccHHHhCCC-CCCcccccccccch
Confidence 12256899999999999764 677899 9999999
Q ss_pred Hhhhcc
Q 019953 325 FNSYRF 330 (333)
Q Consensus 325 ~~l~t~ 330 (333)
|.|++.
T Consensus 429 ~~l~~~ 434 (569)
T 4azs_A 429 FNLPQP 434 (569)
T ss_dssp CCCCTT
T ss_pred hhhccc
Confidence 887653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=250.08 Aligned_cols=144 Identities=30% Similarity=0.506 Sum_probs=127.6
Q ss_pred cCCCceEe-eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHH-HHhcCCceeEEEEEEee----
Q 019953 84 CVDDFELL-TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL-AEVASHCIVKLYYSFQD---- 157 (333)
Q Consensus 84 ~~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~---- 157 (333)
..++|.+. +.||+|+||.||+|.+..+++.||||++.... ...+|+.++ +.++||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 34678777 78999999999999999999999999986432 245677777 56699999999999877
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CCcEEEEeccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGL 232 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~~vkl~DFGl 232 (333)
...+++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 678999999999999999997754 6999999999999999999999999999999999999998 78999999998
Q ss_pred ccc
Q 019953 233 CKP 235 (333)
Q Consensus 233 a~~ 235 (333)
+..
T Consensus 167 a~~ 169 (299)
T 3m2w_A 167 AKE 169 (299)
T ss_dssp CEE
T ss_pred ccc
Confidence 864
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-30 Score=247.71 Aligned_cols=183 Identities=20% Similarity=0.217 Sum_probs=136.4
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhH-----HhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSE-----MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
..+.||+|+||.||+|. ..+..+++|...... .......+.+.+|+.+++.++||||+.+..++......|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 35689999999999994 557889999864322 12222345688999999999999999554455566677999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||+++++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+++..........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 999999999999865 5678999999999999999999999999999998 999999999998754321100
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC--CCCCcccc-hHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK--KGYGMECD-WLVS 321 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~~D-ws~g 321 (333)
.......+.+||+.|||||++.+ ..|+..+| |+..
T Consensus 488 ------------------------------------------~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~v 525 (540)
T 3en9_A 488 ------------------------------------------DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEII 525 (540)
T ss_dssp ------------------------------------------HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHH
T ss_pred ------------------------------------------chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHH
Confidence 00011225689999999999987 67888999 8766
Q ss_pred HHHHh
Q 019953 322 VLHFN 326 (333)
Q Consensus 322 ~il~~ 326 (333)
+-..+
T Consensus 526 l~~l~ 530 (540)
T 3en9_A 526 LELMK 530 (540)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 54443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=211.89 Aligned_cols=134 Identities=13% Similarity=0.133 Sum_probs=107.2
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh---------------hhHHHHHHHHHHHHHhcCCceeEEE
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR---------------GQVEHVRAERNLLAEVASHCIVKLY 152 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~~iv~~~ 152 (333)
|.+.+.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+.+++.++| +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 44559999999999999999 8899999999965322111 134568889999999984 4444
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
+.+.. +..|+||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 44433 45699999999999988 421 23456899999999999999999999999999999 99999999999
Q ss_pred cc
Q 019953 233 CK 234 (333)
Q Consensus 233 a~ 234 (333)
++
T Consensus 239 a~ 240 (282)
T 1zar_A 239 SV 240 (282)
T ss_dssp CE
T ss_pred Ce
Confidence 87
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.9e-23 Score=180.66 Aligned_cols=142 Identities=15% Similarity=0.124 Sum_probs=109.7
Q ss_pred ceEeeeEeeecceEEEEEEEecCCce--EEEEecchhHHhh---------------------hhhHHHHHHHHHHHHHhc
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNI--YAMKKLKKSEMVK---------------------RGQVEHVRAERNLLAEVA 144 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~ 144 (333)
|.+.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999998778999 9999875432110 011235788999999998
Q ss_pred CCce--eEEEEEEeeCCeEEEEEeccCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEecccCCCc
Q 019953 145 SHCI--VKLYYSFQDTEYLYLIMEYLPG-G----DMMTLLMREDTLTENVARFYIAQSVLAIESIH-KHNYIHRDIKPDN 216 (333)
Q Consensus 145 h~~i--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~N 216 (333)
|+++ +.++.. ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8754 444432 246899999942 3 66665432 234467789999999999999 9999999999999
Q ss_pred EEEccCCcEEEEeccCcccCCC
Q 019953 217 LLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 217 ill~~~~~vkl~DFGla~~~~~ 238 (333)
||++. .++|+|||+|.....
T Consensus 202 ILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp EEESS--SEEECCCTTCEETTS
T ss_pred EEEcC--cEEEEECcccccCCC
Confidence 99988 999999999987643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-19 Score=165.80 Aligned_cols=139 Identities=14% Similarity=0.131 Sum_probs=103.2
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh-------------------hhhhHHHHHHHHHHHHHhcCCce
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV-------------------KRGQVEHVRAERNLLAEVASHCI 148 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------------------~~~~~~~~~~e~~~l~~l~h~~i 148 (333)
|.+..+||+|+||.||+|.+ .+|+.||||+++..... .........+|...|..+.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999997 46999999987542110 00011223457778888866544
Q ss_pred --eEEEEEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC---
Q 019953 149 --VKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG--- 223 (333)
Q Consensus 149 --v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~--- 223 (333)
+..++. .. .+|||||++|++|..+... ..+..++.|++.+|.+||++|||||||||.|||++.++
T Consensus 176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--ET--TEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--cC--ceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 333322 22 3799999998888655321 23456789999999999999999999999999998876
Q ss_pred -------cEEEEeccCcccCC
Q 019953 224 -------HMKLSDFGLCKPLD 237 (333)
Q Consensus 224 -------~vkl~DFGla~~~~ 237 (333)
.+.|+||+-+....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETT
T ss_pred cccccccceEEEEeCCcccCC
Confidence 38999999887654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=4.3e-13 Score=117.90 Aligned_cols=141 Identities=12% Similarity=0.057 Sum_probs=111.0
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 164 (333)
+.|.+...++.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+. +..++++++++...+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 4688899999999999998864 36889999987532111 123777999999985 56788899998888899999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK---------------------------------------- 204 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~---------------------------------------- 204 (333)
|||++|.+|.+... +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999998876531 112234678899999999998
Q ss_pred -------------------CCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 205 -------------------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 205 -------------------~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.+++|+|++|.|||++.++.+.|+||+.+...
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 45899999999999987666779999988754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=3.6e-12 Score=111.37 Aligned_cols=138 Identities=13% Similarity=0.130 Sum_probs=100.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc--eeEEEEEEeeCCeEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLYYSFQDTEYLY 162 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~ 162 (333)
...+.+....+.|..+.||++.. .+|..+++|+..... ...+..|+.+++.+.+.+ +++++.+....+..+
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34566655544566699999853 567789999876431 123667899999886554 566888888778899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN------------------------------------ 206 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~------------------------------------ 206 (333)
+||||++|.++. .. ... ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998873 21 111 1245667777777777643
Q ss_pred ----------------------cEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 207 ----------------------YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 207 ----------------------ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
++|+|++|.||+++.++.+.|+|||.+...+
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 9999999999999877667899999987543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.8e-11 Score=109.80 Aligned_cols=143 Identities=17% Similarity=0.236 Sum_probs=105.8
Q ss_pred eEeeeEeeecceEEEEEEEecCCceEEEEecc--hhHHhhhhhHHHHHHHHHHHHHhcC--CceeEEEEEEeeC---CeE
Q 019953 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLK--KSEMVKRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDT---EYL 161 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~ 161 (333)
.-++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+++.+.. ..+++++..+.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34678899999999988643 5678899876 33211 112346779999999974 4578888887765 458
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK------------------------------------- 204 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~------------------------------------- 204 (333)
|+||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999987774421 1346778888889999999999997
Q ss_pred ---------------------CCcEecccCCCcEEEccCC--cEEEEeccCcccCC
Q 019953 205 ---------------------HNYIHRDIKPDNLLLDKNG--HMKLSDFGLCKPLD 237 (333)
Q Consensus 205 ---------------------~~ivHrDlkp~Nill~~~~--~vkl~DFGla~~~~ 237 (333)
.+++|+|++|.|||++.++ .+.|+||+.+...+
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 3699999999999999775 36999999987644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=1e-09 Score=98.55 Aligned_cols=135 Identities=20% Similarity=0.235 Sum_probs=97.0
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CC--ceeEEEEEEeeCC---eEEEE
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SH--CIVKLYYSFQDTE---YLYLI 164 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~--~iv~~~~~~~~~~---~~~lv 164 (333)
++.++.|....||++. ..+++|+.... .....+.+|..+++.+. +. .++.++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3568999999999753 46889986543 22345778999998884 33 3455555543333 34889
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK---------------------------------------- 204 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~---------------------------------------- 204 (333)
|++++|.++..... ..++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999987765332 235666677777788887777775
Q ss_pred ------------------CCcEecccCCCcEEEcc--CCcEEEEeccCcccCC
Q 019953 205 ------------------HNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLD 237 (333)
Q Consensus 205 ------------------~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~~~ 237 (333)
..++|+|++|.||+++. .+.+.|+||+.+...+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 23799999999999998 5568999999987654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=2.1e-07 Score=83.52 Aligned_cols=136 Identities=17% Similarity=0.175 Sum_probs=90.8
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC---ceeEEEEEEe-eCCeEEEEEe
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH---CIVKLYYSFQ-DTEYLYLIME 166 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e 166 (333)
++.++.|....||.. |..+++|+.... .....+..|..+|+.+.+. .++.++.+.. ..+..++||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456788888899976 567888985322 2234578899999999753 4666666663 4556789999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK------------------------------------------ 204 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~------------------------------------------ 204 (333)
+++|.++..... ..++......++.++...|..||+
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999987765321 112333333333444444433332
Q ss_pred ------------------CCcEecccCCCcEEEcc---CCc-EEEEeccCcccCCC
Q 019953 205 ------------------HNYIHRDIKPDNLLLDK---NGH-MKLSDFGLCKPLDC 238 (333)
Q Consensus 205 ------------------~~ivHrDlkp~Nill~~---~~~-vkl~DFGla~~~~~ 238 (333)
..++|+|++|.||+++. ++. +.|+||+.+...+.
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 24699999999999987 355 58999998876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=6.2e-07 Score=78.57 Aligned_cols=135 Identities=17% Similarity=0.161 Sum_probs=93.6
Q ss_pred eEeeecce-EEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC-CceeEEEEEEeeCCeEEEEEeccCC
Q 019953 93 IIGRGAFG-EVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 93 ~lg~G~~g-~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
.+..|..| .||+......+..+.+|+-.... ...+..|...|+.+.. -.+++++.++.+.+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445444 68987776677889999876432 2346778999988843 3477888888888999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 019953 171 GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH--------------------------------------------- 205 (333)
Q Consensus 171 g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------------------------------------------- 205 (333)
.++.+...... .....+..++...|.-||..
T Consensus 105 ~~~~~~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87766543211 11222334444444444421
Q ss_pred -------------CcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 206 -------------NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 206 -------------~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.++|+|+.|.|||++.++.+-|+||+.+...+
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 16999999999999987777899999987643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=4.6e-07 Score=84.18 Aligned_cols=80 Identities=21% Similarity=0.235 Sum_probs=49.6
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhHH-hh---hhhHHHHHHHHHHHHHhcC--C-ceeEEEEEEeeCCeEE
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM-VK---RGQVEHVRAERNLLAEVAS--H-CIVKLYYSFQDTEYLY 162 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~---~~~~~~~~~e~~~l~~l~h--~-~iv~~~~~~~~~~~~~ 162 (333)
-.+.||.|..+.||++.+..++..++||....... .. ......+..|..+++.+.. + .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35688999999999997655678899998653211 00 0122345668888888743 3 44556543 234457
Q ss_pred EEEeccCCC
Q 019953 163 LIMEYLPGG 171 (333)
Q Consensus 163 lv~e~~~~g 171 (333)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=7.9e-07 Score=81.25 Aligned_cols=86 Identities=9% Similarity=0.066 Sum_probs=54.1
Q ss_pred eEeeeE-eeecceEEEEEEEe--c----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC---CceeEEEEEEeeC
Q 019953 89 ELLTII-GRGAFGEVRLCREK--K----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS---HCIVKLYYSFQDT 158 (333)
Q Consensus 89 ~~~~~l-g~G~~g~V~~a~~~--~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~ 158 (333)
...+.| +.|....+|+.... . ++..+++|+..............+..|..+++.+.. ..+++++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 78888999987643 1 256788998754320000001235668888887743 3577777776554
Q ss_pred ---CeEEEEEeccCCCCHH
Q 019953 159 ---EYLYLIMEYLPGGDMM 174 (333)
Q Consensus 159 ---~~~~lv~e~~~~g~L~ 174 (333)
+..++|||+++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999886543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.6e-05 Score=70.26 Aligned_cols=33 Identities=24% Similarity=0.214 Sum_probs=29.3
Q ss_pred CCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.+++|+|++|.|||++.++.+.|+||+.+....
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~ 254 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDL 254 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEECC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcccCC
Confidence 579999999999999888899999999887543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.02 E-value=3e-05 Score=72.48 Aligned_cols=34 Identities=12% Similarity=0.212 Sum_probs=29.3
Q ss_pred HhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 203 H~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+...++|+|++|.|||++.++ +.|+||+.+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 356799999999999998776 9999999988644
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=0.00012 Score=65.75 Aligned_cols=76 Identities=21% Similarity=0.152 Sum_probs=58.5
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc---CCceeEEEEEEeeCCeEEEEEe
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e 166 (333)
-.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+++++......+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 457789999999998763 4678889987543 1344677888888884 2568888888877788999999
Q ss_pred ccCCCCH
Q 019953 167 YLPGGDM 173 (333)
Q Consensus 167 ~~~~g~L 173 (333)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00015 Score=64.45 Aligned_cols=134 Identities=13% Similarity=0.023 Sum_probs=74.1
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce-eEEEEEEeeCCeEEEEEecc-
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDTEYLYLIMEYL- 168 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~- 168 (333)
++.|+.|....+|++ ..+++|+....... . .....|..+++.+....+ ++++... ...-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~---~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-Y---INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----C---CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-e---eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678888999999987 45888987643211 0 112347777777643333 4555443 32346899999
Q ss_pred CCCCHHHH---------------H---HhCC-CC----CH-HHHHHHHH--------------HHHHHHHH----HHh--
Q 019953 169 PGGDMMTL---------------L---MRED-TL----TE-NVARFYIA--------------QSVLAIES----IHK-- 204 (333)
Q Consensus 169 ~~g~L~~~---------------l---~~~~-~~----~~-~~~~~~~~--------------qi~~~L~~----LH~-- 204 (333)
+|.++... + .... .+ .. ..+..+.. .+...+.. +..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66443210 0 0100 01 11 11111110 11111111 111
Q ss_pred --CCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 205 --HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 205 --~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
..++|+|+.|.||+ ..++.+.|+||..+...+
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 24899999999999 566778999999887544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00056 Score=60.28 Aligned_cols=79 Identities=14% Similarity=-0.006 Sum_probs=54.8
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC---ceeEEEEEEeeCCeEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH---CIVKLYYSFQDTEYLY 162 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~ 162 (333)
....-+..+|.|..+.||+.. ..+|+.|.+|+...... .....+..|...|+.+... .+++++... . -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred CCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence 456678899999999999986 46789999998764321 1122366799999988532 355555442 2 37
Q ss_pred EEEeccCCCC
Q 019953 163 LIMEYLPGGD 172 (333)
Q Consensus 163 lv~e~~~~g~ 172 (333)
+||||++++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00029 Score=63.01 Aligned_cols=142 Identities=13% Similarity=0.058 Sum_probs=78.2
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc--eeEEEEE------EeeCC
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLYYS------FQDTE 159 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~ 159 (333)
..-++.|+.|....+|++.. .+| .+++|+..... .. ..+..|..++..+.... +++++.. ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEE-SSC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 34456777788889998764 334 68899886521 11 22445777777764322 2333311 12245
Q ss_pred eEEEEEeccCCCCHHH-----------H---HHh-CC----C----CCHHHHHH---------------HHHHHHHHHHH
Q 019953 160 YLYLIMEYLPGGDMMT-----------L---LMR-ED----T----LTENVARF---------------YIAQSVLAIES 201 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~-----------~---l~~-~~----~----~~~~~~~~---------------~~~qi~~~L~~ 201 (333)
..+++|+|++|..+.. . +.. .. + .....-.. +...+...+..
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 6789999998754310 0 111 00 0 11000000 00113334555
Q ss_pred HHh-------CCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 202 IHK-------HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 202 LH~-------~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+.. .+++|+|++|.|||++.++.+.|+||+.+...
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g 218 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND 218 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence 542 36999999999999988766689999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00025 Score=63.92 Aligned_cols=35 Identities=26% Similarity=0.334 Sum_probs=29.7
Q ss_pred CCcEecccCCCcEEEccC----CcEEEEeccCcccCCCC
Q 019953 205 HNYIHRDIKPDNLLLDKN----GHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~----~~vkl~DFGla~~~~~~ 239 (333)
..++|+|+.+.|||++.+ +.+.|+||+.+...+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~ 221 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRA 221 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTT
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCH
Confidence 479999999999999874 68999999998865543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00074 Score=60.45 Aligned_cols=138 Identities=12% Similarity=0.152 Sum_probs=77.2
Q ss_pred eeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc--eeEEEEE-----EeeCCeEEEE
Q 019953 92 TIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC--IVKLYYS-----FQDTEYLYLI 164 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~lv 164 (333)
..++ |....||++.. .+|..+++|+...... ....+..|..++..+.... ++.++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3556 77788997653 3566799999863311 1233556777777774322 3444332 1224567889
Q ss_pred EeccCCCCHH-----H------HH---H---hCC------CCCHHHH----H------------------HHHHHHHHHH
Q 019953 165 MEYLPGGDMM-----T------LL---M---RED------TLTENVA----R------------------FYIAQSVLAI 199 (333)
Q Consensus 165 ~e~~~~g~L~-----~------~l---~---~~~------~~~~~~~----~------------------~~~~qi~~~L 199 (333)
|++++|..+. . .+ . ... .++.... . ..+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999874321 1 11 0 000 1111110 0 0111112222
Q ss_pred HHH----HhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 200 ESI----HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 200 ~~L----H~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.-+ ....++|+|++|.|||++ + .+.|+||+.+....
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~ 225 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP 225 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence 211 124589999999999998 4 89999999887644
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00079 Score=63.06 Aligned_cols=73 Identities=23% Similarity=0.316 Sum_probs=47.3
Q ss_pred EeeeEeeecceEEEEEEEec-------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce-eEEEEEEeeCCeE
Q 019953 90 LLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDTEYL 161 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~ 161 (333)
-++.|+.|-...||++.... .+..+++|+..... ....+..|..+++.+...++ +++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 35677778889999987542 25789999874311 01234468888888754443 56666553 2
Q ss_pred EEEEeccCCC
Q 019953 162 YLIMEYLPGG 171 (333)
Q Consensus 162 ~lv~e~~~~g 171 (333)
.+|++|++|.
T Consensus 148 g~v~e~l~G~ 157 (429)
T 1nw1_A 148 GRLEEYIPSR 157 (429)
T ss_dssp EEEECCCCEE
T ss_pred CEEEEEeCCc
Confidence 3899999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00083 Score=61.80 Aligned_cols=138 Identities=17% Similarity=0.194 Sum_probs=79.7
Q ss_pred eeEeeecceEEEEEEEec-------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc-eeEEEEEEeeCCeEEE
Q 019953 92 TIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYL 163 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~l 163 (333)
+.|..|-...+|++.... ++..|.+|+.... . .......+|..+++.+...+ .+++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 456667777899887532 3578999986331 1 12334557888888875433 3556655543 39
Q ss_pred EEeccCCCCHHH--------------HHH---h-C----CCC--CHHHHHHHHHHHHH-------------------HHH
Q 019953 164 IMEYLPGGDMMT--------------LLM---R-E----DTL--TENVARFYIAQSVL-------------------AIE 200 (333)
Q Consensus 164 v~e~~~~g~L~~--------------~l~---~-~----~~~--~~~~~~~~~~qi~~-------------------~L~ 200 (333)
||||++|..|.. .+. . . ... ....+..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998754321 111 1 0 111 12444545444321 233
Q ss_pred HH----Hh----CCcEecccCCCcEEEccC----CcEEEEeccCcccCC
Q 019953 201 SI----HK----HNYIHRDIKPDNLLLDKN----GHMKLSDFGLCKPLD 237 (333)
Q Consensus 201 ~L----H~----~~ivHrDlkp~Nill~~~----~~vkl~DFGla~~~~ 237 (333)
.| .. ..++|+|+.+.|||++.+ +.+.|+||..+...+
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~ 256 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNY 256 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCC
Confidence 33 22 259999999999999876 789999999887543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00093 Score=61.07 Aligned_cols=74 Identities=15% Similarity=0.051 Sum_probs=43.0
Q ss_pred eeeEeeecceEEEEEEEec--------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc-eeEEEEEEeeCCeE
Q 019953 91 LTIIGRGAFGEVRLCREKK--------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYL 161 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~ 161 (333)
...|+.|....+|++.... .+..+++|+....... ......|..+++.+...+ .+++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4567778788999887543 1367889987543211 111345788888775444 44666544 22
Q ss_pred EEEEeccCCCC
Q 019953 162 YLIMEYLPGGD 172 (333)
Q Consensus 162 ~lv~e~~~~g~ 172 (333)
++||+|++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0046 Score=55.85 Aligned_cols=34 Identities=18% Similarity=0.175 Sum_probs=29.5
Q ss_pred CCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.+++|+|+.|.||+++.++.+.|+||+.+...+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~ 239 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK 239 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence 4699999999999999888899999998876543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0097 Score=56.10 Aligned_cols=75 Identities=16% Similarity=0.211 Sum_probs=46.7
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce-eEEEEEEeeCCeEEEEEecc
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDTEYLYLIMEYL 168 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 168 (333)
-++.|+.|-...+|++.....+..+++|+..... ...+ ....|..+++.+...++ +++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 3567777888899998764334788899874321 1111 12468889998876554 56666663 2 3599999
Q ss_pred CCCC
Q 019953 169 PGGD 172 (333)
Q Consensus 169 ~~g~ 172 (333)
+|.+
T Consensus 184 ~G~~ 187 (458)
T 2qg7_A 184 DGYA 187 (458)
T ss_dssp CSEE
T ss_pred CCcc
Confidence 8743
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.81 E-value=0.1 Score=43.80 Aligned_cols=59 Identities=14% Similarity=0.132 Sum_probs=44.6
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEe
Q 019953 171 GDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSD 229 (333)
Q Consensus 171 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~D 229 (333)
.+|.++|.. +.++++.+++.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|.+.+
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 478888865 6799999999999999999877621 1212344457889999999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.78 E-value=0.12 Score=47.94 Aligned_cols=75 Identities=12% Similarity=0.061 Sum_probs=45.8
Q ss_pred EeeeEeeecceEEEEEEEecC-------CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc-eeEEEEEEeeCCeE
Q 019953 90 LLTIIGRGAFGEVRLCREKKS-------GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYL 161 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~ 161 (333)
-++.+..|-...+|++..... +..|++++..... ... -...+|..+++.+...+ .+++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKF-YDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 345666677788998875421 5789999865431 111 11345888888775333 34555433 22
Q ss_pred EEEEeccCCCC
Q 019953 162 YLIMEYLPGGD 172 (333)
Q Consensus 162 ~lv~e~~~~g~ 172 (333)
++||+|++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68999998854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.72 E-value=0.45 Score=43.67 Aligned_cols=30 Identities=27% Similarity=0.449 Sum_probs=25.9
Q ss_pred cEecccCCCcEEE------ccCCcEEEEeccCcccC
Q 019953 207 YIHRDIKPDNLLL------DKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 207 ivHrDlkp~Nill------~~~~~vkl~DFGla~~~ 236 (333)
++|+|+.+.|||+ +.+..+.++||..|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6899999999999 45678999999988754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.87 E-value=0.078 Score=49.94 Aligned_cols=63 Identities=6% Similarity=-0.037 Sum_probs=17.0
Q ss_pred eEeeeEeeecceEEEEEEEecCCceEEE------EecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEE
Q 019953 89 ELLTIIGRGAFGEVRLCREKKSGNIYAM------KKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSF 155 (333)
Q Consensus 89 ~~~~~lg~G~~g~V~~a~~~~~~~~vai------K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 155 (333)
.+.+.|| ||.||++.......+||+ |....... .......+.++..+++.++|||+++.+++.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceE
Confidence 3455666 999999988765668888 66554322 233345577788899999999999887654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 333 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-27 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-53
Identities = 64/237 (27%), Positives = 98/237 (41%), Gaps = 51/237 (21%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ ++DFE+ +G+G FG V L REK+S I A+K L K+++ K G +R E + +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ I++LY F D +YLI+EY P G + L + E YI + A+
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
H IHRDIKP+NLLL G +K++DFG S +
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----------------- 164
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GT DY+ PE++ + + + D
Sbjct: 165 ----------------------------------CGTLDYLPPEMIEGRMHDEKVDL 187
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-51
Identities = 67/237 (28%), Positives = 112/237 (47%), Gaps = 47/237 (19%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K +DF+ I+G G+F V L RE + YA+K L+K ++K +V +V ER++++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ VKLY++FQD E LY + Y G+++ + + + E RFY A+ V A+E
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
+H IHRD+KP+N+LL+++ H++++DFG K
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAK--------------------------- 156
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+++ A S VGT Y++PE+L +K D
Sbjct: 157 --------------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL 193
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-48
Identities = 55/234 (23%), Positives = 87/234 (37%), Gaps = 54/234 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DDFE ++ +G G G V K SG + A K + +K + E +L E S
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH-K 204
IV Y +F + + ME++ GG + +L + + E + + + + K
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
H +HRD+KP N+L++ G +KL DFG+ L S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---------------------- 161
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
S VGT Y++PE L Y ++ D
Sbjct: 162 -----------------------------SFVGTRSYMSPERLQGTHYSVQSDI 186
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 50/236 (21%)
Query: 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV 143
V+D++L+ +G GA+GEV+L + + A+K + V E+++ E + +
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKML 60
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
+VK Y ++ YL +EY GG++ + + + E A+ + Q + + +H
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
HRDIKP+NLLLD+ ++K+SDFGL +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN------------------------ 156
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECDW 318
NR +L GT Y+APE+L ++ + D
Sbjct: 157 -----------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 9e-46
Identities = 44/153 (28%), Positives = 81/153 (52%), Gaps = 4/153 (2%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +E++ +G GAFG+V + K++ + A K + ++E E ++LA
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHK 204
IVKL +F L++++E+ GG + +++ E LTE+ + Q++ A+ +H
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ IHRD+K N+L +G +KL+DFG+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-45
Identities = 67/168 (39%), Positives = 100/168 (59%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
K+ ++DF+ L ++G+G FG+V L REK +G YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
+ L Y+FQ + L +MEY GG++ L RE TE ARFY A+ V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
+H + ++RDIK +NL+LDK+GH+K++DFGLCK T
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 168
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 5e-45
Identities = 46/164 (28%), Positives = 85/164 (51%), Gaps = 7/164 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK------RGQVEHVRAERNL 139
+++E I+GRG VR C K + YA+K + + + E E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 140 LAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLA 198
L +V+ H I++L +++ + +L+ + + G++ L + TL+E R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 199 IESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
I ++HK N +HRD+KP+N+LLD + ++KL+DFG LD
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 166
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 8e-45
Identities = 40/157 (25%), Positives = 70/157 (44%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
F L IG G+FG V R+ ++ + A+KK+ S + + + E L ++
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
++ + +L+MEY G L + + L E ++ + +H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
N IHRD+K N+LL + G +KL DFG + + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 171
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-44
Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 50/235 (21%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
++DF L ++G+G+FG+V L KK+ +A+K LKK ++ VE E+ +L+
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 145 SH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
H + ++ +FQ E L+ +MEYL GGD+M + + A FY A+ +L ++ +H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDG 263
++RD+K DN+LLDK+GH+K++DFG+CK
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----------------------- 157
Query: 264 CFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTPDYIAPE+LL + Y DW
Sbjct: 158 --------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDW 186
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-44
Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 12/176 (6%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+D+E+L IG G++G + R K G I K+L M + + + +E NLL E+
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 62
Query: 146 HCIVKLYYSFQDTE--YLYLIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAI 199
IV+ Y D LY++MEY GGD+ +++ + L E + Q LA+
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 200 ESIHK-----HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+ H+ H +HRD+KP N+ LD ++KL DFGL + L+ T +A T
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (382), Expect = 1e-43
Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 56/242 (23%)
Query: 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL 139
+H +D +++ +G GAFG V E+ +GN +A K + + E VR E
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQT 76
Query: 140 LAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLA 198
++ + +V L+ +F+D + +I E++ GG++ + E ++E+ A Y+ Q
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 199 IESIHKHNYIHRDIKPDNLLL--DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMA 256
+ +H++NY+H D+KP+N++ ++ +KL DFGL
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---------------------- 174
Query: 257 EPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316
++ ++ T GT ++ APEV K G
Sbjct: 175 ----------------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 317 DW 318
D
Sbjct: 207 DM 208
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (380), Expect = 1e-43
Identities = 65/152 (42%), Positives = 103/152 (67%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
DF++L +G G+FG V L R + +G YAMK LKK +V+ QVEH ER +L+ V
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
I++++ +FQD + +++IM+Y+ GG++ +LL + VA+FY A+ LA+E +H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ I+RD+KP+N+LLDKNGH+K++DFG K +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (379), Expect = 4e-43
Identities = 57/163 (34%), Positives = 91/163 (55%), Gaps = 3/163 (1%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+DF + IIGRG FGEV CR+ +G +YAMK L K + + ER +L+ V++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 146 HC---IVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
IV + Y+F + L I++ + GGD+ L + +E RFY A+ +L +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 203 HKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
H ++RD+KP N+LLD++GH+++SD GL +A
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 166
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-42
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 8/183 (4%)
Query: 72 ETEFMRLKRHKICVDD----FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR 127
+ E + R + V D + IG+GA G V + +G A++++ + K+
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 128 GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENV 187
E + E ++ E + IV S+ + L+++MEYL GG + ++ E
Sbjct: 62 ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQ 117
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ + A+E +H + IHRDIK DN+LL +G +KL+DFG C +
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 248 KTI 250
T
Sbjct: 178 GTP 180
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (375), Expect = 1e-42
Identities = 53/264 (20%), Positives = 110/264 (41%), Gaps = 56/264 (21%)
Query: 58 MEEQINLIKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMK 117
+ + +D+ +K + D +++L +G GAFG V C EK +G ++ K
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60
Query: 118 KLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLL 177
+ + + V+ E +++ ++ ++ L+ +F+D + LI+E+L GG++ +
Sbjct: 61 FINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 117
Query: 178 MRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--KNGHMKLSDFGLCK 234
ED ++E Y+ Q+ ++ +H+H+ +H DIKP+N++ + K +K+ DFGL
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177
Query: 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294
L+ +
Sbjct: 178 KLNPDEIV--------------------------------------------------KV 187
Query: 295 TVGTPDYIAPEVLLKKGYGMECDW 318
T T ++ APE++ ++ G D
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDM 211
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 1e-41
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 55/236 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D ++ ++G GAF EV L +K++ + A+K + K + G+ + E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV L ++ +LYLIM+ + GG++ ++ + TE A I Q + A++ +H
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 206 NYIHRDIKPDNLLL---DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDID 262
+HRD+KP+NLL D++ + +SDFGL K D ++
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-------------------- 166
Query: 263 GCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ GTP Y+APEVL +K Y D
Sbjct: 167 ------------------------------STACGTPGYVAPEVLAQKPYSKAVDC 192
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 6e-41
Identities = 71/181 (39%), Positives = 114/181 (62%), Gaps = 4/181 (2%)
Query: 59 EEQINLIKDLERKETEFMR----LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIY 114
EQ ++ + L + + +F++ ++ +D F+ + +G G+FG V L + K+SGN Y
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 115 AMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMM 174
AMK L K ++VK Q+EH E+ +L V +VKL +SF+D LY++MEY+ GG+M
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 175 TLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234
+ L R +E ARFY AQ VL E +H + I+RD+KP+NLL+D+ G+++++DFG K
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 235 P 235
Sbjct: 190 R 190
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-40
Identities = 48/238 (20%), Positives = 90/238 (37%), Gaps = 60/238 (25%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC 147
+ IGRG+F V + ++ A +L+ ++ K + + + E +L +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 148 IVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
IV+ Y S++ T + + L+ E + G + T L R + V R + Q + ++ +H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 204 KHNY--IHRDIKPDNLLL-DKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
IHRD+K DN+ + G +K+ D GL
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------------------------- 163
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ R A + +GTP+++APE+ ++ Y D
Sbjct: 164 -------------------------LKRASFAKAVIGTPEFMAPEM-YEEKYDESVDV 195
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 138 bits (349), Expect = 2e-39
Identities = 49/237 (20%), Positives = 83/237 (35%), Gaps = 50/237 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D +EL I+G G EV L R+ + A+K L+ R E A +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 146 HCIVKLYYSFQDTE----YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
IV +Y + + Y++MEY+ G + ++ E +T A IA + A+
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
H++ IHRD+KP N+++ +K+ DFG+ + +
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI------------------------- 161
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
N + +GT Y++PE D
Sbjct: 162 ---------------------ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 197
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 2e-38
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 6/163 (3%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ D + +G G +GEV KK A+K LK+ M +VE E ++ E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM--REDTLTENVARFYIAQSVLAIE 200
+ +V+L Y+I E++ G+++ L ++ V + Q A+E
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+ K N+IHRD+ N L+ +N +K++DFGL + + T A
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 5e-38
Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 7/160 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + + +GRG FG V C E S Y K +K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHK 204
I+ L+ SF+ E L +I E++ G D+ + L E Y+ Q A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 205 HNYIHRDIKPDNLLLD--KNGHMKLSDFGLCKPLDCSTLY 242
HN H DI+P+N++ ++ +K+ +FG + L +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-37
Identities = 56/254 (22%), Positives = 99/254 (38%), Gaps = 70/254 (27%)
Query: 76 MRLKRHKICVDDFELLT-IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVR 134
+++K++ I +DD+++ + ++G G G+V K++ +A+K L+ +R
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 53
Query: 135 AERNLLAEVASH-CIVKLYYSFQDT----EYLYLIMEYLPGGDMMTLLMR--EDTLTENV 187
E L + IV++ +++ + L ++ME L GG++ + + + TE
Sbjct: 54 -EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112
Query: 188 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPLDCSTLYAI 244
A + AI+ +H N HRD+KP+NLL N +KL+DFG K
Sbjct: 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 170
Query: 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAP 304
+ TP Y+AP
Sbjct: 171 ------------------------------------------------TTPCYTPYYVAP 182
Query: 305 EVLLKKGYGMECDW 318
EVL + Y CD
Sbjct: 183 EVLGPEKYDKSCDM 196
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 6e-37
Identities = 67/161 (41%), Positives = 107/161 (66%), Gaps = 5/161 (3%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCRE---KKSGNIYAMKKLKKSEMVKRGQ-VEHVRAER 137
K+ +++FELL ++G GA+G+V L R+ +G +YAMK LKK+ +V++ + EH R ER
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 138 NLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+L + +V L+Y+FQ L+LI++Y+ GG++ T L + + TE+ + Y+ + V
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
LA+E +HK I+RDIK +N+LLD NGH+ L+DFGL K
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-37
Identities = 31/153 (20%), Positives = 63/153 (41%), Gaps = 6/153 (3%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ IG G+FG V + A+K L + + Q++ + E +L +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRH 63
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHK 204
I+ + + L ++ ++ G + L +T Q+ ++ +H
Sbjct: 64 VNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ IHRD+K +N+ L ++ +K+ DFGL
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-37
Identities = 53/240 (22%), Positives = 98/240 (40%), Gaps = 57/240 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQ---VEHVRAERNLLAE 142
D ++ +G G F V+ CREK +G YA K +KK + E + E ++L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESI 202
+ ++ L+ +++ + LI+E + GG++ L +++LTE A ++ Q + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 203 HKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEP 258
H H D+KP+N++L +K+ DFGL +D +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI------------- 176
Query: 259 MDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
GTP+++APE++ + G+E D
Sbjct: 177 -------------------------------------FGTPEFVAPEIVNYEPLGLEADM 199
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-36
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 76 MRLKRHKICVDDFELLTIIGRGAFGEVRLC--REKKSGNIYAMKKLKKSEMVKRGQVEHV 133
+ LKR + + D E +G G FG VR R +K A+K LK+ ++ E +
Sbjct: 3 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56
Query: 134 RAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYI 192
E ++ ++ + IV+L Q L L+ME GG + L+ + + + + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 193 AQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
Q + ++ + + N++HRD+ N+LL + K+SDFGL K L Y
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-36
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 9/174 (5%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA 144
V +E L IG+G FGEV R +K+G A+KK+ K G E +L +
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK 67
Query: 145 SHCIVKLYYSFQDTE--------YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSV 196
+V L + +YL+ ++ L T + + + +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+ IH++ +HRD+K N+L+ ++G +KL+DFGL + + + +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 5e-36
Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 2/163 (1%)
Query: 89 ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM--VKRGQVEHVRAERNLLAEVASH 146
E L +G G F V R+K + I A+KK+K K G E LL E++
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
I+ L +F + L+ +++ + + LT + + Y+ ++ +E +H+H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 207 YIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
+HRD+KP+NLLLD+NG +KL+DFGL K H+ T
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 163
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 45/226 (19%), Positives = 88/226 (38%), Gaps = 39/226 (17%)
Query: 59 EEQINLIKDLERKETEFMRLKRHKICVD--------DFELLTIIGRGAFGEVRLCREKKS 110
E Q+ +++ + E+ + + D + E ++G GAFG+V
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 111 GNI-----YAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLI 164
A+K LK+ + E + +E ++ ++ SH IV L + + +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 165 MEYLPGGDMMTLLMRE-----------------------DTLTENVARFYIAQSVLAIES 201
EY GD++ L + + LT + Q +E
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247
+ + +HRD+ N+L+ +K+ DFGL + + + Y + +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 225
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-35
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 7/166 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEH---VRAERNLLAE 142
+++ ++G G FG V A+K ++K + G++ + V E LL +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 143 VASHC--IVKLYYSFQDTEYLYLIMEYL-PGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
V+S +++L F+ + LI+E P D+ + L E +AR + Q + A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 200 ESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLDCSTLYAI 244
H +HRDIK +N+L+D N G +KL DFG L +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 169
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-35
Identities = 49/238 (20%), Positives = 86/238 (36%), Gaps = 54/238 (22%)
Query: 87 DFELLTI----IGRGAFGEVRLC--REKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
D +LLT+ +G G FG V+ + KK A+K LK E + + AE N++
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVM 62
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
++ + IV++ + E L+ME G + L + + + + Q + ++
Sbjct: 63 QQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMD 260
+ + N++HRD+ N+LL + K+SDFGL K L
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--------------------- 160
Query: 261 IDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
N K + APE + + + D
Sbjct: 161 -------------------------ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 4e-35
Identities = 39/187 (20%), Positives = 75/187 (40%), Gaps = 6/187 (3%)
Query: 65 IKDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK-SE 123
+D EF + +I + ++ +IG G FGEV K G +K
Sbjct: 9 FEDPNEAVREFAK----EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 124 MVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-T 182
Q +E +++ + ++ L + + +I E++ G + + L + D
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
T + ++ + NY+HRD+ N+L++ N K+SDFGL + L+ T
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 243 AIHEHKT 249
+
Sbjct: 185 PTYTSAL 191
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 5e-35
Identities = 34/158 (21%), Positives = 66/158 (41%), Gaps = 6/158 (3%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
D L +G G FG V+ + + A+K +K+ M + + E ++ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHK 204
+V+LY +++I EY+ G ++ L A+E +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
++HRD+ N L++ G +K+SDFGL + +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 7e-35
Identities = 40/161 (24%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ + + +LL IG+G FG+V L + GN A+K +K + AE +++ +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA-----FLAEASVMTQ 56
Query: 143 VASHCIVKLY-YSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAI 199
+ +V+L ++ LY++ EY+ G ++ L L + + A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
E + +N++HRD+ N+L+ ++ K+SDFGL K +
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 9e-35
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 8/163 (4%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
+ + +L+ +G G FGEV + A+K LK+ M + AE NL+ +
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIE 200
+ +V+LY E +Y+I EY+ G ++ L LT N AQ +
Sbjct: 65 LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
I + NYIHRD++ N+L+ K++DFGL + ++ + A
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-34
Identities = 45/217 (20%), Positives = 81/217 (37%), Gaps = 26/217 (11%)
Query: 73 TEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKR 127
T+ + + + +G GAFG+V + + A+K LK S +
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT- 68
Query: 128 GQVEHVRAERNLLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR------- 179
+ E + +E +L+ + +H IV L + +I EY GD++ L R
Sbjct: 69 -EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 180 -----------EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLS 228
E L + Q + + N IHRD+ N+LL K+
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 229 DFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCF 265
DFGL + + + Y + + + + MA + +
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-34
Identities = 37/156 (23%), Positives = 62/156 (39%), Gaps = 5/156 (3%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAE 142
D LL +G G+FG VR A+K LK + + ++ E N +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 143 VASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIES 201
+ +++LY + ++ E P G ++ L + Y Q +
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ +IHRD+ NLLL +K+ DFGL + L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (314), Expect = 2e-34
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 2/152 (1%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + L IG G +G V + G +A+KK++ + G E ++L E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKH 59
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IVKLY + L L+ E+L L + E L A+ ++ Q + I H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+HRD+KP NLL+++ G +K++DFGL +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFG 151
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-34
Identities = 41/176 (23%), Positives = 74/176 (42%), Gaps = 17/176 (9%)
Query: 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+ +D + +IG G FG+V R KK G + E + E +L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 142 EVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------------TLT 184
++ H I+ L + + YLYL +EY P G+++ L + TL+
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 185 ENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
+ A ++ + + +IHRD+ N+L+ +N K++DFGL + +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 4e-34
Identities = 41/187 (21%), Positives = 77/187 (41%), Gaps = 7/187 (3%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L+ IG GA+G V + + A+KK+ E + + E +L
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 146 HCIVKLYYSFQDTEY----LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIES 201
I+ + + ++ +L G D+ LL + L+ + +++ Q + ++
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 202 IHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
IH N +HRD+KP NLLL+ +K+ DFGL + D + + + P +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 262 DGCFPDT 268
T
Sbjct: 185 LNSKGYT 191
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (311), Expect = 1e-33
Identities = 43/212 (20%), Positives = 89/212 (41%), Gaps = 24/212 (11%)
Query: 69 ERKETEFMRLKRHKIC---VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV 125
+ E+ + H + DD++L+ +GRG + EV + +K LK
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--- 71
Query: 126 KRGQVEHVRAERNLLAEVASH-CIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMREDT 182
+ + ++ E +L + I+ L +D + L+ E++ D L
Sbjct: 72 ---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--- 125
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLD---- 237
LT+ RFY+ + + A++ H +HRD+KP N+++D ++ ++L D+GL +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 238 ----CSTLYAIHEHKTIDDENMAEPMDIDGCF 265
++ Y +D + +D+
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 217
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-33
Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 17/167 (10%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ +IG G+FG V + SG + A+KK+ + + K E ++ ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDH 72
Query: 146 HCIVKLYYSF------QDTEYLYLIMEYLPGGDMMTLL---MREDTLTENVARFYIAQSV 196
IV+L Y F +D YL L+++Y+P + TL + Y+ Q
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 197 LAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCSTLY 242
++ IH HRDIKP NLLLD + +KL DFG K L
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-33
Identities = 39/234 (16%), Positives = 78/234 (33%), Gaps = 54/234 (23%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + IG G FG V L + + A+K +++ M + E E ++ +++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSH 59
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL-AIESIHK 204
+V+LY + + L+ E++ G + L + L + V + + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGC 264
IHRD+ N L+ +N +K+SDFG+ + + +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST------------------- 160
Query: 265 FPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
T + +PEV Y + D
Sbjct: 161 -----------------------------GTKFPVKWASPEVFSFSRYSSKSDV 185
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 3e-33
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 2/156 (1%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
++F+ + IG G +G V R K +G + A+KK++ G E +LL E+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDT-LTENVARFYIAQSVLAIESIHK 204
IVKL LYL+ E+L + T + + + Y+ Q + + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
H +HRD+KP NLL++ G +KL+DFGL +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (303), Expect = 1e-32
Identities = 41/186 (22%), Positives = 71/186 (38%), Gaps = 31/186 (16%)
Query: 86 DDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
++ E + IG GAFG V R + + A+K LK+ + E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALM 70
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED------------------- 181
AE + IVKL + + L+ EY+ GD+ L
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 182 -----TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236
L+ Q + + + ++HRD+ N L+ +N +K++DFGL + +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 237 DCSTLY 242
+ Y
Sbjct: 191 YSADYY 196
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 120 bits (302), Expect = 1e-32
Identities = 39/237 (16%), Positives = 77/237 (32%), Gaps = 53/237 (22%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH- 146
+++ IG G+FG + + A+K + R +R E +A
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 147 CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN 206
I +YY Q+ + L+++ L L + + Q + ++SIH+ +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 207 YIHRDIKPDNLLLDK-----NGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
++RDIKPDN L+ + + + DFG+ K
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP---------------------- 159
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
+ + + + + GT Y++ L + D
Sbjct: 160 --------------VTKQHIPYREKK------NLSGTARYMSINTHLGREQSRRDDL 196
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-32
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 8/160 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L +G+G FGEV + A+K LK M E E ++ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRH 71
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED--TLTENVARFYIAQSVLAIESIH 203
+V+LY + E +Y++ EY+ G ++ L E L AQ + +
Sbjct: 72 EKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243
+ NY+HRD++ N+L+ +N K++DFGL + ++ + A
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 3e-32
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 1/164 (0%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+E L IG G +G V + +++ I A+K+++ + G E LL E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 146 HCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKH 205
IV+L+ + L L+ E+ L + + ++ Q + + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 206 NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249
N +HRD+KP NLL+++NG +KL++FGL + E T
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT 164
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 9e-32
Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 3/162 (1%)
Query: 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK-SEMVKRGQVEHVRAERNLLA 141
I + EL IG G FG+V N +K E E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIE 200
+ IVKL + +++IME G++ + L +L Y Q A+
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+ ++HRDI N+L+ N +KL DFGL + ++ ST Y
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 3e-31
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 9/161 (5%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ L +G GA+G V + ++G A+KKL + + E LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRH 76
Query: 146 HCIVKLYYSFQDTE------YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAI 199
++ L F E YL+M ++ G + LM+ + L E+ +F + Q + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 200 ESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240
IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-31
Identities = 30/156 (19%), Positives = 59/156 (37%), Gaps = 2/156 (1%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKK--SEMVKRGQVEHVRAERNLLAEV 143
+F+ + ++G GAFG V G + K E + + E ++A V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 144 ASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH 203
+ + +L + + G + + +D + + Q + +
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 204 KHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
+HRD+ N+L+ H+K++DFGL K L
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-30
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 7/157 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLA 141
+IG G FGEV K S A+K LK Q E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMG 64
Query: 142 EVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIE 200
+ + H I++L + + +I EY+ G + L +D + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ NY+HRD+ N+L++ N K+SDFGL + L+
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-30
Identities = 39/248 (15%), Positives = 94/248 (37%), Gaps = 28/248 (11%)
Query: 86 DDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
+ + +G+G+FG V K + A+K + ++ ++ + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 141 AEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMRED----------TLTENVARF 190
E H +V+L + +IME + GD+ + L + +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 191 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+ + ++ + ++HRD+ N ++ ++ +K+ DFG+ + + + Y +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 251 DDENMAEPMDIDGCFPDTDNKSSW-----------KSPHEQLQHWQMNRRKLAFSTVGTP 299
M+ DG F + S+ + P++ L + Q+ R + + P
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 300 DYIAPEVL 307
D +
Sbjct: 258 DNCPDMLF 265
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 3e-30
Identities = 43/237 (18%), Positives = 71/237 (29%), Gaps = 51/237 (21%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ + L IG G+FG++ L + +G A+K + + E + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQG 61
Query: 146 H-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK 204
I + + + +Y ++ME L + Q + IE IH
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 205 HNYIHRDIKPDNLLLDKNGHMKL---SDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDI 261
N+IHRD+KPDN L+ L DFGL K + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH------------------- 162
Query: 262 DGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 318
Q + + GT Y + L D
Sbjct: 163 -----------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDL 196
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-30
Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 7/159 (4%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
+ ++ L+ +G GA+G V + K+G A+KKL + + E LL +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKH 76
Query: 146 HCIVKLYYSFQDTEYL-----YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIE 200
++ L F L ++ +L G D+ + ++ LT++ +F I Q + ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 201 SIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239
IH + IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-30
Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 17/177 (9%)
Query: 72 ETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVE 131
++ F LKR ++ L IG GA G V + A+KKL + + +
Sbjct: 10 DSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAK 61
Query: 132 HVRAERNLLAEVASHCIVKLYYSF------QDTEYLYLIMEYLPGGDMMTLLMREDTLTE 185
E L+ V I+ L F ++ + +YL+ME + + M D
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---H 118
Query: 186 NVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242
+ + Q + I+ +H IHRD+KP N+++ + +K+ DFGL + S +
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 4e-29
Identities = 51/243 (20%), Positives = 89/243 (36%), Gaps = 59/243 (24%)
Query: 85 VDDFELLTIIGRGAFGEVRLCREKKSGN-IYAMKKLKKSEMVKRGQVEHVR--AERNLLA 141
+E + IG GA+G+V R+ K+G A+K+++ + + +R A L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 142 EVASHCIVKLYYSFQDTE-----YLYLIMEYLPGGDMMTLLM-REDTLTENVARFYIAQS 195
+V+L+ + L L+ E++ L E + + + Q
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 196 VLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENM 255
+ ++ +H H +HRD+KP N+L+ +G +KL+DFGL +
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR--------------------- 164
Query: 256 AEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315
+ + S V T Y APEVLL+ Y
Sbjct: 165 -----------------------------IYSFQMALTSVVVTLWYRAPEVLLQSSYATP 195
Query: 316 CDW 318
D
Sbjct: 196 VDL 198
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-28
Identities = 44/204 (21%), Positives = 76/204 (37%), Gaps = 26/204 (12%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERN 138
D L +G GAFG+V L A+K LK + + +E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEME 70
Query: 139 LLAEVASH-CIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMR----------------ED 181
++ + H I+ L + LY+I+EY G++ L E+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 182 TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241
L+ Q +E + IHRD+ N+L+ ++ MK++DFGL + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 242 YAIHEHKTIDDENMAEPMDIDGCF 265
Y + + + MA D +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIY 214
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-27
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 25/175 (14%)
Query: 86 DDFELLTIIGRGAFGEVRLCR-----EKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLL 140
D +L +GRGAFG+V + + A+K LK+ + + +E +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKIL 70
Query: 141 AEVASHCIVKLY--YSFQDTEYLYLIMEYLPGGDMMTLL----------------MREDT 182
+ H V + L +I+E+ G++ T L + +D
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 183 LTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
LT Y Q +E + IHRD+ N+LL + +K+ DFGL + +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-27
Identities = 33/158 (20%), Positives = 66/158 (41%), Gaps = 7/158 (4%)
Query: 93 IIGRGAFGEV---RLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV 149
+IGRG FG V L A+K L + G+V E ++ + + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 150 KLY-YSFQDTEYLYLIMEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNY 207
L + +++ Y+ GD+ + E T + Q ++ + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 208 IHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245
+HRD+ N +LD+ +K++DFGL + + ++H
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-26
Identities = 37/176 (21%), Positives = 62/176 (35%), Gaps = 17/176 (9%)
Query: 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS 145
L IG+G FGEV + + G A+K E + AE +
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE----RSWFREAEIYQTVMLRH 56
Query: 146 HCIVKLYYSFQDTE----YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIA-------Q 194
I+ + L+L+ +Y G + L R E + + ++
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 195 SVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTI 250
+ + + K HRD+K N+L+ KNG ++D GL D +T
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 86.2 bits (212), Expect = 1e-19
Identities = 28/183 (15%), Positives = 73/183 (39%), Gaps = 14/183 (7%)
Query: 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNL-------L 140
+ L+ +G G F V L ++ + AMK ++ ++ + ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 141 AEVASHCIVKLYYSFQD--TEYLYLIMEYLPGGDMMTLLMRED---TLTENVARFYIAQS 195
+ ++ I+KL F ++++M + G+ + L+++ + + Q
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 196 VLAIESI-HKHNYIHRDIKPDNLLLDKNGHM-KLSDFGLCKPLDCSTLYAIHEHKTIDDE 253
+L ++ + + IH DIKP+N+L++ L + + + + E
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 254 NMA 256
+
Sbjct: 195 YRS 197
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.7 bits (162), Expect = 1e-13
Identities = 20/160 (12%), Positives = 47/160 (29%), Gaps = 28/160 (17%)
Query: 93 IIGRGAFGEVRLCREKKSGNIYAMKKLKKS---------------EMVKRGQVEHVRAER 137
++G G V C + +K K + R E
Sbjct: 7 LMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 138 NLLAEVASHCIVKLYYSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVL 197
L ++ + K+Y + ++ME + ++ + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILE 114
Query: 198 AIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237
+ + +H D+ N+L+ + G + DF +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 333 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.51 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=360.79 Aligned_cols=196 Identities=34% Similarity=0.544 Sum_probs=180.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||+||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999877665666677788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||||++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc----
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998654322
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
....+||+.|||||++.+.+|+.++| ||+||+
T Consensus 161 -----------------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvi 193 (263)
T d2j4za1 161 -----------------------------------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 193 (263)
T ss_dssp -----------------------------------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred -----------------------------------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHH
Confidence 11457999999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 194 lyell~G~ 201 (263)
T d2j4za1 194 CYEFLVGK 201 (263)
T ss_dssp HHHHHHSS
T ss_pred HHHHhcCC
Confidence 99999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=363.72 Aligned_cols=202 Identities=34% Similarity=0.605 Sum_probs=180.6
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
...++|++++.||+|+||+||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.+++.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34468999999999999999999999999999999998776555666778999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+|||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999876533211
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
....+.+||+.|||||++.+.+|+.++| ||+|
T Consensus 165 -----------------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlG 197 (288)
T d1uu3a_ 165 -----------------------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALG 197 (288)
T ss_dssp ----------------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHH
T ss_pred -----------------------------------------------cccccccCCccccCceeeccCCCCcccceehhh
Confidence 1122457999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 198 vilyell~g~ 207 (288)
T d1uu3a_ 198 CIIYQLVAGL 207 (288)
T ss_dssp HHHHHHHHSS
T ss_pred HHHHHHhhCC
Confidence 9999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=366.75 Aligned_cols=200 Identities=40% Similarity=0.694 Sum_probs=183.8
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45678999999999999999999999999999999998876656666778889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 163 LIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
+|||||+||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999987643221
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
...+.+||+.|||||++.+.+|+.++| ||+|
T Consensus 161 ------------------------------------------------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlG 192 (337)
T d1o6la_ 161 ------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192 (337)
T ss_dssp ------------------------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHH
T ss_pred ------------------------------------------------ccccceeCHHHhhhhhccCCCCChhhcccchh
Confidence 122568999999999999999999999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 193 vilyeml~G~ 202 (337)
T d1o6la_ 193 VVMYEMMCGR 202 (337)
T ss_dssp HHHHHHHHSS
T ss_pred hHHHHHHHCC
Confidence 9999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=360.47 Aligned_cols=198 Identities=28% Similarity=0.480 Sum_probs=173.7
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||+||+|.+..+|+.||||++...... ...+.+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 46899999999999999999999999999999999765322 2334578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||||++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~-- 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 159 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc--
Confidence 999999999999988889999999999999999999999999999999999999999999999999999876433211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Ccccc-hHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMECD-WLVSV 322 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~D-ws~g~ 322 (333)
....+.+||+.|||||++.+.++ +.++| ||+||
T Consensus 160 ---------------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGv 194 (271)
T d1nvra_ 160 ---------------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 194 (271)
T ss_dssp ---------------------------------------------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHH
T ss_pred ---------------------------------------------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHH
Confidence 11225689999999999998886 57899 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+|+.
T Consensus 195 ilyeml~G~ 203 (271)
T d1nvra_ 195 VLTAMLAGE 203 (271)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHhCC
Confidence 999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-49 Score=358.52 Aligned_cols=195 Identities=42% Similarity=0.777 Sum_probs=180.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||+||+|++..+|+.||||+++..........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46799999999999999999999999999999999877655566677889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||||+||+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~---- 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---- 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB----
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998764321
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.+.+||+.|||||++.+.+|+.++| ||+||+
T Consensus 159 ------------------------------------------------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvi 190 (316)
T d1fota_ 159 ------------------------------------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL 190 (316)
T ss_dssp ------------------------------------------------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHH
T ss_pred ------------------------------------------------ccccCcccccCHHHHcCCCCCchhhccccchh
Confidence 1457999999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+|+.
T Consensus 191 lyemltG~ 198 (316)
T d1fota_ 191 IYEMLAGY 198 (316)
T ss_dssp HHHHHHSS
T ss_pred HHHHHhCC
Confidence 99999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=353.63 Aligned_cols=194 Identities=28% Similarity=0.491 Sum_probs=174.6
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 4579999999999999999999999999999999876532 2345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||||+||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--- 171 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 171 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc---
Confidence 999999999998765 4699999999999999999999999999999999999999999999999999987653321
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....+||+.|+|||++.+.+|+.++| ||+||+
T Consensus 172 ----------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 205 (293)
T d1yhwa1 172 ----------------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205 (293)
T ss_dssp ----------------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHH
T ss_pred ----------------------------------------------cccccccCCCccChhhhcCCCCCchhceehHhHH
Confidence 112457999999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+|+.
T Consensus 206 lyemltG~ 213 (293)
T d1yhwa1 206 AIEMIEGE 213 (293)
T ss_dssp HHHHHHSS
T ss_pred HHHHhhCC
Confidence 99999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=365.55 Aligned_cols=197 Identities=28% Similarity=0.419 Sum_probs=176.2
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
++..++|++++.||+|+||+||+|++..+|+.||+|+++... .......+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 345678999999999999999999999999999999987542 233456688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999888899999999999999999999997 59999999999999999999999999999864311
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
...+.+||+.|||||++.+.+|+.++| ||
T Consensus 159 --------------------------------------------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWS 188 (322)
T d1s9ja_ 159 --------------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWS 188 (322)
T ss_dssp --------------------------------------------------TC---CCSSCCCCHHHHHCSCCCTTHHHHH
T ss_pred --------------------------------------------------ccccccCCccccCchHHcCCCCCcHHHHHH
Confidence 122568999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+++.
T Consensus 189 lGvil~ell~G~ 200 (322)
T d1s9ja_ 189 MGLSLVEMAVGR 200 (322)
T ss_dssp HHHHHHHHHHSS
T ss_pred HHHHHHHHHHCC
Confidence 999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-49 Score=355.02 Aligned_cols=192 Identities=28% Similarity=0.430 Sum_probs=174.1
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIME 166 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (333)
.|++++.||+|+||+||+|++..+|+.||||++.............+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999976544444556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccccc
Q 019953 167 YLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHE 246 (333)
Q Consensus 167 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~ 246 (333)
||++|+|..++.....+++..++.++.|++.||.|||++|||||||||+|||++.++.+||+|||+|.......
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~------ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------ 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCC------
Confidence 99999998888888899999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CCCCcccc-hHHHH
Q 019953 247 HKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGMECD-WLVSV 322 (333)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~~D-ws~g~ 322 (333)
..+||+.|||||++.+ ..|+.++| ||+||
T Consensus 170 -----------------------------------------------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGv 202 (309)
T d1u5ra_ 170 -----------------------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202 (309)
T ss_dssp -----------------------------------------------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHH
T ss_pred -----------------------------------------------ccccCccccCHHHHhccCCCCcCchhhhhhHHH
Confidence 4579999999999965 45899999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+++.
T Consensus 203 ilyel~~g~ 211 (309)
T d1u5ra_ 203 TCIELAERK 211 (309)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHHCC
Confidence 999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-48 Score=358.18 Aligned_cols=196 Identities=42% Similarity=0.741 Sum_probs=181.3
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|+.++||||+++++++.....+++
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 35789999999999999999999999999999999987665556667778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 164 IMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||||+.+|+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+....
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--- 195 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--- 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc---
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998764321
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSV 322 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~ 322 (333)
.+.+||+.|||||++.+.+|+.++| ||+||
T Consensus 196 -------------------------------------------------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGv 226 (350)
T d1rdqe_ 196 -------------------------------------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGV 226 (350)
T ss_dssp -------------------------------------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred -------------------------------------------------ccccCccccCCHHHHcCCCCCccccccchhH
Confidence 1457999999999999999999999 99999
Q ss_pred HHHhhhccc
Q 019953 323 LHFNSYRFL 331 (333)
Q Consensus 323 il~~l~t~~ 331 (333)
++|+|+|+.
T Consensus 227 ilyemltG~ 235 (350)
T d1rdqe_ 227 LIYEMAAGY 235 (350)
T ss_dssp HHHHHHHSS
T ss_pred HHHHHHhCC
Confidence 999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-49 Score=354.41 Aligned_cols=195 Identities=31% Similarity=0.514 Sum_probs=160.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.+.|++.+.||+|+||+||+|.+..+|+.||||++....... ....+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999997654322 234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc---cCCcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---KNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~---~~~~vkl~DFGla~~~~~~~~ 241 (333)
||||+||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+. .++.+||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 99999999999999888999999999999999999999999999999999999995 47899999999998654322
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
...+.+||+.|||||++.+.+|+.++| ||+
T Consensus 165 -------------------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSl 195 (307)
T d1a06a_ 165 -------------------------------------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 195 (307)
T ss_dssp ---------------------------------------------------------CTTSCHHHHTTCCCCTHHHHHHH
T ss_pred -------------------------------------------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhh
Confidence 112457999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 196 Gvilyell~g~ 206 (307)
T d1a06a_ 196 GVIAYILLCGY 206 (307)
T ss_dssp HHHHHHHHHSS
T ss_pred hHHHHHHHhCC
Confidence 99999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=347.84 Aligned_cols=194 Identities=28% Similarity=0.505 Sum_probs=171.6
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
+.|++++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+++.+++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 56999999999999999999999999999999987542 233455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999998765 5679999999999999999999999999999999999999999999999999997643211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-----CCCCCcccc-h
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-----KKGYGMECD-W 318 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~~D-w 318 (333)
....+.+||+.|||||++. +.+|+.++| |
T Consensus 165 ---------------------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~Diw 199 (288)
T d2jfla1 165 ---------------------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199 (288)
T ss_dssp ---------------------------------------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHH
T ss_pred ---------------------------------------------ccccccccccccCCHHHHhhcccCCCCCChhhhHH
Confidence 1122567999999999984 567899999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++|+|+|+.
T Consensus 200 SlGvilyemltg~ 212 (288)
T d2jfla1 200 SLGITLIEMAEIE 212 (288)
T ss_dssp HHHHHHHHHHHSS
T ss_pred HHHHHHHHHhhCC
Confidence 9999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=346.66 Aligned_cols=197 Identities=33% Similarity=0.607 Sum_probs=163.5
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee--CCeEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--TEYLY 162 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 162 (333)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4679999999999999999999999999999999876543 23345678899999999999999999998864 45689
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEecccCCCcEEEccCCcEEEEeccCc
Q 019953 163 LIMEYLPGGDMMTLLMR----EDTLTENVARFYIAQSVLAIESIHKHN-----YIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
+|||||++|+|.+++.. ...+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999853 467999999999999999999999876 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
+.+..... ...+.+||+.|||||++.+.+|+
T Consensus 162 ~~~~~~~~-------------------------------------------------~~~~~~gt~~Y~APE~l~~~~~~ 192 (269)
T d2java1 162 RILNHDTS-------------------------------------------------FAKAFVGTPYYMSPEQMNRMSYN 192 (269)
T ss_dssp HHC------------------------------------------------------------CCCSCCCHHHHTTCCCC
T ss_pred eecccCCC-------------------------------------------------ccccCCCCcccCCHHHHcCCCCC
Confidence 87653221 11245799999999999999999
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| ||+||++|+|+|+.
T Consensus 193 ~~~DIwSlGvilyel~tg~ 211 (269)
T d2java1 193 EKSDIWSLGCLLYELCALM 211 (269)
T ss_dssp HHHHHHHHHHHHHHHHHSS
T ss_pred hHHHHHhhCHHHHHHhhCC
Confidence 9999 99999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.9e-48 Score=354.86 Aligned_cols=197 Identities=34% Similarity=0.594 Sum_probs=173.0
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHH---HHHHHHhcCCceeEEEEEEeeCCe
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAE---RNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
..++|++++.||+|+||.||+|++..+|+.||||++.............+.+| +.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46799999999999999999999999999999999976654443333344444 556666789999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|+|||||+||+|.+++.....+++..++.++.|++.||.|||++|||||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999998764322
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-CCCCCcccc-h
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD-W 318 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~~D-w 318 (333)
....+||+.|+|||++. +..|+.++| |
T Consensus 162 ---------------------------------------------------~~~~~GT~~y~APE~~~~~~~~~~~~Diw 190 (364)
T d1omwa3 162 ---------------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWF 190 (364)
T ss_dssp ---------------------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHH
T ss_pred ---------------------------------------------------ccccccccccchhHHhhcCCCCCcccchh
Confidence 11457999999999997 467999999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++|+|+|+.
T Consensus 191 SlGvilyemltG~ 203 (364)
T d1omwa3 191 SLGCMLFKLLRGH 203 (364)
T ss_dssp HHHHHHHHHHHSS
T ss_pred HHHHHHHHHHhCC
Confidence 9999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-47 Score=351.66 Aligned_cols=194 Identities=30% Similarity=0.525 Sum_probs=174.0
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976532 2345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc--CCcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK--NGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~--~~~vkl~DFGla~~~~~~~~ 241 (333)
||||+||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.+.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 999999999999854 457999999999999999999999999999999999999964 57899999999987654321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
..+.+||+.|||||++.+.+|+.++| ||+
T Consensus 182 --------------------------------------------------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSl 211 (350)
T d1koaa2 182 --------------------------------------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 211 (350)
T ss_dssp --------------------------------------------------EEEECSCTTTCCHHHHHTCCBCHHHHHHHH
T ss_pred --------------------------------------------------cceecCcccccCHHHHcCCCCChhHhhhhh
Confidence 12457999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+++.
T Consensus 212 Gvilyell~G~ 222 (350)
T d1koaa2 212 GVLSYILLSGL 222 (350)
T ss_dssp HHHHHHHHHSS
T ss_pred hHHHHHHHhCC
Confidence 99999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-48 Score=347.71 Aligned_cols=201 Identities=25% Similarity=0.380 Sum_probs=179.1
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
+..|++..++|++.+.||+|+||+||+|.+..+++.||||+++... ...+.+.+|+.+|+.++|||||++++++.+
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 3568888899999999999999999999999999999999997542 234568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
.+.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999998654 5789999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
....... ......|++.|+|||++.+..|+.+
T Consensus 165 ~~~~~~~------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~k 196 (287)
T d1opja_ 165 MTGDTYT------------------------------------------------AHAGAKFPIKWTAPESLAYNKFSIK 196 (287)
T ss_dssp CCSSSSE------------------------------------------------EETTEEECGGGCCHHHHHHCCCSHH
T ss_pred cCCCCce------------------------------------------------eeccccccccccChHHHcCCCCCch
Confidence 6543211 1113458999999999999999999
Q ss_pred cc-hHHHHHHHhhhcc
Q 019953 316 CD-WLVSVLHFNSYRF 330 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~ 330 (333)
+| ||+||++|+|+++
T Consensus 197 ~DiwS~Gv~l~ell~~ 212 (287)
T d1opja_ 197 SDVWAFGVLLWEIATY 212 (287)
T ss_dssp HHHHHHHHHHHHHHTT
T ss_pred hhhhhHHHHHHHHHhC
Confidence 99 9999999999984
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=343.68 Aligned_cols=197 Identities=28% Similarity=0.503 Sum_probs=176.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhh---hhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVK---RGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 161 (333)
.++|++++.||+|+||+||+|++..+|+.||||++....... ....+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999999999999999997543221 12356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC----cEEEEeccCcccCC
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG----HMKLSDFGLCKPLD 237 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~----~vkl~DFGla~~~~ 237 (333)
|+|||||++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|..+.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999998888999999999999999999999999999999999999998776 59999999998765
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
.... ..+..||+.|+|||++.+..++.++|
T Consensus 169 ~~~~--------------------------------------------------~~~~~~t~~y~APE~~~~~~~~~~~D 198 (293)
T d1jksa_ 169 FGNE--------------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEAD 198 (293)
T ss_dssp TSCB--------------------------------------------------CSCCCCCGGGCCHHHHTTCCBCTHHH
T ss_pred CCcc--------------------------------------------------ccccCCCCcccCHHHHcCCCCCCccc
Confidence 4321 11457999999999999999999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 199 iwSlGvilyell~g~ 213 (293)
T d1jksa_ 199 MWSIGVITYILLSGA 213 (293)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred chhhhHHHHHHHcCC
Confidence 99999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=345.12 Aligned_cols=197 Identities=36% Similarity=0.647 Sum_probs=176.9
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHH-HhcCCceeEEEEEEeeCCeEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLA-EVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
++|++++.||+|+||+||+|.+..+|+.||||++++...........+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999998765555555666667777665 68999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
||||++|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--- 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--- 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc---
Confidence 99999999999999888999999999999999999999999999999999999999999999999999986543221
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
.....+||+.|+|||++.+.+|+.++| ||+||+
T Consensus 159 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 192 (320)
T d1xjda_ 159 ----------------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 192 (320)
T ss_dssp ----------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred ----------------------------------------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHH
Confidence 111457999999999999999999999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+|+.
T Consensus 193 lyemltG~ 200 (320)
T d1xjda_ 193 LYEMLIGQ 200 (320)
T ss_dssp HHHHHHSS
T ss_pred HHHHHhCC
Confidence 99999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=336.77 Aligned_cols=193 Identities=24% Similarity=0.418 Sum_probs=168.9
Q ss_pred CCc-eEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee----CCe
Q 019953 86 DDF-ELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----TEY 160 (333)
Q Consensus 86 ~~y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 160 (333)
++| ++.+.||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 345 788899999999999999999999999999876543 23345668899999999999999999999865 456
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecccCCCcEEEc-cCCcEEEEeccCcccCC
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLD-KNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~Nill~-~~~~vkl~DFGla~~~~ 237 (333)
+|+|||||++|+|.+++.....+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 8999999999999999988889999999999999999999999998 99999999999997 57899999999997543
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
... ..+.+||+.|||||++.+ +|+.++|
T Consensus 167 ~~~---------------------------------------------------~~~~~GT~~Y~aPE~~~~-~~~~~~D 194 (270)
T d1t4ha_ 167 ASF---------------------------------------------------AKAVIGTPEFMAPEMYEE-KYDESVD 194 (270)
T ss_dssp TTS---------------------------------------------------BEESCSSCCCCCGGGGGT-CCCTHHH
T ss_pred CCc---------------------------------------------------cCCcccCccccCHHHhCC-CCCCcCc
Confidence 221 225689999999999875 5999999
Q ss_pred -hHHHHHHHhhhccc
Q 019953 318 -WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 -ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 195 IwSlGvilyel~~g~ 209 (270)
T d1t4ha_ 195 VYAFGMCMLEMATSE 209 (270)
T ss_dssp HHHHHHHHHHHHHSS
T ss_pred hhhHHHHHHHHHHCC
Confidence 99999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-47 Score=350.56 Aligned_cols=194 Identities=28% Similarity=0.534 Sum_probs=173.8
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||+||+|.+..+|+.||||++...... ....+.+|+.+|+.++||||++++++|.+++.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999998765322 234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEc--cCCcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--KNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~--~~~~vkl~DFGla~~~~~~~~ 241 (333)
||||+||+|.+++... .++++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999999999887654 4799999999999999999999999999999999999998 578999999999998754321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
..+..||+.|+|||++.+.+|+.++| ||+
T Consensus 185 --------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 214 (352)
T d1koba_ 185 --------------------------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAI 214 (352)
T ss_dssp --------------------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred --------------------------------------------------eeeccCcccccCHHHHcCCCCCCccchHHH
Confidence 12457999999999999999999999 999
Q ss_pred HHHHHhhhccc
Q 019953 321 SVLHFNSYRFL 331 (333)
Q Consensus 321 g~il~~l~t~~ 331 (333)
||++|+|+|+.
T Consensus 215 GvilyelltG~ 225 (352)
T d1koba_ 215 GVLGYVLLSGL 225 (352)
T ss_dssp HHHHHHHHHSC
T ss_pred HHHHHHHHhCC
Confidence 99999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.8e-47 Score=337.23 Aligned_cols=201 Identities=24% Similarity=0.364 Sum_probs=171.2
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC----e
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----Y 160 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 160 (333)
.++|++.+.||+|+||+||+|.+..+|+.||||+++............+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 578999999999999999999999999999999998765544555667899999999999999999999987643 4
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCc
Q 019953 161 LYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~ 240 (333)
+|+|||||+|++|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999888899999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
.. .....+.+||+.|||||++.+.+|+.++| ||
T Consensus 166 ~~----------------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwS 199 (277)
T d1o6ya_ 166 NS----------------------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199 (277)
T ss_dssp -----------------------------------------------------------TTCCHHHHTTCCCCHHHHHHH
T ss_pred cc----------------------------------------------ccccccccCcccccCHHHHcCCCCCcceeccc
Confidence 11 11122568999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+|+.
T Consensus 200 lGvilyelltG~ 211 (277)
T d1o6ya_ 200 LGCVLYEVLTGE 211 (277)
T ss_dssp HHHHHHHHHHSS
T ss_pred chHHHHHHHhCC
Confidence 999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=337.75 Aligned_cols=200 Identities=19% Similarity=0.234 Sum_probs=167.4
Q ss_pred hccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 80 RHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 80 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
.|++..++|++.+.||+|+||+||+|++. ..||||+++.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 57888899999999999999999999753 3599999975432 2345677889999999999999999999875 45
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+|||++.++.+||+|||+|+....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 689999999999999999754 5799999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC---CCCCcc
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK---KGYGME 315 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~ 315 (333)
.... ....+..||+.|||||++.+ .+|+.+
T Consensus 157 ~~~~-----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ 189 (276)
T d1uwha_ 157 WSGS-----------------------------------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189 (276)
T ss_dssp --------------------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHH
T ss_pred cCCc-----------------------------------------------ccccccccCcccCCHHHHhcccCCCCCch
Confidence 2211 11124579999999999975 358999
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| ||+||++|+|+|+.
T Consensus 190 sDiwS~Gv~l~el~tg~ 206 (276)
T d1uwha_ 190 SDVYAFGIVLYELMTGQ 206 (276)
T ss_dssp HHHHHHHHHHHHHHHSS
T ss_pred hhhhhhHHHHHHHHHCC
Confidence 99 99999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=331.53 Aligned_cols=195 Identities=21% Similarity=0.317 Sum_probs=162.4
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEE
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 162 (333)
+..++|++++.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+.+++.++||||+++++++..++.++
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 34578999999999999999999875 577899999976432 2356888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcc
Q 019953 163 LIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~ 241 (333)
+|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999998664 5688999999999999999999999999999999999999999999999999987643321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
. ......||+.|+|||++.+..|+.++| ||+
T Consensus 157 ~------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~ 188 (263)
T d1sm2a_ 157 T------------------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188 (263)
T ss_dssp --------------------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHH
T ss_pred e------------------------------------------------eecceecCcccCChHHhcCCCCCchhhhcch
Confidence 1 111346999999999999999999999 999
Q ss_pred HHHHHhhhcc
Q 019953 321 SVLHFNSYRF 330 (333)
Q Consensus 321 g~il~~l~t~ 330 (333)
||++|+|+|+
T Consensus 189 Gvil~el~t~ 198 (263)
T d1sm2a_ 189 GVLMWEVFSE 198 (263)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHHHC
Confidence 9999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=341.29 Aligned_cols=202 Identities=23% Similarity=0.374 Sum_probs=171.7
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCc-----eEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGN-----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 152 (333)
..|++..++|++++.||+|+||+||+|.+..+++ .||+|.+..... ......+.+|+.++..+ +|||||+++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 4567888899999999999999999999876554 699999865432 23345678899999998 899999999
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRED-----------------------TLTENVARFYIAQSVLAIESIHKHNYIH 209 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH 209 (333)
+++.+.+.+++|||||++|+|.+++.... .+++..+..++.|++.||.|||+++|||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 99999999999999999999999996542 4788999999999999999999999999
Q ss_pred cccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhh
Q 019953 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (333)
Q Consensus 210 rDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
|||||+|||++.++.+||+|||+|+........
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~----------------------------------------------- 220 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNY----------------------------------------------- 220 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-----------------------------------------------
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCce-----------------------------------------------
Confidence 999999999999999999999999865433211
Q ss_pred ccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc
Q 019953 290 KLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR 329 (333)
Q Consensus 290 ~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t 329 (333)
....+..||+.|||||++.+..|+.++| ||+||++|+|+|
T Consensus 221 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt 261 (325)
T d1rjba_ 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261 (325)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence 1112446899999999999999999999 999999999997
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=334.13 Aligned_cols=198 Identities=25% Similarity=0.392 Sum_probs=172.1
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
+.|++..++|++++.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.+++.++|||||++++++.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 567788899999999999999999999974 67889999997543 233568899999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
+.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 5679999999999999977543 36999999999999999999999999999999999999999999999999999977
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
...... ......||+.|||||++.+..++.++
T Consensus 160 ~~~~~~------------------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~s 191 (272)
T d1qpca_ 160 EDNEYT------------------------------------------------AREGAKFPIKWTAPEAINYGTFTIKS 191 (272)
T ss_dssp SSSCEE------------------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHH
T ss_pred cCCccc------------------------------------------------cccccCCcccccChHHHhCCCCCchh
Confidence 543321 11134689999999999999999999
Q ss_pred c-hHHHHHHHhhhcc
Q 019953 317 D-WLVSVLHFNSYRF 330 (333)
Q Consensus 317 D-ws~g~il~~l~t~ 330 (333)
| ||+||++|+|+|+
T Consensus 192 DvwS~Gvvl~ellt~ 206 (272)
T d1qpca_ 192 DVWSFGILLTEIVTH 206 (272)
T ss_dssp HHHHHHHHHHHHHTT
T ss_pred hhhhhHHHHHHHHhC
Confidence 9 9999999999984
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.9e-46 Score=328.86 Aligned_cols=197 Identities=30% Similarity=0.522 Sum_probs=174.7
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh------hhhhHHHHHHHHHHHHHhc-CCceeEEEEEEee
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV------KRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD 157 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 157 (333)
.++|++.+.||+|+||+||+|++..+|+.||||++...... .....+.+.+|+.+++.+. ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999999999999999998764321 1223456788999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
++.+|+|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC------CC
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK------KG 311 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~ 311 (333)
.... ....+||+.|+|||++.+ ..
T Consensus 162 ~~~~--------------------------------------------------~~~~~gt~~y~~PE~~~~~~~~~~~~ 191 (277)
T d1phka_ 162 PGEK--------------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPG 191 (277)
T ss_dssp TTCC--------------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCC
T ss_pred CCCc--------------------------------------------------eeeeeccCCCCCHHHhhccccccCCC
Confidence 4321 114579999999999863 45
Q ss_pred CCcccc-hHHHHHHHhhhccc
Q 019953 312 YGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 312 ~~~~~D-ws~g~il~~l~t~~ 331 (333)
++.++| ||+||++|+|+++.
T Consensus 192 ~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 192 YGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp BCTHHHHHHHHHHHHHHHHSS
T ss_pred CCchheEcccchhhhhhccCC
Confidence 789999 99999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=337.35 Aligned_cols=194 Identities=26% Similarity=0.409 Sum_probs=173.6
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 164 (333)
.++|++++.||+|+||+||+|.+..+|+.||||+++.... ....+.+|+.+|+.++||||++++++|.+++.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999976532 224477899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC--CcEEEEeccCcccCCCCcc
Q 019953 165 MEYLPGGDMMTLLMRED-TLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN--GHMKLSDFGLCKPLDCSTL 241 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~--~~vkl~DFGla~~~~~~~~ 241 (333)
||||+||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999999997655 79999999999999999999999999999999999999854 4899999999987653321
Q ss_pred cccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHH
Q 019953 242 YAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLV 320 (333)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~ 320 (333)
..+.+||+.|+|||++.+..|+.++| ||+
T Consensus 160 --------------------------------------------------~~~~~~t~~y~ape~~~~~~~~~~~DiWSl 189 (321)
T d1tkia_ 160 --------------------------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp --------------------------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred --------------------------------------------------ccccccccccccchhccCCCCCchhhcccH
Confidence 12457999999999999999999999 999
Q ss_pred HHHHHhhhcccc
Q 019953 321 SVLHFNSYRFLE 332 (333)
Q Consensus 321 g~il~~l~t~~~ 332 (333)
||++|+|+++..
T Consensus 190 Gvily~ll~G~~ 201 (321)
T d1tkia_ 190 GTLVYVLLSGIN 201 (321)
T ss_dssp HHHHHHHHHSSC
T ss_pred HHHHHHHHhCCC
Confidence 999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-46 Score=336.82 Aligned_cols=202 Identities=22% Similarity=0.333 Sum_probs=161.4
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCCc---eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSGN---IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT 158 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 158 (333)
++..++|++.+.||+|+||+||+|.+..+++ .||||.+..... ....+.+.+|+.+|+.++|||||++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4566789999999999999999999876664 589998865422 23445688999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
+.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988764 479999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
...... .........||+.|||||++.+..|+.++|
T Consensus 180 ~~~~~~--------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sD 215 (299)
T d1jpaa_ 180 DDTSDP--------------------------------------------TYTSALGGKIPIRWTAPEAIQYRKFTSASD 215 (299)
T ss_dssp ------------------------------------------------------------CGGGSCHHHHHSCCCCHHHH
T ss_pred CCCCcc--------------------------------------------eeeecccccCCccccCHHHHhcCCCCcccc
Confidence 432110 000111345899999999999999999999
Q ss_pred -hHHHHHHHhhhc
Q 019953 318 -WLVSVLHFNSYR 329 (333)
Q Consensus 318 -ws~g~il~~l~t 329 (333)
||+||++|+|+|
T Consensus 216 vwS~Gvvl~el~t 228 (299)
T d1jpaa_ 216 VWSYGIVMWEVMS 228 (299)
T ss_dssp HHHHHHHHHHHHT
T ss_pred cccchHHHHHHHh
Confidence 999999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=336.27 Aligned_cols=189 Identities=30% Similarity=0.496 Sum_probs=164.8
Q ss_pred CCCceEee-eEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEee----C
Q 019953 85 VDDFELLT-IIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD----T 158 (333)
Q Consensus 85 ~~~y~~~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~ 158 (333)
.++|+++. .||+|+||+||+|.+..+++.||||++.... .+.+|+.++.++ +||||++++++|.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 56899875 5999999999999999999999999986532 355688887655 89999999999875 4
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CCcEEEEeccCc
Q 019953 159 EYLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLC 233 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~~vkl~DFGla 233 (333)
..+|+|||||+||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6799999999999999999764 46999999999999999999999999999999999999985 457999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCC
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYG 313 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 313 (333)
+....... ..+.+||+.|||||++.+..|+
T Consensus 162 ~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~y~ 191 (335)
T d2ozaa1 162 KETTSHNS--------------------------------------------------LTTPCYTPYYVAPEVLGPEKYD 191 (335)
T ss_dssp EECCCCCC--------------------------------------------------CCCCSCCCSSCCCCCCCGGGGS
T ss_pred eeccCCCc--------------------------------------------------cccccCCcccCCcHHHcCCCCC
Confidence 87653321 1145799999999999999999
Q ss_pred cccc-hHHHHHHHhhhccc
Q 019953 314 MECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 314 ~~~D-ws~g~il~~l~t~~ 331 (333)
.++| ||+||++|+|+|+.
T Consensus 192 ~~~DiwSlGvily~lltg~ 210 (335)
T d2ozaa1 192 KSCDMWSLGVIMYILLCGY 210 (335)
T ss_dssp HHHHHHHHHHHHHHHTTSS
T ss_pred HHHHHHhhchhHHHHhhCC
Confidence 9999 99999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=334.32 Aligned_cols=194 Identities=30% Similarity=0.467 Sum_probs=164.6
Q ss_pred EeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhh--hhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEec
Q 019953 90 LLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKR--GQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEY 167 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (333)
.++.||+|+||+||+|.+..+|+.||||+++....... .....+.+|+.+++.++|||||++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46899999999999999999999999999976532211 1224578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccc
Q 019953 168 LPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEH 247 (333)
Q Consensus 168 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~ 247 (333)
|.++++..+......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~------ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR------ 155 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC------
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc------
Confidence 98888777776677899999999999999999999999999999999999999999999999999986643221
Q ss_pred cccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHHHHH
Q 019953 248 KTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSVLHF 325 (333)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~il~ 325 (333)
...+.+||+.|+|||++.+ ..|+.++| ||+||++|
T Consensus 156 -------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 192 (299)
T d1ua2a_ 156 -------------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 192 (299)
T ss_dssp -------------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHH
T ss_pred -------------------------------------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHH
Confidence 1114579999999999875 46899999 99999999
Q ss_pred hhhcccc
Q 019953 326 NSYRFLE 332 (333)
Q Consensus 326 ~l~t~~~ 332 (333)
+|+|+.+
T Consensus 193 el~~g~~ 199 (299)
T d1ua2a_ 193 ELLLRVP 199 (299)
T ss_dssp HHHHSSC
T ss_pred HHHhCcC
Confidence 9999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=327.42 Aligned_cols=201 Identities=22% Similarity=0.314 Sum_probs=165.7
Q ss_pred cccCCCceEeeeEeeecceEEEEEEEecCC----ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 82 KICVDDFELLTIIGRGAFGEVRLCREKKSG----NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 82 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
++..++|++.+.||+|+||.||+|.+..++ ..||||++..... ......+.+|+.+++.++|||||++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 566788999999999999999999887654 4699999865432 2334568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.+.+++|||||.++++.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999999888654 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
....... .......||+.|||||++.+..++.++
T Consensus 161 ~~~~~~~----------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~s 194 (283)
T d1mqba_ 161 EDDPEAT----------------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSAS 194 (283)
T ss_dssp -----------------------------------------------------------CCCGGGSCHHHHHSCCCCHHH
T ss_pred cCCCccc----------------------------------------------eEeccCCCCccccCHHHHccCCCCCcc
Confidence 5432110 011134689999999999999999999
Q ss_pred c-hHHHHHHHhhhcc
Q 019953 317 D-WLVSVLHFNSYRF 330 (333)
Q Consensus 317 D-ws~g~il~~l~t~ 330 (333)
| ||+||++|+|+++
T Consensus 195 DI~S~Gvil~el~t~ 209 (283)
T d1mqba_ 195 DVWSFGIVMWEVMTY 209 (283)
T ss_dssp HHHHHHHHHHHHHTT
T ss_pred cccccHHHHHHHHhC
Confidence 9 9999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=327.75 Aligned_cols=198 Identities=25% Similarity=0.394 Sum_probs=168.0
Q ss_pred ccCCCceEeee-EeeecceEEEEEEEec--CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC
Q 019953 83 ICVDDFELLTI-IGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE 159 (333)
Q Consensus 83 ~~~~~y~~~~~-lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 159 (333)
+..++|.+.+. ||+|+||+||+|.+.. ++..||||+++... .....+.+.+|+.+|+.++|||||++++++.. +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 44567888885 9999999999998754 45579999987543 23345678899999999999999999999865 4
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
.+|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 68999999999999999765 45799999999999999999999999999999999999999999999999999997754
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
..... .......||+.|+|||++.+..++.++|
T Consensus 162 ~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV 195 (285)
T d1u59a_ 162 DDSYY----------------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDV 195 (285)
T ss_dssp CSCEE----------------------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHH
T ss_pred ccccc----------------------------------------------ccccccccCccccChHHHhCCCCCccchh
Confidence 33211 0111346899999999999999999999
Q ss_pred hHHHHHHHhhhc
Q 019953 318 WLVSVLHFNSYR 329 (333)
Q Consensus 318 ws~g~il~~l~t 329 (333)
||+||++|+|+|
T Consensus 196 wS~Gv~l~E~lt 207 (285)
T d1u59a_ 196 WSYGVTMWEALS 207 (285)
T ss_dssp HHHHHHHHHHHT
T ss_pred hcchHHHHHHHh
Confidence 999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=326.56 Aligned_cols=190 Identities=24% Similarity=0.356 Sum_probs=161.7
Q ss_pred eeEeeecceEEEEEEEec--CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEEeccC
Q 019953 92 TIIGRGAFGEVRLCREKK--SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIMEYLP 169 (333)
Q Consensus 92 ~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (333)
++||+|+||+||+|.+.. +++.||||+++... ......+.+.+|+.+|++++|||||++++++.. +..++|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 479999999999998653 45789999997543 234455678999999999999999999999865 45789999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccc
Q 019953 170 GGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKT 249 (333)
Q Consensus 170 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 249 (333)
+|+|.+++.....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------ 164 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence 99999999998999999999999999999999999999999999999999999999999999998765432211
Q ss_pred cCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhh
Q 019953 250 IDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSY 328 (333)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~ 328 (333)
.......||+.|||||++.+..++.++| ||+||++|+|+
T Consensus 165 ----------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell 204 (277)
T d1xbba_ 165 ----------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204 (277)
T ss_dssp ----------------------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence 1111346899999999999999999999 99999999999
Q ss_pred c
Q 019953 329 R 329 (333)
Q Consensus 329 t 329 (333)
|
T Consensus 205 t 205 (277)
T d1xbba_ 205 S 205 (277)
T ss_dssp T
T ss_pred h
Confidence 7
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=326.91 Aligned_cols=196 Identities=27% Similarity=0.398 Sum_probs=168.7
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhh---hHHHHHHHHHHHHHhc--CCceeEEEEEEeeCC
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRG---QVEHVRAERNLLAEVA--SHCIVKLYYSFQDTE 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 159 (333)
.++|++.+.||+|+||+||+|++..+|+.||||++......... ....+.+|+.+++.++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999999999999999999765322111 1122557999999997 899999999999999
Q ss_pred eEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccC-CcEEEEeccCcccCC
Q 019953 160 YLYLIMEYLPG-GDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKN-GHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~-~~vkl~DFGla~~~~ 237 (333)
..++||||+.+ +++.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999975 6888888888899999999999999999999999999999999999999854 799999999998654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCC-Cccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGY-GMEC 316 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~~ 316 (333)
... ..+.+||+.|+|||++.+..+ +.++
T Consensus 163 ~~~---------------------------------------------------~~~~~GT~~y~aPE~~~~~~~~~~~~ 191 (273)
T d1xwsa_ 163 DTV---------------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSA 191 (273)
T ss_dssp SSC---------------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHH
T ss_pred ccc---------------------------------------------------ccccccCCCcCCHHHHcCCCCCCccc
Confidence 221 114579999999999987765 6789
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| ||+||++|+|+|+.
T Consensus 192 DiwSlGvilyell~g~ 207 (273)
T d1xwsa_ 192 AVWSLGILLYDMVCGD 207 (273)
T ss_dssp HHHHHHHHHHHHHHSS
T ss_pred ccccceeeehhHhhCC
Confidence 9 99999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=320.13 Aligned_cols=194 Identities=22% Similarity=0.400 Sum_probs=170.8
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 163 (333)
..++|+++++||+|+||+||+|++ .+++.||||+++.... ..+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 357899999999999999999997 4788999999976532 23568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccc
Q 019953 164 IMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLY 242 (333)
Q Consensus 164 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~ 242 (333)
||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999998755 457899999999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHH
Q 019953 243 AIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVS 321 (333)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g 321 (333)
......||+.|+|||++.+..++.++| ||+|
T Consensus 157 ------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G 188 (258)
T d1k2pa_ 157 ------------------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 188 (258)
T ss_dssp ------------------------------------------------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred ------------------------------------------------eecccCCCCCcCCcHHhcCCCCCcceeecccc
Confidence 011346899999999999999999999 9999
Q ss_pred HHHHhhhcc
Q 019953 322 VLHFNSYRF 330 (333)
Q Consensus 322 ~il~~l~t~ 330 (333)
|++|+|+|+
T Consensus 189 ~~l~el~t~ 197 (258)
T d1k2pa_ 189 VLMWEIYSL 197 (258)
T ss_dssp HHHHHHHTT
T ss_pred hhhHhHHhc
Confidence 999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=321.63 Aligned_cols=198 Identities=25% Similarity=0.343 Sum_probs=160.9
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecC---CceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKS---GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
|++..++|++.+.||+|+||.||+|.+..+ +..||||.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 567788999999999999999999988654 3568999886542 2334566889999999999999999999986
Q ss_pred CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
++.+++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+.+
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 4678999999999999998765 457999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
...... ......||+.|+|||++.+..|+.++
T Consensus 159 ~~~~~~------------------------------------------------~~~~~~gt~~y~apE~l~~~~~~~~~ 190 (273)
T d1mp8a_ 159 EDSTYY------------------------------------------------KASKGKLPIKWMAPESINFRRFTSAS 190 (273)
T ss_dssp ------------------------------------------------------------CCGGGCCHHHHHHCCCSHHH
T ss_pred cCCcce------------------------------------------------eccceecCcccchhhHhccCCCCCcc
Confidence 432211 11134689999999999999999999
Q ss_pred c-hHHHHHHHhhhc
Q 019953 317 D-WLVSVLHFNSYR 329 (333)
Q Consensus 317 D-ws~g~il~~l~t 329 (333)
| ||+||++|+|+|
T Consensus 191 DiwSlGvil~e~lt 204 (273)
T d1mp8a_ 191 DVWMFGVCMWEILM 204 (273)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred ccccchHHHHHHHh
Confidence 9 999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=324.85 Aligned_cols=204 Identities=25% Similarity=0.360 Sum_probs=162.5
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 152 (333)
.+|++..++|++++.||+|+||.||+|.+.. +++.||||+++.... ......+..|..++.++ +|+||+.++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 5667778899999999999999999999754 346899999875432 23345567788888777 577999999
Q ss_pred EEEeeC-CeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCC
Q 019953 153 YSFQDT-EYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPD 215 (333)
Q Consensus 153 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 215 (333)
+++..+ ..+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 887654 4689999999999999999653 24889999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhcccccc
Q 019953 216 NLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFST 295 (333)
Q Consensus 216 Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (333)
|||++.++.+||+|||+|+........ ....+.
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~-----------------------------------------------~~~~~~ 196 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDY-----------------------------------------------VRKGDA 196 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTS-----------------------------------------------CCTTSC
T ss_pred ceeECCCCcEEEccCcchhhccccccc-----------------------------------------------cccCce
Confidence 999999999999999999876433211 111245
Q ss_pred CCCCCCcccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 296 VGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 296 ~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
+||+.|||||++.+..++.++| ||+||++|+|+|+.
T Consensus 197 ~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp CCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred eeCccccchhHhhcCCCCcccceeehHHHHHHHHhCC
Confidence 7999999999999999999999 99999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=323.34 Aligned_cols=199 Identities=24% Similarity=0.372 Sum_probs=167.2
Q ss_pred hhhccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee
Q 019953 78 LKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 157 (333)
Q Consensus 78 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 157 (333)
...|++..++|++.+.||+|+||+||+|.+..+ ..||||++..... ..+.+.+|+.+++.++|||||++++++.+
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 356788889999999999999999999998644 5799999975432 23568899999999999999999999854
Q ss_pred CCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMR--EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
+.+++|||||++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence 567899999999999988854 35799999999999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcc
Q 019953 236 LDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGME 315 (333)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 315 (333)
+..+... ......||+.|+|||++.+..++.+
T Consensus 163 ~~~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k 194 (285)
T d1fmka3 163 IEDNEYT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIK 194 (285)
T ss_dssp -------------------------------------------------------------CCGGGSCHHHHHHCCCCHH
T ss_pred ccCCCce------------------------------------------------eeccccccccccChHHHhCCCCCcH
Confidence 6533211 1113469999999999999999999
Q ss_pred cc-hHHHHHHHhhhcc
Q 019953 316 CD-WLVSVLHFNSYRF 330 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~ 330 (333)
+| ||+||++|+|+++
T Consensus 195 sDI~S~Giil~el~t~ 210 (285)
T d1fmka3 195 SDVWSFGILLTELTTK 210 (285)
T ss_dssp HHHHHHHHHHHHHHTT
T ss_pred HhhhcchHHHHHHHhC
Confidence 99 9999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=322.90 Aligned_cols=195 Identities=29% Similarity=0.466 Sum_probs=165.4
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||+||+|.+..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 689999999999999999999999999999999976532 2233466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-h-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccc
Q 019953 166 EYLPGGDMMTLLM-R-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYA 243 (333)
Q Consensus 166 e~~~~g~L~~~l~-~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~ 243 (333)
||+.++ +.+++. . ...+++..++.++.|++.||.|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 81 e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-- 157 (298)
T d1gz8a_ 81 EFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 157 (298)
T ss_dssp ECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--
T ss_pred eecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc--
Confidence 999654 444443 3 45699999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-CCcccc-hHHH
Q 019953 244 IHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECD-WLVS 321 (333)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~D-ws~g 321 (333)
.....+||+.|+|||++.... ++.++| ||+|
T Consensus 158 -----------------------------------------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlG 190 (298)
T d1gz8a_ 158 -----------------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190 (298)
T ss_dssp -----------------------------------------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHH
T ss_pred -----------------------------------------------cceeecccceeeehhhhccccCCCccccccccc
Confidence 112447999999999988766 488999 9999
Q ss_pred HHHHhhhccc
Q 019953 322 VLHFNSYRFL 331 (333)
Q Consensus 322 ~il~~l~t~~ 331 (333)
|++|+|+++.
T Consensus 191 vily~m~~G~ 200 (298)
T d1gz8a_ 191 CIFAEMVTRR 200 (298)
T ss_dssp HHHHHHHHSS
T ss_pred hhhhHHhhCC
Confidence 9999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-44 Score=324.03 Aligned_cols=203 Identities=24% Similarity=0.373 Sum_probs=174.2
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 153 (333)
..+++..++|++++.||+|+||+||+|++. .++..||||++..... ......+.+|+.+++.++||||+++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCccccee
Confidence 346677889999999999999999999875 3567899999975432 234566889999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMRED------------------------TLTENVARFYIAQSVLAIESIHKHNYIH 209 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH 209 (333)
++...+..++||||+++|+|.+++.... .++...+..++.|++.||.|||+++|||
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 9999999999999999999999986432 3788899999999999999999999999
Q ss_pred cccCCCcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhh
Q 019953 210 RDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRR 289 (333)
Q Consensus 210 rDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
|||||+|||++.++.+||+|||+|+........
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~----------------------------------------------- 196 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYY----------------------------------------------- 196 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-----------------------------------------------
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccc-----------------------------------------------
Confidence 999999999999999999999999866433211
Q ss_pred ccccccCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 290 KLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 290 ~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
....+..|++.|+|||++.+..||.++| ||+||++|+|+++
T Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 1112457899999999999999999999 9999999999887
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=323.63 Aligned_cols=196 Identities=22% Similarity=0.344 Sum_probs=162.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCc----eEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGN----IYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
.++|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+++.++|||||++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3579999999999999999999987776 57888876432 233456788999999999999999999999865 5
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+++|+++.+|+|.+.+... ..+++..+..++.|++.||.|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 67888999999999887664 57999999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... ......||+.|||||++.+..|+.++| |
T Consensus 165 ~~~~-----------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvw 197 (317)
T d1xkka_ 165 EKEY-----------------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVW 197 (317)
T ss_dssp CC-------------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHH
T ss_pred cccc-----------------------------------------------cccccccCccccChHHHhcCCCChhhhhh
Confidence 2110 111346899999999999999999999 9
Q ss_pred HHHHHHHhhhcc
Q 019953 319 LVSVLHFNSYRF 330 (333)
Q Consensus 319 s~g~il~~l~t~ 330 (333)
|+||++|+|+|+
T Consensus 198 S~Gvil~el~t~ 209 (317)
T d1xkka_ 198 SYGVTVWELMTF 209 (317)
T ss_dssp HHHHHHHHHHTT
T ss_pred hHHHHHHHHHHC
Confidence 999999999983
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-44 Score=315.00 Aligned_cols=191 Identities=26% Similarity=0.472 Sum_probs=162.0
Q ss_pred ccccCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-CC
Q 019953 81 HKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-TE 159 (333)
Q Consensus 81 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 159 (333)
|++..++|++++.||+|+||.||+|.+ .|..||||+++... ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 678889999999999999999999987 47899999997542 33558889999999999999999998854 45
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE--DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 689999999999999999654 358999999999999999999999999999999999999999999999999998654
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD 317 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D 317 (333)
... ....+++.|+|||++.+..++.++|
T Consensus 155 ~~~----------------------------------------------------~~~~~~~~y~aPE~l~~~~~t~~sD 182 (262)
T d1byga_ 155 STQ----------------------------------------------------DTGKLPVKWTAPEALREKKFSTKSD 182 (262)
T ss_dssp -----------------------------------------------------------CCTTTSCHHHHHHCCCCHHHH
T ss_pred CCC----------------------------------------------------ccccccccCCChHHHhCCCCChHHH
Confidence 221 1335889999999999999999999
Q ss_pred -hHHHHHHHhhhcc
Q 019953 318 -WLVSVLHFNSYRF 330 (333)
Q Consensus 318 -ws~g~il~~l~t~ 330 (333)
||+||++|+|+|+
T Consensus 183 IwSfG~il~el~t~ 196 (262)
T d1byga_ 183 VWSFGILLWEIYSF 196 (262)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHhHHHHHHHHHHC
Confidence 9999999999983
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=318.75 Aligned_cols=196 Identities=28% Similarity=0.411 Sum_probs=162.1
Q ss_pred CCCceEeeeEeeecceEEEEEEEecC-CceEEEEecchhHHhhhhhHHHHHHHHHHHHHh---cCCceeEEEEEEee---
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKS-GNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQD--- 157 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~--- 157 (333)
.++|++++.||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999765 6779999987543221 1222355677777666 79999999999853
Q ss_pred --CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcc
Q 019953 158 --TEYLYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCK 234 (333)
Q Consensus 158 --~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~ 234 (333)
...++++|||+.++++...... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3478999999988766544433 4579999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCc
Q 019953 235 PLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGM 314 (333)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ 314 (333)
...... .....+||+.|+|||++.+.+|+.
T Consensus 165 ~~~~~~--------------------------------------------------~~~~~~gT~~Y~APE~~~~~~y~~ 194 (305)
T d1blxa_ 165 IYSFQM--------------------------------------------------ALTSVVVTLWYRAPEVLLQSSYAT 194 (305)
T ss_dssp CCCGGG--------------------------------------------------GGCCCCCCCTTCCHHHHTTCCCCT
T ss_pred hhcccc--------------------------------------------------cCCCcccChhhcCcchhcCCCCCh
Confidence 654222 112457999999999999999999
Q ss_pred ccc-hHHHHHHHhhhccc
Q 019953 315 ECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 315 ~~D-ws~g~il~~l~t~~ 331 (333)
++| ||+||++|+|+++.
T Consensus 195 ~~DiwSlG~il~ell~g~ 212 (305)
T d1blxa_ 195 PVDLWSVGCIFAEMFRRK 212 (305)
T ss_dssp HHHHHHHHHHHHHHHHSS
T ss_pred hehhhchHHHHHHHHHCC
Confidence 999 99999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=317.62 Aligned_cols=203 Identities=25% Similarity=0.405 Sum_probs=170.0
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEecCC-------ceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKKSG-------NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVK 150 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 150 (333)
+.|.+..++|++++.||+|+||.||+|++..++ ..||||+++.... ......+.+|...+..+ +||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 557888899999999999999999999876554 4799999976432 23345677888888888 8999999
Q ss_pred EEEEEeeCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCC
Q 019953 151 LYYSFQDTEYLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (333)
Q Consensus 151 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 214 (333)
+++++.+++.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 999999999999999999999999999644 3589999999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccc
Q 019953 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (333)
Q Consensus 215 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (333)
+|||++.++.+||+|||+++........ .....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~ 196 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYY-----------------------------------------------KKTTN 196 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTT-----------------------------------------------CCCTT
T ss_pred cceeecCCCCeEeccchhhccccccccc-----------------------------------------------ccccc
Confidence 9999999999999999999876543211 11124
Q ss_pred cCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 295 TVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 295 ~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
..|++.|+|||++.++.|+.++| ||+||++|+|+++
T Consensus 197 ~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp SCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 57899999999999999999999 9999999999973
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=318.17 Aligned_cols=205 Identities=23% Similarity=0.317 Sum_probs=177.0
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEe-----cCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREK-----KSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLY 152 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 152 (333)
..|++..++|++.+.||+|+||.||+|.+. .+++.||||+++.... ......+.+|+.+++.+ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 467788899999999999999999999863 4567899999976432 23445688899999999 699999999
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecccCC
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMRED------------------TLTENVARFYIAQSVLAIESIHKHNYIHRDIKP 214 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 214 (333)
+++.....+++|||||++|+|.+++.... .+++..+..++.|++.||.|||++++|||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 99999999999999999999999986543 588999999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccc
Q 019953 215 DNLLLDKNGHMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFS 294 (333)
Q Consensus 215 ~Nill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (333)
+||+++.++.+||+|||+++......... ....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~-----------------------------------------------~~~~ 206 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYV-----------------------------------------------VKGN 206 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSE-----------------------------------------------ECSS
T ss_pred ccccccccCcccccccchheeccCCCcce-----------------------------------------------Eeee
Confidence 99999999999999999998765432211 1124
Q ss_pred cCCCCCCcccccccCCCCCcccc-hHHHHHHHhhhc-ccc
Q 019953 295 TVGTPDYIAPEVLLKKGYGMECD-WLVSVLHFNSYR-FLE 332 (333)
Q Consensus 295 ~~gt~~y~APE~~~~~~~~~~~D-ws~g~il~~l~t-~~~ 332 (333)
.+||+.|+|||++.+..++.++| ||+||++|+|+| +.+
T Consensus 207 ~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp SEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence 57999999999999999999999 999999999998 443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-43 Score=315.02 Aligned_cols=195 Identities=28% Similarity=0.434 Sum_probs=168.1
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||+||+|++. +|+.||||++..... .......+.+|+.+|+.++||||+++++++..++..+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 68999999999999999999985 789999999976533 2334566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
|++.++.+..+....+.+++..+..++.|++.||.|||++|||||||||+|||++.++.+||+|||++.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--- 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--- 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc---
Confidence 99988777777777788999999999999999999999999999999999999999999999999999876433211
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~D-ws~g~i 323 (333)
.....|++.|+|||++.+ ..++.++| ||+||+
T Consensus 157 ----------------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~ 190 (286)
T d1ob3a_ 157 ----------------------------------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190 (286)
T ss_dssp ---------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred ----------------------------------------------cceecccchhhhHHHHhCCCCCCcceeehhcCcH
Confidence 114469999999999976 45799999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 191 l~el~~G~ 198 (286)
T d1ob3a_ 191 FAEMVNGT 198 (286)
T ss_dssp HHHHHHSS
T ss_pred HHHHHHCC
Confidence 99999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=319.53 Aligned_cols=197 Identities=25% Similarity=0.423 Sum_probs=167.7
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEecCCce--EEEEecchhHHhhhhhHHHHHHHHHHHHHh-cCCceeEEEEEEeeCC
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREKKSGNI--YAMKKLKKSEMVKRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDTE 159 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 159 (333)
+..++|++.+.||+|+||+||+|.+..+|.. ||||.+..... ....+.+.+|+.+|..+ +||||+++++++.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4567999999999999999999999888764 67777654322 23345688999999998 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMRE----------------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998643 5689999999999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
.+||+|||+++....... .....||+.|+|
T Consensus 165 ~~kl~DfG~a~~~~~~~~--------------------------------------------------~~~~~gt~~y~a 194 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK--------------------------------------------------KTMGRLPVRWMA 194 (309)
T ss_dssp CEEECCTTCEESSCEECC--------------------------------------------------C----CCTTTCC
T ss_pred ceEEcccccccccccccc--------------------------------------------------ccceecCCcccc
Confidence 999999999986543221 113468999999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
||++.+..|+.++| ||+||++|+|+++.
T Consensus 195 PE~l~~~~~~~~sDvwSfGvil~ell~~~ 223 (309)
T d1fvra_ 195 IESLNYSVYTTNSDVWSYGVLLWEIVSLG 223 (309)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred hHHhccCCCCccceeehhHHHHHHHHhcC
Confidence 99999999999999 99999999999853
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=317.83 Aligned_cols=202 Identities=26% Similarity=0.360 Sum_probs=167.2
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-------
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------- 157 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 157 (333)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5789999999999999999999999999999999876543 23344567889999999999999999998854
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 158 -TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 158 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.+.+|+|||||.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999987777666666678999999999999999999999999999999999999999999999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGME 315 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~ 315 (333)
....... .....+.+||+.|+|||++.+. .|+.+
T Consensus 168 ~~~~~~~---------------------------------------------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k 202 (318)
T d3blha1 168 SLAKNSQ---------------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPP 202 (318)
T ss_dssp CC--------------------------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTH
T ss_pred ccccccc---------------------------------------------cccccceecCHHHhhHHHHcCCCCCCcH
Confidence 5332110 0112245799999999999865 78999
Q ss_pred cc-hHHHHHHHhhhcccc
Q 019953 316 CD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~~ 332 (333)
+| ||+||++|+|+++..
T Consensus 203 ~DiwSlGvil~el~~g~~ 220 (318)
T d3blha1 203 IDLWGAGCIMAEMWTRSP 220 (318)
T ss_dssp HHHHHHHHHHHHHHHSSC
T ss_pred HHcccCCceeeeHhhCCC
Confidence 99 999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=313.91 Aligned_cols=200 Identities=23% Similarity=0.361 Sum_probs=159.9
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecC-C--ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCe
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKS-G--NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEY 160 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~-~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 160 (333)
..++|++++.||+|+||+||+|++..+ + ..||||++...........+.+.+|+.+|+.++||||+++++++.+ +.
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 346799999999999999999986533 3 3689999987655555566778999999999999999999999975 46
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 161 LYLIMEYLPGGDMMTLLMR-EDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.++|||||++|++.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 7899999999999988765 457999999999999999999999999999999999999999999999999999987544
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-h
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-W 318 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-w 318 (333)
.... .......|++.|+|||++.+..++.++| |
T Consensus 165 ~~~~----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 198 (273)
T d1u46a_ 165 DDHY----------------------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTW 198 (273)
T ss_dssp CCEE----------------------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHH
T ss_pred CCcc----------------------------------------------eecCccccCcccCCHHHHhCCCCCcchhhh
Confidence 3211 1111346888999999999999999999 9
Q ss_pred HHHHHHHhhhcc
Q 019953 319 LVSVLHFNSYRF 330 (333)
Q Consensus 319 s~g~il~~l~t~ 330 (333)
|+||++|+|+|+
T Consensus 199 S~Gvil~emlt~ 210 (273)
T d1u46a_ 199 MFGVTLWEMFTY 210 (273)
T ss_dssp HHHHHHHHHHTT
T ss_pred hhHHHHHHHHhC
Confidence 999999999983
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-42 Score=309.17 Aligned_cols=200 Identities=21% Similarity=0.225 Sum_probs=169.2
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcC-CceeEEEEEEeeCCeEE
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDTEYLY 162 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 162 (333)
..++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.+.| +|++.+++++......+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 35789999999999999999999999999999999865432 1235678899999976 79999999999999999
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc-----CCcEEEEeccCcccC
Q 019953 163 LIMEYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK-----NGHMKLSDFGLCKPL 236 (333)
Q Consensus 163 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~-----~~~vkl~DFGla~~~ 236 (333)
+||||+ +++|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 78999988764 47999999999999999999999999999999999999974 568999999999986
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCccc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMEC 316 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~ 316 (333)
......... ......+.+||+.|||||++.+.+++.++
T Consensus 157 ~~~~~~~~~------------------------------------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~ 194 (293)
T d1csna_ 157 RDPVTKQHI------------------------------------------PYREKKNLSGTARYMSINTHLGREQSRRD 194 (293)
T ss_dssp BCTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHH
T ss_pred ccCccccce------------------------------------------eecccCceEEchhhcCHHHhcCCCCChHH
Confidence 543211100 00112256899999999999999999999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| ||+||++|+|+|+.
T Consensus 195 DiwSlG~~l~elltg~ 210 (293)
T d1csna_ 195 DLEALGHVFMYFLRGS 210 (293)
T ss_dssp HHHHHHHHHHHHHHSS
T ss_pred HHHHhhHHHHHHHhCC
Confidence 9 99999999999854
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=316.92 Aligned_cols=189 Identities=29% Similarity=0.430 Sum_probs=159.8
Q ss_pred CceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee------CCe
Q 019953 87 DFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------TEY 160 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 160 (333)
+|+.+++||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999975431 12359999999999999999999853 336
Q ss_pred EEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-cEEEEeccCcccC
Q 019953 161 LYLIMEYLPGGDMMTL---LMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPL 236 (333)
Q Consensus 161 ~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~ 236 (333)
+++|||||+++.+..+ ......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999976643333 23456799999999999999999999999999999999999999775 8999999999876
Q ss_pred CCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCcc
Q 019953 237 DCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGME 315 (333)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~ 315 (333)
..... ..+.+|++.|+|||++.+ ..|+.+
T Consensus 174 ~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (350)
T d1q5ka_ 174 VRGEP--------------------------------------------------NVSYICSRYYRAPELIFGATDYTSS 203 (350)
T ss_dssp CTTSC--------------------------------------------------CCSCCSCTTSCCHHHHTTCSSCCTH
T ss_pred cCCcc--------------------------------------------------cccccccccccChHHhhcccCCCcc
Confidence 43321 124579999999999875 578999
Q ss_pred cc-hHHHHHHHhhhcccc
Q 019953 316 CD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~~ 332 (333)
+| ||+||++|+|+++.+
T Consensus 204 ~DIwSlG~il~el~~g~~ 221 (350)
T d1q5ka_ 204 IDVWSAGCVLAELLLGQP 221 (350)
T ss_dssp HHHHHHHHHHHHHHHTSC
T ss_pred eeecccceEEEehhhCCC
Confidence 99 999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-43 Score=314.32 Aligned_cols=203 Identities=17% Similarity=0.288 Sum_probs=175.3
Q ss_pred hhccccCCCceEeeeEeeecceEEEEEEEec-----CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEE
Q 019953 79 KRHKICVDDFELLTIIGRGAFGEVRLCREKK-----SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYY 153 (333)
Q Consensus 79 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 153 (333)
+.|++..++|++.+.||+|+||.||+|.+.. ++..||||+++... .......+.+|+.+++.++||||+++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 4578888999999999999999999998753 35789999997543 2234456889999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC
Q 019953 154 SFQDTEYLYLIMEYLPGGDMMTLLMRE----------DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG 223 (333)
Q Consensus 154 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~ 223 (333)
++...+..++|||||++|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 999999999999999999999988542 2468889999999999999999999999999999999999999
Q ss_pred cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcc
Q 019953 224 HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIA 303 (333)
Q Consensus 224 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~A 303 (333)
++||+|||+++.+...... .......||+.|+|
T Consensus 171 ~~Kl~DFGla~~~~~~~~~-----------------------------------------------~~~~~~~~t~~y~a 203 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYY-----------------------------------------------RKGGKGLLPVRWMS 203 (308)
T ss_dssp CEEECCTTCCCGGGGGGCE-----------------------------------------------EGGGSSEECGGGCC
T ss_pred eEEEeecccceeccCCcce-----------------------------------------------eeccceecccccCC
Confidence 9999999999876433211 11123468999999
Q ss_pred cccccCCCCCcccc-hHHHHHHHhhhcc
Q 019953 304 PEVLLKKGYGMECD-WLVSVLHFNSYRF 330 (333)
Q Consensus 304 PE~~~~~~~~~~~D-ws~g~il~~l~t~ 330 (333)
||.+.+..++.++| ||+|+++|+|+|+
T Consensus 204 Pe~l~~~~~~~~~Dv~S~G~il~El~t~ 231 (308)
T d1p4oa_ 204 PESLKDGVFTTYSDVWSFGVVLWEIATL 231 (308)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHccCCCCcccccccHHHHHHHHHhC
Confidence 99999999999999 9999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=318.15 Aligned_cols=193 Identities=28% Similarity=0.436 Sum_probs=162.4
Q ss_pred cCCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC----
Q 019953 84 CVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE---- 159 (333)
Q Consensus 84 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 159 (333)
..++|++++.||+|+||+||+|.+..+|+.||||+++.... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 35799999999999999999999999999999999975432 3344567889999999999999999999997654
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 160 --YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 160 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
.+|+||||| +.+|..+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 667777664 4579999999999999999999999999999999999999999999999999998754
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccC-CCCCccc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK-KGYGMEC 316 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~~ 316 (333)
... ...+||+.|+|||++.+ ..++.++
T Consensus 173 ~~~----------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~ 200 (346)
T d1cm8a_ 173 SEM----------------------------------------------------TGYVVTRWYRAPEVILNWMRYTQTV 200 (346)
T ss_dssp SSC----------------------------------------------------CSSCSCGGGCCTHHHHTTTCCCTTH
T ss_pred Ccc----------------------------------------------------ccccccccccCHHHHcCCCCCCccc
Confidence 321 14479999999999987 4579999
Q ss_pred c-hHHHHHHHhhhccc
Q 019953 317 D-WLVSVLHFNSYRFL 331 (333)
Q Consensus 317 D-ws~g~il~~l~t~~ 331 (333)
| ||+||++|+|+++.
T Consensus 201 DiwSlGvil~ell~g~ 216 (346)
T d1cm8a_ 201 DIWSVGCIMAEMITGK 216 (346)
T ss_dssp HHHHHHHHHHHHHHSS
T ss_pred hhhcchHHHHHHHHCc
Confidence 9 99999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=307.03 Aligned_cols=196 Identities=25% Similarity=0.402 Sum_probs=174.3
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCCeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTEYLYLIM 165 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (333)
++|++++.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.+....++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 689999999999999999999999999999999976532 3345677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCcccccc
Q 019953 166 EYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAIH 245 (333)
Q Consensus 166 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~~ 245 (333)
+++.++++..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||.++........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--- 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--- 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC---
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc---
Confidence 99999999998888889999999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-CCcccc-hHHHHH
Q 019953 246 EHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECD-WLVSVL 323 (333)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~D-ws~g~i 323 (333)
.....+++.|+|||++.+.. ++.++| ||+||+
T Consensus 158 ----------------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~i 191 (292)
T d1unla_ 158 ----------------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191 (292)
T ss_dssp ----------------------------------------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred ----------------------------------------------ceeeccccchhhhhHhccCCCCCchhhccccchH
Confidence 11335788999999998765 699999 999999
Q ss_pred HHhhhccc
Q 019953 324 HFNSYRFL 331 (333)
Q Consensus 324 l~~l~t~~ 331 (333)
+|+|+++.
T Consensus 192 l~ell~g~ 199 (292)
T d1unla_ 192 FAELANAG 199 (292)
T ss_dssp HHHHTTTS
T ss_pred HHHHhhCC
Confidence 99999853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=315.54 Aligned_cols=197 Identities=27% Similarity=0.417 Sum_probs=163.4
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC-----
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----- 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 159 (333)
.++|++++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 367999999999999999999999999999999997543 2334556888999999999999999999986543
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
.+|++|+ +.+|+|.+++.. ..+++..++.++.|++.||.|||++|||||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~l~~~-~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 85 DVYLVTH-LMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CEEEEEE-CCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEe-ecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 3556555 558999999965 46999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCccccccc-CCCCCcccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLL-KKGYGMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~~D- 317 (333)
.... ......+||+.|+|||++. +..++.++|
T Consensus 163 ~~~~----------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~Di 196 (345)
T d1pmea_ 163 HDHT----------------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDI 196 (345)
T ss_dssp GCBC----------------------------------------------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHH
T ss_pred Cccc----------------------------------------------eeeccccccceechHHHhhcCCCCCchhhh
Confidence 2110 1112457999999999985 456899999
Q ss_pred hHHHHHHHhhhccc
Q 019953 318 WLVSVLHFNSYRFL 331 (333)
Q Consensus 318 ws~g~il~~l~t~~ 331 (333)
||+||++|+|+++.
T Consensus 197 wSlG~il~eml~g~ 210 (345)
T d1pmea_ 197 WSVGCILAEMLSNR 210 (345)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred hccCceehHHhhCC
Confidence 99999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.8e-42 Score=312.51 Aligned_cols=188 Identities=24% Similarity=0.393 Sum_probs=163.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEee--CCeE
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD--TEYL 161 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~ 161 (333)
.++|++++.||+|+||+||+|++..+|+.||||+++... ...+.+|+.+|+.+. ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999987542 245778999999995 9999999999874 4569
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCC-cEEEEeccCcccCCCCc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNG-HMKLSDFGLCKPLDCST 240 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~-~vkl~DFGla~~~~~~~ 240 (333)
++|||||.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999999987664 5699999999999999999999999999999999999998655 69999999998765332
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC-CCCcccc-h
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK-GYGMECD-W 318 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~~D-w 318 (333)
. ....+||+.|+|||++.+. .++.++| |
T Consensus 185 ~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 214 (328)
T d3bqca1 185 E--------------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMW 214 (328)
T ss_dssp C--------------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHH
T ss_pred c--------------------------------------------------ccccccCccccCcccccCCCCCCcccchh
Confidence 1 1145799999999998875 5899999 9
Q ss_pred HHHHHHHhhhccc
Q 019953 319 LVSVLHFNSYRFL 331 (333)
Q Consensus 319 s~g~il~~l~t~~ 331 (333)
|+||++|+|+++.
T Consensus 215 slG~~l~e~~~g~ 227 (328)
T d3bqca1 215 SLGCMLASMIFRK 227 (328)
T ss_dssp HHHHHHHHHHHTC
T ss_pred hhhhhhHHhccCC
Confidence 9999999998874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-41 Score=304.99 Aligned_cols=198 Identities=22% Similarity=0.275 Sum_probs=162.5
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCc-eeEEEEEEeeCCeEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 164 (333)
++|++++.||+|+||.||+|.+..+|+.||||++...... ..+..|+.+++.++|++ |+.+..++......++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5799999999999999999999999999999998754321 23667999999998776 55555667788899999
Q ss_pred EeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEcc---CCcEEEEeccCcccCCCCc
Q 019953 165 MEYLPGGDMMTLLM-REDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDK---NGHMKLSDFGLCKPLDCST 240 (333)
Q Consensus 165 ~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~---~~~vkl~DFGla~~~~~~~ 240 (333)
|||+ ++++...+. ....+++..+..++.|++.||.|||++||+||||||+|||++. +..++|+|||+|+.+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 556665554 4568999999999999999999999999999999999999863 4579999999999875433
Q ss_pred ccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hH
Q 019953 241 LYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WL 319 (333)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws 319 (333)
..... ......+.+||+.|||||++.+.+++.++| ||
T Consensus 161 ~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 198 (299)
T d1ckia_ 161 THQHI------------------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLES 198 (299)
T ss_dssp TCCBC------------------------------------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHH
T ss_pred cccce------------------------------------------eccccCCcCCCccccCHHHHhCCCCCChhhEEe
Confidence 21100 001122567999999999999999999999 99
Q ss_pred HHHHHHhhhccc
Q 019953 320 VSVLHFNSYRFL 331 (333)
Q Consensus 320 ~g~il~~l~t~~ 331 (333)
+||++|+|+|+.
T Consensus 199 lG~~l~el~tg~ 210 (299)
T d1ckia_ 199 LGYVLMYFNLGS 210 (299)
T ss_dssp HHHHHHHHHHSS
T ss_pred cCHHHHHHHhCC
Confidence 999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=313.11 Aligned_cols=201 Identities=39% Similarity=0.689 Sum_probs=171.5
Q ss_pred ccCCCceEeeeEeeecceEEEEEEEe---cCCceEEEEecchhHHh-hhhhHHHHHHHHHHHHHhcC-CceeEEEEEEee
Q 019953 83 ICVDDFELLTIIGRGAFGEVRLCREK---KSGNIYAMKKLKKSEMV-KRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQD 157 (333)
Q Consensus 83 ~~~~~y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~ 157 (333)
+..++|++++.||+|+||+||+|.+. .+|+.||||+++..... .....+.+.+|+.++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 34578999999999999999999874 46899999998654321 11223446779999999987 799999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCC
Q 019953 158 TEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLD 237 (333)
Q Consensus 158 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~ 237 (333)
...+++||||+.+|+|.+++.....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCC--CCCcc
Q 019953 238 CSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKK--GYGME 315 (333)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~ 315 (333)
..... ...+..|++.|+|||++.+. .++.+
T Consensus 181 ~~~~~------------------------------------------------~~~~~~g~~~~~~pe~~~~~~~~~~~k 212 (322)
T d1vzoa_ 181 ADETE------------------------------------------------RAYDFCGTIEYMAPDIVRGGDSGHDKA 212 (322)
T ss_dssp GGGGG------------------------------------------------GGCGGGSCCTTCCHHHHTTCC---CTH
T ss_pred ccccc------------------------------------------------cccccccccccchhHHhhcCCcCCCch
Confidence 43211 11245799999999999764 47889
Q ss_pred cc-hHHHHHHHhhhccc
Q 019953 316 CD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 316 ~D-ws~g~il~~l~t~~ 331 (333)
+| ||+||++|+|+++.
T Consensus 213 sDIWSlG~iLyelltG~ 229 (322)
T d1vzoa_ 213 VDWWSLGVLMYELLTGA 229 (322)
T ss_dssp HHHHHHHHHHHHHHHSS
T ss_pred hhhHHHHHHHHHHHhCC
Confidence 99 99999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=304.16 Aligned_cols=194 Identities=20% Similarity=0.285 Sum_probs=163.0
Q ss_pred EeeeEeeecceEEEEEEEecCC---ceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee-CCeEEEEE
Q 019953 90 LLTIIGRGAFGEVRLCREKKSG---NIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-TEYLYLIM 165 (333)
Q Consensus 90 ~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 165 (333)
+.++||+|+||+||+|.+..++ ..||||.++... .......+.+|+.+|++++||||+++++++.. ++..++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999986543 368999986432 33445678999999999999999999998765 56899999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCCccccc
Q 019953 166 EYLPGGDMMTLLMRE-DTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSTLYAI 244 (333)
Q Consensus 166 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~~~~~~ 244 (333)
|||++|+|.+++... ..++...+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~- 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS- 187 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC-
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc-
Confidence 999999999988754 467788899999999999999999999999999999999999999999999999765433211
Q ss_pred ccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-hHHHHH
Q 019953 245 HEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD-WLVSVL 323 (333)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D-ws~g~i 323 (333)
........||+.|+|||++.+..++.++| ||+|++
T Consensus 188 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGiv 223 (311)
T d1r0pa_ 188 --------------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 223 (311)
T ss_dssp --------------------------------------------TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred --------------------------------------------ceecccccccccccChHHHhcCCCCChhHhhhhHHH
Confidence 00111346899999999999999999999 999999
Q ss_pred HHhhhcc
Q 019953 324 HFNSYRF 330 (333)
Q Consensus 324 l~~l~t~ 330 (333)
+|+|+|+
T Consensus 224 l~El~t~ 230 (311)
T d1r0pa_ 224 LWELMTR 230 (311)
T ss_dssp HHHHHTT
T ss_pred HHHHHHC
Confidence 9999983
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=307.79 Aligned_cols=195 Identities=25% Similarity=0.289 Sum_probs=158.4
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeCC----eE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDTE----YL 161 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~ 161 (333)
.+|.+.+.||+|+||.||+|++ +|+.||||++...... ......|+..+..++||||+++++++...+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4688999999999999999985 5899999998654321 111233555556789999999999987653 68
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEecccCCCcEEEccCCcEEEEeccCc
Q 019953 162 YLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHK--------HNYIHRDIKPDNLLLDKNGHMKLSDFGLC 233 (333)
Q Consensus 162 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~--------~~ivHrDlkp~Nill~~~~~vkl~DFGla 233 (333)
|+|||||++|+|.+++.+. .+++.....++.|++.||.|||+ +|||||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999764 68899999999999999999996 59999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC--
Q 019953 234 KPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-- 311 (333)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-- 311 (333)
+......... .......+||+.|+|||++.+..
T Consensus 156 ~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (303)
T d1vjya_ 156 VRHDSATDTI---------------------------------------------DIAPNHRVGTKRYMAPEVLDDSINM 190 (303)
T ss_dssp EEEETTTTEE---------------------------------------------CC----CCSCGGGCCHHHHTTCSCT
T ss_pred ccccCCCcce---------------------------------------------eccccceecccCcCChhhccccccc
Confidence 9775433211 00112457999999999997643
Q ss_pred ----CCcccc-hHHHHHHHhhhcccc
Q 019953 312 ----YGMECD-WLVSVLHFNSYRFLE 332 (333)
Q Consensus 312 ----~~~~~D-ws~g~il~~l~t~~~ 332 (333)
++.++| ||+||++|+|+|+.+
T Consensus 191 ~~~~~~~k~Di~S~Gvvl~el~tg~~ 216 (303)
T d1vjya_ 191 KHFESFKRADIYAMGLVFWEIARRCS 216 (303)
T ss_dssp TCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred cCCCcCcchhhhhhHHHHHHHhhCCC
Confidence 677999 999999999999754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=311.82 Aligned_cols=194 Identities=27% Similarity=0.405 Sum_probs=158.6
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEee------C
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------T 158 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 158 (333)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3689999999999999999999999999999999976532 23445668899999999999999999999963 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCC
Q 019953 159 EYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDC 238 (333)
Q Consensus 159 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~ 238 (333)
..+|+|||||.++ +.+.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||+++....
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 6899999999654 44444 35689999999999999999999999999999999999999999999999999886543
Q ss_pred CcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCCCCcccc-
Q 019953 239 STLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECD- 317 (333)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~~D- 317 (333)
... ....+||+.|+|||++.+..++.++|
T Consensus 172 ~~~--------------------------------------------------~~~~~~t~~y~aPE~l~~~~~~~~~Di 201 (355)
T d2b1pa1 172 SFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDI 201 (355)
T ss_dssp -----------------------------------------------------------CCTTCCHHHHTTCCCCTTHHH
T ss_pred ccc--------------------------------------------------cccccccccccChhhhcCCCCCCCccc
Confidence 221 11447999999999999999999999
Q ss_pred hHHHHHHHhhhcccc
Q 019953 318 WLVSVLHFNSYRFLE 332 (333)
Q Consensus 318 ws~g~il~~l~t~~~ 332 (333)
||+||++|+|+++..
T Consensus 202 wSlG~~l~ell~g~~ 216 (355)
T d2b1pa1 202 WSVGCIMGEMVRHKI 216 (355)
T ss_dssp HHHHHHHHHHHHSSC
T ss_pred ccccchHHHHhhCCC
Confidence 999999999998754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=309.02 Aligned_cols=194 Identities=27% Similarity=0.391 Sum_probs=162.3
Q ss_pred CCCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCceeEEEEEEeeC-----C
Q 019953 85 VDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIVKLYYSFQDT-----E 159 (333)
Q Consensus 85 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 159 (333)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4789999999999999999999999999999999976432 233445678899999999999999999998633 2
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccCcccCCCC
Q 019953 160 YLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCS 239 (333)
Q Consensus 160 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGla~~~~~~ 239 (333)
..+++|+++.+|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||++......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 34556667779999998854 57999999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCcccccccCCC-CCcccc-
Q 019953 240 TLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLKKG-YGMECD- 317 (333)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~~D- 317 (333)
. .+..|++.|+|||++.+.. ++.++|
T Consensus 175 ~----------------------------------------------------~~~~g~~~y~apE~~~~~~~~~~~~Di 202 (348)
T d2gfsa1 175 M----------------------------------------------------TGYVATRWYRAPEIMLNWMHYNQTVDI 202 (348)
T ss_dssp G----------------------------------------------------SSSCHHHHTSCHHHHTTCSCCCTTHHH
T ss_pred c----------------------------------------------------ccccccccccCchhhcCCccCCcccch
Confidence 1 1457999999999987754 689999
Q ss_pred hHHHHHHHhhhcccc
Q 019953 318 WLVSVLHFNSYRFLE 332 (333)
Q Consensus 318 ws~g~il~~l~t~~~ 332 (333)
||+||++|+|+++..
T Consensus 203 wSlGv~l~~ll~g~~ 217 (348)
T d2gfsa1 203 WSVGCIMAELLTGRT 217 (348)
T ss_dssp HHHHHHHHHHHHSSC
T ss_pred hhhhHHHHHHHhCCC
Confidence 999999999998753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-35 Score=271.50 Aligned_cols=190 Identities=25% Similarity=0.405 Sum_probs=154.4
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-----------CCceeEEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-----------SHCIVKLYYS 154 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~ 154 (333)
++|++++.||+|+||+||+|++..+|+.||||+++.... ..+.+.+|+.+++.+. |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 569999999999999999999999999999999986532 2244667888887775 5789999888
Q ss_pred Eee--CCeEEEEEeccCCCC-HHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecccCCCcEEEccCC-----
Q 019953 155 FQD--TEYLYLIMEYLPGGD-MMTLL--MREDTLTENVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDKNG----- 223 (333)
Q Consensus 155 ~~~--~~~~~lv~e~~~~g~-L~~~l--~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~Nill~~~~----- 223 (333)
+.. ....+++|+++..+. ..... .....+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 456667776654433 22222 234578999999999999999999998 8999999999999998765
Q ss_pred -cEEEEeccCcccCCCCcccccccccccCccccCCCCCCCCCCCCCCCCCCCCCchHHhHHHHhhhhccccccCCCCCCc
Q 019953 224 -HMKLSDFGLCKPLDCSTLYAIHEHKTIDDENMAEPMDIDGCFPDTDNKSSWKSPHEQLQHWQMNRRKLAFSTVGTPDYI 302 (333)
Q Consensus 224 -~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 302 (333)
.++++|||.+....... ...+||+.|+
T Consensus 169 ~~~kl~dfg~s~~~~~~~----------------------------------------------------~~~~gt~~y~ 196 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----------------------------------------------------TNSIQTREYR 196 (362)
T ss_dssp EEEEECCCTTCEETTBCC----------------------------------------------------CSCCSCGGGC
T ss_pred ceeeEeeccccccccccc----------------------------------------------------cccccccccc
Confidence 39999999988654221 1457999999
Q ss_pred ccccccCCCCCcccc-hHHHHHHHhhhccc
Q 019953 303 APEVLLKKGYGMECD-WLVSVLHFNSYRFL 331 (333)
Q Consensus 303 APE~~~~~~~~~~~D-ws~g~il~~l~t~~ 331 (333)
|||++.+..|+.++| ||+||++++|+++.
T Consensus 197 aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226 (362)
T ss_dssp CHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ChhhccccCCCccccccchHHHHHHHHHCC
Confidence 999999999999999 99999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.5e-26 Score=192.00 Aligned_cols=137 Identities=14% Similarity=0.154 Sum_probs=106.6
Q ss_pred ceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHh---------------hhhhHHHHHHHHHHHHHhcCCceeEEE
Q 019953 88 FELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV---------------KRGQVEHVRAERNLLAEVASHCIVKLY 152 (333)
Q Consensus 88 y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~~ 152 (333)
+.+.++||+|+||+||+|.+ .+|+.||||+++..... ..........|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45789999999999999987 47899999987542110 111223455688899999999999887
Q ss_pred EEEeeCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEecccCCCcEEEccCCcEEEEeccC
Q 019953 153 YSFQDTEYLYLIMEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGL 232 (333)
Q Consensus 153 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~Nill~~~~~vkl~DFGl 232 (333)
+... .+++|||+++..+.. ++...+..++.|++.+|.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 279999998765433 3444567789999999999999999999999999999865 589999999
Q ss_pred cccCC
Q 019953 233 CKPLD 237 (333)
Q Consensus 233 a~~~~ 237 (333)
|....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 97654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=1.7e-07 Score=79.60 Aligned_cols=141 Identities=12% Similarity=0.068 Sum_probs=91.7
Q ss_pred CCceEeeeEeeecceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhc-CCceeEEEEEEeeCCeEEEE
Q 019953 86 DDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDTEYLYLI 164 (333)
Q Consensus 86 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 164 (333)
..|++.+..+.++.+.||+.. .++..+.+|+........ ...+.+|...+..+. +-.+++++.+...++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 356777765555567899764 456778889876543222 223566888888774 33467788888888899999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 019953 165 MEYLPGGDMMTLLMREDTLTENVARFYIAQSVLAIESIH----------------------------------------- 203 (333)
Q Consensus 165 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~LH----------------------------------------- 203 (333)
|++++|.++........ . ...++.++...+..||
T Consensus 89 ~~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccccc--c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 99999877754432111 1 1111222222222232
Q ss_pred ------------hC------CcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 204 ------------KH------NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 204 ------------~~------~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.. .++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 11 2699999999999987777789999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=5e-06 Score=69.84 Aligned_cols=136 Identities=12% Similarity=0.104 Sum_probs=81.1
Q ss_pred Eeeec-ceEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCC--ceeEEEEEEeeCCeEEEEEeccCC
Q 019953 94 IGRGA-FGEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASH--CIVKLYYSFQDTEYLYLIMEYLPG 170 (333)
Q Consensus 94 lg~G~-~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~ 170 (333)
+..|. -+.||+... ..+..+.+|....... ..+..|...++.+... .+++++....+++..++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 33444 367898763 4566788897654421 2255678888777544 356777777788889999999987
Q ss_pred CCHHH--------------HHHh-C------CCC--CHHHHHHHH--------------------HHHHHHHHHHHhC--
Q 019953 171 GDMMT--------------LLMR-E------DTL--TENVARFYI--------------------AQSVLAIESIHKH-- 205 (333)
Q Consensus 171 g~L~~--------------~l~~-~------~~~--~~~~~~~~~--------------------~qi~~~L~~LH~~-- 205 (333)
.++.. .+.. + ..+ .......-. ......+..+...
T Consensus 91 ~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (255)
T d1nd4a_ 91 QDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP 170 (255)
T ss_dssp EETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred cccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCC
Confidence 54422 1100 0 000 000000000 0011122333322
Q ss_pred -----CcEecccCCCcEEEccCCcEEEEeccCcccC
Q 019953 206 -----NYIHRDIKPDNLLLDKNGHMKLSDFGLCKPL 236 (333)
Q Consensus 206 -----~ivHrDlkp~Nill~~~~~vkl~DFGla~~~ 236 (333)
.++|+|+.|.|||++.+..+-|+||+.+...
T Consensus 171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 2799999999999998777789999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.15 E-value=2.3e-06 Score=77.27 Aligned_cols=80 Identities=21% Similarity=0.224 Sum_probs=48.2
Q ss_pred eeeEeeecceEEEEEEEecCCceEEEEecchhHHh----hhhhHHHHHHHHHHHHHhcC---CceeEEEEEEeeCCeEEE
Q 019953 91 LTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMV----KRGQVEHVRAERNLLAEVAS---HCIVKLYYSFQDTEYLYL 163 (333)
Q Consensus 91 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~l 163 (333)
.+.||.|....||++.+..+++.|++|.-...... -+........|...|+.+.. ..+++++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 45689999999999987777889999965432100 01122334557878876632 2466666543 334578
Q ss_pred EEeccCCCC
Q 019953 164 IMEYLPGGD 172 (333)
Q Consensus 164 v~e~~~~g~ 172 (333)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.23 E-value=0.0005 Score=59.68 Aligned_cols=67 Identities=6% Similarity=0.163 Sum_probs=42.2
Q ss_pred eEEEEEEEecCCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCcee--EEE-----EEEeeCCeEEEEEeccCCC
Q 019953 100 GEVRLCREKKSGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCIV--KLY-----YSFQDTEYLYLIMEYLPGG 171 (333)
Q Consensus 100 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv--~~~-----~~~~~~~~~~lv~e~~~~g 171 (333)
-.||++.. .+|..|++|+.+... .....+..|...+..|....+. ... ..+...+..+.++++++|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 47998764 578889999986542 1234466688888777533221 111 1223456788999998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.53 E-value=0.0028 Score=54.25 Aligned_cols=31 Identities=26% Similarity=0.290 Sum_probs=27.9
Q ss_pred CCcEecccCCCcEEEccCCcEEEEeccCccc
Q 019953 205 HNYIHRDIKPDNLLLDKNGHMKLSDFGLCKP 235 (333)
Q Consensus 205 ~~ivHrDlkp~Nill~~~~~vkl~DFGla~~ 235 (333)
.|+||+|+.+.||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999888889999998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.51 E-value=0.0048 Score=54.67 Aligned_cols=75 Identities=23% Similarity=0.344 Sum_probs=47.0
Q ss_pred CceEeeeEeeecceEEEEEEEec-------CCceEEEEecchhHHhhhhhHHHHHHHHHHHHHhcCCce-eEEEEEEeeC
Q 019953 87 DFELLTIIGRGAFGEVRLCREKK-------SGNIYAMKKLKKSEMVKRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDT 158 (333)
Q Consensus 87 ~y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~ 158 (333)
++++ +.|+.|-.-.+|++.... ..+.|.+++..... .. ....+|..+++.+...++ +++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 4444 567767778899887542 23567777764221 11 234568888888854444 466666642
Q ss_pred CeEEEEEeccCCC
Q 019953 159 EYLYLIMEYLPGG 171 (333)
Q Consensus 159 ~~~~lv~e~~~~g 171 (333)
++||||++|.
T Consensus 117 ---g~I~efi~g~ 126 (395)
T d1nw1a_ 117 ---GRLEEYIPSR 126 (395)
T ss_dssp ---EEEECCCCEE
T ss_pred ---ceEEEEeccc
Confidence 6889999864
|